{"bottom_cover_set": ["LAMA3", "PBRM1", "TP53", "MMP9", "ACACB", "TNN", "TGFBR2", "APC", "NMUR2", "IRF5", "PIK3CA", "ATM", "MTOR", "TUBB1", "NRBP1", "GFPT2", "TTN", "FLT4", "KRAS", "NCAM1", "SPTB", "DOCK4", "TBXA2R", "SOX9", "FBN2", "TNRC6A", "COL5A3", "TNXB", "DGKB", "ITPR1", "RXFP3", "EXT1", "SP100", "F8", "BAX", "CTNNA1", "TIAM1", "HGF", "TLN1", "OCA2", "MYC", "EP300", "PLCB3", "SMARCE1", "CHUK", "OR5H15", "OR10J5", "OR5D18", "SCN5A", "CACNA2D3", "PPP2R2B", "RGS20", "DLG2", "NRXN2", "CCDC129", "MME", "PLCB1", "EPHB1", "KCNQ2", "GRIA4", "CACNA1B", "NGFR", "A2M", "COL11A1", "TFAP2B", "SERPINE1", "VWF", "AKT1", "CTNNB1", "STAT1", "PRKCB", "PIK3CD", "MCHR2", "MAPK10", "MAP2K1", "ACTN4", "RRAS", "CDH2", "CLTC", "SLC9A1", "GRM7", "GRM4", "TEK", "BRAF", "RELN", "AKAP9", "ELMO1", "ICAM1", "OCRL", "AR", "SPTBN2", "EPHA2", "PLXNA4", "NRG1", "FLNB", "DYNC2H1", "NLK", "TNRC6B", "TSG101", "CTNND1", "NCOA2", "GP9", "RB1", "SMAD4", "RBP1", "CREBBP", "NFATC1", "PPP2CB", "CAMK2G", "PTK2", "ESR1", "NCOA1", "IQGAP1", "HLA-DRA", "NCOR2", "GFRA1", "HLA-A", "ACTA1", "NOS1", "TRIP6", "CHRNA1", "AGRN", "MAD1L1", "LAMA5", "ITGA1", "SPTBN5", "AKAP13", "NME1", "ALB", "ADCY10", "RYR2", "GATA3", "GRM5", "MYH11", "FLNC", "KDELR1", "CACNA1A", "CXCR3", "CACNB1", "ARHGEF1", "EXOC1", "ANK3", "SLC6A3", "FLNA", "PLXNA2", "COL2A1", "OR1L3", "OR2T27", "OR8D1", "ABCB1", "CACNA1E", "ATP2B3", "ATP2B4", "PYGB", "KCNU1", "KCNQ1", "IFT140", "NPHS1", "KCNB1", "SERPING1", "CTNNA2", "ITGB2", "PIP5K1C", "MKL1", "ERBB4", "PDE1B", "TSHR", "FZD6", "NRXN3", "RYR3", "KIF4B", "POU4F2", "ARFGEF1", "RASAL3", "COL4A2", "COL4A3", "PLXNB3", "COL7A1", "NALCN", "CNTN2", "NOTCH3", "COL6A3", "HCN4", "SNAI1", "SCNN1G", "THBS2", "APOB", "PPARGC1A", "EPN1", "LRP2", "LRRFIP1", "CUX1", "AMPD3", "SYNE1", "ERCC6", "NPR2", "TICAM1", "ARID1A", "RIF1", "CRTC1", "SETD2", "MPO", "PLA2G2E", "AXIN2", "PLB1", "TBK1", "UBE4B", "FURIN", "PTPRK", "USP9X", "DDX54", "PFKP", "KLKB1", "SAFB", "EVC2", "LRFN3", "NOTUM", "DERA", "FASN", "CPS1", "SERPINB1", "CYP17A1", "DPYD", "RDH12", "CYP7B1", "PAX5", "ADCY7", "DSCAM", "FGFR2", "HTR2C", "BRPF3", "NRCAM", "SEMA3A", "TGFB1", "DTX1", "GRP", "OBSL1", "PDK2", "NEFH", "GRIN3B", "KCNJ16", "TCF7L2", "TBP", "SCN3B", "COL3A1", "HOXD4", "LRRK2", "SELP", "TFEC", "OR51S1", "SCN2A", "KCNQ5", "TSC2", "PLCG2", "PAX6", "OR2C1", "PRKACG", "ARHGAP35", "TAS2R16", "OR10A2", "OR2A5", "GP6", "PDE6A", "GMIP", "COL4A4", "NCAPD2", "PKD1L1", "TNFRSF10A", "MUC16", "PYGL", "FBN3", "NID1", "TYK2", "HSP90B1", "MAMLD1", "EPN3", "B3GAT2", "WWC2", "ADAMTS9", "MMP19", "GMPR", "GSTM4", "OR8J3", "RASA2", "UBA6", "GRIA2", "COL9A3", "GOLGB1", "CASQ2", "COL6A5", "GRIN3A", "KCNN3", "OR2L3", "MAPK12", "CHRM2", "NOS3", "COL5A1", "ANKRD1", "TGM2", "COL12A1", "MMP16", "DNAH8", "CD109", "AMPD1", "ANK2", "GAD2", "GNAS", "ADAMTS20", "DICER1", "UNC13B", "CYP2E1", "ENPEP", "HTT", "MAPRE3", "AGTR1", "SYCP2", "PTPRG", "ITK", "FNTA", "FYN", "PRKCI", "GUCY1A2", "PCCA", "UGT2B4", "SLC25A3", "KIF5A", "COL24A1", "PLG", "ADCY8", "OPRM1", "JAK3", "MYH6", "CDK5R1", "GABRA5", "SUPT16H", "ACAN", "IRS2", "TAS2R46", "DAPK1", "MED15", "KCNAB2", "WNK1", "AMPH", "OR56B4", "SYT5", "DIRAS1", "ESR2", "PPP2R5A", "PIK3CG", "B2M", "ADCY6", "ADCY5", "MAP3K11", "OR51A2", "GRIA1", "OR2M4", "CACNA1D", "CACNA1C", "CACNA1S", "VCAN", "KCNJ4", "NR2C2", "DRD5", "ITGAL", "ITGA10", "CTSC", "RGS12", "PREX2", "KCNQ3", "KCNJ11", "C6", "SCN8A", "RYR1", "NFASC", "GALE", "SCRIB", "COL4A5", "PKD1", "STAB2", "PPP2R2C", "NCOA3", "NFATC3", "UBQLN2", "CPSF6", "RARB", "APBA1", "PPFIA3", "PTGS1", "APBA2", "ENTPD2", "C9orf3", "AMPD2", "WLS", "DNMBP", "HIF3A", "MED13", "PER2", "DLAT", "NR5A1", "DBT", "ACAT1", "TBL1XR1", "PDGFRB", "IFNG", "GPC5", "ELANE", "GABBR1", "RBMS1", "REG3A", "ARHGEF11", "LEO1", "MYO9B", "PDLIM5", "IFIH1", "HSD3B1", "ALDH1A3", "F2R", "SMAD2", "SHC1", "PTEN", "EPHA6", "DLG1", "COL18A1", "CACNA1G", "ITPR3", "COG4", "ABCA1", "ITGA8", "PLCZ1", "KIF26A", "DOCK3", "OR10R2", "OR4K2", "ZBTB17", "COL6A2", "KCNS3", "GRIK3", "TUBAL3", "AP1G2", "WRN", "NCOA6", "ALOX12B", "BPTF", "EFCAB6", "NOG", "MYO3A", "GPC3", "PRCP", "USP34", "PDHA2", "LRP1", "COL20A1", "ADAMTS14", "TLL2", "STAT5A", "P4HB", "KIT", "FGA", "LAMB3", "LAMC2", "ANGPT1", "COL4A1", "IL2RG", "VAV2", "DVL3", "VTN", "MOV10", "ALOX15B", "GAK", "BMP1", "GRIP1", "KIF2B", "PTCH1", "CHST6", "UGT1A6", "POFUT2", "ADAMTS13", "RAB8A", "GNS", "IGFALS", "CDON", "CACNA1F", "GATA4", "ADAM9", "PKN1", "INPPL1", "OPRD1", "SEMA4D", "CASP9", "MYO5C", "LRP5", "FZD2", "PROS1", "PDGFA", "ADCY1", "COL25A1", "ADAMTSL1", "UGT3A1", "GABBR2", "MUC17", "CSNK2A1", "ADAMTS3", "MMP11", "AGT", "HDAC5", "NRAS", "MMP2", "INSR", "HSPG2", "FN1", "CFTR", "PPARA", "ATP1B4", "FOXO1", "LCP2", "PRKG2", "TNC", "FOXO4", "NTSR2", "KIF3C", "BDNF", "SMPD1", "OR2T33", "OR52K1", "OR6C4", "OR10K1", "OR5M9", "RXFP2", "PDE4D", "SHB", "EPHA7", "ASAP2", "SPP1", "SCN10A", "TAS1R2", "MUC20", "ZFYVE28", "DOCK2", "GRIK2", "SPAG9", "HIPK2", "NLGN4X", "GABRA1", "MYO6", "ARHGEF10L", "MAGI2", "GALNT1", "KAT2A", "SLC2A8", "RXRA", "POLR3A", "MTMR1", "LNPEP", "CASK", "SMARCA2", "PLA2G6", "PLA2G2C", "PTGS2", "PTPRF", "MYT1", "BACE1", "RLBP1", "ERBB2", "TRAF2", "MAML3", "GRIN2C", "ATP1B3", "ROR1", "SALL4", "ENPP6", "HNF4A", "CYP2D6", "DGAT2", "CISH", "TCEA3", "MUC4", "CACNA1H", "PLA2G4D", "NPW", "SPHK1", "INSL3", "TRPC6", "NEFM", "TGIF1", "CCR5", "ITPR2", "EDNRB", "NOS2", "AP2A2", "MEF2A", "GSK3B", "CIITA", "SIN3A", "KCNJ2", "OR2T6", "MTNR1B", "SCN1B", "COPB1", "FZD7", "CACNA2D4", "EPS15", "RASGRP2", "NUP107", "GRIN2A", "A1BG", "DOCK8", "GLI3", "PCSK1", "ITSN2", "RGSL1", "TRPV1", "NLGN4Y", "C8B", "GABRA6", "RGS10", "CTGF", "CHD9", "TBC1D4", "TUBA8", "TFAP2C", "EPN2", "SOD3", "MED24", "SDC4", "SYT1", "PPP2R3A", "TLE1", "GUCY2D", "NSMAF", "E2F7", "GSTP1", "ADO", "CYP3A7", "CSF2RB", "CSNK1A1L", "GP1BA", "IL18", "ACTR1B", "DOCK10", "SRY", "KRT1", "TERT", "GYS1", "ITGA3", "OR5W2", "SOX2", "PHC2", "EPHB4", "PRKD1", "NECAP2", "RASA1", "EPS15L1", "CES1", "TEX15", "APAF1", "PPP2R3B", "CYP4A11", "NUPL2", "ITGB4", "ERBB3", "ITGA7", "ARID1B", "SNX1", "OAT", "CDX2", "ZFPM1", "JMJD7-PLA2G4B", "STAT3", "NGF", "COL4A6", "GPC1", "PLA2G3", "MED14", "ALDH9A1", "PTPN3", "POLR1A", "BMPR1B", "SULT2B1", "GATAD2A", "HSD3B7", "CYP11A1", "OLA1", "DNAJC6", "APOA4", "HLA-DOA", "RGS14", "C8G", "C9", "LRP6", "PIK3AP1", "SCN1A", "PTGES2", "SDC3", "CCT6B", "HRH4", "ABLIM3", "DOK2", "RIPK1", "AMFR", "GRIK5", "MYBPC2", "SCAI", "GNB3", "SPTBN4", "PF4", "SH3GL1", "MAPK8", "CCR10", "HTR1E", "TACR2", "ITGA4", "ITGA6", "ISLR", "OR13A1", "OR5AC2", "OR6B2", "PICK1", "TRPC5", "WNT1", "ETV5", "KAT6A", "PRKD3", "SCN4A", "COL9A1", "FZD10", "SEC16A", "PPFIA1", "SLC32A1", "SCNN1A", "ENTPD4", "ACOX1", "CPT1A", "NCL", "LGI1", "LRIG1", "DDX17", "GPR156", "CSPG4", "SHC4", "OR5K1", "SYT9", "KL", "ALDH1A1", "CYP2A13", "KRT5", "GLUD2", "CYP11B1", "CYP4A22", "IGF1", "APP", "INSRR", "PIK3C2G", "CHL1", "TRIM45", "SLC8A1", "OR4A15", "OR2M2", "OR2H2", "OR52I2", "OR14I1", "TRAPPC5", "CNTNAP1", "AGFG1", "SETDB1", "USP12", "IL22RA1", "LRP12", "CUBN", "FGF8", "RECK", "DSEL", "ADAMTSL4", "NMT1", "GPC6", "NDUFS2", "TBXAS1", "MC4R", "OR11A1", "OR8K5", "OR5M8", "PAK1", "GRB2", "EGFR", "PPP1CA", "GPC2", "DYNC1I1", "TCF4", "B4GALT1", "ATP1A2", "ENPP3", "POLR3B", "MAGED2", "PTPN11", "ITGB1", "SPTBN1", "ARPC1A", "RASGRF1", "MMP3", "LAMB4", "NOTCH1", "CDK4", "PRKCQ", "WNT5A", "NTRK1", "IL5RA", "GATA2", "KIF4A", "ADAM12", "THBS1", "IRAK2", "SERPINA1", "S1PR2", "HEXB", "ETV1", "OR1J1", "OR51Q1", "OR1L4", "OR5K3", "OR13F1", "OR11H4", "OR1N2", "OR2T8", "CACNB2", "ATP2B2", "CATSPERD", "KCNJ12", "KCNQ4", "FOXA1", "KDM6A", "CYP2B6", "CYP7A1", "GSTM3", "ALDH1B1", "IDO2", "ALPL", "ENPP1", "IBSP", "PASK", "PSMB1", "TNIK", "THADA", "MMP14", "SOAT2", "ACYP2", "GMPS", "IL2RB", "CHEK2", "NOX1", "ABLIM2", "TAAR6", "OR4A5", "OR6C68", "OR10C1", "OR8H2", "OR4N4", "OR10H5", "OR2T35", "TAS1R1", "TAS1R3", "ADAM28", "GPLD1", "CALHM1", "YEATS2", "IBTK", "APEX1", "INHBC", "ABCC3", "NPAS3", "COL15A1", "SLC16A8", "ADAMTS2", "ST3GAL3", "SEMA5B", "ADAMTS16", "ADAMTS5", "SETMAR", "GPR50", "WNT5B", "DTNA", "ALOX5", "WDR5", "XCR1", "VCL", "NAPA", "TFDP1", "MITF", "OS9", "SLC2A4", "DGKQ", "BNIP2", "PPIB", "PAX8", "OR6C75", "NF2", "PGM2L1", "PAK4", "PDYN", "PRKAG1", "TUBA1C", "SH2B3", "ASPN", "RASGRF2", "OR10G2", "HLA-G", "KCNC2", "INHBB", "NRIP1", "ELK1", "GH2", "CYP2U1", "WNT11", "KCNG2", "COL27A1", "BAG4", "EHMT1", "OR4D1", "SLC12A2", "PIK3R2", "MAP3K2", "CX3CL1", "RASAL2", "SIPA1L1", "TCF3", "MED17", "APBB1", "DPP4", "B4GALT2", "UGT2B11", "CYP2A6", "AKR1C3", "GGH", "PHACTR2", "COL22A1", "PLOD2", "OR52M1", "TRAF3", "LONP1", "PRKCG", "SCO2", "HSD17B1", "ADCY3", "RAB5A", "EHHADH", "DGKZ", "DGKI", "MYLK3", "BEGAIN", "C4A", "MAP3K12", "PDIA3", "HPR", "CYP1A2", "GGT5", "UGT1A5", "CYP26A1", "CNDP2", "CEL", "DGAT1", "ALDH2", "CYP46A1", "SLC3A2", "REN", "DCLRE1C", "GEMIN5", "TRIM62", "PDCD1LG2", "PIK3R5", "LRPPRC", "TLE4", "MADD", "TPO", "GSTA4", "PTGDS", "GPX5", "AHCYL1", "COG5", "FUT2", "MUC5B", "GALNTL6", "ACTR8", "GNG4", "VAMP3", "ITGAD", "IKBKB", "SERPINB3", "BCL2L14", "NR5A2", "ATAD5", "WDHD1", "RPS6KB1", "UGT2B15", "ARNTL", "OR52L1", "PLA2G4A", "TRIM26", "ETS1", "NCAM2", "CGN", "KCNH1", "PAPSS1", "ANPEP", "GALNT3", "MMRN1", "PCDH7", "DNAH3", "RXRG", "ADH5", "NT5M", "HIPK1", "HIF1A", "ADAMTSL3", "THBS4", "RAF1", "HADHB", "CYP4F3", "OR1A2", "ADRB2", "CFHR3", "SPRED1", "TAS2R30", "NCAN", "DGKH", "PIK3CB", "OR51B4", "EXOC2", "CP", "LAP3", "OR10AG1", "COASY", "KCND2", "DOK6", "CYP2C8", "HEY1", "MYB", "SNIP1", "ALDH3B2", "HSD17B3", "AWAT2", "FABP6", "TLR4", "MAP2K6", "POLA2", "FADS2", "GGCT", "FZD4", "PAK3", "SHC3", "NMU", "LPAR6", "ZSCAN10", "ACOT12", "GPR132", "SOS1", "SMAD3", "RNF165", "RHEB", "ARF5", "TREM2", "OR2G3", "OR2J3", "PDE4B", "RGS4", "RPS6KA4", "CALCOCO1", "GPX7", "ADAMTS10", "FGF12", "MC3R", "PRKX", "STK11", "NR1H3", "GGT7", "SUCLA2", "KLRD1", "PSMD2", "FUT1", "DNER", "EDN1", "ATP6V1B2", "OR2AK2", "PRKACB", "CTPS2", "ABI2", "EDNRA", "ADAMTS17", "GPC4", "MGP", "OR52K2", "CCKAR", "ITGA5", "OR1C1", "MMP10", "C1S", "ADAM2", "ST8SIA2", "GUCA1A", "AKR1B10", "CREB3L3", "KCNMB2", "SMOX", "B3GNTL1", "KLF5", "BCAN", "PEG10", "MLYCD", "G6PD", "PCOLCE2", "TRAPPC6B", "CYP26B1", "OR2L5", "APOOL", "ENO3", "CYP3A5", "EPHX1", "GOT2", "PHF12", "OR52B2", "EZR", "EXOSC8", "HSPA1L", "SDSL", "CSF2", "MASP2", "UTP3", "CNGA3", "OR51F2", "TFDP2", "CBS", "AK3", "PPP1R3F", "SUCLG1", "MMP15", "SLC7A7", "ADAMTS1", "SORT1", "FGF17", "ADSL", "MAX", "F11", "FMOD", "CNTNAP2", "IL20RA", "B4GALT5", "CYP26C1", "ARSI", "CACNB3", "JAG2", "SLC27A5", "NSF", "IFNA2", "NFATC2", "ARSF", "LIPE", "PSMD3", "PTGES3", "UBFD1", "OR8B8", "RASGRP1", "OR6T1", "PTPN5", "OR5AN1", "OR4D6", "GCLC", "OR5P3", "BGN", "SLCO1B3", "ADAMTS15", "YWHAH", "CTSZ", "BICD2", "CYP2C18", "FGF3", "POLR2G", "APCS", "RDH5", "WNT3A", "P4HA2", "VBP1", "BEX1", "DBH", "GSN", "OR2W1", "PPARG", "RPA3", "CBL", "FTL", "CDC37L1", "PSMA1", "OR1M1", "TFF3", "BLNK", "NR1H2", "LHFPL2", "MAT2A", "CYP2S1", "ECHDC1", "PTGES", "RGS8", "KIF22", "SLC17A7"], "top_cover_set": [["TCGA.A6.2671.01", "Glucuronidation"], ["TCGA.A6.2671.01", "Phase II - Conjugation of compounds"], ["TCGA.A6.2675.01", "Collagen formation"], ["TCGA.A6.2675.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.A6.2675.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.A6.2675.01", "Activation of Matrix Metalloproteinases"], ["TCGA.A6.2675.01", "Collagen chain trimerization"], ["TCGA.A6.2675.01", "Ethanol oxidation"], ["TCGA.A6.2675.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.A6.2675.01", "RA biosynthesis pathway"], ["TCGA.A6.2675.01", "Scavenging by Class A Receptors"], ["TCGA.A6.4105.01", "Phase II - Conjugation of compounds"], ["TCGA.A6.4105.01", "FGFR4 ligand binding and activation"], ["TCGA.A6.4105.01", "Interaction between L1 and Ankyrins"], ["TCGA.A6.4105.01", "Cytosolic sulfonation of small molecules"], ["TCGA.A6.4105.01", "Glucuronidation"], ["TCGA.A6.4105.01", "FGFR2 ligand binding and activation"], ["TCGA.A6.4105.01", "APAP ADME"], ["TCGA.A6.4105.01", "FGFR2c ligand binding and activation"], ["TCGA.A6.5656.01", "Blood group systems biosynthesis"], ["TCGA.A6.5656.01", "Lewis blood group biosynthesis"], ["TCGA.A6.5656.01", "RA biosynthesis pathway"], ["TCGA.A6.5656.01", "Phase 4 - resting membrane potential"], ["TCGA.A6.5656.01", "Glucuronidation"], ["TCGA.A6.5656.01", "Phase II - Conjugation of compounds"], ["TCGA.A6.5656.01", "Classical antibody-mediated complement activation"], ["TCGA.A6.5656.01", "Defective B3GALTL causes PpS"], ["TCGA.A6.5656.01", "Sialic acid metabolism"], ["TCGA.A6.5656.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.A6.5656.01", "TNFs bind their physiological receptors"], ["TCGA.A6.5656.01", "Ethanol oxidation"], ["TCGA.A6.5656.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.A6.5656.01", "TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway"], ["TCGA.A6.5656.01", "O-linked glycosylation"], ["TCGA.A6.5656.01", "Heme degradation"], ["TCGA.A6.5657.01", "Phase II - Conjugation of compounds"], ["TCGA.A6.5657.01", "Cytosolic sulfonation of small molecules"], ["TCGA.A6.5657.01", "Collagen chain trimerization"], ["TCGA.A6.5657.01", "Ethanol oxidation"], ["TCGA.A6.5657.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.A6.5657.01", "Glucuronidation"], ["TCGA.A6.5657.01", "APAP ADME"], ["TCGA.A6.5657.01", "Classical antibody-mediated complement activation"], ["TCGA.A6.5657.01", "Transcriptional regulation of testis differentiation"], ["TCGA.A6.5657.01", "Activation of Matrix Metalloproteinases"], ["TCGA.A6.5657.01", "Defective GALNT12 causes CRCS1"], ["TCGA.A6.5659.01", "Cytosolic sulfonation of small molecules"], ["TCGA.A6.5659.01", "APAP ADME"], ["TCGA.A6.5659.01", "Glucagon-type ligand receptors"], ["TCGA.A6.5659.01", "G beta:gamma signalling through BTK"], ["TCGA.A6.5659.01", "Phase 4 - resting membrane potential"], ["TCGA.A6.5659.01", "Ethanol oxidation"], ["TCGA.A6.5659.01", "Presynaptic function of Kainate receptors"], ["TCGA.A6.5659.01", "Inwardly rectifying K+ channels"], ["TCGA.A6.5659.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.A6.5659.01", "Activation of G protein gated Potassium channels"], ["TCGA.A6.5659.01", "G protein gated Potassium channels"], ["TCGA.A6.5659.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.A6.5659.01", "Heme degradation"], ["TCGA.A6.5659.01", "Blood group systems biosynthesis"], ["TCGA.A6.5659.01", "Phase II - Conjugation of compounds"], ["TCGA.A6.5659.01", "RA biosynthesis pathway"], ["TCGA.A6.5659.01", "Phase 0 - rapid depolarisation"], ["TCGA.A6.5660.01", "Voltage gated Potassium channels"], ["TCGA.A6.5660.01", "Interaction between L1 and Ankyrins"], ["TCGA.A6.5660.01", "Cytosolic sulfonation of small molecules"], ["TCGA.A6.5660.01", "Collagen chain trimerization"], ["TCGA.A6.5661.01", "Interaction between L1 and Ankyrins"], ["TCGA.A6.5661.01", "Phase 0 - rapid depolarisation"], ["TCGA.A6.5661.01", "Activation of Matrix Metalloproteinases"], ["TCGA.A6.5661.01", "Potassium Channels"], ["TCGA.A6.5661.01", "Glucagon-type ligand receptors"], ["TCGA.A6.5661.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.A6.5661.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.A6.5661.01", "Synaptic adhesion-like molecules"], ["TCGA.A6.5661.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.A6.5661.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.A6.5661.01", "Arachidonic acid metabolism"], ["TCGA.A6.5661.01", "Cytosolic sulfonation of small molecules"], ["TCGA.A6.5661.01", "Phase II - Conjugation of compounds"], ["TCGA.A6.5661.01", "Diseases of metabolism"], ["TCGA.A6.5661.01", "Diseases of glycosylation"], ["TCGA.A6.5661.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.A6.5661.01", "Defective B3GALTL causes PpS"], ["TCGA.A6.5661.01", "GABA receptor activation"], ["TCGA.A6.5661.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.A6.5661.01", "Collagen chain trimerization"], ["TCGA.A6.5662.01", "Glucuronidation"], ["TCGA.A6.5662.01", "Phase II - Conjugation of compounds"], ["TCGA.A6.5662.01", "Phase I - Functionalization of compounds"], ["TCGA.A6.5662.01", "TNFs bind their physiological receptors"], ["TCGA.A6.5662.01", "Aspirin ADME"], ["TCGA.A6.5662.01", "Ethanol oxidation"], ["TCGA.A6.5662.01", "O-linked glycosylation"], ["TCGA.A6.5662.01", "Signaling by Retinoic Acid"], ["TCGA.A6.5662.01", "Cytosolic sulfonation of small molecules"], ["TCGA.A6.5662.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.A6.5662.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], ["TCGA.A6.5662.01", "Defensins"], ["TCGA.A6.5662.01", "Heme degradation"], ["TCGA.A6.5662.01", "Scavenging of heme from plasma"], ["TCGA.A6.5662.01", "TP53 Regulates Transcription of Caspase Activators and Caspases"], ["TCGA.A6.5662.01", "Collagen chain trimerization"], ["TCGA.A6.5662.01", "Defective GALNT3 causes HFTC"], ["TCGA.A6.5662.01", "Defective GALNT12 causes CRCS1"], ["TCGA.A6.5662.01", "RA biosynthesis pathway"], ["TCGA.A6.5662.01", "Binding and entry of HIV virion"], ["TCGA.A6.5664.01", "Glucuronidation"], ["TCGA.A6.5664.01", "Collagen chain trimerization"], ["TCGA.A6.5664.01", "FGFR4 ligand binding and activation"], ["TCGA.A6.5664.01", "Phospholipase C-mediated cascade; FGFR4"], ["TCGA.A6.5664.01", "Formation of axial mesoderm"], ["TCGA.A6.5664.01", "Phase II - Conjugation of compounds"], ["TCGA.A6.5664.01", "FGFR2c ligand binding and activation"], ["TCGA.A6.5664.01", "Peptide hormone biosynthesis"], ["TCGA.A6.5664.01", "Primitive streak formation"], ["TCGA.A6.5665.01", "Interaction between L1 and Ankyrins"], ["TCGA.A6.5665.01", "Phase 0 - rapid depolarisation"], ["TCGA.A6.5665.01", "Potassium Channels"], ["TCGA.A6.5665.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.A6.5665.01", "Glucagon-type ligand receptors"], ["TCGA.A6.5665.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.A6.5665.01", "RA biosynthesis pathway"], ["TCGA.A6.5665.01", "Synaptic adhesion-like molecules"], ["TCGA.A6.5665.01", "Ethanol oxidation"], ["TCGA.A6.5665.01", "Glucuronidation"], ["TCGA.A6.5665.01", "Voltage gated Potassium channels"], ["TCGA.A6.5665.01", "Phase II - Conjugation of compounds"], ["TCGA.A6.5665.01", "Blood group systems biosynthesis"], ["TCGA.A6.5665.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.A6.5665.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.A6.5665.01", "Stimuli-sensing channels"], ["TCGA.A6.5665.01", "Activation of Matrix Metalloproteinases"], ["TCGA.A6.5665.01", "GABA receptor activation"], ["TCGA.A6.5665.01", "G beta:gamma signalling through BTK"], ["TCGA.A6.5665.01", "LGI-ADAM interactions"], ["TCGA.A6.5665.01", "Collagen chain trimerization"], ["TCGA.A6.5665.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.A6.5665.01", "Arachidonic acid metabolism"], ["TCGA.A6.5665.01", "Other semaphorin interactions"], ["TCGA.A6.5665.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], ["TCGA.A6.5665.01", "Cytosolic sulfonation of small molecules"], ["TCGA.A6.5666.01", "Regulation of Complement cascade"], ["TCGA.A6.5666.01", "Potassium Channels"], ["TCGA.A6.5666.01", "Interaction between L1 and Ankyrins"], ["TCGA.A6.5666.01", "Initial triggering of complement"], ["TCGA.A6.5666.01", "Glucagon-type ligand receptors"], ["TCGA.A6.5666.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.A6.5666.01", "GABA receptor activation"], ["TCGA.A6.5666.01", "TNFs bind their physiological receptors"], ["TCGA.A6.5666.01", "Classical antibody-mediated complement activation"], ["TCGA.A6.5666.01", "Blood group systems biosynthesis"], ["TCGA.A6.5666.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.A6.5666.01", "GABA B receptor activation"], ["TCGA.A6.5666.01", "Activation of GABAB receptors"], ["TCGA.A6.5666.01", "Lewis blood group biosynthesis"], ["TCGA.A6.5666.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.A6.5666.01", "Voltage gated Potassium channels"], ["TCGA.A6.5666.01", "Phase II - Conjugation of compounds"], ["TCGA.A6.5666.01", "Presynaptic function of Kainate receptors"], ["TCGA.A6.5666.01", "Creation of C4 and C2 activators"], ["TCGA.A6.5666.01", "G beta:gamma signalling through BTK"], ["TCGA.A6.5666.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.A6.5666.01", "Adenylate cyclase inhibitory pathway"], ["TCGA.A6.5666.01", "Glucuronidation"], ["TCGA.A6.5666.01", "Heme degradation"], ["TCGA.A6.5666.01", "G beta:gamma signalling through PLC beta"], ["TCGA.A6.5666.01", "Sialic acid metabolism"], ["TCGA.A6.5666.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.A6.5666.01", "Keratan sulfate biosynthesis"], ["TCGA.A6.5666.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.A6.5667.01", "Activation of Matrix Metalloproteinases"], ["TCGA.A6.5667.01", "Blood group systems biosynthesis"], ["TCGA.A6.5667.01", "Phase II - Conjugation of compounds"], ["TCGA.A6.5667.01", "Glucagon-type ligand receptors"], ["TCGA.A6.5667.01", "Inwardly rectifying K+ channels"], ["TCGA.A6.5667.01", "Activation of G protein gated Potassium channels"], ["TCGA.A6.5667.01", "G protein gated Potassium channels"], ["TCGA.A6.5667.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.A6.5667.01", "Lewis blood group biosynthesis"], ["TCGA.A6.5667.01", "Ethanol oxidation"], ["TCGA.A6.5667.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.A6.5667.01", "GABA receptor activation"], ["TCGA.A6.5667.01", "RA biosynthesis pathway"], ["TCGA.A6.5667.01", "G beta:gamma signalling through BTK"], ["TCGA.A6.5667.01", "Glucuronidation"], ["TCGA.A6.5667.01", "GABA B receptor activation"], ["TCGA.A6.5667.01", "Activation of GABAB receptors"], ["TCGA.A6.6137.01", "Activation of Matrix Metalloproteinases"], ["TCGA.A6.6137.01", "IL-6-type cytokine receptor ligand interactions"], ["TCGA.A6.6137.01", "Cytosolic sulfonation of small molecules"], ["TCGA.A6.6137.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], ["TCGA.A6.6137.01", "Glucagon-type ligand receptors"], ["TCGA.A6.6137.01", "Molecules associated with elastic fibres"], ["TCGA.A6.6137.01", "Phase II - Conjugation of compounds"], ["TCGA.A6.6137.01", "Interaction between L1 and Ankyrins"], ["TCGA.A6.6137.01", "Glutathione conjugation"], ["TCGA.A6.6138.01", "Cytosolic sulfonation of small molecules"], ["TCGA.A6.6138.01", "Phase II - Conjugation of compounds"], ["TCGA.A6.6138.01", "Potassium Channels"], ["TCGA.A6.6138.01", "Phase 4 - resting membrane potential"], ["TCGA.A6.6138.01", "Ethanol oxidation"], ["TCGA.A6.6138.01", "RA biosynthesis pathway"], ["TCGA.A6.6138.01", "IL-6-type cytokine receptor ligand interactions"], ["TCGA.A6.6138.01", "Glucuronidation"], ["TCGA.A6.6138.01", "APAP ADME"], ["TCGA.A6.6138.01", "Interaction between L1 and Ankyrins"], ["TCGA.A6.6138.01", "Carnitine metabolism"], ["TCGA.A6.6140.01", "Interaction between L1 and Ankyrins"], ["TCGA.A6.6140.01", "Classical antibody-mediated complement activation"], ["TCGA.A6.6140.01", "Molecules associated with elastic fibres"], ["TCGA.A6.6140.01", "Phase 0 - rapid depolarisation"], ["TCGA.A6.6140.01", "Potassium Channels"], ["TCGA.A6.6140.01", "Heme degradation"], ["TCGA.A6.6140.01", "Activation of Matrix Metalloproteinases"], ["TCGA.A6.6140.01", "Regulation of Complement cascade"], ["TCGA.A6.6140.01", "Neurexins and neuroligins"], ["TCGA.A6.6140.01", "Chemokine receptors bind chemokines"], ["TCGA.A6.6140.01", "Phospholipase C-mediated cascade; FGFR2"], ["TCGA.A6.6140.01", "Complement cascade"], ["TCGA.A6.6140.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.A6.6140.01", "Arachidonic acid metabolism"], ["TCGA.A6.6140.01", "Initial triggering of complement"], ["TCGA.A6.6140.01", "FGFR2 ligand binding and activation"], ["TCGA.A6.6140.01", "Phase II - Conjugation of compounds"], ["TCGA.A6.6140.01", "Phase 4 - resting membrane potential"], ["TCGA.A6.6140.01", "Presynaptic function of Kainate receptors"], ["TCGA.A6.6140.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], ["TCGA.A6.6140.01", "Elastic fibre formation"], ["TCGA.A6.6140.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.A6.6140.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.A6.6140.01", "Activated point mutants of FGFR2"], ["TCGA.A6.6140.01", "MyD88 deficiency (TLR2/4)"], ["TCGA.A6.6140.01", "IRAK4 deficiency (TLR2/4)"], ["TCGA.A6.6140.01", "G beta:gamma signalling through BTK"], ["TCGA.A6.6140.01", "Ion transport by P-type ATPases"], ["TCGA.A6.6140.01", "Porphyrin metabolism"], ["TCGA.A6.6140.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.A6.6140.01", "Glucuronidation"], ["TCGA.A6.6140.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.A6.6140.01", "Creation of C4 and C2 activators"], ["TCGA.A6.6140.01", "GABA receptor activation"], ["TCGA.A6.6141.01", "Neuronal System"], ["TCGA.A6.6141.01", "Activation of Matrix Metalloproteinases"], ["TCGA.A6.6141.01", "Transmission across Chemical Synapses"], ["TCGA.A6.6141.01", "Drug ADME"], ["TCGA.A6.6142.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.A6.6142.01", "Collagen chain trimerization"], ["TCGA.A6.6142.01", "Activation of Matrix Metalloproteinases"], ["TCGA.A6.6142.01", "Interaction between L1 and Ankyrins"], ["TCGA.A6.6142.01", "Phase 0 - rapid depolarisation"], ["TCGA.A6.6142.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.A6.6142.01", "IL-6-type cytokine receptor ligand interactions"], ["TCGA.A6.6142.01", "Glucuronidation"], ["TCGA.A6.6142.01", "Phase 2 - plateau phase"], ["TCGA.A6.6142.01", "WNT ligand biogenesis and trafficking"], ["TCGA.A6.6142.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.A6.6142.01", "Cytosolic sulfonation of small molecules"], ["TCGA.A6.6142.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], ["TCGA.A6.6142.01", "Phase II - Conjugation of compounds"], ["TCGA.A6.6142.01", "Heme degradation"], ["TCGA.A6.6142.01", "Collagen degradation"], ["TCGA.A6.6142.01", "NCAM1 interactions"], ["TCGA.A6.6142.01", "FGFR2 ligand binding and activation"], ["TCGA.A6.6142.01", "APAP ADME"], ["TCGA.A6.6648.01", "Interaction between L1 and Ankyrins"], ["TCGA.A6.6648.01", "Classical antibody-mediated complement activation"], ["TCGA.A6.6648.01", "Neurexins and neuroligins"], ["TCGA.A6.6648.01", "Initial triggering of complement"], ["TCGA.A6.6648.01", "Phase 4 - resting membrane potential"], ["TCGA.A6.6648.01", "Phase 0 - rapid depolarisation"], ["TCGA.A6.6648.01", "LGI-ADAM interactions"], ["TCGA.A6.6648.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], ["TCGA.A6.6649.01", "Activation of Matrix Metalloproteinases"], ["TCGA.A6.6649.01", "Peptide hormone biosynthesis"], ["TCGA.A6.6650.01", "Classical antibody-mediated complement activation"], ["TCGA.A6.6650.01", "Interaction between L1 and Ankyrins"], ["TCGA.A6.6650.01", "Glucagon-type ligand receptors"], ["TCGA.A6.6650.01", "Initial triggering of complement"], ["TCGA.A6.6650.01", "Potassium Channels"], ["TCGA.A6.6650.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.A6.6650.01", "Phase 0 - rapid depolarisation"], ["TCGA.A6.6650.01", "Neurexins and neuroligins"], ["TCGA.A6.6650.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.A6.6650.01", "G beta:gamma signalling through BTK"], ["TCGA.A6.6650.01", "Glucuronidation"], ["TCGA.A6.6650.01", "Erythrocytes take up carbon dioxide and release oxygen"], ["TCGA.A6.6650.01", "O2/CO2 exchange in erythrocytes"], ["TCGA.A6.6650.01", "Keratan sulfate biosynthesis"], ["TCGA.A6.6650.01", "Transport of bile salts and organic acids, metal ions and amine compounds"], ["TCGA.A6.6650.01", "Phase 4 - resting membrane potential"], ["TCGA.A6.6650.01", "Ethanol oxidation"], ["TCGA.A6.6650.01", "Transcriptional regulation of testis differentiation"], ["TCGA.A6.6650.01", "Heme degradation"], ["TCGA.A6.6651.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.A6.6651.01", "Collagen chain trimerization"], ["TCGA.A6.6651.01", "Collagen degradation"], ["TCGA.A6.6651.01", "Phase II - Conjugation of compounds"], ["TCGA.A6.6651.01", "Cytosolic sulfonation of small molecules"], ["TCGA.A6.6651.01", "APAP ADME"], ["TCGA.A6.6651.01", "Glucuronidation"], ["TCGA.A6.6651.01", "Nucleotide catabolism"], ["TCGA.A6.6652.01", "Glucuronidation"], ["TCGA.A6.6652.01", "Complement cascade"], ["TCGA.A6.6652.01", "Regulation of Complement cascade"], ["TCGA.A6.6652.01", "Voltage gated Potassium channels"], ["TCGA.A6.6652.01", "Phase II - Conjugation of compounds"], ["TCGA.A6.6652.01", "Molecules associated with elastic fibres"], ["TCGA.A6.6652.01", "Aspirin ADME"], ["TCGA.A6.6652.01", "Arachidonic acid metabolism"], ["TCGA.A6.6652.01", "Transcriptional regulation of testis differentiation"], ["TCGA.A6.6652.01", "CD22 mediated BCR regulation"], ["TCGA.A6.6652.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.A6.6652.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.A6.6652.01", "Activation of the phototransduction cascade"], ["TCGA.A6.6653.01", "Interaction between L1 and Ankyrins"], ["TCGA.A6.6653.01", "GABA receptor activation"], ["TCGA.A6.6653.01", "Phase 0 - rapid depolarisation"], ["TCGA.A6.6653.01", "Activation of Matrix Metalloproteinases"], ["TCGA.A6.6653.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.A6.6653.01", "CD22 mediated BCR regulation"], ["TCGA.A6.6653.01", "RA biosynthesis pathway"], ["TCGA.A6.6653.01", "Aspartate and asparagine metabolism"], ["TCGA.A6.6653.01", "Glucuronidation"], ["TCGA.A6.6653.01", "GABA B receptor activation"], ["TCGA.A6.6653.01", "Activation of GABAB receptors"], ["TCGA.A6.6653.01", "Adenylate cyclase inhibitory pathway"], ["TCGA.A6.6653.01", "Phase 4 - resting membrane potential"], ["TCGA.A6.6653.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], ["TCGA.A6.6654.01", "Collagen formation"], ["TCGA.A6.6654.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.A6.6654.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.A6.6654.01", "Collagen chain trimerization"], ["TCGA.A6.6654.01", "Activation of Matrix Metalloproteinases"], ["TCGA.A6.6654.01", "Glucuronidation"], ["TCGA.A6.6654.01", "APAP ADME"], ["TCGA.A6.6654.01", "Phase II - Conjugation of compounds"], ["TCGA.A6.6654.01", "Ethanol oxidation"], ["TCGA.A6.6654.01", "Collagen degradation"], ["TCGA.A6.6654.01", "RA biosynthesis pathway"], ["TCGA.A6.6654.01", "Cytosolic sulfonation of small molecules"], ["TCGA.A6.6654.01", "Chondroitin sulfate biosynthesis"], ["TCGA.A6.6654.01", "Defective B3GALTL causes PpS"], ["TCGA.A6.6654.01", "Degradation of cysteine and homocysteine"], ["TCGA.A6.6654.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.A6.6654.01", "Signaling by Retinoic Acid"], ["TCGA.A6.6654.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.A6.6654.01", "TNFs bind their physiological receptors"], ["TCGA.A6.6654.01", "Aspirin ADME"], ["TCGA.A6.6654.01", "Sulfur amino acid metabolism"], ["TCGA.A6.6654.01", "Transcriptional regulation of testis differentiation"], ["TCGA.A6.6654.01", "IL-6-type cytokine receptor ligand interactions"], ["TCGA.A6.6654.01", "Arachidonic acid metabolism"], ["TCGA.A6.6654.01", "WNT ligand biogenesis and trafficking"], ["TCGA.A6.6780.01", "Interaction between L1 and Ankyrins"], ["TCGA.A6.6780.01", "Phase 0 - rapid depolarisation"], ["TCGA.A6.6780.01", "GABA receptor activation"], ["TCGA.A6.6780.01", "Glucagon-type ligand receptors"], ["TCGA.A6.6780.01", "WNT ligand biogenesis and trafficking"], ["TCGA.A6.6780.01", "RA biosynthesis pathway"], ["TCGA.A6.6780.01", "Other semaphorin interactions"], ["TCGA.A6.6780.01", "Collagen chain trimerization"], ["TCGA.A6.6780.01", "Glucuronidation"], ["TCGA.A6.6780.01", "GABA B receptor activation"], ["TCGA.A6.6780.01", "Activation of GABAB receptors"], ["TCGA.A6.6780.01", "O-linked glycosylation"], ["TCGA.A6.6780.01", "Formation of the anterior neural plate"], ["TCGA.A6.6780.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.A6.6780.01", "Transcriptional regulation of testis differentiation"], ["TCGA.A6.6780.01", "NCAM1 interactions"], ["TCGA.A6.6780.01", "Signaling by Retinoic Acid"], ["TCGA.A6.6780.01", "Potassium Channels"], ["TCGA.A6.6780.01", "Activation of Matrix Metalloproteinases"], ["TCGA.A6.6780.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], ["TCGA.A6.6780.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.A6.6780.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.A6.6780.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.A6.6781.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.A6.6781.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.A6.6781.01", "Collagen chain trimerization"], ["TCGA.A6.6781.01", "Activation of Matrix Metalloproteinases"], ["TCGA.A6.6781.01", "Collagen degradation"], ["TCGA.A6.6781.01", "Phase II - Conjugation of compounds"], ["TCGA.A6.6781.01", "Glucuronidation"], ["TCGA.A6.6781.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], ["TCGA.A6.6781.01", "Keratan sulfate biosynthesis"], ["TCGA.A6.6781.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.A6.6781.01", "O-linked glycosylation"], ["TCGA.A6.6781.01", "Defective B3GALTL causes PpS"], ["TCGA.A6.6781.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.A6.6781.01", "Keratan sulfate/keratin metabolism"], ["TCGA.A6.6781.01", "Other semaphorin interactions"], ["TCGA.A6.6781.01", "Glucagon-type ligand receptors"], ["TCGA.A6.6781.01", "Scavenging by Class A Receptors"], ["TCGA.A6.6781.01", "APAP ADME"], ["TCGA.A6.6782.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.A6.6782.01", "Phase II - Conjugation of compounds"], ["TCGA.A6.6782.01", "Collagen chain trimerization"], ["TCGA.A6.6782.01", "Cytosolic sulfonation of small molecules"], ["TCGA.A6.6782.01", "Glucuronidation"], ["TCGA.A6.6782.01", "Nucleotide catabolism"], ["TCGA.A6.6782.01", "Defective GALNT3 causes HFTC"], ["TCGA.A6.6782.01", "Defective GALNT12 causes CRCS1"], ["TCGA.A6.6782.01", "Physiological factors"], ["TCGA.AA.3489.01", "Phase II - Conjugation of compounds"], ["TCGA.AA.3489.01", "Glucuronidation"], ["TCGA.AA.3489.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.AA.3489.01", "Collagen chain trimerization"], ["TCGA.AA.3489.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AA.3489.01", "APAP ADME"], ["TCGA.AA.3489.01", "Collagen degradation"], ["TCGA.AA.3489.01", "Aspirin ADME"], ["TCGA.AA.3489.01", "O-linked glycosylation"], ["TCGA.AA.3489.01", "Defective B3GALTL causes PpS"], ["TCGA.AA.3489.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.AA.3489.01", "Activation of G protein gated Potassium channels"], ["TCGA.AA.3489.01", "G protein gated Potassium channels"], ["TCGA.AA.3489.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.AA.3492.01", "Interaction between L1 and Ankyrins"], ["TCGA.AA.3492.01", "Phase 0 - rapid depolarisation"], ["TCGA.AA.3492.01", "Potassium Channels"], ["TCGA.AA.3492.01", "NCAM1 interactions"], ["TCGA.AA.3492.01", "Phase II - Conjugation of compounds"], ["TCGA.AA.3492.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.AA.3492.01", "Glucuronidation"], ["TCGA.AA.3492.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.AA.3492.01", "GABA receptor activation"], ["TCGA.AA.3492.01", "Chemokine receptors bind chemokines"], ["TCGA.AA.3492.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.AA.3492.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.AA.3492.01", "Glucagon-type ligand receptors"], ["TCGA.AA.3492.01", "Activation of G protein gated Potassium channels"], ["TCGA.AA.3492.01", "G protein gated Potassium channels"], ["TCGA.AA.3492.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.AA.3492.01", "Synaptic adhesion-like molecules"], ["TCGA.AA.3492.01", "Collagen chain trimerization"], ["TCGA.AA.3492.01", "Termination of O-glycan biosynthesis"], ["TCGA.AA.3492.01", "O-linked glycosylation"], ["TCGA.AA.3492.01", "GABA B receptor activation"], ["TCGA.AA.3492.01", "Activation of GABAB receptors"], ["TCGA.AA.3492.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.AA.3492.01", "Phase 4 - resting membrane potential"], ["TCGA.AA.3492.01", "Transcriptional regulation of testis differentiation"], ["TCGA.AA.3492.01", "Voltage gated Potassium channels"], ["TCGA.AA.3492.01", "Presynaptic function of Kainate receptors"], ["TCGA.AA.3492.01", "O-linked glycosylation of mucins"], ["TCGA.AA.3492.01", "Aspirin ADME"], ["TCGA.AA.3492.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.AA.3492.01", "Blood group systems biosynthesis"], ["TCGA.AA.3492.01", "Inwardly rectifying K+ channels"], ["TCGA.AA.3492.01", "Neurexins and neuroligins"], ["TCGA.AA.3502.01", "Potassium Channels"], ["TCGA.AA.3502.01", "Defective B3GALTL causes PpS"], ["TCGA.AA.3502.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.AA.3502.01", "GABA B receptor activation"], ["TCGA.AA.3502.01", "Activation of GABAB receptors"], ["TCGA.AA.3502.01", "Biological oxidations"], ["TCGA.AA.3502.01", "Erythrocytes take up carbon dioxide and release oxygen"], ["TCGA.AA.3502.01", "O2/CO2 exchange in erythrocytes"], ["TCGA.AA.3502.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.AA.3502.01", "GABA receptor activation"], ["TCGA.AA.3502.01", "Glucagon-type ligand receptors"], ["TCGA.AA.3502.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.AA.3502.01", "Transcriptional regulation of testis differentiation"], ["TCGA.AA.3502.01", "Prostacyclin signalling through prostacyclin receptor"], ["TCGA.AA.3502.01", "O-linked glycosylation"], ["TCGA.AA.3502.01", "Inwardly rectifying K+ channels"], ["TCGA.AA.3502.01", "Thromboxane signalling through TP receptor"], ["TCGA.AA.3502.01", "Presynaptic function of Kainate receptors"], ["TCGA.AA.3502.01", "Voltage gated Potassium channels"], ["TCGA.AA.3502.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.AA.3502.01", "Bile acid and bile salt metabolism"], ["TCGA.AA.3502.01", "Activation of G protein gated Potassium channels"], ["TCGA.AA.3502.01", "G protein gated Potassium channels"], ["TCGA.AA.3502.01", "Interaction between L1 and Ankyrins"], ["TCGA.AA.3502.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.AA.3502.01", "RA biosynthesis pathway"], ["TCGA.AA.3502.01", "G beta:gamma signalling through BTK"], ["TCGA.AA.3502.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.AA.3502.01", "G-protein activation"], ["TCGA.AA.3502.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.AA.3502.01", "Phase I - Functionalization of compounds"], ["TCGA.AA.3502.01", "Adenylate cyclase inhibitory pathway"], ["TCGA.AA.3502.01", "G beta:gamma signalling through PLC beta"], ["TCGA.AA.3502.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AA.3502.01", "Phase 4 - resting membrane potential"], ["TCGA.AA.3502.01", "Ethanol oxidation"], ["TCGA.AA.3502.01", "Synthesis of bile acids and bile salts via 27-hydroxycholesterol"], ["TCGA.AA.3502.01", "Synthesis of bile acids and bile salts"], ["TCGA.AA.3502.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], ["TCGA.AA.3502.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.AA.3502.01", "FGFR1 ligand binding and activation"], ["TCGA.AA.3502.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.AA.3502.01", "Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"], ["TCGA.AA.3511.01", "Potassium Channels"], ["TCGA.AA.3511.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.AA.3511.01", "Ethanol oxidation"], ["TCGA.AA.3511.01", "Glucuronidation"], ["TCGA.AA.3511.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.AA.3511.01", "TNFs bind their physiological receptors"], ["TCGA.AA.3511.01", "Phase II - Conjugation of compounds"], ["TCGA.AA.3511.01", "Collagen chain trimerization"], ["TCGA.AA.3511.01", "Voltage gated Potassium channels"], ["TCGA.AA.3511.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AA.3511.01", "Phase 0 - rapid depolarisation"], ["TCGA.AA.3511.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.AA.3655.01", "RA biosynthesis pathway"], ["TCGA.AA.3655.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], ["TCGA.AA.3655.01", "Ethanol oxidation"], ["TCGA.AA.3655.01", "Synthesis of bile acids and bile salts via 27-hydroxycholesterol"], ["TCGA.AA.3655.01", "Phase II - Conjugation of compounds"], ["TCGA.AA.3655.01", "Glucuronidation"], ["TCGA.AA.3655.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AA.3655.01", "Synthesis of bile acids and bile salts"], ["TCGA.AA.3655.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.AA.3655.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], ["TCGA.AA.3655.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AA.3655.01", "Phase 4 - resting membrane potential"], ["TCGA.AA.3655.01", "Transcriptional regulation of testis differentiation"], ["TCGA.AA.3655.01", "Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"], ["TCGA.AA.3655.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.AA.3655.01", "Bile acid and bile salt metabolism"], ["TCGA.AA.3655.01", "Aspirin ADME"], ["TCGA.AA.3655.01", "LGI-ADAM interactions"], ["TCGA.AA.3655.01", "Collagen chain trimerization"], ["TCGA.AA.3660.01", "FGFR4 ligand binding and activation"], ["TCGA.AA.3660.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], ["TCGA.AA.3660.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AA.3660.01", "Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"], ["TCGA.AA.3660.01", "Bile acid and bile salt metabolism"], ["TCGA.AA.3660.01", "Glucuronidation"], ["TCGA.AA.3660.01", "Phase II - Conjugation of compounds"], ["TCGA.AA.3660.01", "Synthesis of bile acids and bile salts"], ["TCGA.AA.3660.01", "FGFR2 ligand binding and activation"], ["TCGA.AA.3660.01", "FGFR2c ligand binding and activation"], ["TCGA.AA.3660.01", "Presynaptic function of Kainate receptors"], ["TCGA.AA.3660.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.AA.3660.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.AA.3660.01", "Collagen chain trimerization"], ["TCGA.AA.3660.01", "Synthesis of bile acids and bile salts via 27-hydroxycholesterol"], ["TCGA.AA.3660.01", "Ethanol oxidation"], ["TCGA.AA.3660.01", "Transcriptional regulation of testis differentiation"], ["TCGA.AA.3660.01", "Activated point mutants of FGFR2"], ["TCGA.AA.3660.01", "G beta:gamma signalling through BTK"], ["TCGA.AA.3660.01", "Prostacyclin signalling through prostacyclin receptor"], ["TCGA.AA.3660.01", "Signaling by activated point mutants of FGFR1"], ["TCGA.AA.3660.01", "G beta:gamma signalling through PLC beta"], ["TCGA.AA.3660.01", "Recycling of bile acids and salts"], ["TCGA.AA.3660.01", "Signaling by activated point mutants of FGFR3"], ["TCGA.AA.3660.01", "FGFR3 mutant receptor activation"], ["TCGA.AA.3660.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.AA.3660.01", "Physiological factors"], ["TCGA.AA.3660.01", "FGFR3 ligand binding and activation"], ["TCGA.AA.3660.01", "FGFR3c ligand binding and activation"], ["TCGA.AA.3660.01", "LGI-ADAM interactions"], ["TCGA.AA.3660.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AA.3662.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.AA.3662.01", "Interaction between L1 and Ankyrins"], ["TCGA.AA.3662.01", "Phase II - Conjugation of compounds"], ["TCGA.AA.3662.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AA.3662.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.AA.3662.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AA.3662.01", "Phase 4 - resting membrane potential"], ["TCGA.AA.3662.01", "Ethanol oxidation"], ["TCGA.AA.3662.01", "Phase 0 - rapid depolarisation"], ["TCGA.AA.3662.01", "GABA receptor activation"], ["TCGA.AA.3662.01", "RA biosynthesis pathway"], ["TCGA.AA.3662.01", "Glucuronidation"], ["TCGA.AA.3662.01", "GABA B receptor activation"], ["TCGA.AA.3662.01", "Activation of GABAB receptors"], ["TCGA.AA.3662.01", "Inwardly rectifying K+ channels"], ["TCGA.AA.3662.01", "FGFR4 ligand binding and activation"], ["TCGA.AA.3662.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.AA.3662.01", "Assembly and cell surface presentation of NMDA receptors"], ["TCGA.AA.3662.01", "TNFs bind their physiological receptors"], ["TCGA.AA.3662.01", "Phospholipase C-mediated cascade; FGFR4"], ["TCGA.AA.3662.01", "G-protein activation"], ["TCGA.AA.3662.01", "Thromboxane signalling through TP receptor"], ["TCGA.AA.3663.01", "Interaction between L1 and Ankyrins"], ["TCGA.AA.3663.01", "Potassium Channels"], ["TCGA.AA.3663.01", "Phase 0 - rapid depolarisation"], ["TCGA.AA.3663.01", "Phase 4 - resting membrane potential"], ["TCGA.AA.3663.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], ["TCGA.AA.3663.01", "Glucagon-type ligand receptors"], ["TCGA.AA.3663.01", "Regulation of Complement cascade"], ["TCGA.AA.3663.01", "Complement cascade"], ["TCGA.AA.3663.01", "Phase II - Conjugation of compounds"], ["TCGA.AA.3663.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.AA.3663.01", "Sensory processing of sound by outer hair cells of the cochlea"], ["TCGA.AA.3663.01", "GABA receptor activation"], ["TCGA.AA.3697.01", "Phase II - Conjugation of compounds"], ["TCGA.AA.3697.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.AA.3697.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AA.3697.01", "Interaction between L1 and Ankyrins"], ["TCGA.AA.3697.01", "Phase 0 - rapid depolarisation"], ["TCGA.AA.3697.01", "GABA receptor activation"], ["TCGA.AA.3697.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.AA.3697.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.AA.3697.01", "Phase 4 - resting membrane potential"], ["TCGA.AA.3697.01", "Ethanol oxidation"], ["TCGA.AA.3697.01", "Molecules associated with elastic fibres"], ["TCGA.AA.3697.01", "Presynaptic nicotinic acetylcholine receptors"], ["TCGA.AA.3697.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.AA.3697.01", "Potassium Channels"], ["TCGA.AA.3697.01", "Glutamate Neurotransmitter Release Cycle"], ["TCGA.AA.3697.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AA.3697.01", "Glucuronidation"], ["TCGA.AA.3697.01", "Glucagon-type ligand receptors"], ["TCGA.AA.3697.01", "GABA B receptor activation"], ["TCGA.AA.3697.01", "Activation of GABAB receptors"], ["TCGA.AA.3697.01", "Inwardly rectifying K+ channels"], ["TCGA.AA.3697.01", "APAP ADME"], ["TCGA.AA.3697.01", "Acetylcholine binding and downstream events"], ["TCGA.AA.3697.01", "Postsynaptic nicotinic acetylcholine receptors"], ["TCGA.AA.3697.01", "Activation of G protein gated Potassium channels"], ["TCGA.AA.3697.01", "G protein gated Potassium channels"], ["TCGA.AA.3697.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.AA.3697.01", "Trafficking of GluR2-containing AMPA receptors"], ["TCGA.AA.3697.01", "SUMOylation of DNA methylation proteins"], ["TCGA.AA.3697.01", "Neurexins and neuroligins"], ["TCGA.AA.3697.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.AA.3697.01", "Activation of the phototransduction cascade"], ["TCGA.AA.3697.01", "Norepinephrine Neurotransmitter Release Cycle"], ["TCGA.AA.3712.01", "Interaction between L1 and Ankyrins"], ["TCGA.AA.3712.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AA.3712.01", "Phase II - Conjugation of compounds"], ["TCGA.AA.3712.01", "Glucuronidation"], ["TCGA.AA.3712.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AA.3712.01", "GABA receptor activation"], ["TCGA.AA.3712.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.AA.3712.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.AA.3712.01", "Phase 0 - rapid depolarisation"], ["TCGA.AA.3712.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.AA.3712.01", "Glucagon-type ligand receptors"], ["TCGA.AA.3712.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.AA.3712.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.AA.3712.01", "Heme degradation"], ["TCGA.AA.3712.01", "GABA B receptor activation"], ["TCGA.AA.3712.01", "Activation of GABAB receptors"], ["TCGA.AA.3712.01", "Glutamate Neurotransmitter Release Cycle"], ["TCGA.AA.3712.01", "G beta:gamma signalling through BTK"], ["TCGA.AA.3712.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.AA.3712.01", "Caspase-mediated cleavage of cytoskeletal proteins"], ["TCGA.AA.3712.01", "Potassium Channels"], ["TCGA.AA.3712.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.AA.3712.01", "Unblocking of NMDA receptors, glutamate binding and activation"], ["TCGA.AA.3713.01", "Resolution of D-loop Structures through Holliday Junction Intermediates"], ["TCGA.AA.3713.01", "Potassium Channels"], ["TCGA.AA.3713.01", "Resolution of D-Loop Structures"], ["TCGA.AA.3713.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.AA.3713.01", "RA biosynthesis pathway"], ["TCGA.AA.3713.01", "Defective homologous recombination repair (HRR) due to BRCA1 loss of function"], ["TCGA.AA.3713.01", "Defective homologous recombination repair (HRR) due to PALB2 loss of function"], ["TCGA.AA.3713.01", "Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function"], ["TCGA.AA.3713.01", "Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function"], ["TCGA.AA.3713.01", "Impaired BRCA2 binding to PALB2"], ["TCGA.AA.3713.01", "Ethanol oxidation"], ["TCGA.AD.5900.01", "Phase II - Conjugation of compounds"], ["TCGA.AD.5900.01", "Glucuronidation"], ["TCGA.AD.5900.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AD.5900.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AD.5900.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.AD.5900.01", "Ethanol oxidation"], ["TCGA.AD.5900.01", "O-linked glycosylation"], ["TCGA.AD.5900.01", "Phase 0 - rapid depolarisation"], ["TCGA.AD.5900.01", "Aspirin ADME"], ["TCGA.AD.5900.01", "WNT ligand biogenesis and trafficking"], ["TCGA.AD.5900.01", "O-linked glycosylation of mucins"], ["TCGA.AD.5900.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.AD.5900.01", "Interaction between L1 and Ankyrins"], ["TCGA.AD.5900.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], ["TCGA.AD.5900.01", "Glycogen synthesis"], ["TCGA.AD.5900.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], ["TCGA.AD.6548.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AD.6548.01", "Phase II - Conjugation of compounds"], ["TCGA.AD.6548.01", "Signaling by Retinoic Acid"], ["TCGA.AD.6548.01", "Ethanol oxidation"], ["TCGA.AD.6548.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AD.6548.01", "WNT ligand biogenesis and trafficking"], ["TCGA.AD.6888.01", "Potassium Channels"], ["TCGA.AD.6888.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.AD.6888.01", "Complement cascade"], ["TCGA.AD.6888.01", "Regulation of Complement cascade"], ["TCGA.AD.6888.01", "Interaction between L1 and Ankyrins"], ["TCGA.AD.6888.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AD.6888.01", "Classical antibody-mediated complement activation"], ["TCGA.AD.6888.01", "Phase 0 - rapid depolarisation"], ["TCGA.AD.6888.01", "Defective B3GALTL causes PpS"], ["TCGA.AD.6888.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.AD.6888.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.AD.6888.01", "Voltage gated Potassium channels"], ["TCGA.AD.6888.01", "IL-6-type cytokine receptor ligand interactions"], ["TCGA.AD.6888.01", "G beta:gamma signalling through BTK"], ["TCGA.AD.6888.01", "NCAM1 interactions"], ["TCGA.AD.6888.01", "GABA receptor activation"], ["TCGA.AD.6888.01", "Prostacyclin signalling through prostacyclin receptor"], ["TCGA.AD.6888.01", "Binding and entry of HIV virion"], ["TCGA.AD.6888.01", "G-protein activation"], ["TCGA.AD.6888.01", "Thromboxane signalling through TP receptor"], ["TCGA.AD.6888.01", "Creation of C4 and C2 activators"], ["TCGA.AD.6888.01", "Presynaptic function of Kainate receptors"], ["TCGA.AD.6888.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AD.6888.01", "Calcitonin-like ligand receptors"], ["TCGA.AD.6888.01", "Keratan sulfate biosynthesis"], ["TCGA.AD.6888.01", "Glucagon-type ligand receptors"], ["TCGA.AD.6888.01", "HS-GAG biosynthesis"], ["TCGA.AD.6888.01", "GABA B receptor activation"], ["TCGA.AD.6888.01", "Activation of GABAB receptors"], ["TCGA.AD.6888.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.AD.6888.01", "TNFs bind their physiological receptors"], ["TCGA.AD.6888.01", "FGFR4 ligand binding and activation"], ["TCGA.AD.6888.01", "CD22 mediated BCR regulation"], ["TCGA.AD.6888.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.AD.6888.01", "Diseases associated with O-glycosylation of proteins"], ["TCGA.AD.6888.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.AD.6888.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.AD.6888.01", "Phospholipase C-mediated cascade; FGFR4"], ["TCGA.AD.6888.01", "O-linked glycosylation"], ["TCGA.AD.6888.01", "Initial triggering of complement"], ["TCGA.AD.6888.01", "FGFR2 ligand binding and activation"], ["TCGA.AD.6888.01", "Insulin processing"], ["TCGA.AD.6888.01", "Scavenging by Class A Receptors"], ["TCGA.AD.6888.01", "G beta:gamma signalling through PLC beta"], ["TCGA.AD.6888.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.AD.6888.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.AD.6888.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.AD.6888.01", "Phospholipase C-mediated cascade: FGFR1"], ["TCGA.AD.6888.01", "Blood group systems biosynthesis"], ["TCGA.AD.6888.01", "Activation of the phototransduction cascade"], ["TCGA.AD.6888.01", "Specification of primordial germ cells"], ["TCGA.AD.6889.01", "Phase 0 - rapid depolarisation"], ["TCGA.AD.6889.01", "Initial triggering of complement"], ["TCGA.AD.6889.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AD.6889.01", "Interaction between L1 and Ankyrins"], ["TCGA.AD.6889.01", "Classical antibody-mediated complement activation"], ["TCGA.AD.6889.01", "Transcriptional regulation of testis differentiation"], ["TCGA.AD.6889.01", "Potassium Channels"], ["TCGA.AD.6889.01", "Glucagon-type ligand receptors"], ["TCGA.AD.6889.01", "Creation of C4 and C2 activators"], ["TCGA.AD.6889.01", "Antimicrobial peptides"], ["TCGA.AD.6889.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.AD.6889.01", "GABA receptor activation"], ["TCGA.AD.6889.01", "Sialic acid metabolism"], ["TCGA.AD.6889.01", "Voltage gated Potassium channels"], ["TCGA.AD.6889.01", "CD22 mediated BCR regulation"], ["TCGA.AD.6889.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.AD.6889.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.AD.6889.01", "Activation of the phototransduction cascade"], ["TCGA.AD.6889.01", "Sensory processing of sound by outer hair cells of the cochlea"], ["TCGA.AD.6889.01", "RA biosynthesis pathway"], ["TCGA.AD.6889.01", "Synaptic adhesion-like molecules"], ["TCGA.AD.6889.01", "LGI-ADAM interactions"], ["TCGA.AD.6889.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.AD.6889.01", "Arachidonic acid metabolism"], ["TCGA.AD.6889.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.AD.6890.01", "Interaction between L1 and Ankyrins"], ["TCGA.AD.6890.01", "Blood group systems biosynthesis"], ["TCGA.AD.6890.01", "Potassium Channels"], ["TCGA.AD.6890.01", "Inwardly rectifying K+ channels"], ["TCGA.AD.6890.01", "Phase 4 - resting membrane potential"], ["TCGA.AD.6890.01", "Lewis blood group biosynthesis"], ["TCGA.AD.6890.01", "Glucagon signaling in metabolic regulation"], ["TCGA.AD.6890.01", "Glucagon-type ligand receptors"], ["TCGA.AD.6890.01", "G beta:gamma signalling through BTK"], ["TCGA.AD.6890.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.AD.6890.01", "Phase 0 - rapid depolarisation"], ["TCGA.AD.6890.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.AD.6890.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AD.6890.01", "Signal amplification"], ["TCGA.AD.6890.01", "GABA receptor activation"], ["TCGA.AD.6890.01", "Presynaptic function of Kainate receptors"], ["TCGA.AD.6890.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.AD.6890.01", "Acyl chain remodelling of PE"], ["TCGA.AD.6890.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AD.6890.01", "Activation of G protein gated Potassium channels"], ["TCGA.AD.6890.01", "G protein gated Potassium channels"], ["TCGA.AD.6890.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.AD.6890.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.AD.6890.01", "GABA B receptor activation"], ["TCGA.AD.6890.01", "Activation of GABAB receptors"], ["TCGA.AD.6890.01", "IL-6-type cytokine receptor ligand interactions"], ["TCGA.AD.6890.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.AD.6890.01", "Prostacyclin signalling through prostacyclin receptor"], ["TCGA.AD.6890.01", "Neurexins and neuroligins"], ["TCGA.AD.6890.01", "Insulin processing"], ["TCGA.AD.6890.01", "G beta:gamma signalling through PLC beta"], ["TCGA.AD.6890.01", "Transport of bile salts and organic acids, metal ions and amine compounds"], ["TCGA.AD.6890.01", "Phase II - Conjugation of compounds"], ["TCGA.AD.6890.01", "Protein-protein interactions at synapses"], ["TCGA.AD.6890.01", "ADORA2B mediated anti-inflammatory cytokines production"], ["TCGA.AD.6890.01", "Biological oxidations"], ["TCGA.AD.6890.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.AD.6895.01", "Phase II - Conjugation of compounds"], ["TCGA.AD.6895.01", "RA biosynthesis pathway"], ["TCGA.AD.6895.01", "Interaction between L1 and Ankyrins"], ["TCGA.AD.6895.01", "Glucuronidation"], ["TCGA.AD.6895.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AD.6895.01", "Phase 0 - rapid depolarisation"], ["TCGA.AD.6895.01", "APAP ADME"], ["TCGA.AD.6895.01", "Signaling by Retinoic Acid"], ["TCGA.AD.6895.01", "Voltage gated Potassium channels"], ["TCGA.AD.6895.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], ["TCGA.AD.6895.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.AD.6895.01", "Collagen chain trimerization"], ["TCGA.AD.6895.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.AD.6895.01", "NCAM1 interactions"], ["TCGA.AD.6895.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.AD.6895.01", "Ethanol oxidation"], ["TCGA.AD.6895.01", "Aspirin ADME"], ["TCGA.AD.6895.01", "Potassium Channels"], ["TCGA.AD.6895.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.AD.6895.01", "Heme degradation"], ["TCGA.AD.6895.01", "Glutathione conjugation"], ["TCGA.AD.6895.01", "O-linked glycosylation"], ["TCGA.AD.6895.01", "IL-6-type cytokine receptor ligand interactions"], ["TCGA.AD.6895.01", "TP53 Regulates Transcription of Death Receptors and Ligands"], ["TCGA.AD.6899.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AD.6899.01", "Phase II - Conjugation of compounds"], ["TCGA.AD.6899.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AD.6899.01", "Ethanol oxidation"], ["TCGA.AD.6901.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.AD.6901.01", "Collagen chain trimerization"], ["TCGA.AD.6901.01", "Glucuronidation"], ["TCGA.AD.6901.01", "APAP ADME"], ["TCGA.AD.6901.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AD.6901.01", "Phase II - Conjugation of compounds"], ["TCGA.AD.6901.01", "Peptide hormone biosynthesis"], ["TCGA.AD.6901.01", "Presynaptic function of Kainate receptors"], ["TCGA.AD.6901.01", "G-protein activation"], ["TCGA.AD.6901.01", "Glucagon-type ligand receptors"], ["TCGA.AD.6901.01", "Prostacyclin signalling through prostacyclin receptor"], ["TCGA.AD.6901.01", "Degradation of cysteine and homocysteine"], ["TCGA.AD.6901.01", "Inwardly rectifying K+ channels"], ["TCGA.AD.6901.01", "G beta:gamma signalling through PLC beta"], ["TCGA.AD.6901.01", "Phase 2 - plateau phase"], ["TCGA.AD.6901.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.AD.6901.01", "Activation of the phototransduction cascade"], ["TCGA.AD.6901.01", "WNT ligand biogenesis and trafficking"], ["TCGA.AD.6963.01", "Phase II - Conjugation of compounds"], ["TCGA.AD.6963.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.AD.6963.01", "Phase 0 - rapid depolarisation"], ["TCGA.AD.6963.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AD.6963.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AD.6963.01", "Aspirin ADME"], ["TCGA.AD.6963.01", "Glucuronidation"], ["TCGA.AD.6963.01", "Phase 4 - resting membrane potential"], ["TCGA.AD.6963.01", "Ethanol oxidation"], ["TCGA.AD.6963.01", "Heme degradation"], ["TCGA.AD.6964.01", "Phase II - Conjugation of compounds"], ["TCGA.AD.6964.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.AD.6964.01", "Collagen chain trimerization"], ["TCGA.AD.6964.01", "Glucuronidation"], ["TCGA.AD.6964.01", "Other semaphorin interactions"], ["TCGA.AD.6964.01", "APAP ADME"], ["TCGA.AD.6964.01", "Glycosaminoglycan metabolism"], ["TCGA.AD.6964.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AD.6964.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.AD.6964.01", "Scavenging by Class A Receptors"], ["TCGA.AD.6964.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.AD.6964.01", "Glutathione conjugation"], ["TCGA.AD.6964.01", "Collagen degradation"], ["TCGA.AD.6964.01", "O-linked glycosylation of mucins"], ["TCGA.AD.6964.01", "Glucagon-type ligand receptors"], ["TCGA.AD.6964.01", "Aspirin ADME"], ["TCGA.AD.6964.01", "O-linked glycosylation"], ["TCGA.AD.6964.01", "Synaptic adhesion-like molecules"], ["TCGA.AD.6964.01", "Scavenging of heme from plasma"], ["TCGA.AD.6964.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], ["TCGA.AD.6964.01", "Interaction between L1 and Ankyrins"], ["TCGA.AD.6964.01", "Recycling of bile acids and salts"], ["TCGA.AD.6964.01", "Defective GALNT3 causes HFTC"], ["TCGA.AD.6964.01", "Defective GALNT12 causes CRCS1"], ["TCGA.AD.6964.01", "Sensory perception of taste"], ["TCGA.AD.6964.01", "Erythrocytes take up carbon dioxide and release oxygen"], ["TCGA.AD.6964.01", "O2/CO2 exchange in erythrocytes"], ["TCGA.AD.6965.01", "Phase 0 - rapid depolarisation"], ["TCGA.AD.6965.01", "Interaction between L1 and Ankyrins"], ["TCGA.AD.6965.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.AD.6965.01", "Phase II - Conjugation of compounds"], ["TCGA.AD.6965.01", "Classical antibody-mediated complement activation"], ["TCGA.AD.6965.01", "Biosynthesis of specialized proresolving mediators (SPMs)"], ["TCGA.AD.6965.01", "Phase 4 - resting membrane potential"], ["TCGA.AD.6965.01", "Defensins"], ["TCGA.AD.6965.01", "Blood group systems biosynthesis"], ["TCGA.AD.6965.01", "Collagen chain trimerization"], ["TCGA.AM.5820.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AM.5820.01", "TNFs bind their physiological receptors"], ["TCGA.AM.5820.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AM.5820.01", "Blood group systems biosynthesis"], ["TCGA.AM.5820.01", "Activation of G protein gated Potassium channels"], ["TCGA.AM.5820.01", "G protein gated Potassium channels"], ["TCGA.AM.5820.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.AM.5820.01", "Inwardly rectifying K+ channels"], ["TCGA.AM.5820.01", "GABA receptor activation"], ["TCGA.AM.5820.01", "Potassium Channels"], ["TCGA.AM.5820.01", "Lewis blood group biosynthesis"], ["TCGA.AM.5820.01", "Neurexins and neuroligins"], ["TCGA.AM.5820.01", "FOXO-mediated transcription of cell death genes"], ["TCGA.AM.5820.01", "Synaptic adhesion-like molecules"], ["TCGA.AM.5820.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.AM.5821.01", "Glucuronidation"], ["TCGA.AM.5821.01", "Phase II - Conjugation of compounds"], ["TCGA.AM.5821.01", "Interaction between L1 and Ankyrins"], ["TCGA.AM.5821.01", "Ethanol oxidation"], ["TCGA.AM.5821.01", "Arachidonic acid metabolism"], ["TCGA.AM.5821.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AM.5821.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.AM.5821.01", "Synthesis of bile acids and bile salts via 27-hydroxycholesterol"], ["TCGA.AM.5821.01", "Bile acid and bile salt metabolism"], ["TCGA.AM.5821.01", "Aspirin ADME"], ["TCGA.AM.5821.01", "Cytochrome P450 - arranged by substrate type"], ["TCGA.AM.5821.01", "Phase 0 - rapid depolarisation"], ["TCGA.AM.5821.01", "Collagen formation"], ["TCGA.AM.5821.01", "Tryptophan catabolism"], ["TCGA.AM.5821.01", "GABA receptor activation"], ["TCGA.AM.5821.01", "Synthesis of bile acids and bile salts"], ["TCGA.AM.5821.01", "Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"], ["TCGA.AM.5821.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.AM.5821.01", "Potassium Channels"], ["TCGA.AM.5821.01", "Amino acid transport across the plasma membrane"], ["TCGA.AM.5821.01", "Free fatty acids regulate insulin secretion"], ["TCGA.AM.5821.01", "Adenylate cyclase inhibitory pathway"], ["TCGA.AM.5821.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], ["TCGA.AM.5821.01", "Neurexins and neuroligins"], ["TCGA.AM.5821.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.AM.5821.01", "GABA B receptor activation"], ["TCGA.AM.5821.01", "Activation of GABAB receptors"], ["TCGA.AM.5821.01", "Defective GALNT12 causes CRCS1"], ["TCGA.AM.5821.01", "APAP ADME"], ["TCGA.AM.5821.01", "O-linked glycosylation"], ["TCGA.AM.5821.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.AM.5821.01", "Aflatoxin activation and detoxification"], ["TCGA.AM.5821.01", "Kinesins"], ["TCGA.AM.5821.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AM.5821.01", "Synaptic adhesion-like molecules"], ["TCGA.AM.5821.01", "Biosynthesis of DHA-derived SPMs"], ["TCGA.AM.5821.01", "Transcriptional regulation of pluripotent stem cells"], ["TCGA.AM.5821.01", "WNT ligand biogenesis and trafficking"], ["TCGA.AM.5821.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], ["TCGA.AM.5821.01", "Phase 2 - plateau phase"], ["TCGA.AU.3779.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AU.3779.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.AU.3779.01", "Peptide ligand-binding receptors"], ["TCGA.AU.3779.01", "Phase II - Conjugation of compounds"], ["TCGA.AU.3779.01", "GABA receptor activation"], ["TCGA.AU.3779.01", "Degradation of the extracellular matrix"], ["TCGA.AU.3779.01", "Glucuronidation"], ["TCGA.AU.3779.01", "Potassium Channels"], ["TCGA.AU.3779.01", "Glucagon-type ligand receptors"], ["TCGA.AU.3779.01", "Chemokine receptors bind chemokines"], ["TCGA.AU.3779.01", "O-linked glycosylation of mucins"], ["TCGA.AU.3779.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.AU.3779.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], ["TCGA.AU.3779.01", "Ethanol oxidation"], ["TCGA.AU.3779.01", "Signaling by BMP"], ["TCGA.AU.3779.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.AU.3779.01", "Signal amplification"], ["TCGA.AU.3779.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.AU.3779.01", "Glucagon signaling in metabolic regulation"], ["TCGA.AU.3779.01", "Aspirin ADME"], ["TCGA.AU.3779.01", "GABA B receptor activation"], ["TCGA.AU.3779.01", "Activation of GABAB receptors"], ["TCGA.AU.3779.01", "Interaction between L1 and Ankyrins"], ["TCGA.AU.3779.01", "Presynaptic function of Kainate receptors"], ["TCGA.AU.3779.01", "Metabolism of amine-derived hormones"], ["TCGA.AU.3779.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.AU.3779.01", "Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding"], ["TCGA.AU.3779.01", "Phase 0 - rapid depolarisation"], ["TCGA.AU.3779.01", "Collagen formation"], ["TCGA.AU.3779.01", "G-protein activation"], ["TCGA.AU.3779.01", "Thromboxane signalling through TP receptor"], ["TCGA.AU.3779.01", "Sensory processing of sound by outer hair cells of the cochlea"], ["TCGA.AU.3779.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AU.3779.01", "Phase 4 - resting membrane potential"], ["TCGA.AU.3779.01", "ADORA2B mediated anti-inflammatory cytokines production"], ["TCGA.AU.3779.01", "Keratan sulfate biosynthesis"], ["TCGA.AU.3779.01", "Interleukin-6 family signaling"], ["TCGA.AU.3779.01", "RA biosynthesis pathway"], ["TCGA.AU.3779.01", "IL-6-type cytokine receptor ligand interactions"], ["TCGA.AU.3779.01", "G beta:gamma signalling through BTK"], ["TCGA.AU.3779.01", "Inwardly rectifying K+ channels"], ["TCGA.AU.3779.01", "Heme degradation"], ["TCGA.AU.6004.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AU.6004.01", "Interaction between L1 and Ankyrins"], ["TCGA.AU.6004.01", "Glucuronidation"], ["TCGA.AU.6004.01", "Phase II - Conjugation of compounds"], ["TCGA.AU.6004.01", "Potassium Channels"], ["TCGA.AU.6004.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.AU.6004.01", "Collagen chain trimerization"], ["TCGA.AU.6004.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], ["TCGA.AU.6004.01", "WNT ligand biogenesis and trafficking"], ["TCGA.AU.6004.01", "Aspirin ADME"], ["TCGA.AU.6004.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.AU.6004.01", "Phase 4 - resting membrane potential"], ["TCGA.AU.6004.01", "NCAM1 interactions"], ["TCGA.AU.6004.01", "Phase 0 - rapid depolarisation"], ["TCGA.AU.6004.01", "O-linked glycosylation"], ["TCGA.AU.6004.01", "Inwardly rectifying K+ channels"], ["TCGA.AU.6004.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.AU.6004.01", "Diseases associated with O-glycosylation of proteins"], ["TCGA.AU.6004.01", "Glucagon-type ligand receptors"], ["TCGA.AU.6004.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AU.6004.01", "Ethanol oxidation"], ["TCGA.AY.5543.01", "Molecules associated with elastic fibres"], ["TCGA.AY.5543.01", "Elastic fibre formation"], ["TCGA.AY.5543.01", "Phase 0 - rapid depolarisation"], ["TCGA.AY.5543.01", "Interaction between L1 and Ankyrins"], ["TCGA.AY.5543.01", "Other semaphorin interactions"], ["TCGA.AY.5543.01", "Insulin processing"], ["TCGA.AY.5543.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.AY.5543.01", "Neurexins and neuroligins"], ["TCGA.AY.5543.01", "Endogenous sterols"], ["TCGA.AY.5543.01", "Glutathione conjugation"], ["TCGA.AY.5543.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.AY.6196.01", "Collagen formation"], ["TCGA.AY.6196.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.AY.6196.01", "Collagen chain trimerization"], ["TCGA.AY.6196.01", "Diseases associated with O-glycosylation of proteins"], ["TCGA.AY.6196.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.AY.6196.01", "APAP ADME"], ["TCGA.AY.6196.01", "O-linked glycosylation"], ["TCGA.AY.6196.01", "Defective B3GALTL causes PpS"], ["TCGA.AY.6196.01", "Phase II - Conjugation of compounds"], ["TCGA.AY.6196.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.AY.6196.01", "Triglyceride biosynthesis"], ["TCGA.AY.6196.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.AY.6196.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], ["TCGA.AY.6196.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AY.6196.01", "Surfactant metabolism"], ["TCGA.AY.6196.01", "Defective GALNT12 causes CRCS1"], ["TCGA.AY.6196.01", "Glucuronidation"], ["TCGA.AY.6196.01", "Other semaphorin interactions"], ["TCGA.AY.6196.01", "Aspirin ADME"], ["TCGA.AY.6196.01", "Scavenging by Class A Receptors"], ["TCGA.AY.6196.01", "Interaction between L1 and Ankyrins"], ["TCGA.AY.6196.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], ["TCGA.AY.6196.01", "Collagen degradation"], ["TCGA.AY.6197.01", "Interaction between L1 and Ankyrins"], ["TCGA.AY.6197.01", "Glucagon-type ligand receptors"], ["TCGA.AY.6197.01", "Potassium Channels"], ["TCGA.AY.6197.01", "Transcriptional regulation of testis differentiation"], ["TCGA.AY.6197.01", "Phase 0 - rapid depolarisation"], ["TCGA.AY.6197.01", "Blood group systems biosynthesis"], ["TCGA.AY.6197.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.AY.6197.01", "Activation of G protein gated Potassium channels"], ["TCGA.AY.6197.01", "G protein gated Potassium channels"], ["TCGA.AY.6197.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.AY.6197.01", "G beta:gamma signalling through BTK"], ["TCGA.AY.6197.01", "Sialic acid metabolism"], ["TCGA.AY.6197.01", "Neurexins and neuroligins"], ["TCGA.AY.6197.01", "GABA receptor activation"], ["TCGA.AY.6197.01", "GABA B receptor activation"], ["TCGA.AY.6197.01", "Activation of GABAB receptors"], ["TCGA.AY.6197.01", "Phase 4 - resting membrane potential"], ["TCGA.AY.6197.01", "Presynaptic function of Kainate receptors"], ["TCGA.AY.6197.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], ["TCGA.AY.6197.01", "Lewis blood group biosynthesis"], ["TCGA.AY.6197.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.AY.6197.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.AY.6197.01", "Inwardly rectifying K+ channels"], ["TCGA.AY.6197.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.AY.6197.01", "IL-6-type cytokine receptor ligand interactions"], ["TCGA.AY.6197.01", "Diseases associated with glycosaminoglycan metabolism"], ["TCGA.AY.6197.01", "Phase II - Conjugation of compounds"], ["TCGA.AY.6197.01", "Glucuronidation"], ["TCGA.AY.6197.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.AY.6197.01", "Prostacyclin signalling through prostacyclin receptor"], ["TCGA.AY.6197.01", "Termination of O-glycan biosynthesis"], ["TCGA.AY.6197.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.AY.6197.01", "Keratan sulfate biosynthesis"], ["TCGA.AY.6386.01", "Interaction between L1 and Ankyrins"], ["TCGA.AY.6386.01", "Potassium Channels"], ["TCGA.AY.6386.01", "Phase 0 - rapid depolarisation"], ["TCGA.AY.6386.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.AY.6386.01", "Glucagon-type ligand receptors"], ["TCGA.AY.6386.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AY.6386.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.AY.6386.01", "GABA receptor activation"], ["TCGA.AY.6386.01", "Class B/2 (Secretin family receptors)"], ["TCGA.AY.6386.01", "NCAM1 interactions"], ["TCGA.AY.6386.01", "Voltage gated Potassium channels"], ["TCGA.AY.6386.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.AY.6386.01", "Regulation of Complement cascade"], ["TCGA.AY.6386.01", "Phase 4 - resting membrane potential"], ["TCGA.AY.6386.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.AY.6386.01", "Inwardly rectifying K+ channels"], ["TCGA.AY.6386.01", "Activation of G protein gated Potassium channels"], ["TCGA.AY.6386.01", "G protein gated Potassium channels"], ["TCGA.AY.6386.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.AY.6386.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.AY.6386.01", "GABA B receptor activation"], ["TCGA.AY.6386.01", "Activation of GABAB receptors"], ["TCGA.AY.6386.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.AY.6386.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], ["TCGA.AY.6386.01", "Molecules associated with elastic fibres"], ["TCGA.AY.6386.01", "Collagen chain trimerization"], ["TCGA.AY.6386.01", "Complement cascade"], ["TCGA.AY.6386.01", "FGFR1 ligand binding and activation"], ["TCGA.AY.6386.01", "G beta:gamma signalling through BTK"], ["TCGA.AY.6386.01", "Arachidonic acid metabolism"], ["TCGA.AY.6386.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.AY.6386.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.AY.6386.01", "Neurexins and neuroligins"], ["TCGA.AY.6386.01", "LGI-ADAM interactions"], ["TCGA.AZ.4323.01", "Peptide hormone biosynthesis"], ["TCGA.AZ.4323.01", "Interaction between L1 and Ankyrins"], ["TCGA.AZ.4323.01", "Potassium Channels"], ["TCGA.AZ.4323.01", "Glucagon-type ligand receptors"], ["TCGA.AZ.4323.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AZ.4323.01", "Phase II - Conjugation of compounds"], ["TCGA.AZ.4323.01", "APAP ADME"], ["TCGA.AZ.4323.01", "O-linked glycosylation"], ["TCGA.AZ.4323.01", "Voltage gated Potassium channels"], ["TCGA.AZ.4323.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.AZ.4323.01", "Glucuronidation"], ["TCGA.AZ.4323.01", "Receptor-type tyrosine-protein phosphatases"], ["TCGA.AZ.4323.01", "Phase 4 - resting membrane potential"], ["TCGA.AZ.4323.01", "Ethanol oxidation"], ["TCGA.AZ.4323.01", "Norepinephrine Neurotransmitter Release Cycle"], ["TCGA.AZ.4323.01", "Defective B3GALTL causes PpS"], ["TCGA.AZ.4323.01", "Presynaptic nicotinic acetylcholine receptors"], ["TCGA.AZ.4615.01", "Interaction between L1 and Ankyrins"], ["TCGA.AZ.4615.01", "Phase 0 - rapid depolarisation"], ["TCGA.AZ.4615.01", "GABA receptor activation"], ["TCGA.AZ.4615.01", "Potassium Channels"], ["TCGA.AZ.4615.01", "Glucagon-type ligand receptors"], ["TCGA.AZ.4615.01", "Phase II - Conjugation of compounds"], ["TCGA.AZ.4615.01", "NCAM1 interactions"], ["TCGA.AZ.4615.01", "O-linked glycosylation"], ["TCGA.AZ.4615.01", "Collagen chain trimerization"], ["TCGA.AZ.4615.01", "Neurexins and neuroligins"], ["TCGA.AZ.4615.01", "GABA B receptor activation"], ["TCGA.AZ.4615.01", "Activation of GABAB receptors"], ["TCGA.AZ.4615.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.AZ.4615.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.AZ.4615.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.AZ.4615.01", "Digestion and absorption"], ["TCGA.AZ.4615.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.AZ.4615.01", "RA biosynthesis pathway"], ["TCGA.AZ.4615.01", "Glutathione conjugation"], ["TCGA.AZ.4615.01", "Digestion"], ["TCGA.AZ.4615.01", "Signaling by Retinoic Acid"], ["TCGA.AZ.4615.01", "APAP ADME"], ["TCGA.AZ.4615.01", "Voltage gated Potassium channels"], ["TCGA.AZ.4615.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AZ.4615.01", "Transcriptional regulation of testis differentiation"], ["TCGA.AZ.4615.01", "O-linked glycosylation of mucins"], ["TCGA.AZ.4615.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AZ.4615.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.AZ.4615.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.AZ.4615.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.AZ.4615.01", "Inwardly rectifying K+ channels"], ["TCGA.AZ.4615.01", "Defective B3GALTL causes PpS"], ["TCGA.AZ.4615.01", "Activation of G protein gated Potassium channels"], ["TCGA.AZ.4615.01", "G protein gated Potassium channels"], ["TCGA.AZ.4615.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.AZ.4615.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.AZ.4615.01", "Antimicrobial peptides"], ["TCGA.AZ.4615.01", "Glutamate Neurotransmitter Release Cycle"], ["TCGA.AZ.4615.01", "Synaptic adhesion-like molecules"], ["TCGA.AZ.4616.01", "Interaction between L1 and Ankyrins"], ["TCGA.AZ.4616.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AZ.4616.01", "Blood group systems biosynthesis"], ["TCGA.AZ.4616.01", "Phase 2 - plateau phase"], ["TCGA.AZ.4616.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], ["TCGA.AZ.4616.01", "Lewis blood group biosynthesis"], ["TCGA.AZ.4681.01", "Binding and entry of HIV virion"], ["TCGA.AZ.4681.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.AZ.4681.01", "Unwinding of DNA"], ["TCGA.AZ.4681.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.AZ.4681.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.AZ.4681.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.AZ.4681.01", "Leishmania parasite growth and survival"], ["TCGA.AZ.4681.01", "G-protein beta:gamma signalling"], ["TCGA.AZ.4681.01", "DNA strand elongation"], ["TCGA.AZ.4681.01", "Cellular response to starvation"], ["TCGA.AZ.4681.01", "Azathioprine ADME"], ["TCGA.AZ.4681.01", "Viral mRNA Translation"], ["TCGA.AZ.4681.01", "Eukaryotic Translation Elongation"], ["TCGA.AZ.4681.01", "Eukaryotic Translation Termination"], ["TCGA.AZ.4681.01", "Peptide chain elongation"], ["TCGA.AZ.4681.01", "Formation of a pool of free 40S subunits"], ["TCGA.AZ.4681.01", "G beta:gamma signalling through CDC42"], ["TCGA.AZ.4681.01", "Glucagon signaling in metabolic regulation"], ["TCGA.AZ.4681.01", "rRNA processing"], ["TCGA.AZ.4681.01", "Selenocysteine synthesis"], ["TCGA.AZ.4681.01", "Regulation of insulin secretion"], ["TCGA.AZ.4681.01", "G alpha (z) signalling events"], ["TCGA.AZ.4681.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.AZ.4681.01", "rRNA processing in the nucleus and cytosol"], ["TCGA.AZ.4681.01", "Immune System"], ["TCGA.AZ.4681.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.AZ.4681.01", "Post-chaperonin tubulin folding pathway"], ["TCGA.AZ.4681.01", "Major pathway of rRNA processing in the nucleolus and cytosol"], ["TCGA.AZ.4681.01", "Influenza Viral RNA Transcription and Replication"], ["TCGA.AZ.4681.01", "Integration of energy metabolism"], ["TCGA.AZ.4681.01", "Leishmania infection"], ["TCGA.AZ.4681.01", "Parasitic Infection Pathways"], ["TCGA.AZ.4681.01", "Signal amplification"], ["TCGA.AZ.4681.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.AZ.4681.01", "Selenoamino acid metabolism"], ["TCGA.AZ.4681.01", "Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)"], ["TCGA.AZ.4681.01", "Response of EIF2AK4 (GCN2) to amino acid deficiency"], ["TCGA.AZ.4681.01", "L13a-mediated translational silencing of Ceruloplasmin expression"], ["TCGA.AZ.4681.01", "GTP hydrolysis and joining of the 60S ribosomal subunit"], ["TCGA.AZ.4681.01", "GPER1 signaling"], ["TCGA.AZ.4681.01", "ADORA2B mediated anti-inflammatory cytokines production"], ["TCGA.AZ.4681.01", "G alpha (i) signalling events"], ["TCGA.AZ.4681.01", "Influenza Infection"], ["TCGA.AZ.4681.01", "Ribavirin ADME"], ["TCGA.AZ.4681.01", "Eukaryotic Translation Initiation"], ["TCGA.AZ.4681.01", "Cap-dependent Translation Initiation"], ["TCGA.AZ.4681.01", "MyD88 deficiency (TLR2/4)"], ["TCGA.AZ.4681.01", "IRAK4 deficiency (TLR2/4)"], ["TCGA.AZ.4681.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], ["TCGA.AZ.4681.01", "Aquaporin-mediated transport"], ["TCGA.AZ.4681.01", "Phosphorylation of CD3 and TCR zeta chains"], ["TCGA.AZ.4681.01", "Protein folding"], ["TCGA.AZ.4681.01", "Cell surface interactions at the vascular wall"], ["TCGA.AZ.4681.01", "Telomere Maintenance"], ["TCGA.AZ.4681.01", "Nonsense-Mediated Decay (NMD)"], ["TCGA.AZ.4681.01", "Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)"], ["TCGA.AZ.4681.01", "Nervous system development"], ["TCGA.AZ.4681.01", "Diseases of Immune System"], ["TCGA.AZ.4681.01", "Defects in Toll-like Receptor Cascades"], ["TCGA.AZ.4681.01", "Chromosome Maintenance"], ["TCGA.AZ.4681.01", "Platelet homeostasis"], ["TCGA.AZ.4681.01", "Extra-nuclear estrogen signaling"], ["TCGA.AZ.4681.01", "Translocation of ZAP-70 to Immunological synapse"], ["TCGA.AZ.4681.01", "Chemokine receptors bind chemokines"], ["TCGA.AZ.4681.01", "SARS-CoV-2 modulates host translation machinery"], ["TCGA.AZ.4681.01", "CD28 dependent PI3K/Akt signaling"], ["TCGA.AZ.4681.01", "Signaling Pathways"], ["TCGA.AZ.4681.01", "SRP-dependent cotranslational protein targeting to membrane"], ["TCGA.AZ.4681.01", "FCGR3A-mediated IL10 synthesis"], ["TCGA.AZ.4681.01", "Interleukin-4 and Interleukin-13 signaling"], ["TCGA.AZ.4681.01", "Translesion synthesis by POLK"], ["TCGA.AZ.4681.01", "Translesion synthesis by POLI"], ["TCGA.AZ.4681.01", "EGR2 and SOX10-mediated initiation of Schwann cell myelination"], ["TCGA.AZ.4681.01", "Opioid Signalling"], ["TCGA.AZ.4681.01", "B Cell Activation"], ["TCGA.AZ.4681.01", "APOBEC3G mediated resistance to HIV-1 infection"], ["TCGA.AZ.4681.01", "CD22 mediated BCR regulation"], ["TCGA.AZ.4681.01", "Early Phase of HIV Life Cycle"], ["TCGA.AZ.4681.01", "Activation of the pre-replicative complex"], ["TCGA.AZ.4681.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.AZ.4681.01", "Heme degradation"], ["TCGA.AZ.4681.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.AZ.4681.01", "Regulation of Complement cascade"], ["TCGA.AZ.4681.01", "Chaperonin-mediated protein folding"], ["TCGA.AZ.4682.01", "GABA receptor activation"], ["TCGA.AZ.4682.01", "GABA B receptor activation"], ["TCGA.AZ.4682.01", "Activation of GABAB receptors"], ["TCGA.AZ.4682.01", "Potassium Channels"], ["TCGA.AZ.4682.01", "Interaction between L1 and Ankyrins"], ["TCGA.AZ.4682.01", "Phase 0 - rapid depolarisation"], ["TCGA.AZ.4682.01", "Chemokine receptors bind chemokines"], ["TCGA.AZ.4682.01", "Presynaptic function of Kainate receptors"], ["TCGA.AZ.4682.01", "Signal amplification"], ["TCGA.AZ.4682.01", "Complement cascade"], ["TCGA.AZ.4682.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.AZ.4682.01", "Regulation of Complement cascade"], ["TCGA.AZ.4682.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.AZ.4682.01", "CD22 mediated BCR regulation"], ["TCGA.AZ.4682.01", "Activation of G protein gated Potassium channels"], ["TCGA.AZ.4682.01", "G protein gated Potassium channels"], ["TCGA.AZ.4682.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.AZ.4682.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.AZ.4682.01", "Inwardly rectifying K+ channels"], ["TCGA.AZ.4682.01", "Glutamate Neurotransmitter Release Cycle"], ["TCGA.AZ.4682.01", "G beta:gamma signalling through BTK"], ["TCGA.AZ.4682.01", "LGI-ADAM interactions"], ["TCGA.AZ.4682.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.AZ.4682.01", "Activation of the phototransduction cascade"], ["TCGA.AZ.4682.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.AZ.4682.01", "ADORA2B mediated anti-inflammatory cytokines production"], ["TCGA.AZ.4682.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.AZ.4682.01", "Adenylate cyclase inhibitory pathway"], ["TCGA.AZ.4682.01", "G beta:gamma signalling through PLC beta"], ["TCGA.AZ.4682.01", "G beta:gamma signalling through CDC42"], ["TCGA.AZ.4682.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AZ.4682.01", "Phase 4 - resting membrane potential"], ["TCGA.AZ.4682.01", "Phase II - Conjugation of compounds"], ["TCGA.AZ.4682.01", "Norepinephrine Neurotransmitter Release Cycle"], ["TCGA.AZ.4682.01", "Glucagon signaling in metabolic regulation"], ["TCGA.AZ.4682.01", "Neurexins and neuroligins"], ["TCGA.AZ.4682.01", "MyD88 deficiency (TLR2/4)"], ["TCGA.AZ.4682.01", "IRAK4 deficiency (TLR2/4)"], ["TCGA.AZ.4682.01", "Arachidonic acid metabolism"], ["TCGA.AZ.4682.01", "Prostacyclin signalling through prostacyclin receptor"], ["TCGA.AZ.5403.01", "TNFs bind their physiological receptors"], ["TCGA.AZ.5403.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AZ.5403.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.AZ.5403.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.AZ.5403.01", "Initial triggering of complement"], ["TCGA.AZ.5403.01", "TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway"], ["TCGA.AZ.5403.01", "Collagen chain trimerization"], ["TCGA.AZ.5403.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AZ.5403.01", "Ethanol oxidation"], ["TCGA.AZ.5407.01", "Interaction between L1 and Ankyrins"], ["TCGA.AZ.5407.01", "Phase 0 - rapid depolarisation"], ["TCGA.AZ.5407.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AZ.5407.01", "Phase II - Conjugation of compounds"], ["TCGA.AZ.5407.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.AZ.5407.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AZ.5407.01", "Transcriptional regulation of testis differentiation"], ["TCGA.AZ.6598.01", "Phase 0 - rapid depolarisation"], ["TCGA.AZ.6598.01", "Interaction between L1 and Ankyrins"], ["TCGA.AZ.6598.01", "NCAM1 interactions"], ["TCGA.AZ.6598.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.AZ.6598.01", "Neurexins and neuroligins"], ["TCGA.AZ.6598.01", "Collagen chain trimerization"], ["TCGA.AZ.6598.01", "Bile acid and bile salt metabolism"], ["TCGA.AZ.6598.01", "GABA receptor activation"], ["TCGA.AZ.6598.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AZ.6598.01", "Synthesis of bile acids and bile salts"], ["TCGA.AZ.6598.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], ["TCGA.AZ.6598.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AZ.6598.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.AZ.6598.01", "Potassium Channels"], ["TCGA.AZ.6598.01", "Glucagon-type ligand receptors"], ["TCGA.AZ.6598.01", "Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"], ["TCGA.AZ.6598.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.AZ.6598.01", "APAP ADME"], ["TCGA.AZ.6598.01", "Synthesis of bile acids and bile salts via 27-hydroxycholesterol"], ["TCGA.AZ.6598.01", "CD22 mediated BCR regulation"], ["TCGA.AZ.6598.01", "Arachidonic acid metabolism"], ["TCGA.AZ.6598.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.AZ.6598.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.AZ.6598.01", "GABA B receptor activation"], ["TCGA.AZ.6598.01", "Activation of GABAB receptors"], ["TCGA.AZ.6598.01", "RA biosynthesis pathway"], ["TCGA.AZ.6598.01", "Synaptic adhesion-like molecules"], ["TCGA.AZ.6598.01", "LGI-ADAM interactions"], ["TCGA.AZ.6598.01", "Erythrocytes take up carbon dioxide and release oxygen"], ["TCGA.AZ.6598.01", "O2/CO2 exchange in erythrocytes"], ["TCGA.AZ.6598.01", "Aspirin ADME"], ["TCGA.AZ.6598.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.AZ.6598.01", "Glucuronidation"], ["TCGA.AZ.6598.01", "Phase II - Conjugation of compounds"], ["TCGA.AZ.6598.01", "Transcriptional regulation of testis differentiation"], ["TCGA.AZ.6599.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.AZ.6599.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AZ.6599.01", "Collagen chain trimerization"], ["TCGA.AZ.6599.01", "Scavenging by Class A Receptors"], ["TCGA.AZ.6599.01", "Classical antibody-mediated complement activation"], ["TCGA.AZ.6599.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], ["TCGA.AZ.6599.01", "GABA receptor activation"], ["TCGA.AZ.6599.01", "Initial triggering of complement"], ["TCGA.AZ.6599.01", "Interaction between L1 and Ankyrins"], ["TCGA.AZ.6599.01", "NCAM1 interactions"], ["TCGA.AZ.6599.01", "Creation of C4 and C2 activators"], ["TCGA.AZ.6599.01", "Phase 0 - rapid depolarisation"], ["TCGA.AZ.6599.01", "Neurexins and neuroligins"], ["TCGA.AZ.6599.01", "FGFR1 ligand binding and activation"], ["TCGA.AZ.6599.01", "G beta:gamma signalling through BTK"], ["TCGA.AZ.6599.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], ["TCGA.AZ.6599.01", "GABA B receptor activation"], ["TCGA.AZ.6599.01", "Activation of GABAB receptors"], ["TCGA.AZ.6599.01", "Defensins"], ["TCGA.AZ.6599.01", "Scavenging of heme from plasma"], ["TCGA.AZ.6599.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], ["TCGA.AZ.6599.01", "G-protein activation"], ["TCGA.AZ.6599.01", "Glucagon-type ligand receptors"], ["TCGA.AZ.6599.01", "G beta:gamma signalling through PLC beta"], ["TCGA.AZ.6599.01", "Presynaptic function of Kainate receptors"], ["TCGA.AZ.6599.01", "Phospholipase C-mediated cascade: FGFR1"], ["TCGA.AZ.6599.01", "Activation of the phototransduction cascade"], ["TCGA.AZ.6599.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.AZ.6599.01", "FGFR1c ligand binding and activation"], ["TCGA.AZ.6599.01", "Erythrocytes take up carbon dioxide and release oxygen"], ["TCGA.AZ.6599.01", "O2/CO2 exchange in erythrocytes"], ["TCGA.AZ.6599.01", "Potassium Channels"], ["TCGA.AZ.6599.01", "Activation of G protein gated Potassium channels"], ["TCGA.AZ.6599.01", "G protein gated Potassium channels"], ["TCGA.AZ.6599.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.AZ.6599.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.AZ.6599.01", "Glucuronidation"], ["TCGA.AZ.6599.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.AZ.6599.01", "Prostacyclin signalling through prostacyclin receptor"], ["TCGA.AZ.6599.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AZ.6599.01", "Transcriptional regulation of testis differentiation"], ["TCGA.AZ.6600.01", "Glucuronidation"], ["TCGA.AZ.6600.01", "Phase II - Conjugation of compounds"], ["TCGA.AZ.6600.01", "Collagen formation"], ["TCGA.AZ.6600.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.AZ.6600.01", "Collagen chain trimerization"], ["TCGA.AZ.6600.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AZ.6600.01", "Aspirin ADME"], ["TCGA.AZ.6600.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AZ.6600.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.AZ.6600.01", "Antimicrobial peptides"], ["TCGA.AZ.6600.01", "mitochondrial fatty acid beta-oxidation of saturated fatty acids"], ["TCGA.AZ.6600.01", "Transcriptional regulation of testis differentiation"], ["TCGA.AZ.6600.01", "Physiological factors"], ["TCGA.AZ.6600.01", "YAP1- and WWTR1 (TAZ)-stimulated gene expression"], ["TCGA.AZ.6600.01", "Glycogen synthesis"], ["TCGA.AZ.6600.01", "Metal ion SLC transporters"], ["TCGA.AZ.6600.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], ["TCGA.AZ.6601.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AZ.6601.01", "Glucuronidation"], ["TCGA.AZ.6601.01", "Phase II - Conjugation of compounds"], ["TCGA.AZ.6601.01", "Collagen chain trimerization"], ["TCGA.AZ.6601.01", "Phase 0 - rapid depolarisation"], ["TCGA.AZ.6601.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AZ.6601.01", "Blood group systems biosynthesis"], ["TCGA.AZ.6601.01", "NCAM1 interactions"], ["TCGA.AZ.6601.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], ["TCGA.AZ.6601.01", "GABA receptor activation"], ["TCGA.AZ.6601.01", "Synaptic adhesion-like molecules"], ["TCGA.AZ.6601.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.AZ.6601.01", "Defective GALNT3 causes HFTC"], ["TCGA.AZ.6601.01", "Defective GALNT12 causes CRCS1"], ["TCGA.AZ.6601.01", "Termination of O-glycan biosynthesis"], ["TCGA.AZ.6601.01", "WNT ligand biogenesis and trafficking"], ["TCGA.AZ.6601.01", "APAP ADME"], ["TCGA.AZ.6601.01", "Defective C1GALT1C1 causes TNPS"], ["TCGA.AZ.6601.01", "Interaction between L1 and Ankyrins"], ["TCGA.AZ.6601.01", "Phase 2 - plateau phase"], ["TCGA.AZ.6603.01", "Phase II - Conjugation of compounds"], ["TCGA.AZ.6603.01", "Glucuronidation"], ["TCGA.AZ.6603.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AZ.6603.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.AZ.6603.01", "Neurexins and neuroligins"], ["TCGA.AZ.6605.01", "Collagen formation"], ["TCGA.AZ.6605.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.AZ.6605.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.AZ.6605.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AZ.6605.01", "Collagen degradation"], ["TCGA.AZ.6605.01", "Collagen chain trimerization"], ["TCGA.AZ.6605.01", "Defective B3GALTL causes PpS"], ["TCGA.AZ.6605.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.AZ.6605.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AZ.6605.01", "Scavenging by Class A Receptors"], ["TCGA.AZ.6605.01", "WNT ligand biogenesis and trafficking"], ["TCGA.AZ.6605.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.AZ.6607.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.AZ.6607.01", "Collagen chain trimerization"], ["TCGA.AZ.6607.01", "Ethanol oxidation"], ["TCGA.AZ.6607.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AZ.6607.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AZ.6607.01", "Collagen degradation"], ["TCGA.AZ.6607.01", "WNT ligand biogenesis and trafficking"], ["TCGA.AZ.6607.01", "Phase II - Conjugation of compounds"], ["TCGA.AZ.6607.01", "Inwardly rectifying K+ channels"], ["TCGA.AZ.6607.01", "Defective B3GALTL causes PpS"], ["TCGA.AZ.6607.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.AZ.6607.01", "Chondroitin sulfate biosynthesis"], ["TCGA.AZ.6607.01", "APAP ADME"], ["TCGA.AZ.6607.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], ["TCGA.AZ.6607.01", "mitochondrial fatty acid beta-oxidation of saturated fatty acids"], ["TCGA.AZ.6607.01", "Bile acid and bile salt metabolism"], ["TCGA.AZ.6607.01", "Keratinization"], ["TCGA.AZ.6607.01", "Potassium Channels"], ["TCGA.AZ.6607.01", "Activation of G protein gated Potassium channels"], ["TCGA.AZ.6607.01", "G protein gated Potassium channels"], ["TCGA.AZ.6607.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.AZ.6607.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.AZ.6607.01", "Formation of the cornified envelope"], ["TCGA.AZ.6607.01", "Phase 0 - rapid depolarisation"], ["TCGA.AZ.6607.01", "Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"], ["TCGA.AZ.6607.01", "Arachidonic acid metabolism"], ["TCGA.AZ.6607.01", "Other semaphorin interactions"], ["TCGA.CA.5796.01", "Phase 0 - rapid depolarisation"], ["TCGA.CA.5796.01", "Glucagon-type ligand receptors"], ["TCGA.CA.5796.01", "Interaction between L1 and Ankyrins"], ["TCGA.CA.5796.01", "LGI-ADAM interactions"], ["TCGA.CA.5796.01", "Biological oxidations"], ["TCGA.CA.5796.01", "GABA receptor activation"], ["TCGA.CA.5796.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.CA.5796.01", "O-linked glycosylation"], ["TCGA.CA.5796.01", "Sensory perception of taste"], ["TCGA.CA.5796.01", "Scavenging by Class A Receptors"], ["TCGA.CA.5796.01", "G beta:gamma signalling through PLC beta"], ["TCGA.CA.5796.01", "Carnitine metabolism"], ["TCGA.CA.5796.01", "Diseases associated with O-glycosylation of proteins"], ["TCGA.CA.5796.01", "Defective B3GALTL causes PpS"], ["TCGA.CA.5796.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.CA.5796.01", "Sensory perception of sweet, bitter, and umami (glutamate) taste"], ["TCGA.CA.5796.01", "Presynaptic function of Kainate receptors"], ["TCGA.CA.5796.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.CA.5796.01", "Glycosaminoglycan metabolism"], ["TCGA.CA.5796.01", "Aspartate and asparagine metabolism"], ["TCGA.CA.5797.01", "Phase 0 - rapid depolarisation"], ["TCGA.CA.5797.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.CA.5797.01", "O-linked glycosylation"], ["TCGA.CA.5797.01", "O-linked glycosylation of mucins"], ["TCGA.CA.5797.01", "APAP ADME"], ["TCGA.CA.5797.01", "Glucagon-type ligand receptors"], ["TCGA.CA.5797.01", "Inwardly rectifying K+ channels"], ["TCGA.CA.5797.01", "Phase 4 - resting membrane potential"], ["TCGA.CA.5797.01", "Activation of G protein gated Potassium channels"], ["TCGA.CA.5797.01", "G protein gated Potassium channels"], ["TCGA.CA.5797.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.CA.5797.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.CA.5797.01", "NCAM1 interactions"], ["TCGA.CA.5797.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.CA.5797.01", "Sensory perception of taste"], ["TCGA.CA.5797.01", "Glucuronidation"], ["TCGA.CA.5797.01", "Presynaptic function of Kainate receptors"], ["TCGA.CA.5797.01", "Phase 2 - plateau phase"], ["TCGA.CA.5797.01", "Activation of the phototransduction cascade"], ["TCGA.CA.6716.01", "RA biosynthesis pathway"], ["TCGA.CA.6716.01", "Initial triggering of complement"], ["TCGA.CA.6716.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.CA.6716.01", "Signaling by Retinoic Acid"], ["TCGA.CA.6716.01", "Aspirin ADME"], ["TCGA.CA.6716.01", "Glucuronidation"], ["TCGA.CA.6716.01", "TNFs bind their physiological receptors"], ["TCGA.CA.6716.01", "Blood group systems biosynthesis"], ["TCGA.CA.6716.01", "Classical antibody-mediated complement activation"], ["TCGA.CA.6716.01", "CD22 mediated BCR regulation"], ["TCGA.CA.6716.01", "Arachidonic acid metabolism"], ["TCGA.CA.6716.01", "Interaction between L1 and Ankyrins"], ["TCGA.CA.6716.01", "Potassium Channels"], ["TCGA.CA.6716.01", "Creation of C4 and C2 activators"], ["TCGA.CA.6716.01", "Activation of the phototransduction cascade"], ["TCGA.CA.6716.01", "Scavenging by Class A Receptors"], ["TCGA.CA.6716.01", "Acyl chain remodelling of PE"], ["TCGA.CA.6716.01", "Phase 4 - resting membrane potential"], ["TCGA.CA.6716.01", "Ethanol oxidation"], ["TCGA.CA.6716.01", "Lewis blood group biosynthesis"], ["TCGA.CA.6716.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], ["TCGA.CA.6716.01", "Defensins"], ["TCGA.CA.6716.01", "Heme degradation"], ["TCGA.CA.6716.01", "Phase II - Conjugation of compounds"], ["TCGA.CA.6716.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.CA.6716.01", "Binding and entry of HIV virion"], ["TCGA.CA.6716.01", "Sialic acid metabolism"], ["TCGA.CA.6716.01", "Defective GALNT12 causes CRCS1"], ["TCGA.CA.6716.01", "G beta:gamma signalling through BTK"], ["TCGA.CA.6717.01", "Metabolism"], ["TCGA.CA.6718.01", "Cytosolic sulfonation of small molecules"], ["TCGA.CA.6718.01", "Ethanol oxidation"], ["TCGA.CA.6718.01", "Phase II - Conjugation of compounds"], ["TCGA.CA.6718.01", "Erythrocytes take up carbon dioxide and release oxygen"], ["TCGA.CA.6718.01", "O2/CO2 exchange in erythrocytes"], ["TCGA.CA.6718.01", "Defective homologous recombination repair (HRR) due to BRCA1 loss of function"], ["TCGA.CA.6718.01", "Defective homologous recombination repair (HRR) due to PALB2 loss of function"], ["TCGA.CA.6718.01", "Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function"], ["TCGA.CA.6718.01", "Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function"], ["TCGA.CA.6718.01", "Impaired BRCA2 binding to PALB2"], ["TCGA.CA.6718.01", "Bile acid and bile salt metabolism"], ["TCGA.CA.6718.01", "Glucuronidation"], ["TCGA.CA.6718.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], ["TCGA.CA.6718.01", "Resolution of D-loop Structures through Holliday Junction Intermediates"], ["TCGA.CA.6718.01", "APAP ADME"], ["TCGA.CA.6718.01", "Resolution of D-Loop Structures"], ["TCGA.CA.6718.01", "Synthesis of bile acids and bile salts via 27-hydroxycholesterol"], ["TCGA.CA.6718.01", "Heme degradation"], ["TCGA.CA.6718.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.CA.6718.01", "Synthesis of bile acids and bile salts"], ["TCGA.CA.6718.01", "Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)"], ["TCGA.CA.6718.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.CA.6718.01", "Interaction between L1 and Ankyrins"], ["TCGA.CA.6718.01", "Synaptic adhesion-like molecules"], ["TCGA.CA.6718.01", "Collagen chain trimerization"], ["TCGA.CA.6718.01", "Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"], ["TCGA.CA.6718.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], ["TCGA.CA.6718.01", "Transport of bile salts and organic acids, metal ions and amine compounds"], ["TCGA.CA.6718.01", "WNT ligand biogenesis and trafficking"], ["TCGA.CA.6718.01", "Activation of Matrix Metalloproteinases"], ["TCGA.CA.6718.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.CA.6718.01", "Diseases of DNA repair"], ["TCGA.CA.6718.01", "Diseases of DNA Double-Strand Break Repair"], ["TCGA.CA.6718.01", "Defective homologous recombination repair (HRR) due to BRCA2 loss of function"], ["TCGA.CA.6718.01", "Aspirin ADME"], ["TCGA.CA.6718.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.CA.6718.01", "Unwinding of DNA"], ["TCGA.CA.6718.01", "Metal ion SLC transporters"], ["TCGA.CA.6718.01", "Blood group systems biosynthesis"], ["TCGA.CA.6718.01", "Presynaptic phase of homologous DNA pairing and strand exchange"], ["TCGA.CA.6718.01", "GABA receptor activation"], ["TCGA.CA.6719.01", "Phase II - Conjugation of compounds"], ["TCGA.CA.6719.01", "Collagen chain trimerization"], ["TCGA.CA.6719.01", "Glucuronidation"], ["TCGA.CA.6719.01", "APAP ADME"], ["TCGA.CA.6719.01", "Cytosolic sulfonation of small molecules"], ["TCGA.CA.6719.01", "Ethanol oxidation"], ["TCGA.CA.6719.01", "Activation of Matrix Metalloproteinases"], ["TCGA.CA.6719.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.CK.4947.01", "RA biosynthesis pathway"], ["TCGA.CK.4947.01", "Cytosolic sulfonation of small molecules"], ["TCGA.CK.4947.01", "Phase II - Conjugation of compounds"], ["TCGA.CK.4947.01", "Activation of Matrix Metalloproteinases"], ["TCGA.CK.4947.01", "Phase 4 - resting membrane potential"], ["TCGA.CK.4947.01", "Ethanol oxidation"], ["TCGA.CK.4947.01", "Interaction between L1 and Ankyrins"], ["TCGA.CK.4948.01", "Phase II - Conjugation of compounds"], ["TCGA.CK.4948.01", "Collagen chain trimerization"], ["TCGA.CK.4948.01", "Glucuronidation"], ["TCGA.CK.4948.01", "Termination of O-glycan biosynthesis"], ["TCGA.CK.4948.01", "O-linked glycosylation of mucins"], ["TCGA.CK.4948.01", "O-linked glycosylation"], ["TCGA.CK.4948.01", "Defective GALNT3 causes HFTC"], ["TCGA.CK.4948.01", "Defective GALNT12 causes CRCS1"], ["TCGA.CK.4948.01", "Defective C1GALT1C1 causes TNPS"], ["TCGA.CK.4948.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.CK.4948.01", "Metal ion SLC transporters"], ["TCGA.CK.4948.01", "Azathioprine ADME"], ["TCGA.CK.4948.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.CK.4950.01", "Transcriptional regulation of testis differentiation"], ["TCGA.CK.4950.01", "Activation of Matrix Metalloproteinases"], ["TCGA.CK.4950.01", "Common Pathway of Fibrin Clot Formation"], ["TCGA.CK.4950.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], ["TCGA.CK.4950.01", "Regulation of TLR by endogenous ligand"], ["TCGA.CK.4950.01", "Signaling by BMP"], ["TCGA.CK.4950.01", "Glutamate Neurotransmitter Release Cycle"], ["TCGA.CK.4950.01", "RA biosynthesis pathway"], ["TCGA.CK.4950.01", "MyD88 deficiency (TLR2/4)"], ["TCGA.CK.4950.01", "IRAK4 deficiency (TLR2/4)"], ["TCGA.CK.4950.01", "IL-6-type cytokine receptor ligand interactions"], ["TCGA.CK.4952.01", "Unwinding of DNA"], ["TCGA.CK.4952.01", "Neurexins and neuroligins"], ["TCGA.CK.4952.01", "Activation of the pre-replicative complex"], ["TCGA.CK.4952.01", "DNA strand elongation"], ["TCGA.CK.4952.01", "CD22 mediated BCR regulation"], ["TCGA.CK.4952.01", "Transcriptional regulation of testis differentiation"], ["TCGA.CK.4952.01", "Interaction between L1 and Ankyrins"], ["TCGA.CK.4952.01", "Synaptic adhesion-like molecules"], ["TCGA.CK.4952.01", "Resolution of D-loop Structures through Holliday Junction Intermediates"], ["TCGA.CK.4952.01", "Resolution of D-Loop Structures"], ["TCGA.CK.4952.01", "Defective homologous recombination repair (HRR) due to BRCA1 loss of function"], ["TCGA.CK.4952.01", "Defective homologous recombination repair (HRR) due to PALB2 loss of function"], ["TCGA.CK.4952.01", "Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function"], ["TCGA.CK.4952.01", "Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function"], ["TCGA.CK.4952.01", "Impaired BRCA2 binding to PALB2"], ["TCGA.CK.4952.01", "Intrinsic Pathway of Fibrin Clot Formation"], ["TCGA.CK.4952.01", "Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)"], ["TCGA.CK.4952.01", "Assembly and cell surface presentation of NMDA receptors"], ["TCGA.CK.4952.01", "Phase II - Conjugation of compounds"], ["TCGA.CK.4952.01", "Arachidonic acid metabolism"], ["TCGA.CK.4952.01", "Glucuronidation"], ["TCGA.CK.4952.01", "Unblocking of NMDA receptors, glutamate binding and activation"], ["TCGA.CK.4952.01", "Carnitine metabolism"], ["TCGA.CK.4952.01", "Synthesis of bile acids and bile salts via 27-hydroxycholesterol"], ["TCGA.CK.5912.01", "Potassium Channels"], ["TCGA.CK.5912.01", "Phase 0 - rapid depolarisation"], ["TCGA.CK.5912.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], ["TCGA.CK.5912.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.CK.5912.01", "Interaction between L1 and Ankyrins"], ["TCGA.CK.5912.01", "Arachidonic acid metabolism"], ["TCGA.CK.5912.01", "Biological oxidations"], ["TCGA.CK.5912.01", "GABA receptor activation"], ["TCGA.CK.5912.01", "Carnitine metabolism"], ["TCGA.CK.5912.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.CK.5912.01", "Activation of Matrix Metalloproteinases"], ["TCGA.CK.5912.01", "Voltage gated Potassium channels"], ["TCGA.CK.5912.01", "Activation of G protein gated Potassium channels"], ["TCGA.CK.5912.01", "G protein gated Potassium channels"], ["TCGA.CK.5912.01", "Platelet calcium homeostasis"], ["TCGA.CK.5912.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.CK.5912.01", "Inwardly rectifying K+ channels"], ["TCGA.CK.5912.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.CK.5912.01", "Neurexins and neuroligins"], ["TCGA.CK.5912.01", "Protein-protein interactions at synapses"], ["TCGA.CK.5912.01", "G-protein beta:gamma signalling"], ["TCGA.CK.5912.01", "GABA B receptor activation"], ["TCGA.CK.5912.01", "Activation of GABAB receptors"], ["TCGA.CK.5912.01", "Phase 2 - plateau phase"], ["TCGA.CK.5912.01", "Keratan sulfate biosynthesis"], ["TCGA.CK.5912.01", "Initial triggering of complement"], ["TCGA.CK.5912.01", "Nucleotide catabolism"], ["TCGA.CK.5912.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.CK.5912.01", "Cytosolic sulfonation of small molecules"], ["TCGA.CK.5912.01", "Phase 4 - resting membrane potential"], ["TCGA.CK.5912.01", "Signal amplification"], ["TCGA.CK.5912.01", "Glucagon-type ligand receptors"], ["TCGA.CK.5912.01", "Ca2+ pathway"], ["TCGA.CK.5912.01", "Heme degradation"], ["TCGA.CK.5912.01", "Scavenging of heme from plasma"], ["TCGA.CK.5912.01", "Synthesis, secretion, and deacylation of Ghrelin"], ["TCGA.CK.5912.01", "Phase I - Functionalization of compounds"], ["TCGA.CK.5912.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.CK.5913.01", "Interaction between L1 and Ankyrins"], ["TCGA.CK.5913.01", "Phase II - Conjugation of compounds"], ["TCGA.CK.5913.01", "Phase 0 - rapid depolarisation"], ["TCGA.CK.5913.01", "Collagen chain trimerization"], ["TCGA.CK.5913.01", "Ethanol oxidation"], ["TCGA.CK.5913.01", "GABA receptor activation"], ["TCGA.CK.5913.01", "Activation of Matrix Metalloproteinases"], ["TCGA.CK.5913.01", "Potassium Channels"], ["TCGA.CK.5913.01", "Glucagon-type ligand receptors"], ["TCGA.CK.5913.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.CK.5913.01", "Defective B3GALTL causes PpS"], ["TCGA.CK.5913.01", "Synaptic adhesion-like molecules"], ["TCGA.CK.5913.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.CK.5913.01", "Glucuronidation"], ["TCGA.CK.5913.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.CK.5913.01", "TNFs bind their physiological receptors"], ["TCGA.CK.5913.01", "Synthesis of bile acids and bile salts via 27-hydroxycholesterol"], ["TCGA.CK.5913.01", "O-linked glycosylation"], ["TCGA.CK.5913.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.CK.5913.01", "Activation of G protein gated Potassium channels"], ["TCGA.CK.5913.01", "G protein gated Potassium channels"], ["TCGA.CK.5913.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.CK.5913.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.CK.5913.01", "Glutathione conjugation"], ["TCGA.CK.5913.01", "GABA B receptor activation"], ["TCGA.CK.5913.01", "Activation of GABAB receptors"], ["TCGA.CK.5914.01", "Interaction between L1 and Ankyrins"], ["TCGA.CK.5914.01", "Phase 0 - rapid depolarisation"], ["TCGA.CK.5914.01", "Potassium Channels"], ["TCGA.CK.5914.01", "GABA receptor activation"], ["TCGA.CK.5914.01", "Glucagon-type ligand receptors"], ["TCGA.CK.5914.01", "Arachidonic acid metabolism"], ["TCGA.CK.5914.01", "Blood group systems biosynthesis"], ["TCGA.CK.5914.01", "GABA B receptor activation"], ["TCGA.CK.5914.01", "Activation of GABAB receptors"], ["TCGA.CK.5914.01", "Activation of Matrix Metalloproteinases"], ["TCGA.CK.5914.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.CK.5914.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.CK.5914.01", "Lewis blood group biosynthesis"], ["TCGA.CK.5914.01", "CD22 mediated BCR regulation"], ["TCGA.CK.5914.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.CK.5914.01", "Phase II - Conjugation of compounds"], ["TCGA.CK.5914.01", "G beta:gamma signalling through BTK"], ["TCGA.CK.5914.01", "Sensory perception of taste"], ["TCGA.CK.5914.01", "Erythrocytes take up carbon dioxide and release oxygen"], ["TCGA.CK.5914.01", "O2/CO2 exchange in erythrocytes"], ["TCGA.CK.5914.01", "Adenylate cyclase inhibitory pathway"], ["TCGA.CK.5914.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], ["TCGA.CK.5914.01", "Cytosolic sulfonation of small molecules"], ["TCGA.CK.5914.01", "Phase 4 - resting membrane potential"], ["TCGA.CK.5914.01", "Nucleotide catabolism"], ["TCGA.CK.5915.01", "Potassium Channels"], ["TCGA.CK.5915.01", "GABA B receptor activation"], ["TCGA.CK.5915.01", "Activation of GABAB receptors"], ["TCGA.CK.5915.01", "GABA receptor activation"], ["TCGA.CK.5915.01", "Arachidonic acid metabolism"], ["TCGA.CK.5915.01", "Glucagon-type ligand receptors"], ["TCGA.CK.5915.01", "Initial triggering of complement"], ["TCGA.CK.5915.01", "TNFs bind their physiological receptors"], ["TCGA.CK.5915.01", "Activation of G protein gated Potassium channels"], ["TCGA.CK.5915.01", "G protein gated Potassium channels"], ["TCGA.CK.5915.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.CK.5915.01", "Interaction between L1 and Ankyrins"], ["TCGA.CK.5915.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.CK.5915.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.CK.5915.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.CK.5915.01", "Inwardly rectifying K+ channels"], ["TCGA.CK.5915.01", "Blood group systems biosynthesis"], ["TCGA.CK.5915.01", "G beta:gamma signalling through BTK"], ["TCGA.CK.5915.01", "Biosynthesis of specialized proresolving mediators (SPMs)"], ["TCGA.CK.5915.01", "Lewis blood group biosynthesis"], ["TCGA.CK.5915.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.CK.5915.01", "Scavenging by Class A Receptors"], ["TCGA.CK.5915.01", "G-protein activation"], ["TCGA.CK.5915.01", "Aspirin ADME"], ["TCGA.CK.5915.01", "Sialic acid metabolism"], ["TCGA.CK.5915.01", "Keratan sulfate biosynthesis"], ["TCGA.CK.5915.01", "Cytosolic sulfonation of small molecules"], ["TCGA.CK.5915.01", "Phase 4 - resting membrane potential"], ["TCGA.CK.5915.01", "Biosynthesis of DHA-derived SPMs"], ["TCGA.CK.5915.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.CK.5915.01", "Voltage gated Potassium channels"], ["TCGA.CK.5915.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.CK.5915.01", "Prostacyclin signalling through prostacyclin receptor"], ["TCGA.CK.5915.01", "CD22 mediated BCR regulation"], ["TCGA.CK.5915.01", "Thromboxane signalling through TP receptor"], ["TCGA.CK.5915.01", "G beta:gamma signalling through PLC beta"], ["TCGA.CK.5915.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.CK.5915.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.CK.5915.01", "Presynaptic function of Kainate receptors"], ["TCGA.CK.5916.01", "Ethanol oxidation"], ["TCGA.CK.5916.01", "Phase 0 - rapid depolarisation"], ["TCGA.CK.5916.01", "Phase II - Conjugation of compounds"], ["TCGA.CK.5916.01", "O-linked glycosylation of mucins"], ["TCGA.CK.5916.01", "APAP ADME"], ["TCGA.CK.5916.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], ["TCGA.CK.5916.01", "Interaction between L1 and Ankyrins"], ["TCGA.CK.5916.01", "Potassium Channels"], ["TCGA.CK.5916.01", "RA biosynthesis pathway"], ["TCGA.CK.5916.01", "Glucuronidation"], ["TCGA.CK.5916.01", "Termination of O-glycan biosynthesis"], ["TCGA.CK.5916.01", "O-linked glycosylation"], ["TCGA.CK.5916.01", "GABA receptor activation"], ["TCGA.CK.5916.01", "Free fatty acids regulate insulin secretion"], ["TCGA.CK.5916.01", "Glutathione conjugation"], ["TCGA.CK.5916.01", "Signaling by Retinoic Acid"], ["TCGA.CK.5916.01", "Defective GALNT3 causes HFTC"], ["TCGA.CK.5916.01", "Defective GALNT12 causes CRCS1"], ["TCGA.CK.5916.01", "Digestion and absorption"], ["TCGA.CK.5916.01", "Keratan sulfate biosynthesis"], ["TCGA.CM.4743.01", "Interaction between L1 and Ankyrins"], ["TCGA.CM.4743.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.CM.4743.01", "Phase 0 - rapid depolarisation"], ["TCGA.CM.4743.01", "Regulation of Complement cascade"], ["TCGA.CM.4743.01", "Complement cascade"], ["TCGA.CM.4743.01", "Synthesis of bile acids and bile salts via 27-hydroxycholesterol"], ["TCGA.CM.4743.01", "NCAM1 interactions"], ["TCGA.CM.4743.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], ["TCGA.CM.4743.01", "Synthesis of bile acids and bile salts"], ["TCGA.CM.4743.01", "Collagen chain trimerization"], ["TCGA.CM.4743.01", "Bile acid and bile salt metabolism"], ["TCGA.CM.4743.01", "Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"], ["TCGA.CM.4743.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.CM.4743.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], ["TCGA.CM.4743.01", "Classical antibody-mediated complement activation"], ["TCGA.CM.4743.01", "CD22 mediated BCR regulation"], ["TCGA.CM.4743.01", "Regulation of signaling by NODAL"], ["TCGA.CM.4743.01", "Chemokine receptors bind chemokines"], ["TCGA.CM.4743.01", "Recycling of bile acids and salts"], ["TCGA.CM.4744.01", "Interaction between L1 and Ankyrins"], ["TCGA.CM.4744.01", "GABA B receptor activation"], ["TCGA.CM.4744.01", "Activation of GABAB receptors"], ["TCGA.CM.4744.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.CM.4744.01", "Ribavirin ADME"], ["TCGA.CM.4744.01", "Adenylate cyclase inhibitory pathway"], ["TCGA.CM.4744.01", "Glucuronidation"], ["TCGA.CM.4744.01", "Phase II - Conjugation of compounds"], ["TCGA.CM.4744.01", "Molecules associated with elastic fibres"], ["TCGA.CM.4744.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.CM.4744.01", "Voltage gated Potassium channels"], ["TCGA.CM.4744.01", "Endogenous sterols"], ["TCGA.CM.4744.01", "LGI-ADAM interactions"], ["TCGA.CM.4744.01", "Cytosolic sulfonation of small molecules"], ["TCGA.CM.4744.01", "Sialic acid metabolism"], ["TCGA.CM.4744.01", "Defective B3GALTL causes PpS"], ["TCGA.CM.4744.01", "Intrinsic Pathway of Fibrin Clot Formation"], ["TCGA.CM.4744.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.CM.4747.01", "Phase II - Conjugation of compounds"], ["TCGA.CM.4747.01", "Glucuronidation"], ["TCGA.CM.4747.01", "Cytosolic sulfonation of small molecules"], ["TCGA.CM.4747.01", "Ethanol oxidation"], ["TCGA.CM.4747.01", "Heme degradation"], ["TCGA.CM.4747.01", "G beta:gamma signalling through BTK"], ["TCGA.CM.4747.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.CM.4747.01", "Physiological factors"], ["TCGA.CM.4747.01", "Inwardly rectifying K+ channels"], ["TCGA.CM.4747.01", "Activation of G protein gated Potassium channels"], ["TCGA.CM.4747.01", "G protein gated Potassium channels"], ["TCGA.CM.4747.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.CM.4748.01", "Peptide hormone biosynthesis"], ["TCGA.CM.4748.01", "Potassium Channels"], ["TCGA.CM.4748.01", "Keratinization"], ["TCGA.CM.4748.01", "Phase 4 - resting membrane potential"], ["TCGA.CM.4748.01", "Transcriptional regulation of testis differentiation"], ["TCGA.CM.4750.01", "Interaction between L1 and Ankyrins"], ["TCGA.CM.4750.01", "Dermatan sulfate biosynthesis"], ["TCGA.CM.4750.01", "Nucleotide catabolism"], ["TCGA.CM.4750.01", "Ribavirin ADME"], ["TCGA.CM.4752.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.CM.4752.01", "Ethanol oxidation"], ["TCGA.CM.4752.01", "G beta:gamma signalling through BTK"], ["TCGA.CM.4752.01", "Prostacyclin signalling through prostacyclin receptor"], ["TCGA.CM.4752.01", "Phase II - Conjugation of compounds"], ["TCGA.CM.4752.01", "Glucagon-type ligand receptors"], ["TCGA.CM.4752.01", "Cytosolic sulfonation of small molecules"], ["TCGA.CM.4752.01", "Heme degradation"], ["TCGA.CM.4752.01", "Activation of G protein gated Potassium channels"], ["TCGA.CM.4752.01", "G protein gated Potassium channels"], ["TCGA.CM.4752.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.CM.5341.01", "Induction of Cell-Cell Fusion"], ["TCGA.CM.5341.01", "Interaction between L1 and Ankyrins"], ["TCGA.CM.5341.01", "TNFs bind their physiological receptors"], ["TCGA.CM.5341.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.CM.5341.01", "Recycling of bile acids and salts"], ["TCGA.CM.5344.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.CM.5344.01", "Collagen formation"], ["TCGA.CM.5344.01", "Collagen chain trimerization"], ["TCGA.CM.5344.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.CM.5344.01", "Activation of Matrix Metalloproteinases"], ["TCGA.CM.5344.01", "Interaction between L1 and Ankyrins"], ["TCGA.CM.5344.01", "Synaptic adhesion-like molecules"], ["TCGA.CM.5344.01", "Phase II - Conjugation of compounds"], ["TCGA.CM.5344.01", "Glucuronidation"], ["TCGA.CM.5344.01", "WNT ligand biogenesis and trafficking"], ["TCGA.CM.5344.01", "Chemokine receptors bind chemokines"], ["TCGA.CM.5344.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.CM.5344.01", "TNFs bind their physiological receptors"], ["TCGA.CM.5344.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.CM.5344.01", "Peptide ligand-binding receptors"], ["TCGA.CM.5348.01", "Cytosolic sulfonation of small molecules"], ["TCGA.CM.5348.01", "Phase II - Conjugation of compounds"], ["TCGA.CM.5348.01", "Glucuronidation"], ["TCGA.CM.5348.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.CM.5348.01", "Collagen chain trimerization"], ["TCGA.CM.5348.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], ["TCGA.CM.5348.01", "APAP ADME"], ["TCGA.CM.5348.01", "LGI-ADAM interactions"], ["TCGA.CM.5349.01", "Phase II - Conjugation of compounds"], ["TCGA.CM.5349.01", "Cytosolic sulfonation of small molecules"], ["TCGA.CM.5349.01", "Collagen degradation"], ["TCGA.CM.5349.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.CM.5349.01", "Glucuronidation"], ["TCGA.CM.5349.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.CM.5349.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.CM.5860.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.CM.5860.01", "Collagen chain trimerization"], ["TCGA.CM.5860.01", "Cytosolic sulfonation of small molecules"], ["TCGA.CM.5860.01", "Activation of Matrix Metalloproteinases"], ["TCGA.CM.5860.01", "Phase 0 - rapid depolarisation"], ["TCGA.CM.5860.01", "APAP ADME"], ["TCGA.CM.5860.01", "Synaptic adhesion-like molecules"], ["TCGA.CM.5860.01", "Voltage gated Potassium channels"], ["TCGA.CM.5860.01", "Defective B3GALTL causes PpS"], ["TCGA.CM.5860.01", "Phase II - Conjugation of compounds"], ["TCGA.CM.5860.01", "Interaction between L1 and Ankyrins"], ["TCGA.CM.5860.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.CM.5860.01", "Diseases associated with O-glycosylation of proteins"], ["TCGA.CM.5860.01", "Common Pathway of Fibrin Clot Formation"], ["TCGA.CM.5860.01", "Heme degradation"], ["TCGA.CM.5860.01", "Peptide hormone biosynthesis"], ["TCGA.CM.5860.01", "Complement cascade"], ["TCGA.CM.5860.01", "TNFs bind their physiological receptors"], ["TCGA.CM.5861.01", "Chemokine receptors bind chemokines"], ["TCGA.CM.5861.01", "Interaction between L1 and Ankyrins"], ["TCGA.CM.5861.01", "Phase 0 - rapid depolarisation"], ["TCGA.CM.5861.01", "RA biosynthesis pathway"], ["TCGA.CM.5861.01", "Transcriptional regulation of testis differentiation"], ["TCGA.CM.5861.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.CM.5861.01", "Glucuronidation"], ["TCGA.CM.5861.01", "NCAM1 interactions"], ["TCGA.CM.5861.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.CM.5861.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.CM.5861.01", "Digestion"], ["TCGA.CM.5861.01", "Complement cascade"], ["TCGA.CM.5861.01", "Ethanol oxidation"], ["TCGA.CM.5861.01", "Signaling by Retinoic Acid"], ["TCGA.CM.5861.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.CM.5861.01", "Aspirin ADME"], ["TCGA.CM.5861.01", "Initial triggering of complement"], ["TCGA.CM.5861.01", "Classical antibody-mediated complement activation"], ["TCGA.CM.5861.01", "CD22 mediated BCR regulation"], ["TCGA.CM.5861.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], ["TCGA.CM.5861.01", "Digestion and absorption"], ["TCGA.CM.5861.01", "Activation of Matrix Metalloproteinases"], ["TCGA.CM.5861.01", "Activation of the phototransduction cascade"], ["TCGA.CM.5861.01", "Synaptic adhesion-like molecules"], ["TCGA.CM.5861.01", "Creation of C4 and C2 activators"], ["TCGA.CM.5861.01", "Nicotinate metabolism"], ["TCGA.CM.5861.01", "Collagen chain trimerization"], ["TCGA.CM.5861.01", "Erythrocytes take up carbon dioxide and release oxygen"], ["TCGA.CM.5861.01", "O2/CO2 exchange in erythrocytes"], ["TCGA.CM.5861.01", "Phase II - Conjugation of compounds"], ["TCGA.CM.5861.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.CM.5861.01", "Regulation of Complement cascade"], ["TCGA.CM.5861.01", "Cytosolic sulfonation of small molecules"], ["TCGA.CM.5862.01", "Cytosolic sulfonation of small molecules"], ["TCGA.CM.5862.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.CM.5862.01", "APAP ADME"], ["TCGA.CM.5862.01", "RA biosynthesis pathway"], ["TCGA.CM.5862.01", "O-linked glycosylation of mucins"], ["TCGA.CM.5862.01", "Termination of O-glycan biosynthesis"], ["TCGA.CM.5862.01", "Phase II - Conjugation of compounds"], ["TCGA.CM.5862.01", "Initial triggering of complement"], ["TCGA.CM.5862.01", "Classical antibody-mediated complement activation"], ["TCGA.CM.5863.01", "Cytosolic sulfonation of small molecules"], ["TCGA.CM.5863.01", "LGI-ADAM interactions"], ["TCGA.CM.5863.01", "Collagen chain trimerization"], ["TCGA.CM.5863.01", "Aspirin ADME"], ["TCGA.CM.5863.01", "Phase II - Conjugation of compounds"], ["TCGA.CM.5863.01", "Peptide hormone biosynthesis"], ["TCGA.CM.5864.01", "Potassium Channels"], ["TCGA.CM.5864.01", "Interaction between L1 and Ankyrins"], ["TCGA.CM.5864.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.CM.5864.01", "Glucagon-type ligand receptors"], ["TCGA.CM.5864.01", "Cytosolic sulfonation of small molecules"], ["TCGA.CM.5864.01", "Transcriptional regulation of testis differentiation"], ["TCGA.CM.5864.01", "Phase 0 - rapid depolarisation"], ["TCGA.CM.5864.01", "Heme degradation"], ["TCGA.CM.5864.01", "GABA receptor activation"], ["TCGA.CM.5864.01", "GABA B receptor activation"], ["TCGA.CM.5864.01", "Activation of GABAB receptors"], ["TCGA.CM.5864.01", "Presynaptic function of Kainate receptors"], ["TCGA.CM.5864.01", "NCAM1 interactions"], ["TCGA.CM.5864.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.CM.5864.01", "Activation of G protein gated Potassium channels"], ["TCGA.CM.5864.01", "G protein gated Potassium channels"], ["TCGA.CM.5864.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.CM.5864.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.CM.5864.01", "G beta:gamma signalling through BTK"], ["TCGA.CM.5864.01", "Inwardly rectifying K+ channels"], ["TCGA.CM.5864.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.CM.5864.01", "G beta:gamma signalling through PLC beta"], ["TCGA.CM.5864.01", "Phase 4 - resting membrane potential"], ["TCGA.CM.5864.01", "Lewis blood group biosynthesis"], ["TCGA.CM.5864.01", "Phase II - Conjugation of compounds"], ["TCGA.CM.5868.01", "Interaction between L1 and Ankyrins"], ["TCGA.CM.5868.01", "GABA receptor activation"], ["TCGA.CM.5868.01", "Phase 0 - rapid depolarisation"], ["TCGA.CM.5868.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.CM.5868.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.CM.5868.01", "Potassium Channels"], ["TCGA.CM.5868.01", "Collagen chain trimerization"], ["TCGA.CM.5868.01", "G beta:gamma signalling through BTK"], ["TCGA.CM.5868.01", "GABA B receptor activation"], ["TCGA.CM.5868.01", "Activation of GABAB receptors"], ["TCGA.CM.5868.01", "NCAM1 interactions"], ["TCGA.CM.5868.01", "Activation of the phototransduction cascade"], ["TCGA.CM.5868.01", "Glucagon-type ligand receptors"], ["TCGA.CM.5868.01", "Presynaptic function of Kainate receptors"], ["TCGA.CM.5868.01", "Transcriptional regulation of testis differentiation"], ["TCGA.CM.5868.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.CM.5868.01", "Inwardly rectifying K+ channels"], ["TCGA.CM.5868.01", "Activation of G protein gated Potassium channels"], ["TCGA.CM.5868.01", "G protein gated Potassium channels"], ["TCGA.CM.5868.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.CM.5868.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.CM.5868.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.CM.5868.01", "Blood group systems biosynthesis"], ["TCGA.CM.5868.01", "Scavenging of heme from plasma"], ["TCGA.CM.5868.01", "TNFs bind their physiological receptors"], ["TCGA.CM.5868.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.CM.5868.01", "RA biosynthesis pathway"], ["TCGA.CM.5868.01", "G-protein activation"], ["TCGA.CM.5868.01", "Thromboxane signalling through TP receptor"], ["TCGA.CM.5868.01", "G alpha (z) signalling events"], ["TCGA.CM.5868.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.CM.5868.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.CM.5868.01", "Prostacyclin signalling through prostacyclin receptor"], ["TCGA.CM.5868.01", "Binding and entry of HIV virion"], ["TCGA.CM.5868.01", "Sensory perception of taste"], ["TCGA.CM.5868.01", "Neurexins and neuroligins"], ["TCGA.CM.5868.01", "LGI-ADAM interactions"], ["TCGA.CM.5868.01", "G beta:gamma signalling through PLC beta"], ["TCGA.CM.5868.01", "Phase II - Conjugation of compounds"], ["TCGA.CM.5868.01", "Sensory perception of sweet, bitter, and umami (glutamate) taste"], ["TCGA.CM.5868.01", "Inactivation, recovery and regulation of the phototransduction cascade"], ["TCGA.CM.6161.01", "Lewis blood group biosynthesis"], ["TCGA.CM.6161.01", "Blood group systems biosynthesis"], ["TCGA.CM.6161.01", "Glucuronidation"], ["TCGA.CM.6161.01", "Phase II - Conjugation of compounds"], ["TCGA.CM.6161.01", "Cytosolic sulfonation of small molecules"], ["TCGA.CM.6161.01", "Phase 4 - resting membrane potential"], ["TCGA.CM.6161.01", "Sialic acid metabolism"], ["TCGA.CM.6161.01", "RA biosynthesis pathway"], ["TCGA.CM.6161.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.CM.6161.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.CM.6161.01", "Defective GALNT12 causes CRCS1"], ["TCGA.CM.6161.01", "Termination of O-glycan biosynthesis"], ["TCGA.CM.6161.01", "Potassium Channels"], ["TCGA.CM.6161.01", "Aspirin ADME"], ["TCGA.CM.6162.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.CM.6162.01", "Collagen chain trimerization"], ["TCGA.CM.6162.01", "Activation of Matrix Metalloproteinases"], ["TCGA.CM.6162.01", "Collagen degradation"], ["TCGA.CM.6162.01", "Cytosolic sulfonation of small molecules"], ["TCGA.CM.6162.01", "Scavenging by Class A Receptors"], ["TCGA.CM.6162.01", "Antimicrobial peptides"], ["TCGA.CM.6162.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], ["TCGA.CM.6162.01", "Phase II - Conjugation of compounds"], ["TCGA.CM.6162.01", "IL-6-type cytokine receptor ligand interactions"], ["TCGA.CM.6162.01", "Glucuronidation"], ["TCGA.CM.6162.01", "Chondroitin sulfate biosynthesis"], ["TCGA.CM.6162.01", "Defensins"], ["TCGA.CM.6162.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], ["TCGA.CM.6163.01", "Activation of Matrix Metalloproteinases"], ["TCGA.CM.6163.01", "Phase 4 - resting membrane potential"], ["TCGA.CM.6163.01", "Ethanol oxidation"], ["TCGA.CM.6163.01", "Collagen chain trimerization"], ["TCGA.CM.6164.01", "Phase II - Conjugation of compounds"], ["TCGA.CM.6164.01", "Glucuronidation"], ["TCGA.CM.6164.01", "Cytosolic sulfonation of small molecules"], ["TCGA.CM.6164.01", "Ethanol oxidation"], ["TCGA.CM.6164.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.CM.6164.01", "Glutathione conjugation"], ["TCGA.CM.6164.01", "Heme degradation"], ["TCGA.CM.6164.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.CM.6164.01", "Aspirin ADME"], ["TCGA.CM.6164.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.CM.6164.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], ["TCGA.CM.6164.01", "Collagen chain trimerization"], ["TCGA.CM.6164.01", "Blood group systems biosynthesis"], ["TCGA.CM.6165.01", "TNFs bind their physiological receptors"], ["TCGA.CM.6165.01", "RA biosynthesis pathway"], ["TCGA.CM.6165.01", "Ethanol oxidation"], ["TCGA.CM.6165.01", "TP53 Regulates Transcription of Death Receptors and Ligands"], ["TCGA.CM.6166.01", "Arachidonic acid metabolism"], ["TCGA.CM.6166.01", "G-protein activation"], ["TCGA.CM.6166.01", "Thromboxane signalling through TP receptor"], ["TCGA.CM.6166.01", "GABA receptor activation"], ["TCGA.CM.6166.01", "Heme degradation"], ["TCGA.CM.6166.01", "TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway"], ["TCGA.CM.6166.01", "Classical antibody-mediated complement activation"], ["TCGA.CM.6166.01", "CD22 mediated BCR regulation"], ["TCGA.CM.6166.01", "Phase 0 - rapid depolarisation"], ["TCGA.CM.6166.01", "TNFs bind their physiological receptors"], ["TCGA.CM.6166.01", "Recycling of bile acids and salts"], ["TCGA.CM.6166.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.CM.6166.01", "Defective GALNT12 causes CRCS1"], ["TCGA.CM.6166.01", "GABA B receptor activation"], ["TCGA.CM.6166.01", "Activation of GABAB receptors"], ["TCGA.CM.6166.01", "RA biosynthesis pathway"], ["TCGA.CM.6166.01", "G beta:gamma signalling through BTK"], ["TCGA.CM.6166.01", "Collagen chain trimerization"], ["TCGA.CM.6166.01", "Erythrocytes take up carbon dioxide and release oxygen"], ["TCGA.CM.6166.01", "O2/CO2 exchange in erythrocytes"], ["TCGA.CM.6166.01", "Glucagon-type ligand receptors"], ["TCGA.CM.6166.01", "Activation of G protein gated Potassium channels"], ["TCGA.CM.6166.01", "G protein gated Potassium channels"], ["TCGA.CM.6166.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.CM.6166.01", "Biosynthesis of specialized proresolving mediators (SPMs)"], ["TCGA.CM.6166.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], ["TCGA.CM.6166.01", "Acyl chain remodelling of PE"], ["TCGA.CM.6166.01", "Cytosolic sulfonation of small molecules"], ["TCGA.CM.6166.01", "Phase 4 - resting membrane potential"], ["TCGA.CM.6168.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.CM.6168.01", "Collagen chain trimerization"], ["TCGA.CM.6169.01", "Cytosolic sulfonation of small molecules"], ["TCGA.CM.6169.01", "APAP ADME"], ["TCGA.CM.6169.01", "Phase II - Conjugation of compounds"], ["TCGA.CM.6169.01", "Glucagon-type ligand receptors"], ["TCGA.CM.6169.01", "Inwardly rectifying K+ channels"], ["TCGA.CM.6169.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], ["TCGA.CM.6169.01", "RA biosynthesis pathway"], ["TCGA.CM.6169.01", "Ethanol oxidation"], ["TCGA.CM.6169.01", "Activation of G protein gated Potassium channels"], ["TCGA.CM.6169.01", "G protein gated Potassium channels"], ["TCGA.CM.6169.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.CM.6169.01", "Repression of WNT target genes"], ["TCGA.CM.6170.01", "Glucuronidation"], ["TCGA.CM.6170.01", "Phase II - Conjugation of compounds"], ["TCGA.CM.6170.01", "Activation of Matrix Metalloproteinases"], ["TCGA.CM.6170.01", "Inwardly rectifying K+ channels"], ["TCGA.CM.6170.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.CM.6170.01", "Cytosolic sulfonation of small molecules"], ["TCGA.CM.6170.01", "Phase 4 - resting membrane potential"], ["TCGA.CM.6170.01", "Blood group systems biosynthesis"], ["TCGA.CM.6170.01", "Heme degradation"], ["TCGA.CM.6170.01", "Aspirin ADME"], ["TCGA.CM.6170.01", "Activation of G protein gated Potassium channels"], ["TCGA.CM.6170.01", "G protein gated Potassium channels"], ["TCGA.CM.6170.01", "Interaction between L1 and Ankyrins"], ["TCGA.CM.6170.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.CM.6170.01", "Presynaptic function of Kainate receptors"], ["TCGA.CM.6170.01", "Signaling by Retinoic Acid"], ["TCGA.CM.6170.01", "SHC1 events in ERBB4 signaling"], ["TCGA.CM.6170.01", "Metabolism of amine-derived hormones"], ["TCGA.CM.6170.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.CM.6170.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.CM.6170.01", "Lewis blood group biosynthesis"], ["TCGA.CM.6170.01", "Glucagon-type ligand receptors"], ["TCGA.CM.6170.01", "G beta:gamma signalling through BTK"], ["TCGA.CM.6170.01", "Arachidonic acid metabolism"], ["TCGA.CM.6170.01", "Prostacyclin signalling through prostacyclin receptor"], ["TCGA.CM.6170.01", "Collagen formation"], ["TCGA.CM.6170.01", "G beta:gamma signalling through PLC beta"], ["TCGA.CM.6170.01", "APAP ADME"], ["TCGA.CM.6170.01", "Physiological factors"], ["TCGA.CM.6171.01", "Blood group systems biosynthesis"], ["TCGA.CM.6171.01", "Lewis blood group biosynthesis"], ["TCGA.CM.6171.01", "Phase II - Conjugation of compounds"], ["TCGA.CM.6171.01", "Interaction between L1 and Ankyrins"], ["TCGA.CM.6171.01", "Potassium Channels"], ["TCGA.CM.6171.01", "Cytosolic sulfonation of small molecules"], ["TCGA.CM.6171.01", "Voltage gated Potassium channels"], ["TCGA.CM.6171.01", "APAP ADME"], ["TCGA.CM.6171.01", "Phase 0 - rapid depolarisation"], ["TCGA.CM.6171.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.CM.6171.01", "Arachidonic acid metabolism"], ["TCGA.CM.6171.01", "Aspirin ADME"], ["TCGA.CM.6171.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], ["TCGA.CM.6171.01", "Defective B3GALTL causes PpS"], ["TCGA.CM.6171.01", "LGI-ADAM interactions"], ["TCGA.CM.6171.01", "Glucuronidation"], ["TCGA.CM.6171.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.CM.6171.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.CM.6171.01", "Transcriptional regulation of testis differentiation"], ["TCGA.CM.6171.01", "O-linked glycosylation"], ["TCGA.CM.6171.01", "Norepinephrine Neurotransmitter Release Cycle"], ["TCGA.CM.6171.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], ["TCGA.CM.6171.01", "Activation of Matrix Metalloproteinases"], ["TCGA.CM.6172.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.CM.6172.01", "Glucagon-type ligand receptors"], ["TCGA.CM.6172.01", "G-protein activation"], ["TCGA.CM.6172.01", "G beta:gamma signalling through BTK"], ["TCGA.CM.6172.01", "Prostacyclin signalling through prostacyclin receptor"], ["TCGA.CM.6172.01", "Potassium Channels"], ["TCGA.CM.6172.01", "G beta:gamma signalling through PLC beta"], ["TCGA.CM.6172.01", "Presynaptic function of Kainate receptors"], ["TCGA.CM.6172.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.CM.6172.01", "Peptide hormone biosynthesis"], ["TCGA.CM.6172.01", "Inwardly rectifying K+ channels"], ["TCGA.CM.6172.01", "Thromboxane signalling through TP receptor"], ["TCGA.CM.6674.01", "Activation of Matrix Metalloproteinases"], ["TCGA.CM.6674.01", "Potassium Channels"], ["TCGA.CM.6674.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.CM.6674.01", "Glucuronidation"], ["TCGA.CM.6674.01", "GABA receptor activation"], ["TCGA.CM.6674.01", "Activation of the phototransduction cascade"], ["TCGA.CM.6674.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.CM.6674.01", "Interaction between L1 and Ankyrins"], ["TCGA.CM.6674.01", "Phase 4 - resting membrane potential"], ["TCGA.CM.6674.01", "Erythrocytes take up carbon dioxide and release oxygen"], ["TCGA.CM.6674.01", "O2/CO2 exchange in erythrocytes"], ["TCGA.CM.6674.01", "Collagen chain trimerization"], ["TCGA.CM.6674.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.CM.6674.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], ["TCGA.CM.6674.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.CM.6674.01", "Phase II - Conjugation of compounds"], ["TCGA.CM.6674.01", "Aspirin ADME"], ["TCGA.CM.6675.01", "Potassium Channels"], ["TCGA.CM.6675.01", "Voltage gated Potassium channels"], ["TCGA.CM.6675.01", "Phase 0 - rapid depolarisation"], ["TCGA.CM.6675.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.CM.6675.01", "Interaction between L1 and Ankyrins"], ["TCGA.CM.6675.01", "Protein-protein interactions at synapses"], ["TCGA.CM.6675.01", "G beta:gamma signalling through BTK"], ["TCGA.CM.6675.01", "Cytosolic sulfonation of small molecules"], ["TCGA.CM.6675.01", "NCAM1 interactions"], ["TCGA.CM.6675.01", "Activation of G protein gated Potassium channels"], ["TCGA.CM.6675.01", "G protein gated Potassium channels"], ["TCGA.CM.6675.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.CM.6675.01", "Glucagon-type ligand receptors"], ["TCGA.CM.6675.01", "GABA receptor activation"], ["TCGA.CM.6675.01", "CD22 mediated BCR regulation"], ["TCGA.CM.6675.01", "Inwardly rectifying K+ channels"], ["TCGA.CM.6675.01", "Presynaptic function of Kainate receptors"], ["TCGA.CM.6675.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.CM.6675.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.CM.6675.01", "Activation of ATR in response to replication stress"], ["TCGA.CM.6675.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.CM.6675.01", "Activation of the phototransduction cascade"], ["TCGA.CM.6675.01", "Synaptic adhesion-like molecules"], ["TCGA.CM.6675.01", "Nicotinate metabolism"], ["TCGA.CM.6675.01", "LGI-ADAM interactions"], ["TCGA.CM.6676.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.CM.6676.01", "Phase II - Conjugation of compounds"], ["TCGA.CM.6676.01", "Activation of the phototransduction cascade"], ["TCGA.CM.6676.01", "Glucuronidation"], ["TCGA.CM.6676.01", "Complement cascade"], ["TCGA.CM.6676.01", "Glucagon-type ligand receptors"], ["TCGA.CM.6676.01", "Inwardly rectifying K+ channels"], ["TCGA.CM.6676.01", "G beta:gamma signalling through BTK"], ["TCGA.CM.6676.01", "Classical antibody-mediated complement activation"], ["TCGA.CM.6676.01", "Initial triggering of complement"], ["TCGA.CM.6676.01", "Regulation of Complement cascade"], ["TCGA.CM.6676.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.CM.6676.01", "Cytosolic sulfonation of small molecules"], ["TCGA.CM.6676.01", "Ligand-dependent caspase activation"], ["TCGA.CM.6676.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.CM.6676.01", "Activation of G protein gated Potassium channels"], ["TCGA.CM.6676.01", "G protein gated Potassium channels"], ["TCGA.CM.6676.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.CM.6676.01", "Peptide ligand-binding receptors"], ["TCGA.CM.6676.01", "Chemokine receptors bind chemokines"], ["TCGA.CM.6676.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.CM.6676.01", "Potassium Channels"], ["TCGA.CM.6676.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.CM.6676.01", "Prostacyclin signalling through prostacyclin receptor"], ["TCGA.CM.6676.01", "GABA receptor activation"], ["TCGA.CM.6676.01", "Creation of C4 and C2 activators"], ["TCGA.CM.6676.01", "FGFR2 ligand binding and activation"], ["TCGA.CM.6676.01", "Insulin processing"], ["TCGA.CM.6676.01", "G beta:gamma signalling through PLC beta"], ["TCGA.CM.6676.01", "Aspirin ADME"], ["TCGA.CM.6677.01", "Phase II - Conjugation of compounds"], ["TCGA.CM.6677.01", "GABA receptor activation"], ["TCGA.CM.6677.01", "Cytosolic sulfonation of small molecules"], ["TCGA.CM.6677.01", "Glucagon-type ligand receptors"], ["TCGA.CM.6677.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.CM.6677.01", "Interaction between L1 and Ankyrins"], ["TCGA.CM.6677.01", "Blood group systems biosynthesis"], ["TCGA.CM.6677.01", "Phase 0 - rapid depolarisation"], ["TCGA.CM.6677.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.CM.6677.01", "Potassium Channels"], ["TCGA.CM.6677.01", "Glucuronidation"], ["TCGA.CM.6677.01", "Signal amplification"], ["TCGA.CM.6677.01", "Inwardly rectifying K+ channels"], ["TCGA.CM.6677.01", "Ethanol oxidation"], ["TCGA.CM.6677.01", "Transcriptional regulation of testis differentiation"], ["TCGA.CM.6677.01", "GABA B receptor activation"], ["TCGA.CM.6677.01", "Activation of GABAB receptors"], ["TCGA.CM.6677.01", "Lewis blood group biosynthesis"], ["TCGA.CM.6677.01", "Activation of G protein gated Potassium channels"], ["TCGA.CM.6677.01", "G protein gated Potassium channels"], ["TCGA.CM.6677.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.CM.6677.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.CM.6677.01", "G beta:gamma signalling through BTK"], ["TCGA.CM.6677.01", "Prostacyclin signalling through prostacyclin receptor"], ["TCGA.CM.6677.01", "Insulin processing"], ["TCGA.CM.6677.01", "G beta:gamma signalling through PLC beta"], ["TCGA.CM.6677.01", "Nucleotide catabolism"], ["TCGA.CM.6677.01", "Presynaptic function of Kainate receptors"], ["TCGA.CM.6677.01", "Signaling by Retinoic Acid"], ["TCGA.CM.6678.01", "Translocation of ZAP-70 to Immunological synapse"], ["TCGA.CM.6678.01", "Activation of Matrix Metalloproteinases"], ["TCGA.CM.6678.01", "Interaction between L1 and Ankyrins"], ["TCGA.CM.6678.01", "Classical antibody-mediated complement activation"], ["TCGA.CM.6678.01", "CD22 mediated BCR regulation"], ["TCGA.CM.6678.01", "TNFs bind their physiological receptors"], ["TCGA.CM.6678.01", "Glucuronidation"], ["TCGA.CM.6678.01", "Phase 0 - rapid depolarisation"], ["TCGA.CM.6678.01", "Potassium Channels"], ["TCGA.CM.6678.01", "Other semaphorin interactions"], ["TCGA.CM.6679.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.CM.6679.01", "Collagen chain trimerization"], ["TCGA.CM.6679.01", "Phase II - Conjugation of compounds"], ["TCGA.CM.6679.01", "Biological oxidations"], ["TCGA.CM.6679.01", "Glucuronidation"], ["TCGA.CM.6679.01", "O-linked glycosylation"], ["TCGA.CM.6679.01", "Defective B3GALTL causes PpS"], ["TCGA.CM.6679.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.CM.6679.01", "GABA receptor activation"], ["TCGA.CM.6679.01", "Cytosolic sulfonation of small molecules"], ["TCGA.CM.6679.01", "Phase 4 - resting membrane potential"], ["TCGA.CM.6679.01", "Ethanol oxidation"], ["TCGA.CM.6679.01", "Activation of G protein gated Potassium channels"], ["TCGA.CM.6679.01", "G protein gated Potassium channels"], ["TCGA.CM.6679.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.CM.6679.01", "Heme degradation"], ["TCGA.CM.6679.01", "APAP ADME"], ["TCGA.CM.6679.01", "Presynaptic function of Kainate receptors"], ["TCGA.CM.6679.01", "GABA B receptor activation"], ["TCGA.CM.6679.01", "Activation of GABAB receptors"], ["TCGA.CM.6679.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.CM.6679.01", "Collagen degradation"], ["TCGA.CM.6679.01", "Voltage gated Potassium channels"], ["TCGA.CM.6680.01", "TNFs bind their physiological receptors"], ["TCGA.CM.6680.01", "Cytosolic sulfonation of small molecules"], ["TCGA.CM.6680.01", "Phase II - Conjugation of compounds"], ["TCGA.CM.6680.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], ["TCGA.CM.6680.01", "Interaction between L1 and Ankyrins"], ["TCGA.D5.5537.01", "Phase 4 - resting membrane potential"], ["TCGA.D5.5537.01", "Ethanol oxidation"], ["TCGA.D5.5537.01", "Heme degradation"], ["TCGA.D5.5537.01", "Collagen chain trimerization"], ["TCGA.D5.5537.01", "RA biosynthesis pathway"], ["TCGA.D5.5537.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.D5.5538.01", "Protein-protein interactions at synapses"], ["TCGA.D5.5538.01", "Neurexins and neuroligins"], ["TCGA.D5.5538.01", "Activation of Matrix Metalloproteinases"], ["TCGA.D5.5538.01", "Interaction between L1 and Ankyrins"], ["TCGA.D5.5538.01", "Phase 0 - rapid depolarisation"], ["TCGA.D5.5538.01", "Ethanol oxidation"], ["TCGA.D5.5538.01", "Transcriptional regulation of testis differentiation"], ["TCGA.D5.5538.01", "Synaptic adhesion-like molecules"], ["TCGA.D5.5538.01", "Glucagon-type ligand receptors"], ["TCGA.D5.5538.01", "Potassium Channels"], ["TCGA.D5.5538.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.D5.5538.01", "Phase 4 - resting membrane potential"], ["TCGA.D5.5538.01", "Dopamine Neurotransmitter Release Cycle"], ["TCGA.D5.5538.01", "O-linked glycosylation"], ["TCGA.D5.5538.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], ["TCGA.D5.5538.01", "Defective GALNT12 causes CRCS1"], ["TCGA.D5.5538.01", "APAP ADME"], ["TCGA.D5.5538.01", "GABA receptor activation"], ["TCGA.D5.5538.01", "NCAM1 interactions"], ["TCGA.D5.5538.01", "Transcriptional regulation of pluripotent stem cells"], ["TCGA.D5.5538.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.D5.5538.01", "Lewis blood group biosynthesis"], ["TCGA.D5.5538.01", "Sensory perception of taste"], ["TCGA.D5.5538.01", "Serotonin Neurotransmitter Release Cycle"], ["TCGA.D5.5538.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.D5.5538.01", "Blood group systems biosynthesis"], ["TCGA.D5.5538.01", "Cytosolic sulfonation of small molecules"], ["TCGA.D5.5539.01", "Extracellular matrix organization"], ["TCGA.D5.5539.01", "Drug ADME"], ["TCGA.D5.5539.01", "Activation of Matrix Metalloproteinases"], ["TCGA.D5.5540.01", "Deposition of new CENPA-containing nucleosomes at the centromere"], ["TCGA.D5.5540.01", "Nucleosome assembly"], ["TCGA.D5.5540.01", "Metabolism of folate and pterines"], ["TCGA.D5.5540.01", "Phase 4 - resting membrane potential"], ["TCGA.D5.5540.01", "Activation of Matrix Metalloproteinases"], ["TCGA.D5.5540.01", "Carnitine metabolism"], ["TCGA.D5.5540.01", "DNA strand elongation"], ["TCGA.D5.5540.01", "Scavenging of heme from plasma"], ["TCGA.D5.5540.01", "Impaired BRCA2 binding to PALB2"], ["TCGA.D5.5540.01", "mRNA decay by 3' to 5' exoribonuclease"], ["TCGA.D5.5540.01", "Collagen chain trimerization"], ["TCGA.D5.5540.01", "Blood group systems biosynthesis"], ["TCGA.D5.5540.01", "LGI-ADAM interactions"], ["TCGA.D5.5541.01", "Interaction between L1 and Ankyrins"], ["TCGA.D5.5541.01", "Cytosolic sulfonation of small molecules"], ["TCGA.D5.5541.01", "APAP ADME"], ["TCGA.D5.5541.01", "Blood group systems biosynthesis"], ["TCGA.D5.5541.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.D5.5541.01", "RA biosynthesis pathway"], ["TCGA.D5.5541.01", "Phase II - Conjugation of compounds"], ["TCGA.D5.5541.01", "GABA receptor activation"], ["TCGA.D5.5541.01", "O-linked glycosylation"], ["TCGA.D5.5541.01", "Ethanol oxidation"], ["TCGA.D5.5541.01", "Lewis blood group biosynthesis"], ["TCGA.D5.5541.01", "O-linked glycosylation of mucins"], ["TCGA.D5.5541.01", "Collagen degradation"], ["TCGA.D5.5541.01", "Signaling by Retinoic Acid"], ["TCGA.D5.5541.01", "Defective GALNT12 causes CRCS1"], ["TCGA.D5.5541.01", "Sensory perception of taste"], ["TCGA.D5.5541.01", "Glucuronidation"], ["TCGA.D5.5541.01", "Glucagon-type ligand receptors"], ["TCGA.D5.5541.01", "Aspirin ADME"], ["TCGA.D5.5541.01", "Transcription of E2F targets under negative control by DREAM complex"], ["TCGA.D5.5541.01", "GABA B receptor activation"], ["TCGA.D5.5541.01", "Activation of GABAB receptors"], ["TCGA.D5.5541.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.D5.5541.01", "Presynaptic function of Kainate receptors"], ["TCGA.D5.5541.01", "Activation of G protein gated Potassium channels"], ["TCGA.D5.5541.01", "G protein gated Potassium channels"], ["TCGA.D5.5541.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.D5.5541.01", "Arachidonic acid metabolism"], ["TCGA.D5.5541.01", "Activation of the phototransduction cascade"], ["TCGA.D5.5541.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.D5.6529.01", "Collagen formation"], ["TCGA.D5.6529.01", "Activation of Matrix Metalloproteinases"], ["TCGA.D5.6529.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.D5.6529.01", "Collagen chain trimerization"], ["TCGA.D5.6529.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.D5.6529.01", "Phase II - Conjugation of compounds"], ["TCGA.D5.6529.01", "Glucagon-type ligand receptors"], ["TCGA.D5.6529.01", "Interaction between L1 and Ankyrins"], ["TCGA.D5.6529.01", "GABA receptor activation"], ["TCGA.D5.6529.01", "Glucuronidation"], ["TCGA.D5.6529.01", "Scavenging by Class A Receptors"], ["TCGA.D5.6529.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], ["TCGA.D5.6529.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.D5.6529.01", "Presynaptic function of Kainate receptors"], ["TCGA.D5.6529.01", "NCAM1 interactions"], ["TCGA.D5.6529.01", "O-linked glycosylation"], ["TCGA.D5.6529.01", "Phase 0 - rapid depolarisation"], ["TCGA.D5.6529.01", "Collagen degradation"], ["TCGA.D5.6529.01", "Potassium Channels"], ["TCGA.D5.6529.01", "SLC-mediated transmembrane transport"], ["TCGA.D5.6529.01", "G-protein activation"], ["TCGA.D5.6529.01", "Thromboxane signalling through TP receptor"], ["TCGA.D5.6529.01", "GABA B receptor activation"], ["TCGA.D5.6529.01", "Activation of GABAB receptors"], ["TCGA.D5.6529.01", "Bile acid and bile salt metabolism"], ["TCGA.D5.6529.01", "Cytosolic sulfonation of small molecules"], ["TCGA.D5.6529.01", "Phase 4 - resting membrane potential"], ["TCGA.D5.6529.01", "Ethanol oxidation"], ["TCGA.D5.6529.01", "Inwardly rectifying K+ channels"], ["TCGA.D5.6529.01", "Defective B3GALTL causes PpS"], ["TCGA.D5.6529.01", "Class B/2 (Secretin family receptors)"], ["TCGA.D5.6529.01", "IL-6-type cytokine receptor ligand interactions"], ["TCGA.D5.6529.01", "G beta:gamma signalling through BTK"], ["TCGA.D5.6529.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.D5.6529.01", "Prostacyclin signalling through prostacyclin receptor"], ["TCGA.D5.6529.01", "Signaling by Retinoic Acid"], ["TCGA.D5.6529.01", "Activation of G protein gated Potassium channels"], ["TCGA.D5.6529.01", "G protein gated Potassium channels"], ["TCGA.D5.6529.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.D5.6529.01", "FGFR2 ligand binding and activation"], ["TCGA.D5.6529.01", "G beta:gamma signalling through PLC beta"], ["TCGA.D5.6529.01", "Diseases associated with O-glycosylation of proteins"], ["TCGA.D5.6531.01", "Cytosolic sulfonation of small molecules"], ["TCGA.D5.6531.01", "Phase II - Conjugation of compounds"], ["TCGA.D5.6531.01", "Activation of Matrix Metalloproteinases"], ["TCGA.D5.6531.01", "Defective GALNT12 causes CRCS1"], ["TCGA.D5.6531.01", "O-linked glycosylation"], ["TCGA.D5.6531.01", "Termination of O-glycan biosynthesis"], ["TCGA.D5.6531.01", "Potassium Channels"], ["TCGA.D5.6531.01", "Signaling by Retinoic Acid"], ["TCGA.D5.6531.01", "APAP ADME"], ["TCGA.D5.6531.01", "Diseases associated with O-glycosylation of proteins"], ["TCGA.D5.6531.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.D5.6531.01", "Transcriptional regulation of granulopoiesis"], ["TCGA.D5.6531.01", "Glucagon-type ligand receptors"], ["TCGA.D5.6531.01", "Inwardly rectifying K+ channels"], ["TCGA.D5.6531.01", "Interaction between L1 and Ankyrins"], ["TCGA.D5.6532.01", "Potassium Channels"], ["TCGA.D5.6532.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.D5.6532.01", "Interaction between L1 and Ankyrins"], ["TCGA.D5.6532.01", "Classical antibody-mediated complement activation"], ["TCGA.D5.6532.01", "RA biosynthesis pathway"], ["TCGA.D5.6532.01", "G beta:gamma signalling through BTK"], ["TCGA.D5.6532.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.D5.6532.01", "Activation of G protein gated Potassium channels"], ["TCGA.D5.6532.01", "G protein gated Potassium channels"], ["TCGA.D5.6532.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.D5.6532.01", "Initial triggering of complement"], ["TCGA.D5.6532.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.D5.6532.01", "GABA B receptor activation"], ["TCGA.D5.6532.01", "Activation of GABAB receptors"], ["TCGA.D5.6532.01", "Glucagon-type ligand receptors"], ["TCGA.D5.6532.01", "Blood group systems biosynthesis"], ["TCGA.D5.6532.01", "Presynaptic function of Kainate receptors"], ["TCGA.D5.6532.01", "Inwardly rectifying K+ channels"], ["TCGA.D5.6532.01", "GABA receptor activation"], ["TCGA.D5.6532.01", "Phase 0 - rapid depolarisation"], ["TCGA.D5.6532.01", "Phase 4 - resting membrane potential"], ["TCGA.D5.6532.01", "Transcriptional regulation of testis differentiation"], ["TCGA.D5.6532.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.D5.6532.01", "Prostacyclin signalling through prostacyclin receptor"], ["TCGA.D5.6532.01", "Scavenging of heme from plasma"], ["TCGA.D5.6532.01", "G beta:gamma signalling through PLC beta"], ["TCGA.D5.6532.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.D5.6532.01", "Lewis blood group biosynthesis"], ["TCGA.D5.6532.01", "CD22 mediated BCR regulation"], ["TCGA.D5.6532.01", "Chemokine receptors bind chemokines"], ["TCGA.D5.6532.01", "Voltage gated Potassium channels"], ["TCGA.D5.6532.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.D5.6532.01", "Activation of the phototransduction cascade"], ["TCGA.D5.6532.01", "Aspartate and asparagine metabolism"], ["TCGA.D5.6532.01", "Synaptic adhesion-like molecules"], ["TCGA.D5.6532.01", "Signaling by Retinoic Acid"], ["TCGA.D5.6532.01", "Creation of C4 and C2 activators"], ["TCGA.D5.6532.01", "Erythrocytes take up carbon dioxide and release oxygen"], ["TCGA.D5.6532.01", "O2/CO2 exchange in erythrocytes"], ["TCGA.D5.6532.01", "Cytosolic sulfonation of small molecules"], ["TCGA.D5.6532.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], ["TCGA.D5.6532.01", "G-protein activation"], ["TCGA.D5.6532.01", "Thromboxane signalling through TP receptor"], ["TCGA.D5.6532.01", "Phase II - Conjugation of compounds"], ["TCGA.D5.6532.01", "Elastic fibre formation"], ["TCGA.D5.6532.01", "Sialic acid metabolism"], ["TCGA.D5.6533.01", "Activation of Matrix Metalloproteinases"], ["TCGA.D5.6533.01", "Phase II - Conjugation of compounds"], ["TCGA.D5.6533.01", "Glutathione conjugation"], ["TCGA.D5.6533.01", "Lewis blood group biosynthesis"], ["TCGA.D5.6533.01", "Aspirin ADME"], ["TCGA.D5.6533.01", "Blood group systems biosynthesis"], ["TCGA.D5.6533.01", "Interaction between L1 and Ankyrins"], ["TCGA.D5.6533.01", "RA biosynthesis pathway"], ["TCGA.D5.6533.01", "Phase 0 - rapid depolarisation"], ["TCGA.D5.6533.01", "Keratan sulfate biosynthesis"], ["TCGA.D5.6533.01", "Arachidonic acid metabolism"], ["TCGA.D5.6533.01", "Erythrocytes take up carbon dioxide and release oxygen"], ["TCGA.D5.6533.01", "O2/CO2 exchange in erythrocytes"], ["TCGA.D5.6533.01", "Acyl chain remodelling of PE"], ["TCGA.D5.6533.01", "Ethanol oxidation"], ["TCGA.D5.6533.01", "Transcriptional regulation of testis differentiation"], ["TCGA.D5.6533.01", "Acyl chain remodelling of PS"], ["TCGA.D5.6533.01", "IL-6-type cytokine receptor ligand interactions"], ["TCGA.D5.6533.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.D5.6533.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.D5.6533.01", "Glucuronidation"], ["TCGA.D5.6534.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.D5.6534.01", "Activation of Matrix Metalloproteinases"], ["TCGA.D5.6534.01", "Collagen chain trimerization"], ["TCGA.D5.6534.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.D5.6534.01", "Phase II - Conjugation of compounds"], ["TCGA.D5.6534.01", "Cytosolic sulfonation of small molecules"], ["TCGA.D5.6534.01", "Glucuronidation"], ["TCGA.D5.6534.01", "Defective B3GALTL causes PpS"], ["TCGA.D5.6534.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.D5.6534.01", "APAP ADME"], ["TCGA.D5.6534.01", "Collagen degradation"], ["TCGA.D5.6534.01", "Degradation of cysteine and homocysteine"], ["TCGA.D5.6534.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.D5.6534.01", "Aspirin ADME"], ["TCGA.D5.6534.01", "mitochondrial fatty acid beta-oxidation of saturated fatty acids"], ["TCGA.D5.6534.01", "Chondroitin sulfate biosynthesis"], ["TCGA.D5.6534.01", "Other semaphorin interactions"], ["TCGA.D5.6534.01", "O-linked glycosylation"], ["TCGA.D5.6534.01", "Scavenging by Class A Receptors"], ["TCGA.D5.6534.01", "Peptide hormone biosynthesis"], ["TCGA.D5.6534.01", "Aflatoxin activation and detoxification"], ["TCGA.D5.6534.01", "LGI-ADAM interactions"], ["TCGA.D5.6535.01", "GABA receptor activation"], ["TCGA.D5.6535.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.D5.6535.01", "Potassium Channels"], ["TCGA.D5.6535.01", "Glucagon-type ligand receptors"], ["TCGA.D5.6535.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.D5.6535.01", "GABA B receptor activation"], ["TCGA.D5.6535.01", "Activation of GABAB receptors"], ["TCGA.D5.6535.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.D5.6535.01", "Activation of Matrix Metalloproteinases"], ["TCGA.D5.6535.01", "Inwardly rectifying K+ channels"], ["TCGA.D5.6535.01", "Activation of G protein gated Potassium channels"], ["TCGA.D5.6535.01", "G protein gated Potassium channels"], ["TCGA.D5.6535.01", "Interaction between L1 and Ankyrins"], ["TCGA.D5.6535.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.D5.6535.01", "Cytosolic sulfonation of small molecules"], ["TCGA.D5.6535.01", "Phase 4 - resting membrane potential"], ["TCGA.D5.6535.01", "Ethanol oxidation"], ["TCGA.D5.6535.01", "Phase 0 - rapid depolarisation"], ["TCGA.D5.6535.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.D5.6535.01", "Phase II - Conjugation of compounds"], ["TCGA.D5.6535.01", "G beta:gamma signalling through BTK"], ["TCGA.D5.6535.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.D5.6535.01", "Prostacyclin signalling through prostacyclin receptor"], ["TCGA.D5.6535.01", "G beta:gamma signalling through PLC beta"], ["TCGA.D5.6535.01", "APAP ADME"], ["TCGA.D5.6535.01", "Presynaptic function of Kainate receptors"], ["TCGA.D5.6535.01", "Aspartate and asparagine metabolism"], ["TCGA.D5.6535.01", "TNFs bind their physiological receptors"], ["TCGA.D5.6535.01", "G-protein activation"], ["TCGA.D5.6535.01", "Thromboxane signalling through TP receptor"], ["TCGA.D5.6536.01", "Phase II - Conjugation of compounds"], ["TCGA.D5.6536.01", "Peptide hormone biosynthesis"], ["TCGA.D5.6536.01", "Collagen chain trimerization"], ["TCGA.D5.6536.01", "Glucuronidation"], ["TCGA.D5.6536.01", "TNFs bind their physiological receptors"], ["TCGA.D5.6536.01", "Erythrocytes take up carbon dioxide and release oxygen"], ["TCGA.D5.6536.01", "O2/CO2 exchange in erythrocytes"], ["TCGA.D5.6536.01", "Cytosolic sulfonation of small molecules"], ["TCGA.D5.6536.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.D5.6536.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.D5.6537.01", "Potassium Channels"], ["TCGA.D5.6537.01", "Interaction between L1 and Ankyrins"], ["TCGA.D5.6537.01", "Complement cascade"], ["TCGA.D5.6537.01", "Regulation of Complement cascade"], ["TCGA.D5.6537.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.D5.6537.01", "Chemokine receptors bind chemokines"], ["TCGA.D5.6537.01", "Phase 0 - rapid depolarisation"], ["TCGA.D5.6537.01", "GABA receptor activation"], ["TCGA.D5.6537.01", "GABA B receptor activation"], ["TCGA.D5.6537.01", "Activation of GABAB receptors"], ["TCGA.D5.6537.01", "Classical antibody-mediated complement activation"], ["TCGA.D5.6537.01", "Initial triggering of complement"], ["TCGA.D5.6537.01", "Blood group systems biosynthesis"], ["TCGA.D5.6537.01", "Glucagon-type ligand receptors"], ["TCGA.D5.6537.01", "Lewis blood group biosynthesis"], ["TCGA.D5.6537.01", "Activation of Matrix Metalloproteinases"], ["TCGA.D5.6537.01", "Recycling of bile acids and salts"], ["TCGA.D5.6537.01", "Activation of the phototransduction cascade"], ["TCGA.D5.6537.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.D5.6537.01", "Inwardly rectifying K+ channels"], ["TCGA.D5.6537.01", "Ion transport by P-type ATPases"], ["TCGA.D5.6537.01", "Cytosolic sulfonation of small molecules"], ["TCGA.D5.6537.01", "G beta:gamma signalling through BTK"], ["TCGA.D5.6537.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.D5.6537.01", "Adenylate cyclase inhibitory pathway"], ["TCGA.D5.6537.01", "Other semaphorin interactions"], ["TCGA.D5.6537.01", "Heme degradation"], ["TCGA.D5.6537.01", "Activation of G protein gated Potassium channels"], ["TCGA.D5.6537.01", "G protein gated Potassium channels"], ["TCGA.D5.6537.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.D5.6537.01", "CD22 mediated BCR regulation"], ["TCGA.D5.6537.01", "G-protein activation"], ["TCGA.D5.6537.01", "Thromboxane signalling through TP receptor"], ["TCGA.D5.6537.01", "Acetylcholine Neurotransmitter Release Cycle"], ["TCGA.D5.6537.01", "Aspirin ADME"], ["TCGA.D5.6537.01", "Keratan sulfate biosynthesis"], ["TCGA.D5.6537.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.D5.6537.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.D5.6537.01", "Voltage gated Potassium channels"], ["TCGA.D5.6537.01", "Presynaptic function of Kainate receptors"], ["TCGA.D5.6537.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.D5.6537.01", "Formation of the anterior neural plate"], ["TCGA.D5.6537.01", "IL-6-type cytokine receptor ligand interactions"], ["TCGA.D5.6537.01", "Creation of C4 and C2 activators"], ["TCGA.D5.6537.01", "Phase II - Conjugation of compounds"], ["TCGA.D5.6537.01", "NCAM1 interactions"], ["TCGA.D5.6538.01", "Classical antibody-mediated complement activation"], ["TCGA.D5.6538.01", "Voltage gated Potassium channels"], ["TCGA.D5.6538.01", "Activation of the phototransduction cascade"], ["TCGA.D5.6538.01", "Trafficking and processing of endosomal TLR"], ["TCGA.D5.6538.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], ["TCGA.D5.6538.01", "Initial triggering of complement"], ["TCGA.D5.6538.01", "Inwardly rectifying K+ channels"], ["TCGA.D5.6538.01", "Keratan sulfate biosynthesis"], ["TCGA.D5.6538.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.D5.6538.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.D5.6538.01", "Defective GALNT12 causes CRCS1"], ["TCGA.D5.6538.01", "Creation of C4 and C2 activators"], ["TCGA.D5.6538.01", "LGI-ADAM interactions"], ["TCGA.D5.6538.01", "Activation of G protein gated Potassium channels"], ["TCGA.D5.6538.01", "G protein gated Potassium channels"], ["TCGA.D5.6538.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.D5.6539.01", "Extracellular matrix organization"], ["TCGA.D5.6540.01", "Interaction between L1 and Ankyrins"], ["TCGA.D5.6540.01", "Ethanol oxidation"], ["TCGA.D5.6540.01", "Phase 0 - rapid depolarisation"], ["TCGA.D5.6540.01", "RA biosynthesis pathway"], ["TCGA.D5.6540.01", "Glucuronidation"], ["TCGA.D5.6540.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.D5.6540.01", "Phase II - Conjugation of compounds"], ["TCGA.D5.6540.01", "NCAM1 interactions"], ["TCGA.D5.6540.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.D5.6540.01", "Potassium Channels"], ["TCGA.D5.6540.01", "Glucagon-type ligand receptors"], ["TCGA.D5.6540.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.D5.6540.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.D5.6540.01", "Activation of Matrix Metalloproteinases"], ["TCGA.D5.6540.01", "Signaling by Retinoic Acid"], ["TCGA.D5.6540.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.D5.6540.01", "Aspirin ADME"], ["TCGA.D5.6540.01", "CD22 mediated BCR regulation"], ["TCGA.D5.6540.01", "GABA receptor activation"], ["TCGA.D5.6540.01", "G beta:gamma signalling through BTK"], ["TCGA.D5.6540.01", "Activation of the phototransduction cascade"], ["TCGA.D5.6540.01", "Arachidonic acid metabolism"], ["TCGA.D5.6540.01", "Nicotinate metabolism"], ["TCGA.D5.6540.01", "LGI-ADAM interactions"], ["TCGA.D5.6540.01", "Collagen chain trimerization"], ["TCGA.D5.6540.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], ["TCGA.D5.6540.01", "Cytosolic sulfonation of small molecules"], ["TCGA.D5.6540.01", "Transcriptional regulation of testis differentiation"], ["TCGA.D5.6540.01", "APAP ADME"], ["TCGA.D5.6541.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.D5.6541.01", "Defective B3GALTL causes PpS"], ["TCGA.D5.6541.01", "Collagen chain trimerization"], ["TCGA.D5.6541.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.D5.6541.01", "Ethanol oxidation"], ["TCGA.D5.6541.01", "O-linked glycosylation"], ["TCGA.D5.6541.01", "Diseases associated with O-glycosylation of proteins"], ["TCGA.D5.6541.01", "Glucagon-type ligand receptors"], ["TCGA.D5.6541.01", "Phase 4 - resting membrane potential"], ["TCGA.D5.6541.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.D5.6541.01", "Heme degradation"], ["TCGA.D5.6541.01", "Arachidonic acid metabolism"], ["TCGA.D5.6541.01", "WNT ligand biogenesis and trafficking"], ["TCGA.D5.6541.01", "Metabolism of amine-derived hormones"], ["TCGA.D5.6541.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], ["TCGA.D5.6898.01", "Blood group systems biosynthesis"], ["TCGA.D5.6898.01", "Phase II - Conjugation of compounds"], ["TCGA.D5.6898.01", "Glucuronidation"], ["TCGA.D5.6898.01", "Lewis blood group biosynthesis"], ["TCGA.D5.6898.01", "Phase 4 - resting membrane potential"], ["TCGA.D5.6898.01", "Ethanol oxidation"], ["TCGA.D5.6898.01", "Potassium Channels"], ["TCGA.D5.6920.01", "Activation of Matrix Metalloproteinases"], ["TCGA.D5.6920.01", "Extracellular matrix organization"], ["TCGA.D5.6920.01", "Interaction between L1 and Ankyrins"], ["TCGA.D5.6920.01", "Neuronal System"], ["TCGA.D5.6920.01", "Transmission across Chemical Synapses"], ["TCGA.D5.6920.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.D5.6920.01", "Chemokine receptors bind chemokines"], ["TCGA.D5.6920.01", "Degradation of the extracellular matrix"], ["TCGA.D5.6920.01", "GPCR ligand binding"], ["TCGA.D5.6920.01", "GABA receptor activation"], ["TCGA.D5.6920.01", "Molecules associated with elastic fibres"], ["TCGA.D5.6920.01", "Cardiac conduction"], ["TCGA.D5.6920.01", "G alpha (i) signalling events"], ["TCGA.D5.6920.01", "L1CAM interactions"], ["TCGA.D5.6920.01", "Diseases associated with glycosaminoglycan metabolism"], ["TCGA.D5.6920.01", "Unblocking of NMDA receptors, glutamate binding and activation"], ["TCGA.D5.6920.01", "Phase 0 - rapid depolarisation"], ["TCGA.D5.6920.01", "Long-term potentiation"], ["TCGA.D5.6920.01", "Class B/2 (Secretin family receptors)"], ["TCGA.D5.6920.01", "Regulation of FZD by ubiquitination"], ["TCGA.D5.6920.01", "Assembly and cell surface presentation of NMDA receptors"], ["TCGA.D5.6920.01", "Biological oxidations"], ["TCGA.D5.6920.01", "Elastic fibre formation"], ["TCGA.D5.6920.01", "Glycosaminoglycan metabolism"], ["TCGA.D5.6920.01", "Peptide hormone metabolism"], ["TCGA.D5.6920.01", "Basigin interactions"], ["TCGA.D5.6920.01", "Visual phototransduction"], ["TCGA.D5.6922.01", "Phase II - Conjugation of compounds"], ["TCGA.D5.6922.01", "Glucuronidation"], ["TCGA.D5.6922.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.D5.6922.01", "Collagen formation"], ["TCGA.D5.6922.01", "Cytosolic sulfonation of small molecules"], ["TCGA.D5.6922.01", "Signaling by Retinoic Acid"], ["TCGA.D5.6924.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.D5.6924.01", "Phase II - Conjugation of compounds"], ["TCGA.D5.6924.01", "Cytosolic sulfonation of small molecules"], ["TCGA.D5.6924.01", "Collagen chain trimerization"], ["TCGA.D5.6924.01", "Blood group systems biosynthesis"], ["TCGA.D5.6924.01", "Heme degradation"], ["TCGA.D5.6924.01", "RA biosynthesis pathway"], ["TCGA.D5.6924.01", "Glucuronidation"], ["TCGA.D5.6924.01", "Defective GALNT12 causes CRCS1"], ["TCGA.D5.6924.01", "APAP ADME"], ["TCGA.D5.6924.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.D5.6924.01", "FGFR4 ligand binding and activation"], ["TCGA.D5.6924.01", "Collagen degradation"], ["TCGA.D5.6924.01", "Lewis blood group biosynthesis"], ["TCGA.D5.6924.01", "Aspartate and asparagine metabolism"], ["TCGA.D5.6924.01", "JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1"], ["TCGA.D5.6924.01", "Tryptophan catabolism"], ["TCGA.D5.6924.01", "Ethanol oxidation"], ["TCGA.D5.6924.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], ["TCGA.D5.6924.01", "Transport of bile salts and organic acids, metal ions and amine compounds"], ["TCGA.D5.6924.01", "Glutathione conjugation"], ["TCGA.D5.6924.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.D5.6924.01", "Defective GALNT3 causes HFTC"], ["TCGA.D5.6924.01", "Erythrocytes take up carbon dioxide and release oxygen"], ["TCGA.D5.6924.01", "O2/CO2 exchange in erythrocytes"], ["TCGA.D5.6924.01", "O-linked glycosylation of mucins"], ["TCGA.D5.6924.01", "FGFR2c ligand binding and activation"], ["TCGA.D5.6924.01", "Peptide hormone biosynthesis"], ["TCGA.D5.6924.01", "Defective C1GALT1C1 causes TNPS"], ["TCGA.D5.6924.01", "TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest"], ["TCGA.D5.6924.01", "O-linked glycosylation"], ["TCGA.D5.6924.01", "Metal ion SLC transporters"], ["TCGA.D5.6924.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], ["TCGA.D5.6926.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.D5.6926.01", "Phase II - Conjugation of compounds"], ["TCGA.D5.6926.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.D5.6926.01", "Collagen chain trimerization"], ["TCGA.D5.6926.01", "Activation of Matrix Metalloproteinases"], ["TCGA.D5.6926.01", "Glucuronidation"], ["TCGA.D5.6926.01", "RA biosynthesis pathway"], ["TCGA.D5.6926.01", "Cytosolic sulfonation of small molecules"], ["TCGA.D5.6926.01", "Ethanol oxidation"], ["TCGA.D5.6926.01", "Signaling by Retinoic Acid"], ["TCGA.D5.6926.01", "Glucagon-type ligand receptors"], ["TCGA.D5.6926.01", "Glutathione conjugation"], ["TCGA.D5.6926.01", "Inwardly rectifying K+ channels"], ["TCGA.D5.6926.01", "APAP ADME"], ["TCGA.D5.6926.01", "Presynaptic function of Kainate receptors"], ["TCGA.D5.6926.01", "Activation of G protein gated Potassium channels"], ["TCGA.D5.6926.01", "G protein gated Potassium channels"], ["TCGA.D5.6926.01", "Interaction between L1 and Ankyrins"], ["TCGA.D5.6926.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.D5.6926.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.D5.6926.01", "TNFs bind their physiological receptors"], ["TCGA.D5.6926.01", "Collagen degradation"], ["TCGA.D5.6927.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.D5.6927.01", "Activation of Matrix Metalloproteinases"], ["TCGA.D5.6927.01", "Interaction between L1 and Ankyrins"], ["TCGA.D5.6927.01", "Collagen chain trimerization"], ["TCGA.D5.6927.01", "RA biosynthesis pathway"], ["TCGA.D5.6927.01", "Phase 0 - rapid depolarisation"], ["TCGA.D5.6927.01", "Signaling by Retinoic Acid"], ["TCGA.D5.6927.01", "Glucuronidation"], ["TCGA.D5.6927.01", "Phase II - Conjugation of compounds"], ["TCGA.D5.6927.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.D5.6927.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], ["TCGA.D5.6927.01", "NCAM1 interactions"], ["TCGA.D5.6927.01", "IL-6-type cytokine receptor ligand interactions"], ["TCGA.D5.6927.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.D5.6928.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.D5.6928.01", "Phase II - Conjugation of compounds"], ["TCGA.D5.6928.01", "Glucuronidation"], ["TCGA.D5.6928.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], ["TCGA.D5.6928.01", "Cytosolic sulfonation of small molecules"], ["TCGA.D5.6928.01", "Ethanol oxidation"], ["TCGA.D5.6928.01", "Potassium Channels"], ["TCGA.D5.6928.01", "TNFs bind their physiological receptors"], ["TCGA.D5.6928.01", "Collagen chain trimerization"], ["TCGA.D5.6928.01", "RA biosynthesis pathway"], ["TCGA.D5.6928.01", "Bile acid and bile salt metabolism"], ["TCGA.D5.6928.01", "Defective GALNT3 causes HFTC"], ["TCGA.D5.6928.01", "Defective GALNT12 causes CRCS1"], ["TCGA.D5.6928.01", "Synthesis of bile acids and bile salts"], ["TCGA.D5.6928.01", "APAP ADME"], ["TCGA.D5.6928.01", "Voltage gated Potassium channels"], ["TCGA.D5.6928.01", "Defective C1GALT1C1 causes TNPS"], ["TCGA.D5.6928.01", "Dectin-2 family"], ["TCGA.D5.6928.01", "O-linked glycosylation"], ["TCGA.D5.6929.01", "Defective B3GALTL causes PpS"], ["TCGA.D5.6929.01", "Glucuronidation"], ["TCGA.D5.6929.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.D5.6929.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.D5.6929.01", "Activation of Matrix Metalloproteinases"], ["TCGA.D5.6929.01", "Collagen formation"], ["TCGA.D5.6929.01", "Diseases associated with O-glycosylation of proteins"], ["TCGA.D5.6929.01", "Glucagon-type ligand receptors"], ["TCGA.D5.6929.01", "Aspirin ADME"], ["TCGA.D5.6929.01", "Collagen chain trimerization"], ["TCGA.D5.6929.01", "Phase II - Conjugation of compounds"], ["TCGA.D5.6929.01", "O-linked glycosylation"], ["TCGA.D5.6929.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.D5.6929.01", "Interaction between L1 and Ankyrins"], ["TCGA.D5.6929.01", "Transcriptional regulation of pluripotent stem cells"], ["TCGA.D5.6929.01", "Potassium Channels"], ["TCGA.D5.6929.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.D5.6929.01", "Blood group systems biosynthesis"], ["TCGA.D5.6929.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], ["TCGA.D5.6929.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.D5.6929.01", "Physiological factors"], ["TCGA.D5.6929.01", "Keratinization"], ["TCGA.D5.6929.01", "YAP1- and WWTR1 (TAZ)-stimulated gene expression"], ["TCGA.D5.6929.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], ["TCGA.D5.6929.01", "Metabolism of amine-derived hormones"], ["TCGA.D5.6930.01", "Phase II - Conjugation of compounds"], ["TCGA.D5.6930.01", "Glucuronidation"], ["TCGA.D5.6930.01", "Activation of Matrix Metalloproteinases"], ["TCGA.D5.6930.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.D5.6930.01", "GABA receptor activation"], ["TCGA.D5.6930.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.D5.6930.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.D5.6930.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], ["TCGA.D5.6930.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.D5.6930.01", "Synthesis of bile acids and bile salts via 27-hydroxycholesterol"], ["TCGA.D5.6930.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.D5.6930.01", "O-linked glycosylation of mucins"], ["TCGA.D5.6930.01", "GABA B receptor activation"], ["TCGA.D5.6930.01", "Activation of GABAB receptors"], ["TCGA.D5.6930.01", "Cytosolic sulfonation of small molecules"], ["TCGA.D5.6930.01", "Phase 4 - resting membrane potential"], ["TCGA.D5.6930.01", "Ethanol oxidation"], ["TCGA.D5.6931.01", "GABA receptor activation"], ["TCGA.D5.6931.01", "Signaling by Retinoic Acid"], ["TCGA.D5.6931.01", "Cytosolic sulfonation of small molecules"], ["TCGA.D5.6931.01", "Activation of Matrix Metalloproteinases"], ["TCGA.D5.6931.01", "Interaction between L1 and Ankyrins"], ["TCGA.D5.6931.01", "Keratinization"], ["TCGA.D5.6931.01", "Defective B3GALTL causes PpS"], ["TCGA.D5.6931.01", "Collagen formation"], ["TCGA.D5.6931.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.D5.6931.01", "RA biosynthesis pathway"], ["TCGA.D5.6931.01", "IL-6-type cytokine receptor ligand interactions"], ["TCGA.D5.6932.01", "Phase II - Conjugation of compounds"], ["TCGA.D5.6932.01", "Activation of Matrix Metalloproteinases"], ["TCGA.D5.6932.01", "Glucuronidation"], ["TCGA.D5.6932.01", "Potassium Channels"], ["TCGA.D5.6932.01", "Interaction between L1 and Ankyrins"], ["TCGA.D5.6932.01", "Aspirin ADME"], ["TCGA.D5.6932.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.D5.6932.01", "Cytosolic sulfonation of small molecules"], ["TCGA.D5.6932.01", "Ethanol oxidation"], ["TCGA.D5.6932.01", "Voltage gated Potassium channels"], ["TCGA.D5.6932.01", "TNFs bind their physiological receptors"], ["TCGA.D5.7000.01", "Cytosolic sulfonation of small molecules"], ["TCGA.D5.7000.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.D5.7000.01", "Phase II - Conjugation of compounds"], ["TCGA.D5.7000.01", "Phase 2 - plateau phase"], ["TCGA.D5.7000.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.D5.7000.01", "TNFs bind their physiological receptors"], ["TCGA.D5.7000.01", "Ethanol oxidation"], ["TCGA.D5.7000.01", "Transcriptional regulation of testis differentiation"], ["TCGA.D5.7000.01", "CD22 mediated BCR regulation"], ["TCGA.DM.A0X9.01", "Cytosolic sulfonation of small molecules"], ["TCGA.DM.A0X9.01", "Activation of Matrix Metalloproteinases"], ["TCGA.DM.A0X9.01", "Phase II - Conjugation of compounds"], ["TCGA.DM.A0X9.01", "Heme degradation"], ["TCGA.DM.A0X9.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.DM.A0XD.01", "Phase II - Conjugation of compounds"], ["TCGA.DM.A0XD.01", "Potassium Channels"], ["TCGA.DM.A0XD.01", "Glucuronidation"], ["TCGA.DM.A0XD.01", "Voltage gated Potassium channels"], ["TCGA.DM.A0XD.01", "Cytosolic sulfonation of small molecules"], ["TCGA.DM.A0XD.01", "Interaction between L1 and Ankyrins"], ["TCGA.DM.A0XF.01", "Phase 0 - rapid depolarisation"], ["TCGA.DM.A0XF.01", "Potassium Channels"], ["TCGA.DM.A0XF.01", "Interaction between L1 and Ankyrins"], ["TCGA.DM.A0XF.01", "Phase 4 - resting membrane potential"], ["TCGA.DM.A0XF.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.DM.A0XF.01", "GABA receptor activation"], ["TCGA.DM.A0XF.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.DM.A0XF.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.DM.A0XF.01", "Glucagon-type ligand receptors"], ["TCGA.DM.A0XF.01", "TNFs bind their physiological receptors"], ["TCGA.DM.A0XF.01", "DNA strand elongation"], ["TCGA.DM.A0XF.01", "CD22 mediated BCR regulation"], ["TCGA.DM.A0XF.01", "Blood group systems biosynthesis"], ["TCGA.DM.A0XF.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.DM.A0XF.01", "Recycling of bile acids and salts"], ["TCGA.DM.A0XF.01", "O-linked glycosylation"], ["TCGA.DM.A0XF.01", "GABA B receptor activation"], ["TCGA.DM.A0XF.01", "Activation of GABAB receptors"], ["TCGA.DM.A0XF.01", "RA biosynthesis pathway"], ["TCGA.DM.A0XF.01", "Synaptic adhesion-like molecules"], ["TCGA.DM.A0XF.01", "Activation of the phototransduction cascade"], ["TCGA.DM.A0XF.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.DM.A0XF.01", "Voltage gated Potassium channels"], ["TCGA.DM.A0XF.01", "Erythrocytes take up carbon dioxide and release oxygen"], ["TCGA.DM.A0XF.01", "O2/CO2 exchange in erythrocytes"], ["TCGA.DM.A0XF.01", "Azathioprine ADME"], ["TCGA.DM.A0XF.01", "Thromboxane signalling through TP receptor"], ["TCGA.DM.A1D0.01", "Initial triggering of complement"], ["TCGA.DM.A1D0.01", "Potassium Channels"], ["TCGA.DM.A1D0.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.DM.A1D0.01", "TNFs bind their physiological receptors"], ["TCGA.DM.A1D0.01", "Nicotinate metabolism"], ["TCGA.DM.A1D0.01", "Trafficking and processing of endosomal TLR"], ["TCGA.DM.A1D0.01", "Defective B3GALTL causes PpS"], ["TCGA.DM.A1D0.01", "Synaptic adhesion-like molecules"], ["TCGA.DM.A1D0.01", "Voltage gated Potassium channels"], ["TCGA.DM.A1D0.01", "Arachidonic acid metabolism"], ["TCGA.DM.A1D0.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.DM.A1D0.01", "CD22 mediated BCR regulation"], ["TCGA.DM.A1D0.01", "Scavenging of heme from plasma"], ["TCGA.DM.A1D0.01", "Norepinephrine Neurotransmitter Release Cycle"], ["TCGA.DM.A1D0.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.DM.A1D0.01", "Acetylcholine Neurotransmitter Release Cycle"], ["TCGA.DM.A1D0.01", "TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway"], ["TCGA.DM.A1D0.01", "Lewis blood group biosynthesis"], ["TCGA.DM.A1D0.01", "FGFR2 ligand binding and activation"], ["TCGA.DM.A1D0.01", "Glucagon-type ligand receptors"], ["TCGA.DM.A1D0.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.DM.A1D0.01", "Diseases associated with O-glycosylation of proteins"], ["TCGA.DM.A1D0.01", "Inwardly rectifying K+ channels"], ["TCGA.DM.A1D0.01", "Serotonin Neurotransmitter Release Cycle"], ["TCGA.DM.A1D0.01", "Blood group systems biosynthesis"], ["TCGA.DM.A1D0.01", "Presynaptic function of Kainate receptors"], ["TCGA.DM.A1D0.01", "Dectin-2 family"], ["TCGA.DM.A1D0.01", "Specification of primordial germ cells"], ["TCGA.DM.A1D4.01", "Classical antibody-mediated complement activation"], ["TCGA.DM.A1D4.01", "Transcriptional regulation of testis differentiation"], ["TCGA.DM.A1D4.01", "Acetylcholine Neurotransmitter Release Cycle"], ["TCGA.DM.A1D4.01", "Initial triggering of complement"], ["TCGA.DM.A1D4.01", "Creation of C4 and C2 activators"], ["TCGA.DM.A1D4.01", "Glutamate Neurotransmitter Release Cycle"], ["TCGA.DM.A1D4.01", "Collagen chain trimerization"], ["TCGA.DM.A1D4.01", "Scavenging of heme from plasma"], ["TCGA.DM.A1D4.01", "CD22 mediated BCR regulation"], ["TCGA.DM.A1D4.01", "Interaction between L1 and Ankyrins"], ["TCGA.DM.A1D4.01", "Synthesis of bile acids and bile salts via 27-hydroxycholesterol"], ["TCGA.DM.A1D4.01", "Glucagon-type ligand receptors"], ["TCGA.DM.A1D4.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.DM.A1D4.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.DM.A1D4.01", "Defective B3GALTL causes PpS"], ["TCGA.DM.A1D4.01", "Blood group systems biosynthesis"], ["TCGA.DM.A1D4.01", "Voltage gated Potassium channels"], ["TCGA.DM.A1D4.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.DM.A1D4.01", "Activation of the phototransduction cascade"], ["TCGA.DM.A1D6.01", "Glucagon-type ligand receptors"], ["TCGA.DM.A1D6.01", "Presynaptic function of Kainate receptors"], ["TCGA.DM.A1D6.01", "G beta:gamma signalling through PLC beta"], ["TCGA.DM.A1D6.01", "G-protein activation"], ["TCGA.DM.A1D6.01", "Inwardly rectifying K+ channels"], ["TCGA.DM.A1D6.01", "Activation of G protein gated Potassium channels"], ["TCGA.DM.A1D6.01", "G protein gated Potassium channels"], ["TCGA.DM.A1D6.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.DM.A1D6.01", "GABA receptor activation"], ["TCGA.DM.A1D6.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.DM.A1D6.01", "Prostacyclin signalling through prostacyclin receptor"], ["TCGA.DM.A1D6.01", "Initial triggering of complement"], ["TCGA.DM.A1D6.01", "GABA B receptor activation"], ["TCGA.DM.A1D6.01", "Activation of GABAB receptors"], ["TCGA.DM.A1D6.01", "Interaction between L1 and Ankyrins"], ["TCGA.DM.A1D6.01", "Creation of C4 and C2 activators"], ["TCGA.DM.A1D6.01", "Erythrocytes take up carbon dioxide and release oxygen"], ["TCGA.DM.A1D6.01", "O2/CO2 exchange in erythrocytes"], ["TCGA.DM.A1D6.01", "TNFs bind their physiological receptors"], ["TCGA.DM.A1D6.01", "Binding and entry of HIV virion"], ["TCGA.DM.A1D6.01", "Molecules associated with elastic fibres"], ["TCGA.DM.A1D6.01", "Activation of the phototransduction cascade"], ["TCGA.DM.A1D6.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.DM.A1D6.01", "Scavenging by Class A Receptors"], ["TCGA.DM.A1D6.01", "Blood group systems biosynthesis"], ["TCGA.DM.A1D6.01", "LGI-ADAM interactions"], ["TCGA.DM.A1D6.01", "Cytosolic sulfonation of small molecules"], ["TCGA.DM.A1D6.01", "Transcriptional regulation of testis differentiation"], ["TCGA.DM.A1D6.01", "Sensory perception of taste"], ["TCGA.DM.A1D6.01", "CD22 mediated BCR regulation"], ["TCGA.DM.A1D6.01", "Sensory perception of sweet, bitter, and umami (glutamate) taste"], ["TCGA.DM.A1D6.01", "Biosynthesis of specialized proresolving mediators (SPMs)"], ["TCGA.DM.A1D6.01", "Heme degradation"], ["TCGA.DM.A1D6.01", "Scavenging of heme from plasma"], ["TCGA.DM.A1D6.01", "Phase II - Conjugation of compounds"], ["TCGA.DM.A1D6.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], ["TCGA.DM.A1D6.01", "TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway"], ["TCGA.DM.A1D6.01", "Lewis blood group biosynthesis"], ["TCGA.DM.A1D7.01", "IL-6-type cytokine receptor ligand interactions"], ["TCGA.DM.A1D7.01", "RA biosynthesis pathway"], ["TCGA.DM.A1D7.01", "TNFs bind their physiological receptors"], ["TCGA.DM.A1D7.01", "Arachidonic acid metabolism"], ["TCGA.DM.A1D7.01", "Trafficking and processing of endosomal TLR"], ["TCGA.DM.A1D7.01", "Heme degradation"], ["TCGA.DM.A1D8.01", "Potassium Channels"], ["TCGA.DM.A1D8.01", "Interaction between L1 and Ankyrins"], ["TCGA.DM.A1D8.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.DM.A1D8.01", "Phase 4 - resting membrane potential"], ["TCGA.DM.A1D8.01", "Voltage gated Potassium channels"], ["TCGA.DM.A1D8.01", "Erythrocytes take up carbon dioxide and release oxygen"], ["TCGA.DM.A1D8.01", "O2/CO2 exchange in erythrocytes"], ["TCGA.DM.A1D8.01", "Glucagon-type ligand receptors"], ["TCGA.DM.A1D8.01", "Blood group systems biosynthesis"], ["TCGA.DM.A1D8.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], ["TCGA.DM.A1D8.01", "Glucuronidation"], ["TCGA.DM.A1D8.01", "Classical antibody-mediated complement activation"], ["TCGA.DM.A1D8.01", "CD22 mediated BCR regulation"], ["TCGA.DM.A1D8.01", "Aspirin ADME"], ["TCGA.DM.A1D8.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.DM.A1D8.01", "Lewis blood group biosynthesis"], ["TCGA.DM.A1D8.01", "Initial triggering of complement"], ["TCGA.DM.A1D8.01", "Sialic acid metabolism"], ["TCGA.DM.A1D8.01", "Sensory perception of taste"], ["TCGA.DM.A1D8.01", "TNFs bind their physiological receptors"], ["TCGA.DM.A1D8.01", "Sensory perception of sweet, bitter, and umami (glutamate) taste"], ["TCGA.DM.A1D8.01", "Activation of the phototransduction cascade"], ["TCGA.DM.A1D8.01", "Intrinsic Pathway of Fibrin Clot Formation"], ["TCGA.DM.A1D8.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.DM.A1D8.01", "G beta:gamma signalling through BTK"], ["TCGA.DM.A1D8.01", "Creation of C4 and C2 activators"], ["TCGA.DM.A1D9.01", "Interaction between L1 and Ankyrins"], ["TCGA.DM.A1D9.01", "Erythrocytes take up carbon dioxide and release oxygen"], ["TCGA.DM.A1D9.01", "O2/CO2 exchange in erythrocytes"], ["TCGA.DM.A1D9.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.DM.A1D9.01", "Initial triggering of complement"], ["TCGA.DM.A1D9.01", "Activation of the phototransduction cascade"], ["TCGA.DM.A1D9.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], ["TCGA.DM.A1D9.01", "Ethanol oxidation"], ["TCGA.DM.A1DA.01", "Interaction between L1 and Ankyrins"], ["TCGA.DM.A1DA.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.DM.A1DA.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.DM.A1DA.01", "FGFR2 ligand binding and activation"], ["TCGA.DM.A1DA.01", "Signaling by activated point mutants of FGFR1"], ["TCGA.DM.A1DA.01", "Potassium Channels"], ["TCGA.DM.A1DA.01", "Phase 0 - rapid depolarisation"], ["TCGA.DM.A1DA.01", "FGFR1 ligand binding and activation"], ["TCGA.DM.A1DA.01", "Activated point mutants of FGFR2"], ["TCGA.DM.A1DA.01", "Transcriptional regulation of testis differentiation"], ["TCGA.DM.A1DA.01", "FGFR1c ligand binding and activation"], ["TCGA.DM.A1DA.01", "FGFR2c ligand binding and activation"], ["TCGA.DM.A1DA.01", "Nicotinate metabolism"], ["TCGA.DM.A1DA.01", "FGFR4 ligand binding and activation"], ["TCGA.DM.A1DA.01", "Signaling by activated point mutants of FGFR3"], ["TCGA.DM.A1DA.01", "FGFR3 mutant receptor activation"], ["TCGA.DM.A1DA.01", "Blood group systems biosynthesis"], ["TCGA.DM.A1DA.01", "FGFR3 ligand binding and activation"], ["TCGA.DM.A1DA.01", "FGFR3c ligand binding and activation"], ["TCGA.DM.A1DA.01", "Voltage gated Potassium channels"], ["TCGA.DM.A1DA.01", "GABA receptor activation"], ["TCGA.DM.A1DA.01", "CD22 mediated BCR regulation"], ["TCGA.DM.A1DB.01", "Transport of bile salts and organic acids, metal ions and amine compounds"], ["TCGA.DM.A1DB.01", "Glucagon-type ligand receptors"], ["TCGA.DM.A1DB.01", "Inwardly rectifying K+ channels"], ["TCGA.DM.A1DB.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.DM.A1DB.01", "Activation of G protein gated Potassium channels"], ["TCGA.DM.A1DB.01", "G protein gated Potassium channels"], ["TCGA.DM.A1DB.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.DM.A1DB.01", "Blood group systems biosynthesis"], ["TCGA.DM.A1DB.01", "Acyl chain remodelling of PE"], ["TCGA.DM.A1DB.01", "Cytosolic sulfonation of small molecules"], ["TCGA.DM.A1DB.01", "O-linked glycosylation of mucins"], ["TCGA.DM.A1DB.01", "G beta:gamma signalling through BTK"], ["TCGA.DM.A1DB.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], ["TCGA.DM.A1DB.01", "CD22 mediated BCR regulation"], ["TCGA.DM.A1DB.01", "Termination of O-glycan biosynthesis"], ["TCGA.DM.A1DB.01", "Phase II - Conjugation of compounds"], ["TCGA.DM.A1DB.01", "Defective pyroptosis"], ["TCGA.DM.A1DB.01", "O-linked glycosylation"], ["TCGA.DM.A1DB.01", "Lewis blood group biosynthesis"], ["TCGA.DM.A1DB.01", "Initial triggering of complement"], ["TCGA.DM.A1DB.01", "G-protein activation"], ["TCGA.DM.A1DB.01", "Resolution of D-loop Structures through Holliday Junction Intermediates"], ["TCGA.DM.A1DB.01", "Defective GALNT12 causes CRCS1"], ["TCGA.DM.A1HA.01", "Arachidonic acid metabolism"], ["TCGA.DM.A1HA.01", "Sialic acid metabolism"], ["TCGA.DM.A1HA.01", "Biosynthesis of specialized proresolving mediators (SPMs)"], ["TCGA.DM.A1HA.01", "Aspirin ADME"], ["TCGA.DM.A1HA.01", "Biosynthesis of DHA-derived SPMs"], ["TCGA.DM.A1HA.01", "Phase 4 - resting membrane potential"], ["TCGA.DM.A1HA.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.DM.A1HA.01", "Classical antibody-mediated complement activation"], ["TCGA.DM.A1HA.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.DM.A1HA.01", "O-linked glycosylation"], ["TCGA.DM.A1HA.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], ["TCGA.DM.A1HA.01", "Interaction between L1 and Ankyrins"], ["TCGA.DM.A1HA.01", "Glucuronidation"], ["TCGA.DM.A1HA.01", "Termination of O-glycan biosynthesis"], ["TCGA.DM.A1HA.01", "Dopamine Neurotransmitter Release Cycle"], ["TCGA.DM.A1HA.01", "Collagen chain trimerization"], ["TCGA.DM.A1HA.01", "Serotonin Neurotransmitter Release Cycle"], ["TCGA.DM.A1HA.01", "Blood group systems biosynthesis"], ["TCGA.DM.A1HA.01", "Phase II - Conjugation of compounds"], ["TCGA.DM.A1HA.01", "Initial triggering of complement"], ["TCGA.DM.A1HA.01", "TNFs bind their physiological receptors"], ["TCGA.DM.A1HA.01", "Defective B3GALTL causes PpS"], ["TCGA.DM.A1HA.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], ["TCGA.DM.A1HA.01", "Synthesis of substrates in N-glycan biosythesis"], ["TCGA.DM.A1HA.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.DM.A1HA.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.DM.A1HA.01", "Defective GALNT3 causes HFTC"], ["TCGA.DM.A1HA.01", "Defective GALNT12 causes CRCS1"], ["TCGA.DM.A1HA.01", "Norepinephrine Neurotransmitter Release Cycle"], ["TCGA.DM.A1HA.01", "Lewis blood group biosynthesis"], ["TCGA.DM.A1HA.01", "Voltage gated Potassium channels"], ["TCGA.DM.A282.01", "TNFs bind their physiological receptors"], ["TCGA.DM.A282.01", "Interaction between L1 and Ankyrins"], ["TCGA.DM.A282.01", "Initial triggering of complement"], ["TCGA.DM.A282.01", "Scavenging of heme from plasma"], ["TCGA.DM.A282.01", "Potassium Channels"], ["TCGA.DM.A282.01", "Platelet calcium homeostasis"], ["TCGA.DM.A282.01", "Erythrocytes take up carbon dioxide and release oxygen"], ["TCGA.DM.A282.01", "O2/CO2 exchange in erythrocytes"], ["TCGA.DM.A282.01", "FGFR4 ligand binding and activation"], ["TCGA.DM.A282.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], ["TCGA.DM.A282.01", "Phase 4 - resting membrane potential"], ["TCGA.DM.A282.01", "Norepinephrine Neurotransmitter Release Cycle"], ["TCGA.DM.A282.01", "Heme degradation"], ["TCGA.DM.A282.01", "Arachidonic acid metabolism"], ["TCGA.DM.A282.01", "Blood group systems biosynthesis"], ["TCGA.DM.A282.01", "Binding and entry of HIV virion"], ["TCGA.DM.A285.01", "Complement cascade"], ["TCGA.DM.A285.01", "Regulation of Complement cascade"], ["TCGA.DM.A285.01", "Activation of Matrix Metalloproteinases"], ["TCGA.DM.A285.01", "Interaction between L1 and Ankyrins"], ["TCGA.DM.A285.01", "Cytosolic sulfonation of small molecules"], ["TCGA.DM.A285.01", "Initial triggering of complement"], ["TCGA.DM.A285.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], ["TCGA.DM.A285.01", "Classical antibody-mediated complement activation"], ["TCGA.DM.A285.01", "CD22 mediated BCR regulation"], ["TCGA.DM.A285.01", "Collagen chain trimerization"], ["TCGA.DM.A285.01", "APAP ADME"], ["TCGA.DM.A285.01", "Phase 4 - resting membrane potential"], ["TCGA.DM.A285.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.DM.A285.01", "Phase II - Conjugation of compounds"], ["TCGA.DM.A28C.01", "Potassium Channels"], ["TCGA.DM.A28C.01", "Arachidonic acid metabolism"], ["TCGA.DM.A28C.01", "Activation of G protein gated Potassium channels"], ["TCGA.DM.A28C.01", "G protein gated Potassium channels"], ["TCGA.DM.A28C.01", "Interaction between L1 and Ankyrins"], ["TCGA.DM.A28C.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.DM.A28C.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.DM.A28C.01", "GABA B receptor activation"], ["TCGA.DM.A28C.01", "Activation of GABAB receptors"], ["TCGA.DM.A28C.01", "Inwardly rectifying K+ channels"], ["TCGA.DM.A28C.01", "Classical antibody-mediated complement activation"], ["TCGA.DM.A28C.01", "Initial triggering of complement"], ["TCGA.DM.A28C.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.DM.A28C.01", "Platelet calcium homeostasis"], ["TCGA.DM.A28C.01", "Presynaptic function of Kainate receptors"], ["TCGA.DM.A28C.01", "GABA receptor activation"], ["TCGA.DM.A28C.01", "G beta:gamma signalling through BTK"], ["TCGA.DM.A28C.01", "Prostacyclin signalling through prostacyclin receptor"], ["TCGA.DM.A28C.01", "Binding and entry of HIV virion"], ["TCGA.DM.A28C.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.DM.A28C.01", "G beta:gamma signalling through PLC beta"], ["TCGA.DM.A28C.01", "G-protein activation"], ["TCGA.DM.A28C.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.DM.A28C.01", "Glucagon-type ligand receptors"], ["TCGA.DM.A28C.01", "Class B/2 (Secretin family receptors)"], ["TCGA.DM.A28C.01", "Keratan sulfate biosynthesis"], ["TCGA.DM.A28C.01", "Creation of C4 and C2 activators"], ["TCGA.DM.A28C.01", "Nicotinate metabolism"], ["TCGA.DM.A28C.01", "Phase 4 - resting membrane potential"], ["TCGA.DM.A28C.01", "Phase 0 - rapid depolarisation"], ["TCGA.DM.A28C.01", "TNFs bind their physiological receptors"], ["TCGA.DM.A28C.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.DM.A28C.01", "Biosynthesis of specialized proresolving mediators (SPMs)"], ["TCGA.DM.A28C.01", "CD22 mediated BCR regulation"], ["TCGA.DM.A28C.01", "O-linked glycosylation of mucins"], ["TCGA.DM.A28C.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.DM.A28C.01", "Thromboxane signalling through TP receptor"], ["TCGA.DM.A28C.01", "Defective GALNT12 causes CRCS1"], ["TCGA.DM.A28C.01", "Ion transport by P-type ATPases"], ["TCGA.DM.A28C.01", "Activation of the phototransduction cascade"], ["TCGA.DM.A28C.01", "Erythrocytes take up carbon dioxide and release oxygen"], ["TCGA.DM.A28C.01", "O2/CO2 exchange in erythrocytes"], ["TCGA.DM.A28C.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], ["TCGA.DM.A28C.01", "LGI-ADAM interactions"], ["TCGA.DM.A28C.01", "Biosynthesis of DHA-derived SPMs"], ["TCGA.DM.A28E.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.DM.A28E.01", "Generation of second messenger molecules"], ["TCGA.DM.A28E.01", "Phosphorylation of CD3 and TCR zeta chains"], ["TCGA.DM.A28E.01", "Translocation of ZAP-70 to Immunological synapse"], ["TCGA.DM.A28E.01", "PD-1 signaling"], ["TCGA.DM.A28E.01", "Cell surface interactions at the vascular wall"], ["TCGA.DM.A28E.01", "Complement cascade"], ["TCGA.DM.A28E.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.DM.A28E.01", "Regulation of Complement cascade"], ["TCGA.DM.A28E.01", "Molecules associated with elastic fibres"], ["TCGA.DM.A28E.01", "Initial triggering of complement"], ["TCGA.DM.A28E.01", "Elastic fibre formation"], ["TCGA.DM.A28E.01", "Glycosaminoglycan metabolism"], ["TCGA.DM.A28E.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.DM.A28E.01", "Keratan sulfate biosynthesis"], ["TCGA.DM.A28E.01", "Costimulation by the CD28 family"], ["TCGA.DM.A28E.01", "G-protein beta:gamma signalling"], ["TCGA.DM.A28E.01", "Class B/2 (Secretin family receptors)"], ["TCGA.DM.A28E.01", "G alpha (q) signalling events"], ["TCGA.DM.A28E.01", "GABA receptor activation"], ["TCGA.DM.A28E.01", "DAP12 signaling"], ["TCGA.DM.A28E.01", "Glucagon-type ligand receptors"], ["TCGA.DM.A28E.01", "Integrin cell surface interactions"], ["TCGA.DM.A28E.01", "GABA B receptor activation"], ["TCGA.DM.A28E.01", "Activation of GABAB receptors"], ["TCGA.DM.A28E.01", "DAP12 interactions"], ["TCGA.DM.A28E.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.DM.A28E.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.DM.A28E.01", "Keratan sulfate/keratin metabolism"], ["TCGA.DM.A28E.01", "Blood group systems biosynthesis"], ["TCGA.DM.A28E.01", "Presynaptic function of Kainate receptors"], ["TCGA.DM.A28E.01", "Sialic acid metabolism"], ["TCGA.DM.A28E.01", "MyD88 deficiency (TLR2/4)"], ["TCGA.DM.A28E.01", "IRAK4 deficiency (TLR2/4)"], ["TCGA.DM.A28E.01", "G beta:gamma signalling through BTK"], ["TCGA.DM.A28E.01", "TNFs bind their physiological receptors"], ["TCGA.DM.A28E.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.DM.A28E.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], ["TCGA.DM.A28E.01", "Other semaphorin interactions"], ["TCGA.DM.A28E.01", "CD22 mediated BCR regulation"], ["TCGA.DM.A28E.01", "G alpha (z) signalling events"], ["TCGA.DM.A28E.01", "Acetylcholine Neurotransmitter Release Cycle"], ["TCGA.DM.A28E.01", "Lewis blood group biosynthesis"], ["TCGA.DM.A28E.01", "Activation of G protein gated Potassium channels"], ["TCGA.DM.A28E.01", "G protein gated Potassium channels"], ["TCGA.DM.A28E.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.DM.A28E.01", "Diseases associated with glycosaminoglycan metabolism"], ["TCGA.DM.A28E.01", "Scavenging by Class A Receptors"], ["TCGA.DM.A28E.01", "G beta:gamma signalling through PLC beta"], ["TCGA.DM.A28E.01", "G beta:gamma signalling through CDC42"], ["TCGA.DM.A28E.01", "FCGR activation"], ["TCGA.DM.A28E.01", "CD28 dependent Vav1 pathway"], ["TCGA.DM.A28E.01", "Phase II - Conjugation of compounds"], ["TCGA.DM.A28E.01", "CRMPs in Sema3A signaling"], ["TCGA.DM.A28E.01", "Inwardly rectifying K+ channels"], ["TCGA.DM.A28E.01", "Activation of the phototransduction cascade"], ["TCGA.DM.A28F.01", "Potassium Channels"], ["TCGA.DM.A28F.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.DM.A28F.01", "Voltage gated Potassium channels"], ["TCGA.DM.A28F.01", "Arachidonic acid metabolism"], ["TCGA.DM.A28F.01", "Phase 4 - resting membrane potential"], ["TCGA.DM.A28F.01", "Glucuronidation"], ["TCGA.DM.A28F.01", "Molecules associated with elastic fibres"], ["TCGA.DM.A28F.01", "Activation of G protein gated Potassium channels"], ["TCGA.DM.A28F.01", "G protein gated Potassium channels"], ["TCGA.DM.A28F.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.DM.A28F.01", "Inwardly rectifying K+ channels"], ["TCGA.DM.A28F.01", "Transcriptional regulation of testis differentiation"], ["TCGA.DM.A28F.01", "Phase II - Conjugation of compounds"], ["TCGA.DM.A28F.01", "Aspirin ADME"], ["TCGA.DM.A28F.01", "Initial triggering of complement"], ["TCGA.DM.A28F.01", "Classical antibody-mediated complement activation"], ["TCGA.DM.A28F.01", "Elastic fibre formation"], ["TCGA.DM.A28F.01", "Keratan sulfate biosynthesis"], ["TCGA.DM.A28F.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.DM.A28F.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.DM.A28F.01", "Activation of the phototransduction cascade"], ["TCGA.DM.A28F.01", "RA biosynthesis pathway"], ["TCGA.DM.A28F.01", "IL-6-type cytokine receptor ligand interactions"], ["TCGA.DM.A28F.01", "G beta:gamma signalling through BTK"], ["TCGA.DM.A28F.01", "Creation of C4 and C2 activators"], ["TCGA.DM.A28F.01", "Endogenous sterols"], ["TCGA.DM.A28F.01", "Erythrocytes take up carbon dioxide and release oxygen"], ["TCGA.DM.A28F.01", "O2/CO2 exchange in erythrocytes"], ["TCGA.DM.A28F.01", "Formation of the anterior neural plate"], ["TCGA.DM.A28F.01", "Biosynthesis of specialized proresolving mediators (SPMs)"], ["TCGA.DM.A28F.01", "Ethanol oxidation"], ["TCGA.DM.A28G.01", "Interaction between L1 and Ankyrins"], ["TCGA.DM.A28G.01", "Phase 0 - rapid depolarisation"], ["TCGA.DM.A28G.01", "Activation of Matrix Metalloproteinases"], ["TCGA.DM.A28G.01", "Regulation of Complement cascade"], ["TCGA.DM.A28G.01", "Molecules associated with elastic fibres"], ["TCGA.DM.A28G.01", "RA biosynthesis pathway"], ["TCGA.DM.A28G.01", "Complement cascade"], ["TCGA.DM.A28G.01", "Drug ADME"], ["TCGA.DM.A28G.01", "Cytosolic sulfonation of small molecules"], ["TCGA.DM.A28G.01", "Regulation of FZD by ubiquitination"], ["TCGA.DM.A28G.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.DM.A28G.01", "Signaling by Retinoic Acid"], ["TCGA.DM.A28G.01", "MyD88 deficiency (TLR2/4)"], ["TCGA.DM.A28G.01", "IRAK4 deficiency (TLR2/4)"], ["TCGA.DM.A28G.01", "G beta:gamma signalling through BTK"], ["TCGA.DM.A28G.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.DM.A28G.01", "Physiological factors"], ["TCGA.DM.A28G.01", "Negative regulation of NMDA receptor-mediated neuronal transmission"], ["TCGA.DM.A28G.01", "GABA receptor activation"], ["TCGA.DM.A28G.01", "Signal amplification"], ["TCGA.DM.A28G.01", "LGI-ADAM interactions"], ["TCGA.DM.A28G.01", "Glucagon signaling in metabolic regulation"], ["TCGA.DM.A28G.01", "Glucagon-type ligand receptors"], ["TCGA.DM.A28G.01", "FGFR2 ligand binding and activation"], ["TCGA.DM.A28G.01", "APAP ADME"], ["TCGA.DM.A28H.01", "Initial triggering of complement"], ["TCGA.DM.A28H.01", "DNA strand elongation"], ["TCGA.DM.A28H.01", "Deposition of new CENPA-containing nucleosomes at the centromere"], ["TCGA.DM.A28H.01", "Nucleosome assembly"], ["TCGA.DM.A28H.01", "Blood group systems biosynthesis"], ["TCGA.DM.A28H.01", "Interaction between L1 and Ankyrins"], ["TCGA.DM.A28H.01", "Binding and entry of HIV virion"], ["TCGA.DM.A28H.01", "Lagging Strand Synthesis"], ["TCGA.DM.A28H.01", "TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway"], ["TCGA.DM.A28H.01", "Lewis blood group biosynthesis"], ["TCGA.DM.A28H.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.DM.A28H.01", "Condensation of Prophase Chromosomes"], ["TCGA.DM.A28H.01", "Chromosome Maintenance"], ["TCGA.DM.A28H.01", "Voltage gated Potassium channels"], ["TCGA.DM.A28H.01", "TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest"], ["TCGA.DM.A28H.01", "Polymerase switching"], ["TCGA.DM.A28H.01", "Leading Strand Synthesis"], ["TCGA.DM.A28H.01", "Removal of the Flap Intermediate"], ["TCGA.DM.A28H.01", "Processive synthesis on the lagging strand"], ["TCGA.DM.A28H.01", "Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex"], ["TCGA.DM.A28H.01", "APOBEC3G mediated resistance to HIV-1 infection"], ["TCGA.DM.A28H.01", "Activation of the pre-replicative complex"], ["TCGA.DM.A28H.01", "TNFs bind their physiological receptors"], ["TCGA.DM.A28H.01", "Unwinding of DNA"], ["TCGA.DM.A28H.01", "Condensation of Prometaphase Chromosomes"], ["TCGA.DM.A28K.01", "Chemokine receptors bind chemokines"], ["TCGA.DM.A28K.01", "Interaction between L1 and Ankyrins"], ["TCGA.DM.A28K.01", "Translocation of ZAP-70 to Immunological synapse"], ["TCGA.DM.A28K.01", "Generation of second messenger molecules"], ["TCGA.DM.A28K.01", "Phosphorylation of CD3 and TCR zeta chains"], ["TCGA.DM.A28K.01", "Complement cascade"], ["TCGA.DM.A28K.01", "Regulation of Complement cascade"], ["TCGA.DM.A28K.01", "PD-1 signaling"], ["TCGA.DM.A28K.01", "Phase 0 - rapid depolarisation"], ["TCGA.DM.A28K.01", "Negative regulation of NMDA receptor-mediated neuronal transmission"], ["TCGA.DM.A28K.01", "Molecules associated with elastic fibres"], ["TCGA.DM.A28K.01", "Initial triggering of complement"], ["TCGA.DM.A28K.01", "Transcriptional regulation of testis differentiation"], ["TCGA.DM.A28K.01", "Activation of SMO"], ["TCGA.DM.A28K.01", "Assembly and cell surface presentation of NMDA receptors"], ["TCGA.DM.A28K.01", "Unblocking of NMDA receptors, glutamate binding and activation"], ["TCGA.DM.A28K.01", "Scavenging of heme from plasma"], ["TCGA.DM.A28K.01", "CD22 mediated BCR regulation"], ["TCGA.DM.A28K.01", "Norepinephrine Neurotransmitter Release Cycle"], ["TCGA.DM.A28K.01", "Glucagon-type ligand receptors"], ["TCGA.DM.A28K.01", "Protein-protein interactions at synapses"], ["TCGA.DM.A28K.01", "Elastic fibre formation"], ["TCGA.DM.A28K.01", "Neurotransmitter release cycle"], ["TCGA.DM.A28K.01", "Serotonin Neurotransmitter Release Cycle"], ["TCGA.DM.A28K.01", "TNFs bind their physiological receptors"], ["TCGA.DM.A28M.01", "Initial triggering of complement"], ["TCGA.DM.A28M.01", "Interaction between L1 and Ankyrins"], ["TCGA.DM.A28M.01", "Phase 0 - rapid depolarisation"], ["TCGA.DM.A28M.01", "Classical antibody-mediated complement activation"], ["TCGA.DM.A28M.01", "Creation of C4 and C2 activators"], ["TCGA.DM.A28M.01", "TNFs bind their physiological receptors"], ["TCGA.DM.A28M.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.DM.A28M.01", "Blood group systems biosynthesis"], ["TCGA.DM.A28M.01", "Keratan sulfate biosynthesis"], ["TCGA.DM.A28M.01", "Other semaphorin interactions"], ["TCGA.DM.A28M.01", "Activation of Matrix Metalloproteinases"], ["TCGA.DM.A28M.01", "Lewis blood group biosynthesis"], ["TCGA.DM.A28M.01", "Formation of the anterior neural plate"], ["TCGA.F4.6459.01", "Collagen chain trimerization"], ["TCGA.F4.6459.01", "Activation of Matrix Metalloproteinases"], ["TCGA.F4.6459.01", "Common Pathway of Fibrin Clot Formation"], ["TCGA.F4.6459.01", "TNFs bind their physiological receptors"], ["TCGA.F4.6459.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.F4.6459.01", "Physiological factors"], ["TCGA.F4.6459.01", "Blood group systems biosynthesis"], ["TCGA.F4.6460.01", "Phase II - Conjugation of compounds"], ["TCGA.F4.6460.01", "Cytosolic sulfonation of small molecules"], ["TCGA.F4.6460.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.F4.6460.01", "Glucuronidation"], ["TCGA.F4.6460.01", "FGFR4 ligand binding and activation"], ["TCGA.F4.6460.01", "Activated point mutants of FGFR2"], ["TCGA.F4.6460.01", "FGFR2 ligand binding and activation"], ["TCGA.F4.6460.01", "Aspirin ADME"], ["TCGA.F4.6460.01", "FGFR2c ligand binding and activation"], ["TCGA.F4.6461.01", "Phase II - Conjugation of compounds"], ["TCGA.F4.6461.01", "Activation of Matrix Metalloproteinases"], ["TCGA.F4.6461.01", "APAP ADME"], ["TCGA.F4.6461.01", "Cytosolic sulfonation of small molecules"], ["TCGA.F4.6461.01", "Ethanol oxidation"], ["TCGA.F4.6461.01", "Aflatoxin activation and detoxification"], ["TCGA.F4.6461.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], ["TCGA.F4.6461.01", "Glutathione conjugation"], ["TCGA.F4.6461.01", "Collagen formation"], ["TCGA.F4.6461.01", "SUMOylation of intracellular receptors"], ["TCGA.F4.6461.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.F4.6463.01", "Blood group systems biosynthesis"], ["TCGA.F4.6463.01", "FGFR4 ligand binding and activation"], ["TCGA.F4.6463.01", "Lewis blood group biosynthesis"], ["TCGA.F4.6463.01", "Activated point mutants of FGFR2"], ["TCGA.F4.6463.01", "Glucuronidation"], ["TCGA.F4.6463.01", "Phase II - Conjugation of compounds"], ["TCGA.F4.6463.01", "Defective GALNT12 causes CRCS1"], ["TCGA.F4.6463.01", "FGFR2 ligand binding and activation"], ["TCGA.F4.6463.01", "APAP ADME"], ["TCGA.F4.6463.01", "FGFR2c ligand binding and activation"], ["TCGA.F4.6463.01", "Peptide hormone biosynthesis"], ["TCGA.F4.6463.01", "FGFRL1 modulation of FGFR1 signaling"], ["TCGA.F4.6463.01", "O-linked glycosylation"], ["TCGA.F4.6463.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], ["TCGA.F4.6463.01", "Metabolism of amine-derived hormones"], ["TCGA.F4.6463.01", "O-linked glycosylation of mucins"], ["TCGA.F4.6463.01", "Bile acid and bile salt metabolism"], ["TCGA.F4.6463.01", "Keratinization"], ["TCGA.F4.6463.01", "Aspirin ADME"], ["TCGA.F4.6463.01", "Ethanol oxidation"], ["TCGA.F4.6463.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.F4.6463.01", "Termination of O-glycan biosynthesis"], ["TCGA.F4.6463.01", "Heme degradation"], ["TCGA.F4.6463.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.F4.6463.01", "Nucleotide catabolism"], ["TCGA.F4.6463.01", "Signaling by activated point mutants of FGFR3"], ["TCGA.F4.6463.01", "FGFR3 mutant receptor activation"], ["TCGA.F4.6463.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.F4.6463.01", "Defective GALNT3 causes HFTC"], ["TCGA.F4.6569.01", "Collagen chain trimerization"], ["TCGA.F4.6569.01", "Diseases associated with O-glycosylation of proteins"], ["TCGA.F4.6569.01", "RA biosynthesis pathway"], ["TCGA.F4.6569.01", "Phase II - Conjugation of compounds"], ["TCGA.F4.6569.01", "O-linked glycosylation"], ["TCGA.F4.6569.01", "Glucuronidation"], ["TCGA.F4.6569.01", "Defective GALNT12 causes CRCS1"], ["TCGA.F4.6569.01", "Inwardly rectifying K+ channels"], ["TCGA.F4.6569.01", "Defective B3GALTL causes PpS"], ["TCGA.F4.6569.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.F4.6569.01", "Activation of G protein gated Potassium channels"], ["TCGA.F4.6569.01", "G protein gated Potassium channels"], ["TCGA.F4.6569.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.F4.6569.01", "Signaling by Retinoic Acid"], ["TCGA.F4.6569.01", "FGFR4 ligand binding and activation"], ["TCGA.F4.6569.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.F4.6569.01", "TNFs bind their physiological receptors"], ["TCGA.F4.6569.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.F4.6569.01", "Blood group systems biosynthesis"], ["TCGA.F4.6569.01", "Glucagon-type ligand receptors"], ["TCGA.F4.6569.01", "Cytosolic sulfonation of small molecules"], ["TCGA.F4.6569.01", "Ethanol oxidation"], ["TCGA.F4.6569.01", "G beta:gamma signalling through BTK"], ["TCGA.F4.6569.01", "Chondroitin sulfate biosynthesis"], ["TCGA.F4.6569.01", "Prostacyclin signalling through prostacyclin receptor"], ["TCGA.F4.6570.01", "Phase II - Conjugation of compounds"], ["TCGA.F4.6570.01", "Collagen chain trimerization"], ["TCGA.F4.6570.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.F4.6570.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.F4.6570.01", "Cytosolic sulfonation of small molecules"], ["TCGA.F4.6570.01", "APAP ADME"], ["TCGA.F4.6570.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], ["TCGA.F4.6570.01", "Glucagon-type ligand receptors"], ["TCGA.F4.6570.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.F4.6570.01", "O-linked glycosylation"], ["TCGA.F4.6570.01", "Phase 0 - rapid depolarisation"], ["TCGA.F4.6570.01", "Glucuronidation"], ["TCGA.F4.6570.01", "Activation of Matrix Metalloproteinases"], ["TCGA.F4.6570.01", "Diseases associated with O-glycosylation of proteins"], ["TCGA.F4.6570.01", "Glutathione conjugation"], ["TCGA.F4.6570.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.F4.6570.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.F4.6570.01", "Defective GALNT3 causes HFTC"], ["TCGA.F4.6570.01", "Defective GALNT12 causes CRCS1"], ["TCGA.F4.6570.01", "Termination of O-glycan biosynthesis"], ["TCGA.F4.6570.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.F4.6570.01", "Defective C1GALT1C1 causes TNPS"], ["TCGA.F4.6570.01", "Defective B3GALTL causes PpS"], ["TCGA.F4.6570.01", "Phase 2 - plateau phase"], ["TCGA.F4.6570.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.F4.6570.01", "Interaction between L1 and Ankyrins"], ["TCGA.F4.6570.01", "O-linked glycosylation of mucins"], ["TCGA.F4.6703.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.F4.6703.01", "Collagen chain trimerization"], ["TCGA.F4.6703.01", "Keratinization"], ["TCGA.F4.6703.01", "Formation of the cornified envelope"], ["TCGA.F4.6703.01", "Collagen degradation"], ["TCGA.F4.6703.01", "Defective GALNT12 causes CRCS1"], ["TCGA.F4.6703.01", "O-linked glycosylation"], ["TCGA.F4.6703.01", "Cytosolic sulfonation of small molecules"], ["TCGA.F4.6703.01", "APAP ADME"], ["TCGA.F4.6703.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.F4.6703.01", "Phase II - Conjugation of compounds"], ["TCGA.F4.6703.01", "Defective GALNT3 causes HFTC"], ["TCGA.F4.6703.01", "Acyl chain remodelling of PS"], ["TCGA.F4.6703.01", "Defective C1GALT1C1 causes TNPS"], ["TCGA.F4.6703.01", "Glucuronidation"], ["TCGA.F4.6703.01", "O-linked glycosylation of mucins"], ["TCGA.F4.6703.01", "Aspirin ADME"], ["TCGA.F4.6703.01", "Acyl chain remodelling of PE"], ["TCGA.F4.6703.01", "Tryptophan catabolism"], ["TCGA.F4.6703.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], ["TCGA.F4.6703.01", "Chondroitin sulfate biosynthesis"], ["TCGA.F4.6703.01", "Termination of O-glycan biosynthesis"], ["TCGA.F4.6703.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.F4.6703.01", "WNT ligand biogenesis and trafficking"], ["TCGA.F4.6703.01", "Dissolution of Fibrin Clot"], ["TCGA.F4.6703.01", "Glucagon-type ligand receptors"], ["TCGA.F4.6704.01", "Phase II - Conjugation of compounds"], ["TCGA.F4.6704.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.F4.6704.01", "Glucuronidation"], ["TCGA.F4.6704.01", "Aspirin ADME"], ["TCGA.F4.6704.01", "Collagen chain trimerization"], ["TCGA.F4.6704.01", "Cytosolic sulfonation of small molecules"], ["TCGA.F4.6704.01", "Ethanol oxidation"], ["TCGA.F4.6704.01", "Glutathione conjugation"], ["TCGA.F4.6704.01", "Blood group systems biosynthesis"], ["TCGA.F4.6704.01", "APAP ADME"], ["TCGA.F4.6704.01", "Peptide hormone biosynthesis"], ["TCGA.F4.6704.01", "ERBB2 Activates PTK6 Signaling"], ["TCGA.F4.6704.01", "Presynaptic function of Kainate receptors"], ["TCGA.F4.6704.01", "Neurotransmitter release cycle"], ["TCGA.F4.6704.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], ["TCGA.F4.6805.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.F4.6805.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.F4.6805.01", "Collagen chain trimerization"], ["TCGA.F4.6805.01", "Activation of Matrix Metalloproteinases"], ["TCGA.F4.6805.01", "Glucuronidation"], ["TCGA.F4.6805.01", "Cytosolic sulfonation of small molecules"], ["TCGA.F4.6805.01", "Scavenging by Class A Receptors"], ["TCGA.F4.6805.01", "Phase II - Conjugation of compounds"], ["TCGA.F4.6805.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.F4.6805.01", "Collagen degradation"], ["TCGA.F4.6805.01", "Metal ion SLC transporters"], ["TCGA.F4.6806.01", "Interaction between L1 and Ankyrins"], ["TCGA.F4.6806.01", "Classical antibody-mediated complement activation"], ["TCGA.F4.6806.01", "Complement cascade"], ["TCGA.F4.6806.01", "Regulation of Complement cascade"], ["TCGA.F4.6806.01", "Activation of Matrix Metalloproteinases"], ["TCGA.F4.6806.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.F4.6806.01", "Common Pathway of Fibrin Clot Formation"], ["TCGA.F4.6806.01", "NCAM1 interactions"], ["TCGA.F4.6806.01", "Collagen degradation"], ["TCGA.F4.6806.01", "Collagen chain trimerization"], ["TCGA.F4.6806.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.F4.6806.01", "Scavenging of heme from plasma"], ["TCGA.F4.6806.01", "IL-6-type cytokine receptor ligand interactions"], ["TCGA.F4.6806.01", "Glucuronidation"], ["TCGA.F4.6806.01", "Initial triggering of complement"], ["TCGA.F4.6806.01", "Creation of C4 and C2 activators"], ["TCGA.F4.6806.01", "Regulation of FZD by ubiquitination"], ["TCGA.F4.6806.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.F4.6806.01", "Defective B3GALTL causes PpS"], ["TCGA.F4.6806.01", "Cytosolic sulfonation of small molecules"], ["TCGA.F4.6806.01", "Transcriptional regulation of testis differentiation"], ["TCGA.F4.6806.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.F4.6806.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], ["TCGA.F4.6807.01", "Phase II - Conjugation of compounds"], ["TCGA.F4.6807.01", "Cytosolic sulfonation of small molecules"], ["TCGA.F4.6807.01", "Glucuronidation"], ["TCGA.F4.6807.01", "Activation of Matrix Metalloproteinases"], ["TCGA.F4.6807.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.F4.6807.01", "Ethanol oxidation"], ["TCGA.F4.6807.01", "Cobalamin (Cbl, vitamin B12) transport and metabolism"], ["TCGA.F4.6807.01", "Degradation of cysteine and homocysteine"], ["TCGA.F4.6807.01", "Aspirin ADME"], ["TCGA.F4.6807.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.F4.6807.01", "Collagen degradation"], ["TCGA.F4.6807.01", "Collagen chain trimerization"], ["TCGA.F4.6808.01", "Complement cascade"], ["TCGA.F4.6808.01", "Regulation of Complement cascade"], ["TCGA.F4.6808.01", "Classical antibody-mediated complement activation"], ["TCGA.F4.6808.01", "Interaction between L1 and Ankyrins"], ["TCGA.F4.6808.01", "Initial triggering of complement"], ["TCGA.F4.6808.01", "Glucagon-type ligand receptors"], ["TCGA.F4.6808.01", "G beta:gamma signalling through BTK"], ["TCGA.F4.6808.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.F4.6808.01", "Activation of Matrix Metalloproteinases"], ["TCGA.F4.6808.01", "GABA B receptor activation"], ["TCGA.F4.6808.01", "Activation of GABAB receptors"], ["TCGA.F4.6808.01", "CD22 mediated BCR regulation"], ["TCGA.F4.6808.01", "Lewis blood group biosynthesis"], ["TCGA.F4.6808.01", "Keratan sulfate biosynthesis"], ["TCGA.F4.6808.01", "Recycling of bile acids and salts"], ["TCGA.F4.6808.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.F4.6808.01", "Blood group systems biosynthesis"], ["TCGA.F4.6808.01", "Activation of the phototransduction cascade"], ["TCGA.F4.6808.01", "IL-6-type cytokine receptor ligand interactions"], ["TCGA.F4.6808.01", "Creation of C4 and C2 activators"], ["TCGA.F4.6808.01", "Potassium Channels"], ["TCGA.F4.6808.01", "NCAM1 interactions"], ["TCGA.F4.6809.01", "Phase II - Conjugation of compounds"], ["TCGA.F4.6809.01", "Glucuronidation"], ["TCGA.F4.6809.01", "Blood group systems biosynthesis"], ["TCGA.F4.6809.01", "Cytosolic sulfonation of small molecules"], ["TCGA.F4.6809.01", "APAP ADME"], ["TCGA.F4.6809.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], ["TCGA.F4.6809.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], ["TCGA.F4.6809.01", "Collagen chain trimerization"], ["TCGA.F4.6809.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], ["TCGA.F4.6854.01", "Activation of Matrix Metalloproteinases"], ["TCGA.F4.6854.01", "Phase II - Conjugation of compounds"], ["TCGA.F4.6854.01", "Biological oxidations"], ["TCGA.F4.6854.01", "Digestion"], ["TCGA.F4.6854.01", "Cytosolic sulfonation of small molecules"], ["TCGA.F4.6854.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.F4.6854.01", "Glucuronidation"], ["TCGA.F4.6854.01", "Digestion and absorption"], ["TCGA.F4.6854.01", "APAP ADME"], ["TCGA.F4.6854.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], ["TCGA.F4.6855.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.F4.6855.01", "Collagen chain trimerization"], ["TCGA.F4.6855.01", "Activation of Matrix Metalloproteinases"], ["TCGA.F4.6855.01", "Glucuronidation"], ["TCGA.F4.6855.01", "Defective B3GALTL causes PpS"], ["TCGA.F4.6855.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.F4.6855.01", "Phase II - Conjugation of compounds"], ["TCGA.F4.6855.01", "Ethanol oxidation"], ["TCGA.F4.6855.01", "TNFs bind their physiological receptors"], ["TCGA.F4.6855.01", "RA biosynthesis pathway"], ["TCGA.F4.6855.01", "O-linked glycosylation"], ["TCGA.F4.6855.01", "Glucagon-type ligand receptors"], ["TCGA.F4.6855.01", "Cytosolic sulfonation of small molecules"], ["TCGA.F4.6855.01", "Phase 4 - resting membrane potential"], ["TCGA.F4.6856.01", "Interaction between L1 and Ankyrins"], ["TCGA.F4.6856.01", "Phase 0 - rapid depolarisation"], ["TCGA.F4.6856.01", "Activation of Matrix Metalloproteinases"], ["TCGA.F4.6856.01", "Classical antibody-mediated complement activation"], ["TCGA.F4.6856.01", "GABA receptor activation"], ["TCGA.F4.6856.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.F4.6856.01", "Defensins"], ["TCGA.F4.6856.01", "Antimicrobial peptides"], ["TCGA.F4.6856.01", "O-linked glycosylation of mucins"], ["TCGA.F4.6856.01", "RA biosynthesis pathway"], ["TCGA.F4.6856.01", "Synaptic adhesion-like molecules"], ["TCGA.F4.6856.01", "G beta:gamma signalling through BTK"], ["TCGA.F4.6856.01", "Glucuronidation"], ["TCGA.F4.6856.01", "Termination of O-glycan biosynthesis"], ["TCGA.F4.6856.01", "Sensory perception of taste"], ["TCGA.F4.6856.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.F4.6856.01", "Nicotinate metabolism"], ["TCGA.F4.6856.01", "Glucagon-type ligand receptors"], ["TCGA.F4.6856.01", "Transport of bile salts and organic acids, metal ions and amine compounds"], ["TCGA.G4.6293.01", "Activation of Matrix Metalloproteinases"], ["TCGA.G4.6293.01", "Interaction between L1 and Ankyrins"], ["TCGA.G4.6293.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], ["TCGA.G4.6293.01", "Phase 0 - rapid depolarisation"], ["TCGA.G4.6293.01", "Cytosolic sulfonation of small molecules"], ["TCGA.G4.6293.01", "Phase 4 - resting membrane potential"], ["TCGA.G4.6293.01", "Transcriptional regulation of testis differentiation"], ["TCGA.G4.6293.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.G4.6293.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.G4.6293.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.G4.6293.01", "Common Pathway of Fibrin Clot Formation"], ["TCGA.G4.6293.01", "Regulation of Complement cascade"], ["TCGA.G4.6293.01", "Keratinization"], ["TCGA.G4.6294.01", "Potassium Channels"], ["TCGA.G4.6294.01", "Interaction between L1 and Ankyrins"], ["TCGA.G4.6294.01", "Phase 0 - rapid depolarisation"], ["TCGA.G4.6294.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.G4.6294.01", "Cytosolic sulfonation of small molecules"], ["TCGA.G4.6294.01", "Scavenging of heme from plasma"], ["TCGA.G4.6294.01", "Phase II - Conjugation of compounds"], ["TCGA.G4.6294.01", "Neurotransmitter release cycle"], ["TCGA.G4.6294.01", "Glutamate Neurotransmitter Release Cycle"], ["TCGA.G4.6294.01", "Synaptic adhesion-like molecules"], ["TCGA.G4.6294.01", "Sensory perception of taste"], ["TCGA.G4.6294.01", "Sialic acid metabolism"], ["TCGA.G4.6294.01", "Glucuronidation"], ["TCGA.G4.6294.01", "Sensory perception of sweet, bitter, and umami (glutamate) taste"], ["TCGA.G4.6294.01", "Erythrocytes take up carbon dioxide and release oxygen"], ["TCGA.G4.6294.01", "O2/CO2 exchange in erythrocytes"], ["TCGA.G4.6294.01", "Keratan sulfate biosynthesis"], ["TCGA.G4.6294.01", "Phase 4 - resting membrane potential"], ["TCGA.G4.6294.01", "Signaling by Retinoic Acid"], ["TCGA.G4.6294.01", "Norepinephrine Neurotransmitter Release Cycle"], ["TCGA.G4.6294.01", "Acetylcholine Neurotransmitter Release Cycle"], ["TCGA.G4.6294.01", "Activation of Matrix Metalloproteinases"], ["TCGA.G4.6294.01", "Voltage gated Potassium channels"], ["TCGA.G4.6294.01", "Arachidonic acid metabolism"], ["TCGA.G4.6295.01", "RA biosynthesis pathway"], ["TCGA.G4.6295.01", "Arachidonic acid metabolism"], ["TCGA.G4.6295.01", "Blood group systems biosynthesis"], ["TCGA.G4.6295.01", "Ethanol oxidation"], ["TCGA.G4.6295.01", "APAP ADME"], ["TCGA.G4.6295.01", "Lewis blood group biosynthesis"], ["TCGA.G4.6295.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.G4.6295.01", "Aflatoxin activation and detoxification"], ["TCGA.G4.6297.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.G4.6297.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.G4.6297.01", "Collagen chain trimerization"], ["TCGA.G4.6297.01", "Phase II - Conjugation of compounds"], ["TCGA.G4.6297.01", "Activation of Matrix Metalloproteinases"], ["TCGA.G4.6297.01", "Cytosolic sulfonation of small molecules"], ["TCGA.G4.6297.01", "Ethanol oxidation"], ["TCGA.G4.6297.01", "Diseases associated with O-glycosylation of proteins"], ["TCGA.G4.6297.01", "RA biosynthesis pathway"], ["TCGA.G4.6297.01", "Glucuronidation"], ["TCGA.G4.6297.01", "Defective GALNT12 causes CRCS1"], ["TCGA.G4.6297.01", "Scavenging by Class A Receptors"], ["TCGA.G4.6297.01", "NCAM1 interactions"], ["TCGA.G4.6297.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], ["TCGA.G4.6297.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], ["TCGA.G4.6297.01", "Defective B3GALTL causes PpS"], ["TCGA.G4.6297.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.G4.6297.01", "Signaling by Retinoic Acid"], ["TCGA.G4.6298.01", "Glucuronidation"], ["TCGA.G4.6298.01", "Phase II - Conjugation of compounds"], ["TCGA.G4.6298.01", "Aspirin ADME"], ["TCGA.G4.6298.01", "Potassium Channels"], ["TCGA.G4.6298.01", "Phase 4 - resting membrane potential"], ["TCGA.G4.6298.01", "Phase 0 - rapid depolarisation"], ["TCGA.G4.6298.01", "Defensins"], ["TCGA.G4.6298.01", "GABA receptor activation"], ["TCGA.G4.6298.01", "TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway"], ["TCGA.G4.6298.01", "Activation of Matrix Metalloproteinases"], ["TCGA.G4.6298.01", "Interaction between L1 and Ankyrins"], ["TCGA.G4.6298.01", "Inwardly rectifying K+ channels"], ["TCGA.G4.6298.01", "TNFs bind their physiological receptors"], ["TCGA.G4.6298.01", "Cytosolic sulfonation of small molecules"], ["TCGA.G4.6298.01", "Collagen chain trimerization"], ["TCGA.G4.6298.01", "GABA B receptor activation"], ["TCGA.G4.6298.01", "Activation of GABAB receptors"], ["TCGA.G4.6298.01", "Activation of G protein gated Potassium channels"], ["TCGA.G4.6298.01", "G protein gated Potassium channels"], ["TCGA.G4.6298.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.G4.6298.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.G4.6298.01", "Classical antibody-mediated complement activation"], ["TCGA.G4.6298.01", "CD22 mediated BCR regulation"], ["TCGA.G4.6298.01", "Initial triggering of complement"], ["TCGA.G4.6298.01", "Ligand-dependent caspase activation"], ["TCGA.G4.6298.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.G4.6298.01", "Interleukin-35 Signalling"], ["TCGA.G4.6298.01", "Blood group systems biosynthesis"], ["TCGA.G4.6298.01", "IL-6-type cytokine receptor ligand interactions"], ["TCGA.G4.6298.01", "G beta:gamma signalling through BTK"], ["TCGA.G4.6298.01", "Creation of C4 and C2 activators"], ["TCGA.G4.6298.01", "LGI-ADAM interactions"], ["TCGA.G4.6298.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.G4.6299.01", "RA biosynthesis pathway"], ["TCGA.G4.6299.01", "Ethanol oxidation"], ["TCGA.G4.6299.01", "Norepinephrine Neurotransmitter Release Cycle"], ["TCGA.G4.6299.01", "Interaction between L1 and Ankyrins"], ["TCGA.G4.6299.01", "Inwardly rectifying K+ channels"], ["TCGA.G4.6299.01", "Glutamate Neurotransmitter Release Cycle"], ["TCGA.G4.6299.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.G4.6299.01", "O-linked glycosylation"], ["TCGA.G4.6299.01", "G-protein activation"], ["TCGA.G4.6299.01", "Thromboxane signalling through TP receptor"], ["TCGA.G4.6299.01", "Glucuronidation"], ["TCGA.G4.6299.01", "O-linked glycosylation of mucins"], ["TCGA.G4.6299.01", "WNT ligand biogenesis and trafficking"], ["TCGA.G4.6299.01", "Phase 4 - resting membrane potential"], ["TCGA.G4.6299.01", "Activation of Matrix Metalloproteinases"], ["TCGA.G4.6299.01", "Phase II - Conjugation of compounds"], ["TCGA.G4.6299.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.G4.6299.01", "Lewis blood group biosynthesis"], ["TCGA.G4.6299.01", "Glucagon-type ligand receptors"], ["TCGA.G4.6299.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], ["TCGA.G4.6299.01", "Activation of G protein gated Potassium channels"], ["TCGA.G4.6299.01", "G protein gated Potassium channels"], ["TCGA.G4.6299.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.G4.6299.01", "Serotonin Neurotransmitter Release Cycle"], ["TCGA.G4.6299.01", "Blood group systems biosynthesis"], ["TCGA.G4.6299.01", "Defective GALNT12 causes CRCS1"], ["TCGA.G4.6299.01", "Phase 0 - rapid depolarisation"], ["TCGA.G4.6299.01", "TNFs bind their physiological receptors"], ["TCGA.G4.6302.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.G4.6302.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.G4.6302.01", "Phase II - Conjugation of compounds"], ["TCGA.G4.6302.01", "O-linked glycosylation"], ["TCGA.G4.6302.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.G4.6302.01", "Collagen chain trimerization"], ["TCGA.G4.6302.01", "Defective B3GALTL causes PpS"], ["TCGA.G4.6302.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.G4.6302.01", "Diseases associated with O-glycosylation of proteins"], ["TCGA.G4.6302.01", "Cytosolic sulfonation of small molecules"], ["TCGA.G4.6302.01", "Glucuronidation"], ["TCGA.G4.6302.01", "Activation of Matrix Metalloproteinases"], ["TCGA.G4.6302.01", "Collagen degradation"], ["TCGA.G4.6302.01", "Regulation of signaling by NODAL"], ["TCGA.G4.6302.01", "Transcriptional regulation of testis differentiation"], ["TCGA.G4.6302.01", "Scavenging by Class A Receptors"], ["TCGA.G4.6302.01", "Degradation of cysteine and homocysteine"], ["TCGA.G4.6302.01", "Dissolution of Fibrin Clot"], ["TCGA.G4.6302.01", "FGFR4 ligand binding and activation"], ["TCGA.G4.6303.01", "Phase II - Conjugation of compounds"], ["TCGA.G4.6303.01", "Activation of Matrix Metalloproteinases"], ["TCGA.G4.6303.01", "Glucuronidation"], ["TCGA.G4.6303.01", "Ethanol oxidation"], ["TCGA.G4.6303.01", "Blood group systems biosynthesis"], ["TCGA.G4.6303.01", "APAP ADME"], ["TCGA.G4.6303.01", "Glutathione conjugation"], ["TCGA.G4.6303.01", "Lewis blood group biosynthesis"], ["TCGA.G4.6303.01", "Collagen degradation"], ["TCGA.G4.6304.01", "Interaction between L1 and Ankyrins"], ["TCGA.G4.6304.01", "Keratan sulfate biosynthesis"], ["TCGA.G4.6304.01", "Glucuronidation"], ["TCGA.G4.6304.01", "Defensins"], ["TCGA.G4.6304.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.G4.6304.01", "Keratan sulfate/keratin metabolism"], ["TCGA.G4.6304.01", "Recycling of bile acids and salts"], ["TCGA.G4.6304.01", "Aspirin ADME"], ["TCGA.G4.6304.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.G4.6304.01", "Activation of Matrix Metalloproteinases"], ["TCGA.G4.6304.01", "Heme degradation"], ["TCGA.G4.6304.01", "Bile acid and bile salt metabolism"], ["TCGA.G4.6304.01", "Glucagon-type ligand receptors"], ["TCGA.G4.6304.01", "CD22 mediated BCR regulation"], ["TCGA.G4.6304.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], ["TCGA.G4.6304.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.G4.6304.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.G4.6304.01", "Phase 0 - rapid depolarisation"], ["TCGA.G4.6304.01", "O-linked glycosylation"], ["TCGA.G4.6306.01", "Interaction between L1 and Ankyrins"], ["TCGA.G4.6306.01", "Phase 0 - rapid depolarisation"], ["TCGA.G4.6306.01", "Initial triggering of complement"], ["TCGA.G4.6306.01", "Classical antibody-mediated complement activation"], ["TCGA.G4.6306.01", "Creation of C4 and C2 activators"], ["TCGA.G4.6306.01", "Potassium Channels"], ["TCGA.G4.6306.01", "Defective B3GALTL causes PpS"], ["TCGA.G4.6306.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.G4.6306.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.G4.6306.01", "GABA receptor activation"], ["TCGA.G4.6306.01", "GABA B receptor activation"], ["TCGA.G4.6306.01", "Activation of GABAB receptors"], ["TCGA.G4.6306.01", "Presynaptic function of Kainate receptors"], ["TCGA.G4.6306.01", "Nicotinate metabolism"], ["TCGA.G4.6306.01", "G beta:gamma signalling through BTK"], ["TCGA.G4.6306.01", "Calcitonin-like ligand receptors"], ["TCGA.G4.6306.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.G4.6306.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.G4.6306.01", "Activation of G protein gated Potassium channels"], ["TCGA.G4.6306.01", "G protein gated Potassium channels"], ["TCGA.G4.6306.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.G4.6306.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.G4.6306.01", "Thromboxane signalling through TP receptor"], ["TCGA.G4.6306.01", "Glucagon-type ligand receptors"], ["TCGA.G4.6306.01", "Diseases associated with O-glycosylation of proteins"], ["TCGA.G4.6306.01", "G beta:gamma signalling through PLC beta"], ["TCGA.G4.6306.01", "Sialic acid metabolism"], ["TCGA.G4.6306.01", "Keratan sulfate biosynthesis"], ["TCGA.G4.6306.01", "Blood group systems biosynthesis"], ["TCGA.G4.6306.01", "Formation of the anterior neural plate"], ["TCGA.G4.6306.01", "Activation of Matrix Metalloproteinases"], ["TCGA.G4.6307.01", "Initial triggering of complement"], ["TCGA.G4.6307.01", "Molecules associated with elastic fibres"], ["TCGA.G4.6307.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.G4.6307.01", "Voltage gated Potassium channels"], ["TCGA.G4.6307.01", "Platelet calcium homeostasis"], ["TCGA.G4.6307.01", "Phase II - Conjugation of compounds"], ["TCGA.G4.6307.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.G4.6307.01", "Keratan sulfate biosynthesis"], ["TCGA.G4.6307.01", "Elastic fibre formation"], ["TCGA.G4.6309.01", "Interaction between L1 and Ankyrins"], ["TCGA.G4.6309.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.G4.6309.01", "Glucagon-type ligand receptors"], ["TCGA.G4.6309.01", "Activation of Matrix Metalloproteinases"], ["TCGA.G4.6309.01", "Phase 0 - rapid depolarisation"], ["TCGA.G4.6309.01", "DNA strand elongation"], ["TCGA.G4.6309.01", "Erythrocytes take up carbon dioxide and release oxygen"], ["TCGA.G4.6309.01", "O2/CO2 exchange in erythrocytes"], ["TCGA.G4.6309.01", "GABA receptor activation"], ["TCGA.G4.6309.01", "Trafficking and processing of endosomal TLR"], ["TCGA.G4.6309.01", "Transcriptional regulation of testis differentiation"], ["TCGA.G4.6309.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.G4.6310.01", "Glucuronidation"], ["TCGA.G4.6310.01", "TNFs bind their physiological receptors"], ["TCGA.G4.6310.01", "Cytosolic sulfonation of small molecules"], ["TCGA.G4.6310.01", "Initial triggering of complement"], ["TCGA.G4.6310.01", "TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway"], ["TCGA.G4.6310.01", "Scavenging of heme from plasma"], ["TCGA.G4.6310.01", "Classical antibody-mediated complement activation"], ["TCGA.G4.6310.01", "CD22 mediated BCR regulation"], ["TCGA.G4.6310.01", "Phase II - Conjugation of compounds"], ["TCGA.G4.6310.01", "Creation of C4 and C2 activators"], ["TCGA.G4.6310.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], ["TCGA.G4.6310.01", "Erythrocytes take up carbon dioxide and release oxygen"], ["TCGA.G4.6310.01", "O2/CO2 exchange in erythrocytes"], ["TCGA.G4.6310.01", "Scavenging by Class A Receptors"], ["TCGA.G4.6310.01", "Inwardly rectifying K+ channels"], ["TCGA.G4.6310.01", "Activation of the phototransduction cascade"], ["TCGA.G4.6310.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.G4.6311.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.G4.6311.01", "Collagen chain trimerization"], ["TCGA.G4.6311.01", "Activation of Matrix Metalloproteinases"], ["TCGA.G4.6311.01", "Cytosolic sulfonation of small molecules"], ["TCGA.G4.6311.01", "Phase II - Conjugation of compounds"], ["TCGA.G4.6311.01", "APAP ADME"], ["TCGA.G4.6311.01", "Interaction between L1 and Ankyrins"], ["TCGA.G4.6311.01", "Ethanol oxidation"], ["TCGA.G4.6311.01", "Presynaptic function of Kainate receptors"], ["TCGA.G4.6311.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.G4.6311.01", "Collagen degradation"], ["TCGA.G4.6311.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.G4.6311.01", "Glucagon-type ligand receptors"], ["TCGA.G4.6311.01", "RA biosynthesis pathway"], ["TCGA.G4.6311.01", "G beta:gamma signalling through BTK"], ["TCGA.G4.6311.01", "Glucuronidation"], ["TCGA.G4.6311.01", "Prostacyclin signalling through prostacyclin receptor"], ["TCGA.G4.6311.01", "Other semaphorin interactions"], ["TCGA.G4.6314.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.G4.6314.01", "Collagen chain trimerization"], ["TCGA.G4.6314.01", "Glucuronidation"], ["TCGA.G4.6314.01", "Phase II - Conjugation of compounds"], ["TCGA.G4.6314.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], ["TCGA.G4.6314.01", "Collagen degradation"], ["TCGA.G4.6314.01", "Formation of axial mesoderm"], ["TCGA.G4.6314.01", "APAP ADME"], ["TCGA.G4.6314.01", "Peptide hormone biosynthesis"], ["TCGA.G4.6314.01", "Aspirin ADME"], ["TCGA.G4.6314.01", "Arachidonic acid metabolism"], ["TCGA.G4.6314.01", "Cytosolic sulfonation of small molecules"], ["TCGA.G4.6314.01", "Ethanol oxidation"], ["TCGA.G4.6314.01", "RA biosynthesis pathway"], ["TCGA.G4.6315.01", "Initial triggering of complement"], ["TCGA.G4.6315.01", "Classical antibody-mediated complement activation"], ["TCGA.G4.6315.01", "Molecules associated with elastic fibres"], ["TCGA.G4.6315.01", "Interaction between L1 and Ankyrins"], ["TCGA.G4.6315.01", "Creation of C4 and C2 activators"], ["TCGA.G4.6315.01", "Elastic fibre formation"], ["TCGA.G4.6315.01", "G beta:gamma signalling through BTK"], ["TCGA.G4.6315.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.G4.6315.01", "Other semaphorin interactions"], ["TCGA.G4.6315.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], ["TCGA.G4.6315.01", "Scavenging by Class A Receptors"], ["TCGA.G4.6315.01", "G beta:gamma signalling through PLC beta"], ["TCGA.G4.6315.01", "Voltage gated Potassium channels"], ["TCGA.G4.6315.01", "Presynaptic function of Kainate receptors"], ["TCGA.G4.6315.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.G4.6315.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.G4.6315.01", "G-protein activation"], ["TCGA.G4.6315.01", "TNFs bind their physiological receptors"], ["TCGA.G4.6317.01", "Potassium Channels"], ["TCGA.G4.6317.01", "GABA B receptor activation"], ["TCGA.G4.6317.01", "Activation of GABAB receptors"], ["TCGA.G4.6317.01", "Inwardly rectifying K+ channels"], ["TCGA.G4.6317.01", "Activation of G protein gated Potassium channels"], ["TCGA.G4.6317.01", "G protein gated Potassium channels"], ["TCGA.G4.6317.01", "Interaction between L1 and Ankyrins"], ["TCGA.G4.6317.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.G4.6317.01", "Glucagon-type ligand receptors"], ["TCGA.G4.6317.01", "G-protein activation"], ["TCGA.G4.6317.01", "Thromboxane signalling through TP receptor"], ["TCGA.G4.6317.01", "G beta:gamma signalling through BTK"], ["TCGA.G4.6317.01", "Presynaptic function of Kainate receptors"], ["TCGA.G4.6317.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.G4.6317.01", "Classical antibody-mediated complement activation"], ["TCGA.G4.6317.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.G4.6317.01", "Prostacyclin signalling through prostacyclin receptor"], ["TCGA.G4.6317.01", "Initial triggering of complement"], ["TCGA.G4.6317.01", "G beta:gamma signalling through PLC beta"], ["TCGA.G4.6317.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.G4.6317.01", "TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway"], ["TCGA.G4.6317.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.G4.6317.01", "Blood group systems biosynthesis"], ["TCGA.G4.6317.01", "Creation of C4 and C2 activators"], ["TCGA.G4.6317.01", "Tryptophan catabolism"], ["TCGA.G4.6317.01", "Keratan sulfate biosynthesis"], ["TCGA.G4.6320.01", "Interaction between L1 and Ankyrins"], ["TCGA.G4.6320.01", "Classical antibody-mediated complement activation"], ["TCGA.G4.6320.01", "Phase 0 - rapid depolarisation"], ["TCGA.G4.6320.01", "Creation of C4 and C2 activators"], ["TCGA.G4.6320.01", "G beta:gamma signalling through BTK"], ["TCGA.G4.6320.01", "Initial triggering of complement"], ["TCGA.G4.6320.01", "Potassium Channels"], ["TCGA.G4.6320.01", "Presynaptic function of Kainate receptors"], ["TCGA.G4.6320.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.G4.6320.01", "Activation of Matrix Metalloproteinases"], ["TCGA.G4.6320.01", "FGFR1 ligand binding and activation"], ["TCGA.G4.6320.01", "Glutamate Neurotransmitter Release Cycle"], ["TCGA.G4.6320.01", "RA biosynthesis pathway"], ["TCGA.G4.6320.01", "Glucagon-type ligand receptors"], ["TCGA.G4.6320.01", "Activation of G protein gated Potassium channels"], ["TCGA.G4.6320.01", "G protein gated Potassium channels"], ["TCGA.G4.6320.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.G4.6320.01", "Erythrocytes take up carbon dioxide and release oxygen"], ["TCGA.G4.6320.01", "O2/CO2 exchange in erythrocytes"], ["TCGA.G4.6320.01", "Formation of the anterior neural plate"], ["TCGA.G4.6320.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.G4.6320.01", "Prostacyclin signalling through prostacyclin receptor"], ["TCGA.G4.6320.01", "Inwardly rectifying K+ channels"], ["TCGA.G4.6320.01", "G-protein activation"], ["TCGA.G4.6320.01", "Thromboxane signalling through TP receptor"], ["TCGA.G4.6320.01", "Cytosolic sulfonation of small molecules"], ["TCGA.G4.6320.01", "Receptor-type tyrosine-protein phosphatases"], ["TCGA.G4.6320.01", "Transcriptional regulation of testis differentiation"], ["TCGA.G4.6320.01", "Scavenging by Class A Receptors"], ["TCGA.G4.6320.01", "G beta:gamma signalling through PLC beta"], ["TCGA.G4.6320.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.G4.6321.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.G4.6321.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.G4.6321.01", "Defective EXT2 causes exostoses 2"], ["TCGA.G4.6321.01", "Defective EXT1 causes exostoses 1, TRPS2 and CHDS"], ["TCGA.G4.6321.01", "HS-GAG degradation"], ["TCGA.G4.6322.01", "Interaction between L1 and Ankyrins"], ["TCGA.G4.6322.01", "Phase I - Functionalization of compounds"], ["TCGA.G4.6322.01", "Activation of Matrix Metalloproteinases"], ["TCGA.G4.6322.01", "Cytosolic sulfonation of small molecules"], ["TCGA.G4.6322.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], ["TCGA.G4.6322.01", "Arachidonic acid metabolism"], ["TCGA.G4.6322.01", "Bile acid and bile salt metabolism"], ["TCGA.G4.6322.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.G4.6322.01", "Complement cascade"], ["TCGA.G4.6322.01", "Transport of bile salts and organic acids, metal ions and amine compounds"], ["TCGA.G4.6322.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], ["TCGA.G4.6322.01", "Phase 4 - resting membrane potential"], ["TCGA.G4.6322.01", "Synthesis of bile acids and bile salts"], ["TCGA.G4.6322.01", "Synthesis of bile acids and bile salts via 27-hydroxycholesterol"], ["TCGA.G4.6322.01", "Dermatan sulfate biosynthesis"], ["TCGA.G4.6322.01", "Chondroitin sulfate/dermatan sulfate metabolism"], ["TCGA.G4.6322.01", "Phase II - Conjugation of compounds"], ["TCGA.G4.6322.01", "Synaptic adhesion-like molecules"], ["TCGA.G4.6322.01", "Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"], ["TCGA.G4.6322.01", "Recycling of bile acids and salts"], ["TCGA.G4.6322.01", "Cytochrome P450 - arranged by substrate type"], ["TCGA.G4.6322.01", "Diseases associated with glycosaminoglycan metabolism"], ["TCGA.G4.6323.01", "Interaction between L1 and Ankyrins"], ["TCGA.G4.6323.01", "Sensory perception of taste"], ["TCGA.G4.6323.01", "Sensory perception of sweet, bitter, and umami (glutamate) taste"], ["TCGA.G4.6323.01", "GABA receptor activation"], ["TCGA.G4.6323.01", "Cytosolic sulfonation of small molecules"], ["TCGA.G4.6323.01", "Phase 4 - resting membrane potential"], ["TCGA.G4.6323.01", "Activation of Matrix Metalloproteinases"], ["TCGA.G4.6323.01", "Keratan sulfate biosynthesis"], ["TCGA.G4.6323.01", "Initial triggering of complement"], ["TCGA.G4.6323.01", "FGFR2 ligand binding and activation"], ["TCGA.G4.6323.01", "Phase 0 - rapid depolarisation"], ["TCGA.G4.6323.01", "Chemokine receptors bind chemokines"], ["TCGA.G4.6323.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.G4.6323.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], ["TCGA.G4.6323.01", "Potassium Channels"], ["TCGA.G4.6323.01", "Keratan sulfate/keratin metabolism"], ["TCGA.G4.6323.01", "GABA B receptor activation"], ["TCGA.G4.6323.01", "Activation of GABAB receptors"], ["TCGA.G4.6323.01", "Glucagon-type ligand receptors"], ["TCGA.G4.6323.01", "Trafficking and processing of endosomal TLR"], ["TCGA.G4.6323.01", "Transcriptional regulation of testis differentiation"], ["TCGA.G4.6323.01", "Activated point mutants of FGFR2"], ["TCGA.G4.6586.01", "Interaction between L1 and Ankyrins"], ["TCGA.G4.6586.01", "Phase 0 - rapid depolarisation"], ["TCGA.G4.6586.01", "Potassium Channels"], ["TCGA.G4.6586.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.G4.6586.01", "Defective B3GALTL causes PpS"], ["TCGA.G4.6586.01", "Collagen chain trimerization"], ["TCGA.G4.6586.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.G4.6586.01", "Voltage gated Potassium channels"], ["TCGA.G4.6586.01", "O-linked glycosylation"], ["TCGA.G4.6586.01", "Glucagon-type ligand receptors"], ["TCGA.G4.6586.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.G4.6586.01", "Glucuronidation"], ["TCGA.G4.6586.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.G4.6586.01", "Platelet calcium homeostasis"], ["TCGA.G4.6586.01", "Keratan sulfate biosynthesis"], ["TCGA.G4.6586.01", "Endogenous sterols"], ["TCGA.G4.6586.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.G4.6586.01", "Sodium/Calcium exchangers"], ["TCGA.G4.6586.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.G4.6586.01", "Antimicrobial peptides"], ["TCGA.G4.6586.01", "GABA B receptor activation"], ["TCGA.G4.6586.01", "Activation of GABAB receptors"], ["TCGA.G4.6586.01", "Scavenging of heme from plasma"], ["TCGA.G4.6586.01", "Synthesis of bile acids and bile salts via 27-hydroxycholesterol"], ["TCGA.G4.6586.01", "FGFR2 ligand binding and activation"], ["TCGA.G4.6586.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.G4.6586.01", "Presynaptic function of Kainate receptors"], ["TCGA.G4.6586.01", "Phase II - Conjugation of compounds"], ["TCGA.G4.6586.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.G4.6586.01", "Activated point mutants of FGFR2"], ["TCGA.G4.6586.01", "IL-6-type cytokine receptor ligand interactions"], ["TCGA.G4.6586.01", "G beta:gamma signalling through BTK"], ["TCGA.G4.6586.01", "Synthesis of bile acids and bile salts"], ["TCGA.G4.6586.01", "Keratan sulfate/keratin metabolism"], ["TCGA.G4.6588.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.G4.6588.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.G4.6588.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.G4.6588.01", "Potassium Channels"], ["TCGA.G4.6588.01", "RA biosynthesis pathway"], ["TCGA.G4.6588.01", "Phase 0 - rapid depolarisation"], ["TCGA.G4.6588.01", "GABA receptor activation"], ["TCGA.G4.6588.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.G4.6588.01", "NCAM1 interactions"], ["TCGA.G4.6588.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.G4.6588.01", "Interaction between L1 and Ankyrins"], ["TCGA.G4.6588.01", "Glucagon-type ligand receptors"], ["TCGA.G4.6588.01", "Ethanol oxidation"], ["TCGA.G4.6588.01", "Collagen chain trimerization"], ["TCGA.G4.6588.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], ["TCGA.G4.6588.01", "Arachidonic acid metabolism"], ["TCGA.G4.6588.01", "Unwinding of DNA"], ["TCGA.G4.6588.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], ["TCGA.G4.6588.01", "Synthesis of bile acids and bile salts via 27-hydroxycholesterol"], ["TCGA.G4.6588.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.G4.6588.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], ["TCGA.G4.6588.01", "CD22 mediated BCR regulation"], ["TCGA.G4.6588.01", "GABA B receptor activation"], ["TCGA.G4.6588.01", "Activation of GABAB receptors"], ["TCGA.G4.6588.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.G4.6588.01", "Signaling by Retinoic Acid"], ["TCGA.G4.6588.01", "Activation of Matrix Metalloproteinases"], ["TCGA.G4.6588.01", "Synaptic adhesion-like molecules"], ["TCGA.G4.6588.01", "G beta:gamma signalling through BTK"], ["TCGA.G4.6588.01", "Activation of the phototransduction cascade"], ["TCGA.G4.6588.01", "Phase II - Conjugation of compounds"], ["TCGA.G4.6588.01", "Activation of G protein gated Potassium channels"], ["TCGA.G4.6588.01", "G protein gated Potassium channels"], ["TCGA.G4.6588.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.G4.6588.01", "Voltage gated Potassium channels"], ["TCGA.G4.6588.01", "Inwardly rectifying K+ channels"], ["TCGA.G4.6588.01", "Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"], ["TCGA.G4.6588.01", "Metabolism of steroid hormones"], ["TCGA.G4.6588.01", "G-protein activation"], ["TCGA.G4.6588.01", "APAP ADME"], ["TCGA.G4.6625.01", "Phase II - Conjugation of compounds"], ["TCGA.G4.6625.01", "Glucuronidation"], ["TCGA.G4.6625.01", "Cytosolic sulfonation of small molecules"], ["TCGA.G4.6625.01", "Ethanol oxidation"], ["TCGA.G4.6625.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.G4.6625.01", "Formation of axial mesoderm"], ["TCGA.G4.6625.01", "Collagen chain trimerization"], ["TCGA.G4.6626.01", "Potassium Channels"], ["TCGA.G4.6626.01", "GABA B receptor activation"], ["TCGA.G4.6626.01", "Activation of GABAB receptors"], ["TCGA.G4.6626.01", "GABA receptor activation"], ["TCGA.G4.6626.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.G4.6626.01", "Glucagon-type ligand receptors"], ["TCGA.G4.6626.01", "Inwardly rectifying K+ channels"], ["TCGA.G4.6626.01", "G beta:gamma signalling through BTK"], ["TCGA.G4.6626.01", "Activation of G protein gated Potassium channels"], ["TCGA.G4.6626.01", "G protein gated Potassium channels"], ["TCGA.G4.6626.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.G4.6626.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.G4.6626.01", "Glucuronidation"], ["TCGA.G4.6626.01", "MyD88 deficiency (TLR2/4)"], ["TCGA.G4.6626.01", "IRAK4 deficiency (TLR2/4)"], ["TCGA.G4.6626.01", "Phase II - Conjugation of compounds"], ["TCGA.G4.6626.01", "Unwinding of DNA"], ["TCGA.G4.6626.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.G4.6626.01", "Prostacyclin signalling through prostacyclin receptor"], ["TCGA.G4.6626.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.G4.6626.01", "Arachidonic acid metabolism"], ["TCGA.G4.6626.01", "Initial triggering of complement"], ["TCGA.G4.6626.01", "G beta:gamma signalling through PLC beta"], ["TCGA.G4.6626.01", "Chemokine receptors bind chemokines"], ["TCGA.G4.6626.01", "G-protein activation"], ["TCGA.G4.6626.01", "Thromboxane signalling through TP receptor"], ["TCGA.G4.6626.01", "Activation of Matrix Metalloproteinases"], ["TCGA.G4.6626.01", "Interaction between L1 and Ankyrins"], ["TCGA.G4.6626.01", "Complement cascade"], ["TCGA.G4.6626.01", "Presynaptic function of Kainate receptors"], ["TCGA.G4.6626.01", "Phase 4 - resting membrane potential"], ["TCGA.G4.6626.01", "Transcriptional regulation of testis differentiation"], ["TCGA.G4.6626.01", "Transcriptional regulation of pluripotent stem cells"], ["TCGA.G4.6626.01", "Regulation of Complement cascade"], ["TCGA.G4.6626.01", "Voltage gated Potassium channels"], ["TCGA.G4.6626.01", "Biosynthesis of specialized proresolving mediators (SPMs)"], ["TCGA.G4.6626.01", "CD22 mediated BCR regulation"], ["TCGA.G4.6626.01", "Molecules associated with elastic fibres"], ["TCGA.G4.6626.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], ["TCGA.G4.6626.01", "Norepinephrine Neurotransmitter Release Cycle"], ["TCGA.G4.6626.01", "Acetylcholine Neurotransmitter Release Cycle"], ["TCGA.G4.6626.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], ["TCGA.G4.6626.01", "NCAM1 interactions"], ["TCGA.G4.6626.01", "Aspirin ADME"], ["TCGA.G4.6626.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.G4.6626.01", "Caspase-mediated cleavage of cytoskeletal proteins"], ["TCGA.G4.6626.01", "Serotonin Neurotransmitter Release Cycle"], ["TCGA.G4.6626.01", "Translocation of ZAP-70 to Immunological synapse"], ["TCGA.G4.6628.01", "Phase II - Conjugation of compounds"], ["TCGA.G4.6628.01", "Ethanol oxidation"], ["TCGA.G4.6628.01", "Glucuronidation"], ["TCGA.G4.6628.01", "APAP ADME"], ["TCGA.G4.6628.01", "Phase 0 - rapid depolarisation"], ["TCGA.G4.6628.01", "Erythrocytes take up carbon dioxide and release oxygen"], ["TCGA.G4.6628.01", "O2/CO2 exchange in erythrocytes"], ["TCGA.G4.6628.01", "Cytosolic sulfonation of small molecules"], ["TCGA.G4.6628.01", "Arachidonic acid metabolism"], ["TCGA.G4.6628.01", "Aspirin ADME"], ["TCGA.G4.6628.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], ["TCGA.G4.6628.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.G4.6628.01", "Interaction between L1 and Ankyrins"], ["TCGA.G4.6628.01", "RA biosynthesis pathway"], ["TCGA.G4.6628.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.G4.6628.01", "Cytochrome P450 - arranged by substrate type"], ["TCGA.G4.6628.01", "Phase 4 - resting membrane potential"], ["TCGA.G4.6628.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.G4.6628.01", "Stimuli-sensing channels"], ["TCGA.G4.6628.01", "Glucagon-type ligand receptors"]], "chosen_edges": [["LAMA3", ["TCGA.A6.2671.01", "Glucuronidation"], {"weight": 0.866572885033259}], ["LAMA3", ["TCGA.AZ.6600.01", "Collagen formation"], {"weight": 0.907086761811972}], ["LAMA3", ["TCGA.AZ.6600.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.919354069015019}], ["LAMA3", ["TCGA.AZ.6600.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.859520459931792}], ["LAMA3", ["TCGA.AZ.6600.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.552707149028404}], ["LAMA3", ["TCGA.AZ.6600.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.867880812190904}], ["LAMA3", ["TCGA.AZ.6600.01", "Antimicrobial peptides"], {"weight": 0.369316340051267}], ["LAMA3", ["TCGA.AZ.6600.01", "Glycogen synthesis"], {"weight": 0.370453457991784}], ["LAMA3", ["TCGA.G4.6302.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.896907283994475}], ["LAMA3", ["TCGA.G4.6302.01", "Collagen degradation"], {"weight": 0.873919209238964}], ["PBRM1", ["TCGA.A6.2671.01", "Phase II - Conjugation of compounds"], {"weight": 0.869156388412229}], ["PBRM1", ["TCGA.DM.A285.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.769107715149396}], ["TP53", ["TCGA.A6.5662.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], {"weight": 0.784328467847748}], ["TP53", ["TCGA.A6.5662.01", "TP53 Regulates Transcription of Caspase Activators and Caspases"], {"weight": 0.723045477678847}], ["TP53", ["TCGA.A6.5662.01", "Collagen chain trimerization"], {"weight": 0.864430553965542}], ["TP53", ["TCGA.A6.6137.01", "IL-6-type cytokine receptor ligand interactions"], {"weight": 0.853102064043427}], ["TP53", ["TCGA.A6.6137.01", "Phase II - Conjugation of compounds"], {"weight": 0.676648196700025}], ["TP53", ["TCGA.A6.6137.01", "Glutathione conjugation"], {"weight": 0.686751895385883}], ["TP53", ["TCGA.A6.6138.01", "APAP ADME"], {"weight": 0.72029583882939}], ["TP53", ["TCGA.A6.6142.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.956200725993516}], ["TP53", ["TCGA.A6.6142.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.944747665934102}], ["TP53", ["TCGA.A6.6142.01", "Phase 0 - rapid depolarisation"], {"weight": 0.868195546484685}], ["TP53", ["TCGA.A6.6142.01", "IL-6-type cytokine receptor ligand interactions"], {"weight": 0.886677460524805}], ["TP53", ["TCGA.A6.6142.01", "Glucuronidation"], {"weight": 0.790561297431688}], ["TP53", ["TCGA.A6.6142.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.690025796327939}], ["TP53", ["TCGA.A6.6142.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], {"weight": 0.849950636960085}], ["TP53", ["TCGA.A6.6142.01", "Phase II - Conjugation of compounds"], {"weight": 0.81399357066296}], ["TP53", ["TCGA.A6.6142.01", "Heme degradation"], {"weight": 0.594458538602647}], ["TP53", ["TCGA.A6.6142.01", "Collagen degradation"], {"weight": 0.933738860606448}], ["TP53", ["TCGA.A6.6142.01", "APAP ADME"], {"weight": 0.579700620940111}], ["TP53", ["TCGA.A6.6650.01", "Transport of bile salts and organic acids, metal ions and amine compounds"], {"weight": 0.668770757199351}], ["TP53", ["TCGA.A6.6651.01", "Phase II - Conjugation of compounds"], {"weight": 0.804153665433178}], ["TP53", ["TCGA.A6.6651.01", "APAP ADME"], {"weight": 0.62366680502953}], ["TP53", ["TCGA.A6.6651.01", "Nucleotide catabolism"], {"weight": 0.677713402353641}], ["TP53", ["TCGA.A6.6652.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.826828803066456}], ["TP53", ["TCGA.AA.3511.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.668194868985191}], ["TP53", ["TCGA.AA.3655.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], {"weight": 0.814194984666105}], ["TP53", ["TCGA.AA.3660.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], {"weight": 0.575998037992174}], ["TP53", ["TCGA.AA.3697.01", "Glutamate Neurotransmitter Release Cycle"], {"weight": 0.773329673614759}], ["TP53", ["TCGA.AA.3712.01", "Interaction between L1 and Ankyrins"], {"weight": 0.928274876855359}], ["TP53", ["TCGA.AA.3712.01", "Glutamate Neurotransmitter Release Cycle"], {"weight": 0.782201266904776}], ["TP53", ["TCGA.AD.6888.01", "Interaction between L1 and Ankyrins"], {"weight": 0.940249525970287}], ["TP53", ["TCGA.AD.6888.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.868990351282434}], ["TP53", ["TCGA.AD.6888.01", "Phase 0 - rapid depolarisation"], {"weight": 0.914871709405181}], ["TP53", ["TCGA.AD.6888.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.830086959538554}], ["TP53", ["TCGA.AD.6901.01", "APAP ADME"], {"weight": 0.758666458581664}], ["TP53", ["TCGA.AD.6963.01", "Phase 0 - rapid depolarisation"], {"weight": 0.930404734971489}], ["TP53", ["TCGA.AD.6963.01", "Ethanol oxidation"], {"weight": 0.78557382085872}], ["TP53", ["TCGA.AD.6965.01", "Phase 0 - rapid depolarisation"], {"weight": 0.90875362265123}], ["TP53", ["TCGA.AD.6965.01", "Interaction between L1 and Ankyrins"], {"weight": 0.890796594824818}], ["TP53", ["TCGA.AD.6965.01", "Collagen chain trimerization"], {"weight": 0.834359283877011}], ["TP53", ["TCGA.AY.5543.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.79737998444877}], ["TP53", ["TCGA.AY.5543.01", "Endogenous sterols"], {"weight": 0.460243331487183}], ["TP53", ["TCGA.AZ.4323.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.737105947166217}], ["TP53", ["TCGA.AZ.4323.01", "Phase II - Conjugation of compounds"], {"weight": 0.855955323484674}], ["TP53", ["TCGA.AZ.4323.01", "APAP ADME"], {"weight": 0.743317889721398}], ["TP53", ["TCGA.AZ.4323.01", "Glucuronidation"], {"weight": 0.72527412433816}], ["TP53", ["TCGA.AZ.4323.01", "Ethanol oxidation"], {"weight": 0.44026941064398}], ["TP53", ["TCGA.AZ.4323.01", "Defective B3GALTL causes PpS"], {"weight": 0.779899814228651}], ["TP53", ["TCGA.AZ.4323.01", "Presynaptic nicotinic acetylcholine receptors"], {"weight": 0.776613808623221}], ["TP53", ["TCGA.AZ.4616.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], {"weight": 0.862136361219613}], ["TP53", ["TCGA.AZ.6600.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], {"weight": 0.639422518378574}], ["TP53", ["TCGA.AZ.6607.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.956930779542216}], ["TP53", ["TCGA.AZ.6607.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.950616242369546}], ["TP53", ["TCGA.AZ.6607.01", "Collagen degradation"], {"weight": 0.902304730081173}], ["TP53", ["TCGA.AZ.6607.01", "Phase II - Conjugation of compounds"], {"weight": 0.829157381983908}], ["TP53", ["TCGA.AZ.6607.01", "Chondroitin sulfate biosynthesis"], {"weight": 0.887826350567955}], ["TP53", ["TCGA.AZ.6607.01", "APAP ADME"], {"weight": 0.72908828112502}], ["TP53", ["TCGA.AZ.6607.01", "Keratinization"], {"weight": 0.869110888237552}], ["TP53", ["TCGA.AZ.6607.01", "Formation of the cornified envelope"], {"weight": 0.827778669604159}], ["TP53", ["TCGA.CA.5797.01", "Glucuronidation"], {"weight": 0.830765003291364}], ["TP53", ["TCGA.CK.4948.01", "Azathioprine ADME"], {"weight": 0.596542378819045}], ["TP53", ["TCGA.CK.5914.01", "Interaction between L1 and Ankyrins"], {"weight": 0.946800533780616}], ["TP53", ["TCGA.CK.5914.01", "Phase 0 - rapid depolarisation"], {"weight": 0.928992053003174}], ["TP53", ["TCGA.CK.5914.01", "Phase II - Conjugation of compounds"], {"weight": 0.795377791159151}], ["TP53", ["TCGA.CK.5914.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], {"weight": 0.837953964961234}], ["TP53", ["TCGA.CM.4750.01", "Interaction between L1 and Ankyrins"], {"weight": 0.926924990691209}], ["TP53", ["TCGA.CM.4752.01", "Heme degradation"], {"weight": 0.0459782707292534}], ["TP53", ["TCGA.CM.5348.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], {"weight": 0.794427435831853}], ["TP53", ["TCGA.CM.5860.01", "APAP ADME"], {"weight": 0.756495918313377}], ["TP53", ["TCGA.CM.5860.01", "Interaction between L1 and Ankyrins"], {"weight": 0.881661944961753}], ["TP53", ["TCGA.CM.5862.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.855073650679276}], ["TP53", ["TCGA.CM.6164.01", "Glutathione conjugation"], {"weight": 0.764022756964489}], ["TP53", ["TCGA.CM.6164.01", "Heme degradation"], {"weight": 0.617071576763989}], ["TP53", ["TCGA.CM.6164.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.765904474024146}], ["TP53", ["TCGA.CM.6164.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.386601593022502}], ["TP53", ["TCGA.CM.6165.01", "TP53 Regulates Transcription of Death Receptors and Ligands"], {"weight": 0.762243421096852}], ["TP53", ["TCGA.CM.6675.01", "Activation of ATR in response to replication stress"], {"weight": 0.87089101297737}], ["TP53", ["TCGA.CM.6676.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.795001068652237}], ["TP53", ["TCGA.CM.6676.01", "Phase II - Conjugation of compounds"], {"weight": 0.786045509455104}], ["TP53", ["TCGA.CM.6676.01", "Glucuronidation"], {"weight": 0.892540588625961}], ["TP53", ["TCGA.CM.6676.01", "Complement cascade"], {"weight": 0.75639076365208}], ["TP53", ["TCGA.CM.6676.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.6447723450729}], ["TP53", ["TCGA.CM.6676.01", "Ligand-dependent caspase activation"], {"weight": 0.725208481440823}], ["TP53", ["TCGA.CM.6676.01", "Aspirin ADME"], {"weight": 0.818632752179582}], ["TP53", ["TCGA.CM.6677.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.728156316096292}], ["TP53", ["TCGA.CM.6677.01", "Glucuronidation"], {"weight": 0.880171371639282}], ["TP53", ["TCGA.CM.6677.01", "Ethanol oxidation"], {"weight": 0.74844675246106}], ["TP53", ["TCGA.CM.6679.01", "Ethanol oxidation"], {"weight": 0.667253607206549}], ["TP53", ["TCGA.D5.5540.01", "DNA strand elongation"], {"weight": 0.914484253933438}], ["TP53", ["TCGA.D5.6531.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.861003836807431}], ["TP53", ["TCGA.D5.6531.01", "Phase II - Conjugation of compounds"], {"weight": 0.903082105944771}], ["TP53", ["TCGA.D5.6531.01", "APAP ADME"], {"weight": 0.66850837583962}], ["TP53", ["TCGA.D5.6531.01", "Transcriptional regulation of granulopoiesis"], {"weight": 0.582701727308334}], ["TP53", ["TCGA.D5.6531.01", "Interaction between L1 and Ankyrins"], {"weight": 0.838167787083001}], ["TP53", ["TCGA.D5.6533.01", "Interaction between L1 and Ankyrins"], {"weight": 0.918000101322944}], ["TP53", ["TCGA.D5.6533.01", "Phase 0 - rapid depolarisation"], {"weight": 0.871613214653888}], ["TP53", ["TCGA.D5.6534.01", "Aflatoxin activation and detoxification"], {"weight": 0.637355259551359}], ["TP53", ["TCGA.D5.6538.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], {"weight": 0.778661972112514}], ["TP53", ["TCGA.D5.6538.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.83652049910058}], ["TP53", ["TCGA.D5.6541.01", "Heme degradation"], {"weight": 0.0474549242949968}], ["TP53", ["TCGA.D5.6541.01", "Metabolism of amine-derived hormones"], {"weight": 0.55563483429329}], ["TP53", ["TCGA.D5.6924.01", "TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest"], {"weight": 0.768492712930263}], ["TP53", ["TCGA.D5.6924.01", "Metal ion SLC transporters"], {"weight": 0.415991204035274}], ["TP53", ["TCGA.D5.6926.01", "Glutathione conjugation"], {"weight": 0.835231095942246}], ["TP53", ["TCGA.D5.6929.01", "Glucuronidation"], {"weight": 0.890776948571409}], ["TP53", ["TCGA.D5.6929.01", "Aspirin ADME"], {"weight": 0.824111699502707}], ["TP53", ["TCGA.D5.6929.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.759213921332158}], ["TP53", ["TCGA.D5.6929.01", "Physiological factors"], {"weight": 0.798835774782022}], ["TP53", ["TCGA.D5.6929.01", "Keratinization"], {"weight": 0.788703642290251}], ["TP53", ["TCGA.D5.6929.01", "YAP1- and WWTR1 (TAZ)-stimulated gene expression"], {"weight": 0.751013355395327}], ["TP53", ["TCGA.D5.6929.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], {"weight": 0.472061872254537}], ["TP53", ["TCGA.D5.6931.01", "Keratinization"], {"weight": 0.825490356536656}], ["TP53", ["TCGA.DM.A0XF.01", "Azathioprine ADME"], {"weight": 0.707895087147062}], ["TP53", ["TCGA.DM.A1D0.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.810299961331538}], ["TP53", ["TCGA.DM.A1D0.01", "Dectin-2 family"], {"weight": 0.797980143046605}], ["TP53", ["TCGA.DM.A1D4.01", "Glutamate Neurotransmitter Release Cycle"], {"weight": 0.873766070270516}], ["TP53", ["TCGA.DM.A1D4.01", "Interaction between L1 and Ankyrins"], {"weight": 0.940159057202128}], ["TP53", ["TCGA.DM.A1D6.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.870956316009728}], ["TP53", ["TCGA.DM.A1D6.01", "Biosynthesis of specialized proresolving mediators (SPMs)"], {"weight": 0.873879026048289}], ["TP53", ["TCGA.DM.A1D6.01", "Heme degradation"], {"weight": 0.799037436589138}], ["TP53", ["TCGA.DM.A1D7.01", "IL-6-type cytokine receptor ligand interactions"], {"weight": 0.905943677776289}], ["TP53", ["TCGA.DM.A1D8.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], {"weight": 0.81416625641726}], ["TP53", ["TCGA.DM.A1D9.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.848885344699641}], ["TP53", ["TCGA.DM.A1D9.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], {"weight": 0.731010388344075}], ["TP53", ["TCGA.DM.A1D9.01", "Ethanol oxidation"], {"weight": 0.7417078908312}], ["TP53", ["TCGA.DM.A1DB.01", "Resolution of D-loop Structures through Holliday Junction Intermediates"], {"weight": 0.889046689783193}], ["TP53", ["TCGA.DM.A28F.01", "IL-6-type cytokine receptor ligand interactions"], {"weight": 0.885188249000424}], ["TP53", ["TCGA.DM.A28F.01", "Endogenous sterols"], {"weight": 0.560377864301179}], ["TP53", ["TCGA.DM.A28H.01", "Deposition of new CENPA-containing nucleosomes at the centromere"], {"weight": 0.902097164356854}], ["TP53", ["TCGA.DM.A28H.01", "Nucleosome assembly"], {"weight": 0.902097164356854}], ["TP53", ["TCGA.DM.A28H.01", "Interaction between L1 and Ankyrins"], {"weight": 0.933088953979856}], ["TP53", ["TCGA.DM.A28H.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.854149031721379}], ["TP53", ["TCGA.DM.A28H.01", "Condensation of Prophase Chromosomes"], {"weight": 0.841185178293083}], ["TP53", ["TCGA.DM.A28H.01", "Chromosome Maintenance"], {"weight": 0.926491482953398}], ["TP53", ["TCGA.DM.A28H.01", "TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest"], {"weight": 0.874618960033136}], ["TP53", ["TCGA.DM.A28H.01", "APOBEC3G mediated resistance to HIV-1 infection"], {"weight": 0.761167657974952}], ["TP53", ["TCGA.DM.A28H.01", "Condensation of Prometaphase Chromosomes"], {"weight": 0.815757752952959}], ["TP53", ["TCGA.F4.6805.01", "Phase II - Conjugation of compounds"], {"weight": 0.586975494921901}], ["TP53", ["TCGA.F4.6854.01", "APAP ADME"], {"weight": 0.753631098957954}], ["TP53", ["TCGA.G4.6294.01", "Neurotransmitter release cycle"], {"weight": 0.9274648370024}], ["TP53", ["TCGA.G4.6294.01", "Glutamate Neurotransmitter Release Cycle"], {"weight": 0.843141538856544}], ["TP53", ["TCGA.G4.6297.01", "Glucuronidation"], {"weight": 0.621274999094168}], ["TP53", ["TCGA.G4.6299.01", "Glutamate Neurotransmitter Release Cycle"], {"weight": 0.809488599437575}], ["TP53", ["TCGA.G4.6306.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.937035329517616}], ["TP53", ["TCGA.G4.6310.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], {"weight": 0.730912879441289}], ["TP53", ["TCGA.G4.6315.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], {"weight": 0.708585133596234}], ["TP53", ["TCGA.G4.6315.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.781284812492897}], ["TP53", ["TCGA.G4.6317.01", "Interaction between L1 and Ankyrins"], {"weight": 0.946815622241584}], ["TP53", ["TCGA.G4.6317.01", "Tryptophan catabolism"], {"weight": 0.788899108136603}], ["TP53", ["TCGA.G4.6320.01", "Glutamate Neurotransmitter Release Cycle"], {"weight": 0.823470638425218}], ["TP53", ["TCGA.G4.6626.01", "Complement cascade"], {"weight": 0.863533553015818}], ["TP53", ["TCGA.G4.6626.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], {"weight": 0.836990723263002}], ["MMP9", ["TCGA.AM.5820.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.807829310079462}], ["MMP9", ["TCGA.AZ.4615.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.827502782140284}], ["TNN", ["TCGA.A6.2675.01", "Collagen formation"], {"weight": 0.885570320067454}], ["ACACB", ["TCGA.A6.2675.01", "Ethanol oxidation"], {"weight": 0.551987179667486}], ["ACACB", ["TCGA.A6.2675.01", "RA biosynthesis pathway"], {"weight": 0.358124838368597}], ["ACACB", ["TCGA.D5.6529.01", "Phase II - Conjugation of compounds"], {"weight": 0.752021100656056}], ["ACACB", ["TCGA.D5.6529.01", "Glucuronidation"], {"weight": 0.717455211769606}], ["ACACB", ["TCGA.D5.6529.01", "Ethanol oxidation"], {"weight": 0.65450124339836}], ["ACACB", ["TCGA.D5.6529.01", "Signaling by Retinoic Acid"], {"weight": 0.564557293991792}], ["TNN", ["TCGA.A6.2675.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.871741864397031}], ["TNN", ["TCGA.A6.2675.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.48127751745003}], ["TNN", ["TCGA.A6.2675.01", "Scavenging by Class A Receptors"], {"weight": 0.340979142196541}], ["TNN", ["TCGA.AY.5543.01", "Other semaphorin interactions"], {"weight": 0.667588737888835}], ["TGFBR2", ["TCGA.A6.2675.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.849705197447077}], ["TGFBR2", ["TCGA.A6.2675.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.889000593648967}], ["TGFBR2", ["TCGA.A6.2675.01", "Collagen chain trimerization"], {"weight": 0.819510180316898}], ["APC", ["TCGA.A6.5659.01", "Blood group systems biosynthesis"], {"weight": 0.590625722090264}], ["APC", ["TCGA.A6.5666.01", "Keratan sulfate biosynthesis"], {"weight": 0.886033484016348}], ["APC", ["TCGA.A6.6137.01", "Molecules associated with elastic fibres"], {"weight": 0.732518787255476}], ["APC", ["TCGA.A6.6142.01", "Collagen chain trimerization"], {"weight": 0.903708918467886}], ["APC", ["TCGA.A6.6142.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.861334603859376}], ["APC", ["TCGA.A6.6142.01", "WNT ligand biogenesis and trafficking"], {"weight": 0.855268905502413}], ["APC", ["TCGA.A6.6142.01", "FGFR2 ligand binding and activation"], {"weight": 0.825959939770889}], ["APC", ["TCGA.A6.6652.01", "Molecules associated with elastic fibres"], {"weight": 0.803455363572621}], ["APC", ["TCGA.AA.3511.01", "TNFs bind their physiological receptors"], {"weight": 0.264884458277304}], ["APC", ["TCGA.AD.6890.01", "Blood group systems biosynthesis"], {"weight": 0.781156639329835}], ["APC", ["TCGA.AD.6890.01", "Lewis blood group biosynthesis"], {"weight": 0.768948771977794}], ["APC", ["TCGA.AU.3779.01", "Metabolism of amine-derived hormones"], {"weight": 0.497834632366947}], ["APC", ["TCGA.AY.5543.01", "Molecules associated with elastic fibres"], {"weight": 0.865892496412087}], ["APC", ["TCGA.AY.5543.01", "Elastic fibre formation"], {"weight": 0.875335771061583}], ["APC", ["TCGA.AY.5543.01", "Insulin processing"], {"weight": 0.805460386727926}], ["APC", ["TCGA.CK.4950.01", "Glutamate Neurotransmitter Release Cycle"], {"weight": 0.547933281430051}], ["APC", ["TCGA.CK.4952.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.827040352335649}], ["APC", ["TCGA.CK.5912.01", "GABA receptor activation"], {"weight": 0.885207271002499}], ["APC", ["TCGA.CK.5912.01", "Keratan sulfate biosynthesis"], {"weight": 0.882539304277438}], ["APC", ["TCGA.CK.5912.01", "Synthesis, secretion, and deacylation of Ghrelin"], {"weight": 0.66400045857323}], ["APC", ["TCGA.CK.5915.01", "Blood group systems biosynthesis"], {"weight": 0.894251379929524}], ["APC", ["TCGA.CK.5915.01", "Lewis blood group biosynthesis"], {"weight": 0.893393245155846}], ["APC", ["TCGA.CK.5915.01", "Keratan sulfate biosynthesis"], {"weight": 0.919974167311185}], ["APC", ["TCGA.CM.4744.01", "Molecules associated with elastic fibres"], {"weight": 0.836438423000658}], ["APC", ["TCGA.CM.4744.01", "Sialic acid metabolism"], {"weight": 0.651664999352887}], ["APC", ["TCGA.CM.5344.01", "WNT ligand biogenesis and trafficking"], {"weight": 0.880208287109226}], ["APC", ["TCGA.CM.5862.01", "O-linked glycosylation of mucins"], {"weight": 0.927700665072389}], ["APC", ["TCGA.CM.5862.01", "Termination of O-glycan biosynthesis"], {"weight": 0.885508465795096}], ["APC", ["TCGA.CM.6164.01", "Blood group systems biosynthesis"], {"weight": 0.52847041782879}], ["APC", ["TCGA.CM.6170.01", "Blood group systems biosynthesis"], {"weight": 0.583783153395458}], ["APC", ["TCGA.CM.6170.01", "Lewis blood group biosynthesis"], {"weight": 0.536215313785605}], ["APC", ["TCGA.D5.5538.01", "Lewis blood group biosynthesis"], {"weight": 0.472246038507106}], ["APC", ["TCGA.D5.5538.01", "Blood group systems biosynthesis"], {"weight": 0.471539446462522}], ["APC", ["TCGA.D5.5540.01", "Blood group systems biosynthesis"], {"weight": 0.840400575236192}], ["APC", ["TCGA.D5.6532.01", "Blood group systems biosynthesis"], {"weight": 0.795320276057919}], ["APC", ["TCGA.D5.6532.01", "Lewis blood group biosynthesis"], {"weight": 0.773624942072589}], ["APC", ["TCGA.D5.6532.01", "Elastic fibre formation"], {"weight": 0.78651197586375}], ["APC", ["TCGA.D5.6532.01", "Sialic acid metabolism"], {"weight": 0.69121102944452}], ["APC", ["TCGA.D5.6920.01", "Molecules associated with elastic fibres"], {"weight": 0.759265110163427}], ["APC", ["TCGA.D5.6920.01", "Regulation of FZD by ubiquitination"], {"weight": 0.767328914119322}], ["APC", ["TCGA.D5.6920.01", "Elastic fibre formation"], {"weight": 0.758157026885963}], ["APC", ["TCGA.DM.A0XF.01", "Blood group systems biosynthesis"], {"weight": 0.808543485261311}], ["APC", ["TCGA.DM.A1D0.01", "Voltage gated Potassium channels"], {"weight": 0.842873400087944}], ["APC", ["TCGA.DM.A1D0.01", "Lewis blood group biosynthesis"], {"weight": 0.706792730018271}], ["APC", ["TCGA.DM.A1D0.01", "Blood group systems biosynthesis"], {"weight": 0.75698731874246}], ["APC", ["TCGA.DM.A1D4.01", "Blood group systems biosynthesis"], {"weight": 0.757699461316984}], ["APC", ["TCGA.DM.A1D4.01", "Activation of the phototransduction cascade"], {"weight": 0.801495954221603}], ["APC", ["TCGA.DM.A1D6.01", "Molecules associated with elastic fibres"], {"weight": 0.82065296675777}], ["APC", ["TCGA.DM.A1D6.01", "Blood group systems biosynthesis"], {"weight": 0.729473288996351}], ["APC", ["TCGA.DM.A1D6.01", "Lewis blood group biosynthesis"], {"weight": 0.642650328772807}], ["APC", ["TCGA.DM.A1DB.01", "O-linked glycosylation of mucins"], {"weight": 0.921795764779189}], ["APC", ["TCGA.DM.A1DB.01", "Termination of O-glycan biosynthesis"], {"weight": 0.889830291246029}], ["APC", ["TCGA.DM.A1DB.01", "O-linked glycosylation"], {"weight": 0.917532604487458}], ["APC", ["TCGA.DM.A28C.01", "Keratan sulfate biosynthesis"], {"weight": 0.905238806669183}], ["APC", ["TCGA.DM.A28C.01", "O-linked glycosylation of mucins"], {"weight": 0.931268057007462}], ["APC", ["TCGA.DM.A28E.01", "Generation of second messenger molecules"], {"weight": 0.920921646845993}], ["APC", ["TCGA.DM.A28E.01", "Phosphorylation of CD3 and TCR zeta chains"], {"weight": 0.91103568448378}], ["APC", ["TCGA.DM.A28E.01", "Translocation of ZAP-70 to Immunological synapse"], {"weight": 0.9079251378468}], ["APC", ["TCGA.DM.A28E.01", "PD-1 signaling"], {"weight": 0.910483218716714}], ["APC", ["TCGA.DM.A28E.01", "Cell surface interactions at the vascular wall"], {"weight": 0.828846965301957}], ["APC", ["TCGA.DM.A28E.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.917933875773867}], ["APC", ["TCGA.DM.A28E.01", "Molecules associated with elastic fibres"], {"weight": 0.895096187745797}], ["APC", ["TCGA.DM.A28E.01", "Elastic fibre formation"], {"weight": 0.906385206402192}], ["APC", ["TCGA.DM.A28E.01", "Glycosaminoglycan metabolism"], {"weight": 0.881055684393074}], ["APC", ["TCGA.DM.A28E.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.700367649206858}], ["APC", ["TCGA.DM.A28E.01", "Keratan sulfate biosynthesis"], {"weight": 0.918473187966597}], ["APC", ["TCGA.DM.A28E.01", "Costimulation by the CD28 family"], {"weight": 0.90511558568353}], ["APC", ["TCGA.DM.A28E.01", "DAP12 signaling"], {"weight": 0.889328184833295}], ["APC", ["TCGA.DM.A28E.01", "Integrin cell surface interactions"], {"weight": 0.891374399339617}], ["APC", ["TCGA.DM.A28E.01", "DAP12 interactions"], {"weight": 0.899606229753595}], ["APC", ["TCGA.DM.A28E.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.879185578376234}], ["APC", ["TCGA.DM.A28E.01", "Keratan sulfate/keratin metabolism"], {"weight": 0.918473187966597}], ["APC", ["TCGA.DM.A28E.01", "Blood group systems biosynthesis"], {"weight": 0.809689495656057}], ["APC", ["TCGA.DM.A28E.01", "Sialic acid metabolism"], {"weight": 0.714204914585361}], ["APC", ["TCGA.DM.A28E.01", "MyD88 deficiency (TLR2/4)"], {"weight": 0.868392764505391}], ["APC", ["TCGA.DM.A28E.01", "IRAK4 deficiency (TLR2/4)"], {"weight": 0.868392764505391}], ["APC", ["TCGA.DM.A28E.01", "TNFs bind their physiological receptors"], {"weight": 0.39275892201014}], ["APC", ["TCGA.DM.A28E.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], {"weight": 0.756495449317843}], ["APC", ["TCGA.DM.A28E.01", "Other semaphorin interactions"], {"weight": 0.647110555817688}], ["APC", ["TCGA.DM.A28E.01", "CD22 mediated BCR regulation"], {"weight": 0.724348227254419}], ["APC", ["TCGA.DM.A28E.01", "Acetylcholine Neurotransmitter Release Cycle"], {"weight": 0.730925044803089}], ["APC", ["TCGA.DM.A28E.01", "Lewis blood group biosynthesis"], {"weight": 0.79604950251933}], ["APC", ["TCGA.DM.A28E.01", "Diseases associated with glycosaminoglycan metabolism"], {"weight": 0.884071723886545}], ["APC", ["TCGA.DM.A28E.01", "FCGR activation"], {"weight": 0.829097978426054}], ["APC", ["TCGA.DM.A28E.01", "CD28 dependent Vav1 pathway"], {"weight": 0.785779611801386}], ["APC", ["TCGA.DM.A28E.01", "Phase II - Conjugation of compounds"], {"weight": 0.716533336699797}], ["APC", ["TCGA.DM.A28E.01", "CRMPs in Sema3A signaling"], {"weight": 0.847323495228455}], ["APC", ["TCGA.DM.A28E.01", "Activation of the phototransduction cascade"], {"weight": 0.822422120413172}], ["APC", ["TCGA.DM.A28F.01", "Molecules associated with elastic fibres"], {"weight": 0.787359080285274}], ["APC", ["TCGA.DM.A28F.01", "Elastic fibre formation"], {"weight": 0.8103485897746}], ["APC", ["TCGA.DM.A28G.01", "Regulation of FZD by ubiquitination"], {"weight": 0.814184939154821}], ["APC", ["TCGA.F4.6569.01", "Blood group systems biosynthesis"], {"weight": 0.502750084138731}], ["APC", ["TCGA.F4.6809.01", "Blood group systems biosynthesis"], {"weight": 0.425249779649118}], ["APC", ["TCGA.F4.6809.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], {"weight": 0.474732355493441}], ["APC", ["TCGA.G4.6294.01", "Sialic acid metabolism"], {"weight": 0.427026353590536}], ["APC", ["TCGA.G4.6294.01", "Keratan sulfate biosynthesis"], {"weight": 0.896127357321181}], ["APC", ["TCGA.G4.6306.01", "Sialic acid metabolism"], {"weight": 0.60090850737643}], ["APC", ["TCGA.G4.6306.01", "Blood group systems biosynthesis"], {"weight": 0.771637645390412}], ["APC", ["TCGA.G4.6307.01", "Molecules associated with elastic fibres"], {"weight": 0.805583952199006}], ["APC", ["TCGA.G4.6307.01", "Elastic fibre formation"], {"weight": 0.816176325947875}], ["APC", ["TCGA.G4.6315.01", "Molecules associated with elastic fibres"], {"weight": 0.762285815157646}], ["APC", ["TCGA.G4.6315.01", "Elastic fibre formation"], {"weight": 0.785083592091877}], ["APC", ["TCGA.G4.6317.01", "Blood group systems biosynthesis"], {"weight": 0.858531308148467}], ["APC", ["TCGA.G4.6317.01", "Keratan sulfate biosynthesis"], {"weight": 0.906889292903512}], ["APC", ["TCGA.G4.6322.01", "Chondroitin sulfate/dermatan sulfate metabolism"], {"weight": 0.781471373460202}], ["APC", ["TCGA.G4.6322.01", "Synaptic adhesion-like molecules"], {"weight": 0.808883358040209}], ["APC", ["TCGA.G4.6322.01", "Diseases associated with glycosaminoglycan metabolism"], {"weight": 0.800236780635155}], ["APC", ["TCGA.G4.6323.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], {"weight": 0.740315948900026}], ["APC", ["TCGA.G4.6625.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.845888050595392}], ["APC", ["TCGA.G4.6625.01", "Formation of axial mesoderm"], {"weight": 0.602535370872532}], ["APC", ["TCGA.G4.6626.01", "Caspase-mediated cleavage of cytoskeletal proteins"], {"weight": 0.839086382376248}], ["NMUR2", ["TCGA.CM.6162.01", "Defensins"], {"weight": 0.168352325100306}], ["NRBP1", ["TCGA.A6.4105.01", "Phase II - Conjugation of compounds"], {"weight": 0.734429508313015}], ["IRF5", ["TCGA.AD.6890.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.664593889543993}], ["IRF5", ["TCGA.AD.6890.01", "Phase II - Conjugation of compounds"], {"weight": 0.695570849299645}], ["IRF5", ["TCGA.AD.6890.01", "Biological oxidations"], {"weight": 0.826729956600649}], ["IRF5", ["TCGA.AD.6963.01", "Phase II - Conjugation of compounds"], {"weight": 0.851899602199605}], ["IRF5", ["TCGA.AD.6963.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.77415549268618}], ["IRF5", ["TCGA.AD.6963.01", "Aspirin ADME"], {"weight": 0.829359403371554}], ["IRF5", ["TCGA.AD.6963.01", "Glucuronidation"], {"weight": 0.855513660881008}], ["IRF5", ["TCGA.AZ.6603.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.755823477682169}], ["IRF5", ["TCGA.CA.6719.01", "Collagen chain trimerization"], {"weight": 0.862850527107719}], ["IRF5", ["TCGA.CA.6719.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.898111719530553}], ["IRF5", ["TCGA.CK.4948.01", "Phase II - Conjugation of compounds"], {"weight": 0.78095706986695}], ["IRF5", ["TCGA.CK.4948.01", "Glucuronidation"], {"weight": 0.850510309167593}], ["IRF5", ["TCGA.CK.5912.01", "Heme degradation"], {"weight": 0.638468074990693}], ["IRF5", ["TCGA.CK.5915.01", "Sialic acid metabolism"], {"weight": 0.545033311871104}], ["IRF5", ["TCGA.CM.4747.01", "Physiological factors"], {"weight": 0.586451030795067}], ["IRF5", ["TCGA.CM.5860.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.808666030059419}], ["IRF5", ["TCGA.CM.5860.01", "Phase II - Conjugation of compounds"], {"weight": 0.857747532494893}], ["IRF5", ["TCGA.D5.6529.01", "Collagen chain trimerization"], {"weight": 0.880871286005429}], ["IRF5", ["TCGA.D5.6529.01", "Scavenging by Class A Receptors"], {"weight": 0.467674322362396}], ["IRF5", ["TCGA.DM.A1D0.01", "Initial triggering of complement"], {"weight": 0.91628917520763}], ["IRF5", ["TCGA.DM.A1D0.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.890820229959217}], ["IRF5", ["TCGA.DM.A1D0.01", "Nicotinate metabolism"], {"weight": 0.808516024205007}], ["IRF5", ["TCGA.DM.A1D0.01", "Trafficking and processing of endosomal TLR"], {"weight": 0.826819744630155}], ["IRF5", ["TCGA.DM.A1D0.01", "Arachidonic acid metabolism"], {"weight": 0.897467790405164}], ["IRF5", ["TCGA.F4.6461.01", "Collagen formation"], {"weight": 0.907755333501067}], ["IRF5", ["TCGA.F4.6461.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.888724264934119}], ["IRF5", ["TCGA.F4.6704.01", "Neurotransmitter release cycle"], {"weight": 0.838334972792319}], ["IRF5", ["TCGA.F4.6807.01", "Glucuronidation"], {"weight": 0.777212487194128}], ["IRF5", ["TCGA.F4.6807.01", "Aspirin ADME"], {"weight": 0.832054835286107}], ["IRF5", ["TCGA.G4.6625.01", "Collagen chain trimerization"], {"weight": 0.750263341670029}], ["PIK3CA", ["TCGA.A6.5666.01", "Classical antibody-mediated complement activation"], {"weight": 0.693995484695898}], ["PIK3CA", ["TCGA.A6.5666.01", "Creation of C4 and C2 activators"], {"weight": 0.744983639292343}], ["PIK3CA", ["TCGA.A6.5666.01", "Adenylate cyclase inhibitory pathway"], {"weight": 0.902961221896893}], ["PIK3CA", ["TCGA.A6.5666.01", "Glucuronidation"], {"weight": 0.771724303818459}], ["PIK3CA", ["TCGA.AA.3712.01", "Caspase-mediated cleavage of cytoskeletal proteins"], {"weight": 0.597702852831884}], ["PIK3CA", ["TCGA.AD.6890.01", "IL-6-type cytokine receptor ligand interactions"], {"weight": 0.889695773773189}], ["PIK3CA", ["TCGA.AD.6965.01", "Classical antibody-mediated complement activation"], {"weight": 0.432718628311872}], ["PIK3CA", ["TCGA.AY.6386.01", "Potassium Channels"], {"weight": 0.950796108687823}], ["PIK3CA", ["TCGA.CM.4748.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.815718404519112}], ["PIK3CA", ["TCGA.CM.5860.01", "Common Pathway of Fibrin Clot Formation"], {"weight": 0.839956508125264}], ["PIK3CA", ["TCGA.CM.5860.01", "Peptide hormone biosynthesis"], {"weight": 0.516283844597517}], ["PIK3CA", ["TCGA.CM.5860.01", "Complement cascade"], {"weight": 0.744598731117466}], ["PIK3CA", ["TCGA.CM.6678.01", "CD22 mediated BCR regulation"], {"weight": 0.80855915043448}], ["PIK3CA", ["TCGA.CM.6678.01", "Other semaphorin interactions"], {"weight": 0.511054625834605}], ["PIK3CA", ["TCGA.D5.6529.01", "IL-6-type cytokine receptor ligand interactions"], {"weight": 0.844822735425772}], ["PIK3CA", ["TCGA.D5.6532.01", "Potassium Channels"], {"weight": 0.955818411598841}], ["PIK3CA", ["TCGA.D5.6532.01", "Classical antibody-mediated complement activation"], {"weight": 0.658876391217506}], ["PIK3CA", ["TCGA.D5.6532.01", "G beta:gamma signalling through BTK"], {"weight": 0.916616010557706}], ["PIK3CA", ["TCGA.D5.6532.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.908714595146502}], ["PIK3CA", ["TCGA.D5.6532.01", "Activation of G protein gated Potassium channels"], {"weight": 0.931071246538684}], ["PIK3CA", ["TCGA.D5.6532.01", "G protein gated Potassium channels"], {"weight": 0.931071246538684}], ["PIK3CA", ["TCGA.D5.6532.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.931071246538684}], ["PIK3CA", ["TCGA.D5.6532.01", "GABA B receptor activation"], {"weight": 0.934710275723479}], ["PIK3CA", ["TCGA.D5.6532.01", "Activation of GABAB receptors"], {"weight": 0.934710275723479}], ["PIK3CA", ["TCGA.D5.6532.01", "Glucagon-type ligand receptors"], {"weight": 0.919487563485548}], ["PIK3CA", ["TCGA.D5.6532.01", "Presynaptic function of Kainate receptors"], {"weight": 0.90233262028423}], ["PIK3CA", ["TCGA.D5.6532.01", "Inwardly rectifying K+ channels"], {"weight": 0.93708810116064}], ["PIK3CA", ["TCGA.D5.6532.01", "GABA receptor activation"], {"weight": 0.891681788891826}], ["PIK3CA", ["TCGA.D5.6532.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.911132376608984}], ["PIK3CA", ["TCGA.D5.6532.01", "Prostacyclin signalling through prostacyclin receptor"], {"weight": 0.884729482493615}], ["PIK3CA", ["TCGA.D5.6532.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.884729482493615}], ["PIK3CA", ["TCGA.D5.6532.01", "CD22 mediated BCR regulation"], {"weight": 0.807798079636154}], ["PIK3CA", ["TCGA.D5.6532.01", "Chemokine receptors bind chemokines"], {"weight": 0.919316530473732}], ["PIK3CA", ["TCGA.D5.6532.01", "Creation of C4 and C2 activators"], {"weight": 0.625773000328616}], ["PIK3CA", ["TCGA.D5.6532.01", "G-protein activation"], {"weight": 0.884729482493615}], ["PIK3CA", ["TCGA.D5.6532.01", "Thromboxane signalling through TP receptor"], {"weight": 0.884729482493615}], ["PIK3CA", ["TCGA.D5.6537.01", "Classical antibody-mediated complement activation"], {"weight": 0.654896093507312}], ["PIK3CA", ["TCGA.D5.6537.01", "Other semaphorin interactions"], {"weight": 0.730819127557054}], ["PIK3CA", ["TCGA.D5.6537.01", "CD22 mediated BCR regulation"], {"weight": 0.880989362029512}], ["PIK3CA", ["TCGA.D5.6537.01", "IL-6-type cytokine receptor ligand interactions"], {"weight": 0.908586794234369}], ["PIK3CA", ["TCGA.D5.6537.01", "Creation of C4 and C2 activators"], {"weight": 0.645116104308235}], ["PIK3CA", ["TCGA.D5.6541.01", "Glucagon-type ligand receptors"], {"weight": 0.916703842748912}], ["PIK3CA", ["TCGA.D5.6541.01", "WNT ligand biogenesis and trafficking"], {"weight": 0.824242582912524}], ["PIK3CA", ["TCGA.D5.6920.01", "L1CAM interactions"], {"weight": 0.785793686871549}], ["PIK3CA", ["TCGA.D5.6920.01", "Peptide hormone metabolism"], {"weight": 0.701251306003336}], ["PIK3CA", ["TCGA.D5.6931.01", "IL-6-type cytokine receptor ligand interactions"], {"weight": 0.831678100841976}], ["PIK3CA", ["TCGA.DM.A1D8.01", "CD22 mediated BCR regulation"], {"weight": 0.877168075332153}], ["PIK3CA", ["TCGA.DM.A285.01", "CD22 mediated BCR regulation"], {"weight": 0.845128596843427}], ["PIK3CA", ["TCGA.DM.A28C.01", "Classical antibody-mediated complement activation"], {"weight": 0.696811347016608}], ["PIK3CA", ["TCGA.DM.A28C.01", "Creation of C4 and C2 activators"], {"weight": 0.76066635220703}], ["PIK3CA", ["TCGA.DM.A28C.01", "TNFs bind their physiological receptors"], {"weight": 0.440728526007818}], ["PIK3CA", ["TCGA.DM.A28M.01", "Classical antibody-mediated complement activation"], {"weight": 0.768829619920724}], ["PIK3CA", ["TCGA.DM.A28M.01", "Creation of C4 and C2 activators"], {"weight": 0.820637695377356}], ["PIK3CA", ["TCGA.DM.A28M.01", "Other semaphorin interactions"], {"weight": 0.71811195314349}], ["PIK3CA", ["TCGA.F4.6461.01", "SUMOylation of intracellular receptors"], {"weight": 0.433363193067028}], ["PIK3CA", ["TCGA.F4.6569.01", "FGFR4 ligand binding and activation"], {"weight": 0.858284515545222}], ["PIK3CA", ["TCGA.F4.6805.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.721837500162699}], ["PIK3CA", ["TCGA.F4.6855.01", "TNFs bind their physiological receptors"], {"weight": 0.275506483003419}], ["PIK3CA", ["TCGA.F4.6855.01", "Phase 4 - resting membrane potential"], {"weight": 0.645593475082408}], ["PIK3CA", ["TCGA.G4.6293.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.823183443997285}], ["PIK3CA", ["TCGA.G4.6311.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.806046509450055}], ["ATM", ["TCGA.DM.A0XF.01", "DNA strand elongation"], {"weight": 0.877507011305597}], ["MTOR", ["TCGA.CM.4752.01", "Phase II - Conjugation of compounds"], {"weight": 0.59867972064256}], ["MTOR", ["TCGA.CM.4752.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.636343098969771}], ["MTOR", ["TCGA.DM.A1D4.01", "CD22 mediated BCR regulation"], {"weight": 0.884960770085835}], ["MTOR", ["TCGA.DM.A1D4.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.833549239174089}], ["MTOR", ["TCGA.DM.A1D4.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.860936947709271}], ["MTOR", ["TCGA.F4.6806.01", "Initial triggering of complement"], {"weight": 0.772980325023701}], ["MTOR", ["TCGA.F4.6806.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.41291819924105}], ["MTOR", ["TCGA.G4.6298.01", "CD22 mediated BCR regulation"], {"weight": 0.848857897267303}], ["MTOR", ["TCGA.G4.6322.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.857906164329633}], ["MTOR", ["TCGA.G4.6322.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], {"weight": 0.705791100206655}], ["MTOR", ["TCGA.G4.6322.01", "Arachidonic acid metabolism"], {"weight": 0.862679696582481}], ["MTOR", ["TCGA.G4.6322.01", "Bile acid and bile salt metabolism"], {"weight": 0.744476065597425}], ["MTOR", ["TCGA.G4.6322.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.835924906789743}], ["MTOR", ["TCGA.G4.6322.01", "Synthesis of bile acids and bile salts"], {"weight": 0.784384631434446}], ["MTOR", ["TCGA.G4.6322.01", "Synthesis of bile acids and bile salts via 27-hydroxycholesterol"], {"weight": 0.75303226344386}], ["MTOR", ["TCGA.G4.6322.01", "Dermatan sulfate biosynthesis"], {"weight": 0.738377689338042}], ["MTOR", ["TCGA.G4.6322.01", "Phase II - Conjugation of compounds"], {"weight": 0.802025617376858}], ["MTOR", ["TCGA.G4.6322.01", "Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"], {"weight": 0.722986339245745}], ["TUBB1", ["TCGA.A6.4105.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.611327400894507}], ["NRBP1", ["TCGA.A6.4105.01", "Glucuronidation"], {"weight": 0.711188069320463}], ["GFPT2", ["TCGA.A6.4105.01", "APAP ADME"], {"weight": 0.783799008945714}], ["FLT4", ["TCGA.A6.4105.01", "FGFR4 ligand binding and activation"], {"weight": 0.858995156767019}], ["TTN", ["TCGA.A6.5657.01", "APAP ADME"], {"weight": 0.508978073215054}], ["TTN", ["TCGA.A6.6140.01", "Heme degradation"], {"weight": 0.685955490402689}], ["TTN", ["TCGA.CM.5862.01", "Initial triggering of complement"], {"weight": 0.821512562109447}], ["TTN", ["TCGA.F4.6460.01", "FGFR4 ligand binding and activation"], {"weight": 0.775213610093283}], ["FLT4", ["TCGA.A6.4105.01", "FGFR2 ligand binding and activation"], {"weight": 0.874954272153203}], ["FLT4", ["TCGA.A6.4105.01", "FGFR2c ligand binding and activation"], {"weight": 0.85171997469939}], ["FLT4", ["TCGA.CA.5796.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.828783372414783}], ["FLT4", ["TCGA.CA.5796.01", "Sensory perception of taste"], {"weight": 0.87154730352486}], ["FLT4", ["TCGA.CA.5796.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.86377385597274}], ["FLT4", ["TCGA.CA.5796.01", "Sensory perception of sweet, bitter, and umami (glutamate) taste"], {"weight": 0.847962512246445}], ["FLT4", ["TCGA.CA.5796.01", "Presynaptic function of Kainate receptors"], {"weight": 0.86377385597274}], ["FLT4", ["TCGA.D5.6541.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.943593420180727}], ["FLT4", ["TCGA.D5.6541.01", "Collagen chain trimerization"], {"weight": 0.92364449231839}], ["FLT4", ["TCGA.D5.6541.01", "Ethanol oxidation"], {"weight": 0.834298964211687}], ["FLT4", ["TCGA.D5.6541.01", "Diseases associated with O-glycosylation of proteins"], {"weight": 0.809019278821685}], ["FLT4", ["TCGA.F4.6805.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.932613964506198}], ["FLT4", ["TCGA.F4.6805.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.879094568051508}], ["FLT4", ["TCGA.F4.6805.01", "Collagen chain trimerization"], {"weight": 0.903074315735304}], ["KRAS", ["TCGA.A6.5657.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.812087011844522}], ["KRAS", ["TCGA.A6.5664.01", "FGFR4 ligand binding and activation"], {"weight": 0.885547600140141}], ["KRAS", ["TCGA.A6.5664.01", "Phospholipase C-mediated cascade; FGFR4"], {"weight": 0.885547600140141}], ["KRAS", ["TCGA.A6.5664.01", "FGFR2c ligand binding and activation"], {"weight": 0.854805044143447}], ["KRAS", ["TCGA.A6.5666.01", "TNFs bind their physiological receptors"], {"weight": 0.51614910772491}], ["KRAS", ["TCGA.A6.6138.01", "Interaction between L1 and Ankyrins"], {"weight": 0.893291488033006}], ["KRAS", ["TCGA.A6.6650.01", "Interaction between L1 and Ankyrins"], {"weight": 0.937548950140913}], ["KRAS", ["TCGA.A6.6650.01", "Phase 0 - rapid depolarisation"], {"weight": 0.918839570393348}], ["KRAS", ["TCGA.AA.3502.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], {"weight": 0.870686975315498}], ["KRAS", ["TCGA.AA.3502.01", "FGFR1 ligand binding and activation"], {"weight": 0.890834604579343}], ["KRAS", ["TCGA.AA.3655.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.679153924890036}], ["KRAS", ["TCGA.AA.3660.01", "FGFR4 ligand binding and activation"], {"weight": 0.864935813087567}], ["KRAS", ["TCGA.AA.3660.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.744359161994479}], ["KRAS", ["TCGA.AA.3660.01", "Signaling by activated point mutants of FGFR1"], {"weight": 0.80676823101983}], ["KRAS", ["TCGA.AA.3660.01", "Signaling by activated point mutants of FGFR3"], {"weight": 0.80676823101983}], ["KRAS", ["TCGA.AA.3660.01", "FGFR3 mutant receptor activation"], {"weight": 0.80676823101983}], ["KRAS", ["TCGA.AA.3660.01", "FGFR3 ligand binding and activation"], {"weight": 0.80676823101983}], ["KRAS", ["TCGA.AA.3660.01", "FGFR3c ligand binding and activation"], {"weight": 0.80676823101983}], ["KRAS", ["TCGA.AY.5543.01", "Neurexins and neuroligins"], {"weight": 0.930363732543209}], ["KRAS", ["TCGA.AZ.4616.01", "Phase 2 - plateau phase"], {"weight": 0.757114330863971}], ["KRAS", ["TCGA.AZ.5407.01", "Phase 0 - rapid depolarisation"], {"weight": 0.921906041704868}], ["KRAS", ["TCGA.AZ.5407.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.685502766866301}], ["KRAS", ["TCGA.AZ.6599.01", "Erythrocytes take up carbon dioxide and release oxygen"], {"weight": 0.782991592888578}], ["KRAS", ["TCGA.AZ.6599.01", "O2/CO2 exchange in erythrocytes"], {"weight": 0.782991592888578}], ["KRAS", ["TCGA.CA.5796.01", "Phase 0 - rapid depolarisation"], {"weight": 0.911349776830351}], ["KRAS", ["TCGA.CA.6716.01", "Interaction between L1 and Ankyrins"], {"weight": 0.909683108397625}], ["KRAS", ["TCGA.CK.4947.01", "Interaction between L1 and Ankyrins"], {"weight": 0.866147714288928}], ["KRAS", ["TCGA.CM.4744.01", "Interaction between L1 and Ankyrins"], {"weight": 0.958543487032982}], ["KRAS", ["TCGA.CM.6166.01", "Phase 0 - rapid depolarisation"], {"weight": 0.909764120035912}], ["KRAS", ["TCGA.CM.6674.01", "Interaction between L1 and Ankyrins"], {"weight": 0.904169800818773}], ["KRAS", ["TCGA.CM.6678.01", "Interaction between L1 and Ankyrins"], {"weight": 0.911064681751709}], ["KRAS", ["TCGA.D5.5538.01", "Protein-protein interactions at synapses"], {"weight": 0.864013752417456}], ["KRAS", ["TCGA.D5.5538.01", "Neurexins and neuroligins"], {"weight": 0.892996377056926}], ["KRAS", ["TCGA.D5.5538.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.806973982008455}], ["KRAS", ["TCGA.D5.5538.01", "Synaptic adhesion-like molecules"], {"weight": 0.883406995533727}], ["KRAS", ["TCGA.D5.5538.01", "O-linked glycosylation"], {"weight": 0.830599808074822}], ["KRAS", ["TCGA.D5.6529.01", "Interaction between L1 and Ankyrins"], {"weight": 0.88629278229916}], ["KRAS", ["TCGA.D5.6529.01", "Phase 0 - rapid depolarisation"], {"weight": 0.734605306946123}], ["KRAS", ["TCGA.D5.6532.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.827164147769998}], ["KRAS", ["TCGA.D5.6532.01", "Synaptic adhesion-like molecules"], {"weight": 0.913572390565109}], ["KRAS", ["TCGA.D5.6535.01", "Interaction between L1 and Ankyrins"], {"weight": 0.900886622632343}], ["KRAS", ["TCGA.D5.6536.01", "Erythrocytes take up carbon dioxide and release oxygen"], {"weight": 0.733559427249597}], ["KRAS", ["TCGA.D5.6536.01", "O2/CO2 exchange in erythrocytes"], {"weight": 0.733559427249597}], ["KRAS", ["TCGA.D5.6541.01", "Arachidonic acid metabolism"], {"weight": 0.834876313125637}], ["KRAS", ["TCGA.D5.6932.01", "Interaction between L1 and Ankyrins"], {"weight": 0.890279834845416}], ["KRAS", ["TCGA.DM.A1D0.01", "TNFs bind their physiological receptors"], {"weight": 0.51268821146525}], ["KRAS", ["TCGA.DM.A1D0.01", "Synaptic adhesion-like molecules"], {"weight": 0.92495389172142}], ["KRAS", ["TCGA.DM.A1D0.01", "Scavenging of heme from plasma"], {"weight": 0.866738023651244}], ["KRAS", ["TCGA.DM.A1D0.01", "FGFR2 ligand binding and activation"], {"weight": 0.926804725487384}], ["KRAS", ["TCGA.DM.A1D0.01", "Diseases associated with O-glycosylation of proteins"], {"weight": 0.87257786021404}], ["KRAS", ["TCGA.DM.A1D0.01", "Specification of primordial germ cells"], {"weight": 0.631808118022435}], ["KRAS", ["TCGA.DM.A1D4.01", "Scavenging of heme from plasma"], {"weight": 0.868733927691534}], ["KRAS", ["TCGA.DM.A1D6.01", "Erythrocytes take up carbon dioxide and release oxygen"], {"weight": 0.821820578523321}], ["KRAS", ["TCGA.DM.A1D6.01", "O2/CO2 exchange in erythrocytes"], {"weight": 0.821820578523321}], ["KRAS", ["TCGA.DM.A1D6.01", "TNFs bind their physiological receptors"], {"weight": 0.478651766147721}], ["KRAS", ["TCGA.DM.A1D6.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.831072436599855}], ["KRAS", ["TCGA.DM.A1D6.01", "Scavenging of heme from plasma"], {"weight": 0.862709132220815}], ["KRAS", ["TCGA.DM.A1D8.01", "Interaction between L1 and Ankyrins"], {"weight": 0.945863653643354}], ["KRAS", ["TCGA.DM.A1D8.01", "Erythrocytes take up carbon dioxide and release oxygen"], {"weight": 0.792088316193517}], ["KRAS", ["TCGA.DM.A1D8.01", "O2/CO2 exchange in erythrocytes"], {"weight": 0.792088316193517}], ["KRAS", ["TCGA.DM.A1D9.01", "Erythrocytes take up carbon dioxide and release oxygen"], {"weight": 0.818903987222853}], ["KRAS", ["TCGA.DM.A1D9.01", "O2/CO2 exchange in erythrocytes"], {"weight": 0.818903987222853}], ["KRAS", ["TCGA.DM.A1D9.01", "Initial triggering of complement"], {"weight": 0.748305561666762}], ["KRAS", ["TCGA.DM.A1D9.01", "Activation of the phototransduction cascade"], {"weight": 0.805640082542402}], ["KRAS", ["TCGA.DM.A1HA.01", "Sialic acid metabolism"], {"weight": 0.773582637710249}], ["KRAS", ["TCGA.DM.A1HA.01", "Synthesis of substrates in N-glycan biosythesis"], {"weight": 0.770173794113868}], ["KRAS", ["TCGA.DM.A282.01", "TNFs bind their physiological receptors"], {"weight": 0.508722407201703}], ["KRAS", ["TCGA.DM.A282.01", "Interaction between L1 and Ankyrins"], {"weight": 0.929592237926161}], ["KRAS", ["TCGA.DM.A282.01", "Scavenging of heme from plasma"], {"weight": 0.725052747558069}], ["KRAS", ["TCGA.DM.A282.01", "Erythrocytes take up carbon dioxide and release oxygen"], {"weight": 0.805565810800912}], ["KRAS", ["TCGA.DM.A282.01", "O2/CO2 exchange in erythrocytes"], {"weight": 0.805565810800912}], ["KRAS", ["TCGA.DM.A282.01", "FGFR4 ligand binding and activation"], {"weight": 0.869322752246759}], ["KRAS", ["TCGA.DM.A285.01", "Interaction between L1 and Ankyrins"], {"weight": 0.917400311644089}], ["KRAS", ["TCGA.DM.A28G.01", "Phase 0 - rapid depolarisation"], {"weight": 0.921381120622236}], ["KRAS", ["TCGA.DM.A28G.01", "MyD88 deficiency (TLR2/4)"], {"weight": 0.803072950155062}], ["KRAS", ["TCGA.DM.A28G.01", "IRAK4 deficiency (TLR2/4)"], {"weight": 0.803072950155062}], ["KRAS", ["TCGA.DM.A28G.01", "Negative regulation of NMDA receptor-mediated neuronal transmission"], {"weight": 0.873553524803437}], ["KRAS", ["TCGA.DM.A28G.01", "FGFR2 ligand binding and activation"], {"weight": 0.888721840749479}], ["KRAS", ["TCGA.DM.A28K.01", "Interaction between L1 and Ankyrins"], {"weight": 0.951660454686077}], ["KRAS", ["TCGA.DM.A28K.01", "Molecules associated with elastic fibres"], {"weight": 0.785897352599799}], ["KRAS", ["TCGA.DM.A28K.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.825273896600825}], ["KRAS", ["TCGA.DM.A28K.01", "Protein-protein interactions at synapses"], {"weight": 0.916991086256881}], ["KRAS", ["TCGA.DM.A28K.01", "Elastic fibre formation"], {"weight": 0.803805596014905}], ["KRAS", ["TCGA.DM.A28K.01", "TNFs bind their physiological receptors"], {"weight": 0.430850072670763}], ["KRAS", ["TCGA.DM.A28M.01", "Interaction between L1 and Ankyrins"], {"weight": 0.952349591403141}], ["KRAS", ["TCGA.F4.6806.01", "Interaction between L1 and Ankyrins"], {"weight": 0.911227879970088}], ["KRAS", ["TCGA.F4.6806.01", "Scavenging of heme from plasma"], {"weight": 0.504041113409246}], ["KRAS", ["TCGA.F4.6806.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.793988416326884}], ["KRAS", ["TCGA.G4.6294.01", "Interaction between L1 and Ankyrins"], {"weight": 0.932766957024159}], ["KRAS", ["TCGA.G4.6294.01", "Synaptic adhesion-like molecules"], {"weight": 0.896595047915658}], ["KRAS", ["TCGA.G4.6323.01", "Interaction between L1 and Ankyrins"], {"weight": 0.907637001825916}], ["KRAS", ["TCGA.G4.6323.01", "FGFR2 ligand binding and activation"], {"weight": 0.871298742907552}], ["KRAS", ["TCGA.G4.6323.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.787290046570887}], ["KRAS", ["TCGA.G4.6323.01", "Activated point mutants of FGFR2"], {"weight": 0.83902408185689}], ["NCAM1", ["TCGA.A6.4105.01", "Interaction between L1 and Ankyrins"], {"weight": 0.907363234077216}], ["NCAM1", ["TCGA.AZ.5407.01", "Interaction between L1 and Ankyrins"], {"weight": 0.930024363782303}], ["NCAM1", ["TCGA.D5.6535.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.852793203092064}], ["NCAM1", ["TCGA.D5.6931.01", "Interaction between L1 and Ankyrins"], {"weight": 0.884482038200691}], ["SPTB", ["TCGA.A6.5661.01", "Interaction between L1 and Ankyrins"], {"weight": 0.939251466977775}], ["SPTB", ["TCGA.A6.5661.01", "Phase 0 - rapid depolarisation"], {"weight": 0.888872766369921}], ["SPTB", ["TCGA.D5.6541.01", "Phase 4 - resting membrane potential"], {"weight": 0.766736804409508}], ["DOCK4", ["TCGA.AA.3697.01", "Norepinephrine Neurotransmitter Release Cycle"], {"weight": 0.518710061037143}], ["TBXA2R", ["TCGA.A6.6780.01", "GABA receptor activation"], {"weight": 0.917638622022847}], ["TBXA2R", ["TCGA.CK.5916.01", "GABA receptor activation"], {"weight": 0.881425521669243}], ["SOX9", ["TCGA.A6.6652.01", "Voltage gated Potassium channels"], {"weight": 0.921122199547541}], ["SOX9", ["TCGA.AD.6890.01", "Interaction between L1 and Ankyrins"], {"weight": 0.910844469131137}], ["SOX9", ["TCGA.AD.6890.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.894485167307699}], ["SOX9", ["TCGA.AD.6890.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.861239468673}], ["SOX9", ["TCGA.AD.6890.01", "ADORA2B mediated anti-inflammatory cytokines production"], {"weight": 0.884818531252199}], ["SOX9", ["TCGA.AY.6386.01", "Phase 0 - rapid depolarisation"], {"weight": 0.898200525557976}], ["SOX9", ["TCGA.AY.6386.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.733708194642252}], ["SOX9", ["TCGA.CM.4744.01", "Voltage gated Potassium channels"], {"weight": 0.923477581595335}], ["SOX9", ["TCGA.D5.6532.01", "Phase 0 - rapid depolarisation"], {"weight": 0.90713425988999}], ["SOX9", ["TCGA.D5.6532.01", "Voltage gated Potassium channels"], {"weight": 0.912662247805127}], ["SOX9", ["TCGA.D5.6929.01", "Transcriptional regulation of pluripotent stem cells"], {"weight": 0.847355731003591}], ["SOX9", ["TCGA.D5.6929.01", "Potassium Channels"], {"weight": 0.86415686297145}], ["SOX9", ["TCGA.D5.6929.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], {"weight": 0.798752371081612}], ["SOX9", ["TCGA.DM.A28K.01", "Chemokine receptors bind chemokines"], {"weight": 0.930332904565246}], ["SOX9", ["TCGA.G4.6293.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.881816589891211}], ["SOX9", ["TCGA.G4.6293.01", "Phase 0 - rapid depolarisation"], {"weight": 0.851789660011323}], ["SOX9", ["TCGA.G4.6306.01", "Formation of the anterior neural plate"], {"weight": 0.651372682510012}], ["FBN2", ["TCGA.G4.6314.01", "Collagen degradation"], {"weight": 0.859580879050492}], ["FBN2", ["TCGA.G4.6321.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.781834251618156}], ["TNXB", ["TCGA.A6.5656.01", "Blood group systems biosynthesis"], {"weight": 0.775628725070806}], ["TNRC6A", ["TCGA.A6.5656.01", "Glucuronidation"], {"weight": 0.88972646882509}], ["TNRC6A", ["TCGA.A6.5656.01", "Heme degradation"], {"weight": 0.742251015728019}], ["TNRC6A", ["TCGA.AD.6888.01", "Blood group systems biosynthesis"], {"weight": 0.815664831082842}], ["TNRC6A", ["TCGA.AZ.6605.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.162540402115952}], ["TNRC6A", ["TCGA.CK.5914.01", "Blood group systems biosynthesis"], {"weight": 0.792367174126899}], ["TNRC6A", ["TCGA.CK.5914.01", "Lewis blood group biosynthesis"], {"weight": 0.774242446339254}], ["COL5A3", ["TCGA.A6.5656.01", "O-linked glycosylation"], {"weight": 0.903065506732039}], ["COL5A3", ["TCGA.AU.6004.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.936902537115283}], ["COL5A3", ["TCGA.AU.6004.01", "O-linked glycosylation"], {"weight": 0.887909076941867}], ["COL5A3", ["TCGA.D5.6540.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.950580719713551}], ["COL5A3", ["TCGA.F4.6855.01", "Collagen chain trimerization"], {"weight": 0.933464292015039}], ["COL5A3", ["TCGA.F4.6855.01", "O-linked glycosylation"], {"weight": 0.85506787891709}], ["COL5A3", ["TCGA.G4.6297.01", "Scavenging by Class A Receptors"], {"weight": 0.609642175808723}], ["COL5A3", ["TCGA.G4.6297.01", "NCAM1 interactions"], {"weight": 0.892872005025662}], ["COL5A3", ["TCGA.G4.6586.01", "Keratan sulfate biosynthesis"], {"weight": 0.932924810909935}], ["COL5A3", ["TCGA.G4.6586.01", "Keratan sulfate/keratin metabolism"], {"weight": 0.932924810909935}], ["TNXB", ["TCGA.A6.5656.01", "Lewis blood group biosynthesis"], {"weight": 0.752382153583519}], ["TNXB", ["TCGA.A6.5656.01", "Sialic acid metabolism"], {"weight": 0.662613677042659}], ["TNXB", ["TCGA.A6.6142.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.780095520092383}], ["TNXB", ["TCGA.A6.6780.01", "O-linked glycosylation"], {"weight": 0.922745591455008}], ["TNXB", ["TCGA.AA.3662.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.855937727366947}], ["DGKB", ["TCGA.A6.5656.01", "RA biosynthesis pathway"], {"weight": 0.851820268240797}], ["DGKB", ["TCGA.A6.5656.01", "Phase II - Conjugation of compounds"], {"weight": 0.842221449151666}], ["DGKB", ["TCGA.A6.5656.01", "Ethanol oxidation"], {"weight": 0.83764047281575}], ["DGKB", ["TCGA.A6.6138.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.836187630370597}], ["DGKB", ["TCGA.A6.6138.01", "Phase II - Conjugation of compounds"], {"weight": 0.883172948532606}], ["DGKB", ["TCGA.A6.6138.01", "Ethanol oxidation"], {"weight": 0.823558427706501}], ["DGKB", ["TCGA.A6.6138.01", "RA biosynthesis pathway"], {"weight": 0.749393796673184}], ["DGKB", ["TCGA.D5.7000.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.657612478870464}], ["DGKB", ["TCGA.D5.7000.01", "Phase II - Conjugation of compounds"], {"weight": 0.702495048596477}], ["DGKB", ["TCGA.G4.6307.01", "Phase II - Conjugation of compounds"], {"weight": 0.803849568629333}], ["ITPR1", ["TCGA.A6.5656.01", "Phase 4 - resting membrane potential"], {"weight": 0.849686782263915}], ["ITPR1", ["TCGA.D5.6536.01", "Peptide hormone biosynthesis"], {"weight": 0.817417770211809}], ["ITPR1", ["TCGA.F4.6570.01", "Interaction between L1 and Ankyrins"], {"weight": 0.888957613851506}], ["ITPR1", ["TCGA.F4.6703.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.842415758302742}], ["ITPR1", ["TCGA.F4.6703.01", "APAP ADME"], {"weight": 0.851207099964859}], ["ITPR1", ["TCGA.F4.6703.01", "Glucagon-type ligand receptors"], {"weight": 0.90775134143531}], ["RXFP3", ["TCGA.A6.5656.01", "Defective B3GALTL causes PpS"], {"weight": 0.865850791401954}], ["RXFP3", ["TCGA.A6.5656.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.865850791401954}], ["RXFP3", ["TCGA.D5.6538.01", "Activation of the phototransduction cascade"], {"weight": 0.899449297503316}], ["RXFP3", ["TCGA.D5.6538.01", "Initial triggering of complement"], {"weight": 0.841520433052574}], ["EXT1", ["TCGA.A6.5656.01", "TNFs bind their physiological receptors"], {"weight": 0.426936311088736}], ["EXT1", ["TCGA.A6.5656.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.760402863737327}], ["SP100", ["TCGA.A6.5656.01", "TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway"], {"weight": 0.804949576828188}], ["SP100", ["TCGA.CM.5348.01", "Glucuronidation"], {"weight": 0.844300807168533}], ["F8", ["TCGA.A6.5656.01", "Classical antibody-mediated complement activation"], {"weight": 0.681294545692504}], ["F8", ["TCGA.CA.5796.01", "LGI-ADAM interactions"], {"weight": 0.82519918759653}], ["F8", ["TCGA.CA.5796.01", "Biological oxidations"], {"weight": 0.836026012361311}], ["F8", ["TCGA.CA.5796.01", "GABA receptor activation"], {"weight": 0.848079128221643}], ["F8", ["TCGA.CA.5796.01", "O-linked glycosylation"], {"weight": 0.844774564226381}], ["BAX", ["TCGA.A6.5657.01", "Phase II - Conjugation of compounds"], {"weight": 0.89306608300507}], ["BAX", ["TCGA.A6.5657.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.855707066438381}], ["BAX", ["TCGA.A6.5657.01", "Ethanol oxidation"], {"weight": 0.586049314482946}], ["BAX", ["TCGA.A6.5657.01", "Glucuronidation"], {"weight": 0.859010570817213}], ["CTNNA1", ["TCGA.A6.5657.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.816972158590352}], ["TIAM1", ["TCGA.AA.3662.01", "Interaction between L1 and Ankyrins"], {"weight": 0.900974871025386}], ["OCA2", ["TCGA.A6.5657.01", "Collagen chain trimerization"], {"weight": 0.853719333927909}], ["HGF", ["TCGA.A6.5657.01", "Classical antibody-mediated complement activation"], {"weight": 0.567560003905336}], ["HGF", ["TCGA.A6.5657.01", "Defective GALNT12 causes CRCS1"], {"weight": 0.737045275767834}], ["HGF", ["TCGA.G4.6295.01", "Blood group systems biosynthesis"], {"weight": 0.8750400842525}], ["HGF", ["TCGA.G4.6295.01", "Lewis blood group biosynthesis"], {"weight": 0.867751195677336}], ["TLN1", ["TCGA.F4.6806.01", "Common Pathway of Fibrin Clot Formation"], {"weight": 0.922727157937842}], ["OCA2", ["TCGA.A6.5657.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.906676541079097}], ["PLCB3", ["TCGA.A6.5659.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.69918447067541}], ["MYC", ["TCGA.A6.5659.01", "Ethanol oxidation"], {"weight": 0.78328194585199}], ["MYC", ["TCGA.A6.5659.01", "RA biosynthesis pathway"], {"weight": 0.734810051519819}], ["MYC", ["TCGA.A6.6781.01", "Scavenging by Class A Receptors"], {"weight": 0.727662742827646}], ["EP300", ["TCGA.A6.5659.01", "APAP ADME"], {"weight": 0.719128553886336}], ["EP300", ["TCGA.A6.5659.01", "Phase II - Conjugation of compounds"], {"weight": 0.751973879593081}], ["EP300", ["TCGA.CA.5796.01", "Carnitine metabolism"], {"weight": 0.663935499633098}], ["EP300", ["TCGA.CA.5796.01", "Glycosaminoglycan metabolism"], {"weight": 0.718144048086673}], ["EP300", ["TCGA.CA.5796.01", "Aspartate and asparagine metabolism"], {"weight": 0.627211500051877}], ["EP300", ["TCGA.D5.6931.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.890664642490149}], ["EP300", ["TCGA.G4.6322.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.929602287055504}], ["SMARCE1", ["TCGA.A6.5659.01", "Heme degradation"], {"weight": 0.678894731577157}], ["CHUK", ["TCGA.CM.6677.01", "Phase II - Conjugation of compounds"], {"weight": 0.799327703130105}], ["OR5D18", ["TCGA.A6.5659.01", "Glucagon-type ligand receptors"], {"weight": 0.896121545307612}], ["OR5H15", ["TCGA.A6.5659.01", "Inwardly rectifying K+ channels"], {"weight": 0.90005454593984}], ["OR5H15", ["TCGA.CM.5861.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.940967776740116}], ["OR5H15", ["TCGA.F4.6569.01", "Activation of G protein gated Potassium channels"], {"weight": 0.888729337384916}], ["OR5H15", ["TCGA.F4.6569.01", "G protein gated Potassium channels"], {"weight": 0.888729337384916}], ["OR5H15", ["TCGA.F4.6569.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.888729337384916}], ["OR5H15", ["TCGA.F4.6569.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.883344568010086}], ["OR5H15", ["TCGA.F4.6569.01", "G beta:gamma signalling through BTK"], {"weight": 0.842452580119097}], ["OR5H15", ["TCGA.F4.6569.01", "Prostacyclin signalling through prostacyclin receptor"], {"weight": 0.842452580119097}], ["OR10J5", ["TCGA.A6.5659.01", "G beta:gamma signalling through BTK"], {"weight": 0.893492948466469}], ["OR10J5", ["TCGA.A6.5659.01", "Phase 4 - resting membrane potential"], {"weight": 0.760344937724515}], ["OR10J5", ["TCGA.A6.5659.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.879167733169629}], ["OR10J5", ["TCGA.A6.5659.01", "Activation of G protein gated Potassium channels"], {"weight": 0.887702341952425}], ["OR10J5", ["TCGA.A6.5659.01", "G protein gated Potassium channels"], {"weight": 0.887702341952425}], ["OR10J5", ["TCGA.A6.5659.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.887702341952425}], ["OR5D18", ["TCGA.A6.5659.01", "Presynaptic function of Kainate receptors"], {"weight": 0.876669319366368}], ["OR5D18", ["TCGA.AD.6901.01", "Presynaptic function of Kainate receptors"], {"weight": 0.879159454455647}], ["OR5D18", ["TCGA.AD.6901.01", "Glucagon-type ligand receptors"], {"weight": 0.900991182491264}], ["OR5D18", ["TCGA.AD.6901.01", "Prostacyclin signalling through prostacyclin receptor"], {"weight": 0.864097174899574}], ["OR5D18", ["TCGA.AD.6901.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.864097174899574}], ["OR5D18", ["TCGA.F4.6704.01", "Peptide hormone biosynthesis"], {"weight": 0.623953277639085}], ["OR5D18", ["TCGA.F4.6704.01", "ERBB2 Activates PTK6 Signaling"], {"weight": 0.785241449149956}], ["OR5D18", ["TCGA.F4.6704.01", "Presynaptic function of Kainate receptors"], {"weight": 0.862000785263456}], ["OR5D18", ["TCGA.F4.6704.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], {"weight": 0.688944236705116}], ["OR5D18", ["TCGA.G4.6299.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.895694126090053}], ["SCN5A", ["TCGA.A6.5659.01", "Phase 0 - rapid depolarisation"], {"weight": 0.874210954319716}], ["SCN5A", ["TCGA.AY.5543.01", "Phase 0 - rapid depolarisation"], {"weight": 0.939040329249239}], ["SCN5A", ["TCGA.AY.5543.01", "Interaction between L1 and Ankyrins"], {"weight": 0.941493553472772}], ["SCN5A", ["TCGA.CK.5916.01", "Phase 0 - rapid depolarisation"], {"weight": 0.919304761493185}], ["SCN5A", ["TCGA.CM.6170.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.717610481063265}], ["SCN5A", ["TCGA.CM.6170.01", "Interaction between L1 and Ankyrins"], {"weight": 0.884327055317443}], ["SCN5A", ["TCGA.F4.6856.01", "Interaction between L1 and Ankyrins"], {"weight": 0.937523401530293}], ["SCN5A", ["TCGA.F4.6856.01", "Phase 0 - rapid depolarisation"], {"weight": 0.930638714355245}], ["CACNA2D3", ["TCGA.CM.5863.01", "LGI-ADAM interactions"], {"weight": 0.670488312779931}], ["CACNA2D3", ["TCGA.G4.6588.01", "Phase 0 - rapid depolarisation"], {"weight": 0.939079566363982}], ["PPP2R2B", ["TCGA.AD.6889.01", "LGI-ADAM interactions"], {"weight": 0.910935032384556}], ["RGS20", ["TCGA.G4.6588.01", "GABA receptor activation"], {"weight": 0.926074305397573}], ["RGS20", ["TCGA.G4.6588.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.94118356917185}], ["RGS20", ["TCGA.G4.6588.01", "GABA B receptor activation"], {"weight": 0.930640381462554}], ["RGS20", ["TCGA.G4.6588.01", "Activation of GABAB receptors"], {"weight": 0.930640381462554}], ["RGS20", ["TCGA.G4.6588.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.915987776211569}], ["DLG2", ["TCGA.AA.3492.01", "Neurexins and neuroligins"], {"weight": 0.93057738711573}], ["DLG2", ["TCGA.AM.5820.01", "Neurexins and neuroligins"], {"weight": 0.904739360214572}], ["NRXN2", ["TCGA.A6.6650.01", "Neurexins and neuroligins"], {"weight": 0.936099266796513}], ["NRXN2", ["TCGA.AY.6197.01", "Neurexins and neuroligins"], {"weight": 0.940619857283752}], ["CCDC129", ["TCGA.DM.A285.01", "Collagen chain trimerization"], {"weight": 0.872107939929378}], ["MME", ["TCGA.D5.6532.01", "Initial triggering of complement"], {"weight": 0.80476912253537}], ["KCNQ2", ["TCGA.A6.5660.01", "Voltage gated Potassium channels"], {"weight": 0.891940450690269}], ["PLCB1", ["TCGA.D5.6535.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.811991021886447}], ["PLCB1", ["TCGA.D5.6535.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.854522564714917}], ["PLCB1", ["TCGA.D5.6535.01", "Presynaptic function of Kainate receptors"], {"weight": 0.854505166754028}], ["EPHB1", ["TCGA.G4.6307.01", "Voltage gated Potassium channels"], {"weight": 0.904387686553846}], ["KCNQ2", ["TCGA.A6.5660.01", "Interaction between L1 and Ankyrins"], {"weight": 0.919981264184331}], ["KCNQ2", ["TCGA.AA.3492.01", "Phase 4 - resting membrane potential"], {"weight": 0.880533598372278}], ["KCNQ2", ["TCGA.AA.3492.01", "Voltage gated Potassium channels"], {"weight": 0.900648433345997}], ["KCNQ2", ["TCGA.AU.6004.01", "Interaction between L1 and Ankyrins"], {"weight": 0.916030618396696}], ["KCNQ2", ["TCGA.AU.6004.01", "Potassium Channels"], {"weight": 0.945733234163135}], ["KCNQ2", ["TCGA.AU.6004.01", "Phase 4 - resting membrane potential"], {"weight": 0.844150013080117}], ["KCNQ2", ["TCGA.AY.6197.01", "Phase 4 - resting membrane potential"], {"weight": 0.883718176059804}], ["KCNQ2", ["TCGA.AZ.4615.01", "Potassium Channels"], {"weight": 0.959348575990083}], ["KCNQ2", ["TCGA.CM.5861.01", "Interaction between L1 and Ankyrins"], {"weight": 0.946358862536506}], ["GRIA4", ["TCGA.AA.3511.01", "Voltage gated Potassium channels"], {"weight": 0.765992725821641}], ["GRIA4", ["TCGA.AA.3511.01", "Phase 0 - rapid depolarisation"], {"weight": 0.776956819539173}], ["GRIA4", ["TCGA.CM.5348.01", "LGI-ADAM interactions"], {"weight": 0.806823414539171}], ["GRIA4", ["TCGA.CM.6675.01", "Voltage gated Potassium channels"], {"weight": 0.9134360809124}], ["GRIA4", ["TCGA.CM.6675.01", "Phase 0 - rapid depolarisation"], {"weight": 0.93543516483486}], ["GRIA4", ["TCGA.CM.6675.01", "Interaction between L1 and Ankyrins"], {"weight": 0.912695501649466}], ["GRIA4", ["TCGA.CM.6675.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.900725655225188}], ["GRIA4", ["TCGA.CM.6675.01", "Nicotinate metabolism"], {"weight": 0.747949482328456}], ["GRIA4", ["TCGA.CM.6675.01", "LGI-ADAM interactions"], {"weight": 0.901236194467004}], ["CACNA1B", ["TCGA.D5.5541.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.918220743291924}], ["CACNA1B", ["TCGA.D5.5541.01", "GABA receptor activation"], {"weight": 0.653356315399844}], ["CACNA1B", ["TCGA.D5.5541.01", "Sensory perception of taste"], {"weight": 0.871807765388719}], ["CACNA1B", ["TCGA.D5.5541.01", "Glucagon-type ligand receptors"], {"weight": 0.905833373427736}], ["CACNA1B", ["TCGA.D5.5541.01", "GABA B receptor activation"], {"weight": 0.916817176552203}], ["CACNA1B", ["TCGA.D5.5541.01", "Activation of GABAB receptors"], {"weight": 0.916817176552203}], ["CACNA1B", ["TCGA.D5.5541.01", "Presynaptic function of Kainate receptors"], {"weight": 0.88708958861366}], ["CACNA1B", ["TCGA.D5.5541.01", "Activation of G protein gated Potassium channels"], {"weight": 0.910148035749492}], ["CACNA1B", ["TCGA.D5.5541.01", "G protein gated Potassium channels"], {"weight": 0.910148035749492}], ["CACNA1B", ["TCGA.D5.5541.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.910148035749492}], ["CACNA1B", ["TCGA.D5.5541.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.883065985941828}], ["CACNA1B", ["TCGA.DM.A1D6.01", "Glucagon-type ligand receptors"], {"weight": 0.943049696883349}], ["CACNA1B", ["TCGA.DM.A1D6.01", "Presynaptic function of Kainate receptors"], {"weight": 0.920357126555351}], ["CACNA1B", ["TCGA.DM.A1D6.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.915473765056807}], ["CACNA1B", ["TCGA.DM.A1D6.01", "G-protein activation"], {"weight": 0.940732463057914}], ["CACNA1B", ["TCGA.DM.A1D6.01", "Inwardly rectifying K+ channels"], {"weight": 0.935460113094146}], ["CACNA1B", ["TCGA.DM.A1D6.01", "Activation of G protein gated Potassium channels"], {"weight": 0.93057653185873}], ["CACNA1B", ["TCGA.DM.A1D6.01", "G protein gated Potassium channels"], {"weight": 0.93057653185873}], ["CACNA1B", ["TCGA.DM.A1D6.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.93057653185873}], ["CACNA1B", ["TCGA.DM.A1D6.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.920497466347242}], ["CACNA1B", ["TCGA.DM.A1D6.01", "Prostacyclin signalling through prostacyclin receptor"], {"weight": 0.91118518967854}], ["CACNA1B", ["TCGA.DM.A1D6.01", "GABA B receptor activation"], {"weight": 0.935457747105672}], ["CACNA1B", ["TCGA.DM.A1D6.01", "Activation of GABAB receptors"], {"weight": 0.935457747105672}], ["CACNA1B", ["TCGA.DM.A1D6.01", "Activation of the phototransduction cascade"], {"weight": 0.915688225048624}], ["CACNA1B", ["TCGA.DM.A1D6.01", "LGI-ADAM interactions"], {"weight": 0.881016964451781}], ["CACNA1B", ["TCGA.DM.A1D6.01", "Sensory perception of taste"], {"weight": 0.928100408308304}], ["CACNA1B", ["TCGA.DM.A1D6.01", "Sensory perception of sweet, bitter, and umami (glutamate) taste"], {"weight": 0.917922768589267}], ["CACNA1B", ["TCGA.DM.A1D8.01", "Sensory perception of taste"], {"weight": 0.92002337978023}], ["CACNA1B", ["TCGA.DM.A1D8.01", "Sensory perception of sweet, bitter, and umami (glutamate) taste"], {"weight": 0.909191183101425}], ["CACNA1B", ["TCGA.G4.6293.01", "Phase 4 - resting membrane potential"], {"weight": 0.806750730536584}], ["NGFR", ["TCGA.A6.5660.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.589068365513069}], ["A2M", ["TCGA.A6.5660.01", "Collagen chain trimerization"], {"weight": 0.851833315382619}], ["A2M", ["TCGA.AA.3502.01", "Defective B3GALTL causes PpS"], {"weight": 0.916260852770186}], ["A2M", ["TCGA.AA.3502.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.916260852770186}], ["A2M", ["TCGA.AA.3502.01", "O-linked glycosylation"], {"weight": 0.856543116545506}], ["A2M", ["TCGA.AA.3502.01", "Bile acid and bile salt metabolism"], {"weight": 0.63737229070547}], ["A2M", ["TCGA.AA.3502.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.910791954294813}], ["A2M", ["TCGA.G4.6299.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.900903126098787}], ["COL11A1", ["TCGA.CM.5860.01", "Defective B3GALTL causes PpS"], {"weight": 0.885466520264083}], ["COL11A1", ["TCGA.CM.5860.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.885466520264083}], ["COL11A1", ["TCGA.CM.5860.01", "Diseases associated with O-glycosylation of proteins"], {"weight": 0.602163736369873}], ["COL11A1", ["TCGA.D5.6924.01", "O-linked glycosylation of mucins"], {"weight": 0.869789814059602}], ["COL11A1", ["TCGA.D5.6924.01", "O-linked glycosylation"], {"weight": 0.891774901856281}], ["COL11A1", ["TCGA.G4.6304.01", "Keratan sulfate biosynthesis"], {"weight": 0.935231439373854}], ["COL11A1", ["TCGA.G4.6304.01", "Keratan sulfate/keratin metabolism"], {"weight": 0.935231439373854}], ["COL11A1", ["TCGA.G4.6304.01", "O-linked glycosylation"], {"weight": 0.927381922446385}], ["TFAP2B", ["TCGA.A6.6649.01", "Peptide hormone biosynthesis"], {"weight": 0.565757068065542}], ["SERPINE1", ["TCGA.A6.5661.01", "Diseases of metabolism"], {"weight": 0.706262504924314}], ["VWF", ["TCGA.D5.6534.01", "Other semaphorin interactions"], {"weight": 0.375525890443669}], ["VWF", ["TCGA.G4.6586.01", "Antimicrobial peptides"], {"weight": 0.699359192630963}], ["AKT1", ["TCGA.A6.5661.01", "Phase II - Conjugation of compounds"], {"weight": 0.715226766501678}], ["AKT1", ["TCGA.CM.6166.01", "TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway"], {"weight": 0.867142256840415}], ["AKT1", ["TCGA.D5.5537.01", "Ethanol oxidation"], {"weight": 0.746440505524798}], ["AKT1", ["TCGA.D5.5537.01", "RA biosynthesis pathway"], {"weight": 0.796557633486437}], ["AKT1", ["TCGA.D5.5537.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.78724421597341}], ["CTNNB1", ["TCGA.CM.6675.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.816328191084344}], ["CTNNB1", ["TCGA.D5.6541.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], {"weight": 0.455914639522364}], ["CTNNB1", ["TCGA.DM.A1D4.01", "Synthesis of bile acids and bile salts via 27-hydroxycholesterol"], {"weight": 0.727960741310274}], ["STAT1", ["TCGA.CM.4743.01", "Phase 0 - rapid depolarisation"], {"weight": 0.933272326936787}], ["PRKCB", ["TCGA.D5.6932.01", "Potassium Channels"], {"weight": 0.866575537678216}], ["PIK3CD", ["TCGA.G4.6304.01", "CD22 mediated BCR regulation"], {"weight": 0.884811780949319}], ["MCHR2", ["TCGA.A6.6652.01", "Complement cascade"], {"weight": 0.865119530209341}], ["MCHR2", ["TCGA.A6.6652.01", "Regulation of Complement cascade"], {"weight": 0.810693614501491}], ["MCHR2", ["TCGA.A6.6652.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.941431463056667}], ["MAPK10", ["TCGA.A6.5661.01", "Potassium Channels"], {"weight": 0.952106316298948}], ["MAPK10", ["TCGA.A6.5661.01", "Glucagon-type ligand receptors"], {"weight": 0.915751245045735}], ["MAPK10", ["TCGA.AA.3713.01", "Potassium Channels"], {"weight": 0.930953665831309}], ["MAPK10", ["TCGA.AD.6888.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.829443823338871}], ["MAP2K1", ["TCGA.A6.5661.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.803050831130023}], ["ACTN4", ["TCGA.CM.6162.01", "Antimicrobial peptides"], {"weight": 0.380058267841295}], ["RRAS", ["TCGA.A6.5661.01", "Diseases of glycosylation"], {"weight": 0.799640489974039}], ["RRAS", ["TCGA.A6.5661.01", "Defective B3GALTL causes PpS"], {"weight": 0.835686412147658}], ["RRAS", ["TCGA.A6.5661.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.835686412147658}], ["CDH2", ["TCGA.CM.4752.01", "Ethanol oxidation"], {"weight": 0.585341101876168}], ["CDH2", ["TCGA.D5.6931.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.471775497728477}], ["CLTC", ["TCGA.AD.6895.01", "Voltage gated Potassium channels"], {"weight": 0.886501570072867}], ["SLC9A1", ["TCGA.CM.6162.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], {"weight": 0.722337754315832}], ["SLC9A1", ["TCGA.CM.6674.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], {"weight": 0.854221092401098}], ["GRM7", ["TCGA.G4.6293.01", "Common Pathway of Fibrin Clot Formation"], {"weight": 0.909477477310559}], ["GRM4", ["TCGA.DM.A1D4.01", "Defective B3GALTL causes PpS"], {"weight": 0.891112698008898}], ["GRM4", ["TCGA.DM.A1D4.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.891112698008898}], ["TEK", ["TCGA.DM.A1D4.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.890685832698744}], ["TEK", ["TCGA.DM.A1D4.01", "Collagen chain trimerization"], {"weight": 0.846669237117512}], ["BRAF", ["TCGA.DM.A1DA.01", "Phase 0 - rapid depolarisation"], {"weight": 0.945581376498031}], ["BRAF", ["TCGA.DM.A28C.01", "Arachidonic acid metabolism"], {"weight": 0.918434406469898}], ["BRAF", ["TCGA.DM.A28C.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.877236362374882}], ["BRAF", ["TCGA.DM.A28C.01", "Ion transport by P-type ATPases"], {"weight": 0.862566892730931}], ["BRAF", ["TCGA.DM.A28C.01", "Biosynthesis of DHA-derived SPMs"], {"weight": 0.84813684453973}], ["RELN", ["TCGA.A6.5661.01", "Synaptic adhesion-like molecules"], {"weight": 0.903273234011044}], ["RELN", ["TCGA.CM.6675.01", "Protein-protein interactions at synapses"], {"weight": 0.921964087330101}], ["RELN", ["TCGA.CM.6675.01", "CD22 mediated BCR regulation"], {"weight": 0.781105244045033}], ["RELN", ["TCGA.CM.6675.01", "Synaptic adhesion-like molecules"], {"weight": 0.818598284818569}], ["RELN", ["TCGA.D5.6541.01", "Defective B3GALTL causes PpS"], {"weight": 0.860633006935343}], ["RELN", ["TCGA.D5.6541.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.860633006935343}], ["RELN", ["TCGA.D5.6541.01", "O-linked glycosylation"], {"weight": 0.884332253358768}], ["RELN", ["TCGA.D5.6541.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.844555457452811}], ["AKAP9", ["TCGA.A6.6140.01", "Phase 0 - rapid depolarisation"], {"weight": 0.91898033380711}], ["AKAP9", ["TCGA.A6.6140.01", "Neurexins and neuroligins"], {"weight": 0.921102886309028}], ["AKAP9", ["TCGA.A6.6140.01", "Ion transport by P-type ATPases"], {"weight": 0.813057076712032}], ["AKAP9", ["TCGA.A6.6142.01", "Phase 2 - plateau phase"], {"weight": 0.795915163999571}], ["AKAP9", ["TCGA.F4.6570.01", "Phase 2 - plateau phase"], {"weight": 0.762479836820047}], ["ELMO1", ["TCGA.AD.6548.01", "WNT ligand biogenesis and trafficking"], {"weight": 0.774458730320661}], ["ELMO1", ["TCGA.CK.4952.01", "CD22 mediated BCR regulation"], {"weight": 0.87647240483464}], ["ELMO1", ["TCGA.DM.A1D0.01", "Potassium Channels"], {"weight": 0.954060698340312}], ["ELMO1", ["TCGA.DM.A1D0.01", "Defective B3GALTL causes PpS"], {"weight": 0.884202917219275}], ["ELMO1", ["TCGA.DM.A1D0.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.884202917219275}], ["ELMO1", ["TCGA.DM.A1D0.01", "CD22 mediated BCR regulation"], {"weight": 0.830856961187371}], ["ELMO1", ["TCGA.DM.A1D0.01", "Norepinephrine Neurotransmitter Release Cycle"], {"weight": 0.747671553414793}], ["ELMO1", ["TCGA.DM.A1D0.01", "Acetylcholine Neurotransmitter Release Cycle"], {"weight": 0.690610731540927}], ["ELMO1", ["TCGA.DM.A1D0.01", "Glucagon-type ligand receptors"], {"weight": 0.914366983726831}], ["ELMO1", ["TCGA.DM.A1D0.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.859395929534899}], ["ELMO1", ["TCGA.DM.A1D0.01", "Inwardly rectifying K+ channels"], {"weight": 0.893126831870535}], ["ELMO1", ["TCGA.DM.A1D0.01", "Serotonin Neurotransmitter Release Cycle"], {"weight": 0.841857633615766}], ["ELMO1", ["TCGA.DM.A1D0.01", "Presynaptic function of Kainate receptors"], {"weight": 0.860878705623999}], ["ICAM1", ["TCGA.AA.3502.01", "Synthesis of bile acids and bile salts"], {"weight": 0.58911137920617}], ["OCRL", ["TCGA.F4.6807.01", "Cobalamin (Cbl, vitamin B12) transport and metabolism"], {"weight": 0.702999566876174}], ["AR", ["TCGA.A6.5661.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.927400617332978}], ["AR", ["TCGA.A6.5661.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.728818318098965}], ["AR", ["TCGA.A6.5661.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.906466601065904}], ["AR", ["TCGA.A6.5667.01", "Inwardly rectifying K+ channels"], {"weight": 0.899268362899883}], ["AR", ["TCGA.A6.5667.01", "Activation of G protein gated Potassium channels"], {"weight": 0.890391950382258}], ["AR", ["TCGA.A6.5667.01", "G protein gated Potassium channels"], {"weight": 0.890391950382258}], ["AR", ["TCGA.A6.5667.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.890391950382258}], ["AR", ["TCGA.A6.5667.01", "GABA receptor activation"], {"weight": 0.824448310798349}], ["AR", ["TCGA.A6.5667.01", "GABA B receptor activation"], {"weight": 0.892112849780592}], ["AR", ["TCGA.A6.5667.01", "Activation of GABAB receptors"], {"weight": 0.892112849780592}], ["AR", ["TCGA.A6.6650.01", "Ethanol oxidation"], {"weight": 0.783571841660764}], ["AR", ["TCGA.AA.3697.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.891944716410984}], ["AR", ["TCGA.AA.3697.01", "GABA B receptor activation"], {"weight": 0.897846317911832}], ["AR", ["TCGA.AA.3697.01", "Activation of GABAB receptors"], {"weight": 0.897846317911832}], ["AR", ["TCGA.AD.6965.01", "Phase 4 - resting membrane potential"], {"weight": 0.782149681480799}], ["AR", ["TCGA.D5.6537.01", "Potassium Channels"], {"weight": 0.960545972986323}], ["AR", ["TCGA.D5.6537.01", "GABA receptor activation"], {"weight": 0.906479283300516}], ["AR", ["TCGA.D5.6537.01", "GABA B receptor activation"], {"weight": 0.933454212064421}], ["AR", ["TCGA.D5.6537.01", "Activation of GABAB receptors"], {"weight": 0.933454212064421}], ["AR", ["TCGA.D5.6537.01", "Inwardly rectifying K+ channels"], {"weight": 0.929376073781691}], ["AR", ["TCGA.D5.6537.01", "Adenylate cyclase inhibitory pathway"], {"weight": 0.902841397044377}], ["AR", ["TCGA.D5.6537.01", "Activation of G protein gated Potassium channels"], {"weight": 0.920370001202518}], ["AR", ["TCGA.D5.6537.01", "G protein gated Potassium channels"], {"weight": 0.920370001202518}], ["AR", ["TCGA.D5.6537.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.920370001202518}], ["AR", ["TCGA.D5.6538.01", "Inwardly rectifying K+ channels"], {"weight": 0.927940086153379}], ["AR", ["TCGA.D5.6538.01", "Activation of G protein gated Potassium channels"], {"weight": 0.922004343135826}], ["AR", ["TCGA.D5.6538.01", "G protein gated Potassium channels"], {"weight": 0.922004343135826}], ["AR", ["TCGA.D5.6538.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.922004343135826}], ["AR", ["TCGA.DM.A0X9.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.762215925477702}], ["AR", ["TCGA.DM.A1DB.01", "Phase II - Conjugation of compounds"], {"weight": 0.762544971129805}], ["AR", ["TCGA.G4.6306.01", "Potassium Channels"], {"weight": 0.950490179809554}], ["AR", ["TCGA.G4.6306.01", "Nicotinate metabolism"], {"weight": 0.764906664442506}], ["AR", ["TCGA.G4.6306.01", "G beta:gamma signalling through BTK"], {"weight": 0.894666564875903}], ["AR", ["TCGA.G4.6306.01", "Activation of G protein gated Potassium channels"], {"weight": 0.900705714101397}], ["AR", ["TCGA.G4.6306.01", "G protein gated Potassium channels"], {"weight": 0.900705714101397}], ["AR", ["TCGA.G4.6306.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.900705714101397}], ["AR", ["TCGA.G4.6306.01", "Thromboxane signalling through TP receptor"], {"weight": 0.889881458797709}], ["AR", ["TCGA.G4.6306.01", "Glucagon-type ligand receptors"], {"weight": 0.924627231407222}], ["AR", ["TCGA.G4.6314.01", "Formation of axial mesoderm"], {"weight": 0.713616550497541}], ["AR", ["TCGA.G4.6314.01", "Peptide hormone biosynthesis"], {"weight": 0.666762836932148}], ["SPTBN2", ["TCGA.AA.3662.01", "Phase 0 - rapid depolarisation"], {"weight": 0.872896756761718}], ["SPTBN2", ["TCGA.AA.3712.01", "GABA receptor activation"], {"weight": 0.864679137301316}], ["SPTBN2", ["TCGA.AA.3712.01", "Phase 0 - rapid depolarisation"], {"weight": 0.86747317241043}], ["SPTBN2", ["TCGA.CM.5868.01", "GABA receptor activation"], {"weight": 0.859768830131445}], ["EPHA2", ["TCGA.DM.A1DA.01", "FGFR2 ligand binding and activation"], {"weight": 0.937684861308694}], ["EPHA2", ["TCGA.DM.A1DA.01", "Signaling by activated point mutants of FGFR1"], {"weight": 0.913761360844007}], ["EPHA2", ["TCGA.DM.A1DA.01", "FGFR1 ligand binding and activation"], {"weight": 0.941457866139081}], ["EPHA2", ["TCGA.DM.A1DA.01", "Activated point mutants of FGFR2"], {"weight": 0.922716342481369}], ["EPHA2", ["TCGA.DM.A1DA.01", "FGFR1c ligand binding and activation"], {"weight": 0.933203477391865}], ["EPHA2", ["TCGA.DM.A1DA.01", "FGFR2c ligand binding and activation"], {"weight": 0.915941634314974}], ["EPHA2", ["TCGA.DM.A1DA.01", "FGFR4 ligand binding and activation"], {"weight": 0.910287959859082}], ["EPHA2", ["TCGA.DM.A1DA.01", "Signaling by activated point mutants of FGFR3"], {"weight": 0.909621033209215}], ["EPHA2", ["TCGA.DM.A1DA.01", "FGFR3 mutant receptor activation"], {"weight": 0.909621033209215}], ["EPHA2", ["TCGA.DM.A1DA.01", "FGFR3 ligand binding and activation"], {"weight": 0.909621033209215}], ["EPHA2", ["TCGA.DM.A1DA.01", "FGFR3c ligand binding and activation"], {"weight": 0.909621033209215}], ["PLXNA4", ["TCGA.A6.5661.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.815128105030457}], ["PLXNA4", ["TCGA.AD.6964.01", "Other semaphorin interactions"], {"weight": 0.723899164199369}], ["NRG1", ["TCGA.A6.6138.01", "IL-6-type cytokine receptor ligand interactions"], {"weight": 0.833565163557757}], ["NRG1", ["TCGA.DM.A282.01", "Arachidonic acid metabolism"], {"weight": 0.857143940067962}], ["FLNB", ["TCGA.D5.6920.01", "Cardiac conduction"], {"weight": 0.903620004761768}], ["FLNB", ["TCGA.D5.6920.01", "Unblocking of NMDA receptors, glutamate binding and activation"], {"weight": 0.825463308377325}], ["FLNB", ["TCGA.D5.6920.01", "Phase 0 - rapid depolarisation"], {"weight": 0.777141160313862}], ["FLNB", ["TCGA.D5.6920.01", "Long-term potentiation"], {"weight": 0.834185658488961}], ["FLNB", ["TCGA.D5.6920.01", "Assembly and cell surface presentation of NMDA receptors"], {"weight": 0.7221702535067}], ["DYNC2H1", ["TCGA.F4.6569.01", "Defective GALNT12 causes CRCS1"], {"weight": 0.819945487948956}], ["NLK", ["TCGA.A6.5661.01", "GABA receptor activation"], {"weight": 0.87731166411057}], ["NLK", ["TCGA.AZ.4615.01", "GABA receptor activation"], {"weight": 0.903726653071536}], ["NLK", ["TCGA.F4.6805.01", "Glucuronidation"], {"weight": 0.606049326119457}], ["NLK", ["TCGA.F4.6805.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.218109512778641}], ["TNRC6B", ["TCGA.AD.6901.01", "Glucuronidation"], {"weight": 0.850918459289514}], ["TNRC6B", ["TCGA.AD.6901.01", "Phase II - Conjugation of compounds"], {"weight": 0.843530826732827}], ["TNRC6B", ["TCGA.CA.6716.01", "CD22 mediated BCR regulation"], {"weight": 0.742058957690944}], ["TNRC6B", ["TCGA.CA.6716.01", "Heme degradation"], {"weight": 0.709465744571954}], ["TNRC6B", ["TCGA.D5.6924.01", "Blood group systems biosynthesis"], {"weight": 0.464975694455757}], ["TNRC6B", ["TCGA.D5.6924.01", "Lewis blood group biosynthesis"], {"weight": 0.386419397425981}], ["TSG101", ["TCGA.A6.5661.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.608805767461262}], ["CTNND1", ["TCGA.A6.5661.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.910476476899181}], ["CTNND1", ["TCGA.AA.3655.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.890815181678485}], ["NCOA2", ["TCGA.A6.5661.01", "Arachidonic acid metabolism"], {"weight": 0.897882637854555}], ["NCOA2", ["TCGA.A6.5662.01", "Glucuronidation"], {"weight": 0.927709141135418}], ["NCOA2", ["TCGA.A6.5662.01", "Phase II - Conjugation of compounds"], {"weight": 0.861455307671277}], ["NCOA2", ["TCGA.A6.5662.01", "Phase I - Functionalization of compounds"], {"weight": 0.953892040090649}], ["NCOA2", ["TCGA.A6.5662.01", "Aspirin ADME"], {"weight": 0.876151230665105}], ["NCOA2", ["TCGA.A6.5662.01", "Ethanol oxidation"], {"weight": 0.8721766895377}], ["NCOA2", ["TCGA.A6.5662.01", "Signaling by Retinoic Acid"], {"weight": 0.793047668365324}], ["NCOA2", ["TCGA.A6.5662.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.818413839595972}], ["NCOA2", ["TCGA.A6.5662.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.831411446136057}], ["NCOA2", ["TCGA.A6.5662.01", "Defensins"], {"weight": 0.404117040766187}], ["NCOA2", ["TCGA.A6.5662.01", "Scavenging of heme from plasma"], {"weight": 0.528026593102018}], ["NCOA2", ["TCGA.A6.5662.01", "RA biosynthesis pathway"], {"weight": 0.825461858959054}], ["NCOA2", ["TCGA.D5.5541.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.813746592453748}], ["NCOA2", ["TCGA.D5.5541.01", "RA biosynthesis pathway"], {"weight": 0.851226751967284}], ["NCOA2", ["TCGA.D5.5541.01", "Phase II - Conjugation of compounds"], {"weight": 0.82518777216626}], ["NCOA2", ["TCGA.D5.5541.01", "Ethanol oxidation"], {"weight": 0.8105239203711}], ["NCOA2", ["TCGA.D5.5541.01", "Signaling by Retinoic Acid"], {"weight": 0.792939229248725}], ["NCOA2", ["TCGA.D5.5541.01", "Glucuronidation"], {"weight": 0.8428792622513}], ["NCOA2", ["TCGA.D5.5541.01", "Aspirin ADME"], {"weight": 0.919655479678314}], ["NCOA2", ["TCGA.G4.6303.01", "Glucuronidation"], {"weight": 0.913735352567044}], ["NCOA2", ["TCGA.G4.6588.01", "Signaling by Retinoic Acid"], {"weight": 0.837045130206942}], ["GP9", ["TCGA.A6.5661.01", "Collagen chain trimerization"], {"weight": 0.837410342663356}], ["RB1", ["TCGA.A6.5662.01", "TNFs bind their physiological receptors"], {"weight": 0.3620218182258}], ["RB1", ["TCGA.A6.5662.01", "O-linked glycosylation"], {"weight": 0.552215857562911}], ["RB1", ["TCGA.A6.5662.01", "Heme degradation"], {"weight": 0.7157720284419}], ["RB1", ["TCGA.A6.5662.01", "Defective GALNT3 causes HFTC"], {"weight": 0.702091030075741}], ["RB1", ["TCGA.A6.5662.01", "Defective GALNT12 causes CRCS1"], {"weight": 0.702091030075741}], ["RB1", ["TCGA.A6.5662.01", "Binding and entry of HIV virion"], {"weight": 0.467079315345728}], ["SMAD4", ["TCGA.A6.5664.01", "Glucuronidation"], {"weight": 0.648256931938629}], ["SMAD4", ["TCGA.A6.5664.01", "Collagen chain trimerization"], {"weight": 0.898111409404793}], ["SMAD4", ["TCGA.A6.5664.01", "Formation of axial mesoderm"], {"weight": 0.630006276945657}], ["SMAD4", ["TCGA.A6.5664.01", "Phase II - Conjugation of compounds"], {"weight": 0.630544388051455}], ["SMAD4", ["TCGA.A6.5664.01", "Peptide hormone biosynthesis"], {"weight": 0.814007362198879}], ["SMAD4", ["TCGA.A6.5664.01", "Primitive streak formation"], {"weight": 0.58429383765844}], ["SMAD4", ["TCGA.AZ.4616.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.778581238102546}], ["SMAD4", ["TCGA.CA.5796.01", "Glucagon-type ligand receptors"], {"weight": 0.879387424448981}], ["SMAD4", ["TCGA.CA.5796.01", "Scavenging by Class A Receptors"], {"weight": 0.280302837894881}], ["SMAD4", ["TCGA.CK.4950.01", "Signaling by BMP"], {"weight": 0.674668860080479}], ["SMAD4", ["TCGA.CM.6170.01", "Glucuronidation"], {"weight": 0.880027650293872}], ["SMAD4", ["TCGA.CM.6170.01", "Heme degradation"], {"weight": 0.621544430032057}], ["SMAD4", ["TCGA.CM.6170.01", "Aspirin ADME"], {"weight": 0.801043911878815}], ["SMAD4", ["TCGA.CM.6170.01", "APAP ADME"], {"weight": 0.641966299865396}], ["SMAD4", ["TCGA.CM.6170.01", "Physiological factors"], {"weight": 0.514383647866297}], ["SMAD4", ["TCGA.D5.5538.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], {"weight": 0.866229537789007}], ["SMAD4", ["TCGA.D5.5538.01", "APAP ADME"], {"weight": 0.628348447920604}], ["SMAD4", ["TCGA.D5.5538.01", "Transcriptional regulation of pluripotent stem cells"], {"weight": 0.892658009972704}], ["SMAD4", ["TCGA.DM.A285.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], {"weight": 0.872798073690957}], ["SMAD4", ["TCGA.F4.6805.01", "Metal ion SLC transporters"], {"weight": 0.285312494488389}], ["SMAD4", ["TCGA.G4.6322.01", "Phase I - Functionalization of compounds"], {"weight": 0.940650902197518}], ["SMAD4", ["TCGA.G4.6322.01", "Transport of bile salts and organic acids, metal ions and amine compounds"], {"weight": 0.415291575988961}], ["SMAD4", ["TCGA.G4.6322.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], {"weight": 0.684997829375775}], ["SMAD4", ["TCGA.G4.6322.01", "Recycling of bile acids and salts"], {"weight": 0.641547171890093}], ["SMAD4", ["TCGA.G4.6322.01", "Cytochrome P450 - arranged by substrate type"], {"weight": 0.692302690845912}], ["RBP1", ["TCGA.CA.6716.01", "RA biosynthesis pathway"], {"weight": 0.928709428601658}], ["RBP1", ["TCGA.CA.6716.01", "Signaling by Retinoic Acid"], {"weight": 0.852651776047006}], ["RBP1", ["TCGA.CA.6716.01", "Ethanol oxidation"], {"weight": 0.862484150392294}], ["RBP1", ["TCGA.D5.7000.01", "Ethanol oxidation"], {"weight": 0.733790135648367}], ["RBP1", ["TCGA.G4.6311.01", "Ethanol oxidation"], {"weight": 0.810410165008524}], ["RBP1", ["TCGA.G4.6311.01", "RA biosynthesis pathway"], {"weight": 0.679666001406259}], ["SCNN1G", ["TCGA.A6.5665.01", "Interaction between L1 and Ankyrins"], {"weight": 0.948734528104811}], ["CREBBP", ["TCGA.AZ.6599.01", "Glucuronidation"], {"weight": 0.838060079867079}], ["CREBBP", ["TCGA.AZ.6599.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.636580567216388}], ["CREBBP", ["TCGA.G4.6625.01", "Phase II - Conjugation of compounds"], {"weight": 0.85465532711998}], ["NFATC1", ["TCGA.A6.6651.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.913348440311512}], ["NFATC1", ["TCGA.A6.6651.01", "Collagen chain trimerization"], {"weight": 0.87264809923416}], ["NFATC1", ["TCGA.A6.6651.01", "Collagen degradation"], {"weight": 0.846567588191243}], ["NFATC1", ["TCGA.A6.6651.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.616731527002808}], ["NFATC1", ["TCGA.A6.6651.01", "Glucuronidation"], {"weight": 0.5742072901463}], ["NFATC1", ["TCGA.AD.6965.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.871922934740203}], ["NFATC1", ["TCGA.AD.6965.01", "Phase II - Conjugation of compounds"], {"weight": 0.74756524594205}], ["NFATC1", ["TCGA.AD.6965.01", "Biosynthesis of specialized proresolving mediators (SPMs)"], {"weight": 0.726482780224327}], ["NFATC1", ["TCGA.AD.6965.01", "Defensins"], {"weight": 0.431960643239482}], ["PPP2CB", ["TCGA.AY.6197.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.912166090465291}], ["CAMK2G", ["TCGA.AZ.4682.01", "Interaction between L1 and Ankyrins"], {"weight": 0.93324258694862}], ["CAMK2G", ["TCGA.CK.5913.01", "Phase 0 - rapid depolarisation"], {"weight": 0.93442698275024}], ["CAMK2G", ["TCGA.CK.5913.01", "Synaptic adhesion-like molecules"], {"weight": 0.82163304334724}], ["PTK2", ["TCGA.G4.6299.01", "Interaction between L1 and Ankyrins"], {"weight": 0.910066169674095}], ["ESR1", ["TCGA.CM.4743.01", "Regulation of Complement cascade"], {"weight": 0.880573971357164}], ["ESR1", ["TCGA.CM.4743.01", "Synthesis of bile acids and bile salts via 27-hydroxycholesterol"], {"weight": 0.858938830132327}], ["ESR1", ["TCGA.CM.4743.01", "Synthesis of bile acids and bile salts"], {"weight": 0.88226967871205}], ["ESR1", ["TCGA.CM.4743.01", "Bile acid and bile salt metabolism"], {"weight": 0.875534828567698}], ["ESR1", ["TCGA.CM.4743.01", "Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"], {"weight": 0.827581449203864}], ["ESR1", ["TCGA.CM.4743.01", "Recycling of bile acids and salts"], {"weight": 0.842883195568886}], ["NCOA1", ["TCGA.CA.6717.01", "Metabolism"], {"weight": 0.821178504567614}], ["IQGAP1", ["TCGA.A6.5665.01", "Voltage gated Potassium channels"], {"weight": 0.90237272867737}], ["IQGAP1", ["TCGA.F4.6570.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.915252688150109}], ["HLA-DRA", ["TCGA.A6.6142.01", "Interaction between L1 and Ankyrins"], {"weight": 0.922497351671697}], ["HLA-DRA", ["TCGA.A6.6142.01", "NCAM1 interactions"], {"weight": 0.917732771824313}], ["NCOR2", ["TCGA.CM.5863.01", "Peptide hormone biosynthesis"], {"weight": 0.406695514804578}], ["NCOR2", ["TCGA.F4.6808.01", "Recycling of bile acids and salts"], {"weight": 0.852136554517331}], ["GFRA1", ["TCGA.D5.6529.01", "Collagen formation"], {"weight": 0.917629908362987}], ["GFRA1", ["TCGA.D5.6529.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.91519480810486}], ["GFRA1", ["TCGA.D5.6529.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.891957009146146}], ["GFRA1", ["TCGA.D5.6529.01", "Collagen degradation"], {"weight": 0.863701795219901}], ["HLA-A", ["TCGA.G4.6298.01", "Classical antibody-mediated complement activation"], {"weight": 0.724125761802825}], ["HLA-A", ["TCGA.G4.6298.01", "Creation of C4 and C2 activators"], {"weight": 0.756156790681635}], ["ACTA1", ["TCGA.F4.6460.01", "Glucuronidation"], {"weight": 0.643750523985458}], ["ACTA1", ["TCGA.F4.6704.01", "Phase II - Conjugation of compounds"], {"weight": 0.867041066654815}], ["ACTA1", ["TCGA.F4.6704.01", "Glucuronidation"], {"weight": 0.774556746284614}], ["ACTA1", ["TCGA.F4.6704.01", "Aspirin ADME"], {"weight": 0.893446561191831}], ["ACTA1", ["TCGA.F4.6704.01", "Collagen chain trimerization"], {"weight": 0.874390511749538}], ["ACTA1", ["TCGA.F4.6704.01", "Glutathione conjugation"], {"weight": 0.820631731369902}], ["NOS1", ["TCGA.A6.5665.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.935403474389082}], ["NOS1", ["TCGA.AD.6889.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.914642064588536}], ["NOS1", ["TCGA.AZ.6599.01", "Neurexins and neuroligins"], {"weight": 0.924964675414548}], ["NOS1", ["TCGA.AZ.6599.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.908321694273966}], ["NOS1", ["TCGA.CK.5913.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.855296594153993}], ["NOS1", ["TCGA.G4.6628.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.838535457079602}], ["TRIP6", ["TCGA.AD.6895.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.903453134399195}], ["TRIP6", ["TCGA.AD.6895.01", "APAP ADME"], {"weight": 0.799476646174635}], ["TRIP6", ["TCGA.G4.6628.01", "APAP ADME"], {"weight": 0.818613148006926}], ["TRIP6", ["TCGA.G4.6628.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.751618625420407}], ["CHRNA1", ["TCGA.D5.6537.01", "Heme degradation"], {"weight": 0.773846943217569}], ["CHRNA1", ["TCGA.DM.A285.01", "Phase 4 - resting membrane potential"], {"weight": 0.754495361381633}], ["AGRN", ["TCGA.AU.6004.01", "NCAM1 interactions"], {"weight": 0.904542445146332}], ["MAD1L1", ["TCGA.AA.3660.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.882879580764813}], ["LAMA5", ["TCGA.AA.3511.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.355922481677449}], ["LAMA5", ["TCGA.AA.3697.01", "Presynaptic nicotinic acetylcholine receptors"], {"weight": 0.781443573214263}], ["LAMA5", ["TCGA.AA.3697.01", "Acetylcholine binding and downstream events"], {"weight": 0.781443573214263}], ["LAMA5", ["TCGA.AA.3697.01", "Postsynaptic nicotinic acetylcholine receptors"], {"weight": 0.781443573214263}], ["LAMA5", ["TCGA.AD.6901.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.818932426028168}], ["LAMA5", ["TCGA.AY.6386.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.924555685454771}], ["LAMA5", ["TCGA.AZ.6603.01", "Phase II - Conjugation of compounds"], {"weight": 0.832016986952992}], ["LAMA5", ["TCGA.AZ.6603.01", "Glucuronidation"], {"weight": 0.835765402716809}], ["LAMA5", ["TCGA.AZ.6603.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.756644821692533}], ["LAMA5", ["TCGA.AZ.6603.01", "Neurexins and neuroligins"], {"weight": 0.752424238929244}], ["LAMA5", ["TCGA.G4.6297.01", "Phase II - Conjugation of compounds"], {"weight": 0.720404177395806}], ["LAMA5", ["TCGA.G4.6297.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.919357980956534}], ["LAMA5", ["TCGA.G4.6297.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.525798166032352}], ["ITGA1", ["TCGA.A6.5665.01", "Other semaphorin interactions"], {"weight": 0.646812618472531}], ["SPTBN5", ["TCGA.AA.3697.01", "GABA receptor activation"], {"weight": 0.843682326085791}], ["SPTBN5", ["TCGA.G4.6294.01", "Phase 0 - rapid depolarisation"], {"weight": 0.899852759916387}], ["SPTBN5", ["TCGA.G4.6294.01", "Voltage gated Potassium channels"], {"weight": 0.875429821031963}], ["AKAP13", ["TCGA.CK.5915.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.840414161508575}], ["NME1", ["TCGA.A6.5665.01", "GABA receptor activation"], {"weight": 0.909138213828902}], ["NME1", ["TCGA.A6.5665.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.926187801738718}], ["ALB", ["TCGA.D5.6898.01", "Phase II - Conjugation of compounds"], {"weight": 0.72816307264495}], ["ALB", ["TCGA.D5.6898.01", "Glucuronidation"], {"weight": 0.713243753089241}], ["ADCY10", ["TCGA.AY.6386.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.798331392335488}], ["RYR2", ["TCGA.AZ.4682.01", "Phase 0 - rapid depolarisation"], {"weight": 0.919932317159497}], ["RYR2", ["TCGA.AZ.4682.01", "LGI-ADAM interactions"], {"weight": 0.81015952889113}], ["RYR2", ["TCGA.AZ.5403.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.867944560867862}], ["RYR2", ["TCGA.D5.6924.01", "Transport of bile salts and organic acids, metal ions and amine compounds"], {"weight": 0.592005648921321}], ["RYR2", ["TCGA.G4.6293.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.835358770507508}], ["GATA3", ["TCGA.AA.3492.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.785458237850193}], ["GATA3", ["TCGA.AD.6901.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.92434192967221}], ["GATA3", ["TCGA.AD.6901.01", "Collagen chain trimerization"], {"weight": 0.888115583392742}], ["GATA3", ["TCGA.AY.6197.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.83963997708148}], ["GATA3", ["TCGA.AY.6197.01", "Sialic acid metabolism"], {"weight": 0.523007094774409}], ["GRM5", ["TCGA.A6.5666.01", "GABA B receptor activation"], {"weight": 0.944304306728737}], ["GRM5", ["TCGA.A6.5666.01", "Activation of GABAB receptors"], {"weight": 0.944304306728737}], ["MYH11", ["TCGA.AD.6901.01", "Degradation of cysteine and homocysteine"], {"weight": 0.462288575110536}], ["FLNC", ["TCGA.DM.A0XF.01", "Phase 0 - rapid depolarisation"], {"weight": 0.938523658356369}], ["FLNC", ["TCGA.DM.A0XF.01", "O-linked glycosylation"], {"weight": 0.860701749790499}], ["KDELR1", ["TCGA.AD.5900.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.860959339804576}], ["CACNA1A", ["TCGA.AD.6901.01", "Phase 2 - plateau phase"], {"weight": 0.693713600482301}], ["CACNA1A", ["TCGA.AZ.6601.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.854143576359511}], ["CACNA1A", ["TCGA.CA.6718.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.904994236931954}], ["CACNA1A", ["TCGA.CM.6674.01", "Potassium Channels"], {"weight": 0.946541621517953}], ["CACNA1A", ["TCGA.F4.6570.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.866434791840917}], ["CACNA1A", ["TCGA.G4.6294.01", "Potassium Channels"], {"weight": 0.959709089810326}], ["CACNA1A", ["TCGA.G4.6294.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.929927445308396}], ["CACNA1A", ["TCGA.G4.6294.01", "Sensory perception of taste"], {"weight": 0.898912472685139}], ["CACNA1A", ["TCGA.G4.6294.01", "Sensory perception of sweet, bitter, and umami (glutamate) taste"], {"weight": 0.884670946378726}], ["CACNA1A", ["TCGA.G4.6294.01", "Phase 4 - resting membrane potential"], {"weight": 0.793101046524418}], ["CACNA1A", ["TCGA.G4.6294.01", "Arachidonic acid metabolism"], {"weight": 0.826152047719616}], ["CACNA1A", ["TCGA.G4.6586.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.913379806051941}], ["CXCR3", ["TCGA.D5.6929.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.792812624071396}], ["CXCR3", ["TCGA.D5.6929.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.912569345693533}], ["CACNB1", ["TCGA.A6.5665.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.879033995539976}], ["ARHGEF1", ["TCGA.AA.3660.01", "Presynaptic function of Kainate receptors"], {"weight": 0.851016720824596}], ["ARHGEF1", ["TCGA.AA.3660.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.861979859802068}], ["ARHGEF1", ["TCGA.AA.3660.01", "Collagen chain trimerization"], {"weight": 0.792453442261091}], ["ARHGEF1", ["TCGA.AA.3660.01", "G beta:gamma signalling through BTK"], {"weight": 0.821449923149302}], ["ARHGEF1", ["TCGA.AA.3660.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.821449923149302}], ["ARHGEF1", ["TCGA.F4.6570.01", "Glucagon-type ligand receptors"], {"weight": 0.922798817625638}], ["EXOC1", ["TCGA.AA.3660.01", "Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"], {"weight": 0.579246118984835}], ["EXOC1", ["TCGA.AA.3660.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.658524084974498}], ["ANK3", ["TCGA.F4.6808.01", "Interaction between L1 and Ankyrins"], {"weight": 0.940608076958352}], ["SLC6A3", ["TCGA.A6.5665.01", "Phase 0 - rapid depolarisation"], {"weight": 0.942192761941752}], ["SLC6A3", ["TCGA.AA.3712.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.910114995323971}], ["FLNA", ["TCGA.F4.6570.01", "Phase 0 - rapid depolarisation"], {"weight": 0.907026925789202}], ["PLXNA2", ["TCGA.A6.6781.01", "Other semaphorin interactions"], {"weight": 0.891702579899458}], ["COL2A1", ["TCGA.CM.6679.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.93635482276295}], ["COL2A1", ["TCGA.CM.6679.01", "O-linked glycosylation"], {"weight": 0.900046433638321}], ["COL2A1", ["TCGA.F4.6570.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.942124380252066}], ["OR1L3", ["TCGA.A6.5665.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.916681602877725}], ["OR1L3", ["TCGA.A6.5665.01", "G beta:gamma signalling through BTK"], {"weight": 0.914221880583961}], ["OR1L3", ["TCGA.A6.6648.01", "Neurexins and neuroligins"], {"weight": 0.866668794209247}], ["OR1L3", ["TCGA.A6.6648.01", "Phase 4 - resting membrane potential"], {"weight": 0.777753259657588}], ["OR1L3", ["TCGA.A6.6648.01", "LGI-ADAM interactions"], {"weight": 0.649830499859756}], ["OR2T27", ["TCGA.A6.5665.01", "Glucagon-type ligand receptors"], {"weight": 0.927768879093478}], ["OR2T27", ["TCGA.CM.4747.01", "G beta:gamma signalling through BTK"], {"weight": 0.882818940005451}], ["OR2T27", ["TCGA.CM.4747.01", "Inwardly rectifying K+ channels"], {"weight": 0.917495600060479}], ["OR2T27", ["TCGA.CM.4747.01", "Activation of G protein gated Potassium channels"], {"weight": 0.904894457634318}], ["OR2T27", ["TCGA.CM.4747.01", "G protein gated Potassium channels"], {"weight": 0.904894457634318}], ["OR2T27", ["TCGA.CM.4747.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.904894457634318}], ["OR8D1", ["TCGA.CK.5914.01", "Adenylate cyclase inhibitory pathway"], {"weight": 0.89229169314935}], ["ABCB1", ["TCGA.AU.6004.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.896964197526963}], ["ABCB1", ["TCGA.G4.6314.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.929484885888357}], ["ABCB1", ["TCGA.G4.6314.01", "Collagen chain trimerization"], {"weight": 0.900224519387377}], ["CACNA1E", ["TCGA.A6.5665.01", "LGI-ADAM interactions"], {"weight": 0.907312066446143}], ["CACNA1E", ["TCGA.A6.5666.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.941894367519868}], ["CACNA1E", ["TCGA.CM.5861.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.90800773162679}], ["CACNA1E", ["TCGA.CM.6676.01", "Insulin processing"], {"weight": 0.790228466976209}], ["ATP2B3", ["TCGA.AU.3779.01", "Phase 0 - rapid depolarisation"], {"weight": 0.807147751442056}], ["ATP2B3", ["TCGA.AU.3779.01", "Sensory processing of sound by outer hair cells of the cochlea"], {"weight": 0.843304141644952}], ["ATP2B3", ["TCGA.CA.5797.01", "Sensory perception of taste"], {"weight": 0.858130620396013}], ["ATP2B3", ["TCGA.CA.5797.01", "Phase 2 - plateau phase"], {"weight": 0.679847606609901}], ["ATP2B3", ["TCGA.G4.6586.01", "Sodium/Calcium exchangers"], {"weight": 0.71362990553639}], ["ATP2B4", ["TCGA.CK.5915.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.770372209525533}], ["ATP2B4", ["TCGA.CK.5915.01", "Voltage gated Potassium channels"], {"weight": 0.846628141888607}], ["ATP2B4", ["TCGA.CK.5915.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.828897535783283}], ["PYGB", ["TCGA.A6.5665.01", "Glucuronidation"], {"weight": 0.910293919929858}], ["PYGB", ["TCGA.AD.5900.01", "Glycogen synthesis"], {"weight": 0.805083151884414}], ["PYGB", ["TCGA.AD.6888.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.824459697807345}], ["PYGB", ["TCGA.CM.5861.01", "Glucuronidation"], {"weight": 0.8612030379498}], ["PYGB", ["TCGA.D5.6922.01", "Phase II - Conjugation of compounds"], {"weight": 0.826105848076766}], ["PYGB", ["TCGA.D5.6922.01", "Glucuronidation"], {"weight": 0.8921590548395}], ["PYGB", ["TCGA.D5.6922.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.879558917686519}], ["PYGB", ["TCGA.D5.6922.01", "Collagen formation"], {"weight": 0.850566089984726}], ["PYGB", ["TCGA.D5.6922.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.685880159787144}], ["PYGB", ["TCGA.F4.6570.01", "Glucuronidation"], {"weight": 0.859902924218927}], ["KCNU1", ["TCGA.AM.5821.01", "Phase 2 - plateau phase"], {"weight": 0.851337807249121}], ["KCNQ1", ["TCGA.G4.6628.01", "Phase 4 - resting membrane potential"], {"weight": 0.870081326826837}], ["IFT140", ["TCGA.D5.6927.01", "Phase 0 - rapid depolarisation"], {"weight": 0.863519945488702}], ["NPHS1", ["TCGA.CM.5868.01", "Interaction between L1 and Ankyrins"], {"weight": 0.879918261563506}], ["NPHS1", ["TCGA.CM.6678.01", "Translocation of ZAP-70 to Immunological synapse"], {"weight": 0.93822979699301}], ["NPHS1", ["TCGA.CM.6678.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.734324939612318}], ["KCNB1", ["TCGA.AA.3492.01", "Potassium Channels"], {"weight": 0.960545188370086}], ["KCNB1", ["TCGA.AA.3502.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.788295801843564}], ["KCNB1", ["TCGA.G4.6309.01", "Phase 0 - rapid depolarisation"], {"weight": 0.89388949441125}], ["SERPING1", ["TCGA.G4.6297.01", "Diseases associated with O-glycosylation of proteins"], {"weight": 0.812939079122109}], ["SERPING1", ["TCGA.G4.6297.01", "Defective GALNT12 causes CRCS1"], {"weight": 0.691835788224216}], ["CTNNA2", ["TCGA.DM.A282.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], {"weight": 0.645019723519951}], ["CTNNA2", ["TCGA.DM.A282.01", "Heme degradation"], {"weight": 0.748285300898621}], ["ITGB2", ["TCGA.DM.A285.01", "APAP ADME"], {"weight": 0.728829087410643}], ["PIP5K1C", ["TCGA.G4.6306.01", "Presynaptic function of Kainate receptors"], {"weight": 0.892967436537643}], ["PIP5K1C", ["TCGA.G4.6306.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.905822580867487}], ["PIP5K1C", ["TCGA.G4.6306.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.886593774081191}], ["MKL1", ["TCGA.CM.5344.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.873682641332174}], ["MKL1", ["TCGA.CM.5344.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.698469973170458}], ["ERBB4", ["TCGA.F4.6463.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.894049769487196}], ["PDE1B", ["TCGA.AM.5820.01", "Activation of G protein gated Potassium channels"], {"weight": 0.914087442126165}], ["PDE1B", ["TCGA.AM.5820.01", "G protein gated Potassium channels"], {"weight": 0.914087442126165}], ["PDE1B", ["TCGA.AM.5820.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.914087442126165}], ["PDE1B", ["TCGA.AM.5820.01", "Inwardly rectifying K+ channels"], {"weight": 0.921203624309732}], ["PDE1B", ["TCGA.AM.5820.01", "Potassium Channels"], {"weight": 0.945219812302328}], ["PDE1B", ["TCGA.D5.6926.01", "Glucagon-type ligand receptors"], {"weight": 0.901370721299607}], ["PDE1B", ["TCGA.D5.6926.01", "Inwardly rectifying K+ channels"], {"weight": 0.841449243637426}], ["PDE1B", ["TCGA.D5.6926.01", "Activation of G protein gated Potassium channels"], {"weight": 0.886274180813202}], ["PDE1B", ["TCGA.D5.6926.01", "G protein gated Potassium channels"], {"weight": 0.886274180813202}], ["PDE1B", ["TCGA.D5.6926.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.886274180813202}], ["PDE1B", ["TCGA.D5.6926.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.875855314355271}], ["TSHR", ["TCGA.G4.6626.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.813100977842709}], ["FZD6", ["TCGA.AY.6197.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], {"weight": 0.912766423465713}], ["FZD6", ["TCGA.CA.6718.01", "WNT ligand biogenesis and trafficking"], {"weight": 0.916464540132818}], ["FZD6", ["TCGA.CM.6170.01", "Presynaptic function of Kainate receptors"], {"weight": 0.871147963848654}], ["FZD6", ["TCGA.CM.6170.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.874895444258726}], ["FZD6", ["TCGA.CM.6170.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.884550191439521}], ["FZD6", ["TCGA.CM.6170.01", "Glucagon-type ligand receptors"], {"weight": 0.883288502627081}], ["FZD6", ["TCGA.CM.6170.01", "G beta:gamma signalling through BTK"], {"weight": 0.837674923180474}], ["FZD6", ["TCGA.CM.6170.01", "Prostacyclin signalling through prostacyclin receptor"], {"weight": 0.837674923180474}], ["FZD6", ["TCGA.CM.6170.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.837674923180474}], ["NRXN3", ["TCGA.G4.6299.01", "Norepinephrine Neurotransmitter Release Cycle"], {"weight": 0.689589874862589}], ["NRXN3", ["TCGA.G4.6299.01", "Serotonin Neurotransmitter Release Cycle"], {"weight": 0.893784699389192}], ["RYR3", ["TCGA.F4.6856.01", "Nicotinate metabolism"], {"weight": 0.64940815512228}], ["KIF4B", ["TCGA.D5.6929.01", "Interaction between L1 and Ankyrins"], {"weight": 0.91402065762624}], ["POU4F2", ["TCGA.CM.5341.01", "Recycling of bile acids and salts"], {"weight": 0.816693191347062}], ["ARFGEF1", ["TCGA.CK.5912.01", "Phase 0 - rapid depolarisation"], {"weight": 0.895110907364506}], ["ARFGEF1", ["TCGA.CK.5912.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.867574361034689}], ["ARFGEF1", ["TCGA.CK.5912.01", "Interaction between L1 and Ankyrins"], {"weight": 0.890610408526657}], ["ARFGEF1", ["TCGA.CK.5912.01", "Arachidonic acid metabolism"], {"weight": 0.910826063601663}], ["ARFGEF1", ["TCGA.CK.5912.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.731118081888469}], ["ARFGEF1", ["TCGA.CK.5912.01", "Platelet calcium homeostasis"], {"weight": 0.880051421523796}], ["ARFGEF1", ["TCGA.CK.5912.01", "Phase 2 - plateau phase"], {"weight": 0.690639562823608}], ["ARFGEF1", ["TCGA.CK.5912.01", "Initial triggering of complement"], {"weight": 0.73987735811926}], ["ARFGEF1", ["TCGA.CK.5912.01", "Phase 4 - resting membrane potential"], {"weight": 0.819334543819008}], ["RASAL3", ["TCGA.DM.A28C.01", "Erythrocytes take up carbon dioxide and release oxygen"], {"weight": 0.808106804988241}], ["RASAL3", ["TCGA.DM.A28C.01", "O2/CO2 exchange in erythrocytes"], {"weight": 0.808106804988241}], ["COL4A2", ["TCGA.G4.6311.01", "Collagen chain trimerization"], {"weight": 0.915029279084655}], ["COL4A2", ["TCGA.G4.6311.01", "Collagen degradation"], {"weight": 0.910671952239316}], ["COL4A2", ["TCGA.G4.6311.01", "Glucuronidation"], {"weight": 0.460366319046627}], ["COL4A2", ["TCGA.G4.6315.01", "Other semaphorin interactions"], {"weight": 0.658217932250537}], ["COL4A2", ["TCGA.G4.6315.01", "TNFs bind their physiological receptors"], {"weight": 0.496656407416206}], ["COL4A3", ["TCGA.D5.6533.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.76385727554926}], ["PLXNB3", ["TCGA.AD.5900.01", "O-linked glycosylation"], {"weight": 0.86723163111719}], ["PLXNB3", ["TCGA.AD.6895.01", "O-linked glycosylation"], {"weight": 0.864141573185856}], ["PLXNB3", ["TCGA.AU.6004.01", "Diseases associated with O-glycosylation of proteins"], {"weight": 0.562339973687439}], ["PLXNB3", ["TCGA.G4.6586.01", "Defective B3GALTL causes PpS"], {"weight": 0.926060061482565}], ["PLXNB3", ["TCGA.G4.6586.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.926060061482565}], ["PLXNB3", ["TCGA.G4.6586.01", "O-linked glycosylation"], {"weight": 0.931969448456057}], ["COL7A1", ["TCGA.G4.6304.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.937287181528023}], ["NALCN", ["TCGA.A6.5665.01", "Stimuli-sensing channels"], {"weight": 0.872396242714921}], ["NALCN", ["TCGA.DM.A0XF.01", "Synaptic adhesion-like molecules"], {"weight": 0.757367459768518}], ["CNTN2", ["TCGA.F4.6856.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.873846701307293}], ["NOTCH3", ["TCGA.A6.5665.01", "Blood group systems biosynthesis"], {"weight": 0.888835317210814}], ["NOTCH3", ["TCGA.D5.6536.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.726127742710348}], ["NOTCH3", ["TCGA.D5.6537.01", "Blood group systems biosynthesis"], {"weight": 0.920301887731059}], ["NOTCH3", ["TCGA.D5.6537.01", "Lewis blood group biosynthesis"], {"weight": 0.917843840043484}], ["NOTCH3", ["TCGA.D5.6537.01", "Keratan sulfate biosynthesis"], {"weight": 0.931713314131604}], ["COL6A3", ["TCGA.A6.5665.01", "Collagen chain trimerization"], {"weight": 0.895793769563901}], ["COL6A3", ["TCGA.D5.6920.01", "Glycosaminoglycan metabolism"], {"weight": 0.716234355370713}], ["COL6A3", ["TCGA.DM.A28F.01", "Keratan sulfate biosynthesis"], {"weight": 0.893632002549872}], ["COL6A3", ["TCGA.F4.6703.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.952859403975567}], ["COL6A3", ["TCGA.F4.6703.01", "Collagen chain trimerization"], {"weight": 0.934156770340676}], ["COL6A3", ["TCGA.F4.6703.01", "Collagen degradation"], {"weight": 0.901097697909057}], ["COL6A3", ["TCGA.G4.6298.01", "Collagen chain trimerization"], {"weight": 0.934840929172608}], ["COL6A3", ["TCGA.G4.6298.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.948880845397609}], ["HCN4", ["TCGA.A6.5665.01", "Potassium Channels"], {"weight": 0.960975630072919}], ["HCN4", ["TCGA.AD.6889.01", "Potassium Channels"], {"weight": 0.962515336099233}], ["HCN4", ["TCGA.CM.6171.01", "Potassium Channels"], {"weight": 0.961627345227516}], ["HCN4", ["TCGA.D5.6540.01", "Potassium Channels"], {"weight": 0.959937956179755}], ["SNAI1", ["TCGA.A6.6782.01", "Physiological factors"], {"weight": 0.552162658627917}], ["THBS2", ["TCGA.DM.A1HA.01", "O-linked glycosylation"], {"weight": 0.945660172928454}], ["THBS2", ["TCGA.DM.A1HA.01", "Defective B3GALTL causes PpS"], {"weight": 0.932453559455844}], ["THBS2", ["TCGA.DM.A1HA.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.932436205921479}], ["APOB", ["TCGA.A6.6650.01", "Classical antibody-mediated complement activation"], {"weight": 0.696614533550667}], ["APOB", ["TCGA.A6.6650.01", "Erythrocytes take up carbon dioxide and release oxygen"], {"weight": 0.699773550026767}], ["APOB", ["TCGA.A6.6650.01", "O2/CO2 exchange in erythrocytes"], {"weight": 0.699773550026767}], ["APOB", ["TCGA.CA.6716.01", "Classical antibody-mediated complement activation"], {"weight": 0.692068598929241}], ["APOB", ["TCGA.CA.6716.01", "Creation of C4 and C2 activators"], {"weight": 0.645959744649947}], ["APOB", ["TCGA.CA.6716.01", "Scavenging by Class A Receptors"], {"weight": 0.533360290549124}], ["APOB", ["TCGA.CM.4743.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.889747617101886}], ["APOB", ["TCGA.D5.6931.01", "Signaling by Retinoic Acid"], {"weight": 0.613221082359213}], ["APOB", ["TCGA.D5.6931.01", "RA biosynthesis pathway"], {"weight": 0.719215451073886}], ["APOB", ["TCGA.F4.6854.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], {"weight": 0.64334985408678}], ["PPARGC1A", ["TCGA.D5.6537.01", "Recycling of bile acids and salts"], {"weight": 0.884499305732994}], ["EPN1", ["TCGA.D5.6535.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.649671866525226}], ["EPN1", ["TCGA.D5.6535.01", "Phase II - Conjugation of compounds"], {"weight": 0.731536316634172}], ["LRP2", ["TCGA.A6.5666.01", "Blood group systems biosynthesis"], {"weight": 0.814825020336586}], ["LRP2", ["TCGA.A6.5666.01", "Lewis blood group biosynthesis"], {"weight": 0.801692797959435}], ["LRP2", ["TCGA.A6.5666.01", "Voltage gated Potassium channels"], {"weight": 0.920862453169417}], ["LRP2", ["TCGA.AZ.4615.01", "O-linked glycosylation of mucins"], {"weight": 0.937439007521571}], ["LRP2", ["TCGA.CM.6677.01", "Blood group systems biosynthesis"], {"weight": 0.503609173011566}], ["LRP2", ["TCGA.CM.6677.01", "Lewis blood group biosynthesis"], {"weight": 0.439635537616712}], ["LRP2", ["TCGA.D5.6529.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], {"weight": 0.686854706140901}], ["LRP2", ["TCGA.D5.6529.01", "O-linked glycosylation"], {"weight": 0.863084246325947}], ["LRP2", ["TCGA.D5.6529.01", "Diseases associated with O-glycosylation of proteins"], {"weight": 0.788596164333432}], ["LRP2", ["TCGA.DM.A1HA.01", "Termination of O-glycan biosynthesis"], {"weight": 0.954055331726997}], ["LRP2", ["TCGA.DM.A1HA.01", "Defective GALNT3 causes HFTC"], {"weight": 0.938833098987758}], ["LRP2", ["TCGA.DM.A1HA.01", "Defective GALNT12 causes CRCS1"], {"weight": 0.938833098987758}], ["LRP2", ["TCGA.DM.A28H.01", "Blood group systems biosynthesis"], {"weight": 0.90594453927025}], ["LRP2", ["TCGA.DM.A28H.01", "Binding and entry of HIV virion"], {"weight": 0.792912736932736}], ["LRP2", ["TCGA.DM.A28H.01", "Lewis blood group biosynthesis"], {"weight": 0.904086033030392}], ["LRP2", ["TCGA.DM.A28H.01", "Voltage gated Potassium channels"], {"weight": 0.850514294473802}], ["LRP2", ["TCGA.DM.A28H.01", "Activation of the pre-replicative complex"], {"weight": 0.888770312147345}], ["LRRFIP1", ["TCGA.D5.6538.01", "Classical antibody-mediated complement activation"], {"weight": 0.715914885921911}], ["LRRFIP1", ["TCGA.D5.6538.01", "Creation of C4 and C2 activators"], {"weight": 0.70339886707425}], ["CUX1", ["TCGA.F4.6570.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], {"weight": 0.880919925676446}], ["AMPD3", ["TCGA.D5.6532.01", "Activation of the phototransduction cascade"], {"weight": 0.824774070065039}], ["AMPD3", ["TCGA.D5.6532.01", "Aspartate and asparagine metabolism"], {"weight": 0.812441460497795}], ["SYNE1", ["TCGA.A6.6648.01", "Initial triggering of complement"], {"weight": 0.815891719672801}], ["SYNE1", ["TCGA.AD.6888.01", "Complement cascade"], {"weight": 0.922922002963282}], ["SYNE1", ["TCGA.AD.6888.01", "Regulation of Complement cascade"], {"weight": 0.894475041970422}], ["SYNE1", ["TCGA.CA.6716.01", "Initial triggering of complement"], {"weight": 0.829938388648614}], ["SYNE1", ["TCGA.DM.A28F.01", "Initial triggering of complement"], {"weight": 0.802087064589148}], ["ERCC6", ["TCGA.DM.A28H.01", "DNA strand elongation"], {"weight": 0.896014781316698}], ["ERCC6", ["TCGA.DM.A28H.01", "Lagging Strand Synthesis"], {"weight": 0.869321834960286}], ["ERCC6", ["TCGA.DM.A28H.01", "Polymerase switching"], {"weight": 0.840316173528888}], ["ERCC6", ["TCGA.DM.A28H.01", "Leading Strand Synthesis"], {"weight": 0.840316173528888}], ["ERCC6", ["TCGA.DM.A28H.01", "Removal of the Flap Intermediate"], {"weight": 0.850293736942721}], ["ERCC6", ["TCGA.DM.A28H.01", "Processive synthesis on the lagging strand"], {"weight": 0.850293736942721}], ["NPR2", ["TCGA.CM.6171.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.813444408824154}], ["TICAM1", ["TCGA.CM.5860.01", "TNFs bind their physiological receptors"], {"weight": 0.571089460452318}], ["ARID1A", ["TCGA.AZ.4681.01", "Binding and entry of HIV virion"], {"weight": 0.808950426412199}], ["ARID1A", ["TCGA.AZ.4681.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.885076605105382}], ["ARID1A", ["TCGA.AZ.4681.01", "Unwinding of DNA"], {"weight": 0.838559484970467}], ["ARID1A", ["TCGA.AZ.4681.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.910513537857931}], ["ARID1A", ["TCGA.AZ.4681.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.907423404876472}], ["ARID1A", ["TCGA.AZ.4681.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.888561234581935}], ["ARID1A", ["TCGA.AZ.4681.01", "Leishmania parasite growth and survival"], {"weight": 0.888561234581935}], ["ARID1A", ["TCGA.AZ.4681.01", "G-protein beta:gamma signalling"], {"weight": 0.918597349836982}], ["ARID1A", ["TCGA.AZ.4681.01", "DNA strand elongation"], {"weight": 0.886466706360728}], ["ARID1A", ["TCGA.AZ.4681.01", "Cellular response to starvation"], {"weight": 0.907999304362668}], ["ARID1A", ["TCGA.AZ.4681.01", "Azathioprine ADME"], {"weight": 0.76758726858327}], ["ARID1A", ["TCGA.AZ.4681.01", "Viral mRNA Translation"], {"weight": 0.912701067376955}], ["ARID1A", ["TCGA.AZ.4681.01", "Eukaryotic Translation Elongation"], {"weight": 0.898598829965745}], ["ARID1A", ["TCGA.AZ.4681.01", "Eukaryotic Translation Termination"], {"weight": 0.897777999045885}], ["ARID1A", ["TCGA.AZ.4681.01", "Peptide chain elongation"], {"weight": 0.912701067376955}], ["ARID1A", ["TCGA.AZ.4681.01", "Formation of a pool of free 40S subunits"], {"weight": 0.916749703611186}], ["ARID1A", ["TCGA.AZ.4681.01", "G beta:gamma signalling through CDC42"], {"weight": 0.854740626448252}], ["ARID1A", ["TCGA.AZ.4681.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.896519220468514}], ["ARID1A", ["TCGA.AZ.4681.01", "rRNA processing"], {"weight": 0.908368096100807}], ["ARID1A", ["TCGA.AZ.4681.01", "Selenocysteine synthesis"], {"weight": 0.912701067376955}], ["ARID1A", ["TCGA.AZ.4681.01", "Regulation of insulin secretion"], {"weight": 0.913072332536733}], ["ARID1A", ["TCGA.AZ.4681.01", "G alpha (z) signalling events"], {"weight": 0.887690571338944}], ["ARID1A", ["TCGA.AZ.4681.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.826786674705249}], ["ARID1A", ["TCGA.AZ.4681.01", "rRNA processing in the nucleus and cytosol"], {"weight": 0.924852757925055}], ["ARID1A", ["TCGA.AZ.4681.01", "Immune System"], {"weight": 0.905796605513371}], ["ARID1A", ["TCGA.AZ.4681.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.798943794859881}], ["ARID1A", ["TCGA.AZ.4681.01", "Post-chaperonin tubulin folding pathway"], {"weight": 0.838805946174866}], ["ARID1A", ["TCGA.AZ.4681.01", "Major pathway of rRNA processing in the nucleolus and cytosol"], {"weight": 0.934272649338135}], ["ARID1A", ["TCGA.AZ.4681.01", "Influenza Viral RNA Transcription and Replication"], {"weight": 0.919531785516477}], ["ARID1A", ["TCGA.AZ.4681.01", "Integration of energy metabolism"], {"weight": 0.931690674073726}], ["ARID1A", ["TCGA.AZ.4681.01", "Leishmania infection"], {"weight": 0.886688106121637}], ["ARID1A", ["TCGA.AZ.4681.01", "Parasitic Infection Pathways"], {"weight": 0.886688106121637}], ["ARID1A", ["TCGA.AZ.4681.01", "Signal amplification"], {"weight": 0.869612745075304}], ["ARID1A", ["TCGA.AZ.4681.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.870831832009804}], ["ARID1A", ["TCGA.AZ.4681.01", "Selenoamino acid metabolism"], {"weight": 0.9022233385137}], ["ARID1A", ["TCGA.AZ.4681.01", "Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)"], {"weight": 0.912701067376955}], ["ARID1A", ["TCGA.AZ.4681.01", "Response of EIF2AK4 (GCN2) to amino acid deficiency"], {"weight": 0.90238589294543}], ["ARID1A", ["TCGA.AZ.4681.01", "L13a-mediated translational silencing of Ceruloplasmin expression"], {"weight": 0.927948568009263}], ["ARID1A", ["TCGA.AZ.4681.01", "GTP hydrolysis and joining of the 60S ribosomal subunit"], {"weight": 0.916749703611186}], ["ARID1A", ["TCGA.AZ.4681.01", "GPER1 signaling"], {"weight": 0.902105602595483}], ["ARID1A", ["TCGA.AZ.4681.01", "ADORA2B mediated anti-inflammatory cytokines production"], {"weight": 0.902105602595483}], ["ARID1A", ["TCGA.AZ.4681.01", "G alpha (i) signalling events"], {"weight": 0.934326257222425}], ["ARID1A", ["TCGA.AZ.4681.01", "Influenza Infection"], {"weight": 0.920503769159575}], ["ARID1A", ["TCGA.AZ.4681.01", "Ribavirin ADME"], {"weight": 0.686894063982581}], ["ARID1A", ["TCGA.AZ.4681.01", "Eukaryotic Translation Initiation"], {"weight": 0.90361810389096}], ["ARID1A", ["TCGA.AZ.4681.01", "Cap-dependent Translation Initiation"], {"weight": 0.90361810389096}], ["ARID1A", ["TCGA.AZ.4681.01", "MyD88 deficiency (TLR2/4)"], {"weight": 0.893276095781017}], ["ARID1A", ["TCGA.AZ.4681.01", "IRAK4 deficiency (TLR2/4)"], {"weight": 0.893276095781017}], ["ARID1A", ["TCGA.AZ.4681.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], {"weight": 0.897589103991812}], ["ARID1A", ["TCGA.AZ.4681.01", "Aquaporin-mediated transport"], {"weight": 0.897589103991812}], ["ARID1A", ["TCGA.AZ.4681.01", "Phosphorylation of CD3 and TCR zeta chains"], {"weight": 0.86735428719483}], ["ARID1A", ["TCGA.AZ.4681.01", "Protein folding"], {"weight": 0.912556254571702}], ["ARID1A", ["TCGA.AZ.4681.01", "Cell surface interactions at the vascular wall"], {"weight": 0.799317399639485}], ["ARID1A", ["TCGA.AZ.4681.01", "Telomere Maintenance"], {"weight": 0.870700918318038}], ["ARID1A", ["TCGA.AZ.4681.01", "Nonsense-Mediated Decay (NMD)"], {"weight": 0.912457833476053}], ["ARID1A", ["TCGA.AZ.4681.01", "Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)"], {"weight": 0.912457833476053}], ["ARID1A", ["TCGA.AZ.4681.01", "Nervous system development"], {"weight": 0.911049595516924}], ["ARID1A", ["TCGA.AZ.4681.01", "Diseases of Immune System"], {"weight": 0.881259823423914}], ["ARID1A", ["TCGA.AZ.4681.01", "Defects in Toll-like Receptor Cascades"], {"weight": 0.881259823423914}], ["ARID1A", ["TCGA.AZ.4681.01", "Chromosome Maintenance"], {"weight": 0.882239603416473}], ["ARID1A", ["TCGA.AZ.4681.01", "Platelet homeostasis"], {"weight": 0.866167306696729}], ["ARID1A", ["TCGA.AZ.4681.01", "Extra-nuclear estrogen signaling"], {"weight": 0.914037922921}], ["ARID1A", ["TCGA.AZ.4681.01", "Translocation of ZAP-70 to Immunological synapse"], {"weight": 0.862168434967704}], ["ARID1A", ["TCGA.AZ.4681.01", "Chemokine receptors bind chemokines"], {"weight": 0.911859994811885}], ["ARID1A", ["TCGA.AZ.4681.01", "SARS-CoV-2 modulates host translation machinery"], {"weight": 0.842492476124659}], ["ARID1A", ["TCGA.AZ.4681.01", "CD28 dependent PI3K/Akt signaling"], {"weight": 0.857796712672805}], ["ARID1A", ["TCGA.AZ.4681.01", "Signaling Pathways"], {"weight": 0.928863388051056}], ["ARID1A", ["TCGA.AZ.4681.01", "SRP-dependent cotranslational protein targeting to membrane"], {"weight": 0.912701067376955}], ["ARID1A", ["TCGA.AZ.4681.01", "FCGR3A-mediated IL10 synthesis"], {"weight": 0.874294701915894}], ["ARID1A", ["TCGA.AZ.4681.01", "Interleukin-4 and Interleukin-13 signaling"], {"weight": 0.819800462222553}], ["ARID1A", ["TCGA.AZ.4681.01", "Translesion synthesis by POLK"], {"weight": 0.807547478339125}], ["ARID1A", ["TCGA.AZ.4681.01", "Translesion synthesis by POLI"], {"weight": 0.807547478339125}], ["ARID1A", ["TCGA.AZ.4681.01", "EGR2 and SOX10-mediated initiation of Schwann cell myelination"], {"weight": 0.813614675411215}], ["ARID1A", ["TCGA.AZ.4681.01", "Opioid Signalling"], {"weight": 0.874378480303583}], ["ARID1A", ["TCGA.AZ.4681.01", "B Cell Activation"], {"weight": 0.924898117935135}], ["ARID1A", ["TCGA.AZ.4681.01", "APOBEC3G mediated resistance to HIV-1 infection"], {"weight": 0.701071873796892}], ["ARID1A", ["TCGA.AZ.4681.01", "CD22 mediated BCR regulation"], {"weight": 0.671212434054145}], ["ARID1A", ["TCGA.AZ.4681.01", "Early Phase of HIV Life Cycle"], {"weight": 0.739773019967334}], ["ARID1A", ["TCGA.AZ.4681.01", "Activation of the pre-replicative complex"], {"weight": 0.849572699608636}], ["ARID1A", ["TCGA.AZ.4681.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.748269148448164}], ["ARID1A", ["TCGA.AZ.4681.01", "Heme degradation"], {"weight": 0.807592645077542}], ["ARID1A", ["TCGA.AZ.4681.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.751853980841921}], ["ARID1A", ["TCGA.AZ.4681.01", "Regulation of Complement cascade"], {"weight": 0.812281092989582}], ["ARID1A", ["TCGA.AZ.4681.01", "Chaperonin-mediated protein folding"], {"weight": 0.914421546101147}], ["RIF1", ["TCGA.AY.6196.01", "Triglyceride biosynthesis"], {"weight": 0.76025325080634}], ["CRTC1", ["TCGA.A6.6653.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.92262957363323}], ["CRTC1", ["TCGA.A6.6653.01", "Aspartate and asparagine metabolism"], {"weight": 0.593608839933167}], ["CRTC1", ["TCGA.A6.6780.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.770526769875141}], ["CRTC1", ["TCGA.AZ.6598.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.913902324312759}], ["CRTC1", ["TCGA.AZ.6601.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.892846479044386}], ["CRTC1", ["TCGA.D5.6930.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.924307505060268}], ["SETD2", ["TCGA.AD.6548.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.78824478057481}], ["SETD2", ["TCGA.DM.A0XF.01", "Recycling of bile acids and salts"], {"weight": 0.74229949416588}], ["SETD2", ["TCGA.F4.6809.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], {"weight": 0.75904004446101}], ["SETD2", ["TCGA.F4.6809.01", "Collagen chain trimerization"], {"weight": 0.77983800835737}], ["SETD2", ["TCGA.F4.6809.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], {"weight": 0.48484116475591}], ["MPO", ["TCGA.A6.5665.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.914570703330781}], ["MPO", ["TCGA.A6.5665.01", "Arachidonic acid metabolism"], {"weight": 0.905945511154833}], ["PLA2G2E", ["TCGA.A6.5665.01", "Phase II - Conjugation of compounds"], {"weight": 0.850545692839786}], ["PLA2G2E", ["TCGA.AD.6889.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.91052216492446}], ["PLA2G2E", ["TCGA.AD.6889.01", "Arachidonic acid metabolism"], {"weight": 0.936844453256176}], ["AXIN2", ["TCGA.DM.A1D6.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.844934474424218}], ["AXIN2", ["TCGA.DM.A1D6.01", "Phase II - Conjugation of compounds"], {"weight": 0.859874379363912}], ["PLB1", ["TCGA.A6.6140.01", "Phase II - Conjugation of compounds"], {"weight": 0.763483346245084}], ["PLB1", ["TCGA.AY.6197.01", "Phase II - Conjugation of compounds"], {"weight": 0.754653175218679}], ["PLB1", ["TCGA.CM.5868.01", "Scavenging of heme from plasma"], {"weight": 0.780327106401578}], ["PLB1", ["TCGA.CM.5868.01", "Phase II - Conjugation of compounds"], {"weight": 0.831143975535717}], ["PLB1", ["TCGA.CM.6161.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.821446489945706}], ["PLB1", ["TCGA.D5.6540.01", "Aspirin ADME"], {"weight": 0.916661305084801}], ["TBK1", ["TCGA.G4.6309.01", "Trafficking and processing of endosomal TLR"], {"weight": 0.844657089763522}], ["UBE4B", ["TCGA.G4.6298.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.832663482261279}], ["FURIN", ["TCGA.A6.5665.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.810682143846604}], ["FURIN", ["TCGA.AD.6889.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.932206076550522}], ["PTPRK", ["TCGA.DM.A1D8.01", "Initial triggering of complement"], {"weight": 0.734555247445462}], ["USP9X", ["TCGA.AZ.4682.01", "GABA receptor activation"], {"weight": 0.877198984050699}], ["USP9X", ["TCGA.AZ.4682.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.619103478404186}], ["USP9X", ["TCGA.AZ.4682.01", "Phase II - Conjugation of compounds"], {"weight": 0.711328990093487}], ["USP9X", ["TCGA.CK.5912.01", "Biological oxidations"], {"weight": 0.921373277485495}], ["USP9X", ["TCGA.CK.5912.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.799611103688708}], ["USP9X", ["TCGA.CM.5862.01", "APAP ADME"], {"weight": 0.825724238099195}], ["USP9X", ["TCGA.CM.6680.01", "Phase II - Conjugation of compounds"], {"weight": 0.666369177877569}], ["DDX54", ["TCGA.G4.6320.01", "Initial triggering of complement"], {"weight": 0.798797750698444}], ["PFKP", ["TCGA.AD.6889.01", "Sialic acid metabolism"], {"weight": 0.721351831749426}], ["KLKB1", ["TCGA.AM.5821.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.956956188958222}], ["KLKB1", ["TCGA.CM.6171.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.751824330641816}], ["KLKB1", ["TCGA.D5.6927.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.921469882068327}], ["SAFB", ["TCGA.D5.6930.01", "O-linked glycosylation of mucins"], {"weight": 0.888397757259045}], ["EVC2", ["TCGA.AA.3502.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.754854368135266}], ["EVC2", ["TCGA.DM.A28C.01", "Binding and entry of HIV virion"], {"weight": 0.708444640873267}], ["EVC2", ["TCGA.DM.A28C.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.811926307598791}], ["LRFN3", ["TCGA.A6.5665.01", "Synaptic adhesion-like molecules"], {"weight": 0.8338583293349}], ["NOTUM", ["TCGA.AZ.6601.01", "WNT ligand biogenesis and trafficking"], {"weight": 0.878805121656301}], ["DERA", ["TCGA.A6.5667.01", "Phase II - Conjugation of compounds"], {"weight": 0.645724863913616}], ["DERA", ["TCGA.A6.5667.01", "Glucuronidation"], {"weight": 0.707707749169058}], ["FASN", ["TCGA.CK.5913.01", "Synthesis of bile acids and bile salts via 27-hydroxycholesterol"], {"weight": 0.742412263139763}], ["CPS1", ["TCGA.D5.5541.01", "APAP ADME"], {"weight": 0.752682600732888}], ["CPS1", ["TCGA.D5.5541.01", "Arachidonic acid metabolism"], {"weight": 0.809916734805028}], ["SERPINB1", ["TCGA.CK.5913.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.918749479690187}], ["CYP17A1", ["TCGA.CM.6171.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.919048687107758}], ["CYP17A1", ["TCGA.CM.6171.01", "APAP ADME"], {"weight": 0.88214281670268}], ["DPYD", ["TCGA.CK.5913.01", "Ethanol oxidation"], {"weight": 0.8921006669646}], ["RDH12", ["TCGA.A6.5665.01", "RA biosynthesis pathway"], {"weight": 0.922807360768459}], ["RDH12", ["TCGA.A6.5665.01", "Ethanol oxidation"], {"weight": 0.91290413509343}], ["CYP7B1", ["TCGA.A6.5665.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], {"weight": 0.852797259221355}], ["CYP7B1", ["TCGA.A6.5665.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.753136046949291}], ["CYP7B1", ["TCGA.CA.6718.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.928186358322174}], ["CYP7B1", ["TCGA.CA.6718.01", "Synthesis of bile acids and bile salts via 27-hydroxycholesterol"], {"weight": 0.914249533772203}], ["CYP7B1", ["TCGA.CA.6718.01", "Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"], {"weight": 0.84933982436778}], ["CYP7B1", ["TCGA.CA.6718.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], {"weight": 0.916604634587442}], ["PAX5", ["TCGA.DM.A1DA.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.90131496173995}], ["ADCY7", ["TCGA.A6.5666.01", "Regulation of Complement cascade"], {"weight": 0.898064714264417}], ["ADCY7", ["TCGA.A6.5666.01", "Initial triggering of complement"], {"weight": 0.934787844976771}], ["ADCY7", ["TCGA.A6.5666.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.906329186418223}], ["ADCY7", ["TCGA.A6.5666.01", "Phase II - Conjugation of compounds"], {"weight": 0.847434697280773}], ["ADCY7", ["TCGA.A6.5666.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.798571077278152}], ["ADCY7", ["TCGA.AZ.6605.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.543937258834437}], ["DSCAM", ["TCGA.A6.5666.01", "Heme degradation"], {"weight": 0.776933977648628}], ["DSCAM", ["TCGA.AZ.4682.01", "Complement cascade"], {"weight": 0.834053758274632}], ["DSCAM", ["TCGA.AZ.4682.01", "Regulation of Complement cascade"], {"weight": 0.80543874528926}], ["DSCAM", ["TCGA.AZ.4682.01", "Arachidonic acid metabolism"], {"weight": 0.778342971178824}], ["FGFR2", ["TCGA.A6.5666.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.925812033440798}], ["FGFR2", ["TCGA.A6.5666.01", "Presynaptic function of Kainate receptors"], {"weight": 0.91379967392745}], ["FGFR2", ["TCGA.A6.5666.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.911028773944442}], ["FGFR2", ["TCGA.A6.5666.01", "Sialic acid metabolism"], {"weight": 0.61603122729231}], ["HTR2C", ["TCGA.A6.5666.01", "Potassium Channels"], {"weight": 0.921146142327392}], ["HTR2C", ["TCGA.A6.5666.01", "Glucagon-type ligand receptors"], {"weight": 0.942752371172416}], ["HTR2C", ["TCGA.A6.5666.01", "GABA receptor activation"], {"weight": 0.931230312645611}], ["HTR2C", ["TCGA.A6.5666.01", "G beta:gamma signalling through BTK"], {"weight": 0.931444706372826}], ["HTR2C", ["TCGA.A6.5666.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.928468212146744}], ["BRPF3", ["TCGA.A6.5666.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.846855895211645}], ["NRCAM", ["TCGA.A6.5666.01", "Interaction between L1 and Ankyrins"], {"weight": 0.945177436449654}], ["SEMA3A", ["TCGA.DM.A0XF.01", "CD22 mediated BCR regulation"], {"weight": 0.764941772406173}], ["GRP", ["TCGA.A6.5667.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.791862871657635}], ["TGFB1", ["TCGA.AY.6386.01", "Regulation of Complement cascade"], {"weight": 0.84320438869256}], ["TGFB1", ["TCGA.AY.6386.01", "Molecules associated with elastic fibres"], {"weight": 0.788758469631417}], ["TGFB1", ["TCGA.AY.6386.01", "Complement cascade"], {"weight": 0.855539411520577}], ["TGFB1", ["TCGA.F4.6703.01", "Keratinization"], {"weight": 0.883150307127094}], ["TGFB1", ["TCGA.F4.6703.01", "Formation of the cornified envelope"], {"weight": 0.780942750884443}], ["TGFB1", ["TCGA.F4.6703.01", "Chondroitin sulfate biosynthesis"], {"weight": 0.890947646418541}], ["DTX1", ["TCGA.A6.5667.01", "Blood group systems biosynthesis"], {"weight": 0.801536552111808}], ["DTX1", ["TCGA.A6.5667.01", "Lewis blood group biosynthesis"], {"weight": 0.791754502753403}], ["GRP", ["TCGA.AZ.6607.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.901223979999602}], ["OBSL1", ["TCGA.A6.5667.01", "Ethanol oxidation"], {"weight": 0.816679076093387}], ["OBSL1", ["TCGA.A6.5667.01", "RA biosynthesis pathway"], {"weight": 0.831938855710784}], ["OBSL1", ["TCGA.AA.3662.01", "Ethanol oxidation"], {"weight": 0.801291966202714}], ["OBSL1", ["TCGA.AA.3662.01", "RA biosynthesis pathway"], {"weight": 0.799292349491639}], ["OBSL1", ["TCGA.CM.6161.01", "RA biosynthesis pathway"], {"weight": 0.779916902538605}], ["OBSL1", ["TCGA.CM.6161.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.734514609328229}], ["KCNJ16", ["TCGA.A6.5667.01", "Glucagon-type ligand receptors"], {"weight": 0.889391428117967}], ["PDK2", ["TCGA.DM.A1D8.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.775135452863899}], ["NEFH", ["TCGA.A6.6650.01", "Heme degradation"], {"weight": 0.798286586701193}], ["NEFH", ["TCGA.A6.6652.01", "Arachidonic acid metabolism"], {"weight": 0.890610081284412}], ["NEFH", ["TCGA.AD.6890.01", "Acyl chain remodelling of PE"], {"weight": 0.777530385367888}], ["NEFH", ["TCGA.AM.5820.01", "FOXO-mediated transcription of cell death genes"], {"weight": 0.643989769770134}], ["NEFH", ["TCGA.CM.6170.01", "Metabolism of amine-derived hormones"], {"weight": 0.449864425556487}], ["NEFH", ["TCGA.CM.6170.01", "Arachidonic acid metabolism"], {"weight": 0.79842846974828}], ["NEFH", ["TCGA.DM.A1D8.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.805123554215652}], ["NEFH", ["TCGA.DM.A1DB.01", "Acyl chain remodelling of PE"], {"weight": 0.84050698334722}], ["GRIN3B", ["TCGA.AA.3662.01", "Assembly and cell surface presentation of NMDA receptors"], {"weight": 0.726464247653676}], ["GRIN3B", ["TCGA.AY.6386.01", "Neurexins and neuroligins"], {"weight": 0.926480511718633}], ["GRIN3B", ["TCGA.D5.6537.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.890097935861755}], ["KCNJ16", ["TCGA.A6.5667.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.887663252874977}], ["KCNJ16", ["TCGA.A6.5667.01", "G beta:gamma signalling through BTK"], {"weight": 0.885681142382958}], ["KCNJ16", ["TCGA.AD.6895.01", "Potassium Channels"], {"weight": 0.890675420873678}], ["TFEC", ["TCGA.A6.6137.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.840222433596833}], ["TCF7L2", ["TCGA.A6.6137.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], {"weight": 0.70239949558231}], ["TCF7L2", ["TCGA.CK.4950.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], {"weight": 0.777591816365152}], ["TCF7L2", ["TCGA.CK.5915.01", "Glucagon-type ligand receptors"], {"weight": 0.936868109592331}], ["TCF7L2", ["TCGA.CK.5915.01", "TNFs bind their physiological receptors"], {"weight": 0.509664256179122}], ["TCF7L2", ["TCGA.CM.5349.01", "Phase II - Conjugation of compounds"], {"weight": 0.781469067685038}], ["TCF7L2", ["TCGA.G4.6293.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], {"weight": 0.855978273385153}], ["TCF7L2", ["TCGA.G4.6293.01", "Keratinization"], {"weight": 0.757686359051558}], ["TBP", ["TCGA.AA.3511.01", "Ethanol oxidation"], {"weight": 0.690952235327523}], ["TBP", ["TCGA.AA.3660.01", "Ethanol oxidation"], {"weight": 0.62586538460021}], ["TBP", ["TCGA.DM.A1DB.01", "Defective pyroptosis"], {"weight": 0.721086283089759}], ["TBP", ["TCGA.F4.6460.01", "Aspirin ADME"], {"weight": 0.675930906327872}], ["TBP", ["TCGA.F4.6463.01", "Ethanol oxidation"], {"weight": 0.625369081008934}], ["SCN3B", ["TCGA.G4.6311.01", "Interaction between L1 and Ankyrins"], {"weight": 0.884171689440004}], ["COL3A1", ["TCGA.CM.6164.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.929238229864467}], ["COL3A1", ["TCGA.G4.6588.01", "Collagen chain trimerization"], {"weight": 0.92779295176095}], ["HOXD4", ["TCGA.A6.6137.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.411152106796596}], ["LRRK2", ["TCGA.AD.6964.01", "APAP ADME"], {"weight": 0.621581163833865}], ["SELP", ["TCGA.DM.A28F.01", "Erythrocytes take up carbon dioxide and release oxygen"], {"weight": 0.810890526683056}], ["SELP", ["TCGA.DM.A28F.01", "O2/CO2 exchange in erythrocytes"], {"weight": 0.810890526683056}], ["OR51S1", ["TCGA.A6.6137.01", "Glucagon-type ligand receptors"], {"weight": 0.873244767770455}], ["SCN2A", ["TCGA.A6.6137.01", "Interaction between L1 and Ankyrins"], {"weight": 0.878758275787841}], ["SCN2A", ["TCGA.AA.3663.01", "Phase 0 - rapid depolarisation"], {"weight": 0.939170658240929}], ["SCN2A", ["TCGA.AU.3779.01", "Interaction between L1 and Ankyrins"], {"weight": 0.875512973143786}], ["SCN2A", ["TCGA.AU.3779.01", "Phase 4 - resting membrane potential"], {"weight": 0.596292341139515}], ["SCN2A", ["TCGA.CM.5861.01", "Phase 0 - rapid depolarisation"], {"weight": 0.945120407311791}], ["SCN2A", ["TCGA.D5.6540.01", "Interaction between L1 and Ankyrins"], {"weight": 0.946920315400741}], ["SCN2A", ["TCGA.G4.6306.01", "Interaction between L1 and Ankyrins"], {"weight": 0.9531918494413}], ["SCN2A", ["TCGA.G4.6306.01", "Phase 0 - rapid depolarisation"], {"weight": 0.947717062034201}], ["SCN2A", ["TCGA.G4.6315.01", "Interaction between L1 and Ankyrins"], {"weight": 0.942496533537451}], ["SCN2A", ["TCGA.G4.6628.01", "Stimuli-sensing channels"], {"weight": 0.921630867228014}], ["KCNQ5", ["TCGA.AY.6197.01", "Interaction between L1 and Ankyrins"], {"weight": 0.939968167498591}], ["KCNQ5", ["TCGA.CM.6170.01", "Inwardly rectifying K+ channels"], {"weight": 0.915075817692186}], ["KCNQ5", ["TCGA.CM.6170.01", "Phase 4 - resting membrane potential"], {"weight": 0.868373109874984}], ["KCNQ5", ["TCGA.CM.6170.01", "Activation of G protein gated Potassium channels"], {"weight": 0.900041328907449}], ["KCNQ5", ["TCGA.CM.6170.01", "G protein gated Potassium channels"], {"weight": 0.900041328907449}], ["KCNQ5", ["TCGA.CM.6170.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.900041328907449}], ["KCNQ5", ["TCGA.D5.6529.01", "Phase 4 - resting membrane potential"], {"weight": 0.835331166557301}], ["TSC2", ["TCGA.A6.6138.01", "Glucuronidation"], {"weight": 0.848628401243995}], ["TSC2", ["TCGA.A6.6138.01", "Carnitine metabolism"], {"weight": 0.622135801403448}], ["PLCG2", ["TCGA.G4.6586.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.939455119283507}], ["PAX6", ["TCGA.A6.6781.01", "Glucagon-type ligand receptors"], {"weight": 0.909695495765684}], ["PAX6", ["TCGA.DM.A28F.01", "Formation of the anterior neural plate"], {"weight": 0.716281676302947}], ["PAX6", ["TCGA.DM.A28K.01", "CD22 mediated BCR regulation"], {"weight": 0.824642870175469}], ["OR2C1", ["TCGA.A6.6138.01", "Potassium Channels"], {"weight": 0.94933414421137}], ["OR2C1", ["TCGA.A6.6138.01", "Phase 4 - resting membrane potential"], {"weight": 0.809361049397848}], ["PRKACG", ["TCGA.A6.6140.01", "Interaction between L1 and Ankyrins"], {"weight": 0.932424677969895}], ["PRKACG", ["TCGA.AD.5900.01", "Phase 0 - rapid depolarisation"], {"weight": 0.875849516515846}], ["ARHGAP35", ["TCGA.G4.6311.01", "Other semaphorin interactions"], {"weight": 0.597608076409422}], ["TAS2R16", ["TCGA.A6.6140.01", "Initial triggering of complement"], {"weight": 0.825762655871216}], ["OR10A2", ["TCGA.A6.6140.01", "Phase 4 - resting membrane potential"], {"weight": 0.794468564609379}], ["OR10A2", ["TCGA.A6.6140.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.895297981993549}], ["OR2A5", ["TCGA.A6.6140.01", "Potassium Channels"], {"weight": 0.945575134195225}], ["OR2A5", ["TCGA.A6.6140.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.890548721848643}], ["OR2A5", ["TCGA.A6.6140.01", "Presynaptic function of Kainate receptors"], {"weight": 0.867459092009048}], ["OR2A5", ["TCGA.A6.6140.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.899960616969836}], ["OR2A5", ["TCGA.A6.6140.01", "G beta:gamma signalling through BTK"], {"weight": 0.885414493760369}], ["OR2A5", ["TCGA.A6.6140.01", "GABA receptor activation"], {"weight": 0.83370531121991}], ["OR2A5", ["TCGA.A6.6650.01", "Glucagon-type ligand receptors"], {"weight": 0.925205932190356}], ["OR2A5", ["TCGA.A6.6650.01", "Potassium Channels"], {"weight": 0.93467541621728}], ["OR2A5", ["TCGA.A6.6650.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.910400123105745}], ["OR2A5", ["TCGA.A6.6650.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.897230206258559}], ["OR2A5", ["TCGA.A6.6650.01", "G beta:gamma signalling through BTK"], {"weight": 0.90076404686036}], ["GP6", ["TCGA.AA.3492.01", "Collagen chain trimerization"], {"weight": 0.912680480992953}], ["GP6", ["TCGA.CK.5913.01", "Collagen chain trimerization"], {"weight": 0.927696621541243}], ["GP6", ["TCGA.CM.5868.01", "Collagen chain trimerization"], {"weight": 0.91885839731927}], ["GP6", ["TCGA.CM.5868.01", "NCAM1 interactions"], {"weight": 0.928768850978995}], ["GP6", ["TCGA.CM.5868.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.933767540036591}], ["GP6", ["TCGA.CM.6674.01", "Collagen chain trimerization"], {"weight": 0.91802656886157}], ["GP6", ["TCGA.D5.6924.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.941320408728281}], ["GP6", ["TCGA.D5.6924.01", "Collagen chain trimerization"], {"weight": 0.912396721740759}], ["GP6", ["TCGA.D5.6924.01", "Collagen degradation"], {"weight": 0.910171390872394}], ["PDE6A", ["TCGA.G4.6304.01", "Glucagon-type ligand receptors"], {"weight": 0.931543105925988}], ["GMIP", ["TCGA.D5.6537.01", "Acetylcholine Neurotransmitter Release Cycle"], {"weight": 0.669762185836471}], ["COL4A4", ["TCGA.A6.6782.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.63766154805594}], ["COL4A4", ["TCGA.AY.6196.01", "Glucuronidation"], {"weight": 0.843728784327244}], ["COL4A4", ["TCGA.AZ.6601.01", "Collagen chain trimerization"], {"weight": 0.916905375504068}], ["NCAPD2", ["TCGA.G4.6293.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.694105794421699}], ["PKD1L1", ["TCGA.D5.6532.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.8845861017939}], ["TNFRSF10A", ["TCGA.A6.6140.01", "Porphyrin metabolism"], {"weight": 0.598507624604088}], ["MUC16", ["TCGA.A6.6650.01", "Keratan sulfate biosynthesis"], {"weight": 0.931279790995175}], ["MUC16", ["TCGA.A6.6781.01", "O-linked glycosylation"], {"weight": 0.865176777519559}], ["MUC16", ["TCGA.CA.6716.01", "Blood group systems biosynthesis"], {"weight": 0.852316623741754}], ["MUC16", ["TCGA.CA.6716.01", "Lewis blood group biosynthesis"], {"weight": 0.846194042599415}], ["MUC16", ["TCGA.CA.6716.01", "Sialic acid metabolism"], {"weight": 0.638013040248064}], ["MUC16", ["TCGA.CA.6716.01", "Defective GALNT12 causes CRCS1"], {"weight": 0.880734049068453}], ["MUC16", ["TCGA.CM.5868.01", "Blood group systems biosynthesis"], {"weight": 0.591467845542533}], ["MUC16", ["TCGA.D5.6898.01", "Blood group systems biosynthesis"], {"weight": 0.84582470258422}], ["MUC16", ["TCGA.D5.6898.01", "Lewis blood group biosynthesis"], {"weight": 0.832606004767327}], ["MUC16", ["TCGA.DM.A1DA.01", "Blood group systems biosynthesis"], {"weight": 0.873971790322689}], ["MUC16", ["TCGA.DM.A28G.01", "Regulation of Complement cascade"], {"weight": 0.692512868904025}], ["MUC16", ["TCGA.DM.A28G.01", "Complement cascade"], {"weight": 0.767704128409044}], ["MUC16", ["TCGA.DM.A28M.01", "Initial triggering of complement"], {"weight": 0.919737174859326}], ["MUC16", ["TCGA.DM.A28M.01", "Blood group systems biosynthesis"], {"weight": 0.759685151124698}], ["MUC16", ["TCGA.DM.A28M.01", "Keratan sulfate biosynthesis"], {"weight": 0.934729877392421}], ["MUC16", ["TCGA.DM.A28M.01", "Lewis blood group biosynthesis"], {"weight": 0.717888604865144}], ["MUC16", ["TCGA.G4.6299.01", "O-linked glycosylation"], {"weight": 0.912928600808892}], ["MUC16", ["TCGA.G4.6299.01", "O-linked glycosylation of mucins"], {"weight": 0.938416938919212}], ["MUC16", ["TCGA.G4.6299.01", "Lewis blood group biosynthesis"], {"weight": 0.756856619793839}], ["MUC16", ["TCGA.G4.6299.01", "Blood group systems biosynthesis"], {"weight": 0.756856619793839}], ["MUC16", ["TCGA.G4.6299.01", "Defective GALNT12 causes CRCS1"], {"weight": 0.86319829007936}], ["PYGL", ["TCGA.A6.6140.01", "Glucuronidation"], {"weight": 0.836992499323366}], ["PYGL", ["TCGA.CM.5862.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.882254310177675}], ["FBN3", ["TCGA.A6.6140.01", "Molecules associated with elastic fibres"], {"weight": 0.816011722100343}], ["FBN3", ["TCGA.A6.6140.01", "Elastic fibre formation"], {"weight": 0.819341361069293}], ["NID1", ["TCGA.A6.6140.01", "Regulation of Complement cascade"], {"weight": 0.796449109136957}], ["NID1", ["TCGA.A6.6140.01", "Complement cascade"], {"weight": 0.858544948206173}], ["NID1", ["TCGA.F4.6570.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.918589615648755}], ["HSP90B1", ["TCGA.A6.6140.01", "Classical antibody-mediated complement activation"], {"weight": 0.705814977725024}], ["TYK2", ["TCGA.A6.6140.01", "Chemokine receptors bind chemokines"], {"weight": 0.908379690060609}], ["HSP90B1", ["TCGA.A6.6140.01", "Creation of C4 and C2 activators"], {"weight": 0.705814977725024}], ["HSP90B1", ["TCGA.F4.6856.01", "Classical antibody-mediated complement activation"], {"weight": 0.636400187214743}], ["MAMLD1", ["TCGA.DM.A1D8.01", "Blood group systems biosynthesis"], {"weight": 0.805319173095911}], ["MAMLD1", ["TCGA.DM.A1D8.01", "Lewis blood group biosynthesis"], {"weight": 0.788959655991737}], ["EPN3", ["TCGA.A6.6140.01", "Phospholipase C-mediated cascade; FGFR2"], {"weight": 0.893095255692532}], ["EPN3", ["TCGA.A6.6140.01", "FGFR2 ligand binding and activation"], {"weight": 0.904488969224476}], ["EPN3", ["TCGA.A6.6140.01", "Activated point mutants of FGFR2"], {"weight": 0.872013728336216}], ["B3GAT2", ["TCGA.A6.6140.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], {"weight": 0.824803182472524}], ["WWC2", ["TCGA.A6.6140.01", "MyD88 deficiency (TLR2/4)"], {"weight": 0.815142631158727}], ["WWC2", ["TCGA.A6.6140.01", "IRAK4 deficiency (TLR2/4)"], {"weight": 0.815142631158727}], ["ADAMTS9", ["TCGA.F4.6808.01", "Lewis blood group biosynthesis"], {"weight": 0.713498530598862}], ["ADAMTS9", ["TCGA.F4.6808.01", "Blood group systems biosynthesis"], {"weight": 0.763018253401876}], ["MMP19", ["TCGA.A6.6140.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.748954341199389}], ["GMPR", ["TCGA.A6.6140.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.808682098829344}], ["GSTM4", ["TCGA.A6.6140.01", "Arachidonic acid metabolism"], {"weight": 0.859708267988957}], ["GSTM4", ["TCGA.A6.6140.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.873145256346208}], ["GRIA2", ["TCGA.A6.6141.01", "Neuronal System"], {"weight": 0.874761264363278}], ["OR8J3", ["TCGA.AA.3502.01", "Potassium Channels"], {"weight": 0.957737454388117}], ["OR8J3", ["TCGA.AA.3502.01", "GABA B receptor activation"], {"weight": 0.937291553260794}], ["OR8J3", ["TCGA.AA.3502.01", "Activation of GABAB receptors"], {"weight": 0.937291553260794}], ["OR8J3", ["TCGA.AA.3502.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.918008127742941}], ["OR8J3", ["TCGA.AA.3502.01", "GABA receptor activation"], {"weight": 0.889914061347595}], ["OR8J3", ["TCGA.AA.3502.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.929330346327554}], ["OR8J3", ["TCGA.AA.3502.01", "Prostacyclin signalling through prostacyclin receptor"], {"weight": 0.906994538938716}], ["OR8J3", ["TCGA.AA.3502.01", "Inwardly rectifying K+ channels"], {"weight": 0.933834500526555}], ["OR8J3", ["TCGA.AA.3502.01", "Thromboxane signalling through TP receptor"], {"weight": 0.891418265231541}], ["OR8J3", ["TCGA.AA.3502.01", "Presynaptic function of Kainate receptors"], {"weight": 0.896378553553418}], ["OR8J3", ["TCGA.AA.3502.01", "Activation of G protein gated Potassium channels"], {"weight": 0.927072598178895}], ["OR8J3", ["TCGA.AA.3502.01", "G protein gated Potassium channels"], {"weight": 0.927072598178895}], ["OR8J3", ["TCGA.AA.3502.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.927072598178895}], ["OR8J3", ["TCGA.AA.3502.01", "G beta:gamma signalling through BTK"], {"weight": 0.882223083535854}], ["OR8J3", ["TCGA.AA.3502.01", "G-protein activation"], {"weight": 0.912986778985543}], ["OR8J3", ["TCGA.AA.3502.01", "Adenylate cyclase inhibitory pathway"], {"weight": 0.899121109398781}], ["OR8J3", ["TCGA.AA.3502.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.882223083535854}], ["RASA2", ["TCGA.AD.6964.01", "Scavenging of heme from plasma"], {"weight": 0.714631397759931}], ["UBA6", ["TCGA.F4.6854.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.577102620037726}], ["GRIA2", ["TCGA.A6.6141.01", "Transmission across Chemical Synapses"], {"weight": 0.84346070265818}], ["GRIA2", ["TCGA.F4.6704.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.923486251835336}], ["COL9A3", ["TCGA.F4.6570.01", "Collagen chain trimerization"], {"weight": 0.924133659220891}], ["COL9A3", ["TCGA.F4.6570.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.928103924160755}], ["COL9A3", ["TCGA.G4.6626.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.925062590707712}], ["COL9A3", ["TCGA.G4.6626.01", "NCAM1 interactions"], {"weight": 0.943957388160295}], ["GOLGB1", ["TCGA.A6.6780.01", "Interaction between L1 and Ankyrins"], {"weight": 0.939614480438065}], ["GOLGB1", ["TCGA.AA.3502.01", "Interaction between L1 and Ankyrins"], {"weight": 0.92388765270624}], ["GOLGB1", ["TCGA.D5.6927.01", "Interaction between L1 and Ankyrins"], {"weight": 0.920800144156834}], ["GOLGB1", ["TCGA.DM.A0XF.01", "Interaction between L1 and Ankyrins"], {"weight": 0.941901447118171}], ["CASQ2", ["TCGA.AZ.6598.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.886051693149137}], ["COL6A5", ["TCGA.CM.6168.01", "Collagen chain trimerization"], {"weight": 0.892706254909396}], ["COL6A5", ["TCGA.F4.6805.01", "Scavenging by Class A Receptors"], {"weight": 0.631869927417779}], ["COL6A5", ["TCGA.F4.6805.01", "Collagen degradation"], {"weight": 0.839563199179269}], ["GRIN3A", ["TCGA.D5.6529.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.92130299316297}], ["KCNN3", ["TCGA.AA.3662.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.828234525950906}], ["KCNN3", ["TCGA.AA.3697.01", "Potassium Channels"], {"weight": 0.941086127849641}], ["OR2L3", ["TCGA.CK.5912.01", "Potassium Channels"], {"weight": 0.957252143364412}], ["OR2L3", ["TCGA.CK.5912.01", "Carnitine metabolism"], {"weight": 0.67228416542985}], ["OR2L3", ["TCGA.CK.5912.01", "Voltage gated Potassium channels"], {"weight": 0.865287441656554}], ["OR2L3", ["TCGA.CK.5912.01", "Activation of G protein gated Potassium channels"], {"weight": 0.930566683195436}], ["OR2L3", ["TCGA.CK.5912.01", "G protein gated Potassium channels"], {"weight": 0.930566683195436}], ["OR2L3", ["TCGA.CK.5912.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.930566683195436}], ["OR2L3", ["TCGA.CK.5912.01", "Inwardly rectifying K+ channels"], {"weight": 0.936179114432457}], ["OR2L3", ["TCGA.CK.5912.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.903695600346146}], ["OR2L3", ["TCGA.CK.5912.01", "Neurexins and neuroligins"], {"weight": 0.870576392773191}], ["OR2L3", ["TCGA.CK.5912.01", "Protein-protein interactions at synapses"], {"weight": 0.866953608013966}], ["OR2L3", ["TCGA.CK.5912.01", "G-protein beta:gamma signalling"], {"weight": 0.912819547123256}], ["OR2L3", ["TCGA.CK.5912.01", "GABA B receptor activation"], {"weight": 0.93178006406288}], ["OR2L3", ["TCGA.CK.5912.01", "Activation of GABAB receptors"], {"weight": 0.93178006406288}], ["OR2L3", ["TCGA.CK.5912.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.87026539753561}], ["OR2L3", ["TCGA.CK.5912.01", "Signal amplification"], {"weight": 0.907887506434099}], ["OR2L3", ["TCGA.CK.5912.01", "Glucagon-type ligand receptors"], {"weight": 0.928368835759832}], ["OR2L3", ["TCGA.CK.5912.01", "Ca2+ pathway"], {"weight": 0.843208029382937}], ["OR2L3", ["TCGA.CK.5912.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.91661838977805}], ["MAPK12", ["TCGA.DM.A1D4.01", "Glucagon-type ligand receptors"], {"weight": 0.929291446671488}], ["CHRM2", ["TCGA.D5.6931.01", "GABA receptor activation"], {"weight": 0.854601863258665}], ["NOS3", ["TCGA.AY.6197.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.843711523421452}], ["COL5A1", ["TCGA.CK.4948.01", "Collagen chain trimerization"], {"weight": 0.925664439004031}], ["COL5A1", ["TCGA.CK.4948.01", "O-linked glycosylation"], {"weight": 0.915712173403961}], ["COL5A1", ["TCGA.CK.5913.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.942767592074362}], ["COL5A1", ["TCGA.CM.6163.01", "Collagen chain trimerization"], {"weight": 0.875799303390273}], ["ANKRD1", ["TCGA.F4.6854.01", "Phase II - Conjugation of compounds"], {"weight": 0.706918623823233}], ["ANKRD1", ["TCGA.F4.6854.01", "Glucuronidation"], {"weight": 0.771948400911568}], ["TGM2", ["TCGA.CM.5864.01", "Potassium Channels"], {"weight": 0.955478904789891}], ["TGM2", ["TCGA.CM.5864.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.913365659621476}], ["TGM2", ["TCGA.CM.5864.01", "Glucagon-type ligand receptors"], {"weight": 0.916902062877283}], ["TGM2", ["TCGA.CM.5864.01", "GABA receptor activation"], {"weight": 0.880501798540971}], ["TGM2", ["TCGA.CM.5864.01", "GABA B receptor activation"], {"weight": 0.933745032477251}], ["TGM2", ["TCGA.CM.5864.01", "Activation of GABAB receptors"], {"weight": 0.933745032477251}], ["TGM2", ["TCGA.CM.5864.01", "Presynaptic function of Kainate receptors"], {"weight": 0.895865650084658}], ["TGM2", ["TCGA.CM.5864.01", "Activation of G protein gated Potassium channels"], {"weight": 0.927429928131357}], ["TGM2", ["TCGA.CM.5864.01", "G protein gated Potassium channels"], {"weight": 0.927429928131357}], ["TGM2", ["TCGA.CM.5864.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.929421217420546}], ["TGM2", ["TCGA.CM.5864.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.927429928131357}], ["TGM2", ["TCGA.CM.5864.01", "G beta:gamma signalling through BTK"], {"weight": 0.909986040850172}], ["TGM2", ["TCGA.CM.5864.01", "Inwardly rectifying K+ channels"], {"weight": 0.931979792667126}], ["TGM2", ["TCGA.CM.5864.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.650851494437267}], ["TGM2", ["TCGA.CM.5864.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.884450444297889}], ["TGM2", ["TCGA.CM.5864.01", "Phase 4 - resting membrane potential"], {"weight": 0.827279045786901}], ["COL12A1", ["TCGA.F4.6807.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.91141643412789}], ["COL12A1", ["TCGA.F4.6807.01", "Collagen degradation"], {"weight": 0.889843441527787}], ["COL12A1", ["TCGA.F4.6807.01", "Collagen chain trimerization"], {"weight": 0.86781257764357}], ["MMP16", ["TCGA.CM.5860.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.949126625725177}], ["DNAH8", ["TCGA.DM.A1HA.01", "Serotonin Neurotransmitter Release Cycle"], {"weight": 0.873962454425818}], ["DNAH8", ["TCGA.DM.A1HA.01", "Norepinephrine Neurotransmitter Release Cycle"], {"weight": 0.574125058616211}], ["CD109", ["TCGA.A6.6781.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.873171605006068}], ["AMPD1", ["TCGA.AY.5543.01", "Glutathione conjugation"], {"weight": 0.792451365162727}], ["AMPD1", ["TCGA.AY.5543.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.799933932516705}], ["ANK2", ["TCGA.DM.A1D6.01", "GABA receptor activation"], {"weight": 0.913849055277455}], ["ANK2", ["TCGA.DM.A1D6.01", "CD22 mediated BCR regulation"], {"weight": 0.827545140901142}], ["ANK2", ["TCGA.DM.A1DA.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.859989182454067}], ["ANK2", ["TCGA.DM.A1DB.01", "Defective GALNT12 causes CRCS1"], {"weight": 0.783830952107307}], ["GAD2", ["TCGA.A6.6654.01", "APAP ADME"], {"weight": 0.780145709514604}], ["GAD2", ["TCGA.A6.6654.01", "Phase II - Conjugation of compounds"], {"weight": 0.778599817650985}], ["GAD2", ["TCGA.A6.6654.01", "Degradation of cysteine and homocysteine"], {"weight": 0.696774978206499}], ["GAD2", ["TCGA.A6.6654.01", "Sulfur amino acid metabolism"], {"weight": 0.828299650451598}], ["GAD2", ["TCGA.CM.6165.01", "RA biosynthesis pathway"], {"weight": 0.649981836673093}], ["GNAS", ["TCGA.AA.3489.01", "APAP ADME"], {"weight": 0.525192369995755}], ["GNAS", ["TCGA.AA.3489.01", "Activation of G protein gated Potassium channels"], {"weight": 0.873270685877128}], ["GNAS", ["TCGA.AA.3489.01", "G protein gated Potassium channels"], {"weight": 0.873270685877128}], ["GNAS", ["TCGA.AA.3489.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.873270685877128}], ["GNAS", ["TCGA.AA.3502.01", "Glucagon-type ligand receptors"], {"weight": 0.925482458679393}], ["GNAS", ["TCGA.AA.3660.01", "Prostacyclin signalling through prostacyclin receptor"], {"weight": 0.840589688905785}], ["GNAS", ["TCGA.AA.3660.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.738430359558704}], ["GNAS", ["TCGA.AA.3663.01", "Glucagon-type ligand receptors"], {"weight": 0.930864259815897}], ["GNAS", ["TCGA.AA.3697.01", "Glucagon-type ligand receptors"], {"weight": 0.902732486721449}], ["GNAS", ["TCGA.AU.6004.01", "Glucagon-type ligand receptors"], {"weight": 0.897468239322054}], ["GNAS", ["TCGA.AY.6386.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.820570262997303}], ["GNAS", ["TCGA.AY.6386.01", "Arachidonic acid metabolism"], {"weight": 0.861657125863468}], ["GNAS", ["TCGA.AZ.6598.01", "Glucagon-type ligand receptors"], {"weight": 0.942132698554461}], ["GNAS", ["TCGA.AZ.6599.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], {"weight": 0.813790829210134}], ["GNAS", ["TCGA.CM.6161.01", "Phase 4 - resting membrane potential"], {"weight": 0.770352393235241}], ["GNAS", ["TCGA.CM.6161.01", "Potassium Channels"], {"weight": 0.937790847561265}], ["GNAS", ["TCGA.CM.6675.01", "Potassium Channels"], {"weight": 0.959149510468019}], ["GNAS", ["TCGA.CM.6675.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.933583117841421}], ["GNAS", ["TCGA.CM.6675.01", "G beta:gamma signalling through BTK"], {"weight": 0.922534447347602}], ["GNAS", ["TCGA.CM.6675.01", "Activation of G protein gated Potassium channels"], {"weight": 0.918670841863315}], ["GNAS", ["TCGA.CM.6675.01", "G protein gated Potassium channels"], {"weight": 0.918670841863315}], ["GNAS", ["TCGA.CM.6675.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.918670841863315}], ["GNAS", ["TCGA.CM.6675.01", "Glucagon-type ligand receptors"], {"weight": 0.937102566428865}], ["GNAS", ["TCGA.CM.6675.01", "GABA receptor activation"], {"weight": 0.921327829344778}], ["GNAS", ["TCGA.CM.6675.01", "Inwardly rectifying K+ channels"], {"weight": 0.924794286707413}], ["GNAS", ["TCGA.CM.6675.01", "Presynaptic function of Kainate receptors"], {"weight": 0.912406159173965}], ["GNAS", ["TCGA.CM.6675.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.835528505931978}], ["GNAS", ["TCGA.CM.6675.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.915759186719964}], ["GNAS", ["TCGA.CM.6675.01", "Activation of the phototransduction cascade"], {"weight": 0.800870023264708}], ["ADAMTS20", ["TCGA.CM.6679.01", "Defective B3GALTL causes PpS"], {"weight": 0.883830707247413}], ["ADAMTS20", ["TCGA.CM.6679.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.883759234926206}], ["DICER1", ["TCGA.A6.6652.01", "Glucuronidation"], {"weight": 0.90603524126953}], ["DICER1", ["TCGA.A6.6652.01", "Phase II - Conjugation of compounds"], {"weight": 0.855989144147192}], ["DICER1", ["TCGA.A6.6652.01", "Aspirin ADME"], {"weight": 0.837129296628659}], ["UNC13B", ["TCGA.CM.5861.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], {"weight": 0.919877236529587}], ["CYP2E1", ["TCGA.A6.6141.01", "Drug ADME"], {"weight": 0.845401339703436}], ["ENPEP", ["TCGA.A6.6141.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.729407730142554}], ["HTT", ["TCGA.AA.3713.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.78839889751608}], ["HTT", ["TCGA.AM.5820.01", "Synaptic adhesion-like molecules"], {"weight": 0.885429495532913}], ["HTT", ["TCGA.AY.6197.01", "Glucuronidation"], {"weight": 0.751232231390554}], ["HTT", ["TCGA.CA.6719.01", "Phase II - Conjugation of compounds"], {"weight": 0.844859826381846}], ["HTT", ["TCGA.CA.6719.01", "Glucuronidation"], {"weight": 0.874367467476135}], ["HTT", ["TCGA.F4.6570.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.804696413017174}], ["HTT", ["TCGA.G4.6323.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.683512462775843}], ["HTT", ["TCGA.G4.6323.01", "Phase 0 - rapid depolarisation"], {"weight": 0.843371122161143}], ["MAPRE3", ["TCGA.AD.6889.01", "Classical antibody-mediated complement activation"], {"weight": 0.716863062949229}], ["AGTR1", ["TCGA.CK.5913.01", "GABA receptor activation"], {"weight": 0.90773167777567}], ["AGTR1", ["TCGA.CM.4744.01", "Defective B3GALTL causes PpS"], {"weight": 0.88989059850944}], ["AGTR1", ["TCGA.CM.4744.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.88989059850944}], ["AGTR1", ["TCGA.CM.5861.01", "Regulation of Complement cascade"], {"weight": 0.763652748982093}], ["SYCP2", ["TCGA.CK.5912.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], {"weight": 0.824883117751886}], ["PTPRG", ["TCGA.AD.6889.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.906799976411729}], ["ITK", ["TCGA.CM.4747.01", "Ethanol oxidation"], {"weight": 0.794164778413428}], ["FNTA", ["TCGA.AA.3697.01", "Phase 4 - resting membrane potential"], {"weight": 0.770872212655894}], ["FYN", ["TCGA.A6.6653.01", "CD22 mediated BCR regulation"], {"weight": 0.847021018812253}], ["FYN", ["TCGA.CM.5341.01", "Interaction between L1 and Ankyrins"], {"weight": 0.907603199812789}], ["FYN", ["TCGA.CM.5341.01", "TNFs bind their physiological receptors"], {"weight": 0.361577277671819}], ["PRKCI", ["TCGA.D5.5540.01", "LGI-ADAM interactions"], {"weight": 0.86483947424644}], ["GUCY1A2", ["TCGA.AA.3712.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.88934144812369}], ["PCCA", ["TCGA.D5.6534.01", "APAP ADME"], {"weight": 0.540588041013828}], ["PCCA", ["TCGA.D5.6534.01", "mitochondrial fatty acid beta-oxidation of saturated fatty acids"], {"weight": 0.142782637759018}], ["UGT2B4", ["TCGA.G4.6625.01", "Glucuronidation"], {"weight": 0.855966011071594}], ["UGT2B4", ["TCGA.G4.6625.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.613762327446619}], ["UGT2B4", ["TCGA.G4.6625.01", "Ethanol oxidation"], {"weight": 0.783330120642788}], ["SLC25A3", ["TCGA.F4.6459.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.825880407136201}], ["KIF5A", ["TCGA.G4.6626.01", "Translocation of ZAP-70 to Immunological synapse"], {"weight": 0.884418326550481}], ["COL24A1", ["TCGA.AD.6895.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.94577945891941}], ["COL24A1", ["TCGA.D5.6534.01", "Collagen chain trimerization"], {"weight": 0.921906862608247}], ["PLG", ["TCGA.F4.6856.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.891029035327149}], ["CDK5R1", ["TCGA.A6.6648.01", "Interaction between L1 and Ankyrins"], {"weight": 0.857868268557767}], ["ADCY8", ["TCGA.A6.6648.01", "Phase 0 - rapid depolarisation"], {"weight": 0.887497047222849}], ["ADCY8", ["TCGA.AD.6890.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.818603185980776}], ["OPRM1", ["TCGA.DM.A1HA.01", "Initial triggering of complement"], {"weight": 0.852450530182539}], ["JAK3", ["TCGA.A6.6648.01", "Classical antibody-mediated complement activation"], {"weight": 0.469751696318161}], ["JAK3", ["TCGA.G4.6310.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.841908910033631}], ["JAK3", ["TCGA.G4.6310.01", "TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway"], {"weight": 0.879291010041406}], ["MYH6", ["TCGA.A6.6648.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], {"weight": 0.525234983061448}], ["GABRA5", ["TCGA.CK.5915.01", "GABA receptor activation"], {"weight": 0.927722183146884}], ["SUPT16H", ["TCGA.CK.4952.01", "Resolution of D-loop Structures through Holliday Junction Intermediates"], {"weight": 0.900766055806696}], ["SUPT16H", ["TCGA.CK.4952.01", "Resolution of D-Loop Structures"], {"weight": 0.900766055806696}], ["SUPT16H", ["TCGA.CK.4952.01", "Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)"], {"weight": 0.885458420619174}], ["ACAN", ["TCGA.A6.6649.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.895969019390039}], ["ACAN", ["TCGA.AM.5821.01", "O-linked glycosylation"], {"weight": 0.94641230485658}], ["ACAN", ["TCGA.AZ.4616.01", "Blood group systems biosynthesis"], {"weight": 0.677910264143448}], ["ACAN", ["TCGA.AZ.4616.01", "Lewis blood group biosynthesis"], {"weight": 0.630024633739096}], ["ACAN", ["TCGA.D5.6534.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.935281993164667}], ["ACAN", ["TCGA.D5.6534.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.935565992458781}], ["ACAN", ["TCGA.D5.6534.01", "Collagen degradation"], {"weight": 0.913536402800488}], ["ACAN", ["TCGA.D5.6534.01", "O-linked glycosylation"], {"weight": 0.814434130734177}], ["ACAN", ["TCGA.G4.6302.01", "O-linked glycosylation"], {"weight": 0.885892451371741}], ["ACAN", ["TCGA.G4.6302.01", "Diseases associated with O-glycosylation of proteins"], {"weight": 0.833395126353171}], ["IRS2", ["TCGA.AY.6386.01", "FGFR1 ligand binding and activation"], {"weight": 0.907828577942563}], ["TAS2R46", ["TCGA.A6.6650.01", "Initial triggering of complement"], {"weight": 0.886852683045842}], ["TAS2R46", ["TCGA.DM.A1DB.01", "Initial triggering of complement"], {"weight": 0.814051736084965}], ["DAPK1", ["TCGA.CA.6716.01", "Arachidonic acid metabolism"], {"weight": 0.884500171428933}], ["DAPK1", ["TCGA.CA.6716.01", "Acyl chain remodelling of PE"], {"weight": 0.74103949234341}], ["MED15", ["TCGA.A6.6650.01", "Glucuronidation"], {"weight": 0.818908854394937}], ["MED15", ["TCGA.G4.6321.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.418567252331402}], ["KCNAB2", ["TCGA.A6.6650.01", "Phase 4 - resting membrane potential"], {"weight": 0.812966666918011}], ["WNK1", ["TCGA.A6.6650.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.651540844355163}], ["WNK1", ["TCGA.F4.6806.01", "Regulation of FZD by ubiquitination"], {"weight": 0.76789911659451}], ["AMPH", ["TCGA.AU.3779.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.911010306116656}], ["AMPH", ["TCGA.AU.3779.01", "Peptide ligand-binding receptors"], {"weight": 0.909502770598158}], ["AMPH", ["TCGA.AU.3779.01", "GABA receptor activation"], {"weight": 0.849473535997822}], ["OR56B4", ["TCGA.A6.6652.01", "Activation of the phototransduction cascade"], {"weight": 0.834312807369114}], ["SYT5", ["TCGA.A6.6652.01", "CD22 mediated BCR regulation"], {"weight": 0.831933551379361}], ["SYT5", ["TCGA.D5.6540.01", "Phase 0 - rapid depolarisation"], {"weight": 0.94347297275619}], ["SYT5", ["TCGA.D5.6540.01", "NCAM1 interactions"], {"weight": 0.942491917594235}], ["DIRAS1", ["TCGA.A6.6652.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.842087453836901}], ["SCN8A", ["TCGA.A6.6653.01", "Interaction between L1 and Ankyrins"], {"weight": 0.944340535045211}], ["ESR2", ["TCGA.D5.6926.01", "Phase II - Conjugation of compounds"], {"weight": 0.872592397699113}], ["ESR2", ["TCGA.D5.6926.01", "Glucuronidation"], {"weight": 0.885480700061353}], ["ESR2", ["TCGA.D5.6926.01", "Signaling by Retinoic Acid"], {"weight": 0.715182841418864}], ["PPP2R5A", ["TCGA.D5.6536.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.765405119978201}], ["PPP2R5A", ["TCGA.D5.6536.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.842692306993163}], ["PIK3CG", ["TCGA.AA.3660.01", "FGFR2 ligand binding and activation"], {"weight": 0.861496561709756}], ["PIK3CG", ["TCGA.AA.3660.01", "FGFR2c ligand binding and activation"], {"weight": 0.837608082623029}], ["PIK3CG", ["TCGA.AA.3660.01", "Activated point mutants of FGFR2"], {"weight": 0.837608082623029}], ["PIK3CG", ["TCGA.D5.6533.01", "IL-6-type cytokine receptor ligand interactions"], {"weight": 0.890616625536242}], ["B2M", ["TCGA.D5.5538.01", "Defective GALNT12 causes CRCS1"], {"weight": 0.690481050782398}], ["B2M", ["TCGA.D5.5538.01", "NCAM1 interactions"], {"weight": 0.913395466800652}], ["B2M", ["TCGA.DM.A28F.01", "Classical antibody-mediated complement activation"], {"weight": 0.66380088607278}], ["B2M", ["TCGA.DM.A28F.01", "Creation of C4 and C2 activators"], {"weight": 0.745728933248473}], ["ADCY6", ["TCGA.AA.3492.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.843956304882894}], ["ADCY6", ["TCGA.G4.6588.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.85669687768659}], ["ADCY5", ["TCGA.G4.6309.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.860811894668869}], ["MAP3K11", ["TCGA.D5.6920.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.880546973249887}], ["MAP3K11", ["TCGA.D5.6920.01", "Visual phototransduction"], {"weight": 0.793613359193389}], ["OR51A2", ["TCGA.A6.6653.01", "GABA B receptor activation"], {"weight": 0.921851317154255}], ["OR51A2", ["TCGA.A6.6653.01", "Activation of GABAB receptors"], {"weight": 0.921851317154255}], ["OR51A2", ["TCGA.AZ.4615.01", "Inwardly rectifying K+ channels"], {"weight": 0.927335796861898}], ["GRIA1", ["TCGA.AD.6890.01", "Phase 0 - rapid depolarisation"], {"weight": 0.921925650863732}], ["GRIA1", ["TCGA.AD.6890.01", "Insulin processing"], {"weight": 0.611044661349741}], ["OR2M4", ["TCGA.DM.A0XF.01", "Potassium Channels"], {"weight": 0.960448771850045}], ["OR2M4", ["TCGA.DM.A0XF.01", "Phase 4 - resting membrane potential"], {"weight": 0.861869284695899}], ["OR2M4", ["TCGA.DM.A0XF.01", "GABA receptor activation"], {"weight": 0.915528009099176}], ["OR2M4", ["TCGA.DM.A0XF.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.906722999402263}], ["OR2M4", ["TCGA.DM.A0XF.01", "Glucagon-type ligand receptors"], {"weight": 0.923507240492741}], ["OR2M4", ["TCGA.DM.A0XF.01", "GABA B receptor activation"], {"weight": 0.927779873695806}], ["OR2M4", ["TCGA.DM.A0XF.01", "Activation of GABAB receptors"], {"weight": 0.927779873695806}], ["OR2M4", ["TCGA.DM.A0XF.01", "Activation of the phototransduction cascade"], {"weight": 0.776454441574848}], ["OR2M4", ["TCGA.DM.A0XF.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.919196932649048}], ["OR2M4", ["TCGA.DM.A0XF.01", "Voltage gated Potassium channels"], {"weight": 0.886192716308493}], ["OR2M4", ["TCGA.DM.A0XF.01", "Thromboxane signalling through TP receptor"], {"weight": 0.89560070692546}], ["OR2M4", ["TCGA.G4.6309.01", "Glucagon-type ligand receptors"], {"weight": 0.925910774425838}], ["CACNA1D", ["TCGA.DM.A1DA.01", "Potassium Channels"], {"weight": 0.965817829026539}], ["CACNA1D", ["TCGA.DM.A1DA.01", "GABA receptor activation"], {"weight": 0.935067630155878}], ["CACNA1C", ["TCGA.CM.6171.01", "LGI-ADAM interactions"], {"weight": 0.899193426160686}], ["CACNA1S", ["TCGA.AA.3655.01", "Phase 4 - resting membrane potential"], {"weight": 0.76593012527603}], ["CACNA1S", ["TCGA.AA.3655.01", "LGI-ADAM interactions"], {"weight": 0.738505559087164}], ["CACNA1S", ["TCGA.DM.A28K.01", "Phase 0 - rapid depolarisation"], {"weight": 0.944567729068336}], ["CACNA1S", ["TCGA.DM.A28K.01", "Negative regulation of NMDA receptor-mediated neuronal transmission"], {"weight": 0.876057179651119}], ["CACNA1S", ["TCGA.DM.A28K.01", "Assembly and cell surface presentation of NMDA receptors"], {"weight": 0.877417604754791}], ["CACNA1S", ["TCGA.DM.A28K.01", "Unblocking of NMDA receptors, glutamate binding and activation"], {"weight": 0.909001073657091}], ["VCAN", ["TCGA.AU.3779.01", "O-linked glycosylation of mucins"], {"weight": 0.889073170481642}], ["VCAN", ["TCGA.AU.3779.01", "Keratan sulfate biosynthesis"], {"weight": 0.82690907043973}], ["VCAN", ["TCGA.G4.6299.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], {"weight": 0.790273709827596}], ["VCAN", ["TCGA.G4.6299.01", "TNFs bind their physiological receptors"], {"weight": 0.283913647281098}], ["KCNJ4", ["TCGA.A6.6653.01", "Phase 4 - resting membrane potential"], {"weight": 0.883546009989713}], ["KCNJ4", ["TCGA.CK.5916.01", "Potassium Channels"], {"weight": 0.948564920778547}], ["KCNJ4", ["TCGA.D5.5538.01", "Phase 4 - resting membrane potential"], {"weight": 0.881370135015259}], ["KCNJ4", ["TCGA.D5.5538.01", "GABA receptor activation"], {"weight": 0.864597480854699}], ["NR2C2", ["TCGA.D5.6920.01", "Chemokine receptors bind chemokines"], {"weight": 0.855531612114476}], ["NR2C2", ["TCGA.D5.6920.01", "Degradation of the extracellular matrix"], {"weight": 0.855212579981669}], ["NR2C2", ["TCGA.D5.6920.01", "Diseases associated with glycosaminoglycan metabolism"], {"weight": 0.7851702989567}], ["NR2C2", ["TCGA.D5.6920.01", "Biological oxidations"], {"weight": 0.787709338225873}], ["DRD5", ["TCGA.CM.4752.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.883178445467296}], ["DRD5", ["TCGA.CM.4752.01", "G beta:gamma signalling through BTK"], {"weight": 0.860738445238141}], ["DRD5", ["TCGA.CM.4752.01", "Prostacyclin signalling through prostacyclin receptor"], {"weight": 0.860738445238141}], ["DRD5", ["TCGA.CM.4752.01", "Glucagon-type ligand receptors"], {"weight": 0.878377916672161}], ["DRD5", ["TCGA.CM.4752.01", "Activation of G protein gated Potassium channels"], {"weight": 0.860738445238141}], ["DRD5", ["TCGA.CM.4752.01", "G protein gated Potassium channels"], {"weight": 0.860738445238141}], ["DRD5", ["TCGA.CM.4752.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.860738445238141}], ["ITGAL", ["TCGA.CM.6676.01", "FGFR2 ligand binding and activation"], {"weight": 0.827005291241119}], ["ITGAL", ["TCGA.G4.6626.01", "Molecules associated with elastic fibres"], {"weight": 0.884862200059148}], ["ITGA10", ["TCGA.AA.3712.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.937624336990848}], ["ITGA10", ["TCGA.AA.3712.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.899012793745344}], ["ITGA10", ["TCGA.DM.A1HA.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.948581422128565}], ["ITGA10", ["TCGA.DM.A1HA.01", "Collagen chain trimerization"], {"weight": 0.934483740828252}], ["CTSC", ["TCGA.AM.5821.01", "Synaptic adhesion-like molecules"], {"weight": 0.835901324227836}], ["RGS12", ["TCGA.A6.6653.01", "Adenylate cyclase inhibitory pathway"], {"weight": 0.889755357639761}], ["RGS12", ["TCGA.AA.3492.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.929012344892372}], ["RGS12", ["TCGA.AA.3492.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.918462939470163}], ["RGS12", ["TCGA.AA.3492.01", "GABA B receptor activation"], {"weight": 0.935585421544267}], ["RGS12", ["TCGA.AA.3492.01", "Activation of GABAB receptors"], {"weight": 0.935585421544267}], ["RGS12", ["TCGA.AZ.4615.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.905115107931528}], ["RGS12", ["TCGA.D5.6927.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.914009885327353}], ["PREX2", ["TCGA.D5.6538.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.804245566549876}], ["KCNQ3", ["TCGA.AA.3663.01", "Interaction between L1 and Ankyrins"], {"weight": 0.940043015797663}], ["KCNQ3", ["TCGA.AA.3663.01", "Potassium Channels"], {"weight": 0.95861034944602}], ["KCNQ3", ["TCGA.AA.3663.01", "Sensory processing of sound by outer hair cells of the cochlea"], {"weight": 0.930073904226803}], ["KCNQ3", ["TCGA.AZ.4616.01", "Interaction between L1 and Ankyrins"], {"weight": 0.929708494102791}], ["KCNQ3", ["TCGA.D5.6926.01", "Interaction between L1 and Ankyrins"], {"weight": 0.891660657241485}], ["KCNQ3", ["TCGA.G4.6309.01", "Interaction between L1 and Ankyrins"], {"weight": 0.939068578197971}], ["KCNJ11", ["TCGA.G4.6299.01", "Inwardly rectifying K+ channels"], {"weight": 0.914902729409944}], ["KCNJ11", ["TCGA.G4.6299.01", "Phase 0 - rapid depolarisation"], {"weight": 0.851376886161896}], ["C6", ["TCGA.AZ.6599.01", "Initial triggering of complement"], {"weight": 0.76567484792323}], ["SCN8A", ["TCGA.A6.6653.01", "Phase 0 - rapid depolarisation"], {"weight": 0.940104885615178}], ["SCN8A", ["TCGA.G4.6588.01", "Interaction between L1 and Ankyrins"], {"weight": 0.945597004949577}], ["RYR1", ["TCGA.AA.3502.01", "Phase 4 - resting membrane potential"], {"weight": 0.803517181793878}], ["RYR1", ["TCGA.D5.6540.01", "Nicotinate metabolism"], {"weight": 0.841485537760596}], ["NFASC", ["TCGA.A6.6780.01", "Phase 0 - rapid depolarisation"], {"weight": 0.941132780597396}], ["NFASC", ["TCGA.AA.3697.01", "Interaction between L1 and Ankyrins"], {"weight": 0.914830967313035}], ["NFASC", ["TCGA.AY.6197.01", "Phase 0 - rapid depolarisation"], {"weight": 0.892831895530659}], ["NFASC", ["TCGA.AY.6197.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.8692502649754}], ["NFASC", ["TCGA.D5.6532.01", "Interaction between L1 and Ankyrins"], {"weight": 0.948807584031561}], ["NFASC", ["TCGA.D5.6532.01", "Phase 4 - resting membrane potential"], {"weight": 0.857936527846143}], ["NFASC", ["TCGA.DM.A28C.01", "Phase 0 - rapid depolarisation"], {"weight": 0.940227721566625}], ["NFASC", ["TCGA.G4.6320.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.858942854449802}], ["GALE", ["TCGA.A6.6653.01", "Glucuronidation"], {"weight": 0.842624773238702}], ["SCRIB", ["TCGA.AA.3697.01", "Neurexins and neuroligins"], {"weight": 0.904354570644567}], ["SCRIB", ["TCGA.AA.3712.01", "Unblocking of NMDA receptors, glutamate binding and activation"], {"weight": 0.890097868882656}], ["COL4A5", ["TCGA.F4.6569.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.721699492948152}], ["PKD1", ["TCGA.D5.6540.01", "Activation of the phototransduction cascade"], {"weight": 0.885483669699187}], ["PKD1", ["TCGA.G4.6588.01", "Activation of the phototransduction cascade"], {"weight": 0.895112437749102}], ["STAB2", ["TCGA.DM.A28K.01", "Scavenging of heme from plasma"], {"weight": 0.619548489008133}], ["STAB2", ["TCGA.DM.A28K.01", "Norepinephrine Neurotransmitter Release Cycle"], {"weight": 0.703302302548108}], ["STAB2", ["TCGA.DM.A28K.01", "Neurotransmitter release cycle"], {"weight": 0.895258877518314}], ["STAB2", ["TCGA.DM.A28K.01", "Serotonin Neurotransmitter Release Cycle"], {"weight": 0.850942198372728}], ["DNMBP", ["TCGA.A6.6653.01", "GABA receptor activation"], {"weight": 0.911961391737677}], ["PPP2R2C", ["TCGA.D5.6540.01", "LGI-ADAM interactions"], {"weight": 0.90130511239847}], ["NCOA3", ["TCGA.F4.6569.01", "Signaling by Retinoic Acid"], {"weight": 0.775177691813232}], ["NFATC3", ["TCGA.D5.6540.01", "Arachidonic acid metabolism"], {"weight": 0.900571556302592}], ["UBQLN2", ["TCGA.D5.6920.01", "Extracellular matrix organization"], {"weight": 0.831680599633731}], ["CPSF6", ["TCGA.DM.A1D8.01", "Classical antibody-mediated complement activation"], {"weight": 0.634897731603275}], ["CPSF6", ["TCGA.DM.A1D8.01", "TNFs bind their physiological receptors"], {"weight": 0.377869305588796}], ["CPSF6", ["TCGA.DM.A1D8.01", "Creation of C4 and C2 activators"], {"weight": 0.703505035859914}], ["RARB", ["TCGA.A6.6780.01", "Formation of the anterior neural plate"], {"weight": 0.68479159555888}], ["APBA1", ["TCGA.CM.6676.01", "Initial triggering of complement"], {"weight": 0.600271058691538}], ["APBA1", ["TCGA.CM.6676.01", "Peptide ligand-binding receptors"], {"weight": 0.911842255330798}], ["PPFIA3", ["TCGA.G4.6588.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], {"weight": 0.919140655246094}], ["PTGS1", ["TCGA.AD.6895.01", "Glutathione conjugation"], {"weight": 0.88387847748472}], ["PTGS1", ["TCGA.AM.5821.01", "Synthesis of bile acids and bile salts"], {"weight": 0.903458648887985}], ["PTGS1", ["TCGA.AM.5821.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], {"weight": 0.878103545113853}], ["PTGS1", ["TCGA.AM.5821.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], {"weight": 0.822441011873879}], ["PTGS1", ["TCGA.CM.5861.01", "Aspirin ADME"], {"weight": 0.950346344042861}], ["APBA2", ["TCGA.AD.6901.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.777393536317963}], ["APBA2", ["TCGA.AZ.4615.01", "Neurexins and neuroligins"], {"weight": 0.914442575992183}], ["APBA2", ["TCGA.AZ.6598.01", "Neurexins and neuroligins"], {"weight": 0.927995392149184}], ["APBA2", ["TCGA.D5.6532.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.718559473091947}], ["APBA2", ["TCGA.F4.6856.01", "Transport of bile salts and organic acids, metal ions and amine compounds"], {"weight": 0.56885140601407}], ["APBA2", ["TCGA.G4.6298.01", "Defensins"], {"weight": 0.697363211120478}], ["APBA2", ["TCGA.G4.6298.01", "Initial triggering of complement"], {"weight": 0.73515635787059}], ["APBA2", ["TCGA.G4.6298.01", "LGI-ADAM interactions"], {"weight": 0.784116822333187}], ["ENTPD2", ["TCGA.DM.A28C.01", "Nicotinate metabolism"], {"weight": 0.673122660892282}], ["C9orf3", ["TCGA.A6.6653.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.935169661531693}], ["AMPD2", ["TCGA.G4.6320.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.826998137562009}], ["WLS", ["TCGA.A6.6653.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], {"weight": 0.817972898888433}], ["HIF3A", ["TCGA.CM.5349.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.670319212382714}], ["HIF3A", ["TCGA.CM.5349.01", "Glucuronidation"], {"weight": 0.796594304229595}], ["MED13", ["TCGA.D5.6932.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.887239307876897}], ["MED13", ["TCGA.D5.6932.01", "Glucuronidation"], {"weight": 0.87806036311788}], ["MED13", ["TCGA.D5.6932.01", "Aspirin ADME"], {"weight": 0.790009140327312}], ["MED13", ["TCGA.G4.6626.01", "MyD88 deficiency (TLR2/4)"], {"weight": 0.916182547394539}], ["MED13", ["TCGA.G4.6626.01", "IRAK4 deficiency (TLR2/4)"], {"weight": 0.916182547394539}], ["PER2", ["TCGA.DM.A1DA.01", "Voltage gated Potassium channels"], {"weight": 0.88973385915111}], ["DLAT", ["TCGA.AA.3662.01", "Glucuronidation"], {"weight": 0.679282733265996}], ["NR5A1", ["TCGA.AZ.6598.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.839976751348026}], ["NR5A1", ["TCGA.CM.6171.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.901370456198574}], ["DBT", ["TCGA.A6.6653.01", "RA biosynthesis pathway"], {"weight": 0.813481265451232}], ["DBT", ["TCGA.D5.6540.01", "Phase II - Conjugation of compounds"], {"weight": 0.881816228938543}], ["DBT", ["TCGA.D5.6540.01", "Signaling by Retinoic Acid"], {"weight": 0.82742935194771}], ["ACAT1", ["TCGA.G4.6297.01", "Ethanol oxidation"], {"weight": 0.775326609455231}], ["ELANE", ["TCGA.A6.6654.01", "Collagen formation"], {"weight": 0.937597034678399}], ["TBL1XR1", ["TCGA.A6.6654.01", "Signaling by Retinoic Acid"], {"weight": 0.802166886455977}], ["TBL1XR1", ["TCGA.D5.6927.01", "Signaling by Retinoic Acid"], {"weight": 0.707095597477975}], ["PDGFRB", ["TCGA.A6.6654.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.544212476106517}], ["IFNG", ["TCGA.A6.6654.01", "IL-6-type cytokine receptor ligand interactions"], {"weight": 0.838655079367759}], ["GPC5", ["TCGA.A6.6654.01", "Chondroitin sulfate biosynthesis"], {"weight": 0.856650837012626}], ["ELANE", ["TCGA.A6.6654.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.936375519624886}], ["ELANE", ["TCGA.A6.6654.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.923915646116508}], ["ELANE", ["TCGA.A6.6654.01", "Collagen chain trimerization"], {"weight": 0.902974193706029}], ["ELANE", ["TCGA.A6.6654.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.945121077253577}], ["ELANE", ["TCGA.A6.6654.01", "Collagen degradation"], {"weight": 0.92987853363906}], ["GABBR1", ["TCGA.CM.6674.01", "Phase 4 - resting membrane potential"], {"weight": 0.859405981848869}], ["RBMS1", ["TCGA.A6.6654.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.730572759008548}], ["REG3A", ["TCGA.A6.6654.01", "Defective B3GALTL causes PpS"], {"weight": 0.847731125606404}], ["REG3A", ["TCGA.A6.6654.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.847731125606404}], ["ARHGEF11", ["TCGA.A6.6654.01", "WNT ligand biogenesis and trafficking"], {"weight": 0.831600463748758}], ["LEO1", ["TCGA.A6.6782.01", "Nucleotide catabolism"], {"weight": 0.540659190506615}], ["MYO9B", ["TCGA.D5.7000.01", "CD22 mediated BCR regulation"], {"weight": 0.519298960903147}], ["PDLIM5", ["TCGA.AM.5821.01", "Neurexins and neuroligins"], {"weight": 0.956427631397803}], ["IFIH1", ["TCGA.A6.6654.01", "TNFs bind their physiological receptors"], {"weight": 0.0084365477280307}], ["HSD3B1", ["TCGA.A6.6654.01", "Glucuronidation"], {"weight": 0.851158493139031}], ["HSD3B1", ["TCGA.A6.6654.01", "Aspirin ADME"], {"weight": 0.916520101194775}], ["HSD3B1", ["TCGA.A6.6654.01", "Arachidonic acid metabolism"], {"weight": 0.846514561117702}], ["ALDH1A3", ["TCGA.A6.6654.01", "Ethanol oxidation"], {"weight": 0.882512544862972}], ["ALDH1A3", ["TCGA.A6.6654.01", "RA biosynthesis pathway"], {"weight": 0.907542869009298}], ["ALDH1A3", ["TCGA.A6.6654.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.795718729673566}], ["ALDH1A3", ["TCGA.AA.3655.01", "RA biosynthesis pathway"], {"weight": 0.870467613464025}], ["ALDH1A3", ["TCGA.AA.3655.01", "Ethanol oxidation"], {"weight": 0.924079810410594}], ["ALDH1A3", ["TCGA.AA.3655.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.791652217983449}], ["ALDH1A3", ["TCGA.AA.3655.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.823289095151751}], ["ALDH1A3", ["TCGA.CK.5916.01", "Glutathione conjugation"], {"weight": 0.898555608308483}], ["ALDH1A3", ["TCGA.D5.6930.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.734695370192947}], ["ALDH1A3", ["TCGA.D5.6930.01", "Ethanol oxidation"], {"weight": 0.88223313426016}], ["F2R", ["TCGA.AA.3511.01", "Potassium Channels"], {"weight": 0.888762025971936}], ["F2R", ["TCGA.AA.3511.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.873560590026379}], ["F2R", ["TCGA.AZ.6599.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.8985613119475}], ["SMAD2", ["TCGA.AZ.6600.01", "Metal ion SLC transporters"], {"weight": 0.386225731698495}], ["SMAD2", ["TCGA.DM.A28M.01", "Phase 0 - rapid depolarisation"], {"weight": 0.948765817405836}], ["SMAD2", ["TCGA.DM.A28M.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.878432601397027}], ["SMAD2", ["TCGA.DM.A28M.01", "Formation of the anterior neural plate"], {"weight": 0.776342276553651}], ["SHC1", ["TCGA.CM.6162.01", "IL-6-type cytokine receptor ligand interactions"], {"weight": 0.749334618318511}], ["PTEN", ["TCGA.DM.A1DA.01", "CD22 mediated BCR regulation"], {"weight": 0.84175578418436}], ["PTEN", ["TCGA.DM.A28C.01", "Biosynthesis of specialized proresolving mediators (SPMs)"], {"weight": 0.896810263250499}], ["PTEN", ["TCGA.DM.A28C.01", "CD22 mediated BCR regulation"], {"weight": 0.875977372581267}], ["PTEN", ["TCGA.DM.A28C.01", "Defective GALNT12 causes CRCS1"], {"weight": 0.798493271208819}], ["EPHA6", ["TCGA.AZ.5403.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.92310326331711}], ["EPHA6", ["TCGA.AZ.5403.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.906021025886179}], ["EPHA6", ["TCGA.AZ.5403.01", "Ethanol oxidation"], {"weight": 0.591023211566332}], ["EPHA6", ["TCGA.F4.6460.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.840184705393969}], ["EPHA6", ["TCGA.F4.6460.01", "Activated point mutants of FGFR2"], {"weight": 0.760994004528985}], ["EPHA6", ["TCGA.F4.6460.01", "FGFR2 ligand binding and activation"], {"weight": 0.760994004528985}], ["EPHA6", ["TCGA.F4.6460.01", "FGFR2c ligand binding and activation"], {"weight": 0.705689930673868}], ["DLG1", ["TCGA.AD.6964.01", "Synaptic adhesion-like molecules"], {"weight": 0.730970535684036}], ["DLG1", ["TCGA.CA.6718.01", "Synaptic adhesion-like molecules"], {"weight": 0.837546720626912}], ["COL18A1", ["TCGA.AA.3489.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.903203324666073}], ["COL18A1", ["TCGA.AA.3489.01", "Collagen degradation"], {"weight": 0.906671747642093}], ["COL18A1", ["TCGA.AA.3511.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.932232057332309}], ["COL18A1", ["TCGA.AA.3511.01", "Collagen chain trimerization"], {"weight": 0.897658332689867}], ["COL18A1", ["TCGA.AD.6964.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.922942460716742}], ["COL18A1", ["TCGA.AD.6964.01", "Collagen degradation"], {"weight": 0.899586849010204}], ["COL18A1", ["TCGA.AZ.6598.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.9402781558274}], ["COL18A1", ["TCGA.CM.5863.01", "Collagen chain trimerization"], {"weight": 0.886745798251419}], ["COL18A1", ["TCGA.CM.6162.01", "Collagen degradation"], {"weight": 0.915816396461505}], ["COL18A1", ["TCGA.CM.6674.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.943299801223978}], ["COL18A1", ["TCGA.CM.6674.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.937963028341947}], ["COL18A1", ["TCGA.D5.6537.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.931485021249771}], ["COL18A1", ["TCGA.D5.6537.01", "NCAM1 interactions"], {"weight": 0.938580051946055}], ["COL18A1", ["TCGA.F4.6806.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.910169096301473}], ["COL18A1", ["TCGA.F4.6806.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.933207343875373}], ["COL18A1", ["TCGA.F4.6806.01", "Collagen degradation"], {"weight": 0.929923971502832}], ["COL18A1", ["TCGA.F4.6806.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.935521358315383}], ["COL18A1", ["TCGA.G4.6297.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.948560400966682}], ["COL18A1", ["TCGA.G4.6297.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.91015771776672}], ["COL18A1", ["TCGA.G4.6297.01", "Collagen chain trimerization"], {"weight": 0.922445536198394}], ["CACNA1G", ["TCGA.A6.6780.01", "NCAM1 interactions"], {"weight": 0.935572540139174}], ["CACNA1G", ["TCGA.AA.3492.01", "NCAM1 interactions"], {"weight": 0.933923996611535}], ["ITPR3", ["TCGA.D5.6540.01", "CD22 mediated BCR regulation"], {"weight": 0.850702930557574}], ["COG4", ["TCGA.D5.6537.01", "Interaction between L1 and Ankyrins"], {"weight": 0.944459293235974}], ["ABCA1", ["TCGA.CM.6679.01", "Phase II - Conjugation of compounds"], {"weight": 0.787715474817646}], ["ABCA1", ["TCGA.CM.6679.01", "Biological oxidations"], {"weight": 0.847622061930864}], ["ABCA1", ["TCGA.CM.6679.01", "Glucuronidation"], {"weight": 0.850795893732157}], ["ABCA1", ["TCGA.CM.6679.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.559358705803913}], ["ABCA1", ["TCGA.D5.6535.01", "Phase 0 - rapid depolarisation"], {"weight": 0.844907176718175}], ["ABCA1", ["TCGA.DM.A28F.01", "Glucuronidation"], {"weight": 0.896229462516359}], ["ABCA1", ["TCGA.DM.A28F.01", "Aspirin ADME"], {"weight": 0.834031083886833}], ["ABCA1", ["TCGA.F4.6806.01", "Glucuronidation"], {"weight": 0.662491460167844}], ["ITGA8", ["TCGA.D5.6931.01", "Defective B3GALTL causes PpS"], {"weight": 0.79314341568951}], ["ITGA8", ["TCGA.D5.6931.01", "Collagen formation"], {"weight": 0.878767756935172}], ["ITGA8", ["TCGA.D5.6931.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.79314341568951}], ["ITGA8", ["TCGA.DM.A1D8.01", "Intrinsic Pathway of Fibrin Clot Formation"], {"weight": 0.891095207520024}], ["PLCZ1", ["TCGA.CA.6716.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.845516012976005}], ["KIF26A", ["TCGA.AY.6386.01", "Interaction between L1 and Ankyrins"], {"weight": 0.942449752684886}], ["KIF26A", ["TCGA.CK.4952.01", "Interaction between L1 and Ankyrins"], {"weight": 0.947186606865874}], ["DOCK3", ["TCGA.AZ.4682.01", "Chemokine receptors bind chemokines"], {"weight": 0.889098985086163}], ["DOCK3", ["TCGA.AZ.4682.01", "MyD88 deficiency (TLR2/4)"], {"weight": 0.8057280948266}], ["DOCK3", ["TCGA.AZ.4682.01", "IRAK4 deficiency (TLR2/4)"], {"weight": 0.8057280948266}], ["OR10R2", ["TCGA.A6.6780.01", "Glucagon-type ligand receptors"], {"weight": 0.933775298932609}], ["OR10R2", ["TCGA.A6.6780.01", "GABA B receptor activation"], {"weight": 0.927238088580492}], ["OR10R2", ["TCGA.A6.6780.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.9047621979577}], ["OR4K2", ["TCGA.A6.6780.01", "Activation of GABAB receptors"], {"weight": 0.927238088580492}], ["OR4K2", ["TCGA.A6.6780.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.924823350074569}], ["ZBTB17", ["TCGA.DM.A28H.01", "Initial triggering of complement"], {"weight": 0.825370615625755}], ["ZBTB17", ["TCGA.F4.6807.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.869243331348549}], ["COL6A2", ["TCGA.AY.6196.01", "Collagen chain trimerization"], {"weight": 0.92153520028335}], ["COL6A2", ["TCGA.AY.6196.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.872538622372627}], ["COL6A2", ["TCGA.AY.6196.01", "Scavenging by Class A Receptors"], {"weight": 0.618297118623212}], ["COL6A2", ["TCGA.AY.6196.01", "Collagen degradation"], {"weight": 0.819817615853633}], ["COL6A2", ["TCGA.AZ.6599.01", "Scavenging by Class A Receptors"], {"weight": 0.59929646086256}], ["COL6A2", ["TCGA.CM.6679.01", "Collagen chain trimerization"], {"weight": 0.914028802622461}], ["COL6A2", ["TCGA.CM.6679.01", "Collagen degradation"], {"weight": 0.885662181140333}], ["KCNS3", ["TCGA.A6.6780.01", "Potassium Channels"], {"weight": 0.948215102319589}], ["KCNS3", ["TCGA.AY.6197.01", "Potassium Channels"], {"weight": 0.943913297357707}], ["GRIK3", ["TCGA.DM.A1HA.01", "Voltage gated Potassium channels"], {"weight": 0.892171718279508}], ["TUBAL3", ["TCGA.CA.5797.01", "O-linked glycosylation"], {"weight": 0.577625920600825}], ["TUBAL3", ["TCGA.CA.5797.01", "O-linked glycosylation of mucins"], {"weight": 0.874720051478855}], ["TUBAL3", ["TCGA.CA.5797.01", "APAP ADME"], {"weight": 0.808230088318629}], ["AP1G2", ["TCGA.G4.6299.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.830380776582288}], ["WRN", ["TCGA.AA.3713.01", "Defective homologous recombination repair (HRR) due to BRCA1 loss of function"], {"weight": 0.822036008032466}], ["WRN", ["TCGA.AA.3713.01", "Defective homologous recombination repair (HRR) due to PALB2 loss of function"], {"weight": 0.822036008032466}], ["WRN", ["TCGA.AA.3713.01", "Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function"], {"weight": 0.822036008032466}], ["WRN", ["TCGA.AA.3713.01", "Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function"], {"weight": 0.822036008032466}], ["WRN", ["TCGA.AA.3713.01", "Impaired BRCA2 binding to PALB2"], {"weight": 0.822108926899947}], ["NCOA6", ["TCGA.A6.6780.01", "Glucuronidation"], {"weight": 0.829919072060341}], ["NCOA6", ["TCGA.AD.6964.01", "Glucuronidation"], {"weight": 0.825245538102105}], ["NCOA6", ["TCGA.AD.6964.01", "Aspirin ADME"], {"weight": 0.923744738466476}], ["NCOA6", ["TCGA.AZ.4615.01", "Signaling by Retinoic Acid"], {"weight": 0.818486626143753}], ["NCOA6", ["TCGA.CA.6716.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.929641705580686}], ["NCOA6", ["TCGA.CA.6716.01", "Aspirin ADME"], {"weight": 0.838023872791422}], ["NCOA6", ["TCGA.CA.6716.01", "Glucuronidation"], {"weight": 0.897286786867133}], ["NCOA6", ["TCGA.CA.6716.01", "Phase II - Conjugation of compounds"], {"weight": 0.837960124454612}], ["ALOX12B", ["TCGA.A6.6780.01", "RA biosynthesis pathway"], {"weight": 0.851547021679917}], ["BPTF", ["TCGA.D5.5540.01", "Collagen chain trimerization"], {"weight": 0.895745223604564}], ["EFCAB6", ["TCGA.CA.5797.01", "Phase 0 - rapid depolarisation"], {"weight": 0.872851006599702}], ["NOG", ["TCGA.A6.6780.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.745791587741163}], ["MYO3A", ["TCGA.A6.6780.01", "Other semaphorin interactions"], {"weight": 0.762850231884139}], ["MYO3A", ["TCGA.AD.6889.01", "Sensory processing of sound by outer hair cells of the cochlea"], {"weight": 0.944468118520912}], ["GPC3", ["TCGA.A6.6780.01", "WNT ligand biogenesis and trafficking"], {"weight": 0.934681785402023}], ["GPC3", ["TCGA.A6.6780.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], {"weight": 0.899071213746856}], ["PRCP", ["TCGA.A6.6780.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.872667367768535}], ["USP34", ["TCGA.A6.6781.01", "Phase II - Conjugation of compounds"], {"weight": 0.851977383095551}], ["USP34", ["TCGA.A6.6781.01", "APAP ADME"], {"weight": 0.714407178772573}], ["USP34", ["TCGA.AZ.4615.01", "APAP ADME"], {"weight": 0.836249931492877}], ["USP34", ["TCGA.AZ.4615.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.906550161755018}], ["USP34", ["TCGA.DM.A1D7.01", "Trafficking and processing of endosomal TLR"], {"weight": 0.746847755265544}], ["PDHA2", ["TCGA.A6.6780.01", "Signaling by Retinoic Acid"], {"weight": 0.812881840902429}], ["PDHA2", ["TCGA.CK.5916.01", "Signaling by Retinoic Acid"], {"weight": 0.766917329993705}], ["LRP1", ["TCGA.CM.5341.01", "Induction of Cell-Cell Fusion"], {"weight": 0.482167127551242}], ["LRP1", ["TCGA.CM.5861.01", "Erythrocytes take up carbon dioxide and release oxygen"], {"weight": 0.854890821211044}], ["LRP1", ["TCGA.CM.5861.01", "O2/CO2 exchange in erythrocytes"], {"weight": 0.854890821211044}], ["LRP1", ["TCGA.CM.6166.01", "Erythrocytes take up carbon dioxide and release oxygen"], {"weight": 0.88866210827644}], ["LRP1", ["TCGA.CM.6166.01", "O2/CO2 exchange in erythrocytes"], {"weight": 0.88866210827644}], ["LRP1", ["TCGA.D5.6924.01", "Erythrocytes take up carbon dioxide and release oxygen"], {"weight": 0.78637713941625}], ["LRP1", ["TCGA.D5.6924.01", "O2/CO2 exchange in erythrocytes"], {"weight": 0.78637713941625}], ["LRP1", ["TCGA.F4.6463.01", "Activated point mutants of FGFR2"], {"weight": 0.867933999569661}], ["LRP1", ["TCGA.F4.6463.01", "FGFR2 ligand binding and activation"], {"weight": 0.867933999569661}], ["LRP1", ["TCGA.F4.6463.01", "APAP ADME"], {"weight": 0.627723249063724}], ["LRP1", ["TCGA.F4.6463.01", "FGFR2c ligand binding and activation"], {"weight": 0.857299017467893}], ["LRP1", ["TCGA.F4.6463.01", "Peptide hormone biosynthesis"], {"weight": 0.405816265693698}], ["LRP1", ["TCGA.F4.6463.01", "Bile acid and bile salt metabolism"], {"weight": 0.654395426741452}], ["LRP1", ["TCGA.F4.6463.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.483328515329554}], ["LRP1", ["TCGA.F4.6463.01", "Heme degradation"], {"weight": 0.309105348010166}], ["LRP1", ["TCGA.G4.6320.01", "Erythrocytes take up carbon dioxide and release oxygen"], {"weight": 0.86593944887941}], ["LRP1", ["TCGA.G4.6320.01", "O2/CO2 exchange in erythrocytes"], {"weight": 0.86593944887941}], ["COL20A1", ["TCGA.CM.5349.01", "Collagen degradation"], {"weight": 0.919707790929062}], ["COL20A1", ["TCGA.CM.5349.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.925713596320038}], ["COL20A1", ["TCGA.CM.5349.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.917059073081947}], ["COL20A1", ["TCGA.G4.6586.01", "Collagen chain trimerization"], {"weight": 0.931069574121761}], ["ADAMTS14", ["TCGA.D5.6927.01", "Collagen chain trimerization"], {"weight": 0.926372140120573}], ["ADAMTS14", ["TCGA.G4.6302.01", "Collagen chain trimerization"], {"weight": 0.908584357438669}], ["ADAMTS14", ["TCGA.G4.6302.01", "Scavenging by Class A Receptors"], {"weight": 0.694193716960184}], ["TLL2", ["TCGA.A6.6780.01", "Collagen chain trimerization"], {"weight": 0.922630359618168}], ["TLL2", ["TCGA.A6.6780.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.939599927645809}], ["TLL2", ["TCGA.AD.6895.01", "Collagen chain trimerization"], {"weight": 0.917961576809842}], ["TLL2", ["TCGA.D5.6929.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.947079273447108}], ["TLL2", ["TCGA.D5.6929.01", "Collagen formation"], {"weight": 0.935217221107234}], ["TLL2", ["TCGA.D5.6929.01", "Collagen chain trimerization"], {"weight": 0.927000557660756}], ["TLL2", ["TCGA.D5.6929.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.909169031149541}], ["ADAM9", ["TCGA.A6.6781.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.960385161546217}], ["STAT5A", ["TCGA.D5.5537.01", "Collagen chain trimerization"], {"weight": 0.853471708696294}], ["P4HB", ["TCGA.AA.3492.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.944971865554963}], ["KIT", ["TCGA.CM.6164.01", "Phase II - Conjugation of compounds"], {"weight": 0.825806255878127}], ["KIT", ["TCGA.CM.6164.01", "Glucuronidation"], {"weight": 0.851926119753995}], ["KIT", ["TCGA.CM.6164.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.74626061049921}], ["KIT", ["TCGA.CM.6164.01", "Ethanol oxidation"], {"weight": 0.769470793769459}], ["KIT", ["TCGA.CM.6164.01", "Aspirin ADME"], {"weight": 0.733682065621188}], ["KIT", ["TCGA.D5.5541.01", "Defective GALNT12 causes CRCS1"], {"weight": 0.735648596366647}], ["FGA", ["TCGA.G4.6294.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.724702462400935}], ["LAMB3", ["TCGA.A6.6781.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.947874993564317}], ["LAMC2", ["TCGA.D5.6926.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.946294702531176}], ["LAMC2", ["TCGA.D5.6926.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.919626021826844}], ["LAMC2", ["TCGA.D5.6926.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.945433203776331}], ["LAMC2", ["TCGA.D5.6926.01", "Collagen degradation"], {"weight": 0.915717902157086}], ["ANGPT1", ["TCGA.CM.6162.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.934870760426004}], ["COL4A1", ["TCGA.G4.6586.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.959652508794907}], ["IL2RG", ["TCGA.AM.5820.01", "TNFs bind their physiological receptors"], {"weight": 0.61315159099939}], ["VAV2", ["TCGA.CM.4743.01", "CD22 mediated BCR regulation"], {"weight": 0.834738093777137}], ["DVL3", ["TCGA.D5.6535.01", "Phase 4 - resting membrane potential"], {"weight": 0.726016355818149}], ["VTN", ["TCGA.G4.6302.01", "Dissolution of Fibrin Clot"], {"weight": 0.81539096269291}], ["MOV10", ["TCGA.CK.4947.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.475364329221636}], ["MOV10", ["TCGA.CK.4947.01", "Phase II - Conjugation of compounds"], {"weight": 0.704541982792565}], ["ALOX15B", ["TCGA.AA.3663.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.879355756461836}], ["ALOX15B", ["TCGA.D5.6540.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.910990462336087}], ["GAK", ["TCGA.DM.A1D4.01", "Acetylcholine Neurotransmitter Release Cycle"], {"weight": 0.777114782217842}], ["GAK", ["TCGA.DM.A1D4.01", "Voltage gated Potassium channels"], {"weight": 0.854932396186001}], ["BMP1", ["TCGA.A6.6781.01", "Collagen chain trimerization"], {"weight": 0.93943424825203}], ["BMP1", ["TCGA.AD.6895.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.930319781957174}], ["BMP1", ["TCGA.AZ.6598.01", "Collagen chain trimerization"], {"weight": 0.931442463841028}], ["GRIP1", ["TCGA.DM.A28G.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.753833564261499}], ["GRIP1", ["TCGA.DM.A28G.01", "GABA receptor activation"], {"weight": 0.818432532476995}], ["KIF2B", ["TCGA.AZ.4323.01", "Interaction between L1 and Ankyrins"], {"weight": 0.926746355271612}], ["KIF2B", ["TCGA.AZ.4323.01", "O-linked glycosylation"], {"weight": 0.884792694934115}], ["KIF2B", ["TCGA.AZ.4323.01", "Receptor-type tyrosine-protein phosphatases"], {"weight": 0.625818111757801}], ["KIF2B", ["TCGA.AZ.4323.01", "Norepinephrine Neurotransmitter Release Cycle"], {"weight": 0.588404221057766}], ["KIF2B", ["TCGA.D5.5540.01", "Deposition of new CENPA-containing nucleosomes at the centromere"], {"weight": 0.921900822798193}], ["KIF2B", ["TCGA.D5.5540.01", "Nucleosome assembly"], {"weight": 0.921900822798193}], ["PTCH1", ["TCGA.DM.A285.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.568071265409419}], ["CHST6", ["TCGA.A6.6781.01", "Keratan sulfate biosynthesis"], {"weight": 0.88594725793442}], ["CHST6", ["TCGA.A6.6781.01", "Keratan sulfate/keratin metabolism"], {"weight": 0.88594725793442}], ["UGT1A6", ["TCGA.A6.6781.01", "Glucuronidation"], {"weight": 0.831712226167006}], ["UGT1A6", ["TCGA.G4.6586.01", "Glucuronidation"], {"weight": 0.862450218752362}], ["POFUT2", ["TCGA.A6.6781.01", "Defective B3GALTL causes PpS"], {"weight": 0.896310634896817}], ["POFUT2", ["TCGA.A6.6781.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.913319355124045}], ["POFUT2", ["TCGA.F4.6806.01", "Defective B3GALTL causes PpS"], {"weight": 0.864222507714944}], ["POFUT2", ["TCGA.F4.6806.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.873213823838052}], ["ADAMTS13", ["TCGA.F4.6855.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.944315323241809}], ["ADAMTS13", ["TCGA.F4.6855.01", "Defective B3GALTL causes PpS"], {"weight": 0.893541752949015}], ["ADAMTS13", ["TCGA.F4.6855.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.893480937243598}], ["RAB8A", ["TCGA.AZ.6599.01", "Activation of the phototransduction cascade"], {"weight": 0.861505395798776}], ["GNS", ["TCGA.CA.6718.01", "Blood group systems biosynthesis"], {"weight": 0.698103204988569}], ["IGFALS", ["TCGA.A6.6781.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.950635284861684}], ["IGFALS", ["TCGA.G4.6298.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.91587865425372}], ["IGFALS", ["TCGA.G4.6309.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.886977861227975}], ["CDON", ["TCGA.AY.6196.01", "Defective GALNT12 causes CRCS1"], {"weight": 0.798516809086774}], ["CACNA1F", ["TCGA.CM.6163.01", "Phase 4 - resting membrane potential"], {"weight": 0.729288134281903}], ["GATA4", ["TCGA.CK.4950.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.836177645165786}], ["ADAM9", ["TCGA.A6.6781.01", "Collagen degradation"], {"weight": 0.932981059569832}], ["PKN1", ["TCGA.CM.6166.01", "Recycling of bile acids and salts"], {"weight": 0.893817697621755}], ["INPPL1", ["TCGA.AZ.6601.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], {"weight": 0.743210652936562}], ["INPPL1", ["TCGA.G4.6626.01", "CD22 mediated BCR regulation"], {"weight": 0.744632253353932}], ["OPRD1", ["TCGA.CK.5915.01", "Initial triggering of complement"], {"weight": 0.868245977898746}], ["OPRD1", ["TCGA.F4.6855.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.855595155187266}], ["SEMA4D", ["TCGA.F4.6463.01", "FGFR4 ligand binding and activation"], {"weight": 0.832442060388574}], ["SEMA4D", ["TCGA.F4.6463.01", "FGFRL1 modulation of FGFR1 signaling"], {"weight": 0.81092908836829}], ["SEMA4D", ["TCGA.F4.6463.01", "Signaling by activated point mutants of FGFR3"], {"weight": 0.766287932682733}], ["SEMA4D", ["TCGA.F4.6463.01", "FGFR3 mutant receptor activation"], {"weight": 0.766287932682733}], ["CASP9", ["TCGA.AA.3662.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.791345410512608}], ["CASP9", ["TCGA.CM.6170.01", "Phase II - Conjugation of compounds"], {"weight": 0.830911642557989}], ["CASP9", ["TCGA.CM.6170.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.780581559995063}], ["CASP9", ["TCGA.D5.6537.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.829863987520018}], ["CASP9", ["TCGA.G4.6311.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.766944310803328}], ["CASP9", ["TCGA.G4.6311.01", "Phase II - Conjugation of compounds"], {"weight": 0.713307562490466}], ["MYO5C", ["TCGA.AD.6888.01", "Insulin processing"], {"weight": 0.822164104156027}], ["MYO5C", ["TCGA.AD.6888.01", "Activation of the phototransduction cascade"], {"weight": 0.78472337115319}], ["LRP5", ["TCGA.A6.6781.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], {"weight": 0.905867989189492}], ["FZD2", ["TCGA.CM.6171.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], {"weight": 0.897540969207105}], ["COL25A1", ["TCGA.A6.6782.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.919490195727908}], ["PROS1", ["TCGA.DM.A1D4.01", "Classical antibody-mediated complement activation"], {"weight": 0.795754269729394}], ["PROS1", ["TCGA.DM.A1D4.01", "Initial triggering of complement"], {"weight": 0.864747253542073}], ["PROS1", ["TCGA.DM.A1D4.01", "Creation of C4 and C2 activators"], {"weight": 0.864952072377129}], ["PROS1", ["TCGA.G4.6320.01", "Classical antibody-mediated complement activation"], {"weight": 0.73242974042682}], ["PROS1", ["TCGA.G4.6320.01", "Creation of C4 and C2 activators"], {"weight": 0.831717439808999}], ["PDGFA", ["TCGA.CK.4950.01", "IL-6-type cytokine receptor ligand interactions"], {"weight": 0.661864331404621}], ["ADCY1", ["TCGA.DM.A285.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.782450973944222}], ["COL25A1", ["TCGA.A6.6782.01", "Collagen chain trimerization"], {"weight": 0.885944840331625}], ["ADAMTSL1", ["TCGA.CM.6171.01", "Defective B3GALTL causes PpS"], {"weight": 0.9035554511143}], ["ADAMTSL1", ["TCGA.CM.6171.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.903504031493364}], ["UGT3A1", ["TCGA.A6.6782.01", "Phase II - Conjugation of compounds"], {"weight": 0.780163503254258}], ["UGT3A1", ["TCGA.A6.6782.01", "Glucuronidation"], {"weight": 0.79516217690959}], ["GABBR2", ["TCGA.CK.5913.01", "Potassium Channels"], {"weight": 0.952864140054904}], ["GABBR2", ["TCGA.CK.5913.01", "Activation of G protein gated Potassium channels"], {"weight": 0.916619334804961}], ["GABBR2", ["TCGA.CK.5913.01", "G protein gated Potassium channels"], {"weight": 0.916619334804961}], ["GABBR2", ["TCGA.CK.5913.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.916619334804961}], ["GABBR2", ["TCGA.CK.5913.01", "GABA B receptor activation"], {"weight": 0.924685631137922}], ["GABBR2", ["TCGA.CK.5913.01", "Activation of GABAB receptors"], {"weight": 0.924685631137922}], ["GABBR2", ["TCGA.G4.6309.01", "GABA receptor activation"], {"weight": 0.901488000997967}], ["MUC17", ["TCGA.A6.6782.01", "Defective GALNT3 causes HFTC"], {"weight": 0.800852221030508}], ["MUC17", ["TCGA.A6.6782.01", "Defective GALNT12 causes CRCS1"], {"weight": 0.800852221030508}], ["MUC17", ["TCGA.CK.5916.01", "O-linked glycosylation of mucins"], {"weight": 0.939129695773196}], ["MUC17", ["TCGA.CM.6161.01", "Lewis blood group biosynthesis"], {"weight": 0.831446965426477}], ["MUC17", ["TCGA.CM.6161.01", "Blood group systems biosynthesis"], {"weight": 0.831446965426477}], ["MUC17", ["TCGA.CM.6161.01", "Defective GALNT12 causes CRCS1"], {"weight": 0.862960176813747}], ["CSNK2A1", ["TCGA.AA.3489.01", "Phase II - Conjugation of compounds"], {"weight": 0.826675885591905}], ["CSNK2A1", ["TCGA.AA.3489.01", "Glucuronidation"], {"weight": 0.821383190962004}], ["ADAMTS3", ["TCGA.AA.3489.01", "Collagen chain trimerization"], {"weight": 0.90992092358545}], ["ADAMTS3", ["TCGA.AA.3489.01", "O-linked glycosylation"], {"weight": 0.88367317322008}], ["ADAMTS3", ["TCGA.AA.3489.01", "Defective B3GALTL causes PpS"], {"weight": 0.866836273209179}], ["ADAMTS3", ["TCGA.AA.3489.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.866765790404564}], ["MMP11", ["TCGA.AA.3489.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.831108262426458}], ["MMP11", ["TCGA.AA.3489.01", "Aspirin ADME"], {"weight": 0.811518475687771}], ["SCN10A", ["TCGA.AA.3492.01", "Interaction between L1 and Ankyrins"], {"weight": 0.947605654219948}], ["AGT", ["TCGA.CA.6718.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.830130294867509}], ["AGT", ["TCGA.G4.6323.01", "Sensory perception of taste"], {"weight": 0.884694380504052}], ["AGT", ["TCGA.G4.6323.01", "Sensory perception of sweet, bitter, and umami (glutamate) taste"], {"weight": 0.870810480595803}], ["AGT", ["TCGA.G4.6323.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.795025702597937}], ["AGT", ["TCGA.G4.6323.01", "Chemokine receptors bind chemokines"], {"weight": 0.898105162716034}], ["HDAC5", ["TCGA.AZ.6598.01", "Phase 0 - rapid depolarisation"], {"weight": 0.945923739987915}], ["HDAC5", ["TCGA.G4.6298.01", "Potassium Channels"], {"weight": 0.955092441336455}], ["HDAC5", ["TCGA.G4.6298.01", "GABA receptor activation"], {"weight": 0.910171973499266}], ["HDAC5", ["TCGA.G4.6298.01", "Inwardly rectifying K+ channels"], {"weight": 0.922951081568876}], ["HDAC5", ["TCGA.G4.6298.01", "GABA B receptor activation"], {"weight": 0.923077324318354}], ["HDAC5", ["TCGA.G4.6298.01", "Activation of GABAB receptors"], {"weight": 0.923077324318354}], ["HDAC5", ["TCGA.G4.6298.01", "Activation of G protein gated Potassium channels"], {"weight": 0.915501749320714}], ["HDAC5", ["TCGA.G4.6298.01", "G protein gated Potassium channels"], {"weight": 0.915501749320714}], ["HDAC5", ["TCGA.G4.6298.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.915501749320714}], ["HDAC5", ["TCGA.G4.6298.01", "Blood group systems biosynthesis"], {"weight": 0.808643072415755}], ["NRAS", ["TCGA.AA.3662.01", "FGFR4 ligand binding and activation"], {"weight": 0.87897765696003}], ["NRAS", ["TCGA.AA.3662.01", "Phospholipase C-mediated cascade; FGFR4"], {"weight": 0.87897765696003}], ["NRAS", ["TCGA.CM.5864.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.726221955812316}], ["NRAS", ["TCGA.CM.5864.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.65960423359824}], ["NRAS", ["TCGA.CM.6680.01", "Interaction between L1 and Ankyrins"], {"weight": 0.863481926009685}], ["NRAS", ["TCGA.DM.A1D9.01", "Interaction between L1 and Ankyrins"], {"weight": 0.93570179237335}], ["NRAS", ["TCGA.DM.A1DA.01", "Interaction between L1 and Ankyrins"], {"weight": 0.956672808439454}], ["NRAS", ["TCGA.DM.A1DA.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.832411032835893}], ["NRAS", ["TCGA.G4.6298.01", "Interaction between L1 and Ankyrins"], {"weight": 0.937272689942032}], ["MMP2", ["TCGA.AA.3492.01", "O-linked glycosylation"], {"weight": 0.90519942663724}], ["MMP2", ["TCGA.AD.5900.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.940192311624526}], ["MMP2", ["TCGA.G4.6588.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.909202952382508}], ["INSR", ["TCGA.AZ.6599.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], {"weight": 0.887673404774103}], ["INSR", ["TCGA.AZ.6599.01", "Phospholipase C-mediated cascade: FGFR1"], {"weight": 0.881798930127778}], ["INSR", ["TCGA.AZ.6599.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.805569141053025}], ["HSPG2", ["TCGA.AD.6889.01", "Antimicrobial peptides"], {"weight": 0.73004277595321}], ["HSPG2", ["TCGA.AY.6386.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.755134914428134}], ["HSPG2", ["TCGA.AY.6386.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.829600780487801}], ["HSPG2", ["TCGA.AY.6386.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.922791292140803}], ["HSPG2", ["TCGA.AY.6386.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], {"weight": 0.855446623791345}], ["HSPG2", ["TCGA.CK.4950.01", "Common Pathway of Fibrin Clot Formation"], {"weight": 0.861501789855508}], ["HSPG2", ["TCGA.CK.4950.01", "Regulation of TLR by endogenous ligand"], {"weight": 0.669402480808003}], ["HSPG2", ["TCGA.CK.4950.01", "RA biosynthesis pathway"], {"weight": 0.353946065597194}], ["HSPG2", ["TCGA.CK.4950.01", "MyD88 deficiency (TLR2/4)"], {"weight": 0.671649774086647}], ["HSPG2", ["TCGA.CK.4950.01", "IRAK4 deficiency (TLR2/4)"], {"weight": 0.671649774086647}], ["HSPG2", ["TCGA.D5.5540.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.940980363218755}], ["HSPG2", ["TCGA.D5.5540.01", "Scavenging of heme from plasma"], {"weight": 0.774041536325572}], ["HSPG2", ["TCGA.F4.6808.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.814039294919007}], ["HSPG2", ["TCGA.G4.6311.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.94081880312901}], ["HSPG2", ["TCGA.G4.6311.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.943636606987338}], ["HSPG2", ["TCGA.G4.6311.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.769529450236802}], ["FN1", ["TCGA.AA.3660.01", "Recycling of bile acids and salts"], {"weight": 0.517553445073222}], ["CFTR", ["TCGA.DM.A28M.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.862772504395311}], ["PPARA", ["TCGA.AA.3492.01", "Glucuronidation"], {"weight": 0.86064567421899}], ["PPARA", ["TCGA.AA.3492.01", "Chemokine receptors bind chemokines"], {"weight": 0.920194440996549}], ["ATP1B4", ["TCGA.AD.6963.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.751685785938763}], ["ATP1B4", ["TCGA.AD.6963.01", "Heme degradation"], {"weight": 0.68689994940628}], ["ATP1B4", ["TCGA.D5.7000.01", "Phase 2 - plateau phase"], {"weight": 0.576781260253317}], ["ATP1B4", ["TCGA.D5.7000.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.619660147597278}], ["FOXO1", ["TCGA.D5.6535.01", "Ethanol oxidation"], {"weight": 0.712043301371564}], ["LCP2", ["TCGA.CK.4948.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.815945178296491}], ["PRKG2", ["TCGA.AZ.4682.01", "CD22 mediated BCR regulation"], {"weight": 0.69518055073428}], ["TNC", ["TCGA.F4.6459.01", "TNFs bind their physiological receptors"], {"weight": 0.188824456931489}], ["TNC", ["TCGA.F4.6459.01", "Blood group systems biosynthesis"], {"weight": 0.657465845752731}], ["FOXO4", ["TCGA.D5.6534.01", "Glucuronidation"], {"weight": 0.82099234395183}], ["FOXO4", ["TCGA.D5.6534.01", "Peptide hormone biosynthesis"], {"weight": 0.691629022318261}], ["FOXO4", ["TCGA.F4.6806.01", "Classical antibody-mediated complement activation"], {"weight": 0.808918834289052}], ["FOXO4", ["TCGA.F4.6806.01", "Complement cascade"], {"weight": 0.779680121858545}], ["FOXO4", ["TCGA.F4.6806.01", "Creation of C4 and C2 activators"], {"weight": 0.808918834289052}], ["FOXO4", ["TCGA.F4.6806.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], {"weight": 0.736378738788646}], ["NTSR2", ["TCGA.AY.6196.01", "Surfactant metabolism"], {"weight": 0.853726777314882}], ["NTSR2", ["TCGA.D5.6924.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.864798806405977}], ["NTSR2", ["TCGA.DM.A1D6.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], {"weight": 0.932047665167386}], ["NTSR2", ["TCGA.G4.6293.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.908056681844721}], ["KIF3C", ["TCGA.AD.6895.01", "Interaction between L1 and Ankyrins"], {"weight": 0.920329487228794}], ["KIF3C", ["TCGA.DM.A28G.01", "Interaction between L1 and Ankyrins"], {"weight": 0.925239071429599}], ["BDNF", ["TCGA.AZ.5407.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.916458206502507}], ["SMPD1", ["TCGA.AA.3662.01", "TNFs bind their physiological receptors"], {"weight": 0.503702474349617}], ["OR2T33", ["TCGA.AA.3662.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.90592109608334}], ["OR2T33", ["TCGA.AA.3662.01", "GABA receptor activation"], {"weight": 0.825289349843436}], ["OR2T33", ["TCGA.AA.3662.01", "GABA B receptor activation"], {"weight": 0.900296824311065}], ["OR2T33", ["TCGA.AA.3662.01", "Activation of GABAB receptors"], {"weight": 0.900296824311065}], ["OR2T33", ["TCGA.AA.3662.01", "Inwardly rectifying K+ channels"], {"weight": 0.841199651880359}], ["OR2T33", ["TCGA.AA.3662.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.878415234627197}], ["OR2T33", ["TCGA.AA.3662.01", "G-protein activation"], {"weight": 0.887562044038712}], ["OR2T33", ["TCGA.AA.3662.01", "Thromboxane signalling through TP receptor"], {"weight": 0.861525370497121}], ["OR2T33", ["TCGA.DM.A1DB.01", "Glucagon-type ligand receptors"], {"weight": 0.935616592463769}], ["OR2T33", ["TCGA.DM.A1DB.01", "Inwardly rectifying K+ channels"], {"weight": 0.92931915940249}], ["OR2T33", ["TCGA.DM.A1DB.01", "Activation of G protein gated Potassium channels"], {"weight": 0.917275315428432}], ["OR2T33", ["TCGA.DM.A1DB.01", "G protein gated Potassium channels"], {"weight": 0.917275315428432}], ["OR2T33", ["TCGA.DM.A1DB.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.917275315428432}], ["OR2T33", ["TCGA.DM.A1DB.01", "G beta:gamma signalling through BTK"], {"weight": 0.895157183829026}], ["OR2T33", ["TCGA.DM.A1DB.01", "G-protein activation"], {"weight": 0.936788454887237}], ["OR52K1", ["TCGA.G4.6626.01", "Potassium Channels"], {"weight": 0.959862599879826}], ["OR52K1", ["TCGA.G4.6626.01", "GABA receptor activation"], {"weight": 0.907350576279689}], ["OR52K1", ["TCGA.G4.6626.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.918201101325134}], ["OR52K1", ["TCGA.G4.6626.01", "Prostacyclin signalling through prostacyclin receptor"], {"weight": 0.90512335325557}], ["OR6C4", ["TCGA.DM.A28K.01", "Glucagon-type ligand receptors"], {"weight": 0.928205040366806}], ["OR10K1", ["TCGA.AZ.4615.01", "GABA B receptor activation"], {"weight": 0.935070729386966}], ["OR10K1", ["TCGA.AZ.4615.01", "Activation of GABAB receptors"], {"weight": 0.935070729386966}], ["OR10K1", ["TCGA.D5.6898.01", "Potassium Channels"], {"weight": 0.933791477730281}], ["OR5M9", ["TCGA.CM.6166.01", "G-protein activation"], {"weight": 0.921595841715187}], ["OR5M9", ["TCGA.CM.6166.01", "Thromboxane signalling through TP receptor"], {"weight": 0.902259499309015}], ["OR5M9", ["TCGA.CM.6166.01", "GABA receptor activation"], {"weight": 0.706729036402251}], ["OR5M9", ["TCGA.CM.6166.01", "GABA B receptor activation"], {"weight": 0.923836039098546}], ["OR5M9", ["TCGA.CM.6166.01", "Activation of GABAB receptors"], {"weight": 0.923836039098546}], ["OR5M9", ["TCGA.CM.6166.01", "G beta:gamma signalling through BTK"], {"weight": 0.921330100397181}], ["OR5M9", ["TCGA.CM.6166.01", "Glucagon-type ligand receptors"], {"weight": 0.919450485272347}], ["OR5M9", ["TCGA.CM.6166.01", "Activation of G protein gated Potassium channels"], {"weight": 0.919873805056577}], ["OR5M9", ["TCGA.CM.6166.01", "G protein gated Potassium channels"], {"weight": 0.919873805056577}], ["OR5M9", ["TCGA.CM.6166.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.919873805056577}], ["OR5M9", ["TCGA.CM.6166.01", "Phase 4 - resting membrane potential"], {"weight": 0.766322317797731}], ["RXFP2", ["TCGA.CK.5915.01", "Potassium Channels"], {"weight": 0.964464025930737}], ["RXFP2", ["TCGA.CK.5915.01", "GABA B receptor activation"], {"weight": 0.93461799301511}], ["RXFP2", ["TCGA.CK.5915.01", "Activation of GABAB receptors"], {"weight": 0.93461799301511}], ["RXFP2", ["TCGA.CK.5915.01", "Activation of G protein gated Potassium channels"], {"weight": 0.930928901221012}], ["RXFP2", ["TCGA.CK.5915.01", "G protein gated Potassium channels"], {"weight": 0.930928901221012}], ["RXFP2", ["TCGA.CK.5915.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.926592486118438}], ["RXFP2", ["TCGA.CK.5915.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.930928901221012}], ["RXFP2", ["TCGA.CK.5915.01", "Inwardly rectifying K+ channels"], {"weight": 0.933663401250113}], ["RXFP2", ["TCGA.CK.5915.01", "G beta:gamma signalling through BTK"], {"weight": 0.911791769909819}], ["RXFP2", ["TCGA.CK.5915.01", "G-protein activation"], {"weight": 0.912596800939268}], ["RXFP2", ["TCGA.CK.5915.01", "Phase 4 - resting membrane potential"], {"weight": 0.889531747488754}], ["RXFP2", ["TCGA.CK.5915.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.907333307236326}], ["RXFP2", ["TCGA.CK.5915.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.882480857456546}], ["RXFP2", ["TCGA.CK.5915.01", "Prostacyclin signalling through prostacyclin receptor"], {"weight": 0.899008184802518}], ["RXFP2", ["TCGA.CK.5915.01", "Thromboxane signalling through TP receptor"], {"weight": 0.903703521734159}], ["RXFP2", ["TCGA.CK.5915.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.899008184802518}], ["RXFP2", ["TCGA.CK.5915.01", "Presynaptic function of Kainate receptors"], {"weight": 0.899008184802518}], ["PDE4D", ["TCGA.DM.A0XF.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.866802572583232}], ["SHB", ["TCGA.CM.5860.01", "Synaptic adhesion-like molecules"], {"weight": 0.856401018752563}], ["EPHA7", ["TCGA.AZ.6605.01", "WNT ligand biogenesis and trafficking"], {"weight": 0.795094384127865}], ["ASAP2", ["TCGA.CM.6170.01", "SHC1 events in ERBB4 signaling"], {"weight": 0.760942031605355}], ["SPP1", ["TCGA.G4.6302.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.890486417585938}], ["SCN10A", ["TCGA.AA.3492.01", "Phase 0 - rapid depolarisation"], {"weight": 0.939445954203028}], ["SCN10A", ["TCGA.CM.6677.01", "Interaction between L1 and Ankyrins"], {"weight": 0.908449017268886}], ["SCN10A", ["TCGA.CM.6677.01", "Phase 0 - rapid depolarisation"], {"weight": 0.854601974833783}], ["SCN10A", ["TCGA.G4.6586.01", "Interaction between L1 and Ankyrins"], {"weight": 0.956751599818428}], ["SCN10A", ["TCGA.G4.6586.01", "Phase 0 - rapid depolarisation"], {"weight": 0.957276137703225}], ["TAS1R2", ["TCGA.AA.3492.01", "Glucagon-type ligand receptors"], {"weight": 0.917875905260851}], ["TAS1R2", ["TCGA.AA.3492.01", "Activation of G protein gated Potassium channels"], {"weight": 0.930400026735751}], ["TAS1R2", ["TCGA.AA.3492.01", "G protein gated Potassium channels"], {"weight": 0.930400026735751}], ["TAS1R2", ["TCGA.AA.3492.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.930400026735751}], ["TAS1R2", ["TCGA.AA.3492.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.918412958024685}], ["TAS1R2", ["TCGA.AA.3492.01", "Presynaptic function of Kainate receptors"], {"weight": 0.905122717862096}], ["TAS1R2", ["TCGA.AA.3492.01", "Inwardly rectifying K+ channels"], {"weight": 0.930400026735751}], ["TAS1R2", ["TCGA.AA.3712.01", "Glucagon-type ligand receptors"], {"weight": 0.911428936915391}], ["TAS1R2", ["TCGA.AA.3712.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.903202238685835}], ["TAS1R2", ["TCGA.AA.3712.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.91509621471194}], ["TAS1R2", ["TCGA.AA.3712.01", "GABA B receptor activation"], {"weight": 0.916053820495058}], ["TAS1R2", ["TCGA.AA.3712.01", "Activation of GABAB receptors"], {"weight": 0.916053820495058}], ["TAS1R2", ["TCGA.AA.3712.01", "G beta:gamma signalling through BTK"], {"weight": 0.90404882253057}], ["TAS1R2", ["TCGA.AA.3712.01", "Potassium Channels"], {"weight": 0.944791366720837}], ["TAS1R2", ["TCGA.AA.3712.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.904953729979033}], ["TAS1R2", ["TCGA.AZ.6598.01", "GABA receptor activation"], {"weight": 0.926315851910195}], ["TAS1R2", ["TCGA.AZ.6598.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.940974397088739}], ["TAS1R2", ["TCGA.AZ.6598.01", "GABA B receptor activation"], {"weight": 0.941362943173227}], ["TAS1R2", ["TCGA.AZ.6598.01", "Activation of GABAB receptors"], {"weight": 0.941362943173227}], ["TAS1R2", ["TCGA.D5.6540.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.942434706894473}], ["TAS1R2", ["TCGA.D5.6540.01", "Glucagon-type ligand receptors"], {"weight": 0.929227470073317}], ["TAS1R2", ["TCGA.D5.6540.01", "GABA receptor activation"], {"weight": 0.916808146177909}], ["TAS1R2", ["TCGA.D5.6540.01", "G beta:gamma signalling through BTK"], {"weight": 0.917854620824282}], ["TAS1R2", ["TCGA.D5.6930.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.887300711474483}], ["TAS1R2", ["TCGA.D5.6930.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.859742244915204}], ["TAS1R2", ["TCGA.D5.6930.01", "GABA B receptor activation"], {"weight": 0.887512717220988}], ["TAS1R2", ["TCGA.D5.6930.01", "Activation of GABAB receptors"], {"weight": 0.887512717220988}], ["MUC20", ["TCGA.AA.3492.01", "Termination of O-glycan biosynthesis"], {"weight": 0.937220997444869}], ["MUC20", ["TCGA.AA.3492.01", "Blood group systems biosynthesis"], {"weight": 0.821346719545972}], ["ZFYVE28", ["TCGA.D5.6928.01", "Dectin-2 family"], {"weight": 0.768823746643491}], ["ZFYVE28", ["TCGA.G4.6315.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.697790234523863}], ["DOCK2", ["TCGA.F4.6808.01", "IL-6-type cytokine receptor ligand interactions"], {"weight": 0.861784710488199}], ["GRIK2", ["TCGA.D5.6926.01", "Presynaptic function of Kainate receptors"], {"weight": 0.872709169968413}], ["GRIK2", ["TCGA.G4.6586.01", "Presynaptic function of Kainate receptors"], {"weight": 0.931674562914085}], ["SPAG9", ["TCGA.CM.5864.01", "Heme degradation"], {"weight": 0.729665497833266}], ["HIPK2", ["TCGA.CM.5861.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.925083060560286}], ["HIPK2", ["TCGA.DM.A1D6.01", "TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway"], {"weight": 0.860875336760111}], ["NLGN4X", ["TCGA.CM.5868.01", "Neurexins and neuroligins"], {"weight": 0.882893618865898}], ["GABRA1", ["TCGA.AA.3492.01", "GABA receptor activation"], {"weight": 0.916247008561784}], ["MYO6", ["TCGA.AA.3492.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.877936199065777}], ["MYO6", ["TCGA.CM.4744.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.907537167665034}], ["MYO6", ["TCGA.CM.4744.01", "Ribavirin ADME"], {"weight": 0.647881867339913}], ["MYO6", ["TCGA.CM.4744.01", "LGI-ADAM interactions"], {"weight": 0.919412737786729}], ["ARHGEF10L", ["TCGA.AD.6889.01", "GABA receptor activation"], {"weight": 0.906391253579597}], ["MAGI2", ["TCGA.F4.6569.01", "Chondroitin sulfate biosynthesis"], {"weight": 0.789319835301662}], ["GALNT1", ["TCGA.AA.3492.01", "O-linked glycosylation of mucins"], {"weight": 0.951815944754646}], ["KAT2A", ["TCGA.AA.3660.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.480864802419487}], ["KAT2A", ["TCGA.AA.3660.01", "Bile acid and bile salt metabolism"], {"weight": 0.642914496950983}], ["KAT2A", ["TCGA.AA.3660.01", "Glucuronidation"], {"weight": 0.804438421132606}], ["KAT2A", ["TCGA.AA.3660.01", "Phase II - Conjugation of compounds"], {"weight": 0.695375232992513}], ["KAT2A", ["TCGA.AA.3660.01", "Synthesis of bile acids and bile salts"], {"weight": 0.641657067029335}], ["KAT2A", ["TCGA.AA.3660.01", "Synthesis of bile acids and bile salts via 27-hydroxycholesterol"], {"weight": 0.616723528680284}], ["KAT2A", ["TCGA.F4.6704.01", "Blood group systems biosynthesis"], {"weight": 0.685445691076826}], ["SLC2A8", ["TCGA.CK.5915.01", "Scavenging by Class A Receptors"], {"weight": 0.527160710815539}], ["RXRA", ["TCGA.D5.6928.01", "Bile acid and bile salt metabolism"], {"weight": 0.735493508447678}], ["POLR3A", ["TCGA.CK.5912.01", "Nucleotide catabolism"], {"weight": 0.821015442815159}], ["MTMR1", ["TCGA.CK.5915.01", "CD22 mediated BCR regulation"], {"weight": 0.829291192169315}], ["LNPEP", ["TCGA.G4.6626.01", "Biosynthesis of specialized proresolving mediators (SPMs)"], {"weight": 0.878954213767427}], ["LNPEP", ["TCGA.G4.6626.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.826588715494039}], ["CASK", ["TCGA.CM.6171.01", "Norepinephrine Neurotransmitter Release Cycle"], {"weight": 0.753056451330308}], ["SMARCA2", ["TCGA.CK.5912.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.834416104440728}], ["SMARCA2", ["TCGA.CK.5912.01", "Scavenging of heme from plasma"], {"weight": 0.521045106741092}], ["SMARCA2", ["TCGA.CK.5912.01", "Phase I - Functionalization of compounds"], {"weight": 0.904992230661837}], ["SMARCA2", ["TCGA.G4.6293.01", "Regulation of Complement cascade"], {"weight": 0.743315224031888}], ["PLA2G6", ["TCGA.AA.3492.01", "Phase II - Conjugation of compounds"], {"weight": 0.84769657834873}], ["PLA2G6", ["TCGA.AA.3492.01", "Aspirin ADME"], {"weight": 0.856116639930317}], ["PLA2G6", ["TCGA.AD.6895.01", "Signaling by Retinoic Acid"], {"weight": 0.746704326167846}], ["PLA2G6", ["TCGA.AD.6895.01", "Aspirin ADME"], {"weight": 0.873430019530113}], ["PLA2G6", ["TCGA.CM.5861.01", "Signaling by Retinoic Acid"], {"weight": 0.876556437009725}], ["PLA2G2C", ["TCGA.G4.6586.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.908588176617528}], ["PLA2G2C", ["TCGA.G4.6586.01", "Phase II - Conjugation of compounds"], {"weight": 0.856975139743185}], ["PLA2G2C", ["TCGA.G4.6628.01", "Aspirin ADME"], {"weight": 0.931548462880707}], ["PTGS2", ["TCGA.AZ.6598.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], {"weight": 0.784198421517045}], ["PTPRF", ["TCGA.AA.3492.01", "Synaptic adhesion-like molecules"], {"weight": 0.837158549175299}], ["PTPRF", ["TCGA.AZ.4615.01", "Synaptic adhesion-like molecules"], {"weight": 0.797062495424149}], ["PTPRF", ["TCGA.G4.6588.01", "Synaptic adhesion-like molecules"], {"weight": 0.837116547259487}], ["MYT1", ["TCGA.CM.6677.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.85234897190044}], ["MYT1", ["TCGA.CM.6677.01", "Signaling by Retinoic Acid"], {"weight": 0.614914320371809}], ["BACE1", ["TCGA.CK.5914.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.897111342704839}], ["RLBP1", ["TCGA.CK.5916.01", "RA biosynthesis pathway"], {"weight": 0.867480622164259}], ["ERBB2", ["TCGA.AD.6888.01", "IL-6-type cytokine receptor ligand interactions"], {"weight": 0.913240996493567}], ["ERBB2", ["TCGA.G4.6298.01", "Interleukin-35 Signalling"], {"weight": 0.870753734657143}], ["ERBB2", ["TCGA.G4.6298.01", "IL-6-type cytokine receptor ligand interactions"], {"weight": 0.893366172354534}], ["TRAF2", ["TCGA.AA.3502.01", "RA biosynthesis pathway"], {"weight": 0.781049150317832}], ["MAML3", ["TCGA.AA.3502.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.679523935264633}], ["MAML3", ["TCGA.AA.3502.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.639985900186253}], ["MAML3", ["TCGA.AA.3502.01", "Synthesis of bile acids and bile salts via 27-hydroxycholesterol"], {"weight": 0.538234930941357}], ["MAML3", ["TCGA.AZ.6600.01", "Glucuronidation"], {"weight": 0.655915478003439}], ["MAML3", ["TCGA.AZ.6600.01", "Phase II - Conjugation of compounds"], {"weight": 0.673252502561174}], ["MAML3", ["TCGA.AZ.6600.01", "Collagen chain trimerization"], {"weight": 0.827105264584871}], ["MAML3", ["TCGA.AZ.6600.01", "Aspirin ADME"], {"weight": 0.833538125546644}], ["MAML3", ["TCGA.AZ.6600.01", "mitochondrial fatty acid beta-oxidation of saturated fatty acids"], {"weight": 0.585120722871855}], ["MAML3", ["TCGA.AZ.6600.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.657764370046936}], ["MAML3", ["TCGA.AZ.6600.01", "Physiological factors"], {"weight": 0.623509373702486}], ["MAML3", ["TCGA.AZ.6600.01", "YAP1- and WWTR1 (TAZ)-stimulated gene expression"], {"weight": 0.562347246942775}], ["MAML3", ["TCGA.CM.6169.01", "Repression of WNT target genes"], {"weight": 0.769858478638896}], ["MAML3", ["TCGA.G4.6303.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.886853289223701}], ["GRIN2C", ["TCGA.F4.6856.01", "Synaptic adhesion-like molecules"], {"weight": 0.777879396172135}], ["ATP1B3", ["TCGA.AA.3502.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.847081327184397}], ["ROR1", ["TCGA.AA.3502.01", "Biological oxidations"], {"weight": 0.932713226931708}], ["ROR1", ["TCGA.AA.3502.01", "Voltage gated Potassium channels"], {"weight": 0.879169871719106}], ["ROR1", ["TCGA.AA.3502.01", "Phase I - Functionalization of compounds"], {"weight": 0.900308085394891}], ["ROR1", ["TCGA.AA.3502.01", "Ethanol oxidation"], {"weight": 0.664229939299987}], ["SALL4", ["TCGA.AA.3502.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.894033730375403}], ["SALL4", ["TCGA.AA.3502.01", "Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"], {"weight": 0.480848355482392}], ["SALL4", ["TCGA.CM.6166.01", "Classical antibody-mediated complement activation"], {"weight": 0.669755985884183}], ["SALL4", ["TCGA.CM.6678.01", "Classical antibody-mediated complement activation"], {"weight": 0.57899327680909}], ["ENPP6", ["TCGA.AA.3502.01", "Erythrocytes take up carbon dioxide and release oxygen"], {"weight": 0.79486543997863}], ["ENPP6", ["TCGA.AA.3502.01", "O2/CO2 exchange in erythrocytes"], {"weight": 0.79486543997863}], ["HNF4A", ["TCGA.AA.3511.01", "Glucuronidation"], {"weight": 0.62681720859778}], ["HNF4A", ["TCGA.AA.3511.01", "Phase II - Conjugation of compounds"], {"weight": 0.519245205427487}], ["CYP2D6", ["TCGA.AA.3655.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], {"weight": 0.826231761897415}], ["CYP2D6", ["TCGA.AA.3655.01", "Synthesis of bile acids and bile salts via 27-hydroxycholesterol"], {"weight": 0.819872749511333}], ["CYP2D6", ["TCGA.AA.3655.01", "Phase II - Conjugation of compounds"], {"weight": 0.803645340108632}], ["CYP2D6", ["TCGA.AA.3655.01", "Glucuronidation"], {"weight": 0.910623440356994}], ["CYP2D6", ["TCGA.AA.3655.01", "Synthesis of bile acids and bile salts"], {"weight": 0.78898554331003}], ["CYP2D6", ["TCGA.AA.3655.01", "Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"], {"weight": 0.77068223938239}], ["CYP2D6", ["TCGA.AA.3655.01", "Bile acid and bile salt metabolism"], {"weight": 0.788791994987324}], ["CYP2D6", ["TCGA.AA.3655.01", "Aspirin ADME"], {"weight": 0.823383334938752}], ["DGAT2", ["TCGA.AA.3655.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.643682007636386}], ["CISH", ["TCGA.AA.3655.01", "Collagen chain trimerization"], {"weight": 0.833184874687831}], ["TCEA3", ["TCGA.AA.3660.01", "Physiological factors"], {"weight": 0.66168080205177}], ["MUC4", ["TCGA.G4.6323.01", "Keratan sulfate biosynthesis"], {"weight": 0.883792115856475}], ["MUC4", ["TCGA.G4.6323.01", "Keratan sulfate/keratin metabolism"], {"weight": 0.883792115856475}], ["CACNA1H", ["TCGA.AA.3660.01", "LGI-ADAM interactions"], {"weight": 0.616686505949381}], ["CACNA1H", ["TCGA.AD.6895.01", "NCAM1 interactions"], {"weight": 0.919148445021586}], ["CACNA1H", ["TCGA.AY.6386.01", "NCAM1 interactions"], {"weight": 0.922198055379071}], ["CACNA1H", ["TCGA.AY.6386.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.81173933156504}], ["CACNA1H", ["TCGA.AY.6386.01", "LGI-ADAM interactions"], {"weight": 0.794495522640012}], ["CACNA1H", ["TCGA.AZ.6601.01", "NCAM1 interactions"], {"weight": 0.911141109869888}], ["CACNA1H", ["TCGA.CM.5860.01", "Phase 0 - rapid depolarisation"], {"weight": 0.891444073673023}], ["CACNA1H", ["TCGA.F4.6808.01", "NCAM1 interactions"], {"weight": 0.935676676644114}], ["PLA2G4D", ["TCGA.AA.3662.01", "Phase II - Conjugation of compounds"], {"weight": 0.760741579463961}], ["PLA2G4D", ["TCGA.CM.4743.01", "Collagen chain trimerization"], {"weight": 0.87982282193989}], ["PLA2G4D", ["TCGA.CM.6166.01", "Biosynthesis of specialized proresolving mediators (SPMs)"], {"weight": 0.915455010481513}], ["PLA2G4D", ["TCGA.CM.6166.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], {"weight": 0.829575179575151}], ["PLA2G4D", ["TCGA.CM.6166.01", "Acyl chain remodelling of PE"], {"weight": 0.851150060710959}], ["PLA2G4D", ["TCGA.G4.6298.01", "Phase II - Conjugation of compounds"], {"weight": 0.915329182549292}], ["PLA2G4D", ["TCGA.G4.6298.01", "Aspirin ADME"], {"weight": 0.933121057005296}], ["PLA2G4D", ["TCGA.G4.6298.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.907839443804074}], ["PLA2G4D", ["TCGA.G4.6311.01", "APAP ADME"], {"weight": 0.820699824223515}], ["NPW", ["TCGA.D5.6537.01", "Complement cascade"], {"weight": 0.90565278749736}], ["NPW", ["TCGA.D5.6537.01", "Regulation of Complement cascade"], {"weight": 0.889254126687493}], ["NPW", ["TCGA.D5.6537.01", "Initial triggering of complement"], {"weight": 0.915356171218789}], ["SPHK1", ["TCGA.AA.3697.01", "Trafficking of GluR2-containing AMPA receptors"], {"weight": 0.851848888591724}], ["SPHK1", ["TCGA.F4.6463.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], {"weight": 0.471008207450223}], ["INSL3", ["TCGA.AA.3697.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.831815737793086}], ["INSL3", ["TCGA.AA.3697.01", "Inwardly rectifying K+ channels"], {"weight": 0.901476298572344}], ["INSL3", ["TCGA.AA.3697.01", "Activation of G protein gated Potassium channels"], {"weight": 0.886353313298266}], ["INSL3", ["TCGA.AA.3697.01", "G protein gated Potassium channels"], {"weight": 0.886353313298266}], ["INSL3", ["TCGA.AA.3697.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.886353313298266}], ["TRPC6", ["TCGA.AA.3662.01", "Phase 4 - resting membrane potential"], {"weight": 0.774315960974191}], ["TRPC6", ["TCGA.CM.6676.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.926248848200581}], ["NEFM", ["TCGA.G4.6626.01", "Arachidonic acid metabolism"], {"weight": 0.926257390207321}], ["TGIF1", ["TCGA.G4.6297.01", "Signaling by Retinoic Acid"], {"weight": 0.680472868574177}], ["CCR5", ["TCGA.G4.6322.01", "Complement cascade"], {"weight": 0.761790638097758}], ["CCR5", ["TCGA.G4.6322.01", "Phase 4 - resting membrane potential"], {"weight": 0.774632355377986}], ["ITPR2", ["TCGA.AZ.4615.01", "Glutamate Neurotransmitter Release Cycle"], {"weight": 0.769425338392248}], ["ITPR2", ["TCGA.G4.6588.01", "CD22 mediated BCR regulation"], {"weight": 0.845674779448259}], ["EDNRB", ["TCGA.D5.6926.01", "Collagen chain trimerization"], {"weight": 0.926237766570691}], ["EDNRB", ["TCGA.G4.6323.01", "GABA receptor activation"], {"weight": 0.547748913982431}], ["EDNRB", ["TCGA.G4.6323.01", "GABA B receptor activation"], {"weight": 0.882850129118799}], ["EDNRB", ["TCGA.G4.6323.01", "Activation of GABAB receptors"], {"weight": 0.882850129118799}], ["EDNRB", ["TCGA.G4.6323.01", "Glucagon-type ligand receptors"], {"weight": 0.885181771902982}], ["NOS2", ["TCGA.AM.5821.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.887829325241248}], ["NOS2", ["TCGA.CM.5861.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.860342199830273}], ["AP2A2", ["TCGA.AD.6889.01", "Voltage gated Potassium channels"], {"weight": 0.942162822678941}], ["MEF2A", ["TCGA.CK.4952.01", "Assembly and cell surface presentation of NMDA receptors"], {"weight": 0.889779680882158}], ["MEF2A", ["TCGA.CK.4952.01", "Unblocking of NMDA receptors, glutamate binding and activation"], {"weight": 0.91503602374561}], ["MEF2A", ["TCGA.F4.6569.01", "Phase II - Conjugation of compounds"], {"weight": 0.798017662554223}], ["MEF2A", ["TCGA.F4.6569.01", "Glucuronidation"], {"weight": 0.758082795380761}], ["MEF2A", ["TCGA.F4.6569.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.702576343506044}], ["MEF2A", ["TCGA.G4.6298.01", "Glucuronidation"], {"weight": 0.925877575358798}], ["MEF2A", ["TCGA.G4.6298.01", "Phase 0 - rapid depolarisation"], {"weight": 0.929508129491021}], ["GSK3B", ["TCGA.DM.A285.01", "Phase II - Conjugation of compounds"], {"weight": 0.78965225946594}], ["CIITA", ["TCGA.G4.6322.01", "Interaction between L1 and Ankyrins"], {"weight": 0.899930362724474}], ["SIN3A", ["TCGA.AA.3697.01", "SUMOylation of DNA methylation proteins"], {"weight": 0.713702563741622}], ["SIN3A", ["TCGA.G4.6293.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.789904385921061}], ["KCNJ2", ["TCGA.AA.3663.01", "Phase 4 - resting membrane potential"], {"weight": 0.917597993814496}], ["KCNJ2", ["TCGA.CM.6172.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.872443642720565}], ["KCNJ2", ["TCGA.CM.6172.01", "Glucagon-type ligand receptors"], {"weight": 0.875096188430535}], ["KCNJ2", ["TCGA.CM.6172.01", "G-protein activation"], {"weight": 0.879822650357995}], ["KCNJ2", ["TCGA.CM.6172.01", "G beta:gamma signalling through BTK"], {"weight": 0.842087127384903}], ["KCNJ2", ["TCGA.CM.6172.01", "Prostacyclin signalling through prostacyclin receptor"], {"weight": 0.842087127384903}], ["KCNJ2", ["TCGA.CM.6172.01", "Potassium Channels"], {"weight": 0.920713922955689}], ["KCNJ2", ["TCGA.CM.6172.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.842087127384903}], ["KCNJ2", ["TCGA.CM.6172.01", "Presynaptic function of Kainate receptors"], {"weight": 0.842087127384903}], ["KCNJ2", ["TCGA.CM.6172.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.771837479896179}], ["KCNJ2", ["TCGA.CM.6172.01", "Inwardly rectifying K+ channels"], {"weight": 0.868254348669343}], ["KCNJ2", ["TCGA.CM.6172.01", "Thromboxane signalling through TP receptor"], {"weight": 0.842087127384903}], ["KCNJ2", ["TCGA.D5.6930.01", "Phase 4 - resting membrane potential"], {"weight": 0.816015279796109}], ["OR2T6", ["TCGA.CM.6676.01", "Activation of the phototransduction cascade"], {"weight": 0.78603180753777}], ["OR2T6", ["TCGA.CM.6676.01", "Glucagon-type ligand receptors"], {"weight": 0.903446979995957}], ["OR2T6", ["TCGA.CM.6676.01", "Inwardly rectifying K+ channels"], {"weight": 0.916515122490889}], ["OR2T6", ["TCGA.CM.6676.01", "G beta:gamma signalling through BTK"], {"weight": 0.89713202299519}], ["OR2T6", ["TCGA.CM.6676.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.887790551793512}], ["OR2T6", ["TCGA.CM.6676.01", "Activation of G protein gated Potassium channels"], {"weight": 0.90087086553749}], ["OR2T6", ["TCGA.CM.6676.01", "G protein gated Potassium channels"], {"weight": 0.90087086553749}], ["OR2T6", ["TCGA.CM.6676.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.90087086553749}], ["OR2T6", ["TCGA.CM.6676.01", "Chemokine receptors bind chemokines"], {"weight": 0.879573591566996}], ["OR2T6", ["TCGA.CM.6676.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.719939491769965}], ["OR2T6", ["TCGA.CM.6676.01", "Potassium Channels"], {"weight": 0.942925738933003}], ["OR2T6", ["TCGA.CM.6676.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.822854227939003}], ["OR2T6", ["TCGA.CM.6676.01", "Prostacyclin signalling through prostacyclin receptor"], {"weight": 0.851618217221875}], ["OR2T6", ["TCGA.CM.6676.01", "GABA receptor activation"], {"weight": 0.586285632081347}], ["OR2T6", ["TCGA.CM.6676.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.851618217221875}], ["MTNR1B", ["TCGA.DM.A1D6.01", "Initial triggering of complement"], {"weight": 0.893477723123613}], ["SCN1B", ["TCGA.AZ.6599.01", "Interaction between L1 and Ankyrins"], {"weight": 0.935011421196598}], ["SCN1B", ["TCGA.AZ.6599.01", "Phase 0 - rapid depolarisation"], {"weight": 0.934072620544152}], ["COPB1", ["TCGA.CM.5864.01", "Interaction between L1 and Ankyrins"], {"weight": 0.939745019583598}], ["FZD7", ["TCGA.DM.A1HA.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], {"weight": 0.941381479391175}], ["CACNA2D4", ["TCGA.D5.6532.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.925460611967686}], ["EPS15", ["TCGA.D5.6529.01", "FGFR2 ligand binding and activation"], {"weight": 0.856033533905661}], ["RASGRP2", ["TCGA.AZ.6598.01", "LGI-ADAM interactions"], {"weight": 0.912311646480632}], ["NUP107", ["TCGA.D5.5540.01", "Metabolism of folate and pterines"], {"weight": 0.884332066881765}], ["GRIN2A", ["TCGA.D5.6537.01", "Phase 0 - rapid depolarisation"], {"weight": 0.938546983157623}], ["GRIN2A", ["TCGA.D5.6537.01", "Activation of the phototransduction cascade"], {"weight": 0.831756659199413}], ["GRIN2A", ["TCGA.D5.6537.01", "Ion transport by P-type ATPases"], {"weight": 0.905370229464004}], ["GRIN2A", ["TCGA.DM.A1DB.01", "CD22 mediated BCR regulation"], {"weight": 0.75813502255463}], ["A1BG", ["TCGA.D5.6531.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.83417389218068}], ["A1BG", ["TCGA.D5.6531.01", "Defective GALNT12 causes CRCS1"], {"weight": 0.80144725713437}], ["A1BG", ["TCGA.D5.6531.01", "O-linked glycosylation"], {"weight": 0.876220297109492}], ["A1BG", ["TCGA.D5.6531.01", "Termination of O-glycan biosynthesis"], {"weight": 0.839218978504606}], ["A1BG", ["TCGA.D5.6531.01", "Potassium Channels"], {"weight": 0.921260759485724}], ["A1BG", ["TCGA.D5.6531.01", "Signaling by Retinoic Acid"], {"weight": 0.67993433560492}], ["A1BG", ["TCGA.D5.6531.01", "Diseases associated with O-glycosylation of proteins"], {"weight": 0.835659722236363}], ["A1BG", ["TCGA.D5.6531.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.729786532965431}], ["A1BG", ["TCGA.D5.6531.01", "Glucagon-type ligand receptors"], {"weight": 0.856493241531024}], ["A1BG", ["TCGA.D5.6531.01", "Inwardly rectifying K+ channels"], {"weight": 0.861147058230308}], ["DOCK8", ["TCGA.AA.3663.01", "Complement cascade"], {"weight": 0.87215907766882}], ["DOCK8", ["TCGA.AY.6196.01", "Other semaphorin interactions"], {"weight": 0.589638601199023}], ["GLI3", ["TCGA.DM.A28F.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.727102509279255}], ["PCSK1", ["TCGA.G4.6628.01", "Glucagon-type ligand receptors"], {"weight": 0.920344757903621}], ["ITSN2", ["TCGA.AM.5821.01", "WNT ligand biogenesis and trafficking"], {"weight": 0.934816983165587}], ["RGSL1", ["TCGA.AY.6386.01", "Phase 4 - resting membrane potential"], {"weight": 0.824487572189515}], ["TRPV1", ["TCGA.D5.6538.01", "LGI-ADAM interactions"], {"weight": 0.819100996840974}], ["NLGN4Y", ["TCGA.AD.6890.01", "Neurexins and neuroligins"], {"weight": 0.881595267329246}], ["C8B", ["TCGA.AA.3663.01", "Regulation of Complement cascade"], {"weight": 0.861837577067176}], ["GABRA6", ["TCGA.AA.3663.01", "GABA receptor activation"], {"weight": 0.920982151283166}], ["RGS10", ["TCGA.G4.6586.01", "GABA B receptor activation"], {"weight": 0.943714716898519}], ["RGS10", ["TCGA.G4.6586.01", "Activation of GABAB receptors"], {"weight": 0.943714716898519}], ["RGS10", ["TCGA.G4.6586.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.932674071845909}], ["CTGF", ["TCGA.AZ.6599.01", "FGFR1 ligand binding and activation"], {"weight": 0.914554890458412}], ["CTGF", ["TCGA.AZ.6599.01", "Scavenging of heme from plasma"], {"weight": 0.861337775630732}], ["CTGF", ["TCGA.AZ.6599.01", "FGFR1c ligand binding and activation"], {"weight": 0.89059695952686}], ["CHD9", ["TCGA.AA.3663.01", "Phase II - Conjugation of compounds"], {"weight": 0.772491395214391}], ["TBC1D4", ["TCGA.AM.5820.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.748217591710635}], ["TUBA8", ["TCGA.AA.3663.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], {"weight": 0.804063635497823}], ["TFAP2C", ["TCGA.CM.6162.01", "Glucuronidation"], {"weight": 0.698397976914903}], ["TFAP2C", ["TCGA.D5.6537.01", "Phase II - Conjugation of compounds"], {"weight": 0.798871671875777}], ["TFAP2C", ["TCGA.DM.A1D8.01", "Glucuronidation"], {"weight": 0.897116115945132}], ["TFAP2C", ["TCGA.DM.A1D8.01", "Aspirin ADME"], {"weight": 0.843972980114747}], ["EPN2", ["TCGA.CM.6166.01", "Defective GALNT12 causes CRCS1"], {"weight": 0.78932406499447}], ["SOD3", ["TCGA.D5.6537.01", "Aspirin ADME"], {"weight": 0.802191013481337}], ["SOD3", ["TCGA.D5.6537.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.861569502056444}], ["MED24", ["TCGA.CA.6719.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.760394959973961}], ["CYP3A7", ["TCGA.AA.3697.01", "Phase II - Conjugation of compounds"], {"weight": 0.809417151423465}], ["SDC4", ["TCGA.AA.3697.01", "Molecules associated with elastic fibres"], {"weight": 0.711561648230538}], ["SYT1", ["TCGA.AA.3697.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.60706764553703}], ["PPP2R3A", ["TCGA.AA.3697.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.900204384976328}], ["TLE1", ["TCGA.CM.5344.01", "Collagen chain trimerization"], {"weight": 0.889102832090545}], ["TLE1", ["TCGA.CM.5344.01", "Phase II - Conjugation of compounds"], {"weight": 0.822378989270168}], ["TLE1", ["TCGA.CM.5344.01", "Glucuronidation"], {"weight": 0.863882898306332}], ["GUCY2D", ["TCGA.AA.3697.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.822797873357625}], ["GUCY2D", ["TCGA.AA.3697.01", "Activation of the phototransduction cascade"], {"weight": 0.819844058382504}], ["NSMAF", ["TCGA.D5.6535.01", "TNFs bind their physiological receptors"], {"weight": 0.390112957867316}], ["NSMAF", ["TCGA.D5.6932.01", "TNFs bind their physiological receptors"], {"weight": 0.374388302870248}], ["E2F7", ["TCGA.D5.5541.01", "Transcription of E2F targets under negative control by DREAM complex"], {"weight": 0.840092629646588}], ["GSTP1", ["TCGA.AA.3697.01", "APAP ADME"], {"weight": 0.827050288269374}], ["GSTP1", ["TCGA.AM.5821.01", "APAP ADME"], {"weight": 0.940859750394705}], ["GSTP1", ["TCGA.D5.6533.01", "Glutathione conjugation"], {"weight": 0.886408499021716}], ["GSTP1", ["TCGA.D5.6533.01", "RA biosynthesis pathway"], {"weight": 0.87158384200977}], ["GSTP1", ["TCGA.D5.6533.01", "Ethanol oxidation"], {"weight": 0.917457450895655}], ["GSTP1", ["TCGA.D5.6533.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.870906989172426}], ["ADO", ["TCGA.G4.6297.01", "RA biosynthesis pathway"], {"weight": 0.694426714724892}], ["CYP3A7", ["TCGA.AA.3697.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.880576339401863}], ["CYP3A7", ["TCGA.AA.3697.01", "Ethanol oxidation"], {"weight": 0.865591593686242}], ["CYP3A7", ["TCGA.AA.3697.01", "Glucuronidation"], {"weight": 0.863012920172147}], ["CSF2RB", ["TCGA.G4.6315.01", "Classical antibody-mediated complement activation"], {"weight": 0.694816627183325}], ["CSF2RB", ["TCGA.G4.6315.01", "Creation of C4 and C2 activators"], {"weight": 0.654543192452281}], ["CSNK1A1L", ["TCGA.AA.3697.01", "Phase 0 - rapid depolarisation"], {"weight": 0.867970600452268}], ["GP1BA", ["TCGA.CM.6171.01", "O-linked glycosylation"], {"weight": 0.92437073994725}], ["IL18", ["TCGA.CA.6716.01", "Binding and entry of HIV virion"], {"weight": 0.71370366964229}], ["ACTR1B", ["TCGA.AD.6964.01", "Interaction between L1 and Ankyrins"], {"weight": 0.862739871561486}], ["DOCK10", ["TCGA.AD.6901.01", "WNT ligand biogenesis and trafficking"], {"weight": 0.818162642811088}], ["SRY", ["TCGA.AA.3697.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.854628109324113}], ["SRY", ["TCGA.AD.6889.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.911791223686947}], ["KRT1", ["TCGA.CK.4950.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.916000901888254}], ["KRT1", ["TCGA.G4.6297.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], {"weight": 0.69040601151694}], ["TERT", ["TCGA.AA.3712.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.78229539162241}], ["GYS1", ["TCGA.AA.3712.01", "Phase II - Conjugation of compounds"], {"weight": 0.847451756279456}], ["GYS1", ["TCGA.AA.3712.01", "Glucuronidation"], {"weight": 0.902414650398903}], ["GYS1", ["TCGA.AA.3712.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.819665917266037}], ["ITGA3", ["TCGA.DM.A1DB.01", "Transport of bile salts and organic acids, metal ions and amine compounds"], {"weight": 0.489086632735667}], ["OR5W2", ["TCGA.AU.3779.01", "Potassium Channels"], {"weight": 0.864014855567785}], ["OR5W2", ["TCGA.AU.3779.01", "Glucagon-type ligand receptors"], {"weight": 0.910421807557298}], ["OR5W2", ["TCGA.AU.3779.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.912216829389828}], ["OR5W2", ["TCGA.AU.3779.01", "Signaling by BMP"], {"weight": 0.811960176182193}], ["OR5W2", ["TCGA.AU.3779.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.904529723366056}], ["OR5W2", ["TCGA.AU.3779.01", "Signal amplification"], {"weight": 0.909992547113957}], ["OR5W2", ["TCGA.AU.3779.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.897225040489133}], ["OR5W2", ["TCGA.AU.3779.01", "GABA B receptor activation"], {"weight": 0.916938097202}], ["OR5W2", ["TCGA.AU.3779.01", "Activation of GABAB receptors"], {"weight": 0.916938097202}], ["OR5W2", ["TCGA.AU.3779.01", "Presynaptic function of Kainate receptors"], {"weight": 0.884542624643584}], ["OR5W2", ["TCGA.AU.3779.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.887171437331586}], ["OR5W2", ["TCGA.AU.3779.01", "Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding"], {"weight": 0.899207807817322}], ["OR5W2", ["TCGA.AU.3779.01", "G-protein activation"], {"weight": 0.897679224962627}], ["OR5W2", ["TCGA.AU.3779.01", "Thromboxane signalling through TP receptor"], {"weight": 0.891755752338562}], ["OR5W2", ["TCGA.AU.3779.01", "ADORA2B mediated anti-inflammatory cytokines production"], {"weight": 0.89712541952136}], ["OR5W2", ["TCGA.AU.3779.01", "G beta:gamma signalling through BTK"], {"weight": 0.868729409074679}], ["OR5W2", ["TCGA.AU.3779.01", "Inwardly rectifying K+ channels"], {"weight": 0.858898265202123}], ["SOX2", ["TCGA.AA.3712.01", "Heme degradation"], {"weight": 0.590993054238296}], ["SOX2", ["TCGA.AD.6964.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], {"weight": 0.846163641896464}], ["PHC2", ["TCGA.AA.3713.01", "Resolution of D-loop Structures through Holliday Junction Intermediates"], {"weight": 0.84168523792282}], ["PHC2", ["TCGA.AA.3713.01", "Resolution of D-Loop Structures"], {"weight": 0.84168523792282}], ["EPHB4", ["TCGA.F4.6569.01", "TNFs bind their physiological receptors"], {"weight": 0.298674871697066}], ["PRKD1", ["TCGA.D5.6538.01", "Keratan sulfate biosynthesis"], {"weight": 0.868192040050695}], ["NECAP2", ["TCGA.F4.6703.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], {"weight": 0.795452048000424}], ["NECAP2", ["TCGA.F4.6703.01", "WNT ligand biogenesis and trafficking"], {"weight": 0.914980578180031}], ["RASA1", ["TCGA.G4.6586.01", "Scavenging of heme from plasma"], {"weight": 0.705401053904834}], ["EPS15L1", ["TCGA.D5.6926.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.834402015124474}], ["EPS15L1", ["TCGA.D5.6926.01", "APAP ADME"], {"weight": 0.643544094373152}], ["CES1", ["TCGA.AA.3713.01", "Ethanol oxidation"], {"weight": 0.471629656378961}], ["CES1", ["TCGA.AD.5900.01", "Phase II - Conjugation of compounds"], {"weight": 0.88515958875963}], ["CES1", ["TCGA.AD.5900.01", "Glucuronidation"], {"weight": 0.882283864202488}], ["CES1", ["TCGA.AD.5900.01", "Aspirin ADME"], {"weight": 0.924250067490304}], ["CES1", ["TCGA.G4.6628.01", "Glucuronidation"], {"weight": 0.879190166146396}], ["CES1", ["TCGA.G4.6628.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.82296207559032}], ["TEX15", ["TCGA.CK.4952.01", "Defective homologous recombination repair (HRR) due to BRCA1 loss of function"], {"weight": 0.880471687970793}], ["TEX15", ["TCGA.CK.4952.01", "Defective homologous recombination repair (HRR) due to PALB2 loss of function"], {"weight": 0.880471687970793}], ["TEX15", ["TCGA.CK.4952.01", "Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function"], {"weight": 0.880471687970793}], ["TEX15", ["TCGA.CK.4952.01", "Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function"], {"weight": 0.880471687970793}], ["TEX15", ["TCGA.CK.4952.01", "Impaired BRCA2 binding to PALB2"], {"weight": 0.880471687970793}], ["APAF1", ["TCGA.D5.5538.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.550602061628079}], ["APAF1", ["TCGA.G4.6320.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.69483586802652}], ["PPP2R3B", ["TCGA.AD.6964.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.885229017299405}], ["CYP4A11", ["TCGA.DM.A1HA.01", "Arachidonic acid metabolism"], {"weight": 0.955355926211637}], ["CYP4A11", ["TCGA.DM.A1HA.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.939581772402661}], ["CYP4A11", ["TCGA.DM.A1HA.01", "Phase II - Conjugation of compounds"], {"weight": 0.875974705929621}], ["CYP4A11", ["TCGA.DM.A1HA.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], {"weight": 0.891755445004826}], ["NUPL2", ["TCGA.DM.A0XF.01", "TNFs bind their physiological receptors"], {"weight": 0.405124500942849}], ["ITGB4", ["TCGA.D5.6536.01", "Collagen chain trimerization"], {"weight": 0.917355317539}], ["ITGB4", ["TCGA.F4.6570.01", "O-linked glycosylation"], {"weight": 0.921444567083273}], ["ITGB4", ["TCGA.F4.6570.01", "Diseases associated with O-glycosylation of proteins"], {"weight": 0.899588316268711}], ["ERBB3", ["TCGA.D5.6534.01", "LGI-ADAM interactions"], {"weight": 0.688736414466769}], ["ITGA7", ["TCGA.CM.6162.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.944221326719343}], ["ARID1B", ["TCGA.AD.5900.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], {"weight": 0.769331945620637}], ["SNX1", ["TCGA.AY.6196.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], {"weight": 0.811958369980446}], ["OAT", ["TCGA.AA.3713.01", "RA biosynthesis pathway"], {"weight": 0.481542383976271}], ["CDX2", ["TCGA.AD.6889.01", "Glucagon-type ligand receptors"], {"weight": 0.936675397320599}], ["CDX2", ["TCGA.G4.6586.01", "Glucagon-type ligand receptors"], {"weight": 0.941006045308547}], ["ZFPM1", ["TCGA.CM.5868.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.80844510355151}], ["JMJD7-PLA2G4B", ["TCGA.G4.6588.01", "Phase II - Conjugation of compounds"], {"weight": 0.818433930753615}], ["STAT3", ["TCGA.AU.3779.01", "Glucuronidation"], {"weight": 0.864173880157701}], ["STAT3", ["TCGA.AU.3779.01", "Chemokine receptors bind chemokines"], {"weight": 0.911043724200708}], ["STAT3", ["TCGA.AU.3779.01", "Aspirin ADME"], {"weight": 0.769766257272044}], ["STAT3", ["TCGA.AU.3779.01", "Interleukin-6 family signaling"], {"weight": 0.890545996726776}], ["STAT3", ["TCGA.AU.3779.01", "IL-6-type cytokine receptor ligand interactions"], {"weight": 0.787362617911357}], ["STAT3", ["TCGA.DM.A1HA.01", "Classical antibody-mediated complement activation"], {"weight": 0.741755019494073}], ["STAT3", ["TCGA.DM.A1HA.01", "TNFs bind their physiological receptors"], {"weight": 0.558889205711162}], ["NGF", ["TCGA.CM.4743.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.943049644662008}], ["COL4A6", ["TCGA.DM.A0XD.01", "Glucuronidation"], {"weight": 0.885008791867851}], ["GPC1", ["TCGA.CM.6678.01", "TNFs bind their physiological receptors"], {"weight": 0.406610917722856}], ["PLA2G3", ["TCGA.AM.5821.01", "Aspirin ADME"], {"weight": 0.932188543238673}], ["PLA2G3", ["TCGA.CK.4952.01", "Phase II - Conjugation of compounds"], {"weight": 0.850771192681611}], ["MED14", ["TCGA.F4.6704.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.772708239066612}], ["MED14", ["TCGA.F4.6704.01", "Ethanol oxidation"], {"weight": 0.635809200244412}], ["MED14", ["TCGA.F4.6704.01", "APAP ADME"], {"weight": 0.685538266020863}], ["ALDH9A1", ["TCGA.AD.5900.01", "Ethanol oxidation"], {"weight": 0.860704741650932}], ["PTPN3", ["TCGA.AM.5820.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.849361756390525}], ["PTPN3", ["TCGA.CK.5914.01", "CD22 mediated BCR regulation"], {"weight": 0.807526933243598}], ["PTPN3", ["TCGA.CK.5914.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.739663639000192}], ["PTPN3", ["TCGA.CM.6162.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.627863745502091}], ["PTPN3", ["TCGA.CM.6162.01", "Phase II - Conjugation of compounds"], {"weight": 0.751166409569811}], ["PTPN3", ["TCGA.CM.6166.01", "CD22 mediated BCR regulation"], {"weight": 0.80009777242848}], ["PTPN3", ["TCGA.CM.6166.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.808224091121402}], ["POLR1A", ["TCGA.G4.6317.01", "GABA B receptor activation"], {"weight": 0.940819394075444}], ["POLR1A", ["TCGA.G4.6317.01", "Activation of GABAB receptors"], {"weight": 0.940819394075444}], ["POLR1A", ["TCGA.G4.6317.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.928502780513359}], ["BMPR1B", ["TCGA.G4.6320.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.724184706455909}], ["SULT2B1", ["TCGA.AZ.6598.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.909558877538194}], ["SULT2B1", ["TCGA.AZ.6598.01", "Synthesis of bile acids and bile salts via 27-hydroxycholesterol"], {"weight": 0.80377709127572}], ["GATAD2A", ["TCGA.F4.6569.01", "Ethanol oxidation"], {"weight": 0.518758063918102}], ["HSD3B7", ["TCGA.AD.5900.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], {"weight": 0.851874787417779}], ["HSD3B7", ["TCGA.G4.6588.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], {"weight": 0.891188125845829}], ["HSD3B7", ["TCGA.G4.6588.01", "Synthesis of bile acids and bile salts via 27-hydroxycholesterol"], {"weight": 0.936690455581804}], ["HSD3B7", ["TCGA.G4.6588.01", "Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"], {"weight": 0.899329318305966}], ["CYP11A1", ["TCGA.AD.5900.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.908905681777616}], ["OLA1", ["TCGA.CM.4743.01", "Complement cascade"], {"weight": 0.919047806263496}], ["OLA1", ["TCGA.CM.4743.01", "Classical antibody-mediated complement activation"], {"weight": 0.60126425369502}], ["OLA1", ["TCGA.CM.4743.01", "Regulation of signaling by NODAL"], {"weight": 0.861802286968849}], ["OLA1", ["TCGA.CM.4743.01", "Chemokine receptors bind chemokines"], {"weight": 0.93627073125626}], ["DNAJC6", ["TCGA.G4.6320.01", "Scavenging by Class A Receptors"], {"weight": 0.461035862903663}], ["APOA4", ["TCGA.D5.6926.01", "RA biosynthesis pathway"], {"weight": 0.851927335793944}], ["APOA4", ["TCGA.D5.6926.01", "TNFs bind their physiological receptors"], {"weight": 0.365153180814509}], ["HLA-DOA", ["TCGA.AD.5900.01", "Interaction between L1 and Ankyrins"], {"weight": 0.878283781561132}], ["HLA-DOA", ["TCGA.AM.5821.01", "Kinesins"], {"weight": 0.894205390756805}], ["RGS14", ["TCGA.AD.5900.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.875367100118418}], ["RGS14", ["TCGA.AD.6890.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.433353186052535}], ["C8G", ["TCGA.AD.5900.01", "O-linked glycosylation of mucins"], {"weight": 0.886484677982158}], ["C9", ["TCGA.F4.6856.01", "Antimicrobial peptides"], {"weight": 0.637629380441509}], ["LRP6", ["TCGA.AD.5900.01", "WNT ligand biogenesis and trafficking"], {"weight": 0.869141184713123}], ["PIK3AP1", ["TCGA.AD.6889.01", "CD22 mediated BCR regulation"], {"weight": 0.872075108271238}], ["SCN1A", ["TCGA.AZ.4615.01", "Interaction between L1 and Ankyrins"], {"weight": 0.950727917950141}], ["SCN1A", ["TCGA.CM.6171.01", "Interaction between L1 and Ankyrins"], {"weight": 0.934182752956726}], ["SCN1A", ["TCGA.CM.6171.01", "Phase 0 - rapid depolarisation"], {"weight": 0.889337368402575}], ["SCN1A", ["TCGA.D5.5538.01", "Interaction between L1 and Ankyrins"], {"weight": 0.919536983676705}], ["SCN1A", ["TCGA.D5.5538.01", "Phase 0 - rapid depolarisation"], {"weight": 0.919433824064966}], ["SCN1A", ["TCGA.D5.5538.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.14498090470521}], ["SCN1A", ["TCGA.D5.5538.01", "Sensory perception of taste"], {"weight": 0.902134247731339}], ["SCN1A", ["TCGA.DM.A1HA.01", "Interaction between L1 and Ankyrins"], {"weight": 0.944183834048361}], ["PTGES2", ["TCGA.AD.6548.01", "Phase II - Conjugation of compounds"], {"weight": 0.874063059312155}], ["PTGES2", ["TCGA.AD.6548.01", "Signaling by Retinoic Acid"], {"weight": 0.638257146909194}], ["PTGES2", ["TCGA.AD.6548.01", "Ethanol oxidation"], {"weight": 0.78584212672591}], ["PTGES2", ["TCGA.AD.6548.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.839455774570048}], ["CCT6B", ["TCGA.AD.6888.01", "Potassium Channels"], {"weight": 0.964509602482036}], ["SDC3", ["TCGA.AD.6888.01", "G-protein activation"], {"weight": 0.932221617599795}], ["SDC3", ["TCGA.AD.6888.01", "Calcitonin-like ligand receptors"], {"weight": 0.826225599090136}], ["SDC3", ["TCGA.AD.6888.01", "HS-GAG biosynthesis"], {"weight": 0.928156826608234}], ["SDC3", ["TCGA.AD.6888.01", "FGFR4 ligand binding and activation"], {"weight": 0.894062508858868}], ["SDC3", ["TCGA.AD.6888.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.88328373457359}], ["SDC3", ["TCGA.AD.6888.01", "Phospholipase C-mediated cascade; FGFR4"], {"weight": 0.894062508858868}], ["SDC3", ["TCGA.AD.6888.01", "FGFR2 ligand binding and activation"], {"weight": 0.9186468248667}], ["SDC3", ["TCGA.AD.6888.01", "Scavenging by Class A Receptors"], {"weight": 0.508625943091848}], ["SDC3", ["TCGA.AD.6888.01", "Phospholipase C-mediated cascade: FGFR1"], {"weight": 0.907189180087418}], ["CCT6B", ["TCGA.AD.6888.01", "Classical antibody-mediated complement activation"], {"weight": 0.7329590147793}], ["CCT6B", ["TCGA.AD.6888.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.927615977378315}], ["CCT6B", ["TCGA.AD.6888.01", "G beta:gamma signalling through BTK"], {"weight": 0.914352376816078}], ["CCT6B", ["TCGA.AD.6888.01", "GABA receptor activation"], {"weight": 0.919135113659151}], ["CCT6B", ["TCGA.AD.6888.01", "Prostacyclin signalling through prostacyclin receptor"], {"weight": 0.903162128228377}], ["CCT6B", ["TCGA.AD.6888.01", "Thromboxane signalling through TP receptor"], {"weight": 0.902009936175368}], ["CCT6B", ["TCGA.AD.6888.01", "Creation of C4 and C2 activators"], {"weight": 0.776564509134162}], ["CCT6B", ["TCGA.AD.6888.01", "Glucagon-type ligand receptors"], {"weight": 0.935806319443076}], ["CCT6B", ["TCGA.AD.6888.01", "GABA B receptor activation"], {"weight": 0.927773901992208}], ["CCT6B", ["TCGA.AD.6888.01", "Activation of GABAB receptors"], {"weight": 0.927773901992208}], ["CCT6B", ["TCGA.AD.6888.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.910470973449745}], ["CCT6B", ["TCGA.AD.6888.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.90030364306515}], ["HRH4", ["TCGA.AD.6888.01", "Binding and entry of HIV virion"], {"weight": 0.830114505619257}], ["HRH4", ["TCGA.AD.6888.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.934717748436607}], ["HRH4", ["TCGA.AD.6888.01", "Specification of primordial germ cells"], {"weight": 0.867814032330703}], ["ABLIM3", ["TCGA.AD.6888.01", "CD22 mediated BCR regulation"], {"weight": 0.790052018454753}], ["DOK2", ["TCGA.AD.6888.01", "NCAM1 interactions"], {"weight": 0.941920200326176}], ["RIPK1", ["TCGA.D5.5538.01", "Ethanol oxidation"], {"weight": 0.785125559595636}], ["AMFR", ["TCGA.AD.6888.01", "TNFs bind their physiological receptors"], {"weight": 0.443160400754883}], ["GRIK5", ["TCGA.AD.6888.01", "Voltage gated Potassium channels"], {"weight": 0.868142044171881}], ["GRIK5", ["TCGA.AD.6888.01", "Presynaptic function of Kainate receptors"], {"weight": 0.912812187562619}], ["GRIK5", ["TCGA.AD.6888.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.919781438566119}], ["GRIK5", ["TCGA.AD.6888.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.821045927608708}], ["MYBPC2", ["TCGA.AD.6888.01", "Initial triggering of complement"], {"weight": 0.817193904550891}], ["MYBPC2", ["TCGA.F4.6459.01", "Physiological factors"], {"weight": 0.755376776760824}], ["SCAI", ["TCGA.AD.6888.01", "Defective B3GALTL causes PpS"], {"weight": 0.902971713854781}], ["SCAI", ["TCGA.AD.6888.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.902971713854781}], ["SCAI", ["TCGA.AD.6888.01", "Keratan sulfate biosynthesis"], {"weight": 0.909925632245951}], ["SCAI", ["TCGA.AD.6888.01", "Diseases associated with O-glycosylation of proteins"], {"weight": 0.755820975041464}], ["SCAI", ["TCGA.AD.6888.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.917698890860527}], ["SCAI", ["TCGA.AD.6888.01", "O-linked glycosylation"], {"weight": 0.910536301250238}], ["LGI1", ["TCGA.AD.6889.01", "Phase 0 - rapid depolarisation"], {"weight": 0.942602846784098}], ["GNB3", ["TCGA.D5.5537.01", "Phase 4 - resting membrane potential"], {"weight": 0.888354565383944}], ["SPTBN4", ["TCGA.AD.6889.01", "Interaction between L1 and Ankyrins"], {"weight": 0.950971732181479}], ["SPTBN4", ["TCGA.AY.6196.01", "Interaction between L1 and Ankyrins"], {"weight": 0.858479778015742}], ["SPTBN4", ["TCGA.AZ.6601.01", "Interaction between L1 and Ankyrins"], {"weight": 0.912986700569045}], ["PF4", ["TCGA.CM.5861.01", "Complement cascade"], {"weight": 0.799512023024816}], ["SH3GL1", ["TCGA.CM.6674.01", "GABA receptor activation"], {"weight": 0.854536995222774}], ["MAPK8", ["TCGA.CM.4743.01", "NCAM1 interactions"], {"weight": 0.935068968421881}], ["CCR10", ["TCGA.DM.A28E.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.806400342720927}], ["CCR10", ["TCGA.DM.A28E.01", "Complement cascade"], {"weight": 0.937550193034492}], ["CCR10", ["TCGA.DM.A28E.01", "Regulation of Complement cascade"], {"weight": 0.904892095127753}], ["CCR10", ["TCGA.DM.A28E.01", "Initial triggering of complement"], {"weight": 0.886418661505244}], ["CCR10", ["TCGA.DM.A28E.01", "G-protein beta:gamma signalling"], {"weight": 0.930716123658204}], ["CCR10", ["TCGA.DM.A28E.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.919544266171863}], ["CCR10", ["TCGA.DM.A28E.01", "G alpha (q) signalling events"], {"weight": 0.905398740394873}], ["CCR10", ["TCGA.DM.A28E.01", "GABA receptor activation"], {"weight": 0.918317353499438}], ["CCR10", ["TCGA.DM.A28E.01", "Glucagon-type ligand receptors"], {"weight": 0.932105765660676}], ["CCR10", ["TCGA.DM.A28E.01", "GABA B receptor activation"], {"weight": 0.928724257132783}], ["CCR10", ["TCGA.DM.A28E.01", "Activation of GABAB receptors"], {"weight": 0.928724257132783}], ["CCR10", ["TCGA.DM.A28E.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.914859287034827}], ["CCR10", ["TCGA.DM.A28E.01", "Presynaptic function of Kainate receptors"], {"weight": 0.896758513146394}], ["CCR10", ["TCGA.DM.A28E.01", "G beta:gamma signalling through BTK"], {"weight": 0.90581429094872}], ["CCR10", ["TCGA.DM.A28E.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.907948673466901}], ["CCR10", ["TCGA.DM.A28E.01", "G alpha (z) signalling events"], {"weight": 0.921605353134634}], ["CCR10", ["TCGA.DM.A28E.01", "Activation of G protein gated Potassium channels"], {"weight": 0.919540205763288}], ["CCR10", ["TCGA.DM.A28E.01", "G protein gated Potassium channels"], {"weight": 0.919540205763288}], ["CCR10", ["TCGA.DM.A28E.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.919540205763288}], ["CCR10", ["TCGA.DM.A28E.01", "Scavenging by Class A Receptors"], {"weight": 0.347042621505415}], ["CCR10", ["TCGA.DM.A28E.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.891307386664233}], ["CCR10", ["TCGA.DM.A28E.01", "G beta:gamma signalling through CDC42"], {"weight": 0.894289462848477}], ["CCR10", ["TCGA.DM.A28E.01", "Inwardly rectifying K+ channels"], {"weight": 0.92750276029963}], ["HTR1E", ["TCGA.CM.6172.01", "Peptide hormone biosynthesis"], {"weight": 0.695286628326212}], ["TACR2", ["TCGA.D5.6537.01", "Chemokine receptors bind chemokines"], {"weight": 0.935193122597611}], ["TACR2", ["TCGA.G4.6311.01", "Presynaptic function of Kainate receptors"], {"weight": 0.851440713616609}], ["TACR2", ["TCGA.G4.6311.01", "Glucagon-type ligand receptors"], {"weight": 0.872039016176672}], ["TACR2", ["TCGA.G4.6311.01", "G beta:gamma signalling through BTK"], {"weight": 0.821474457286162}], ["TACR2", ["TCGA.G4.6311.01", "Prostacyclin signalling through prostacyclin receptor"], {"weight": 0.821474457286162}], ["ITGA4", ["TCGA.AZ.6598.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.945243576154279}], ["ITGA4", ["TCGA.CA.5796.01", "Interaction between L1 and Ankyrins"], {"weight": 0.869976541064905}], ["ITGA4", ["TCGA.CA.5796.01", "Diseases associated with O-glycosylation of proteins"], {"weight": 0.623857462975863}], ["ITGA4", ["TCGA.CA.5796.01", "Defective B3GALTL causes PpS"], {"weight": 0.838201572033901}], ["ITGA4", ["TCGA.CA.5796.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.838241050484248}], ["ITGA4", ["TCGA.CA.5796.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.84042174609869}], ["ITGA4", ["TCGA.G4.6298.01", "Ligand-dependent caspase activation"], {"weight": 0.793655938909842}], ["ITGA6", ["TCGA.CM.6161.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.771653655132547}], ["ITGA6", ["TCGA.F4.6703.01", "Tryptophan catabolism"], {"weight": 0.68537234774876}], ["ISLR", ["TCGA.AD.6889.01", "Initial triggering of complement"], {"weight": 0.842511630297751}], ["ISLR", ["TCGA.AD.6889.01", "Creation of C4 and C2 activators"], {"weight": 0.817919291050681}], ["OR13A1", ["TCGA.AD.6889.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.924531192545301}], ["OR5AC2", ["TCGA.D5.5538.01", "Glucagon-type ligand receptors"], {"weight": 0.918511945955484}], ["OR5AC2", ["TCGA.D5.5538.01", "Potassium Channels"], {"weight": 0.946496837276918}], ["OR5AC2", ["TCGA.D5.5538.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.903069071570386}], ["OR5AC2", ["TCGA.D5.5538.01", "Dopamine Neurotransmitter Release Cycle"], {"weight": 0.818470686861764}], ["OR5AC2", ["TCGA.D5.5538.01", "Serotonin Neurotransmitter Release Cycle"], {"weight": 0.766053325667322}], ["OR5AC2", ["TCGA.D5.5538.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.611170379946293}], ["OR6B2", ["TCGA.AD.6889.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.932572663498906}], ["PICK1", ["TCGA.AD.6889.01", "Synaptic adhesion-like molecules"], {"weight": 0.837032359251483}], ["TRPC5", ["TCGA.G4.6628.01", "Phase 0 - rapid depolarisation"], {"weight": 0.922416784081357}], ["WNT1", ["TCGA.CM.4743.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], {"weight": 0.902377420397014}], ["ETV5", ["TCGA.CM.5861.01", "Chemokine receptors bind chemokines"], {"weight": 0.934416992148447}], ["KAT6A", ["TCGA.AZ.4682.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.699398831672745}], ["PRKD3", ["TCGA.DM.A1D7.01", "Heme degradation"], {"weight": 0.648743016574542}], ["SCN4A", ["TCGA.AD.6895.01", "Phase 0 - rapid depolarisation"], {"weight": 0.925555967919157}], ["SCN4A", ["TCGA.CK.5915.01", "Interaction between L1 and Ankyrins"], {"weight": 0.953866881792291}], ["SCN4A", ["TCGA.G4.6320.01", "Interaction between L1 and Ankyrins"], {"weight": 0.946936823501628}], ["SCN4A", ["TCGA.G4.6320.01", "Phase 0 - rapid depolarisation"], {"weight": 0.941347209450374}], ["COL9A1", ["TCGA.DM.A28G.01", "Molecules associated with elastic fibres"], {"weight": 0.743088405954665}], ["FZD10", ["TCGA.AU.6004.01", "WNT ligand biogenesis and trafficking"], {"weight": 0.898620080630967}], ["SEC16A", ["TCGA.AZ.6601.01", "Synaptic adhesion-like molecules"], {"weight": 0.748532743943213}], ["PPFIA1", ["TCGA.CK.5916.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], {"weight": 0.822699658837331}], ["SLC32A1", ["TCGA.AD.6889.01", "RA biosynthesis pathway"], {"weight": 0.817291908450393}], ["SLC32A1", ["TCGA.F4.6460.01", "Phase II - Conjugation of compounds"], {"weight": 0.78015826507963}], ["SLC32A1", ["TCGA.G4.6626.01", "Phase II - Conjugation of compounds"], {"weight": 0.763115577189522}], ["SLC32A1", ["TCGA.G4.6626.01", "Norepinephrine Neurotransmitter Release Cycle"], {"weight": 0.785476698963198}], ["SLC32A1", ["TCGA.G4.6626.01", "Acetylcholine Neurotransmitter Release Cycle"], {"weight": 0.746528245299463}], ["SLC32A1", ["TCGA.G4.6626.01", "Serotonin Neurotransmitter Release Cycle"], {"weight": 0.892075365644969}], ["SCNN1A", ["TCGA.AZ.6598.01", "Interaction between L1 and Ankyrins"], {"weight": 0.952144864899592}], ["ENTPD4", ["TCGA.AD.6889.01", "Activation of the phototransduction cascade"], {"weight": 0.886652116305227}], ["ACOX1", ["TCGA.AZ.6607.01", "Collagen chain trimerization"], {"weight": 0.923518300230006}], ["ACOX1", ["TCGA.AZ.6607.01", "Ethanol oxidation"], {"weight": 0.785323364071383}], ["ACOX1", ["TCGA.AZ.6607.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], {"weight": 0.822191979393329}], ["ACOX1", ["TCGA.AZ.6607.01", "mitochondrial fatty acid beta-oxidation of saturated fatty acids"], {"weight": 0.82050958227161}], ["ACOX1", ["TCGA.AZ.6607.01", "Bile acid and bile salt metabolism"], {"weight": 0.820156434182842}], ["ACOX1", ["TCGA.AZ.6607.01", "Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"], {"weight": 0.842921191595454}], ["ACOX1", ["TCGA.AZ.6607.01", "Arachidonic acid metabolism"], {"weight": 0.849252750088233}], ["ACOX1", ["TCGA.CM.6171.01", "Aspirin ADME"], {"weight": 0.847307109846555}], ["CPT1A", ["TCGA.F4.6805.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.865656784071374}], ["NCL", ["TCGA.AD.6964.01", "Glutathione conjugation"], {"weight": 0.759568208172578}], ["NCL", ["TCGA.CK.4952.01", "Glucuronidation"], {"weight": 0.869670340763201}], ["NCL", ["TCGA.CM.6674.01", "Phase II - Conjugation of compounds"], {"weight": 0.718073674181424}], ["LRIG1", ["TCGA.CM.6169.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], {"weight": 0.785477685890478}], ["LRIG1", ["TCGA.F4.6808.01", "CD22 mediated BCR regulation"], {"weight": 0.77651775908281}], ["DDX17", ["TCGA.CM.6674.01", "Aspirin ADME"], {"weight": 0.754238577786791}], ["GPR156", ["TCGA.CK.5914.01", "Arachidonic acid metabolism"], {"weight": 0.913243685505748}], ["GPR156", ["TCGA.CK.5914.01", "Phase 4 - resting membrane potential"], {"weight": 0.847267823687819}], ["CSPG4", ["TCGA.D5.6932.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.865920967337683}], ["SHC4", ["TCGA.AD.6890.01", "Protein-protein interactions at synapses"], {"weight": 0.864843568016044}], ["OR5K1", ["TCGA.AD.6890.01", "Potassium Channels"], {"weight": 0.944373964962552}], ["OR5K1", ["TCGA.AD.6890.01", "Inwardly rectifying K+ channels"], {"weight": 0.916965019812919}], ["OR5K1", ["TCGA.AD.6890.01", "Phase 4 - resting membrane potential"], {"weight": 0.81170845478527}], ["OR5K1", ["TCGA.AD.6890.01", "Glucagon-type ligand receptors"], {"weight": 0.907743416231634}], ["OR5K1", ["TCGA.AD.6890.01", "G beta:gamma signalling through BTK"], {"weight": 0.896025714345365}], ["OR5K1", ["TCGA.AD.6890.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.838001131328701}], ["OR5K1", ["TCGA.AD.6890.01", "Signal amplification"], {"weight": 0.853534996385533}], ["OR5K1", ["TCGA.AD.6890.01", "GABA receptor activation"], {"weight": 0.84261256137813}], ["OR5K1", ["TCGA.AD.6890.01", "Presynaptic function of Kainate receptors"], {"weight": 0.875701744252168}], ["OR5K1", ["TCGA.AD.6890.01", "Activation of G protein gated Potassium channels"], {"weight": 0.89400045529878}], ["OR5K1", ["TCGA.AD.6890.01", "G protein gated Potassium channels"], {"weight": 0.89400045529878}], ["OR5K1", ["TCGA.AD.6890.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.89400045529878}], ["OR5K1", ["TCGA.AD.6890.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.891729239794393}], ["OR5K1", ["TCGA.AD.6890.01", "GABA B receptor activation"], {"weight": 0.900999386429451}], ["OR5K1", ["TCGA.AD.6890.01", "Activation of GABAB receptors"], {"weight": 0.900999386429451}], ["OR5K1", ["TCGA.AD.6890.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.887087162904349}], ["OR5K1", ["TCGA.AD.6890.01", "Prostacyclin signalling through prostacyclin receptor"], {"weight": 0.857911429064578}], ["OR5K1", ["TCGA.AD.6890.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.857911429064578}], ["OR5K1", ["TCGA.AD.6890.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.896263098498621}], ["OR5K1", ["TCGA.AZ.4615.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.921857048731189}], ["SYT9", ["TCGA.AD.6890.01", "Transport of bile salts and organic acids, metal ions and amine compounds"], {"weight": 0.108005980196511}], ["CYP2A13", ["TCGA.AD.6895.01", "Phase II - Conjugation of compounds"], {"weight": 0.87910118440181}], ["KL", ["TCGA.AD.6895.01", "Glucuronidation"], {"weight": 0.906327303427264}], ["KL", ["TCGA.AD.6895.01", "Heme degradation"], {"weight": 0.691174478154584}], ["KL", ["TCGA.AZ.6598.01", "Glucuronidation"], {"weight": 0.878380316275513}], ["KL", ["TCGA.CK.5916.01", "Phase II - Conjugation of compounds"], {"weight": 0.825460139060196}], ["KL", ["TCGA.CK.5916.01", "Glucuronidation"], {"weight": 0.877917601483174}], ["KL", ["TCGA.D5.6930.01", "Glucuronidation"], {"weight": 0.913765419474465}], ["ALDH1A1", ["TCGA.AD.6895.01", "RA biosynthesis pathway"], {"weight": 0.862571342301414}], ["ALDH1A1", ["TCGA.AD.6895.01", "Ethanol oxidation"], {"weight": 0.91141625551375}], ["CYP2A13", ["TCGA.D5.6930.01", "Phase II - Conjugation of compounds"], {"weight": 0.88693077414734}], ["KRT5", ["TCGA.D5.6929.01", "Metabolism of amine-derived hormones"], {"weight": 0.510914891086638}], ["GLUD2", ["TCGA.G4.6303.01", "Phase II - Conjugation of compounds"], {"weight": 0.823396020288114}], ["GLUD2", ["TCGA.G4.6303.01", "APAP ADME"], {"weight": 0.718992777566046}], ["GLUD2", ["TCGA.G4.6303.01", "Glutathione conjugation"], {"weight": 0.87685961455148}], ["CYP11B1", ["TCGA.CM.5861.01", "RA biosynthesis pathway"], {"weight": 0.930751026026146}], ["CYP11B1", ["TCGA.CM.5861.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.90803413383389}], ["CYP11B1", ["TCGA.D5.6928.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], {"weight": 0.610325536198241}], ["CYP11B1", ["TCGA.D5.6928.01", "Synthesis of bile acids and bile salts"], {"weight": 0.65696127990602}], ["CYP4A22", ["TCGA.AM.5821.01", "Arachidonic acid metabolism"], {"weight": 0.949463303134523}], ["IGF1", ["TCGA.D5.6535.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.788311339565406}], ["APP", ["TCGA.G4.6310.01", "Initial triggering of complement"], {"weight": 0.799782343718419}], ["APP", ["TCGA.G4.6310.01", "Scavenging of heme from plasma"], {"weight": 0.748698578688385}], ["APP", ["TCGA.G4.6310.01", "Classical antibody-mediated complement activation"], {"weight": 0.741357354999119}], ["APP", ["TCGA.G4.6310.01", "Creation of C4 and C2 activators"], {"weight": 0.681191261288809}], ["APP", ["TCGA.G4.6310.01", "Erythrocytes take up carbon dioxide and release oxygen"], {"weight": 0.743771180982014}], ["APP", ["TCGA.G4.6310.01", "O2/CO2 exchange in erythrocytes"], {"weight": 0.743771180982014}], ["APP", ["TCGA.G4.6310.01", "Scavenging by Class A Receptors"], {"weight": 0.393465987250296}], ["APP", ["TCGA.G4.6310.01", "Inwardly rectifying K+ channels"], {"weight": 0.90739227827247}], ["APP", ["TCGA.G4.6310.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.673450285446036}], ["INSRR", ["TCGA.D5.6929.01", "Defective B3GALTL causes PpS"], {"weight": 0.869251448495687}], ["INSRR", ["TCGA.D5.6929.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.869251448495687}], ["INSRR", ["TCGA.D5.6929.01", "Diseases associated with O-glycosylation of proteins"], {"weight": 0.826985295172545}], ["INSRR", ["TCGA.D5.6929.01", "O-linked glycosylation"], {"weight": 0.881363074731553}], ["INSRR", ["TCGA.F4.6570.01", "Defective GALNT3 causes HFTC"], {"weight": 0.867475030469214}], ["INSRR", ["TCGA.F4.6570.01", "Defective GALNT12 causes CRCS1"], {"weight": 0.867475030469214}], ["INSRR", ["TCGA.F4.6570.01", "Termination of O-glycan biosynthesis"], {"weight": 0.887101169624969}], ["INSRR", ["TCGA.F4.6570.01", "Defective C1GALT1C1 causes TNPS"], {"weight": 0.867475030469214}], ["PIK3C2G", ["TCGA.G4.6294.01", "Norepinephrine Neurotransmitter Release Cycle"], {"weight": 0.824418767127934}], ["CHL1", ["TCGA.CA.6718.01", "Interaction between L1 and Ankyrins"], {"weight": 0.90912041425843}], ["CHL1", ["TCGA.G4.6321.01", "Defective EXT2 causes exostoses 2"], {"weight": 0.714834632060726}], ["CHL1", ["TCGA.G4.6321.01", "Defective EXT1 causes exostoses 1, TRPS2 and CHDS"], {"weight": 0.714834632060726}], ["CHL1", ["TCGA.G4.6321.01", "HS-GAG degradation"], {"weight": 0.797879390960224}], ["TRIM45", ["TCGA.DM.A28K.01", "Translocation of ZAP-70 to Immunological synapse"], {"weight": 0.928278322029894}], ["TRIM45", ["TCGA.DM.A28K.01", "Generation of second messenger molecules"], {"weight": 0.905347998083268}], ["TRIM45", ["TCGA.DM.A28K.01", "Phosphorylation of CD3 and TCR zeta chains"], {"weight": 0.926405832454662}], ["TRIM45", ["TCGA.DM.A28K.01", "PD-1 signaling"], {"weight": 0.924401966959394}], ["SLC8A1", ["TCGA.AD.6895.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], {"weight": 0.887677378809421}], ["OR4A15", ["TCGA.AY.6386.01", "Glucagon-type ligand receptors"], {"weight": 0.927598952625209}], ["OR4A15", ["TCGA.AY.6386.01", "GABA receptor activation"], {"weight": 0.874495287053309}], ["OR4A15", ["TCGA.AY.6386.01", "Inwardly rectifying K+ channels"], {"weight": 0.919938985328768}], ["OR4A15", ["TCGA.AY.6386.01", "Activation of G protein gated Potassium channels"], {"weight": 0.914157143851348}], ["OR4A15", ["TCGA.AY.6386.01", "G protein gated Potassium channels"], {"weight": 0.914157143851348}], ["OR4A15", ["TCGA.AY.6386.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.914157143851348}], ["OR4A15", ["TCGA.AY.6386.01", "GABA B receptor activation"], {"weight": 0.921046638230349}], ["OR4A15", ["TCGA.AY.6386.01", "Activation of GABAB receptors"], {"weight": 0.921046638230349}], ["OR4A15", ["TCGA.AY.6386.01", "G beta:gamma signalling through BTK"], {"weight": 0.880656982403447}], ["OR4A15", ["TCGA.G4.6586.01", "G beta:gamma signalling through BTK"], {"weight": 0.926454588619758}], ["OR2M2", ["TCGA.CA.5797.01", "Glucagon-type ligand receptors"], {"weight": 0.905601011711933}], ["OR2M2", ["TCGA.CA.5797.01", "Inwardly rectifying K+ channels"], {"weight": 0.922893913684958}], ["OR2M2", ["TCGA.CA.5797.01", "Phase 4 - resting membrane potential"], {"weight": 0.840607162463123}], ["OR2M2", ["TCGA.CA.5797.01", "Activation of G protein gated Potassium channels"], {"weight": 0.91317388600628}], ["OR2M2", ["TCGA.CA.5797.01", "G protein gated Potassium channels"], {"weight": 0.91317388600628}], ["OR2M2", ["TCGA.CA.5797.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.91317388600628}], ["OR2M2", ["TCGA.CA.5797.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.899395105229916}], ["OR2M2", ["TCGA.CA.5797.01", "NCAM1 interactions"], {"weight": 0.871454567897808}], ["OR2M2", ["TCGA.CA.5797.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.902683551872679}], ["OR2M2", ["TCGA.CA.5797.01", "Presynaptic function of Kainate receptors"], {"weight": 0.8910493923531}], ["OR2H2", ["TCGA.AD.6895.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.91897592126159}], ["OR52I2", ["TCGA.CM.4748.01", "Peptide hormone biosynthesis"], {"weight": 0.799153761326508}], ["OR52I2", ["TCGA.CM.4748.01", "Potassium Channels"], {"weight": 0.95752051701287}], ["OR52I2", ["TCGA.CM.4748.01", "Phase 4 - resting membrane potential"], {"weight": 0.778947173351345}], ["OR52I2", ["TCGA.DM.A28F.01", "Potassium Channels"], {"weight": 0.962981937408151}], ["OR14I1", ["TCGA.CM.5868.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.909123060105524}], ["OR14I1", ["TCGA.CM.5868.01", "G beta:gamma signalling through BTK"], {"weight": 0.907854435830677}], ["OR14I1", ["TCGA.CM.5868.01", "GABA B receptor activation"], {"weight": 0.915215029063464}], ["OR14I1", ["TCGA.CM.5868.01", "Activation of GABAB receptors"], {"weight": 0.915215029063464}], ["OR14I1", ["TCGA.CM.5868.01", "Activation of the phototransduction cascade"], {"weight": 0.773862839754921}], ["OR14I1", ["TCGA.CM.5868.01", "Glucagon-type ligand receptors"], {"weight": 0.910699827291952}], ["OR14I1", ["TCGA.CM.5868.01", "Presynaptic function of Kainate receptors"], {"weight": 0.898566902410247}], ["OR14I1", ["TCGA.CM.5868.01", "Inwardly rectifying K+ channels"], {"weight": 0.916771491967141}], ["OR14I1", ["TCGA.CM.5868.01", "Activation of G protein gated Potassium channels"], {"weight": 0.910839789640189}], ["OR14I1", ["TCGA.CM.5868.01", "G protein gated Potassium channels"], {"weight": 0.910839789640189}], ["OR14I1", ["TCGA.CM.5868.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.908427838412495}], ["OR14I1", ["TCGA.CM.5868.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.910839789640189}], ["OR14I1", ["TCGA.CM.5868.01", "G-protein activation"], {"weight": 0.908722378117778}], ["OR14I1", ["TCGA.CM.5868.01", "Thromboxane signalling through TP receptor"], {"weight": 0.883747356068555}], ["OR14I1", ["TCGA.CM.5868.01", "G alpha (z) signalling events"], {"weight": 0.911745502366942}], ["OR14I1", ["TCGA.CM.5868.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.903975555004712}], ["OR14I1", ["TCGA.CM.5868.01", "Prostacyclin signalling through prostacyclin receptor"], {"weight": 0.878166836729276}], ["OR14I1", ["TCGA.CM.5868.01", "Sensory perception of taste"], {"weight": 0.868951561354057}], ["OR14I1", ["TCGA.CM.5868.01", "LGI-ADAM interactions"], {"weight": 0.621834033931284}], ["OR14I1", ["TCGA.CM.5868.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.878166836729276}], ["OR14I1", ["TCGA.CM.5868.01", "Sensory perception of sweet, bitter, and umami (glutamate) taste"], {"weight": 0.862157253370338}], ["OR14I1", ["TCGA.CM.5868.01", "Inactivation, recovery and regulation of the phototransduction cascade"], {"weight": 0.771305145192926}], ["TRAPPC5", ["TCGA.AY.6386.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.936913512265357}], ["TRAPPC5", ["TCGA.CK.4952.01", "Synaptic adhesion-like molecules"], {"weight": 0.869599851224075}], ["TRAPPC5", ["TCGA.CK.4952.01", "Intrinsic Pathway of Fibrin Clot Formation"], {"weight": 0.900227426702271}], ["CNTNAP1", ["TCGA.CK.5916.01", "Interaction between L1 and Ankyrins"], {"weight": 0.922467396632827}], ["AGFG1", ["TCGA.AZ.4682.01", "Glutamate Neurotransmitter Release Cycle"], {"weight": 0.767338489623428}], ["AGFG1", ["TCGA.AZ.4682.01", "Norepinephrine Neurotransmitter Release Cycle"], {"weight": 0.736025005739421}], ["AGFG1", ["TCGA.AZ.4682.01", "Neurexins and neuroligins"], {"weight": 0.88626941788678}], ["SETDB1", ["TCGA.G4.6588.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.955246322600387}], ["USP12", ["TCGA.DM.A28H.01", "TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway"], {"weight": 0.848226695875846}], ["USP12", ["TCGA.DM.A28H.01", "TNFs bind their physiological receptors"], {"weight": 0.487462328224206}], ["USP12", ["TCGA.DM.A28H.01", "Unwinding of DNA"], {"weight": 0.773583428051782}], ["IL22RA1", ["TCGA.AD.6895.01", "IL-6-type cytokine receptor ligand interactions"], {"weight": 0.894299280450055}], ["LRP12", ["TCGA.AD.6964.01", "Scavenging by Class A Receptors"], {"weight": 0.697470228445094}], ["LRP12", ["TCGA.AD.6964.01", "Erythrocytes take up carbon dioxide and release oxygen"], {"weight": 0.552389465642259}], ["LRP12", ["TCGA.AD.6964.01", "O2/CO2 exchange in erythrocytes"], {"weight": 0.552389465642259}], ["LRP12", ["TCGA.G4.6628.01", "Erythrocytes take up carbon dioxide and release oxygen"], {"weight": 0.801601467423178}], ["LRP12", ["TCGA.G4.6628.01", "O2/CO2 exchange in erythrocytes"], {"weight": 0.801601467423178}], ["CUBN", ["TCGA.G4.6309.01", "Erythrocytes take up carbon dioxide and release oxygen"], {"weight": 0.701032576687837}], ["CUBN", ["TCGA.G4.6309.01", "O2/CO2 exchange in erythrocytes"], {"weight": 0.701032576687837}], ["FGF8", ["TCGA.G4.6320.01", "FGFR1 ligand binding and activation"], {"weight": 0.909972740775438}], ["RECK", ["TCGA.AD.6895.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.860055099753176}], ["RECK", ["TCGA.D5.6930.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.796297257291039}], ["DSEL", ["TCGA.D5.6534.01", "Chondroitin sulfate biosynthesis"], {"weight": 0.853140727893743}], ["DSEL", ["TCGA.D5.6539.01", "Extracellular matrix organization"], {"weight": 0.613055803941105}], ["ADAMTSL4", ["TCGA.AY.6196.01", "Collagen formation"], {"weight": 0.91301698277229}], ["ADAMTSL4", ["TCGA.AY.6196.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.946332964634089}], ["ADAMTSL4", ["TCGA.AY.6196.01", "Diseases associated with O-glycosylation of proteins"], {"weight": 0.868551008845934}], ["ADAMTSL4", ["TCGA.AY.6196.01", "O-linked glycosylation"], {"weight": 0.911653794230466}], ["ADAMTSL4", ["TCGA.AY.6196.01", "Defective B3GALTL causes PpS"], {"weight": 0.90177797850056}], ["ADAMTSL4", ["TCGA.AY.6196.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.901725611216235}], ["ADAMTSL4", ["TCGA.D5.6534.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.943012546867367}], ["ADAMTSL4", ["TCGA.D5.6534.01", "Defective B3GALTL causes PpS"], {"weight": 0.891965365387056}], ["ADAMTSL4", ["TCGA.D5.6534.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.891903649149043}], ["NMT1", ["TCGA.AD.6895.01", "TP53 Regulates Transcription of Death Receptors and Ligands"], {"weight": 0.636199285622615}], ["GPC6", ["TCGA.AD.6899.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.891949820304043}], ["GPC6", ["TCGA.D5.6534.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.769358267483387}], ["GPC6", ["TCGA.D5.6534.01", "Scavenging by Class A Receptors"], {"weight": 0.747509246844131}], ["TBXAS1", ["TCGA.AD.6899.01", "Phase II - Conjugation of compounds"], {"weight": 0.73998283073572}], ["NDUFS2", ["TCGA.AD.6899.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.376305908421904}], ["TBXAS1", ["TCGA.AD.6899.01", "Ethanol oxidation"], {"weight": 0.676570567274169}], ["MC4R", ["TCGA.AD.6901.01", "Peptide hormone biosynthesis"], {"weight": 0.633408439795759}], ["OR11A1", ["TCGA.AD.6901.01", "Activation of the phototransduction cascade"], {"weight": 0.837629359633676}], ["OR11A1", ["TCGA.CM.6679.01", "Voltage gated Potassium channels"], {"weight": 0.695240442852819}], ["OR8K5", ["TCGA.AD.6901.01", "G-protein activation"], {"weight": 0.900201169199991}], ["OR5M8", ["TCGA.AD.6901.01", "Inwardly rectifying K+ channels"], {"weight": 0.818729224101392}], ["PAK1", ["TCGA.AD.6963.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.882438833768544}], ["PAK1", ["TCGA.AD.6963.01", "Phase 4 - resting membrane potential"], {"weight": 0.7609342617374}], ["ENPP3", ["TCGA.AD.6964.01", "Phase II - Conjugation of compounds"], {"weight": 0.840100195859395}], ["GRB2", ["TCGA.AD.6964.01", "Defective GALNT3 causes HFTC"], {"weight": 0.797118303507576}], ["GRB2", ["TCGA.AD.6964.01", "Defective GALNT12 causes CRCS1"], {"weight": 0.797118303507576}], ["EGFR", ["TCGA.AZ.6599.01", "Classical antibody-mediated complement activation"], {"weight": 0.715057782601958}], ["EGFR", ["TCGA.AZ.6599.01", "Creation of C4 and C2 activators"], {"weight": 0.757081895810059}], ["PPP1CA", ["TCGA.AD.6964.01", "Glycosaminoglycan metabolism"], {"weight": 0.753615439184495}], ["GPC2", ["TCGA.F4.6703.01", "Defective GALNT12 causes CRCS1"], {"weight": 0.843633883563019}], ["GPC2", ["TCGA.F4.6703.01", "O-linked glycosylation"], {"weight": 0.904882648081616}], ["GPC2", ["TCGA.F4.6703.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.856308200427704}], ["GPC2", ["TCGA.F4.6703.01", "Defective GALNT3 causes HFTC"], {"weight": 0.824401375559849}], ["GPC2", ["TCGA.F4.6703.01", "Defective C1GALT1C1 causes TNPS"], {"weight": 0.824401375559849}], ["GPC2", ["TCGA.F4.6703.01", "O-linked glycosylation of mucins"], {"weight": 0.907504139074372}], ["GPC2", ["TCGA.F4.6703.01", "Termination of O-glycan biosynthesis"], {"weight": 0.824401375559849}], ["DYNC1I1", ["TCGA.CM.5348.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.643668936483366}], ["DYNC1I1", ["TCGA.CM.5348.01", "APAP ADME"], {"weight": 0.66636749178531}], ["TCF4", ["TCGA.CM.4744.01", "Glucuronidation"], {"weight": 0.82073905057486}], ["TCF4", ["TCGA.CM.4744.01", "Phase II - Conjugation of compounds"], {"weight": 0.82982107253054}], ["TCF4", ["TCGA.CM.4744.01", "Endogenous sterols"], {"weight": 0.640012450200878}], ["B4GALT1", ["TCGA.AD.6964.01", "O-linked glycosylation of mucins"], {"weight": 0.924291829446699}], ["ATP1A2", ["TCGA.D5.6924.01", "Heme degradation"], {"weight": 0.642284888781034}], ["ATP1A2", ["TCGA.G4.6304.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.795150230995677}], ["ENPP3", ["TCGA.AD.6964.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.873530741284538}], ["ENPP3", ["TCGA.D5.6928.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.8855780108371}], ["POLR3B", ["TCGA.AY.6196.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.873653847429492}], ["MMP3", ["TCGA.AD.6964.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.94194991323115}], ["MAGED2", ["TCGA.AD.6964.01", "Recycling of bile acids and salts"], {"weight": 0.762586783709191}], ["PTPN11", ["TCGA.CM.6675.01", "NCAM1 interactions"], {"weight": 0.938166473044942}], ["PTPN11", ["TCGA.D5.6538.01", "Trafficking and processing of endosomal TLR"], {"weight": 0.866711737021064}], ["ITGB1", ["TCGA.AD.6964.01", "O-linked glycosylation"], {"weight": 0.890466670971208}], ["SPTBN1", ["TCGA.CM.6164.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], {"weight": 0.775241639012382}], ["SPTBN1", ["TCGA.G4.6304.01", "Interaction between L1 and Ankyrins"], {"weight": 0.944393959246309}], ["SPTBN1", ["TCGA.G4.6304.01", "Phase 0 - rapid depolarisation"], {"weight": 0.911322413768766}], ["ARPC1A", ["TCGA.CM.5868.01", "Binding and entry of HIV virion"], {"weight": 0.682981871217073}], ["RASGRF1", ["TCGA.AD.6964.01", "Glucagon-type ligand receptors"], {"weight": 0.890011933978536}], ["RASGRF1", ["TCGA.AD.6964.01", "Sensory perception of taste"], {"weight": 0.801348357643676}], ["RASGRF1", ["TCGA.F4.6855.01", "Glucagon-type ligand receptors"], {"weight": 0.896947755649675}], ["MMP3", ["TCGA.AD.6964.01", "Collagen chain trimerization"], {"weight": 0.911610501090401}], ["LAMB4", ["TCGA.DM.A0XF.01", "Erythrocytes take up carbon dioxide and release oxygen"], {"weight": 0.706310596289565}], ["LAMB4", ["TCGA.DM.A0XF.01", "O2/CO2 exchange in erythrocytes"], {"weight": 0.706310596289565}], ["NOTCH1", ["TCGA.AD.6965.01", "Blood group systems biosynthesis"], {"weight": 0.681689356920845}], ["NOTCH1", ["TCGA.AY.6197.01", "Blood group systems biosynthesis"], {"weight": 0.767530083292704}], ["NOTCH1", ["TCGA.AY.6197.01", "Lewis blood group biosynthesis"], {"weight": 0.732491897286138}], ["NOTCH1", ["TCGA.AY.6197.01", "Termination of O-glycan biosynthesis"], {"weight": 0.872876159073346}], ["NOTCH1", ["TCGA.AY.6197.01", "Keratan sulfate biosynthesis"], {"weight": 0.926423069831947}], ["CDK4", ["TCGA.AY.6196.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], {"weight": 0.750620882694068}], ["PRKCQ", ["TCGA.CM.5344.01", "TNFs bind their physiological receptors"], {"weight": 0.302915248479125}], ["WNT5A", ["TCGA.AM.5820.01", "GABA receptor activation"], {"weight": 0.889472734396858}], ["WNT5A", ["TCGA.AZ.6601.01", "GABA receptor activation"], {"weight": 0.873443989104286}], ["NTRK1", ["TCGA.CM.5862.01", "Classical antibody-mediated complement activation"], {"weight": 0.615250330814682}], ["IL5RA", ["TCGA.CM.4743.01", "Interaction between L1 and Ankyrins"], {"weight": 0.909526551972023}], ["GATA2", ["TCGA.CM.6170.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.915996439449098}], ["GATA2", ["TCGA.CM.6170.01", "Signaling by Retinoic Acid"], {"weight": 0.584871158480664}], ["KIF4A", ["TCGA.DM.A1D6.01", "Interaction between L1 and Ankyrins"], {"weight": 0.947221931556945}], ["ADAM12", ["TCGA.G4.6323.01", "Initial triggering of complement"], {"weight": 0.641710428924241}], ["ADAM12", ["TCGA.G4.6323.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.652048375031883}], ["THBS1", ["TCGA.D5.6928.01", "O-linked glycosylation"], {"weight": 0.889411585938968}], ["IRAK2", ["TCGA.F4.6856.01", "Defensins"], {"weight": 0.554668940384087}], ["SERPINA1", ["TCGA.F4.6703.01", "Dissolution of Fibrin Clot"], {"weight": 0.911672295604732}], ["S1PR2", ["TCGA.CM.5349.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.732545724058011}], ["HEXB", ["TCGA.AM.5820.01", "Blood group systems biosynthesis"], {"weight": 0.743665516004468}], ["HEXB", ["TCGA.AM.5820.01", "Lewis blood group biosynthesis"], {"weight": 0.720770005142697}], ["ETV1", ["TCGA.AM.5821.01", "Free fatty acids regulate insulin secretion"], {"weight": 0.817020784748343}], ["OR1J1", ["TCGA.CM.6678.01", "Phase 0 - rapid depolarisation"], {"weight": 0.789293343663844}], ["OR1J1", ["TCGA.CM.6678.01", "Potassium Channels"], {"weight": 0.941381075140804}], ["OR51Q1", ["TCGA.G4.6315.01", "G beta:gamma signalling through BTK"], {"weight": 0.875897960337138}], ["OR51Q1", ["TCGA.G4.6315.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.873193564658895}], ["OR51Q1", ["TCGA.G4.6315.01", "Voltage gated Potassium channels"], {"weight": 0.833806252335976}], ["OR51Q1", ["TCGA.G4.6315.01", "Presynaptic function of Kainate receptors"], {"weight": 0.873193564658895}], ["OR51Q1", ["TCGA.G4.6315.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.87572787669027}], ["OR51Q1", ["TCGA.G4.6315.01", "G-protein activation"], {"weight": 0.872405530718862}], ["OR1L4", ["TCGA.CK.5914.01", "Potassium Channels"], {"weight": 0.956379495363985}], ["OR1L4", ["TCGA.CK.5914.01", "GABA receptor activation"], {"weight": 0.698101793741842}], ["OR1L4", ["TCGA.CK.5914.01", "Glucagon-type ligand receptors"], {"weight": 0.933916713357061}], ["OR1L4", ["TCGA.CK.5914.01", "GABA B receptor activation"], {"weight": 0.926079994618719}], ["OR1L4", ["TCGA.CK.5914.01", "Activation of GABAB receptors"], {"weight": 0.926079994618719}], ["OR1L4", ["TCGA.CK.5914.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.725033103146113}], ["OR1L4", ["TCGA.CK.5914.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.926435464334998}], ["OR1L4", ["TCGA.CK.5914.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.908470212751914}], ["OR1L4", ["TCGA.CK.5914.01", "G beta:gamma signalling through BTK"], {"weight": 0.902205012148399}], ["OR1L4", ["TCGA.CK.5914.01", "Sensory perception of taste"], {"weight": 0.905805897065931}], ["OR5K3", ["TCGA.DM.A28F.01", "Activation of the phototransduction cascade"], {"weight": 0.78770259980242}], ["OR13F1", ["TCGA.DM.A28G.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.870705377810094}], ["OR13F1", ["TCGA.DM.A28G.01", "G beta:gamma signalling through BTK"], {"weight": 0.851690675873405}], ["OR13F1", ["TCGA.DM.A28G.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.848283651962602}], ["OR13F1", ["TCGA.DM.A28G.01", "Signal amplification"], {"weight": 0.865595291723985}], ["OR13F1", ["TCGA.DM.A28G.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.881292443525765}], ["OR13F1", ["TCGA.DM.A28G.01", "Glucagon-type ligand receptors"], {"weight": 0.901746095278656}], ["OR11H4", ["TCGA.AZ.6599.01", "GABA receptor activation"], {"weight": 0.916836917883129}], ["OR11H4", ["TCGA.AZ.6599.01", "G beta:gamma signalling through BTK"], {"weight": 0.909375695570784}], ["OR11H4", ["TCGA.AZ.6599.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], {"weight": 0.926051087505086}], ["OR11H4", ["TCGA.AZ.6599.01", "GABA B receptor activation"], {"weight": 0.928293618595688}], ["OR11H4", ["TCGA.AZ.6599.01", "Activation of GABAB receptors"], {"weight": 0.928293618595688}], ["OR11H4", ["TCGA.AZ.6599.01", "G-protein activation"], {"weight": 0.908182965804964}], ["OR11H4", ["TCGA.AZ.6599.01", "Glucagon-type ligand receptors"], {"weight": 0.925222952402047}], ["OR11H4", ["TCGA.AZ.6599.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.899055344521254}], ["OR11H4", ["TCGA.AZ.6599.01", "Presynaptic function of Kainate receptors"], {"weight": 0.899055344521254}], ["OR11H4", ["TCGA.AZ.6599.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.903900064772002}], ["OR11H4", ["TCGA.AZ.6599.01", "Potassium Channels"], {"weight": 0.908577479909661}], ["OR11H4", ["TCGA.AZ.6599.01", "Activation of G protein gated Potassium channels"], {"weight": 0.912607251379539}], ["OR11H4", ["TCGA.AZ.6599.01", "G protein gated Potassium channels"], {"weight": 0.912607251379539}], ["OR11H4", ["TCGA.AZ.6599.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.92050093930267}], ["OR11H4", ["TCGA.AZ.6599.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.912607251379539}], ["OR11H4", ["TCGA.AZ.6599.01", "Prostacyclin signalling through prostacyclin receptor"], {"weight": 0.894347109706012}], ["OR1N2", ["TCGA.CM.6677.01", "GABA receptor activation"], {"weight": 0.631430358289039}], ["OR1N2", ["TCGA.CM.6677.01", "Glucagon-type ligand receptors"], {"weight": 0.907160038604685}], ["OR1N2", ["TCGA.CM.6677.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.906353114723936}], ["OR1N2", ["TCGA.CM.6677.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.833087834889556}], ["OR1N2", ["TCGA.CM.6677.01", "Potassium Channels"], {"weight": 0.941685633785343}], ["OR1N2", ["TCGA.CM.6677.01", "Signal amplification"], {"weight": 0.844668227568651}], ["OR1N2", ["TCGA.CM.6677.01", "Inwardly rectifying K+ channels"], {"weight": 0.914299320871855}], ["OR1N2", ["TCGA.CM.6677.01", "GABA B receptor activation"], {"weight": 0.91239990208076}], ["OR1N2", ["TCGA.CM.6677.01", "Activation of GABAB receptors"], {"weight": 0.91239990208076}], ["OR1N2", ["TCGA.CM.6677.01", "Activation of G protein gated Potassium channels"], {"weight": 0.906610334137702}], ["OR1N2", ["TCGA.CM.6677.01", "G protein gated Potassium channels"], {"weight": 0.906610334137702}], ["OR1N2", ["TCGA.CM.6677.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.906610334137702}], ["OR1N2", ["TCGA.CM.6677.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.890879631536004}], ["OR1N2", ["TCGA.CM.6677.01", "G beta:gamma signalling through BTK"], {"weight": 0.864078403684131}], ["OR1N2", ["TCGA.CM.6677.01", "Prostacyclin signalling through prostacyclin receptor"], {"weight": 0.864078403684131}], ["OR1N2", ["TCGA.CM.6677.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.864078403684131}], ["OR1N2", ["TCGA.CM.6677.01", "Presynaptic function of Kainate receptors"], {"weight": 0.864078403684131}], ["OR2T8", ["TCGA.G4.6586.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.938452548531712}], ["CACNB2", ["TCGA.D5.6928.01", "Potassium Channels"], {"weight": 0.905392123099145}], ["ATP2B2", ["TCGA.DM.A28G.01", "LGI-ADAM interactions"], {"weight": 0.639541481835188}], ["ATP2B2", ["TCGA.F4.6856.01", "Sensory perception of taste"], {"weight": 0.896922836069872}], ["CATSPERD", ["TCGA.CM.5864.01", "Phase 0 - rapid depolarisation"], {"weight": 0.882028930440081}], ["CATSPERD", ["TCGA.CM.5864.01", "NCAM1 interactions"], {"weight": 0.924224306133151}], ["KCNJ12", ["TCGA.AZ.4615.01", "Voltage gated Potassium channels"], {"weight": 0.897687727737518}], ["KCNJ12", ["TCGA.D5.6537.01", "Glucagon-type ligand receptors"], {"weight": 0.935415000720483}], ["KCNJ12", ["TCGA.D5.6537.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.928810424245626}], ["KCNJ12", ["TCGA.D5.6537.01", "G beta:gamma signalling through BTK"], {"weight": 0.904019864994146}], ["KCNJ12", ["TCGA.D5.6537.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.911374100462336}], ["KCNJ12", ["TCGA.D5.6537.01", "G-protein activation"], {"weight": 0.923083204355831}], ["KCNJ12", ["TCGA.D5.6537.01", "Thromboxane signalling through TP receptor"], {"weight": 0.900785594745917}], ["KCNJ12", ["TCGA.D5.6537.01", "Voltage gated Potassium channels"], {"weight": 0.916460188225401}], ["KCNJ12", ["TCGA.D5.6537.01", "Presynaptic function of Kainate receptors"], {"weight": 0.905957961351239}], ["KCNJ12", ["TCGA.D5.6537.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.91734451811741}], ["KCNJ12", ["TCGA.G4.6298.01", "Phase 4 - resting membrane potential"], {"weight": 0.920291915946602}], ["KCNJ12", ["TCGA.G4.6588.01", "Voltage gated Potassium channels"], {"weight": 0.906150619246504}], ["KCNQ4", ["TCGA.DM.A1D8.01", "Potassium Channels"], {"weight": 0.96017020438095}], ["KCNQ4", ["TCGA.DM.A1D8.01", "Phase 4 - resting membrane potential"], {"weight": 0.9200065014947}], ["KCNQ4", ["TCGA.DM.A1D8.01", "Voltage gated Potassium channels"], {"weight": 0.898776937836051}], ["PASK", ["TCGA.AM.5821.01", "Glucuronidation"], {"weight": 0.944338783715898}], ["FOXA1", ["TCGA.G4.6588.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.838498643346601}], ["KDM6A", ["TCGA.CM.4747.01", "Phase II - Conjugation of compounds"], {"weight": 0.760095003654496}], ["KDM6A", ["TCGA.CM.4747.01", "Glucuronidation"], {"weight": 0.856188530272095}], ["KDM6A", ["TCGA.CM.4747.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.490532594712703}], ["KDM6A", ["TCGA.F4.6463.01", "Glucuronidation"], {"weight": 0.686857437742418}], ["KDM6A", ["TCGA.F4.6463.01", "Phase II - Conjugation of compounds"], {"weight": 0.581297955202351}], ["KDM6A", ["TCGA.F4.6463.01", "Metabolism of amine-derived hormones"], {"weight": 0.738900943556895}], ["KDM6A", ["TCGA.F4.6463.01", "Keratinization"], {"weight": 0.872694701601214}], ["KDM6A", ["TCGA.F4.6463.01", "Aspirin ADME"], {"weight": 0.701251538875212}], ["KDM6A", ["TCGA.F4.6463.01", "Nucleotide catabolism"], {"weight": 0.447543748624216}], ["KDM6A", ["TCGA.F4.6463.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.554221473389395}], ["CYP2B6", ["TCGA.AM.5821.01", "Phase II - Conjugation of compounds"], {"weight": 0.927369176538864}], ["CYP2B6", ["TCGA.AM.5821.01", "Biosynthesis of DHA-derived SPMs"], {"weight": 0.840676003411403}], ["CYP7A1", ["TCGA.AM.5821.01", "Synthesis of bile acids and bile salts via 27-hydroxycholesterol"], {"weight": 0.881617294716564}], ["CYP7A1", ["TCGA.AM.5821.01", "Cytochrome P450 - arranged by substrate type"], {"weight": 0.890595422014527}], ["CYP7A1", ["TCGA.AM.5821.01", "Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"], {"weight": 0.900911500386435}], ["CYP7A1", ["TCGA.AY.6196.01", "APAP ADME"], {"weight": 0.894289677243481}], ["CYP7A1", ["TCGA.AY.6196.01", "Aspirin ADME"], {"weight": 0.846998674074619}], ["CYP7A1", ["TCGA.CA.6719.01", "APAP ADME"], {"weight": 0.710388578199002}], ["CYP7A1", ["TCGA.CA.6719.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.785642979762944}], ["CYP7A1", ["TCGA.CA.6719.01", "Ethanol oxidation"], {"weight": 0.636580010958281}], ["CYP7A1", ["TCGA.CM.5868.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.883559855778671}], ["CYP7A1", ["TCGA.CM.5868.01", "RA biosynthesis pathway"], {"weight": 0.86309622340523}], ["CYP7A1", ["TCGA.G4.6586.01", "Endogenous sterols"], {"weight": 0.716962534205509}], ["CYP7A1", ["TCGA.G4.6586.01", "Synthesis of bile acids and bile salts via 27-hydroxycholesterol"], {"weight": 0.858642238921461}], ["GSTM3", ["TCGA.AM.5821.01", "Aflatoxin activation and detoxification"], {"weight": 0.907563114081745}], ["GSTM3", ["TCGA.CK.4952.01", "Arachidonic acid metabolism"], {"weight": 0.912444205790814}], ["GSTM3", ["TCGA.DM.A28G.01", "RA biosynthesis pathway"], {"weight": 0.905136190313101}], ["GSTM3", ["TCGA.DM.A28G.01", "Drug ADME"], {"weight": 0.822441661442743}], ["GSTM3", ["TCGA.DM.A28G.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.560803337092089}], ["GSTM3", ["TCGA.DM.A28G.01", "Signaling by Retinoic Acid"], {"weight": 0.741078024955186}], ["GSTM3", ["TCGA.DM.A28G.01", "APAP ADME"], {"weight": 0.745260009005874}], ["ALDH1B1", ["TCGA.G4.6588.01", "RA biosynthesis pathway"], {"weight": 0.90054031686701}], ["ALDH1B1", ["TCGA.G4.6588.01", "Ethanol oxidation"], {"weight": 0.937539702634574}], ["IDO2", ["TCGA.AM.5821.01", "Tryptophan catabolism"], {"weight": 0.918940125174428}], ["IDO2", ["TCGA.F4.6809.01", "Glucuronidation"], {"weight": 0.780688674785526}], ["IDO2", ["TCGA.F4.6809.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.383848097954841}], ["IDO2", ["TCGA.F4.6809.01", "APAP ADME"], {"weight": 0.428155039463633}], ["ALPL", ["TCGA.CA.6718.01", "Collagen chain trimerization"], {"weight": 0.925614475182053}], ["ALPL", ["TCGA.CA.6718.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.942320270449133}], ["ALPL", ["TCGA.CM.6162.01", "Collagen chain trimerization"], {"weight": 0.928640649106139}], ["ENPP1", ["TCGA.AZ.6601.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.877329917140426}], ["ENPP1", ["TCGA.CM.5861.01", "Nicotinate metabolism"], {"weight": 0.822799590553155}], ["ENPP1", ["TCGA.CM.5861.01", "Collagen chain trimerization"], {"weight": 0.924784889785107}], ["ENPP1", ["TCGA.CM.5861.01", "Phase II - Conjugation of compounds"], {"weight": 0.886704415099849}], ["ENPP1", ["TCGA.CM.5861.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.876589976032101}], ["ENPP1", ["TCGA.F4.6570.01", "Phase II - Conjugation of compounds"], {"weight": 0.88989564731172}], ["ENPP1", ["TCGA.F4.6570.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.911211564186244}], ["IBSP", ["TCGA.AZ.4615.01", "NCAM1 interactions"], {"weight": 0.939271888953405}], ["IBSP", ["TCGA.AZ.6598.01", "NCAM1 interactions"], {"weight": 0.9467970043842}], ["PSMB1", ["TCGA.DM.A28M.01", "TNFs bind their physiological receptors"], {"weight": 0.467542997413514}], ["TNIK", ["TCGA.AZ.6599.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.937937222860302}], ["TNIK", ["TCGA.AZ.6599.01", "Collagen chain trimerization"], {"weight": 0.87993950487619}], ["TNIK", ["TCGA.D5.5538.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.85293337631117}], ["THADA", ["TCGA.G4.6588.01", "APAP ADME"], {"weight": 0.793510683353806}], ["MMP14", ["TCGA.F4.6570.01", "APAP ADME"], {"weight": 0.853325970065594}], ["SOAT2", ["TCGA.AM.5821.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.933349047718324}], ["ACYP2", ["TCGA.AM.5821.01", "Ethanol oxidation"], {"weight": 0.943079362533109}], ["GMPS", ["TCGA.D5.6540.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.880671626607538}], ["CALHM1", ["TCGA.AM.5821.01", "Interaction between L1 and Ankyrins"], {"weight": 0.954554231490814}], ["IL2RB", ["TCGA.D5.6928.01", "TNFs bind their physiological receptors"], {"weight": 0.453623697919698}], ["CHEK2", ["TCGA.DM.A1D6.01", "Scavenging by Class A Receptors"], {"weight": 0.441951685689535}], ["NOX1", ["TCGA.CM.4747.01", "Heme degradation"], {"weight": 0.656161284500669}], ["NOX1", ["TCGA.CM.4747.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.665093175031803}], ["ABLIM2", ["TCGA.F4.6854.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.878668534002505}], ["TAAR6", ["TCGA.AZ.4323.01", "Peptide hormone biosynthesis"], {"weight": 0.920745233949621}], ["TAAR6", ["TCGA.AZ.4323.01", "Potassium Channels"], {"weight": 0.949201563403432}], ["TAAR6", ["TCGA.AZ.4323.01", "Glucagon-type ligand receptors"], {"weight": 0.912971911729892}], ["TAAR6", ["TCGA.AZ.4323.01", "Voltage gated Potassium channels"], {"weight": 0.910983033173533}], ["TAAR6", ["TCGA.AZ.4323.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.811457956286144}], ["TAAR6", ["TCGA.AZ.4323.01", "Phase 4 - resting membrane potential"], {"weight": 0.765511149569023}], ["OR4A5", ["TCGA.DM.A282.01", "Potassium Channels"], {"weight": 0.894312895424121}], ["OR4A5", ["TCGA.DM.A282.01", "Platelet calcium homeostasis"], {"weight": 0.875034837493517}], ["OR4A5", ["TCGA.DM.A282.01", "Norepinephrine Neurotransmitter Release Cycle"], {"weight": 0.659520132461039}], ["OR6C68", ["TCGA.D5.6920.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.853348375576408}], ["OR10C1", ["TCGA.CA.6716.01", "Potassium Channels"], {"weight": 0.949485457314205}], ["OR10C1", ["TCGA.CA.6716.01", "Activation of the phototransduction cascade"], {"weight": 0.810571280692767}], ["OR10C1", ["TCGA.CA.6716.01", "Phase 4 - resting membrane potential"], {"weight": 0.799182287563138}], ["OR10C1", ["TCGA.CA.6716.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], {"weight": 0.872479064382826}], ["OR10C1", ["TCGA.CA.6716.01", "G beta:gamma signalling through BTK"], {"weight": 0.907725235336441}], ["OR10C1", ["TCGA.F4.6806.01", "Regulation of Complement cascade"], {"weight": 0.557485293508897}], ["OR8H2", ["TCGA.DM.A28C.01", "Potassium Channels"], {"weight": 0.95959284133647}], ["OR8H2", ["TCGA.DM.A28C.01", "Activation of G protein gated Potassium channels"], {"weight": 0.928460080455994}], ["OR8H2", ["TCGA.DM.A28C.01", "G protein gated Potassium channels"], {"weight": 0.928460080455994}], ["OR8H2", ["TCGA.DM.A28C.01", "Interaction between L1 and Ankyrins"], {"weight": 0.924219885493152}], ["OR8H2", ["TCGA.DM.A28C.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.928460080455994}], ["OR8H2", ["TCGA.DM.A28C.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.877961945437147}], ["OR8H2", ["TCGA.DM.A28C.01", "GABA B receptor activation"], {"weight": 0.932491304934337}], ["OR8H2", ["TCGA.DM.A28C.01", "Activation of GABAB receptors"], {"weight": 0.932491304934337}], ["OR8H2", ["TCGA.DM.A28C.01", "Inwardly rectifying K+ channels"], {"weight": 0.931524471928796}], ["OR8H2", ["TCGA.DM.A28C.01", "Initial triggering of complement"], {"weight": 0.887098388774045}], ["OR8H2", ["TCGA.DM.A28C.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.923837678414653}], ["OR8H2", ["TCGA.DM.A28C.01", "Platelet calcium homeostasis"], {"weight": 0.917747075890187}], ["OR8H2", ["TCGA.DM.A28C.01", "Presynaptic function of Kainate receptors"], {"weight": 0.913779049765112}], ["OR8H2", ["TCGA.DM.A28C.01", "GABA receptor activation"], {"weight": 0.896073554151134}], ["OR8H2", ["TCGA.DM.A28C.01", "G beta:gamma signalling through BTK"], {"weight": 0.910008386006004}], ["OR8H2", ["TCGA.DM.A28C.01", "Prostacyclin signalling through prostacyclin receptor"], {"weight": 0.900527688340057}], ["OR8H2", ["TCGA.DM.A28C.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.907503019814163}], ["OR8H2", ["TCGA.DM.A28C.01", "G-protein activation"], {"weight": 0.931262086150466}], ["OR8H2", ["TCGA.DM.A28C.01", "Glucagon-type ligand receptors"], {"weight": 0.928359461120687}], ["OR8H2", ["TCGA.DM.A28C.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.944041838405649}], ["OR8H2", ["TCGA.DM.A28C.01", "Phase 4 - resting membrane potential"], {"weight": 0.859747906764107}], ["OR8H2", ["TCGA.DM.A28C.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.90429631832029}], ["OR8H2", ["TCGA.DM.A28C.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.915491480093923}], ["OR8H2", ["TCGA.DM.A28C.01", "Thromboxane signalling through TP receptor"], {"weight": 0.898160523401831}], ["OR8H2", ["TCGA.DM.A28C.01", "Activation of the phototransduction cascade"], {"weight": 0.856719132849522}], ["OR8H2", ["TCGA.DM.A28C.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], {"weight": 0.89984030440724}], ["OR8H2", ["TCGA.DM.A28C.01", "LGI-ADAM interactions"], {"weight": 0.865744448826433}], ["OR8H2", ["TCGA.F4.6569.01", "Inwardly rectifying K+ channels"], {"weight": 0.838547439967985}], ["OR8H2", ["TCGA.F4.6569.01", "Glucagon-type ligand receptors"], {"weight": 0.900127709266995}], ["OR4N4", ["TCGA.G4.6298.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.936360628421743}], ["OR4N4", ["TCGA.G4.6298.01", "G beta:gamma signalling through BTK"], {"weight": 0.923003601063832}], ["OR10H5", ["TCGA.D5.6920.01", "Neuronal System"], {"weight": 0.85125704755201}], ["OR10H5", ["TCGA.D5.6920.01", "Transmission across Chemical Synapses"], {"weight": 0.854726989093429}], ["OR10H5", ["TCGA.D5.6920.01", "GPCR ligand binding"], {"weight": 0.904448450404661}], ["OR10H5", ["TCGA.D5.6920.01", "GABA receptor activation"], {"weight": 0.514015937038323}], ["OR10H5", ["TCGA.D5.6920.01", "G alpha (i) signalling events"], {"weight": 0.883987368535863}], ["OR10H5", ["TCGA.D5.6920.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.854999270585549}], ["OR10H5", ["TCGA.D5.6920.01", "Basigin interactions"], {"weight": 0.69934130810619}], ["OR2T35", ["TCGA.AM.5821.01", "GABA receptor activation"], {"weight": 0.934053579612231}], ["OR2T35", ["TCGA.AM.5821.01", "Adenylate cyclase inhibitory pathway"], {"weight": 0.919570486128559}], ["TAS1R1", ["TCGA.AM.5821.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.94717216274999}], ["TAS1R1", ["TCGA.AM.5821.01", "Potassium Channels"], {"weight": 0.966134496024404}], ["TAS1R1", ["TCGA.G4.6320.01", "G beta:gamma signalling through BTK"], {"weight": 0.891525200064611}], ["TAS1R1", ["TCGA.G4.6320.01", "Potassium Channels"], {"weight": 0.94976784841869}], ["TAS1R1", ["TCGA.G4.6320.01", "Presynaptic function of Kainate receptors"], {"weight": 0.899838506415578}], ["TAS1R1", ["TCGA.G4.6320.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.889715813408957}], ["TAS1R1", ["TCGA.G4.6320.01", "Glucagon-type ligand receptors"], {"weight": 0.918532357307054}], ["TAS1R1", ["TCGA.G4.6320.01", "Activation of G protein gated Potassium channels"], {"weight": 0.909886612359027}], ["TAS1R1", ["TCGA.G4.6320.01", "G protein gated Potassium channels"], {"weight": 0.909886612359027}], ["TAS1R1", ["TCGA.G4.6320.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.909886612359027}], ["TAS1R1", ["TCGA.G4.6320.01", "Prostacyclin signalling through prostacyclin receptor"], {"weight": 0.883037503891664}], ["TAS1R1", ["TCGA.G4.6320.01", "Inwardly rectifying K+ channels"], {"weight": 0.914537515551915}], ["TAS1R1", ["TCGA.G4.6320.01", "G-protein activation"], {"weight": 0.915576418175793}], ["TAS1R1", ["TCGA.G4.6320.01", "Thromboxane signalling through TP receptor"], {"weight": 0.888514302963472}], ["TAS1R1", ["TCGA.G4.6320.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.883037503891664}], ["TAS1R3", ["TCGA.AM.5821.01", "GABA B receptor activation"], {"weight": 0.947569567519483}], ["TAS1R3", ["TCGA.AM.5821.01", "Activation of GABAB receptors"], {"weight": 0.947569567519483}], ["TAS1R3", ["TCGA.AY.6197.01", "Glucagon-type ligand receptors"], {"weight": 0.91523032552086}], ["TAS1R3", ["TCGA.AY.6197.01", "Activation of G protein gated Potassium channels"], {"weight": 0.897370273867459}], ["TAS1R3", ["TCGA.AY.6197.01", "G protein gated Potassium channels"], {"weight": 0.897370273867459}], ["TAS1R3", ["TCGA.AY.6197.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.897370273867459}], ["TAS1R3", ["TCGA.AY.6197.01", "G beta:gamma signalling through BTK"], {"weight": 0.873422618969523}], ["TAS1R3", ["TCGA.AY.6197.01", "GABA receptor activation"], {"weight": 0.866708338458193}], ["TAS1R3", ["TCGA.AY.6197.01", "GABA B receptor activation"], {"weight": 0.916964689444051}], ["TAS1R3", ["TCGA.AY.6197.01", "Activation of GABAB receptors"], {"weight": 0.916964689444051}], ["TAS1R3", ["TCGA.AY.6197.01", "Presynaptic function of Kainate receptors"], {"weight": 0.878988644046323}], ["TAS1R3", ["TCGA.AY.6197.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.87954446350637}], ["TAS1R3", ["TCGA.AY.6197.01", "Inwardly rectifying K+ channels"], {"weight": 0.897370273867459}], ["TAS1R3", ["TCGA.AY.6197.01", "Prostacyclin signalling through prostacyclin receptor"], {"weight": 0.861014132084234}], ["TAS1R3", ["TCGA.AY.6197.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.88800749978065}], ["TAS1R3", ["TCGA.CM.6679.01", "GABA receptor activation"], {"weight": 0.794336546557102}], ["TAS1R3", ["TCGA.CM.6679.01", "Phase 4 - resting membrane potential"], {"weight": 0.681366120753084}], ["TAS1R3", ["TCGA.CM.6679.01", "Activation of G protein gated Potassium channels"], {"weight": 0.884731068950339}], ["TAS1R3", ["TCGA.CM.6679.01", "G protein gated Potassium channels"], {"weight": 0.884731068950339}], ["TAS1R3", ["TCGA.CM.6679.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.884731068950339}], ["TAS1R3", ["TCGA.CM.6679.01", "Presynaptic function of Kainate receptors"], {"weight": 0.857844390688463}], ["TAS1R3", ["TCGA.CM.6679.01", "GABA B receptor activation"], {"weight": 0.88951548550854}], ["TAS1R3", ["TCGA.CM.6679.01", "Activation of GABAB receptors"], {"weight": 0.88951548550854}], ["TAS1R3", ["TCGA.CM.6679.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.856405678673122}], ["TAS1R3", ["TCGA.G4.6588.01", "Potassium Channels"], {"weight": 0.957333023407089}], ["TAS1R3", ["TCGA.G4.6588.01", "Glucagon-type ligand receptors"], {"weight": 0.93074037014278}], ["TAS1R3", ["TCGA.G4.6588.01", "G beta:gamma signalling through BTK"], {"weight": 0.913266326087461}], ["TAS1R3", ["TCGA.G4.6588.01", "Activation of G protein gated Potassium channels"], {"weight": 0.922226650798351}], ["TAS1R3", ["TCGA.G4.6588.01", "G protein gated Potassium channels"], {"weight": 0.922226650798351}], ["TAS1R3", ["TCGA.G4.6588.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.922226650798351}], ["TAS1R3", ["TCGA.G4.6588.01", "Inwardly rectifying K+ channels"], {"weight": 0.926934451046844}], ["TAS1R3", ["TCGA.G4.6588.01", "G-protein activation"], {"weight": 0.91426715360113}], ["ADAM28", ["TCGA.AZ.6605.01", "Collagen formation"], {"weight": 0.917792335932087}], ["ADAM28", ["TCGA.AZ.6605.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.920205224612098}], ["ADAM28", ["TCGA.AZ.6605.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.891270426555574}], ["ADAM28", ["TCGA.AZ.6605.01", "Collagen degradation"], {"weight": 0.881869491453638}], ["ADAM28", ["TCGA.AZ.6605.01", "Collagen chain trimerization"], {"weight": 0.857207528752429}], ["ADAM28", ["TCGA.AZ.6605.01", "Defective B3GALTL causes PpS"], {"weight": 0.810367858716355}], ["ADAM28", ["TCGA.AZ.6605.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.810367858716355}], ["ADAM28", ["TCGA.AZ.6605.01", "Scavenging by Class A Receptors"], {"weight": 0.580622451925647}], ["GPLD1", ["TCGA.D5.6540.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.957126858529595}], ["CALHM1", ["TCGA.AM.5821.01", "Phase 0 - rapid depolarisation"], {"weight": 0.941045068153467}], ["YEATS2", ["TCGA.DM.A28G.01", "Physiological factors"], {"weight": 0.657448036201969}], ["IBTK", ["TCGA.AZ.6598.01", "CD22 mediated BCR regulation"], {"weight": 0.843829035458705}], ["APEX1", ["TCGA.AM.5821.01", "Transcriptional regulation of pluripotent stem cells"], {"weight": 0.933440656012948}], ["INHBC", ["TCGA.G4.6302.01", "Regulation of signaling by NODAL"], {"weight": 0.844000984747567}], ["ABCC3", ["TCGA.AM.5821.01", "Bile acid and bile salt metabolism"], {"weight": 0.880440345650708}], ["NPAS3", ["TCGA.AU.3779.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.899423730606297}], ["NPAS3", ["TCGA.AU.3779.01", "Degradation of the extracellular matrix"], {"weight": 0.831983729115722}], ["NPAS3", ["TCGA.AU.3779.01", "Heme degradation"], {"weight": 0.536416586046687}], ["COL15A1", ["TCGA.AM.5821.01", "Collagen formation"], {"weight": 0.96182730443204}], ["COL15A1", ["TCGA.AM.5821.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.947731021383125}], ["COL15A1", ["TCGA.D5.6930.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.935040252661838}], ["SLC16A8", ["TCGA.AM.5821.01", "Amino acid transport across the plasma membrane"], {"weight": 0.87581910761209}], ["ADAMTS2", ["TCGA.D5.6540.01", "Collagen chain trimerization"], {"weight": 0.923548479425592}], ["ST3GAL3", ["TCGA.AM.5821.01", "Defective GALNT12 causes CRCS1"], {"weight": 0.919425120864985}], ["SEMA5B", ["TCGA.F4.6459.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.9254799605978}], ["ADAMTS16", ["TCGA.AZ.4615.01", "O-linked glycosylation"], {"weight": 0.917624026590901}], ["ADAMTS16", ["TCGA.AZ.4615.01", "Defective B3GALTL causes PpS"], {"weight": 0.889584685739514}], ["ADAMTS16", ["TCGA.AZ.4615.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.889523202249179}], ["ADAMTS16", ["TCGA.CK.5916.01", "O-linked glycosylation"], {"weight": 0.916076133613036}], ["ADAMTS16", ["TCGA.G4.6303.01", "Blood group systems biosynthesis"], {"weight": 0.499271317114436}], ["ADAMTS16", ["TCGA.G4.6303.01", "Lewis blood group biosynthesis"], {"weight": 0.42088802879042}], ["ADAMTS16", ["TCGA.G4.6303.01", "Collagen degradation"], {"weight": 0.793084458264487}], ["ADAMTS5", ["TCGA.AZ.5403.01", "Initial triggering of complement"], {"weight": 0.552478519262346}], ["ADAMTS5", ["TCGA.AZ.5403.01", "Collagen chain trimerization"], {"weight": 0.838110315846102}], ["SETMAR", ["TCGA.AM.5821.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.955406358568747}], ["GPR50", ["TCGA.CM.5868.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.761680329462915}], ["WNT5B", ["TCGA.AU.3779.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], {"weight": 0.795182018243939}], ["DTNA", ["TCGA.AU.3779.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.899273717926523}], ["DTNA", ["TCGA.AU.3779.01", "Collagen formation"], {"weight": 0.912470553885785}], ["ALOX5", ["TCGA.AU.3779.01", "Phase II - Conjugation of compounds"], {"weight": 0.805528910760929}], ["ALOX5", ["TCGA.AU.3779.01", "Ethanol oxidation"], {"weight": 0.854610692975445}], ["ALOX5", ["TCGA.AU.3779.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.714871391482517}], ["ALOX5", ["TCGA.AU.3779.01", "RA biosynthesis pathway"], {"weight": 0.789863878480294}], ["ALOX5", ["TCGA.CM.6171.01", "Arachidonic acid metabolism"], {"weight": 0.895680784209879}], ["WDR5", ["TCGA.F4.6809.01", "Phase II - Conjugation of compounds"], {"weight": 0.680155659182063}], ["XCR1", ["TCGA.DM.A282.01", "Phase 4 - resting membrane potential"], {"weight": 0.695557600776831}], ["VCL", ["TCGA.CM.4744.01", "Intrinsic Pathway of Fibrin Clot Formation"], {"weight": 0.901898433070648}], ["NAPA", ["TCGA.CM.5344.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.941780884021414}], ["NAPA", ["TCGA.CM.5344.01", "Collagen formation"], {"weight": 0.925946444522909}], ["NAPA", ["TCGA.CM.5344.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.900196225756093}], ["NAPA", ["TCGA.CM.5344.01", "Interaction between L1 and Ankyrins"], {"weight": 0.904679500008488}], ["NAPA", ["TCGA.CM.5344.01", "Synaptic adhesion-like molecules"], {"weight": 0.785656792170118}], ["TFDP1", ["TCGA.AU.6004.01", "Aspirin ADME"], {"weight": 0.840272599177629}], ["MITF", ["TCGA.DM.A0X9.01", "Heme degradation"], {"weight": 0.745869006593687}], ["MITF", ["TCGA.G4.6586.01", "IL-6-type cytokine receptor ligand interactions"], {"weight": 0.921258166326353}], ["OS9", ["TCGA.D5.6535.01", "APAP ADME"], {"weight": 0.667185830450093}], ["SLC2A4", ["TCGA.CK.4952.01", "Synthesis of bile acids and bile salts via 27-hydroxycholesterol"], {"weight": 0.871065826219787}], ["DGKQ", ["TCGA.AU.6004.01", "Ethanol oxidation"], {"weight": 0.831645381478599}], ["BNIP2", ["TCGA.D5.6537.01", "Formation of the anterior neural plate"], {"weight": 0.582250357775483}], ["PPIB", ["TCGA.AU.6004.01", "Collagen chain trimerization"], {"weight": 0.905204505058783}], ["PPIB", ["TCGA.AU.6004.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.931200156013329}], ["PAX8", ["TCGA.AU.6004.01", "Phase 0 - rapid depolarisation"], {"weight": 0.834835295919472}], ["OR6C75", ["TCGA.AU.6004.01", "Inwardly rectifying K+ channels"], {"weight": 0.908834863604624}], ["OR6C75", ["TCGA.AU.6004.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.889803267852027}], ["NF2", ["TCGA.AU.6004.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], {"weight": 0.770364565738439}], ["PGM2L1", ["TCGA.AU.6004.01", "Glucuronidation"], {"weight": 0.816037930225725}], ["PGM2L1", ["TCGA.AU.6004.01", "Phase II - Conjugation of compounds"], {"weight": 0.782963444704945}], ["PGM2L1", ["TCGA.AU.6004.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.641144311984457}], ["PGM2L1", ["TCGA.D5.6540.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.837386882663115}], ["PAK4", ["TCGA.D5.5540.01", "Phase 4 - resting membrane potential"], {"weight": 0.86960047534739}], ["PDYN", ["TCGA.F4.6854.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.902082665131722}], ["PRKAG1", ["TCGA.CM.5348.01", "Phase II - Conjugation of compounds"], {"weight": 0.778302382819517}], ["PRKAG1", ["TCGA.CM.6165.01", "TNFs bind their physiological receptors"], {"weight": 0.274641558396966}], ["TUBA1C", ["TCGA.AY.6196.01", "Phase II - Conjugation of compounds"], {"weight": 0.793552910936129}], ["SH2B3", ["TCGA.G4.6320.01", "Receptor-type tyrosine-protein phosphatases"], {"weight": 0.76363597507174}], ["ASPN", ["TCGA.AY.6196.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.711503379147074}], ["RASGRF2", ["TCGA.AZ.6601.01", "Phase 0 - rapid depolarisation"], {"weight": 0.861909976702655}], ["RASGRF2", ["TCGA.AZ.6601.01", "Phase 2 - plateau phase"], {"weight": 0.830959317125555}], ["OR10G2", ["TCGA.F4.6808.01", "Glucagon-type ligand receptors"], {"weight": 0.930287908097055}], ["OR10G2", ["TCGA.F4.6808.01", "G beta:gamma signalling through BTK"], {"weight": 0.903598819293944}], ["OR10G2", ["TCGA.F4.6808.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.906705253342076}], ["OR10G2", ["TCGA.F4.6808.01", "GABA B receptor activation"], {"weight": 0.913734396546806}], ["OR10G2", ["TCGA.F4.6808.01", "Activation of GABAB receptors"], {"weight": 0.913734396546806}], ["OR10G2", ["TCGA.F4.6808.01", "Activation of the phototransduction cascade"], {"weight": 0.821368272518183}], ["OR10G2", ["TCGA.F4.6808.01", "Potassium Channels"], {"weight": 0.905655268692102}], ["HLA-G", ["TCGA.CM.6676.01", "Classical antibody-mediated complement activation"], {"weight": 0.578291717569915}], ["HLA-G", ["TCGA.CM.6676.01", "Regulation of Complement cascade"], {"weight": 0.712502873225547}], ["HLA-G", ["TCGA.CM.6676.01", "Creation of C4 and C2 activators"], {"weight": 0.562365040882012}], ["KCNC2", ["TCGA.AZ.6598.01", "Potassium Channels"], {"weight": 0.958802828802517}], ["INHBB", ["TCGA.AY.6197.01", "Diseases associated with glycosaminoglycan metabolism"], {"weight": 0.880238817373859}], ["NRIP1", ["TCGA.D5.6922.01", "Signaling by Retinoic Acid"], {"weight": 0.613916043700847}], ["ELK1", ["TCGA.F4.6703.01", "Acyl chain remodelling of PS"], {"weight": 0.836403282968249}], ["ELK1", ["TCGA.F4.6703.01", "Acyl chain remodelling of PE"], {"weight": 0.743795294110007}], ["GH2", ["TCGA.AY.6197.01", "IL-6-type cytokine receptor ligand interactions"], {"weight": 0.908654074999091}], ["CYP2U1", ["TCGA.AY.6197.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.867302684367445}], ["CYP2U1", ["TCGA.D5.6533.01", "Arachidonic acid metabolism"], {"weight": 0.852057397298041}], ["CYP2U1", ["TCGA.D5.6533.01", "Erythrocytes take up carbon dioxide and release oxygen"], {"weight": 0.744954698540419}], ["CYP2U1", ["TCGA.D5.6533.01", "O2/CO2 exchange in erythrocytes"], {"weight": 0.744954698540419}], ["CYP2U1", ["TCGA.D5.6533.01", "Acyl chain remodelling of PE"], {"weight": 0.852004048410678}], ["CYP2U1", ["TCGA.D5.6533.01", "Acyl chain remodelling of PS"], {"weight": 0.878206084322088}], ["WNT11", ["TCGA.AY.6386.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.910253300669432}], ["KCNG2", ["TCGA.AY.6386.01", "Voltage gated Potassium channels"], {"weight": 0.850379716544859}], ["KCNG2", ["TCGA.G4.6586.01", "Potassium Channels"], {"weight": 0.965637429479183}], ["KCNG2", ["TCGA.G4.6586.01", "Voltage gated Potassium channels"], {"weight": 0.950726262203278}], ["COL27A1", ["TCGA.AY.6386.01", "Collagen chain trimerization"], {"weight": 0.888752408155478}], ["COL27A1", ["TCGA.F4.6569.01", "Collagen chain trimerization"], {"weight": 0.932250806375452}], ["COL27A1", ["TCGA.G4.6586.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.947928642076316}], ["BAG4", ["TCGA.D5.6540.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.73185526393812}], ["EHMT1", ["TCGA.D5.6920.01", "Interaction between L1 and Ankyrins"], {"weight": 0.847109852161885}], ["OR4D1", ["TCGA.AZ.4615.01", "Glucagon-type ligand receptors"], {"weight": 0.933304912169071}], ["OR4D1", ["TCGA.AZ.4615.01", "Activation of G protein gated Potassium channels"], {"weight": 0.921857048731189}], ["OR4D1", ["TCGA.AZ.4615.01", "G protein gated Potassium channels"], {"weight": 0.921857048731189}], ["SLC12A2", ["TCGA.D5.6898.01", "Phase 4 - resting membrane potential"], {"weight": 0.748688338270258}], ["PIK3R2", ["TCGA.AZ.4615.01", "Phase 0 - rapid depolarisation"], {"weight": 0.919468904400612}], ["PIK3R2", ["TCGA.AZ.4615.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.902257536474661}], ["PIK3R2", ["TCGA.AZ.4615.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.93848503451016}], ["MAP3K2", ["TCGA.AZ.4615.01", "Digestion and absorption"], {"weight": 0.646880972876636}], ["MAP3K2", ["TCGA.AZ.4615.01", "Digestion"], {"weight": 0.663743110946459}], ["CX3CL1", ["TCGA.AZ.4615.01", "Antimicrobial peptides"], {"weight": 0.695612590225207}], ["CX3CL1", ["TCGA.DM.A1D6.01", "Binding and entry of HIV virion"], {"weight": 0.864071979514245}], ["RASAL2", ["TCGA.CA.6718.01", "Erythrocytes take up carbon dioxide and release oxygen"], {"weight": 0.898382766686907}], ["RASAL2", ["TCGA.CA.6718.01", "O2/CO2 exchange in erythrocytes"], {"weight": 0.898382766686907}], ["SIPA1L1", ["TCGA.CM.5861.01", "Synaptic adhesion-like molecules"], {"weight": 0.919654841600454}], ["TCF3", ["TCGA.AZ.6607.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.781594643401051}], ["MED17", ["TCGA.F4.6460.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.716575975407245}], ["APBB1", ["TCGA.DM.A1HA.01", "Dopamine Neurotransmitter Release Cycle"], {"weight": 0.894181218033683}], ["DPP4", ["TCGA.AZ.4615.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.764024222602222}], ["AKR1C3", ["TCGA.AZ.4615.01", "Phase II - Conjugation of compounds"], {"weight": 0.891939380227519}], ["B4GALT2", ["TCGA.CM.6171.01", "Blood group systems biosynthesis"], {"weight": 0.923484997901315}], ["B4GALT2", ["TCGA.CM.6171.01", "Lewis blood group biosynthesis"], {"weight": 0.916728919216277}], ["UGT2B11", ["TCGA.AZ.4615.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.876080424133371}], ["UGT2B11", ["TCGA.AZ.4615.01", "RA biosynthesis pathway"], {"weight": 0.909564539422741}], ["CYP2A6", ["TCGA.CM.6166.01", "Arachidonic acid metabolism"], {"weight": 0.92223339781805}], ["CYP2A6", ["TCGA.CM.6166.01", "Heme degradation"], {"weight": 0.812703254058183}], ["CYP2A6", ["TCGA.CM.6166.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.914077165908706}], ["CYP2A6", ["TCGA.CM.6166.01", "RA biosynthesis pathway"], {"weight": 0.909390637172265}], ["CYP2A6", ["TCGA.D5.6533.01", "Phase II - Conjugation of compounds"], {"weight": 0.868827386716913}], ["CYP2A6", ["TCGA.D5.6533.01", "Aspirin ADME"], {"weight": 0.859970689962882}], ["CYP2A6", ["TCGA.D5.6533.01", "Glucuronidation"], {"weight": 0.924605709438584}], ["AKR1C3", ["TCGA.AZ.4615.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.841870051967964}], ["AKR1C3", ["TCGA.AZ.4615.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.760418349520638}], ["GGH", ["TCGA.AZ.4615.01", "Glutathione conjugation"], {"weight": 0.919469026372525}], ["PHACTR2", ["TCGA.CM.5861.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.904049940794294}], ["COL22A1", ["TCGA.AZ.4615.01", "Collagen chain trimerization"], {"weight": 0.920539205282595}], ["PLOD2", ["TCGA.AZ.4615.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.936792818034249}], ["OR52M1", ["TCGA.AZ.4682.01", "GABA B receptor activation"], {"weight": 0.919802114395461}], ["OR52M1", ["TCGA.AZ.4682.01", "Activation of GABAB receptors"], {"weight": 0.919802114395461}], ["OR52M1", ["TCGA.AZ.4682.01", "Potassium Channels"], {"weight": 0.946775445902203}], ["OR52M1", ["TCGA.AZ.4682.01", "Presynaptic function of Kainate receptors"], {"weight": 0.898902088223388}], ["OR52M1", ["TCGA.AZ.4682.01", "Signal amplification"], {"weight": 0.86342492837022}], ["OR52M1", ["TCGA.AZ.4682.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.905944405352572}], ["OR52M1", ["TCGA.AZ.4682.01", "Activation of G protein gated Potassium channels"], {"weight": 0.907735872794821}], ["OR52M1", ["TCGA.AZ.4682.01", "G protein gated Potassium channels"], {"weight": 0.907735872794821}], ["OR52M1", ["TCGA.AZ.4682.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.915237695053491}], ["OR52M1", ["TCGA.AZ.4682.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.907735872794821}], ["OR52M1", ["TCGA.AZ.4682.01", "Inwardly rectifying K+ channels"], {"weight": 0.91598132881035}], ["OR52M1", ["TCGA.AZ.4682.01", "G beta:gamma signalling through BTK"], {"weight": 0.911391244412205}], ["OR52M1", ["TCGA.AZ.4682.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.843065199235246}], ["OR52M1", ["TCGA.AZ.4682.01", "Activation of the phototransduction cascade"], {"weight": 0.868208839857882}], ["OR52M1", ["TCGA.AZ.4682.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.610888324888764}], ["OR52M1", ["TCGA.AZ.4682.01", "ADORA2B mediated anti-inflammatory cytokines production"], {"weight": 0.90500231706221}], ["OR52M1", ["TCGA.AZ.4682.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.90430337960592}], ["OR52M1", ["TCGA.AZ.4682.01", "Adenylate cyclase inhibitory pathway"], {"weight": 0.868851628442891}], ["OR52M1", ["TCGA.AZ.4682.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.888113370474258}], ["OR52M1", ["TCGA.AZ.4682.01", "G beta:gamma signalling through CDC42"], {"weight": 0.907061481858569}], ["OR52M1", ["TCGA.AZ.4682.01", "Phase 4 - resting membrane potential"], {"weight": 0.790159176052411}], ["OR52M1", ["TCGA.AZ.4682.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.890510281367291}], ["OR52M1", ["TCGA.AZ.4682.01", "Prostacyclin signalling through prostacyclin receptor"], {"weight": 0.874572118262483}], ["TRAF3", ["TCGA.AZ.5403.01", "TNFs bind their physiological receptors"], {"weight": 0.467967299831389}], ["TRAF3", ["TCGA.AZ.5403.01", "TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway"], {"weight": 0.863994066332278}], ["LONP1", ["TCGA.AZ.5403.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.543504022333508}], ["PRKCG", ["TCGA.D5.7000.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.820336353613053}], ["PRKCG", ["TCGA.DM.A1DA.01", "Nicotinate metabolism"], {"weight": 0.860143308492921}], ["SCO2", ["TCGA.AZ.5407.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.676817656121257}], ["HSD17B1", ["TCGA.AZ.5407.01", "Phase II - Conjugation of compounds"], {"weight": 0.768862624161583}], ["HSD17B1", ["TCGA.AZ.5407.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.810477455293253}], ["HSD17B1", ["TCGA.AZ.6601.01", "Glucuronidation"], {"weight": 0.91799098495775}], ["HSD17B1", ["TCGA.CM.5863.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.682121153973648}], ["HSD17B1", ["TCGA.CM.5863.01", "Aspirin ADME"], {"weight": 0.691009801444465}], ["HSD17B1", ["TCGA.CM.5863.01", "Phase II - Conjugation of compounds"], {"weight": 0.642771990350423}], ["HSD17B1", ["TCGA.D5.6927.01", "RA biosynthesis pathway"], {"weight": 0.823725825449863}], ["HSD17B1", ["TCGA.D5.6927.01", "Glucuronidation"], {"weight": 0.858845734605664}], ["HSD17B1", ["TCGA.D5.6927.01", "Phase II - Conjugation of compounds"], {"weight": 0.836026327969275}], ["HSD17B1", ["TCGA.D5.6927.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.865325786518313}], ["HSD17B1", ["TCGA.D5.6928.01", "Phase II - Conjugation of compounds"], {"weight": 0.9081372446895}], ["HSD17B1", ["TCGA.D5.6928.01", "Glucuronidation"], {"weight": 0.907344540709285}], ["HSD17B1", ["TCGA.F4.6855.01", "Glucuronidation"], {"weight": 0.878115541747626}], ["HSD17B1", ["TCGA.F4.6855.01", "Phase II - Conjugation of compounds"], {"weight": 0.846845533475632}], ["HSD17B1", ["TCGA.F4.6855.01", "Ethanol oxidation"], {"weight": 0.776517798800334}], ["HSD17B1", ["TCGA.F4.6855.01", "RA biosynthesis pathway"], {"weight": 0.801309409307297}], ["HSD17B1", ["TCGA.F4.6855.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.539098378632396}], ["HSD17B1", ["TCGA.G4.6302.01", "Phase II - Conjugation of compounds"], {"weight": 0.843892981470525}], ["HSD17B1", ["TCGA.G4.6302.01", "Glucuronidation"], {"weight": 0.912681497703331}], ["ADCY3", ["TCGA.D5.6924.01", "Peptide hormone biosynthesis"], {"weight": 0.60694480648734}], ["RAB5A", ["TCGA.D5.6932.01", "Voltage gated Potassium channels"], {"weight": 0.827164479187263}], ["RAB5A", ["TCGA.G4.6304.01", "Defensins"], {"weight": 0.786203730694526}], ["RAB5A", ["TCGA.G4.6304.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.788057196391891}], ["RAB5A", ["TCGA.G4.6304.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], {"weight": 0.880096117626608}], ["EHHADH", ["TCGA.CK.5913.01", "Phase II - Conjugation of compounds"], {"weight": 0.845650432398843}], ["DGKZ", ["TCGA.G4.6320.01", "RA biosynthesis pathway"], {"weight": 0.845979632931696}], ["DGKI", ["TCGA.CM.5862.01", "RA biosynthesis pathway"], {"weight": 0.880942239679449}], ["DGKI", ["TCGA.CM.5862.01", "Phase II - Conjugation of compounds"], {"weight": 0.763496048309374}], ["DGKI", ["TCGA.D5.6932.01", "Phase II - Conjugation of compounds"], {"weight": 0.832303863891224}], ["DGKI", ["TCGA.D5.6932.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.797522417089057}], ["DGKI", ["TCGA.D5.6932.01", "Ethanol oxidation"], {"weight": 0.852751214288818}], ["MYLK3", ["TCGA.CA.5797.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.847568773235112}], ["MYLK3", ["TCGA.CA.5797.01", "Activation of the phototransduction cascade"], {"weight": 0.710704728847719}], ["BEGAIN", ["TCGA.AZ.6598.01", "Synaptic adhesion-like molecules"], {"weight": 0.845787921508216}], ["C4A", ["TCGA.D5.5541.01", "Interaction between L1 and Ankyrins"], {"weight": 0.879146969669735}], ["MAP3K12", ["TCGA.CK.5916.01", "Free fatty acids regulate insulin secretion"], {"weight": 0.668663184358815}], ["PDIA3", ["TCGA.F4.6808.01", "Classical antibody-mediated complement activation"], {"weight": 0.781260228041597}], ["PDIA3", ["TCGA.F4.6808.01", "Creation of C4 and C2 activators"], {"weight": 0.745051777867353}], ["HPR", ["TCGA.AZ.6598.01", "Erythrocytes take up carbon dioxide and release oxygen"], {"weight": 0.871477072233686}], ["HPR", ["TCGA.AZ.6598.01", "O2/CO2 exchange in erythrocytes"], {"weight": 0.871477072233686}], ["CYP1A2", ["TCGA.AZ.6598.01", "Phase II - Conjugation of compounds"], {"weight": 0.897762370156623}], ["CYP1A2", ["TCGA.CK.5915.01", "Arachidonic acid metabolism"], {"weight": 0.932462229902522}], ["CYP1A2", ["TCGA.CK.5915.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.926434958414519}], ["CYP1A2", ["TCGA.CK.5915.01", "Biosynthesis of specialized proresolving mediators (SPMs)"], {"weight": 0.939195698307791}], ["CYP1A2", ["TCGA.CK.5915.01", "Aspirin ADME"], {"weight": 0.826328293740552}], ["CYP1A2", ["TCGA.CK.5915.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.887406606768414}], ["CYP1A2", ["TCGA.CK.5915.01", "Biosynthesis of DHA-derived SPMs"], {"weight": 0.900872640463948}], ["CYP1A2", ["TCGA.CM.6169.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.897390632710506}], ["CYP1A2", ["TCGA.CM.6169.01", "APAP ADME"], {"weight": 0.779973130646274}], ["CYP1A2", ["TCGA.CM.6169.01", "Phase II - Conjugation of compounds"], {"weight": 0.922612797088302}], ["CYP1A2", ["TCGA.CM.6169.01", "Ethanol oxidation"], {"weight": 0.858481687942741}], ["CYP1A2", ["TCGA.G4.6314.01", "Glucuronidation"], {"weight": 0.865279971835236}], ["CYP1A2", ["TCGA.G4.6314.01", "Phase II - Conjugation of compounds"], {"weight": 0.878851096627641}], ["CYP1A2", ["TCGA.G4.6314.01", "APAP ADME"], {"weight": 0.769919571241719}], ["CYP1A2", ["TCGA.G4.6314.01", "Aspirin ADME"], {"weight": 0.915562694258478}], ["CYP1A2", ["TCGA.G4.6314.01", "Arachidonic acid metabolism"], {"weight": 0.862107701323115}], ["CYP1A2", ["TCGA.G4.6314.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.724703637431179}], ["CYP1A2", ["TCGA.G4.6314.01", "Ethanol oxidation"], {"weight": 0.514992927763836}], ["CYP1A2", ["TCGA.G4.6314.01", "RA biosynthesis pathway"], {"weight": 0.883336252877436}], ["GGT5", ["TCGA.AZ.6598.01", "Arachidonic acid metabolism"], {"weight": 0.928672323561216}], ["GGT5", ["TCGA.CK.5916.01", "APAP ADME"], {"weight": 0.81523600530389}], ["UGT1A5", ["TCGA.AZ.6598.01", "Aspirin ADME"], {"weight": 0.944285254095121}], ["CYP26A1", ["TCGA.AZ.6598.01", "RA biosynthesis pathway"], {"weight": 0.922342449497293}], ["CNDP2", ["TCGA.AZ.6598.01", "APAP ADME"], {"weight": 0.895428256054728}], ["CEL", ["TCGA.AZ.6598.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.783702373032831}], ["DGAT1", ["TCGA.G4.6628.01", "RA biosynthesis pathway"], {"weight": 0.851682082545794}], ["ALDH2", ["TCGA.D5.6928.01", "Ethanol oxidation"], {"weight": 0.781094089381102}], ["CYP46A1", ["TCGA.AZ.6598.01", "Bile acid and bile salt metabolism"], {"weight": 0.837293545671215}], ["CYP46A1", ["TCGA.AZ.6598.01", "Synthesis of bile acids and bile salts"], {"weight": 0.813269649676485}], ["CYP46A1", ["TCGA.AZ.6598.01", "Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"], {"weight": 0.792685994786978}], ["SLC3A2", ["TCGA.CM.6171.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], {"weight": 0.937954581589851}], ["REN", ["TCGA.AZ.6598.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.94178751435799}], ["DCLRE1C", ["TCGA.D5.5540.01", "Carnitine metabolism"], {"weight": 0.775041533542659}], ["DCLRE1C", ["TCGA.D5.5540.01", "Impaired BRCA2 binding to PALB2"], {"weight": 0.898370859187839}], ["GEMIN5", ["TCGA.G4.6626.01", "Glucuronidation"], {"weight": 0.882072817461242}], ["GEMIN5", ["TCGA.G4.6626.01", "Unwinding of DNA"], {"weight": 0.78240354286956}], ["GEMIN5", ["TCGA.G4.6626.01", "Aspirin ADME"], {"weight": 0.785409422258259}], ["TRIM62", ["TCGA.AZ.6599.01", "NCAM1 interactions"], {"weight": 0.937194236584919}], ["PDCD1LG2", ["TCGA.AZ.6599.01", "Defensins"], {"weight": 0.679895084439221}], ["PIK3R5", ["TCGA.CK.5913.01", "TNFs bind their physiological receptors"], {"weight": 0.55664755785707}], ["LRPPRC", ["TCGA.D5.6929.01", "Phase II - Conjugation of compounds"], {"weight": 0.814354016521542}], ["TLE4", ["TCGA.CM.5864.01", "Lewis blood group biosynthesis"], {"weight": 0.721280027239419}], ["MADD", ["TCGA.G4.6626.01", "Transcriptional regulation of pluripotent stem cells"], {"weight": 0.881067546662662}], ["MADD", ["TCGA.G4.6626.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], {"weight": 0.84168018463003}], ["TPO", ["TCGA.G4.6302.01", "Degradation of cysteine and homocysteine"], {"weight": 0.0991137709943335}], ["GSTA4", ["TCGA.F4.6461.01", "Phase II - Conjugation of compounds"], {"weight": 0.831413457043977}], ["GSTA4", ["TCGA.F4.6461.01", "APAP ADME"], {"weight": 0.848395872204282}], ["GSTA4", ["TCGA.F4.6461.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.80194804463071}], ["GSTA4", ["TCGA.F4.6461.01", "Ethanol oxidation"], {"weight": 0.775230830911829}], ["GSTA4", ["TCGA.F4.6461.01", "Aflatoxin activation and detoxification"], {"weight": 0.872345853703406}], ["GSTA4", ["TCGA.F4.6461.01", "Glutathione conjugation"], {"weight": 0.850131761458577}], ["PTGDS", ["TCGA.AZ.6601.01", "Phase II - Conjugation of compounds"], {"weight": 0.911624758598395}], ["GPX5", ["TCGA.AZ.6601.01", "APAP ADME"], {"weight": 0.892987603203642}], ["AHCYL1", ["TCGA.CA.6718.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], {"weight": 0.917767432920779}], ["COG5", ["TCGA.DM.A0XD.01", "Interaction between L1 and Ankyrins"], {"weight": 0.934900745825388}], ["FUT2", ["TCGA.AZ.6601.01", "Blood group systems biosynthesis"], {"weight": 0.771315727592198}], ["MUC5B", ["TCGA.AZ.6601.01", "Termination of O-glycan biosynthesis"], {"weight": 0.909683796007302}], ["MUC5B", ["TCGA.CK.5916.01", "Termination of O-glycan biosynthesis"], {"weight": 0.918750660277499}], ["MUC5B", ["TCGA.F4.6463.01", "Blood group systems biosynthesis"], {"weight": 0.731489616106916}], ["MUC5B", ["TCGA.F4.6463.01", "Lewis blood group biosynthesis"], {"weight": 0.69985016889129}], ["MUC5B", ["TCGA.F4.6463.01", "Defective GALNT12 causes CRCS1"], {"weight": 0.876674030750914}], ["MUC5B", ["TCGA.F4.6463.01", "O-linked glycosylation"], {"weight": 0.89069135823393}], ["MUC5B", ["TCGA.F4.6463.01", "O-linked glycosylation of mucins"], {"weight": 0.913721448269157}], ["MUC5B", ["TCGA.F4.6463.01", "Termination of O-glycan biosynthesis"], {"weight": 0.889321108854349}], ["MUC5B", ["TCGA.F4.6463.01", "Defective GALNT3 causes HFTC"], {"weight": 0.863038715154733}], ["GALNTL6", ["TCGA.AZ.6601.01", "Defective GALNT3 causes HFTC"], {"weight": 0.883034242632463}], ["GALNTL6", ["TCGA.AZ.6601.01", "Defective GALNT12 causes CRCS1"], {"weight": 0.883034242632463}], ["GALNTL6", ["TCGA.AZ.6601.01", "Defective C1GALT1C1 causes TNPS"], {"weight": 0.883034242632463}], ["ACTR8", ["TCGA.AZ.6605.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.915788739521629}], ["GNG4", ["TCGA.AZ.6607.01", "Inwardly rectifying K+ channels"], {"weight": 0.872608424658908}], ["GNG4", ["TCGA.AZ.6607.01", "Potassium Channels"], {"weight": 0.858207861504114}], ["GNG4", ["TCGA.AZ.6607.01", "Activation of G protein gated Potassium channels"], {"weight": 0.904908134767736}], ["GNG4", ["TCGA.AZ.6607.01", "G protein gated Potassium channels"], {"weight": 0.904908134767736}], ["GNG4", ["TCGA.AZ.6607.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.904908134767736}], ["GNG4", ["TCGA.AZ.6607.01", "Phase 0 - rapid depolarisation"], {"weight": 0.902891443226738}], ["VAMP3", ["TCGA.AZ.6607.01", "WNT ligand biogenesis and trafficking"], {"weight": 0.930024381639711}], ["ITGAD", ["TCGA.AZ.6607.01", "Defective B3GALTL causes PpS"], {"weight": 0.878933751917815}], ["ITGAD", ["TCGA.AZ.6607.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.878933751917815}], ["ITGAD", ["TCGA.AZ.6607.01", "Other semaphorin interactions"], {"weight": 0.700274154662369}], ["IKBKB", ["TCGA.CA.6716.01", "TNFs bind their physiological receptors"], {"weight": 0.380583695693105}], ["IKBKB", ["TCGA.CA.6716.01", "Defensins"], {"weight": 0.531995118508815}], ["SERPINB3", ["TCGA.CA.6718.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.930040800240866}], ["SERPINB3", ["TCGA.G4.6320.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.759820858956925}], ["BCL2L14", ["TCGA.G4.6293.01", "Interaction between L1 and Ankyrins"], {"weight": 0.875815169966797}], ["NR5A2", ["TCGA.G4.6304.01", "Glucuronidation"], {"weight": 0.885386895513635}], ["NR5A2", ["TCGA.G4.6304.01", "Recycling of bile acids and salts"], {"weight": 0.937944927190326}], ["NR5A2", ["TCGA.G4.6304.01", "Aspirin ADME"], {"weight": 0.937252071264988}], ["NR5A2", ["TCGA.G4.6304.01", "Bile acid and bile salt metabolism"], {"weight": 0.92506532558311}], ["ATAD5", ["TCGA.CA.6718.01", "Diseases of DNA repair"], {"weight": 0.886551345517845}], ["ATAD5", ["TCGA.CA.6718.01", "Diseases of DNA Double-Strand Break Repair"], {"weight": 0.886551345517845}], ["ATAD5", ["TCGA.CA.6718.01", "Defective homologous recombination repair (HRR) due to BRCA2 loss of function"], {"weight": 0.886551345517845}], ["ATAD5", ["TCGA.CA.6718.01", "Presynaptic phase of homologous DNA pairing and strand exchange"], {"weight": 0.886551345517845}], ["WDHD1", ["TCGA.CA.6718.01", "Defective homologous recombination repair (HRR) due to BRCA1 loss of function"], {"weight": 0.877725901354099}], ["WDHD1", ["TCGA.CA.6718.01", "Defective homologous recombination repair (HRR) due to PALB2 loss of function"], {"weight": 0.877725901354099}], ["WDHD1", ["TCGA.CA.6718.01", "Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function"], {"weight": 0.877725901354099}], ["WDHD1", ["TCGA.CA.6718.01", "Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function"], {"weight": 0.877725901354099}], ["WDHD1", ["TCGA.CA.6718.01", "Impaired BRCA2 binding to PALB2"], {"weight": 0.877725901354099}], ["WDHD1", ["TCGA.CA.6718.01", "Resolution of D-loop Structures through Holliday Junction Intermediates"], {"weight": 0.892948162587031}], ["WDHD1", ["TCGA.CA.6718.01", "Resolution of D-Loop Structures"], {"weight": 0.892948162587031}], ["WDHD1", ["TCGA.CA.6718.01", "Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)"], {"weight": 0.877725901354099}], ["WDHD1", ["TCGA.CA.6718.01", "Unwinding of DNA"], {"weight": 0.819419023775437}], ["RPS6KB1", ["TCGA.CM.5861.01", "CD22 mediated BCR regulation"], {"weight": 0.872949373149333}], ["UGT2B15", ["TCGA.CA.6718.01", "Aspirin ADME"], {"weight": 0.943886761549776}], ["ARNTL", ["TCGA.D5.6924.01", "Glucuronidation"], {"weight": 0.853392303729046}], ["ARNTL", ["TCGA.D5.6924.01", "Tryptophan catabolism"], {"weight": 0.54030793063441}], ["OR52L1", ["TCGA.G4.6299.01", "G-protein activation"], {"weight": 0.898876900070545}], ["OR52L1", ["TCGA.G4.6299.01", "Thromboxane signalling through TP receptor"], {"weight": 0.877890235447836}], ["OR52L1", ["TCGA.G4.6299.01", "Phase 4 - resting membrane potential"], {"weight": 0.766173319589526}], ["OR52L1", ["TCGA.G4.6299.01", "Glucagon-type ligand receptors"], {"weight": 0.916403125078096}], ["OR52L1", ["TCGA.G4.6299.01", "Activation of G protein gated Potassium channels"], {"weight": 0.895694126090053}], ["OR52L1", ["TCGA.G4.6299.01", "G protein gated Potassium channels"], {"weight": 0.895694126090053}], ["PLA2G4A", ["TCGA.CM.6165.01", "Ethanol oxidation"], {"weight": 0.695446880785926}], ["TRIM26", ["TCGA.DM.A1D8.01", "Sialic acid metabolism"], {"weight": 0.615239106014158}], ["ETS1", ["TCGA.CM.6679.01", "Heme degradation"], {"weight": 0.355564109785869}], ["ETS1", ["TCGA.CM.6679.01", "APAP ADME"], {"weight": 0.0273321839660052}], ["NCAM2", ["TCGA.CM.5341.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.820808566572181}], ["CGN", ["TCGA.G4.6323.01", "Trafficking and processing of endosomal TLR"], {"weight": 0.653706386762686}], ["KCNH1", ["TCGA.DM.A0XD.01", "Potassium Channels"], {"weight": 0.959374861335038}], ["KCNH1", ["TCGA.DM.A0XD.01", "Voltage gated Potassium channels"], {"weight": 0.915857748195373}], ["PAPSS1", ["TCGA.F4.6459.01", "Collagen chain trimerization"], {"weight": 0.850482455497213}], ["ANPEP", ["TCGA.D5.5539.01", "Extracellular matrix organization"], {"weight": 0.791116882799785}], ["ANPEP", ["TCGA.D5.5539.01", "Drug ADME"], {"weight": 0.711427815705006}], ["ANPEP", ["TCGA.D5.5539.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.783787969595419}], ["ANPEP", ["TCGA.DM.A28K.01", "Complement cascade"], {"weight": 0.881172437345498}], ["ANPEP", ["TCGA.DM.A28K.01", "Regulation of Complement cascade"], {"weight": 0.872903005411238}], ["GALNT3", ["TCGA.CK.5916.01", "Defective GALNT3 causes HFTC"], {"weight": 0.900038265272307}], ["GALNT3", ["TCGA.CK.5916.01", "Defective GALNT12 causes CRCS1"], {"weight": 0.896890464534256}], ["MMRN1", ["TCGA.G4.6306.01", "Initial triggering of complement"], {"weight": 0.90896601859025}], ["MMRN1", ["TCGA.G4.6306.01", "Classical antibody-mediated complement activation"], {"weight": 0.771726664195995}], ["MMRN1", ["TCGA.G4.6306.01", "Creation of C4 and C2 activators"], {"weight": 0.863333822712367}], ["MMRN1", ["TCGA.G4.6306.01", "Defective B3GALTL causes PpS"], {"weight": 0.882938665631838}], ["MMRN1", ["TCGA.G4.6306.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.882918188887722}], ["MMRN1", ["TCGA.G4.6306.01", "Diseases associated with O-glycosylation of proteins"], {"weight": 0.695079786354537}], ["MMRN1", ["TCGA.G4.6306.01", "Keratan sulfate biosynthesis"], {"weight": 0.898091139169635}], ["PCDH7", ["TCGA.D5.6540.01", "APAP ADME"], {"weight": 0.908415990503263}], ["DNAH3", ["TCGA.CK.4948.01", "Termination of O-glycan biosynthesis"], {"weight": 0.878921897105226}], ["DNAH3", ["TCGA.CK.4948.01", "O-linked glycosylation of mucins"], {"weight": 0.913193664172571}], ["DNAH3", ["TCGA.CK.4948.01", "Defective GALNT3 causes HFTC"], {"weight": 0.843431249702812}], ["DNAH3", ["TCGA.CK.4948.01", "Defective GALNT12 causes CRCS1"], {"weight": 0.843431249702812}], ["DNAH3", ["TCGA.CK.4948.01", "Defective C1GALT1C1 causes TNPS"], {"weight": 0.843431249702812}], ["RXRG", ["TCGA.D5.6529.01", "SLC-mediated transmembrane transport"], {"weight": 0.683580298240186}], ["RXRG", ["TCGA.D5.6529.01", "Bile acid and bile salt metabolism"], {"weight": 0.439967012231112}], ["RXRG", ["TCGA.D5.6529.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.339298950596446}], ["RXRG", ["TCGA.D5.6529.01", "Defective B3GALTL causes PpS"], {"weight": 0.814054227309581}], ["RXRG", ["TCGA.D5.6529.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.814054227309581}], ["RXRG", ["TCGA.F4.6703.01", "Phase II - Conjugation of compounds"], {"weight": 0.847293778956766}], ["RXRG", ["TCGA.F4.6703.01", "Glucuronidation"], {"weight": 0.854020440610357}], ["RXRG", ["TCGA.F4.6703.01", "Aspirin ADME"], {"weight": 0.90619773005965}], ["ADH5", ["TCGA.CA.6718.01", "Phase II - Conjugation of compounds"], {"weight": 0.939905033126062}], ["NT5M", ["TCGA.CM.6674.01", "Activation of the phototransduction cascade"], {"weight": 0.879611529938387}], ["HIPK1", ["TCGA.G4.6302.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.87350487897314}], ["HIF1A", ["TCGA.CA.6718.01", "Transport of bile salts and organic acids, metal ions and amine compounds"], {"weight": 0.765546176325566}], ["HIF1A", ["TCGA.CA.6718.01", "Metal ion SLC transporters"], {"weight": 0.759604283932795}], ["HIF1A", ["TCGA.CK.5916.01", "Digestion and absorption"], {"weight": 0.680423209161935}], ["HIF1A", ["TCGA.CM.6674.01", "Glucuronidation"], {"weight": 0.737076916794594}], ["HIF1A", ["TCGA.D5.6928.01", "APAP ADME"], {"weight": 0.770626823137116}], ["HIF1A", ["TCGA.G4.6628.01", "Cytochrome P450 - arranged by substrate type"], {"weight": 0.882328571145229}], ["ADAMTSL3", ["TCGA.F4.6569.01", "O-linked glycosylation"], {"weight": 0.908949163127394}], ["ADAMTSL3", ["TCGA.F4.6569.01", "Defective B3GALTL causes PpS"], {"weight": 0.897228206554743}], ["ADAMTSL3", ["TCGA.F4.6569.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.897164976948553}], ["THBS4", ["TCGA.CM.4750.01", "Dermatan sulfate biosynthesis"], {"weight": 0.740049894565522}], ["THBS4", ["TCGA.CM.6166.01", "TNFs bind their physiological receptors"], {"weight": 0.577213926031823}], ["THBS4", ["TCGA.CM.6166.01", "Collagen chain trimerization"], {"weight": 0.884791880412871}], ["RAF1", ["TCGA.DM.A28H.01", "Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex"], {"weight": 0.831021240493827}], ["HADHB", ["TCGA.CM.5861.01", "Ethanol oxidation"], {"weight": 0.925888412317101}], ["CYP4F3", ["TCGA.G4.6588.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.920708341696179}], ["CYP4F3", ["TCGA.G4.6588.01", "Arachidonic acid metabolism"], {"weight": 0.909526281338652}], ["OR1A2", ["TCGA.D5.6535.01", "GABA receptor activation"], {"weight": 0.898948642835967}], ["OR1A2", ["TCGA.D5.6535.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.911827560875882}], ["OR1A2", ["TCGA.D5.6535.01", "Potassium Channels"], {"weight": 0.867119230643021}], ["OR1A2", ["TCGA.D5.6535.01", "Glucagon-type ligand receptors"], {"weight": 0.908543446506815}], ["OR1A2", ["TCGA.D5.6535.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.888913065928044}], ["OR1A2", ["TCGA.D5.6535.01", "GABA B receptor activation"], {"weight": 0.913108311362074}], ["OR1A2", ["TCGA.D5.6535.01", "Activation of GABAB receptors"], {"weight": 0.913108311362074}], ["OR1A2", ["TCGA.D5.6535.01", "Inwardly rectifying K+ channels"], {"weight": 0.859259802645908}], ["OR1A2", ["TCGA.D5.6535.01", "Activation of G protein gated Potassium channels"], {"weight": 0.898678969346881}], ["OR1A2", ["TCGA.D5.6535.01", "G protein gated Potassium channels"], {"weight": 0.898678969346881}], ["OR1A2", ["TCGA.D5.6535.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.898678969346881}], ["OR1A2", ["TCGA.D5.6535.01", "G beta:gamma signalling through BTK"], {"weight": 0.847073740065439}], ["OR1A2", ["TCGA.D5.6535.01", "Prostacyclin signalling through prostacyclin receptor"], {"weight": 0.847073740065439}], ["OR1A2", ["TCGA.D5.6535.01", "G-protein activation"], {"weight": 0.847073740065439}], ["OR1A2", ["TCGA.D5.6535.01", "Thromboxane signalling through TP receptor"], {"weight": 0.847073740065439}], ["ADRB2", ["TCGA.G4.6304.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.941749652120321}], ["CFHR3", ["TCGA.G4.6315.01", "Initial triggering of complement"], {"weight": 0.852122997587562}], ["SPRED1", ["TCGA.CK.5914.01", "Erythrocytes take up carbon dioxide and release oxygen"], {"weight": 0.753359028545237}], ["SPRED1", ["TCGA.CK.5914.01", "O2/CO2 exchange in erythrocytes"], {"weight": 0.753359028545237}], ["TAS2R30", ["TCGA.DM.A282.01", "Initial triggering of complement"], {"weight": 0.805367290466067}], ["TAS2R30", ["TCGA.DM.A282.01", "Binding and entry of HIV virion"], {"weight": 0.692502363796524}], ["NCAN", ["TCGA.F4.6808.01", "Keratan sulfate biosynthesis"], {"weight": 0.853853340534671}], ["DGKH", ["TCGA.CM.5864.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.840102548853439}], ["DGKH", ["TCGA.CM.5864.01", "Phase II - Conjugation of compounds"], {"weight": 0.819229109455019}], ["PIK3CB", ["TCGA.D5.7000.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.803905726048859}], ["PIK3CB", ["TCGA.D5.7000.01", "TNFs bind their physiological receptors"], {"weight": 0.334968839804698}], ["OR51B4", ["TCGA.G4.6309.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.907161062554377}], ["EXOC2", ["TCGA.CM.4744.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.773615973990214}], ["CP", ["TCGA.F4.6806.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.615521460986439}], ["CP", ["TCGA.G4.6304.01", "Heme degradation"], {"weight": 0.818272902576199}], ["CP", ["TCGA.G4.6304.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.877795806329851}], ["LAP3", ["TCGA.F4.6807.01", "Phase II - Conjugation of compounds"], {"weight": 0.771559430725129}], ["LAP3", ["TCGA.F4.6807.01", "Degradation of cysteine and homocysteine"], {"weight": 0.476386402356919}], ["LAP3", ["TCGA.F4.6807.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.919351370265061}], ["OR10AG1", ["TCGA.CK.4947.01", "Phase 4 - resting membrane potential"], {"weight": 0.761271400587191}], ["COASY", ["TCGA.D5.6930.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.674279617540627}], ["KCND2", ["TCGA.CM.6171.01", "Voltage gated Potassium channels"], {"weight": 0.917258373450901}], ["KCND2", ["TCGA.G4.6323.01", "Potassium Channels"], {"weight": 0.936201142166902}], ["DOK6", ["TCGA.D5.5541.01", "Collagen degradation"], {"weight": 0.868835570264997}], ["DOK6", ["TCGA.G4.6588.01", "NCAM1 interactions"], {"weight": 0.943578776451072}], ["CYP2C8", ["TCGA.D5.6532.01", "RA biosynthesis pathway"], {"weight": 0.92539450413144}], ["CYP2C8", ["TCGA.D5.6532.01", "Scavenging of heme from plasma"], {"weight": 0.67374614679141}], ["CYP2C8", ["TCGA.D5.6532.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.898271718667685}], ["CYP2C8", ["TCGA.D5.6532.01", "Signaling by Retinoic Acid"], {"weight": 0.798419011426434}], ["CYP2C8", ["TCGA.D5.6532.01", "Erythrocytes take up carbon dioxide and release oxygen"], {"weight": 0.765255073892661}], ["CYP2C8", ["TCGA.D5.6532.01", "O2/CO2 exchange in erythrocytes"], {"weight": 0.765255073892661}], ["CYP2C8", ["TCGA.D5.6532.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.816626943688748}], ["CYP2C8", ["TCGA.D5.6532.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], {"weight": 0.663817574226359}], ["CYP2C8", ["TCGA.D5.6532.01", "Phase II - Conjugation of compounds"], {"weight": 0.819664124439101}], ["HEY1", ["TCGA.D5.6533.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.890778230628496}], ["HEY1", ["TCGA.D5.6533.01", "Lewis blood group biosynthesis"], {"weight": 0.870004478868911}], ["HEY1", ["TCGA.D5.6533.01", "Blood group systems biosynthesis"], {"weight": 0.870004478868911}], ["HEY1", ["TCGA.D5.6533.01", "Keratan sulfate biosynthesis"], {"weight": 0.880130725884321}], ["HEY1", ["TCGA.D5.6533.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.679285022774269}], ["MYB", ["TCGA.F4.6570.01", "Glutathione conjugation"], {"weight": 0.871922224488732}], ["MYB", ["TCGA.F4.6570.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.754406628373316}], ["SNIP1", ["TCGA.CM.6163.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.733257323094544}], ["ALDH3B2", ["TCGA.DM.A1D7.01", "RA biosynthesis pathway"], {"weight": 0.897778489110363}], ["HSD17B3", ["TCGA.CA.6718.01", "Glucuronidation"], {"weight": 0.942975318995844}], ["HSD17B3", ["TCGA.CA.6718.01", "Heme degradation"], {"weight": 0.755897719531569}], ["AWAT2", ["TCGA.CA.6718.01", "Ethanol oxidation"], {"weight": 0.916436576069745}], ["AWAT2", ["TCGA.CA.6718.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.835642319426057}], ["AWAT2", ["TCGA.F4.6807.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.641792272908625}], ["AWAT2", ["TCGA.F4.6807.01", "Ethanol oxidation"], {"weight": 0.66556706572259}], ["FABP6", ["TCGA.CA.6718.01", "Bile acid and bile salt metabolism"], {"weight": 0.888573039384217}], ["FABP6", ["TCGA.CA.6718.01", "Synthesis of bile acids and bile salts"], {"weight": 0.891190899247151}], ["TLR4", ["TCGA.D5.6898.01", "Ethanol oxidation"], {"weight": 0.682372407740964}], ["MAP2K6", ["TCGA.CM.5868.01", "TNFs bind their physiological receptors"], {"weight": 0.455104606204463}], ["POLA2", ["TCGA.CK.4952.01", "Unwinding of DNA"], {"weight": 0.894537139459551}], ["POLA2", ["TCGA.CK.4952.01", "Activation of the pre-replicative complex"], {"weight": 0.910381138584246}], ["POLA2", ["TCGA.CK.4952.01", "DNA strand elongation"], {"weight": 0.903701948384052}], ["FADS2", ["TCGA.G4.6317.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.879870144508175}], ["GGCT", ["TCGA.CA.6718.01", "APAP ADME"], {"weight": 0.845966691854794}], ["FZD4", ["TCGA.CA.6718.01", "GABA receptor activation"], {"weight": 0.8837345634924}], ["PAK3", ["TCGA.F4.6569.01", "Diseases associated with O-glycosylation of proteins"], {"weight": 0.840249353126685}], ["SHC3", ["TCGA.CM.5348.01", "Collagen chain trimerization"], {"weight": 0.851997712806905}], ["NMU", ["TCGA.F4.6808.01", "Complement cascade"], {"weight": 0.902858960125413}], ["NMU", ["TCGA.F4.6808.01", "Regulation of Complement cascade"], {"weight": 0.860913685658021}], ["NMU", ["TCGA.F4.6808.01", "Initial triggering of complement"], {"weight": 0.837423792273248}], ["LPAR6", ["TCGA.CK.5915.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.939826971726444}], ["ZSCAN10", ["TCGA.G4.6588.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], {"weight": 0.887370503342182}], ["ACOT12", ["TCGA.CK.4947.01", "RA biosynthesis pathway"], {"weight": 0.847907956423825}], ["ACOT12", ["TCGA.CK.4947.01", "Ethanol oxidation"], {"weight": 0.733452308291553}], ["GPR132", ["TCGA.CK.4947.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.714288674187172}], ["SOS1", ["TCGA.D5.6536.01", "TNFs bind their physiological receptors"], {"weight": 0.404657866803325}], ["SOS1", ["TCGA.F4.6703.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.818295596804759}], ["SMAD3", ["TCGA.CK.4948.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.802123581853546}], ["SMAD3", ["TCGA.CK.4948.01", "Metal ion SLC transporters"], {"weight": 0.556721335199791}], ["SMAD3", ["TCGA.G4.6310.01", "Glucuronidation"], {"weight": 0.854828179946486}], ["SMAD3", ["TCGA.G4.6310.01", "Phase II - Conjugation of compounds"], {"weight": 0.889373441574667}], ["RNF165", ["TCGA.CK.4952.01", "Neurexins and neuroligins"], {"weight": 0.93645351691057}], ["RHEB", ["TCGA.CK.4952.01", "Carnitine metabolism"], {"weight": 0.79012792270677}], ["ARF5", ["TCGA.CK.5913.01", "Interaction between L1 and Ankyrins"], {"weight": 0.928712775489111}], ["ARF5", ["TCGA.G4.6626.01", "Interaction between L1 and Ankyrins"], {"weight": 0.946614250837277}], ["TREM2", ["TCGA.CK.5913.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.838791902594136}], ["OR2G3", ["TCGA.CK.5913.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.928435606738522}], ["OR2J3", ["TCGA.CK.5913.01", "Glucagon-type ligand receptors"], {"weight": 0.918712815244082}], ["PDE4B", ["TCGA.DM.A28F.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.814279931399799}], ["RGS4", ["TCGA.G4.6306.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.796979182785693}], ["RGS4", ["TCGA.G4.6306.01", "GABA receptor activation"], {"weight": 0.718476315062579}], ["RGS4", ["TCGA.G4.6306.01", "GABA B receptor activation"], {"weight": 0.922355036586783}], ["RGS4", ["TCGA.G4.6306.01", "Activation of GABAB receptors"], {"weight": 0.922355036586783}], ["RGS4", ["TCGA.G4.6306.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.912407187007001}], ["RGS4", ["TCGA.G4.6306.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.920238456852837}], ["RPS6KA4", ["TCGA.CM.6677.01", "Insulin processing"], {"weight": 0.69264992874338}], ["CALCOCO1", ["TCGA.CK.5913.01", "Glucuronidation"], {"weight": 0.845188555081084}], ["GPX7", ["TCGA.CK.5913.01", "Glutathione conjugation"], {"weight": 0.908683762117049}], ["ADAMTS10", ["TCGA.CK.5913.01", "Defective B3GALTL causes PpS"], {"weight": 0.905333361080253}], ["ADAMTS10", ["TCGA.CK.5913.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.905282889355881}], ["ADAMTS10", ["TCGA.CK.5913.01", "O-linked glycosylation"], {"weight": 0.91730210019368}], ["FGF12", ["TCGA.D5.6538.01", "Voltage gated Potassium channels"], {"weight": 0.890399013574379}], ["FGF12", ["TCGA.D5.6538.01", "Defective GALNT12 causes CRCS1"], {"weight": 0.768324099007847}], ["FGF12", ["TCGA.G4.6586.01", "FGFR2 ligand binding and activation"], {"weight": 0.918594947251972}], ["FGF12", ["TCGA.G4.6586.01", "Activated point mutants of FGFR2"], {"weight": 0.897602609318648}], ["MC3R", ["TCGA.CK.5914.01", "Nucleotide catabolism"], {"weight": 0.724621320720722}], ["PRKX", ["TCGA.D5.6537.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.807853689047619}], ["SUCLA2", ["TCGA.CK.5916.01", "Ethanol oxidation"], {"weight": 0.90996980500607}], ["STK11", ["TCGA.G4.6294.01", "Phase II - Conjugation of compounds"], {"weight": 0.830373143871742}], ["STK11", ["TCGA.G4.6294.01", "Glucuronidation"], {"weight": 0.859797438448684}], ["STK11", ["TCGA.G4.6294.01", "Signaling by Retinoic Acid"], {"weight": 0.77198848019848}], ["NR1H3", ["TCGA.CM.6674.01", "Erythrocytes take up carbon dioxide and release oxygen"], {"weight": 0.729600663769351}], ["NR1H3", ["TCGA.CM.6674.01", "O2/CO2 exchange in erythrocytes"], {"weight": 0.729600663769351}], ["GGT7", ["TCGA.D5.6924.01", "Phase II - Conjugation of compounds"], {"weight": 0.887424308727919}], ["GGT7", ["TCGA.D5.6924.01", "RA biosynthesis pathway"], {"weight": 0.79291054573515}], ["GGT7", ["TCGA.D5.6924.01", "APAP ADME"], {"weight": 0.835047771968545}], ["GGT7", ["TCGA.D5.6924.01", "Aspartate and asparagine metabolism"], {"weight": 0.678394872716715}], ["GGT7", ["TCGA.D5.6924.01", "Ethanol oxidation"], {"weight": 0.733842535374846}], ["GGT7", ["TCGA.D5.6924.01", "Glutathione conjugation"], {"weight": 0.762673812832513}], ["GGT7", ["TCGA.D5.6924.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.823061500029695}], ["GGT7", ["TCGA.D5.6924.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], {"weight": 0.687912027804861}], ["KLRD1", ["TCGA.G4.6302.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.83697199083679}], ["PSMD2", ["TCGA.G4.6298.01", "TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway"], {"weight": 0.89331670882726}], ["PSMD2", ["TCGA.G4.6298.01", "TNFs bind their physiological receptors"], {"weight": 0.526305720518541}], ["FUT1", ["TCGA.CK.5916.01", "Keratan sulfate biosynthesis"], {"weight": 0.893730675195688}], ["DNER", ["TCGA.DM.A1HA.01", "Blood group systems biosynthesis"], {"weight": 0.924130162065609}], ["DNER", ["TCGA.DM.A1HA.01", "Lewis blood group biosynthesis"], {"weight": 0.923959118494234}], ["EDN1", ["TCGA.CM.4743.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], {"weight": 0.927328972863924}], ["ATP6V1B2", ["TCGA.CM.4744.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.848551538831031}], ["OR2AK2", ["TCGA.CM.4744.01", "GABA B receptor activation"], {"weight": 0.939588632476947}], ["OR2AK2", ["TCGA.CM.4744.01", "Activation of GABAB receptors"], {"weight": 0.939588632476947}], ["OR2AK2", ["TCGA.CM.4744.01", "Adenylate cyclase inhibitory pathway"], {"weight": 0.916587617517767}], ["PRKACB", ["TCGA.CM.4748.01", "Keratinization"], {"weight": 0.410676544715126}], ["CTPS2", ["TCGA.CM.4750.01", "Nucleotide catabolism"], {"weight": 0.809009760331029}], ["CTPS2", ["TCGA.CM.4750.01", "Ribavirin ADME"], {"weight": 0.700376241465027}], ["ABI2", ["TCGA.CM.5344.01", "Chemokine receptors bind chemokines"], {"weight": 0.865041730870934}], ["ABI2", ["TCGA.CM.5344.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.889034449009024}], ["ABI2", ["TCGA.CM.5344.01", "Peptide ligand-binding receptors"], {"weight": 0.86472922179297}], ["EDNRA", ["TCGA.CM.5348.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.94389835521293}], ["ADAMTS17", ["TCGA.D5.6927.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.942714620565909}], ["ADAMTS17", ["TCGA.G4.6302.01", "Defective B3GALTL causes PpS"], {"weight": 0.870735827812258}], ["ADAMTS17", ["TCGA.G4.6302.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.870661983915383}], ["MGP", ["TCGA.CM.5860.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.922893160352446}], ["GPC4", ["TCGA.CM.6680.01", "TNFs bind their physiological receptors"], {"weight": 0.361676487171761}], ["MGP", ["TCGA.CM.5860.01", "Collagen chain trimerization"], {"weight": 0.886918194465547}], ["MGP", ["TCGA.CM.5860.01", "Heme degradation"], {"weight": 0.676181989350583}], ["OR52K2", ["TCGA.CM.5860.01", "Voltage gated Potassium channels"], {"weight": 0.854142842583616}], ["CCKAR", ["TCGA.G4.6317.01", "Potassium Channels"], {"weight": 0.962040347032394}], ["CCKAR", ["TCGA.G4.6317.01", "Inwardly rectifying K+ channels"], {"weight": 0.940555468114807}], ["CCKAR", ["TCGA.G4.6317.01", "Activation of G protein gated Potassium channels"], {"weight": 0.933753143443214}], ["CCKAR", ["TCGA.G4.6317.01", "G protein gated Potassium channels"], {"weight": 0.933753143443214}], ["CCKAR", ["TCGA.G4.6317.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.933753143443214}], ["CCKAR", ["TCGA.G4.6317.01", "Glucagon-type ligand receptors"], {"weight": 0.935136543623871}], ["CCKAR", ["TCGA.G4.6317.01", "G-protein activation"], {"weight": 0.935824454040513}], ["CCKAR", ["TCGA.G4.6317.01", "Thromboxane signalling through TP receptor"], {"weight": 0.915161893872115}], ["CCKAR", ["TCGA.G4.6317.01", "G beta:gamma signalling through BTK"], {"weight": 0.919165695857408}], ["CCKAR", ["TCGA.G4.6317.01", "Presynaptic function of Kainate receptors"], {"weight": 0.921395016024058}], ["CCKAR", ["TCGA.G4.6317.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.92866002236538}], ["CCKAR", ["TCGA.G4.6317.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.920608085414938}], ["CCKAR", ["TCGA.G4.6317.01", "Prostacyclin signalling through prostacyclin receptor"], {"weight": 0.908429601994062}], ["CCKAR", ["TCGA.G4.6317.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.909706117746342}], ["ITGA5", ["TCGA.D5.6928.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.936731874820127}], ["ITGA5", ["TCGA.D5.6928.01", "Collagen chain trimerization"], {"weight": 0.897830594224602}], ["OR1C1", ["TCGA.G4.6323.01", "Phase 4 - resting membrane potential"], {"weight": 0.771638725525202}], ["MMP10", ["TCGA.CM.5861.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.822460624476608}], ["MMP10", ["TCGA.CM.6674.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.913194834841828}], ["C1S", ["TCGA.CM.5861.01", "Initial triggering of complement"], {"weight": 0.748288991516393}], ["C1S", ["TCGA.CM.5861.01", "Classical antibody-mediated complement activation"], {"weight": 0.812254827691754}], ["C1S", ["TCGA.CM.5861.01", "Creation of C4 and C2 activators"], {"weight": 0.724423298419793}], ["ADAM2", ["TCGA.D5.5541.01", "Blood group systems biosynthesis"], {"weight": 0.788628598240906}], ["ADAM2", ["TCGA.D5.5541.01", "O-linked glycosylation"], {"weight": 0.636675584770771}], ["ADAM2", ["TCGA.D5.5541.01", "Lewis blood group biosynthesis"], {"weight": 0.774023889247349}], ["ADAM2", ["TCGA.D5.5541.01", "O-linked glycosylation of mucins"], {"weight": 0.89835915330939}], ["ADAM2", ["TCGA.D5.5541.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.90769549647374}], ["ST8SIA2", ["TCGA.CM.5861.01", "NCAM1 interactions"], {"weight": 0.946394810819572}], ["GUCA1A", ["TCGA.CM.5861.01", "Activation of the phototransduction cascade"], {"weight": 0.904399787403382}], ["AKR1B10", ["TCGA.CM.5861.01", "Digestion"], {"weight": 0.715990659265484}], ["AKR1B10", ["TCGA.CM.5861.01", "Digestion and absorption"], {"weight": 0.714500714120623}], ["AKR1B10", ["TCGA.DM.A1DB.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.864552960615625}], ["AKR1B10", ["TCGA.DM.A1DB.01", "Blood group systems biosynthesis"], {"weight": 0.805354169248909}], ["AKR1B10", ["TCGA.DM.A1DB.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.831196590415588}], ["AKR1B10", ["TCGA.DM.A1DB.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], {"weight": 0.805977603710712}], ["AKR1B10", ["TCGA.DM.A1DB.01", "Lewis blood group biosynthesis"], {"weight": 0.786034642977618}], ["CREB3L3", ["TCGA.CM.5868.01", "Phase 0 - rapid depolarisation"], {"weight": 0.920895781034395}], ["KCNMB2", ["TCGA.CM.5868.01", "Potassium Channels"], {"weight": 0.947034702802945}], ["KCNMB2", ["TCGA.CM.5868.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.621194681624015}], ["SMOX", ["TCGA.CM.5868.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.63216594277393}], ["B3GNTL1", ["TCGA.CM.6161.01", "Sialic acid metabolism"], {"weight": 0.615780137239911}], ["B3GNTL1", ["TCGA.CM.6161.01", "Termination of O-glycan biosynthesis"], {"weight": 0.901810003763717}], ["KLF5", ["TCGA.CM.6161.01", "Glucuronidation"], {"weight": 0.89235986982987}], ["KLF5", ["TCGA.CM.6161.01", "Phase II - Conjugation of compounds"], {"weight": 0.89684156810266}], ["KLF5", ["TCGA.CM.6161.01", "Aspirin ADME"], {"weight": 0.905490808611472}], ["BCAN", ["TCGA.CM.6162.01", "Chondroitin sulfate biosynthesis"], {"weight": 0.864737284690163}], ["PEG10", ["TCGA.CM.6162.01", "Scavenging by Class A Receptors"], {"weight": 0.747341914700306}], ["PEG10", ["TCGA.CM.6162.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], {"weight": 0.67970553004718}], ["MLYCD", ["TCGA.CM.6163.01", "Ethanol oxidation"], {"weight": 0.735808770084622}], ["G6PD", ["TCGA.CM.6678.01", "Glucuronidation"], {"weight": 0.813607831338131}], ["G6PD", ["TCGA.F4.6854.01", "Biological oxidations"], {"weight": 0.827458798938223}], ["G6PD", ["TCGA.F4.6854.01", "Digestion"], {"weight": 0.412923863769163}], ["G6PD", ["TCGA.F4.6854.01", "Digestion and absorption"], {"weight": 0.411124789553851}], ["PCOLCE2", ["TCGA.CM.6164.01", "Collagen chain trimerization"], {"weight": 0.887928170552842}], ["TRAPPC6B", ["TCGA.CM.6168.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.93126183991662}], ["CYP26B1", ["TCGA.CM.6169.01", "RA biosynthesis pathway"], {"weight": 0.851369405095421}], ["CYP26B1", ["TCGA.D5.6540.01", "RA biosynthesis pathway"], {"weight": 0.935665941547333}], ["CYP26B1", ["TCGA.D5.6540.01", "Glucuronidation"], {"weight": 0.912168166529993}], ["CYP26B1", ["TCGA.DM.A1HA.01", "Biosynthesis of specialized proresolving mediators (SPMs)"], {"weight": 0.94866829971158}], ["CYP26B1", ["TCGA.DM.A1HA.01", "Aspirin ADME"], {"weight": 0.92693249415669}], ["CYP26B1", ["TCGA.DM.A1HA.01", "Biosynthesis of DHA-derived SPMs"], {"weight": 0.919167152321497}], ["CYP26B1", ["TCGA.DM.A1HA.01", "Glucuronidation"], {"weight": 0.928977711431686}], ["OR2L5", ["TCGA.CM.6169.01", "Glucagon-type ligand receptors"], {"weight": 0.860446956172774}], ["OR2L5", ["TCGA.CM.6169.01", "Inwardly rectifying K+ channels"], {"weight": 0.899970260764334}], ["OR2L5", ["TCGA.CM.6169.01", "Activation of G protein gated Potassium channels"], {"weight": 0.886869767818732}], ["OR2L5", ["TCGA.CM.6169.01", "G protein gated Potassium channels"], {"weight": 0.886869767818732}], ["OR2L5", ["TCGA.CM.6169.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.886869767818732}], ["APOOL", ["TCGA.CM.6170.01", "Collagen formation"], {"weight": 0.88586722863165}], ["CYP3A5", ["TCGA.CM.6171.01", "Phase II - Conjugation of compounds"], {"weight": 0.895313449755262}], ["ENO3", ["TCGA.G4.6588.01", "Metabolism of steroid hormones"], {"weight": 0.910298832047069}], ["CYP3A5", ["TCGA.CM.6171.01", "Glucuronidation"], {"weight": 0.854066963048119}], ["EPHX1", ["TCGA.CM.6171.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.907508560456592}], ["EPHX1", ["TCGA.G4.6295.01", "RA biosynthesis pathway"], {"weight": 0.884771785903425}], ["EPHX1", ["TCGA.G4.6295.01", "Arachidonic acid metabolism"], {"weight": 0.935582611434727}], ["EPHX1", ["TCGA.G4.6295.01", "Ethanol oxidation"], {"weight": 0.848565637800305}], ["EPHX1", ["TCGA.G4.6295.01", "APAP ADME"], {"weight": 0.810024857749833}], ["EPHX1", ["TCGA.G4.6295.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.901074340395486}], ["EPHX1", ["TCGA.G4.6295.01", "Aflatoxin activation and detoxification"], {"weight": 0.819720047419009}], ["GOT2", ["TCGA.G4.6297.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], {"weight": 0.597422617621931}], ["PHF12", ["TCGA.F4.6569.01", "RA biosynthesis pathway"], {"weight": 0.752406026286477}], ["OR52B2", ["TCGA.F4.6856.01", "GABA receptor activation"], {"weight": 0.889601714961397}], ["OR52B2", ["TCGA.F4.6856.01", "G beta:gamma signalling through BTK"], {"weight": 0.890294062922567}], ["OR52B2", ["TCGA.F4.6856.01", "Glucagon-type ligand receptors"], {"weight": 0.90469318617088}], ["EZR", ["TCGA.CM.6674.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.702187410758108}], ["EZR", ["TCGA.CM.6674.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.789038002139945}], ["EXOSC8", ["TCGA.CM.6677.01", "Nucleotide catabolism"], {"weight": 0.542297523765647}], ["HSPA1L", ["TCGA.D5.6928.01", "Voltage gated Potassium channels"], {"weight": 0.865193796067396}], ["SDSL", ["TCGA.CM.6680.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.562683575536775}], ["SDSL", ["TCGA.CM.6680.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], {"weight": 0.904121680927141}], ["CSF2", ["TCGA.D5.5537.01", "Heme degradation"], {"weight": 0.657833583446219}], ["MASP2", ["TCGA.DM.A285.01", "Complement cascade"], {"weight": 0.887369509678725}], ["MASP2", ["TCGA.DM.A285.01", "Regulation of Complement cascade"], {"weight": 0.831492089820106}], ["MASP2", ["TCGA.DM.A285.01", "Initial triggering of complement"], {"weight": 0.787033538489861}], ["MASP2", ["TCGA.DM.A285.01", "Classical antibody-mediated complement activation"], {"weight": 0.64748315475995}], ["UTP3", ["TCGA.D5.5540.01", "mRNA decay by 3' to 5' exoribonuclease"], {"weight": 0.850512598635172}], ["CNGA3", ["TCGA.D5.5541.01", "Activation of the phototransduction cascade"], {"weight": 0.756986303844399}], ["OR51F2", ["TCGA.D5.6529.01", "Glucagon-type ligand receptors"], {"weight": 0.900543623541093}], ["OR51F2", ["TCGA.D5.6529.01", "GABA receptor activation"], {"weight": 0.600797898242907}], ["OR51F2", ["TCGA.D5.6529.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.894740325513714}], ["OR51F2", ["TCGA.D5.6529.01", "Presynaptic function of Kainate receptors"], {"weight": 0.87808722452172}], ["OR51F2", ["TCGA.D5.6529.01", "NCAM1 interactions"], {"weight": 0.725120138397041}], ["OR51F2", ["TCGA.D5.6529.01", "Potassium Channels"], {"weight": 0.930533738922476}], ["OR51F2", ["TCGA.D5.6529.01", "G-protein activation"], {"weight": 0.886923268977039}], ["OR51F2", ["TCGA.D5.6529.01", "Thromboxane signalling through TP receptor"], {"weight": 0.860738677611746}], ["OR51F2", ["TCGA.D5.6529.01", "GABA B receptor activation"], {"weight": 0.893694257050616}], ["OR51F2", ["TCGA.D5.6529.01", "Activation of GABAB receptors"], {"weight": 0.893694257050616}], ["OR51F2", ["TCGA.D5.6529.01", "Inwardly rectifying K+ channels"], {"weight": 0.898030168314446}], ["OR51F2", ["TCGA.D5.6529.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.914469989874785}], ["OR51F2", ["TCGA.D5.6529.01", "G beta:gamma signalling through BTK"], {"weight": 0.850386655848324}], ["OR51F2", ["TCGA.D5.6529.01", "Prostacyclin signalling through prostacyclin receptor"], {"weight": 0.850386655848324}], ["OR51F2", ["TCGA.D5.6529.01", "Activation of G protein gated Potassium channels"], {"weight": 0.878946304780996}], ["OR51F2", ["TCGA.D5.6529.01", "G protein gated Potassium channels"], {"weight": 0.878946304780996}], ["OR51F2", ["TCGA.D5.6529.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.878946304780996}], ["OR51F2", ["TCGA.D5.6529.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.850386655848324}], ["TFDP2", ["TCGA.D5.6534.01", "Aspirin ADME"], {"weight": 0.875967674903421}], ["CBS", ["TCGA.D5.6534.01", "Phase II - Conjugation of compounds"], {"weight": 0.807034941257592}], ["CBS", ["TCGA.D5.6534.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.827414286588013}], ["CBS", ["TCGA.D5.6534.01", "Degradation of cysteine and homocysteine"], {"weight": 0.827707664261462}], ["AK3", ["TCGA.D5.6535.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.731940743635528}], ["AK3", ["TCGA.D5.6535.01", "Aspartate and asparagine metabolism"], {"weight": 0.578113571254799}], ["PPP1R3F", ["TCGA.D5.6536.01", "Phase II - Conjugation of compounds"], {"weight": 0.850086755178399}], ["PPP1R3F", ["TCGA.D5.6536.01", "Glucuronidation"], {"weight": 0.876642110401222}], ["SUCLG1", ["TCGA.D5.6540.01", "Ethanol oxidation"], {"weight": 0.942991104287935}], ["MMP15", ["TCGA.D5.6540.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.942053789556472}], ["SLC7A7", ["TCGA.D5.6540.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], {"weight": 0.92358456318906}], ["ADAMTS1", ["TCGA.G4.6297.01", "Defective B3GALTL causes PpS"], {"weight": 0.880904463824973}], ["ADAMTS1", ["TCGA.G4.6297.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.880827091580857}], ["SORT1", ["TCGA.D5.6924.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.83116772128816}], ["SORT1", ["TCGA.D5.6924.01", "JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1"], {"weight": 0.154758725679816}], ["SORT1", ["TCGA.D5.6924.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], {"weight": 0.757962231080757}], ["FGF17", ["TCGA.D5.6924.01", "Defective GALNT12 causes CRCS1"], {"weight": 0.649284743759884}], ["FGF17", ["TCGA.D5.6924.01", "FGFR4 ligand binding and activation"], {"weight": 0.731632616897015}], ["FGF17", ["TCGA.D5.6924.01", "Defective GALNT3 causes HFTC"], {"weight": 0.593096255231146}], ["FGF17", ["TCGA.D5.6924.01", "FGFR2c ligand binding and activation"], {"weight": 0.825852473640072}], ["FGF17", ["TCGA.D5.6924.01", "Defective C1GALT1C1 causes TNPS"], {"weight": 0.5930012903692}], ["ADSL", ["TCGA.D5.6926.01", "Ethanol oxidation"], {"weight": 0.836963718585103}], ["MAX", ["TCGA.D5.6927.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], {"weight": 0.898990009245147}], ["MAX", ["TCGA.F4.6461.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.832278825998702}], ["MAX", ["TCGA.F4.6461.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], {"weight": 0.631378816610159}], ["F11", ["TCGA.DM.A1D6.01", "Creation of C4 and C2 activators"], {"weight": 0.861669786461015}], ["FMOD", ["TCGA.F4.6570.01", "O-linked glycosylation of mucins"], {"weight": 0.945008213604616}], ["CNTNAP2", ["TCGA.D5.6927.01", "NCAM1 interactions"], {"weight": 0.929005279657631}], ["IL20RA", ["TCGA.D5.6927.01", "IL-6-type cytokine receptor ligand interactions"], {"weight": 0.885216242594461}], ["B4GALT5", ["TCGA.D5.6928.01", "Defective GALNT3 causes HFTC"], {"weight": 0.882117479073985}], ["B4GALT5", ["TCGA.D5.6928.01", "Defective GALNT12 causes CRCS1"], {"weight": 0.882117479073985}], ["B4GALT5", ["TCGA.D5.6928.01", "Defective C1GALT1C1 causes TNPS"], {"weight": 0.882117479073985}], ["CYP26C1", ["TCGA.D5.6928.01", "RA biosynthesis pathway"], {"weight": 0.901146043790913}], ["ARSI", ["TCGA.DM.A0X9.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.866623331132653}], ["CACNB3", ["TCGA.D5.6929.01", "Glucagon-type ligand receptors"], {"weight": 0.916606823081286}], ["JAG2", ["TCGA.D5.6929.01", "Blood group systems biosynthesis"], {"weight": 0.612669949444411}], ["JAG2", ["TCGA.DM.A282.01", "Blood group systems biosynthesis"], {"weight": 0.554629741770132}], ["SLC27A5", ["TCGA.D5.6930.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], {"weight": 0.875844996200954}], ["SLC27A5", ["TCGA.D5.6930.01", "Synthesis of bile acids and bile salts via 27-hydroxycholesterol"], {"weight": 0.849993039755803}], ["NSF", ["TCGA.D5.6930.01", "GABA receptor activation"], {"weight": 0.847490083441804}], ["IFNA2", ["TCGA.F4.6806.01", "IL-6-type cytokine receptor ligand interactions"], {"weight": 0.869056131445945}], ["NFATC2", ["TCGA.DM.A0X9.01", "Phase II - Conjugation of compounds"], {"weight": 0.767345471713775}], ["NFATC2", ["TCGA.DM.A0X9.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.899977564210346}], ["ARSF", ["TCGA.DM.A0XD.01", "Phase II - Conjugation of compounds"], {"weight": 0.873561934699264}], ["ARSF", ["TCGA.DM.A0XD.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.865299215435438}], ["LIPE", ["TCGA.DM.A0XF.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.787222859372807}], ["LIPE", ["TCGA.DM.A0XF.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.822714804153794}], ["LIPE", ["TCGA.DM.A0XF.01", "RA biosynthesis pathway"], {"weight": 0.860265179082276}], ["LIPE", ["TCGA.G4.6299.01", "RA biosynthesis pathway"], {"weight": 0.88171794545819}], ["PSMD3", ["TCGA.DM.A1D0.01", "TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway"], {"weight": 0.915429167591316}], ["PTGES3", ["TCGA.DM.A1D7.01", "Arachidonic acid metabolism"], {"weight": 0.863496097465381}], ["UBFD1", ["TCGA.DM.A1D7.01", "TNFs bind their physiological receptors"], {"weight": 0.241653754555855}], ["OR8B8", ["TCGA.DM.A1D8.01", "Glucagon-type ligand receptors"], {"weight": 0.933936331836353}], ["OR8B8", ["TCGA.DM.A1D8.01", "Activation of the phototransduction cascade"], {"weight": 0.818342258151036}], ["OR8B8", ["TCGA.DM.A1D8.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.908531909326202}], ["OR8B8", ["TCGA.DM.A1D8.01", "G beta:gamma signalling through BTK"], {"weight": 0.892654042888442}], ["RASGRP1", ["TCGA.DM.A1HA.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.91626674632187}], ["OR6T1", ["TCGA.DM.A1HA.01", "Phase 4 - resting membrane potential"], {"weight": 0.904977826607947}], ["PTPN5", ["TCGA.DM.A28F.01", "Arachidonic acid metabolism"], {"weight": 0.903351435743567}], ["OR5AN1", ["TCGA.DM.A28F.01", "Voltage gated Potassium channels"], {"weight": 0.880308161464637}], ["OR5AN1", ["TCGA.DM.A28F.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.914639232147539}], ["OR4D6", ["TCGA.DM.A28F.01", "Phase 4 - resting membrane potential"], {"weight": 0.870178249695926}], ["OR4D6", ["TCGA.DM.A28F.01", "Activation of G protein gated Potassium channels"], {"weight": 0.927969131464439}], ["OR4D6", ["TCGA.DM.A28F.01", "G protein gated Potassium channels"], {"weight": 0.927969131464439}], ["OR4D6", ["TCGA.DM.A28F.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.927969131464439}], ["OR4D6", ["TCGA.DM.A28F.01", "Inwardly rectifying K+ channels"], {"weight": 0.931612344887263}], ["OR4D6", ["TCGA.DM.A28F.01", "G beta:gamma signalling through BTK"], {"weight": 0.901472453112831}], ["GCLC", ["TCGA.DM.A28F.01", "Phase II - Conjugation of compounds"], {"weight": 0.808017164290106}], ["GCLC", ["TCGA.DM.A28F.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.860398011827643}], ["GCLC", ["TCGA.DM.A28F.01", "RA biosynthesis pathway"], {"weight": 0.83167042263332}], ["GCLC", ["TCGA.DM.A28F.01", "Biosynthesis of specialized proresolving mediators (SPMs)"], {"weight": 0.835059125661185}], ["GCLC", ["TCGA.DM.A28F.01", "Ethanol oxidation"], {"weight": 0.818868450083798}], ["OR5P3", ["TCGA.DM.A28K.01", "Initial triggering of complement"], {"weight": 0.796181648642033}], ["OR5P3", ["TCGA.DM.A28K.01", "Activation of SMO"], {"weight": 0.773548266975183}], ["BGN", ["TCGA.F4.6806.01", "NCAM1 interactions"], {"weight": 0.898180705374009}], ["BGN", ["TCGA.F4.6806.01", "Collagen chain trimerization"], {"weight": 0.896092813982455}], ["SLCO1B3", ["TCGA.F4.6459.01", "Common Pathway of Fibrin Clot Formation"], {"weight": 0.836606909471845}], ["ADAMTS15", ["TCGA.F4.6570.01", "Defective B3GALTL causes PpS"], {"weight": 0.88607482632873}], ["ADAMTS15", ["TCGA.F4.6570.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.886004734685636}], ["YWHAH", ["TCGA.F4.6808.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.833935142158367}], ["CTSZ", ["TCGA.F4.6856.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.777035391576606}], ["BICD2", ["TCGA.F4.6856.01", "O-linked glycosylation of mucins"], {"weight": 0.892418624041298}], ["BICD2", ["TCGA.F4.6856.01", "Termination of O-glycan biosynthesis"], {"weight": 0.828951068576331}], ["CYP2C18", ["TCGA.F4.6856.01", "RA biosynthesis pathway"], {"weight": 0.85795393112355}], ["CYP2C18", ["TCGA.F4.6856.01", "Glucuronidation"], {"weight": 0.811692795709001}], ["FGF3", ["TCGA.G4.6309.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.728858897197747}], ["POLR2G", ["TCGA.G4.6294.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.825518855870728}], ["APCS", ["TCGA.G4.6294.01", "Scavenging of heme from plasma"], {"weight": 0.663092270297244}], ["APCS", ["TCGA.G4.6294.01", "Erythrocytes take up carbon dioxide and release oxygen"], {"weight": 0.787899113862205}], ["APCS", ["TCGA.G4.6294.01", "O2/CO2 exchange in erythrocytes"], {"weight": 0.787899113862205}], ["APCS", ["TCGA.G4.6294.01", "Acetylcholine Neurotransmitter Release Cycle"], {"weight": 0.83150765581894}], ["RDH5", ["TCGA.G4.6299.01", "Ethanol oxidation"], {"weight": 0.931799910760906}], ["RDH5", ["TCGA.G4.6299.01", "Glucuronidation"], {"weight": 0.893472537271934}], ["RDH5", ["TCGA.G4.6299.01", "Phase II - Conjugation of compounds"], {"weight": 0.908479511592067}], ["WNT3A", ["TCGA.G4.6299.01", "WNT ligand biogenesis and trafficking"], {"weight": 0.902534333734431}], ["WNT3A", ["TCGA.G4.6299.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.748000890652379}], ["P4HA2", ["TCGA.G4.6302.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.944356557568311}], ["VBP1", ["TCGA.G4.6302.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.758170606796363}], ["BEX1", ["TCGA.G4.6302.01", "FGFR4 ligand binding and activation"], {"weight": 0.75110458074229}], ["DBH", ["TCGA.G4.6303.01", "Ethanol oxidation"], {"weight": 0.836194843885804}], ["GSN", ["TCGA.G4.6306.01", "Calcitonin-like ligand receptors"], {"weight": 0.859554760963583}], ["OR2W1", ["TCGA.G4.6307.01", "Initial triggering of complement"], {"weight": 0.804348991020076}], ["OR2W1", ["TCGA.G4.6307.01", "Platelet calcium homeostasis"], {"weight": 0.887765753860113}], ["OR2W1", ["TCGA.G4.6307.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.814902761195251}], ["PPARG", ["TCGA.G4.6307.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.852891499245848}], ["PPARG", ["TCGA.G4.6307.01", "Keratan sulfate biosynthesis"], {"weight": 0.888740274744432}], ["RPA3", ["TCGA.G4.6309.01", "DNA strand elongation"], {"weight": 0.878127476181867}], ["CBL", ["TCGA.G4.6310.01", "TNFs bind their physiological receptors"], {"weight": 0.610831692551056}], ["CBL", ["TCGA.G4.6310.01", "CD22 mediated BCR regulation"], {"weight": 0.860035735695862}], ["CBL", ["TCGA.G4.6310.01", "Activation of the phototransduction cascade"], {"weight": 0.734611822291416}], ["CBL", ["TCGA.G4.6314.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], {"weight": 0.800287672742671}], ["FTL", ["TCGA.G4.6315.01", "Scavenging by Class A Receptors"], {"weight": 0.553809702942985}], ["CDC37L1", ["TCGA.G4.6317.01", "Classical antibody-mediated complement activation"], {"weight": 0.850760064402659}], ["CDC37L1", ["TCGA.G4.6317.01", "Initial triggering of complement"], {"weight": 0.896930391018466}], ["CDC37L1", ["TCGA.G4.6317.01", "Creation of C4 and C2 activators"], {"weight": 0.899170551408257}], ["PSMA1", ["TCGA.G4.6317.01", "TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway"], {"weight": 0.908647835618289}], ["OR1M1", ["TCGA.G4.6626.01", "GABA B receptor activation"], {"weight": 0.934150671069613}], ["OR1M1", ["TCGA.G4.6626.01", "Activation of GABAB receptors"], {"weight": 0.934150671069613}], ["OR1M1", ["TCGA.G4.6626.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.930275679111209}], ["OR1M1", ["TCGA.G4.6626.01", "Glucagon-type ligand receptors"], {"weight": 0.933120625667087}], ["OR1M1", ["TCGA.G4.6626.01", "Inwardly rectifying K+ channels"], {"weight": 0.932288968114071}], ["OR1M1", ["TCGA.G4.6626.01", "G beta:gamma signalling through BTK"], {"weight": 0.91294231208065}], ["OR1M1", ["TCGA.G4.6626.01", "Activation of G protein gated Potassium channels"], {"weight": 0.926629677446389}], ["OR1M1", ["TCGA.G4.6626.01", "G protein gated Potassium channels"], {"weight": 0.926629677446389}], ["OR1M1", ["TCGA.G4.6626.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.926629677446389}], ["OR1M1", ["TCGA.G4.6626.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.881814180730555}], ["OR1M1", ["TCGA.G4.6626.01", "Initial triggering of complement"], {"weight": 0.784179160247981}], ["OR1M1", ["TCGA.G4.6626.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.90512335325557}], ["OR1M1", ["TCGA.G4.6626.01", "Chemokine receptors bind chemokines"], {"weight": 0.909164290712869}], ["OR1M1", ["TCGA.G4.6626.01", "G-protein activation"], {"weight": 0.911305071380404}], ["OR1M1", ["TCGA.G4.6626.01", "Thromboxane signalling through TP receptor"], {"weight": 0.911305071380404}], ["OR1M1", ["TCGA.G4.6626.01", "Presynaptic function of Kainate receptors"], {"weight": 0.90512335325557}], ["OR1M1", ["TCGA.G4.6626.01", "Phase 4 - resting membrane potential"], {"weight": 0.858740984007867}], ["OR1M1", ["TCGA.G4.6626.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.787142231151765}], ["OR1M1", ["TCGA.G4.6626.01", "Regulation of Complement cascade"], {"weight": 0.837058509433496}], ["OR1M1", ["TCGA.G4.6626.01", "Voltage gated Potassium channels"], {"weight": 0.900021621525564}], ["TFF3", ["TCGA.G4.6320.01", "Formation of the anterior neural plate"], {"weight": 0.590615137440778}], ["BLNK", ["TCGA.G4.6586.01", "Platelet calcium homeostasis"], {"weight": 0.943126074390948}], ["NR1H2", ["TCGA.G4.6586.01", "Synthesis of bile acids and bile salts"], {"weight": 0.883164229020497}], ["LHFPL2", ["TCGA.G4.6588.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.893047777130912}], ["MAT2A", ["TCGA.G4.6588.01", "Unwinding of DNA"], {"weight": 0.745633197838773}], ["CYP2S1", ["TCGA.G4.6628.01", "Phase II - Conjugation of compounds"], {"weight": 0.856024192163825}], ["ECHDC1", ["TCGA.G4.6628.01", "Ethanol oxidation"], {"weight": 0.90655888178214}], ["PTGES", ["TCGA.G4.6628.01", "Arachidonic acid metabolism"], {"weight": 0.934671916312307}], ["RGS8", ["TCGA.G4.6628.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.924773221463817}], ["KIF22", ["TCGA.G4.6628.01", "Interaction between L1 and Ankyrins"], {"weight": 0.914391566251743}], ["SLC17A7", ["TCGA.G4.6628.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], {"weight": 0.851586312162599}]], "not_cover_set": ["RBBP7", "LAMC3", "LAMA2", "NPFFR1", "NPSR1", "DYNC1H1", "MEIS1", "ASH2L", "GDNF", "OGT", "DCN", "NEDD4", "POLD1", "TRIM36", "BMP7", "PPP1R15A", "ESRRB", "PDS5B", "NT5C", "MTCH2", "NKD1", "BTC", "APBB1IP", "EXOC6", "PIK3C2B", "NFIC", "SOX3", "NEDD4L", "CDC25C", "IRS4", "RPL5", "FBXW7", "ATP1A3", "LTN1", "PCF11", "GNRHR", "COG7", "CACNA1I", "PRDM4", "ADCY2", "IRS1", "OR6P1", "OR51I1", "OR2W3", "OR5H1", "FFAR1", "CANT1", "INPP5B", "PDGFRA", "SCN9A", "DLGAP2", "IPMK", "UNC5A", "TUBGCP6", "CAV3", "BAIAP2", "IQCA1", "NAALADL2", "CCT8L2", "DKK2", "KCNN2", "OR5AS1", "OR5B21", "OR2B11", "GPR27", "GNA12", "MYF6", "ABL1", "GNAO1", "ACTN2", "PPP1CB", "HRG", "ITIH3", "PPP2R5E", "PPP2R5D", "MAP3K1", "CSNK1D", "GRM2", "DNM2", "CDH1", "KALRN", "BLK", "TAS2R8", "TAS2R4", "SSTR1", "SEC24A", "VAV1", "DOCK1", "ARHGEF6", "PSMB8", "PGR", "QRFPR", "AVPR1B", "DAG1", "SHC2", "NRG3", "TRIP10", "MAPK6", "IL6", "GTF3A", "CLOCK", ["TCGA.A6.5662.01", "Phase 4 - resting membrane potential"], "RPS6KA1", "INTS4", "CAPN1", "MYLK", "SP5", "ACTB", "F2", "HSPA2", "AJUBA", "TUBA4A", "KAT2B", "ARHGDIB", "CREB3L2", "HIST1H2BL", "TUBB4A", "JAK1", "RAB1B", "GNG12", "GNAQ", "B9D2", "BCAR1", "IRF3", "NCOR1", "CAD", "PARP1", "SFN", "PRKCD", "HMMR", "C3", "FGFR4", "CENPE", "DCTN1", "PELP1", "HSPB1", "CXCR2", "ITGA2", "PPBP", "TRIO", "TUBGCP4", "FBF1", "SCLT1", "NPHP4", "CEP192", "CEP250", "CEP76", "HAUS3", "CEP72", "CDK5RAP2", "OFD1", "CEP164", "ERCC3", "PRKCZ", "PICALM", "S1PR4", "MAP2K7", "SMAD1", "FGFR3", "AP1M1", "ERCC6L", "NUP133", "CENPI", "CENPM", "EXOC7", "JAM3", "MYH9", "CYSLTR1", "OXT", "GPR4", "AVPR1A", "RB1CC1", "CNKSR1", "CDK12", "MUSK", "GRM8", "GRM6", "TAS2R40", "OXER1", "GALR1", "SSTR4", "AP4B1", "PDE3A", "SOS2", "CAPN2", "VLDLR", "IFNGR2", "HLA-B", "GRIN2D", "CHN1", "ARHGAP6", "SEC31A", "MYH2", "GPSM1", "OR2K2", "OR2T10", "OR4C15", "OR4C11", "OR13C5", "OR4S1", "OR10A5", "OR2B6", "OR4K13", "OR4F6", "OR51E1", "AKAP7", "PDE4DIP", "CDK14", "IQGAP3", "CHD4", "FERMT3", "SERPINA4", "SERPINF2", "SCN7A", "PRKCH", "KIF23", "NUMB", "TAF1", "CIT", "SEC24B", "MPL", "AXL", "CSF1", "UNC5C", "LHCGR", "ESPL1", "HRH2", "PTGER2", "TUB", "GRIK1", "SCN3A", "FZD1", "SGMS1", "PRKDC", "DLC1", "ARHGEF18", "DKK1", "KIF20A", "ARHGAP32", "OBSCN", "LMO7", "GHRH", "ING5", "CNGA2", "ARFGEF2", "ATG14", "MCF2", "ARHGAP33", "FAM13A", "MAP4K2", "CHRNG", "NLGN3", "RGS22", "KTN1", "TUBB6", "DOCK7", "RAPGEF2", "SCFD1", "RRH", "MRVI1", "DLGAP3", "HIST1H1E", "LIG3", "PPP1R13B", "CADM1", "ZFYVE16", "CEP170", "SIRPB1", "LMAN2L", "PKD2", "PMEL", "KIF21A", "NUMA1", "ATP6V1B1", "CLEC4M", "RHPN1", "TRAPPC6A", "DES", "KIF1C", "KIFC2", "KIF13B", "NCAPD3", "STK4", "CPLX2", "EPRS", "PARP2", "TOPBP1", "LLGL1", "TAF1L", "GATAD2B", "ACVR2A", "DPYSL5", "SCYL1", "MYH7B", "USE1", "RAD9B", "BRIP1", "SESN2", "IFT57", "TP53BP1", "APOA1", "POLR2F", "CD38", "HNF1A", "EGR1", "DGKD", "BMPR2", "SYNJ2", "MLST8", "CDC23", "TEP1", "MED12", "TF", "IRAK4", "SLC18A3", "SNAP91", "CARD11", "MALT1", "RAD23A", "PPM1B", "PPP4R4", "NTRK2", "UBTF", "RGS2", "CTCF", "PHC3", "CBX8", "CHD5", "INTS1", "DDB1", "SMG6", "PBX1", "UBE3A", "PDE5A", "AK1", "HCFC1", "FAT1", "ASH1L", "MTMR8", "NPEPL1", "PKNOX1", "PDE7A", "FOXM1", "USP4", "EFCAB1", "LIG1", "UVSSA", "TNFAIP3", "PPFIA2", "PLCH1", "CHRNA6", "CHRNA4", "TAF1D", "ETF1", "SMG9", "UPF2", "KRT14", "HSPA12A", "SRSF9", "NUP210", "MAP4K5", "TAOK2", "TANC2", "PPP1R16A", "SPEN", "MYO1A", "PPP6R3", "FANCI", "SYNE2", "IL13RA1", "IL27RA", "MASTL", "IL13RA2", "DNAJB6", "CHRD", "SUV39H1", "HUWE1", "DCUN1D1", "NOP56", "DERL1", "SNTA1", "GREB1", "ABCA3", "CEP68", "KLHL11", "HERC1", "UBE3B", "KLHL5", "KLHL25", "RNF220", "ASB11", "TRIM37", "UBOX5", "RNF126", "SH3GLB2", "KIR2DL3", "PLAT", "ANXA2", "PTPN23", "SDK2", "GGA2", "CFH", "ZNF14", "SMPD2", "FDPS", "SRSF1", "ZNRF3", "RNF43", "VDAC3", "TRA2B", "PRCC", "DHX16", "RBM5", "RBM22", "SF3B3", "U2AF2", "DCAF5", "PNPLA6", "HOXB2", "ENO1", "ZC3H13", "RRM2", "NAT8L", "POU2F2", "MDC1", "GLB1", "PAFAH2", "UGDH", "STS", "AOX1", "UGT1A8", "ARSE", "FAHD2A", "MAF", "MOGAT3", "PCCB", "CES5A", "HK3", "ACTL6B", "TRPV6", "CATSPER1", "DEPDC1B", ["TCGA.A6.5666.01", "Cytosolic sulfonation of small molecules"], "IGF1R", "EPHA3", "RHOT2", "RPS6KA6", "DOCK9", "PLEKHG6", "BBS5", "PLXNB2", "RGS9BP", "DNASE2", "COL1A2", "OPN4", "PLXNA3", "ARID2", "OR5M3", "PSME4", "TGFBR1", "HTR5A", "NRP2", "NMUR1", "TFRC", "NUF2", "EXOC4", "GLI2", "MYO5A", "OAS1", "ROBO1", "HAUS5", "TNS1", "OR4D5", "OR6C74", "OR10P1", "PPP1R3A", "IQGAP2", "RFC1", "CD82", "IFT122", "ZNF429", "KIF1B", "KIF20B", "CEACAM8", "COL23A1", "RGMB", "MTMR6", "RNF6", "ASB18", "MCM8", "PFKM", "UIMC1", "UTP20", "PLEC", "SLX4", "LILRB3", "PIWIL4", "POLR3E", "CBX2", "ZNF217", "FTSJ3", "BDP1", "ITGA9", "ITGAX", "CFI", "TIMM44", "ZNF830", "COBLL1", "CNGB1", "UNC5D", "PCNT", "NGLY1", "MGA", "NLGN1", "GPRC6A", "KCNA2", "KCNA3", "ASXL2", "QKI", "TPD52L1", "ALDH3A2", "ANAPC4", "EEF1A1", "PFN2", "TRIM5", "CYTH3", "RGS3", "HIST1H1A", "FCER1A", "GPR65", "VAV3", "GSTA1", "GSTA3", "PPID", "EPHA8", "SERPINI1", "MSR1", "COPS2", "COL6A6", "GPN3", "MAP1B", "GPR119", "DAB2", "CCDC22", "ZNF219", "UTP14C", "CNOT1", "CDH12", "KDM4C", "RPL8", "REST", "MAP3K13", "STAMBPL1", "TNKS1BP1", "KCNS2", "GPR18", "EFCAB3", "RPGRIP1L", "NLRC5", "DNAH17", "DNAH10", "DHX9", "DMD", "LRRC41", "LRRC49", "PAX3", "NMD3", "CLUAP1", "REV3L", "CHN2", "MRPS23", "HS3ST2", "MET", "GABRP", "OR3A1", "ZNF473", "IREB2", "TMEM181", "TAF5", "OTUD7A", "CSAD", "MAPK14", "BMP2K", "IPO8", "PAPPA", "PIK3C2A", "NAE1", "NPAS4", "MED30", "FGF10", "NONO", "GALNT13", "LIMK2", "CACNA2D1", "KCNH7", "UBR5", "TTF1", "ANXA7", "M6PR", "DNAH2", "DNAH6", "TP53BP2", "SGIP1", "POLE", "LPA", "KIF14", "KIF15", "SPARC", "MYO18B", "OR51A7", "DSPP", "TPR", "PPP4R1", "DZIP1", "SGCZ", "ADCYAP1R1", "CENPJ", "EZH2", "SARS", "IFNA6", "MAP2K4", "BORA", "GYS2", "UTRN", "BCR", "EVI5", "MYSM1", "CDK13", "S100A9", "DRG1", "NEB", "PFDN4", "RPGRIP1", "CPSF3", "RLN2", "CRNKL1", "ZNF451", "WSB1", "KAT8", "VIPR2", "GUCY2F", "DNTTIP1", "TRPV5", "ARHGEF10", "MYOM1", "SIRT1", "TAS2R1", "ASPA", "ESRRG", "ASB15", "NNT", "AQR", "SCP2", "RALGAPA2", "TES", "OR4K5", "CDKN2C", "OR2AG1", "NME3", "MED7", "UST", "IQCG", "OR6C65", "CASP3", "UNC13C", "GABRA2", "CEP290", "DMAP1", "LYST", "SEC23B", "CD163", "RBPJ", "NUP54", "IL22RA2", "ANKRD28", "EXO1", "RAB9A", "HDC", "SCCPDH", "HMGXB3", "OR11H6", "BCAR3", "KLRC1", "SDHAF2", "CAMK4", "FRG1", "EIF2AK3", "PIGY", "AKAP6", "PCLO", "DNAJC2", "GOSR1", "MICAL1", "AAK1", "CAPN11", "OAS2", "PTPRR", "PTPRM", "GAPVD1", "IFIT1", "WDR33", "IRF6", "DGKA", "BBS7", "RAB11A", "IL31RA", "HOXC4", "ANKHD1", "ILK", "NUP205", "SMCHD1", "NAA38", "RANBP2", "LIG4", "COG3", "MYOF", "STK24", "POLD3", "OR10K2", "AP3B2", "RING1", "TRIP12", "FOXK2", "TNPO1", "ASZ1", "FKBP6", "PTK2B", "UNC80", "RPS27L", "TAF13", "RGS21", "DOK5", "LIFR", "CDK1", "ACSL1", "PKD2L1", "FMO5", "SH2D2A", "LIN9", "MYH8", "CAPN7", "NTS", "SPTAN1", "OR10H1", "USP2", "ALDOB", "NSD1", "MIS18BP1", "RUNX1T1", "AHNAK", "MMAA", "SLC12A7", "NR2E1", "CHAF1A", "GTPBP10", "ABCC2", "QPRT", "GINS1", "GK2", "AHCYL2", "MAP3K5", "HDAC9", "TEC", "ATR", "SMARCD3", "MFGE8", "HDAC7", "P2RY6", "CCT6A", "FSHR", "OR1A1", "FGD1", "MLXIPL", "ARHGEF9", ["TCGA.A6.6651.01", "RA biosynthesis pathway"], "FPR2", "OR14J1", "OR56A1", "OR6F1", "DAB2IP", "RAE1", "STRADB", "ARSB", "PLCG1", "SDC1", "PPP2R1A", "PPP2R2A", "CHRM5", "TACR1", "ADCY9", "PROKR2", "PTGER3", "OPRL1", "CCR1", "STAT5B", "NFKBIA", "SNW1", "RHO", "CDKN1B", "TGFB3", "CD14", "CREM", "GRIN1", "DCC", "NGEF", "SH3BP2", "KITLG", "ARPC2", "OR10Q1", "OR6C2", "OR5J2", "OR9K2", "WWP1", "SOCS3", "FBXW11", "PTPRJ", "LAMB2", "NOX3", "EHMT2", "ARHGAP10", "KLC2", "CLASP1", "CKAP5", "BRD1", "RANGAP1", "STAG1", "EPB41L1", "GPR32", "KHDRBS1", "MNAT1", "CSF2RA", "RAPGEF3", "CCNK", "SSRP1", "OSBPL1A", "ARAP1", "PKN2", "RAB3IP", "PHKG1", "SYNGAP1", "TRIM28", "NRXN1", "RGL2", "RASSF1", "MYO10", "NEDD1", "CHD3", "MAGI1", "ARHGAP22", "ARHGAP20", "ARHGEF3", "FGD2", "SRGAP1", "SRGAP3", "SHANK1", "CNGA1", "LRCH1", "STRN4", "RTKN", "TP73", "DYRK2", "KIF16B", "KIF26B", "DGCR8", "SLC2A2", "USP24", "COL9A2", "NOC2L", "TUBB2B", "NBAS", "TJP2", "LDB3", "GABRG1", "WNK4", "STON2", "HIP1", "STAT6", "GTF2A1", "TLE2", "PPARD", "NUP188", "SRSF4", "ITPKB", "MTA3", "ADAM10", "EGLN2", "TBL1Y", "LPIN3", "RPS7", "FRAT1", "CUL4A", "GGA1", "RAN", "SF1", "PRPF38A", "PI4K2A", "PLEKHA7", "ACP1", "MOCS1", "PROCR", "F13B", "NCOA7", "FCGR3B", "CHD8", "PTPRB", "TEAD2", "CHP2", "USP26", "PHLPP1", "CHRNB2", "KEL", "SCAF11", "INHA", "GTF3C1", "RTF1", "RXRB", "SMARCC2", "HEYL", "HMG20B", "DNAJC3", "HERC2", "MIB2", "TRIM4", "FBXO41", "RNF130", "FBXW12", "UNKL", "KDM6B", "ACLY", "CAV1", "PSMA8", "HIST1H2AA", "FNBP1", "CHST5", "SMG8", "NOL6", "GAB1", "KDR", "CAMK2B", "HCK", "HDAC1", "PRKAR2A", "CD28", "GNB4", "PLK1", "GNA11", "CCKBR", "EFNA5", "CASR", "FLT1", "SELE", "NCKAP1L", "ITGAM", "PSMD1", "PSMD4", "MARK3", "CCT4", "HMGB1", "GAS6", "SEC24D", "GOSR2", "REPS1", "IGF2R", "CAV2", "PLA2G4E", "TYROBP", "SMG5", "CD8B", "TLR2", "PRKAA2", "RBL1", "SIN3B", "BUB1", "RHOBTB2", "ANK1", "EPS8", "PIP4K2A", "SMC1A", "PLD1", "CACNG5", "WWTR1", "TMED10", "ABL2", "ATP1B2", "ULK1", "TAS2R60", "TAS2R13", "PTGDR2", "CNR1", "HCAR3", "HTR1B", "ITGA11", "THPO", "MAP3K9", "NUP214", "TRIM10", "GBP1", "ARHGEF17", "ARHGEF19", "ABR", "ARHGAP11A", "ARHGAP39", "DOCK6", "DOCK5", "OR56B1", "OR2AG2", "STK3", "PDS5A", "MADCAM1", "MAGI3", "ADM2", "LHB", "HTR7", "MYL1", "CPLX1", "RIN2", "CATSPER4", "RNF111", "IQSEC1", "RNF34", "RAB3GAP2", "TUBA1B", "ATP6V0D1", "COMP", "CNGA4", "BLM", "ECSIT", "LAMA4", "LAMA1", "KIF21B", "KIF19", "KIF1A", "PDLIM7", "MYH7", "RAD17", "MLH1", "DRAP1", "CPN1", "HIST1H1D", "MCM6", "YIPF5", "SKP1", "MAML1", "LDLR", "KIAA0319", "BTRC", "MTA1", "COPS7A", "TCF7", "TCF7L1", "IGSF5", "CDC16", "NKX2-5", "TH", "PYGO1", "BCL9L", "BCL9", "ME1", "MCMBP", "PAXIP1", "RIMS1", "XPO6", "RPL27", "RPL22", "HOXB3", "NR2F1", "MED23", "ETV3", "USP11", "EBF1", "CIB3", "MAP3K6", "BCOR", "SLC8A2", "CBX3", "BAZ2A", "STX19", "EIF2AK4", "FANCL", "ITCH", "DUSP7", "DHX15", "RBM17", "DNAJC8", "RBMX", "SNRNP200", "ITM2B", "LTF", "EEF2K", "KRIT1", "DIAPH3", "ELK4", "SOX7", "APBB2", "NAA25", "GORASP2", "CHRNB3", "ETV6", "GAB4", "LONP2", "ZC3H8", "DNAJA4", "FKBP9", "PDSS2", "SCAF4", "CHST8", "LSP1", "EIF4B", "EIF3B", "USP28", "UBR4", "SUPT7L", "MGRN1", "UBR2", "LONRF1", "FBXL4", "RNF213", "STAB1", "MYCT1", "NOP14", "MPHOSPH10", "LY6G6F", "DST", "ADAMTS4", "CHST3", "CHST15", "THSD7A", "ADAMTS19", "ADAMTS8", "THSD4", "NMNAT3", "FOS", "RAC1", "ACTN1", "TEX264", "AHSG", "ITGB6", "PAK2", "MAPK13", "PAK6", "LPAR3", "PARD3", "NR3C1", "CD247", "XYLT2", "WASL", "EFNB3", "ROCK2", "CTBP1", "DOK1", "PABPC1", "COL5A2", "NOTCH2", "PML", "FBN1", "LTB4R", "HRH1", "PDGFC", "BCL2L11", "RAB5C", "LDLRAP1", "SCARB2", "TRRAP", "HS3ST1", "NDST2", "RARA", "ACTL6A", "SHMT1", "KIF18A", "INCENP", "SNX2", "CHST12", "CABIN1", "KIF5B", "GSPT1", "AP1S1", "VDR", "CBX4", "KIF3A", "ADAMTSL2", "ATP2B1", "TGFB1I1", "ADAMTS7", "PPP1R12A", "NF1", "CTSD", "PHF20", "CCNA1", "MCM4", "CHSY1", "VCP", "GCK", "MRPL11", "DHH", "TRIM8", "CTSF", "SMG1", "PRODH2", "KANSL1", "MTMR4", "IMP3", "PRPF19", "PLK4", "CACNA2D2", "CD101", "BRPF1", "SETD1B", "SETD1A", "PANK4", "KDM4B", "MRPS9", "RFC5", "COG2", "PCK1", "APOA5", "NID2", "ZNF225", "DTNB", "MVK", "SIK1", "TOP3A", "TTBK2", "DERL2", "EHD2", "DDX23", "UBA1", "CCR2", "DIAPH1", "PTPN12", "SSTR2", "RIPK2", "APC2", "DTX4", "MAPK8IP3", "ARHGEF2", "HTRA1", "MYL2", "EIF3J", "CD19", "SQSTM1", "C4BPA", "RPN1", "CCNF", "TRAF5", "POLE2", "PKN3", "MED25", "ATP6V1A", "ITPA", "WNT8A", "E2F2", "PER1", "CCR3", "BRS3", "F2RL3", "RPS6KA2", "RHOBTB1", "RBCK1", "GIPR", "CASP8", "COL6A1", ["TCGA.AA.3489.01", "mitochondrial fatty acid beta-oxidation of saturated fatty acids"], "HLA-DRB1", "CDK2", "AXIN1", "AP2A1", "KIF2A", "GBF1", "HIP1R", "ITSN1", "ARF4", "CRKL", "DYNC2LI1", "TMEM67", "CCP110", "CEP78", "NINL", "CSNK1E", "COPB2", "TNRC6C", "CACNG3", "MLC1", "ARAF", "TAOK1", "CENPN", "SH3KBP1", "TJP1", "ARHGEF12", "GRM1", "PSMC5", "PROKR1", "S1PR3", "ACVR1", "PHKB", "RPA1", "ARHGAP5", "SLIT2", "UGCG", "OR5D14", "OR56A4", "OR5T3", "OR5L2", "OR10T2", "OR4P4", "OR2A2", "OR7C1", "OR13H1", "PTH", "GPR20", "GPR83", "POMC", "CSNK1G3", "PKIA", "TXK", "ARAP2", "PIK3C3", "RALBP1", "KCNJ3", "PLD2", "KLHL20", "CXCL1", "PCBP2", "WIPF1", "WIPF2", "CD2", "IGLL5", "RAP1GAP2", "DYRK1A", "GTF2H1", "PLCD1", "BRCA1", "UBE2M", "RGS9", "MAP4K4", "BID", "SPRED3", "FES", "MYH14", "KPNB1", "PIK3R4", "LMOD1", "PARD6B", "PLXNA1", "RASA3", "ARHGAP30", "SYDE2", "PLEKHG5", "ARHGAP19", "MTA2", "GPSM2", "PTPN13", "RAP1GDS1", "CTSO", "SHANK2", "SGK2", "RTN4", "RAD21", "MAPK8IP1", "MEN1", "KIF6", "KPNA4", "COL1A1", "KIF5C", "ZFYVE9", "IDE", "RGP1", "SEC22C", "IL4", "SYNJ1", "HDAC6", "IL4R", "PRKD2", "DDIT3", "NT5C2", "IL18R1", "NOD1", "CTTNBP2", "MTMR7", "RNF2", "MYF5", "HSPA6", "EOMES", "NFATC4", "CARD9", "PHF21A", "CDC25B", "XAB2", "TAOK3", "ATG3", "MIB1", "CSTF1", "SEL1L", "CDRT1", "CUL7", "NDUFV3", "ERF", "F10", "SND1", "CDC42BPA", "ATP6AP2", "WNT16", "DYSF", "SKIV2L", "VSIG4", "PDCL3", "CR1", "BBS12", "TMPRSS2", "PFKFB2", "DHDDS", "CHERP", "SRRM1", "SRSF6", "WBP4", "CXCR5", "PCM1", "CBX6", "MCF2L", "LPXN", "PLCH2", "CPSF2", ["TCGA.AA.3502.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], "LPAR1", "COPA", "FPR1", "DPF3", "COPS6", "STXBP3", "DMTF1", "SNRPB", "RUVBL2", "PIAS1", "SF3B1", "GNAT1", "INHBA", "MYO1C", "CX3CR1", "OPRK1", "OR2T12", "OR5F1", "TAAR5", "HLA-C", "RGS11", "GRIK4", "KCNIP3", "EMD", "GCFC2", "SMAD9", "CDC25A", "TNR", "ADCY4", "CAMK2D", "CREB1", "CDC42", "IRF1", "MAP2K3", "ARRB1", "VEGFA", "ATF6B", "PDE3B", "ATF4", "ATF2", "HDAC2", "FOXO3", "E2F4", "CSF1R", "FHL2", "PSMD6", "ATP1A1", "IFNB1", "PSMF1", "OR4A47", "OR1J2", "OR10G7", "OR51I2", "OR5H2", "OR6K2", "OR2D2", "OR2L13", "P2RY13", "GAL", "HTR1F", "ADORA1", "CCR7", "CXCR4", "TRH", "EDN3", "ADRA1A", "ADRA1D", "P2RY11", "STXBP1", "PAQR5", "CRHR2", "PTGER4", "RAMP3", "CRHR1", "OPN1SW", "BIRC5", "HLA-DPB1", "RET", "WASF3", "SPRY1", "ITGAV", "CDK11A", "ARHGEF7", "TCTN3", "TCTN2", "YES1", "CEP70", "SSNA1", "HAUS4", "SNX9", "MAPKAPK3", "ASPH", "GRB10", "RCC2", "CENPF", "TBC1D8B", "AP3B1", "PPP5C", "IGF2", "ORM1", "SPP2", "GFRA2", "WAS", "EPHB3", "WDR19", "WDR35", "HCLS1", "EPHA4", "EPHA1", "NLGN2", "AKAP11", "AKAP10", "AKAP4", "SF3A1", "YAP1", "KCNK5", "ATRN", "NET1", "ARHGAP29", "SYDE1", "ARAP3", "ARHGAP17", "KIF27", "PTBP1", "SKI", "AFP", "SKIL", "GTF2F1", "CEBPA", "RPS5", "ANAPC1", "FBXO6", "FBXL3", "PKLR", "TRIB3", "ANAPC7", "SH3D19", "MTMR3", "MYO18A", "PACSIN1", "PDE9A", "MX2", "USP8", "MATK", "XRN2", "IRAK1", "PCK2", "DUSP8", "RPL7", "PHKA1", "ARHGAP36", "XRCC1", "ZNF541", "HOXB1", "SNRPA1", "INTS7", "SARS2", "ESRRA", "PDHX", "L2HGDH", "TAAR1", "ERCC2", "NPHP1", "TUBGCP3", "APBA3", "KLRC2", "STXBP2", "SH3BP5", "PRDX5", "WDR61", "DPP7", "BHLHE41", "MZT1", "USP15", "HOMER3", "DOCK11", "CTSA", "RAB6A", "EP400", "GDF15", "NUAK1", "PARP4", "MAP3K4", "CST3", "TTC37", "PRSS54", "AP5S1", "CDK7", "CLASP2", "FGFR1", "CAMKK2", "ATP6V1H", "FGF21", "WNT8B", "WNT10A", "PLD4", "SYN3", "KREMEN2", "NBN", "GUCY2C", "POLR3D", "NPR1", "STAT4", "PRPF4", "SPCS1", "PRPF40A", "WBP11", "CDC5L", "SRSF7", "GNAI3", "PPIE", "MEF2D", "IRF7", "HSF1", "FGF23", "CD40LG", "PDIA2", "MMS19", "NOD2", "MKS1", "HAUS8", "HUS1", "BMP2", "ENAH", "SCNN1B", "CRY2", "FBXW5", "PSMC3", "CSNK1A1", "KLHL22", "HECTD3", "ASB16", "KBTBD13", "SPSB1", "UBE2Q2", "RNF123", "LNX1", "RCHY1", "FBXO17", "RBBP6", "JUP", "MED16", "SVIL", "SYCE1", "NDUFA9", "ISG20L2", "TRAM1", "UPF3A", "UPF1", "EIF3G", "LPL", "PTPN1", "ITGB8", "GOLGA2", "PROC", "LAMB1", "MAK", "PA2G4", "MAST4", "CHD1", "RAB40AL", "KAT7", "TACC1", "UGGT2", "TTK", "MPHOSPH8", "CPSF4L", "EEF1A2", "TSC1", "IK", "LATS2", "KDM1B", "MED12L", "SLIT1", "DOT1L", "KARS", "BRD8", "FEN1", "COMMD4", "ATXN3L", "RNF44", "AFF4", "ARID4A", "NCAPH2", "MLLT3", "RPRD1A", "TELO2", "MYBBP1A", "ARID4B", "SNAPC2", "RARG", "NHLRC1", "TAF1B", "LGR4", "POLQ", "USP5", "CNOT8", "DLL1", "CNTN6", "DHX37", "ECT2", "CDH5", "MYH13", "MYH4", "HMGCS2", "MYLK4", "ADSSL1", "NUMBL", "DLL3", "USP44", "ZNF543", "ZNF701", "ZNF133", "ZNF480", "ZNF180", "ZNF234", "ZNF500", "ZNF506", "ZNF688", "EDC4", "LSM1", "SHROOM1", "HIVEP1", "BRD3", "NR4A2", "FMN1", "HFM1", "MSL3", "NOTCH4", "PPAT", "LARS", "MGAT3", "DARS", "BAZ1A", "EPB41L3", "PHF20L1", "ACTR6", "DACT1", "FBXL6", "KDM2A", "KIF7", "BCORL1", "API5", "FAM160A2", "PPP6R2", "CAND2", "AMOTL2", "EIF2AK1", "SPATA5L1", "ALOX15", "LYN", "CHRM1", "LEF1", "NT5C1A", "CASP7", "RBBP8", "ARHGAP1", "SLC2A1", "RBL2", "HEY2", "NUP153", "PC", "ACADM", "XIAP", "BST1", "STUB1", "PSMD11", "BMP4", "MAP3K3", "HSF2", "CA9", "GRHL1", "SRXN1", "ZFYVE19", "PHKA2", "ENTPD8", "RPL23A", "RPL18A", "TAF6", "NAT2", "HNRNPL", "CTNNBL1", "PRPF6", "ARHGAP24", "ARHGAP15", "RORC", "KRT17", "LBP", "LSS", "FGG", "GNG7", "ECM1", "FAM3C", "ARPC4", "RANBP9", "NAPG", "RAPGEF1", "PROK1", "FFAR2", "RAPSN", "HTR1A", "NCF4", "TRIM24", "TPM1", "RUNX2", "IL3RA", "RALGDS", "OPTN", "TTC21B", "CCM2", "CYSLTR2", "KCNMA1", "SLC25A4", "MAP2K2", "DYNC1I2", "GNAI2", "PRKCA", "LPAR5", "ACTG1", "PSMB5", "CREB3L4", "PPP3CA", "XCL2", "XCL1", "TAS2R14", "UTS2R", "RHOT1", "POLR2D", "LEFTY2", "KCNJ5", "MEF2C", "ARFGAP1", "MYH10", "CPD", "TAB1", "PIM1", "IL12RB2", "AHI1", "TCTN1", "SFI1", "FAS", "CDK9", "OR8J1", "OR7A5", "OR5B3", "OR9Q1", "OR14A16", "OR4X1", "OR2G2", "OR4C3", "OR2AT4", "OR10H3", "OR10H4", "KLC1", "GRB14", "UNC5B", "GIT2", "DTNBP1", "RPS3", "IAPP", "HTR4", "PPP1R14A", "SORBS1", "FARP2", "NPAS2", "EPHA10", "USP7", "COPS3", "PTH1R", "TRIM46", "PLXNB1", "ATF6", "HDAC4", "NUDC", "PLK3", "USP10", "DGKE", "PIAS3", "FZD8", "ACVRL1", "ARHGAP28", "ARHGAP31", "ARHGAP9", "USP21", "CYLD", "IFNA10", "SAG", "FBXO43", "AKT1S1", "ASIP", "EGR2", "MECOM", "ERCC1", "TRAPPC9", "TRAPPC10", "MYH1", "ATP6V0D2", "TMOD1", "CCNA2", "E2F3", "TAF6L", "SNX4", "NFYA", "SAMHD1", "CALML4", "HPCAL4", "MSH2", "PFDN2", "SUZ12", "XRCC5", "LRFN2", "POT1", "INTS9", "STIP1", "TAF3", "PPP1R7", "SCNN1D", "RUNX1", "MYO1F", "ABCB4", "GSC", "C8A", "EXOSC3", "CPB2", "STAMBP", "ANXA6", "NR0B1", "BBS1", "INSC", "TAP2", "LPIN1", "SHH", "SLC9A3", "CUL2", "FBXO10", "HERC3", "FBXL20", "HECW2", "FBXO30", "DZIP3", "SPSB4", "ASB2", "BTBD6", "ZBTB16", "DET1", "WNT10B", "EIF3D", "RNF31", "EIF3I", "HDLBP", "HPSE2", "HPSE", "XYLT1", "MCM7", "GCC2", "UFC1", "DUSP4", "TBX3", "HNRNPK", "SRRM2", "SF3B4", "CSTF3", "UBXN7", "BOC", "PTCH2", "DTL", "SSR2", "PRR5", "TCL1A", "ROBO2", "VANGL2", "G3BP1", "PPEF1", "SART3", "FLOT1", "CLVS2", "AP5Z1", "PNPLA7", "LPCAT1", "UPP1", "TKTL2", "TRIM29", "LIMS1", "CDKN1A", "HIST2H2AC", "CREB5", "RHOA", "VAMP2", "CAMK2A", "GTF2E1", "CTSW", "TUBB4B", "CD8A", "PRKG1", "CCT8", "CCNT1", "KIF2C", "SUGP1", "SMC3", "CYP2C19", "PRMT1", "UBE2L3", "RPS28", "MED13L", "MTM1", "INTS2", "IDO1", "IL4I1", "TUBA3E", "ESD", "HNRNPH2", "LSM4", "AIFM1", "NMNAT1", "POR", "PSAT1", "SMPD3", "PDE10A", "VPS28", "CDC34", "KLHL21", "TRIM71", "KBTBD6", "MKRN1", "UBA7", "PRTN3", "SNRNP27", "HNRNPR", "PUF60", "GEMIN4", "GEMIN7", "GLDC", "TOP2A", "ZNF143", "ELL2", "CYP8B1", "MOGAT2", "IDH3B", "PITRM1", "AGL", "DGUOK", "TNFSF13B", "PLD3", "SPATA5", "PRPF4B", "MTFMT", "ITGA2B", "AP2M1", "NCK2", "FGF2", "TPX2", "CEP152", "CNTRL", "TPM3", "GPR68", "ACTG2", "CLTB", "ARHGEF25", "PACSIN3", "LIMK1", "NANOG", "IL6R", "MID1", "IRF8", "PDGFD", "GRM3", "ADRA2A", "NPM1", "ROR2", "CATSPERB", "OR52I1", "OR2G6", "OR6K6", "FZD3", "CD209", "CAMKK1", "TCIRG1", "ZMPSTE24", "BRD7", "BARD1", "TRAPPC2", "SCN11A", "GPBAR1", "GPR45", "HTR6", "PSEN2", "CNTN1", "SEC31B", "FMNL1", "TNNI2", "TRPC1", "DPYSL2", "HIST1H1C", "E4F1", "NLRC4", "STEAP3", "FBXO11", "RMI2", "TNFRSF10C", "IL16", "TMF1", "RINT1", "PCSK2", "DAAM2", "IFT172", "GABRD", "GABRB3", "MAN1A1", "WNK3", "MX1", "CRY1", "NUP155", "MYOG", "SPN", "POLR1D", "XPC", "PTPN2", "CIB2", "RCVRN", "OTC", "GTF2IRD1", "KIDINS220", "TRPC7", "RRAGB", "COL17A1", "SFXN3", "SENP3", "KHSRP", "TTC27", "MTRF1L", "CRCP", "GAPDHS", "DDX39A", "EXOSC5", "ERRFI1", "SRP68", "EIF3L", "CCL17", "COL8A2", "COL14A1", "NDST4", "NOP58", "ERLEC1", "B4GALT6", "CHST2", "ST3GAL6", "PDIA6", "SV2B", "DDX47", "BMS1", "RGMA", "CHRM3", "AVPR2", "EPOR", "OR52N4", "ASAP1", "CABP7", "EGF", "IRF9", "XPO1", "PSMA6", "PRKAB2", "CDCA8", "NUP43", "KNTC1", "HIST2H2BF", "NCBP1", "EXOSC1", "FDFT1", "TAF4B", "MKNK1", "RPL3", "RPS2", "ORC1", "TPD52", "RPTOR", "GDI2", "MED10", "MED8", "DHCR7", "CHEK1", "GRPR", "CALD1", "DVL1", "EPHB2", "TUBG2", "CD74", "COL21A1", "FAU", "LMAN1", "RANBP10", "SH3GL2", "JAK2", "GLI1", "RAB7A", "IRF2", "CCNE2", "SRA1", "CUL1", "INPP1", "DDX20", "YY1", "CYP4F2", "GTF2F2", "HLA-DPA1", "TGOLN2", "DAPP1", "MS4A2", "LRP8", "CD86", "CD80", "IL12RB1", "GHR", "CLEC1B", "ADAM17", "REPS2", "CD4", "LAMC1", "ELMO2", "EFNA1", "GBP3", "CDH15", "HERC5", "PRKAG3", "DTX2", "TLR3", "SSR1", "FBXW9", "AHCTF1", "NSL1", "SKA1", "ZW10", "NUP160", "OTUB1", "IL7R", "OR52E2", "CTSB", "RPS6KB2", "NOSTRIN", "ERLIN1", "TNFRSF14", "GFRA3", "IFNA17", "RAD23B", "WDR48", "PILRA", "SH2B1", "CHRNA7", "PEX19", "POLK", "ELL", "GZMB", "RNF41", "NCF2", "PIKFYVE", "F5", "UTS2", "NMB", "HTR2A", "P2RY2", "TAS2R20", "TAS2R50", "TAS2R43", "GPR55", "HRH3", "TAS2R31", "ITIH4", "F13A1", "AP4M1", "MYL9", "NRP1", "TRIM6", "TRIM34", "GBP6", "NPHS2", "HLA-DMB", "PPFIA4", "SFTPD", "MST1R", "ZFP36L1", "STRN", "NOXO1", "CPB1", "GRK6", "GRK4", "SFRP2", "GGCX", "AP4S1", "C7", "CR2", "SFTPA2", "APPBP2", "MMP7", "RAPGEF4", "C2CD3", "CEP89", "PFKFB1", "INPP5E", "TXNDC5", "PTPN7", "DUSP6", "OR6V1", "OR2T34", "OR13G1", "OR2F2", "OR5D16", "OR2L2", "OR2V2", "OR2M7", "OR14C36", "OR10J1", "OR10J3", "OR8U1", "OR7E24", "OR7G2", "OR9Q2", "OR8H3", "OR4B1", "OR2AE1", "OR10G3", "OR4M1", "OR6B1", "OR6B3", "OR51A4", "OR52A1", "OR5M10", "OR8S1", "OR1D2", "OR7A10", "OR7A17", "OR51D1", "OR52W1", "OR6Q1", "OR6Y1", "OR2S2", "OR5K4", "OR4K17", "OR8A1", "OR9G4", "OR4N2", "OR3A2", "OR6C1", "OR51B5", "OR52D1", "OR1N1", "OR6K3", "OR51M1", "OR52E8", "OR5M1", "OR6N1", "OR2T4", "OR2T1", "OR51E2", "IL17RD", "SCTR", "STARD8", "TTF2", "TAAR2", "CALCR", "GLP2R", "KCNJ15", "CACNG1", "ALK", "SLC2A14", "SPATA21", "EVC", "INPP5A", "KIF25", "DEPTOR", "GHRL", "ALS2", "COPZ1", "SFRP4", "FARP1", "TYR", "RHPN2", "SFTPC", "BBS9", "BBS4", "GTPBP4", "IGLL1", "ATG16L1", "CGB5", "KREMEN1", "AK7", "AK5", "STK25", "RFXANK", "PITPNA", "CHRNA5", "KLK3", "NFE2L2", "IL1A", "HSD17B12", "CAMK1G", "UMPS", "RAD1", "DPF2", "PLIN2", "AGXT2", "PGM1", "UGT2B7", "CRYZ", "FMO2", "FMO3", "RETSAT", "AOC2", "NR2F6", "EPHX2", "CES3", "CDA", "NADSYN1", "CCT2", "HLA-DRB5", "PSMD13", "PSMB7", "SPRY2", "SOD2", "CLIP1", "LYZ", "TAF4", "NUP62", "PIP4K2C", "ZWILCH", "NDC80", "CWC22", "CWC27", "USP39", "DDX58", "STARD13", "DEPDC7", "ARHGEF4", "VAPA", "CALU", "PDE6C", "KDM3A", "PEMT", "DNMT3B", "SRPRB", "NACA2", "CDO1", "ARSG", "P4HA3", "PDE11A", "IARS", "LIPG", "PNPLA3", "PNPLA2", "RPL3L", "ENTPD6", "SLC25A6", "ACSBG1", "HECTD2", "PJA2", "UBAC1", "FBXL19", "PRODH", "DNMT3L", "GPT", "CHMP4C", "OXCT1", "ACADS", "GCAT", "MYBL1", "FAHD1", "TUBA3C", "MARS2", "APOH", "NPS", "NMS", "CEP57", "ACVR1C", "CCR8", "TDGF1", "FGF6", "TAS2R38", "TAS2R7", "CTLA4", "AP1S3", "ERLIN2", "FCGR3A", "CBLC", "COG1", "TAF7L", "TRIM48", "TRIM22", "TRIM31", "GBP7", "GBP4", "GBP2", "ADRB1", "PARVB", "HLA-DQB1", "HLA-DQA1", "OR52J3", "GLP1R", "AKAP1", "SIRPA", "MC5R", "GPR15", "SERPINB5", "OR8B4", "OR6C6", "OR2T2", "OR5H14", "OR5K2", "OR5AU1", "OR5T2", "OR5AK2", "OR1L1", "OR5B2", "OR6A2", "OR52B6", "OR4K15", "OR2Y1", "OR4Q3", "OR7D4", "OR10H2", "OR1I1", "BCL6", "NODAL", "OPN1LW", "TULP3", "LGMN", "SEC16B", "RUNX3", "PCMT1", "GOLGA1", "CCNG1", "FOXG1", "VPS53", "SESN3", "DNAH5", "TP53RK", "TCTEX1D1", "TRAF3IP1", "IFT43", "IFT80", "SLAMF1", "CAPG", "GABRA4", "GOLGA5", "CCDC114", "ZFAND2B", "VPREB1", "SCFD2", "SLK", "ADD1", "PTPRZ1", "RRP8", "BAHD1", "MCAT", "GLA", "IL23R", "CD3EAP", "FGF5", "MEP1B", "ISG15", "IFNAR2", "DMP1", "TIMELESS", "IL10RA", "BRCA2", "TTI1", "MTMR2", "ILKAP", "MBD6", "LEPR", "CLSPN", "EPC1", "TNIP2", "SYCP1", "SMC1B", "DCAF13", "PARP14", "IL27", "ORC4", "ORC3", "NSUN2", "APLF", "SCARF1", "PADI4", "KDM2B", "PRDM9", "MSH4", "HJURP", "RSF1", "TBC1D1", "FANCA", "FANCF", "POLH", "MEP1A", "FKBPL", "TAPBP", "PAPPA2", "TDRD9", "CTBP2", "TACC3", "APLP2", "PRSS3", "PCSK5", "HS6ST3", "GLCE", "B4GALT7", "AHRR", "SIM1", "COL28A1", "IL17F", "CFHR1", "CNPY3", "SPON2", "DDX18", "ATF5", "PRELP", "B4GALT4", "EME1", "MUS81", "NTN4", "ADAMTS18", "TLR8", "CDH24", "CDH11", "CDH18", "CDH9", "CDH3", "CHST13", "CSGALNACT2", "MIA3", "MIA2", "ICAM5", "ELN", "EPSTI1", "TPSAB1", "KRT2", "CABP5", "AK8", "STK36", "KIR2DL1", "MCM3AP", "DDX24", "FBLIM1", "USP35", "STRN3", "THOC5", "PPP6R1", "LATS1", "CETP", "GFAP", "GAA", "OPA1", "ZNF423", "PPT1", "ATRX", "SCYL2", "SNAP47", "FANCM", "MYH15", "IL10RB", "KIAA0753", "EML4", "IMP4", "HEATR1", "UTP14A", "SRP72", "EIF5B", "KXD1", "ENGASE", "LGR5", "REV1", "MRPS27", "GFM2", "MRPL23", "FYTTD1", "MRPL10", "MRPL35", "MRPL52", "MRPL47", "MRPS31", "MRPL3", "CCDC130", "FYCO1", "GAS8", "CCRL2", "ASCC3", "TNKS2", "LILRB5", "BAG2", "GC", "NLRP3", "ARNT", "HIST1H2AC", "FGR", "MYOD1", "TUBA1A", "PRKAG2", "HTR2B", "GRK5", "HLA-E", "HES1", "KIFAP3", "NPY1R", "NAPB", "TRIM2", "UBE2D2", "SNX18", "CD79B", "SLC9A3R2", "TRADD", "WNT3", "RGS19", "FLT3", "MYD88", "POLE4", "VDAC1", "SP3", "UBQLN1", "FGD3", "COG6", "ARHGAP25", "SPRY4", "MYLK2", "RASAL1", "ELAVL1", "RPL10L", "INPP4B", "INPP4A", "PPWD1", "RICTOR", "EFNB1", "TADA3", "SYN1", "JAM2", "DVL2", "PRKAR1A", "CXCL12", "SYK", "LPAR2", "PRKAA1", "EIF2AK2", "F2RL2", "FGF18", "NTSR1", "GHSR", "PRKAB1", "OR4C13", "OR6C76", "TIMP3", "CXCL9", "PNOC", "CXCL3", "CXCL5", "PSMC1", "OAS3", "AP1M2", "SCN4B", "CATSPER3", "CDK5", "ARHGAP4", "DLGAP4", "DLGAP1", "KIF12", "HDAC11", "THRA", "CDC27", "BIN1", "SH3GL3", "ANAPC2", "SPHK2", "POLR1B", "CD40", "IPCEF1", "ADK", "GUCA1C", "KCNIP2", "SERPIND1", "CTHRC1", "USP20", "ARL6", "SH2D3C", "TRIM72", "WDR20", "KIF13A", "AVP", "KISS1", "DUSP5", "SORBS3", "FBXO2", "HERC6", "HSPA12B", "B3GAT1", "PLAU", "GNGT1", "PSMD9", "VAMP8", "NPFFR2", "SNAP25", "CLEC3B", "ARF1", "PTHLH", "RHOQ", "SGK1", "SSTR5", "CD2AP", "ARFGAP2", "ATG13", "GORASP1", "WNT4", "OR2M3", "OR51V1", "OR10G8", "FLOT2", "MYO9A", "ARR3", "CYTH4", "DAPK2", "EVL", "CCAR1", "TNFRSF10B", "PREB", "RRM2B", "TMOD3", "STX18", "E2F5", "KCNIP1", "CALB1", "NCS1", "PDE7B", "MAP3K10", "AKR7A2", "ADAM20", "MRPS7", "DERL3", "BBS2", "TNK2", "ETV7", "GGPS1", "CD2BP2", "HNRNPUL1", "HNRNPA2B1", "SNRPN", "CDC40", "DIRAS2", "RPF1", "PRPF3", "INTS8", "ATIC", "UBR1", "TRIM9", "FBXL13", "HACE1", "CBR3", ["TCGA.AZ.4681.01", "G beta:gamma signalling through BTK"], ["TCGA.AZ.4681.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.AZ.4681.01", "tRNA modification in the nucleus and cytosol"], ["TCGA.AZ.4681.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.AZ.4681.01", "Prostacyclin signalling through prostacyclin receptor"], ["TCGA.AZ.4681.01", "Glucagon-type ligand receptors"], ["TCGA.AZ.4681.01", "G beta:gamma signalling through PLC beta"], ["TCGA.AZ.4681.01", "Thromboxane signalling through TP receptor"], ["TCGA.AZ.4681.01", "Presynaptic function of Kainate receptors"], ["TCGA.AZ.4681.01", "G-protein activation"], ["TCGA.AZ.4681.01", "Activation of G protein gated Potassium channels"], ["TCGA.AZ.4681.01", "G protein gated Potassium channels"], ["TCGA.AZ.4681.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.AZ.4681.01", "GABA receptor activation"], ["TCGA.AZ.4681.01", "GABA B receptor activation"], ["TCGA.AZ.4681.01", "Activation of GABAB receptors"], "SDC2", "VCAM1", "DBNL", "WASF1", "RPRD1B", "CCNB2", "ADCYAP1", "RELA", "CD36", "FOSB", "MAPK9", "PENK", "PSMD5", "SMURF1", "ROCK1", "THRB", "CENPK", "NCBP2", "GTPBP2", "DRD2", "MARK4", "NTF3", "MPG", "HGS", "MAPK7", "FOSL2", "IFNGR1", "NUP85", "VAMP4", "CCR9", "NPBWR1", "C3AR1", "S1PR5", "SMO", "ARPC5", "CEP97", "ARTN", "CALML6", "SEC23A", "TRIM68", "TRIM35", "PYCARD", "NCF1", "FCHO2", "MYL12B", "EPHA5", "CACNG4", "CITED2", "MAP4K1", "SYT2", "POLR1E", "COPG1", "WIPF3", "NCKIPSD", "AKAP8", "MOS", "NFYB", "NUP93", "MED21", "OR9A4", "OR13J1", "OR7G3", "OR5I1", "OR5M11", "OR13D1", "OR2B2", "OR2A14", "OR6N2", "TNNC1", "ARHGAP40", "ARHGEF16", "FAM13B", "ATP6V0A1", "KCNMB3", "PYGO2", "AQP2", "CCNY", "POU2F1", "HCST", "NOXA1", "NUP88", "RPL19", "VIPR1", "LMAN2", "FDXR", "STXBP4", "BAZ1B", "STRA6", "SSH1", "INPP5J", "TRAPPC1", "STIM1", "SLC18A2", "CETN1", "STX11", "HSPA14", "ASXL1", "IL21R", "EPX", "BANF1", "PPP4C", "CNTFR", "SYVN1", "GLS2", "L3MBTL1", "BANP", "PPP1R13L", "USP42", "DROSHA", "ZNF385A", "RABGGTA", "PPP1R16B", "TRPM8", "RPAP3", "CHD7", "LEMD3", "SF3B2", "MBP", "C2", "PLIN3", "ARHGEF15", "ADAM8", "ADAM15", "MAN1A2", "VPS54", "NPNT", "IFT88", "SMC2", "ALPP", "IHH", "LIPC", "DUSP16", "DUSP3", "UBE2H", "LIMA1", "TRPV4", "WNT7A", "FBXO40", "FBXO21", "ZC3H11A", "NDST1", "AMN", "ABCA7", "ZBP1", "MMP13", "DLG5", "CAT", "ALDH4A1", "ALDH3A1", "RNF5", "DOLK", "KRT19", "EXOSC4", "TFIP11", "TXNL4A", "PRPF31", "DLD", "APBB3", "TEX10", "USP19", "AMT", "FOXK1", "INO80E", "CHMP6", "LTB", "ACAP1", "VPS37B", "PELI3", "TAX1BP1", "VPS37C", "VPS37A", "PRDM15", "CYP51A1", "IDI1", "CTDP1", "GBA", "DNAJA1", "PPARGC1B", "PHF10", "ZCRB1", "PDIA5", "BRF2", "ZMAT5", "PNPT1", "IDH1", "TAT", "SCLY", "BCAT2", "PAIP1", "LIN54", "JARID2", "PHF1", "ATXN7L3", "ISL1", "MRPL2", "TMEM87A", "HHIP", "ELF1", "ATP2A2", "HIST1H2BJ", "ARPC1B", "MAP3K7", "STRAP", "RPRD2", "VHL", "INPP5D", "CASP2", "SRGN", "LGALS3BP", "SMURF2", "FGF22", "RAB1A", "ETS2", "SP1", "GNA15", "PSMA5", "GNG11", "GNB5", "TLE3", "ACVR1B", "ERN1", "ZAP70", "P2RY1", "GCG", "AGTR2", "SMARCC1", "CRTC2", "MYL10", "BIRC3", "KSR2", "B3GNT4", "OMD", "TRIM3", "ITGAE", "PTK6", "HOXA1", "SLA2", "MYL4", "MYBPC3", "GTF2E2", "DGKG", "COL8A1", "THBS3", "DPYSL4", "SMARCD2", "JAG1", "SMARCA5", "CUL3", "PARVG", "BATF", "LRP10", "TNFSF11", "ERCC4", "GTF2H4", "VARS", "FBXW8", "RNF14", "FBXO31", "PISD", "TAF2", "MAGED1", "GAPDH", "TP63", "F12", "REL", "FKBP8", "KDM5B", "CHPF2", "DSE", "TEAD4", "MAFK", "CNOT10", "TNFRSF10D", "PPT2", "ATP2A3", "SOCS6", "BGLAP", "PLA2G12B", "ALDH6A1", "HKDC1", "TOMM22", "FPGS", "CES2", "HSD11B2", "ACSF3", "RNPS1", "RPS10", "SUPT5H", "PDE2A", "VANGL1", "ARSA", "PHF21B", "CLPB", "ATAD2B", "EFTUD2", "MFN1", "NCKAP1", "TGFBRAP1", "OR2C3", "OR2M5", "MICU1", "CNST", "TESC", "TRPC3", "IFNA8", "RAB11FIP3", "CHRNA3", "MKNK2", "AMBRA1", "USP46", "ADAM11", "GBA2", "MUC6", "TG", "RRP36", "NOC4L", "DDX41", "EIF5", "TBC1D7", "RAB6B", "MAN2A1", "DNAH1", ["TCGA.AZ.6603.01", "Ethanol oxidation"], ["TCGA.AZ.6603.01", "APAP ADME"], "CXCR1", "PDCD11", ["TCGA.AZ.6607.01", "Degradation of cysteine and homocysteine"], "FFAR3", "PIN1", "TCOF1", "NSRP1", "BCL2A1", "CPEB4", "CPEB3", "CPEB2", "CFP", "ZNF479", "ZNF471", "NR1D2", "OR52N2", "HOXA10", "GALNTL5", "GCNT4", "PDK4", "SEC61A1", "TMEFF1", "ZNF300", "PPP3CC", "FUBP1", "TTC28", "BCLAF1", "EPB41L2", "EPB41L5", "ACSS3", "ACSS2", "UTY", "PACRG", "LMX1B", "RSRC1", "ABI1", "AOC3", "CLINT1", "DDI1", "KCNA4", "ZDHHC9", "BPNT1", "SERPINB4", "ELP2", "ZNF682", "HFE", "RIN3", "PDCL", "ZNF416", "TTC30A", "TTC30B", "TMPRSS6", "SLC17A8", "EAF2", "SYNCRIP", "ZNF202", "SLU7", "ZNF655", "TCTEX1D2", "RAPGEF5", "RAPGEF6", "MARK1", "APEH", "DEFB136", "RIMKLB", "POMT1", "POMT2", "EDC3", "EXOSC10", "MND1", "RAB27A", "ZNF770", "DPH2", "PAH", "FLRT3", "HSPA4L", "SEL1L2", "RGS5", "CAB39", "BLOC1S1", "NPC1", "SREK1", "ZNF490", "PDE1C", "TRAIP", "HSPD1", "CTSG", "CTSS", "AFF1", "PDPR", "PDP2", "UBA5", "IP6K3", "NFKBIE", "FOXN2", "FERMT2", "USP16", "KLC3", "ZNF519", "ZNF510", "ZNF20", "SI", "SPHKAP", "PON1", "ZNF750", "ZNF665", "PIR", "PHAX", "TSR1", "SLC17A6", "ARL13B", "GFM1", "KCMF1", "PLCL1", "IGSF3", "ITGB7", "SLC37A1", "OSBP", "TMED7", "ZNF304", "GADD45G", "ZNF273", "KCNV2", "HERC4", "PEX5L", "CD58", "MAP2", "MAP7", "PTPN22", "MTPN", "MAPT", "CHRNA2", "TRAPPC8", "RELT", "PTH2R", "KLK2", "ZNF596", "ZNF599", "SSB", "ZNF334", "ZNF333", "SNRNP40", "CYP24A1", "ZNF33B", "SNRNP48", "NPY2R", "ZFP90", "FBXO45", "MRPL15", "MRPL17", "DIS3", "CHKA", "DSP", "ALKBH8", "CDK20", "OCIAD1", "HELQ", "IL1B", "ZNF154", "NIT2", "CUZD1", "RASGRP3", "C7orf26", "ZNF426", "PHF7", "RPS24", "OR1E1", "ZC3H6", "SNAPC1", "DIAPH2", "SNX32", "GABRR2", "TRIM55", "ZNF212", "PRMT3", "HSD17B2", "HSD17B4", "SHOC2", "MRPS16", "ZFPM2", "UBE2O", "CDH10", "OR4A16", "NIPBL", "MEFV", "IL9R", "AARS", "OR9I1", "GTF3C6", "GARS", "MTIF2", "AGGF1", "ISY1", "TRIM50", "HPX", "UGT8", "ZNF624", "TLL1", "PBK", "TAGLN3", "MCTS1", "POU1F1", "ZNF549", "SLC25A5", "SYF2", "ZNF625", "VPS52", "NRK", "MOGS", "SALL1", "ZNF782", "UBE3C", "UBE3D", "GLOD4", "STX3", "CNKSR2", "AUTS2", "ATP7A", "TADA2B", "KIF9", "AP3M1", "AP3M2", "ESYT2", "AQP5", "ACTC1", "DNA2", "GRK7", "KLHL8", "SV2C", "ARNT2", "LETM1", "RAD51AP1", "DKK4", "CEP350", "HDAC8", "CST6", "ZNF547", "CEBPZ", "CERS6", "CERS5", "LCT", "OXGR1", "ZNF700", "ZNF704", "DHX8", "NUP98", "TCEA1", "MR1", "CLIC4", "EREG", "RSAD2", "DYNC1LI1", "ABCG2", "ABCG8", "AKR1B15", "ZNF136", "DAZL", "CCL28", "CCL26", "AASDH", "LRRC40", "ATP6V0A4", "KRT3", "ZNF382", "RIPK4", "NUFIP1", "FBXO32", "ALAS2", "TIGIT", "RNF19A", "NEK7", "OR6X1", "IMPACT", "APPL1", "APPL2", "OR6S1", "ROBO3", "TBPL1", "ATP5S", "KRT10", "ARIH1", "OR8H1", "SIPA1L2", "RORB", "ZNF470", "BOLL", "ZKSCAN5", "TAF7", "FNIP1", "FNIP2", "SEC22A", "ZNF677", "ZNF676", "ACSM1", "ACSM4", "EIF4ENIF1", "GNPAT", "OR4D10", "KMO", "TMPO", "NAP1L1", "KANK1", "MYLIP", "ESCO2", "ESCO1", "TARBP2", "PSPC1", "WDFY4", "WDFY3", "IFI16", "SPECC1", "USP22", "ZNF311", "COCH", "MAEL", "PARG", "DDX4", "ZNF211", "SLC7A5", "IPO5", "MST1", "FUT5", "FUT8", "OR1J4", "CSPP1", "GLRX", "MMP1", "USP38", "ZNF532", "AP4E1", "FSTL1", "MED31", "FGF14", "OXNAD1", "PUM1", "LCP1", "TESK2", "LAMP2", "NAT10", "NCAPG", "BCAS3", "AFG3L2", "PTBP2", "ARL6IP5", "ABCD2", "KCNH3", "KCNH8", "SYTL4", "MTRR", "BMP10", "ZNF454", "GPNMB", "PSMA4", "INVS", "SAE1", "SDHD", "TOMM6", "EIF3A", "EIF3E", "MKKS", "OR10G4", "OR10G9", "DBF4B", "ZNF732", "INPP5F", "CHIA", "ADAM23", "ANXA1", "ANXA3", "POU5F1", "SASS6", "PUS7", "PFAS", "PMS1", "FAF1", "FAF2", "VPS35", "TAS2R41", "BRAP", "ALG10", "DNAH7", "OR8K1", "CSTF2", "JMJD1C", "EFCAB7", "SIAE", "NPEPPS", "GNPNAT1", "HNRNPH1", "HNRNPUL2", "DCAF12", "SIGLEC11", "PLXND1", "UROS", "NXF3", "POLN", "IL17A", "CHRDL1", "SGMS2", "ZNF649", "ZNF644", "ZNF397", "IFT52", "GALNT5", "GALNT7", "GALNT2", "KIF11", "NLRP4", "NLRP1", "NLRP2", "NLRP8", "ZFP30", "LOXL3", "DEFB126", "ZNF616", "BOD1L1", "MAP4K3", "KHK", "TRAK1", "ZFC3H1", "PLS1", "RAD54L2", "HACL1", "SESN1", "ZNF680", "PDE8A", "MED1", "MDN1", "PLA2R1", "TSSK1B", "CD34", "TOPORS", "ADAMTS12", "KERA", "ZNF483", "ZNF485", "NR1H4", "NOXRED1", "EIF2S2", "TRAT1", "SNAI2", "ECHS1", "PVALB", "SCIN", "TACC2", "ST8SIA4", "OR2A25", "CTDNEP1", "CD180", "ZNF556", "RNASEL", "ZNF558", "ZNF568", "ZNF564", "SDAD1", "NMRK1", "XYLB", "DDX55", "BTAF1", "LHX6", "FOLH1", "EXOC3", "HAP1", "CENPO", "CENPH", "SSH2", "CENPW", "DHX30", "DHX34", "ARSJ", "ABCC1", "STAP1", "MRRF", "PGGT1B", "RBM34", "TIE1", "ZNF804B", "LYPLA1", "MC2R", "RBPMS2", "MTHFD2L", "GOPC", "ARHGEF26", "OSMR", "BIVM", "SPTSSB", "ANKRA2", "NBEAL1", "NBEAL2", "ACSM2A", "TRA2A", "ETFA", "TRAF3IP3", "INTS6", "MPP1", "MPP4", "YME1L1", "FNDC3A", "CCDC138", "KDM5A", "CACYBP", "OVCH1", "FBXL17", "FBXL18", "AFTPH", "ZC3H15", "ATP1A4", "HMG20A", "LARP4B", "MYO1H", "MYO1E", "MYO1D", "MYO1B", "NEMF", "MYO16", "TRNT1", "ZFAND5", "TERF1", "CAP1", "CAP2", "TTC5", "TTC4", "TTC8", "PRDM16", "RMI1", "IL6ST", "TAS2R10", "RRP12", "ERC1", "ERC2", "SLC37A2", "B3GNT2", "ZNF157", "NT5E", "ZNF430", "PTCD3", "NAA15", "TMCO3", "ACTR3", "KHDRBS2", "LARP7", "BIRC6", "S100A7", "AIP", "ZNF528", "KDM3B", "URB1", "SHF", "STX7", "UVRAG", "PCGF5", "MTHFR", "F9", "TTLL5", "DBF4", "GCC1", "ZNF398", "ZNF583", "GPD1L", "TIMM9", "KCNE2", "PRAM1", "DIMT1", "FTCD", "MINPP1", "GANAB", "RAB2A", "ETNK2", "RAB23", "ARRDC1", "ZNF610", "ZNF615", "SLC3A1", "MS4A13", "OR1L8", "MSRB3", "HHAT", "WDR5B", "TDRD3", "TDRD7", "TLK2", "CACNB4", "B3GALNT1", "GNAT3", "ZNF551", "ZNF559", "OR13C4", "SENP5", "SEPSECS", "CEPT1", "ZNF790", "ZNF791", "ZNF792", "DCTD", "UBE2T", "ASMT", "BIRC7", "EIF1", "BIRC2", "ANKRD17", "SIGLEC10", "HIBADH", "SCAF8", "GPD2", "FBLN5", "ZNF184", "ZNF189", "SEMA5A", "TGFB2", "TNIP3", "HSPH1", "FBXO5", "FBXO7", "SNTB2", "CORO1C", "ADAD1", "GPR22", "NAGK", "WNK2", "TNIP1", "LBR", "SNX5", "FABP4", "FABP9", "NPY5R", "NEU1", "RSPO3", "STK39", "ZNF716", "ZNF713", "RPP38", "TROVE2", "DNM1L", "DPYS", "YLPM1", "RABL2A", "SLC16A1", "PIBF1", "XPOT", "NSMCE1", "MBD3L1", "DSG2", "DSG3", "DSG1", "KCNJ8", "MTTP", "FOXR1", "PSMC2", "MARCH6", "OR4S2", "LUC7L2", "KATNAL2", "DUSP11", "NRAP", "CABLES1", "ZNF607", "MRPL53", "IQCE", "DSTYK", "ATXN2", "SULT1E1", "MYBPC1", "SPRY3", "NDUFS1", "CCNB3", "CCNB1", "CWF19L2", "ERN2", "MDH1", "CASP6", "CASP4", "AKT3", "HYAL4", "UNC13A", "KCNB2", "OR8I2", "BLZF1", "G3BP2", "RPTN", "IRAK3", "CAPNS2", "CDC123", "WDR60", "ATXN7L1", "BTLA", "RAB18", "LSM3", "USP48", "SON", "PON3", "PON2", "UGP2", "NDST3", "NBEA", "DCAF4L1", "DIS3L", "HOMER2", "BTK", "ATXN2L", "WTAP", "XDH", "DDIT4L", "PRICKLE2", "PCYOX1", "CD1B", "CELF6", "SPAM1", "GNL3", "GNL2", "SMARCAL1", "RSPO4", "MTDH", "LRRTM4", "LRRTM3", "EPAS1", "KNG1", "SEMA6D", "SCN2B", "ZNF208", "DECR1", "OR5C1", "TDRD12", "QARS", "OGDHL", "ZFYVE1", "RXFP1", "CCDC88A", "FBXL5", "CTR9", "SLC26A2", "LRP4", "AKAP14", "WDR88", "PTPN21", "CDH8", "CDH7", "DOPEY2", "DOPEY1", "ZNF436", "ZNF431", "MERTK", "IMMT", "MAPRE1", "MAPRE2", "SEPT6", "NVL", "ST13", "ZNF546", "SPOCK3", "YTHDC2", "NR3C2", "SEC23IP", "PDE6B", "ZNF19", "ZNF17", "ZNF10", "RRN3", "TGFBR3", "SOX6", "STAU2", "ABCC8", "GOLGA4", "ENPP2", "ZNF287", "RFXAP", "TIMM22", "CRYAB", "CFL2", "RNF17", "RIT2", "SUGP2", "TUFM", "OR4L1", "ZNF587", "ZNF326", "PIGF", "PIGK", "PIGP", "PIGV", "ATG2B", "C1orf35", "TPRKB", "MLH3", "ZNF418", "EIF2D", "EIF2A", "CETN3", "DNAJC7", "TAS2R5", "TAS2R3", "NEO1", "ME2", "ANGPT2", "ANGPT4", "ZNF99", "RAET1E", "BCAP29", "NDUFS6", "ZRANB1", "ZRANB2", "MICAL2", "ZNF597", "ZDHHC17", "DDX42", "DDX46", "LSM14A", "OR10AD1", "GPR161", "MTHFD1", "AZI2", "ZNF433", "ZNF439", "SECISBP2", "TXLNG", "GTF3C3", "ACOT4", "ACOT2", "RBBP5", "ZFP28", "TCP1", "NARF", "LRBA", "NAMPT", "PAG1", "ZNF667", "ZEB1", "OR1F1", "PTPRO", "IFIT2", "WDR36", "WDR31", "CDC7", "MBD5", "SLC25A12", "CCDC14", "RDX", "PPP1R42", "CTH", "RAB11FIP1", "CLIP3", "CD47", "FPGT", "ZNF43", "OR8D4", "WEE2", "CLGN", "SMARCA1", "LRIT1", "MEX3C", "LACTB2", "FRS3", "MGAT4B", "MUL1", "ZNF571", "ZNF577", "SETDB2", "MORF4L1", "IL2", "PI4K2B", "CENPP", "TLR1", "TLR6", "TLR7", "SSBP2", "ZCCHC12", "NAA35", "PGD", "DMXL2", "DMXL1", "ADAR", "RNF113B", "RNF113A", "RANBP6", "UBQLNL", "SLC9A4", "MSMO1", "TRMT1", "SEMA3C", "SEMA3D", "SEMA3G", "ZNF253", "ZNF257", "NDUFAB1", "NDUFB8", "TRPC4AP", "MARS", "TAF8", "CNOT7", "GNPDA1", "PIWIL2", "PIWIL1", "GABARAPL2", "KDM4D", "NARS2", "NOP10", "ZNF860", "ZFP2", "XRN1", "PABPC3", "ORC2", "RARS2", "BAK1", "TACR3", "MRPL37", "MRPL38", "THOC2", "ZNF671", "RNF103", "ZNF679", "ZNF678", "PHLDB2", "MTMR14", "MTMR12", "CEP135", "MON1B", "PPM1A", "PPM1L", "GINS3", "RMND5A", "MPPED1", "ZYX", "IL1R2", "ARPC3", "IL1RN", "HIVEP2", "ARHGAP12", "SETX", "ZNF540", "ARFIP1", "TRIP11", "NTPCR", "TCTE3", "MSH3", "MSH6", "HAL", "MCMDC2", "RBMS3", "BRMS1", "TNPO3", "SLC18B1", "HCFC2", "ACE2", "SOAT1", "SMC5", "PYROXD1", "SMC6", "LTV1", "PCMTD1", "CLVS1", "ZNF354B", "VPS33B", "OLAH", "OR7D2", "F7", "ATP4A", "SELL", "OR52E6", "EXOC6B", "CYP39A1", "ZNF442", "ZNF443", "AP1G1", "ARMC1", "HSPA5", "HSPA4", "HSPA8", "TTR", "MIOS", "SRPK2", "BDKRB1", "PES1", "ZNF600", "ZNF606", "PRPF40B", "PAPOLG", "PAPOLA", "USP45", "USP47", "ADRB3", "TPP2", "ULBP3", "ULBP1", "IFIT1B", "DHFR", "SNTG2", "SLC1A3", "SLC11A1", "NOC3L", "ELOVL2", "ELOVL1", "TRPA1", "ACTA2", "ZNF221", "ZNF224", "ZNF226", "OTUD5", "SPCS3", "MGAT4A", "BZW1", "CYP3A4", "LDB1", "SEC62", "MGAM", "CADM3", "PNLIPRP3", "GPR37", "GK5", "SEPT10", "CLDN18", "PHIP", "ZNF521", "ZNF529", "IFNA14", "MAN2C1", "LAT", "PANK1", "ST6GALNAC3", "HPS4", "USP1", "USP6", "ZNF721", "ETFDH", "MYO5B", "UBLCP1", "DARS2", "APH1B", "HTATSF1", "TMOD2", "ZNF71", "ACAP2", "NOM1", "PPP3R1", "CCNE1", "SRSF11", "EXOSC7", "NMI", "MYBL2", "NDUFS5", "UCHL1", "TNKS", "GSTO2", "MOGAT1", "SDHA", "ACSL6", "IMPAD1", "HSPA9", "TAF1A", "TIAL1", "DDC", "LDHAL6A", "ACADSB", "KYNU", "YWHAZ", "YWHAG", "MAPKAPK2", "TAF9", "POLR3C", "POLR3F", "TAB3", "SAP30L", "MTF2", "FBXO15", "ASB5", "ATP6V0A2", "EXOSC9", "CRMP1", "TMX3", "QSOX1", "DCTN3", "CEP41", "FGF7", "FGF20", "COPS4", "RALA", "FNBP1L", "SYT11", "RNF8", "PIAS2", "CACNG2", "NCAPG2", "SNRNP35", "TERF2IP", "ESRP2", "IGF2BP1", "TEX12", "NFIX", "HIRA", "ELP4", "ING3", "SEPT7", "NFRKB", "INO80", "NOL11", "RCL1", "TIMM21", "RABGGTB", "CNOT2", "RAD18", "THOC1", "CSDE1", "TFCP2", "ABHD5", "EIF2S3", "ENSA", "ORC5", "FAN1", "DCLRE1B", "ZSWIM2", "NRIP3", "MOCS3", "WWOX", "ATXN3", "RSPO2", "HECW1", "ICOS", "STIL", "TWF1", "KPNA1", "DCAF11", "ABCB7", "TOP1MT", "ERMAP", "GLRX3", "RGPD3", "RAD54B", "NSMCE4A", "RAD54L", "DISP1", "RAB3C", "ZNF214", "ZNF514", "ZNF28", "ZNF660", "ZNF664", "ZNF33A", "ZNF627", "ZNF675", "ZNF530", "ZNF737", "ZNF566", "ZNF563", "ZNF562", "ZNF169", "ZNF692", "ZNF347", "ZNF354A", "ZNF614", "ZNF37A", "ZNF461", "ZNF350", "ZNF669", "ZNF749", "ZNF45", "ZNF419", "ZNF440", "ZNF77", "ZNF354C", "C8orf34", "FMNL3", "NR4A3", "ZNF592", "EGLN1", "SUCNR1", "CXCL16", "RAB14", "NR2F2", "SIM2", "KLC4", "AP1S2", "AP3S1", "COL13A1", "CTTN", "PIP5K1A", "USP6NL", "OR13C9", "PCBP1", "RNF139", "UBL7", "CEP63", "KBTBD7", "TRIM39", "STAG3", "RRP9", "RTEL1", "CFL1", "BCL3", "SVIP", "ATP6V0E2", "CNOT6", "NFKBIZ", "MDH2", "PRMT6", "BCAS4", "TUBGCP2", "RPLP1", ["TCGA.CK.5912.01", "Classical antibody-mediated complement activation"], "CLTA", "TRHR", "C5", "PYY", "SLA", "OR4K14", "OR1Q1", "KCNAB3", "ATP6V1C1", "ENG", "YBX1", "SNRPB2", "PRIM1", "RPL30", "RPL31", "BCAT1", "SMG7", "DEK", "TFPI", "RALGAPB", "SFTPB", "C4BPB", "RAB3A", "MED4", "MED9", "ALDH1A2", "FMO1", "BCKDHA", "GLYR1", "GAMT", "CDC37", "STX5", "HLA-DMA", "HAUS6", "PRMT5", "BUB3", "PDCD1", "TAS2R19", "EXOC5", "PREX1", "IGFBP3", "SMAD6", "CYBB", "OR10S1", "OR4C46", "KCNJ9", "SIK2", "MCU", "STRADA", "TRIM17", "ARHGAP44", "ANAPC5", "RFC4", "ACVR2B", "GPR84", "NFKB2", "CNIH2", "NFYC", "GYG2", "PRNP", "RGS6", "HIC1", "ERCC8", "SAP130", "IFNAR1", "LRFN4", "ALDH1L1", "THBD", "MRPS2", "RBM14", "NDUFB7", "UBE2K", "ELOVL7", "KLHL3", "RNF25", "HECTD1", "LRR1", "NDUFA5", "UFM1", "MUC15", "HIF1AN", "ASAH1", "ZC3H18", "LINGO1", "FER", "TNF", "BABAM1", "ITPKA", "ATP6V0C", "KIF17", ["TCGA.CM.5344.01", "Ethanol oxidation"], ["TCGA.CM.5344.01", "Nucleotide catabolism"], "UBE2V2", "TK1", "PACSIN2", "HIST1H2BD", "PRKAR1B", "PPP2R5B", "POLR2C", "FGF16", "HCRTR2", "CCT5", "CGA", "RPS25", "FPR3", "RPL14", "RASGRP4", "ADSS", "H2AFY", "INTS5", "RGR", "DNMT1", "RNF19B", "RNF138", "ASB14", "UBE2E2", "ARHGAP26", "CASP10", "HS3ST3A1", "RPN2", "EEFSEC", "GIPC1", "IFI35", "PINK1", "C3orf58", "TTLL12", "ATG4B", "SH3PXD2A", "SMYD2", "ATP6V0B", "MAG", "ORAI2", "ACIN1", "OLFM2", "HPCA", "CABP4", "GSTM5", "NR1I3", "HNRNPA1", "U2AF1", "WNT2B", "ACO2", "LILRA6", "THEM4", "LDHAL6B", "UCKL1", "XBP1", "SERPINA3", "HS3ST4", "SST", "CLEC7A", "AGAP2", "TRAF1", "SHROOM4", "HRAS", "UBC", "UBA52", "STAM2", "TAF11", "PAFAH1B1", "S1PR1", "RPS11", "RPL32", "GPAM", "NRTN", "RGS1", "LYVE1", "TP53AIP1", "NMNAT2", "AAAS", "POLR3K", "XRCC2", "LTBP1", "PIGR", "RAC3", "RANBP3", "LMNB1", "KLK1", "TECR", "CANX", "SARDH", "KDM1A", "SEC24C", "IVL", "P2RY10", ["TCGA.CM.6170.01", "Ethanol oxidation"], ["TCGA.CM.6170.01", "RA biosynthesis pathway"], "NCSTN", "FCER2", "HSP90AA1", "PLRG1", "ITGB5", "FZR1", "RPL7A", "DNMT3A", "ATG7", "MAPK4", "AHCY", "ADA", "SREBF2", "NRG2", "RARRES2", "OR51T1", "OR5P2", "XRCC6", "LAT2", "RASGEF1A", "CNOT4", "DEF6", "BICD1", "PRDM1", "TRIM33", "SERPINA5", "IFITM1", "KLF4", "KEAP1", "SMARCB1", "TPI1", "UBE2E1", "SUPT3H", "ADORA2A", "STX1A", "RALB", "DAPK3", "ALOX12", ["TCGA.CM.6676.01", "RA biosynthesis pathway"], "CALN1", "LCOR", "LCK", "KLB", "CD79A", "BCAP31", ["TCGA.D5.5538.01", "RA biosynthesis pathway"], "NFATC2IP", "PTK7", "RPL35", "FZD9", "ISYNA1", "NMBR", "APLNR", "POLR3GL", ["TCGA.D5.6529.01", "Heme degradation"], ["TCGA.D5.6531.01", "Phase 4 - resting membrane potential"], ["TCGA.D5.6531.01", "Blood group systems biosynthesis"], ["TCGA.D5.6531.01", "RA biosynthesis pathway"], ["TCGA.D5.6531.01", "Lewis blood group biosynthesis"], "CREB3", ["TCGA.D5.6535.01", "RA biosynthesis pathway"], "MCFD2", "CCR4", "OPHN1", "BRD4", "ARRB2", "PXN", "UBB", "CAPNS1", "PTP4A3", "HLA-DQA2", "TUBB", "CENPQ", "NDEL1", "SNAP23", "ARCN1", "PTGIR", "CATSPERG", "BAMBI", "SPRED2", "TMEM115", "TWIST1", "SREBF1", "DYNLT1", "DIABLO", "DBN1", "GAD1", "UGT1A4", "GFPT1", "CNDP1", "LDHD", "PNMT", "ACAD9", "PLAA", "USP30", "CDC42BPB", "LDHA", "SYT8", "GSPT2", "HSPA13", "CSF3R", "BAG3", "AMY2A", "CH25H", "THRAP3", "HBP1", "PFKL", "LPCAT4", "POLA1", "UBE2J2", "ASB1", "UBE4A", "FBXL7", "FBXL15", "MCRS1", "LILRB1", "AHR", "COX5B", "TIA1", "PCDHGB6", "NFIB", "PFDN1", "PTCRA", "NDUFB10", "CHMP4B", "LTBR", "WDR11", "DNAL4", "SLC10A1", ["TCGA.D5.6541.01", "RA biosynthesis pathway"], "SEPT2", ["TCGA.D5.6922.01", "RA biosynthesis pathway"], "H2AFZ", "HDAC3", "EFNA4", "CACNG6", "CSNK2A2", "CALR", "BATF2", "ATRIP", "RORA", "TGIF2", "HS3ST5", "CHSY3", "TUBB2A", "UTP18", "PWP2", "APOBR", "HIST1H2AH", "GH1", "FBXO44", "DDX21", "ACE", "HOXD1", "NDUFV2", "BRWD1", "OR52E4", "RIN1", "RCAN2", "TCF12", "JUN", "LMO4", "COPE", "FCHO1", "B3GNT3", "CYR61", "HOXA2", "TRIM21", "AURKB", "LCAT", "RAB11B", "CBLB", "UGT2A3", "BCL7C", "FADD", "H6PD", "DNAJC5", "RAB3GAP1", "RND1", "CYBA", "CHRNB1", "YWHAE", "HOXB4", "ALAS1", "RPS6", "PRPF8", "U2AF1L4", "VDAC2", "TANK", "NSDHL", "EIF4G1", "TFAP2D", "SDS", "RCN1", "MTR", "ADRA1B", "GPR17", "TAS2R42", "NPY", "GIT1", "OTUB2", "FCGR2A", "CDC73", "MYL3", "ANGPTL3", "KDM4A", "CRIM1", "MRPS24", "DAP3", "MRPL32", "ASPSCR1", "OR9A2", "OR4K1", "PTGDR", "DUSP9", "CABP2", "IWS1", "MCCC2", "RPS6KA3", "ITGB3BP", "ASB7", "FOXRED1", "CD22", ["TCGA.DM.A1D0.01", "Classical antibody-mediated complement activation"], ["TCGA.DM.A1D0.01", "Creation of C4 and C2 activators"], "GZMH", ["TCGA.DM.A1D9.01", "Classical antibody-mediated complement activation"], ["TCGA.DM.A1D9.01", "Creation of C4 and C2 activators"], "CDC26", "NXT1", "NOL9", "ZIC3", "GNB2", "IFT81", "KLHL9", "FBXO4", ["TCGA.DM.A28C.01", "RA biosynthesis pathway"], ["TCGA.DM.A28E.01", "Aspartate and asparagine metabolism"], "OR10V1", "CARD6", "HNRNPA3", "MED6", "ATP6V1G2", "GSK3A", "PIP5K1B", ["TCGA.F4.6463.01", "Phase 4 - resting membrane potential"], ["TCGA.F4.6463.01", "Defensins"], "CER1", "TBL1X", "CSK", "PPP2R5C", "POLR2B", "CCT7", "RPS13", "BUB1B", "SAP18", "RPL27A", "NDUFA13", "TNFRSF1A", "PSMA2", "GRB7", "CHAD", "CSNK1G1", "NFKB1", "MED26", "IKZF3", "IL1RAP", ["TCGA.F4.6809.01", "Lewis blood group biosynthesis"], "PIK3R3", "SDCCAG8", "PLOD1", "SNRNP70", "RPS27", "ADRA2C", "HLA-F", "LY96", "GNRH1", "GNA13", "PSMC4", "OR1E2", "OASL", "SPATA13", "CTSH", "PPP1R3C", "POLR2E", "ENTPD3", "ASS1", "INPP5K", "RPL23", "BHLHE40", "GRPEL1", "LPIN2", "WNT9B", "WNT7B", "PJA1", "ASB8", "SOX13", "SRP14", "AKR1B1", "CNGB3", "LIF", "RAC2", ["TCGA.G4.6294.01", "RA biosynthesis pathway"], "STX4", "DAO", "RDH16", "HNRNPF", "FANCD2", "VASP", "PTGFR", "TGFBI", "LUM", "BSG", "PTPN6", "PSMB4", "LMAN1L", "CCNT2", "CCL2", "RPS4X", "ELL3", "MFAP2", "MFAP5", "RIOK3", "CACNG7", "HNRNPM", "PLIN1", "ARIH2", "SH3RF1", "PLCD4", "HAPLN1", "ORC6", "USP43", "MASP1", "PCYOX1L", "CAMK1", "OR2T3", ["TCGA.G4.6306.01", "Erythrocytes take up carbon dioxide and release oxygen"], ["TCGA.G4.6306.01", "O2/CO2 exchange in erythrocytes"], "CCND1", "RBBP4", "CCK", "CNR2", "CHRM4", "PARD6G", "CALML3", "OR11L1", "OR2Z1", "CFB", "BNIP1", "PRL", "PLA2G16", "HOXD3", "H2BFWT", "NSA2", "PARN", "IRF4", "RGS7", "TESPA1", "TRIM32", "HIST3H3", "HSP90AB1", "PHKG2", "PIAS4", "STAT2", "NPPA", "UBA3", "SERPINC1", "SPCS2", "ZMIZ1", "WNT2", "TBL2", "COL16A1", ["TCGA.G4.6321.01", "RA biosynthesis pathway"], "GTSE1", "SERPINE2", "P2RY14", "RGL1", "PPP1R1A", "SHMT2", "RAMP1", "DAXX", "FOSL1", "NTRK3", "PIP5KL1", "ARG2", "H2AFY2", "PPP1R12C", "TNFRSF21", "SNRPA", "CPSF7", "USP33", "SPOPL", "XK", "TALDO1", "SPI1", "GPN2", "NDUFA12", "PTDSS1", "ARSH", "CYC1", "PPP2R1B", "PLCB2", "HMOX1", "FCGR1B", "RPS9", "RPL13", "DUSP10", "NME4", "USP18", "KCNMB4", "PCYT1A", "PDPN", "EIF4H", "CUL4B", "CLP1", "RPL10", "RPL39", "TMEM173", "CHRNE", "SUN2", "RNF168", "PRDX6", "PSMD12", "MEAF6", "ZWINT", "ADM", "PDX1", "NFKBIB", "SNAPC3", "GTF3C5", "GDF1", "CTDSP1", "HIST3H2A", "ABAT", "TYMP", "FBXL14", "RBPJL", "GATM", "TSHB", "SCT", "TIPRL", "ITPKC", "UBQLN4", "GRK1", "WNT9A", "RTN4R", "GZMM", "TKT", "SOX4", "RNGTT", "DCTN4", "TOR1A", "FKBP1A", "DUSP1", "ADORA2B", "UGT1A9", "ATP1B1", "IL12A", "BHMT", "CHPT1", "GLS", "PSMC6", "PNPO", "UBE2N", "FAH", "PNLIP", "SAP30BP", "POLR3G", "ACAA2", "FUS", "LDHB", "UPRT", "UBXN1", "LPCAT3", "MBOAT1", "PYGM", "BCS1L", "SHARPIN", "PIF1", "DDOST", "VEGFB", "GZMA", "INSL5", "RXFP4", "OR10Z1", "OR1L6", "PTPRA", "RAB4A", "AKAP5", "IFNA4", "IFNA7", "CALB2", "XPA", "STK38", "PRC1", "ZNF420", "FANCC", "GPN1"], "total_weight": 10041.327913009636, "adjusted_gene_weights": {"LAMA3": 8.48371842828784, "PBRM1": 2.138264103561625, "TP53": 150.46328223342684, "MMP9": 2.135332092219746, "TNN": 3.7471575819998915, "ACACB": 4.0986468678518975, "TGFBR2": 2.5582159714129418, "APC": 106.84968362079175, "NMUR2": 0.168352325100306, "NRBP1": 1.4456175776334779, "IRF5": 30.765245746301556, "PIK3CA": 59.493733990961836, "ATM": 0.877507011305597, "MTOR": 15.656810672458466, "TUBB1": 0.611327400894507, "GFPT2": 0.783799008945714, "FLT4": 14.58684930757668, "TTN": 4.291659735820472, "KRAS": 96.89965931169392, "NCAM1": 5.074662839152274, "SPTB": 3.094861037757204, "DOCK4": 0.518710061037143, "TBXA2R": 2.29906414369209, "SOX9": 18.673269447436695, "FBN2": 2.1414151306686477, "TNXB": 6.249403394611322, "TNRC6A": 5.676792338218056, "COL5A3": 11.335353814089125, "DGKB": 9.487952089587376, "ITPR1": 6.65743636603014, "RXFP3": 3.9726713133597977, "EXT1": 1.187339174826063, "SP100": 2.149250383996721, "F8": 4.535373438098369, "BAX": 3.19383303474361, "CTNNA1": 0.816972158590352, "TIAM1": 0.900974871025386, "OCA2": 1.760395875007006, "HGF": 3.5473965596030057, "TLN1": 0.922727157937842, "PLCB3": 0.69918447067541, "MYC": 2.745754740199455, "EP300": 6.800660410796718, "SMARCE1": 0.678894731577157, "CHUK": 0.799327703130105, "OR5D18": 10.636969726267704, "OR5H15": 8.075460063082984, "OR10J5": 5.196112645217887, "SCN5A": 9.144149250801158, "CACNA2D3": 2.109567879143913, "PPP2R2B": 0.910935032384556, "RGS20": 4.6445264137060995, "DLG2": 2.3353167473303023, "NRXN2": 2.3767191240802648, "CCDC129": 0.872107939929378, "MME": 0.80476912253537, "KCNQ2": 11.588443226819216, "PLCB1": 2.521018753355392, "EPHB1": 0.904387686553846, "GRIA4": 8.66125103931736, "CACNA1B": 28.61154680269369, "NGFR": 0.589068365513069, "A2M": 6.9899655085675665, "COL11A1": 7.932506294008014, "TFAP2B": 0.565757068065542, "SERPINE1": 0.706262504924314, "VWF": 1.5748850830746322, "AKT1": 4.912611378326739, "CTNNB1": 3.000203571916982, "STAT1": 0.933272326936787, "PRKCB": 0.866575537678216, "PIK3CD": 0.884811780949319, "MCHR2": 2.617244607767499, "MAPK10": 4.628255050514863, "MAP2K1": 0.803050831130023, "ACTN4": 0.380058267841295, "RRAS": 2.471013314269355, "CDH2": 1.557116599604645, "CLTC": 0.886501570072867, "SLC9A1": 2.07655884671693, "GRM7": 0.909477477310559, "GRM4": 1.782225396017796, "TEK": 1.7373550698162559, "BRAF": 4.951955882613472, "RELN": 7.8750945748870125, "AKAP9": 5.211535297647788, "ELMO1": 12.012162998449284, "ICAM1": 0.58911137920617, "OCRL": 0.702999566876174, "AR": 40.04820643236469, "SPTBN2": 4.464817896604909, "EPHA2": 10.11353763517593, "PLXNA4": 2.039027269229826, "NRG1": 2.190709103625719, "FLNB": 4.062580385448616, "DYNC2H1": 0.819945487948956, "NLK": 3.6051971560802043, "TNRC6B": 4.997369080166977, "TSG101": 0.608805767461262, "CTNND1": 2.301291658577666, "NCOA2": 19.196684984790032, "GP9": 0.837410342663356, "RB1": 3.5012710797278217, "SMAD4": 21.197263240821098, "RBP1": 5.867711657104109, "SCNN1G": 0.948734528104811, "CREBBP": 2.829295974203447, "NFATC1": 7.101434549032085, "PPP2CB": 0.912166090465291, "CAMK2G": 3.1893026130460997, "PTK2": 0.910066169674095, "ESR1": 5.167781953541989, "NCOA1": 0.821178504567614, "IQGAP1": 2.317625416827479, "HLA-DRA": 1.84023012349601, "NCOR2": 1.758832069321909, "GFRA1": 3.588483520833894, "HLA-A": 1.4802825524844598, "ACTA1": 5.373817141236158, "NOS1": 7.377163959899727, "TRIP6": 3.773161554001163, "CHRNA1": 2.028342304599202, "AGRN": 0.904542445146332, "MAD1L1": 0.882879580764813, "LAMA5": 12.286153087479446, "ITGA1": 0.646812618472531, "SPTBN5": 3.1189649070341408, "AKAP13": 0.840414161508575, "NME1": 1.8353260155676199, "ALB": 1.441406825734191, "ADCY10": 0.798331392335488, "RYR2": 5.525400826347318, "GATA3": 4.960562822771035, "GRM5": 1.888608613457474, "MYH11": 0.462288575110536, "FLNC": 1.799225408146868, "KDELR1": 0.860959339804576, "CACNA1A": 13.471680681611197, "CXCR3": 1.7053819697649288, "CACNB1": 0.879033995539976, "ARHGEF1": 5.571148686811997, "EXOC1": 1.237770203959333, "ANK3": 0.940608076958352, "SLC6A3": 2.352307757265723, "FLNA": 0.907026925789202, "PLXNA2": 0.891702579899458, "COL2A1": 3.2785256366533373, "OR1L3": 4.625156037188277, "OR2T27": 5.942766792062362, "OR8D1": 0.89229169314935, "ABCB1": 3.226673602802697, "CACNA1E": 5.04744263256901, "ATP2B3": 4.9020600256293125, "ATP2B4": 2.445897887197423, "PYGB": 10.895212802164998, "KCNU1": 0.851337807249121, "KCNQ1": 0.870081326826837, "IFT140": 0.863519945488702, "NPHS1": 3.052472998168834, "KCNB1": 3.6427304846249, "SERPING1": 1.504774867346325, "CTNNA2": 1.3933050244185718, "ITGB2": 0.728829087410643, "PIP5K1C": 2.6853837914863212, "MKL1": 1.5721526145026319, "ERBB4": 0.894049769487196, "PDE1B": 10.386183584722463, "TSHR": 0.813100977842709, "FZD6": 8.856137835313934, "NRXN3": 1.583374574251781, "RYR3": 0.64940815512228, "KIF4B": 0.91402065762624, "POU4F2": 0.816693191347062, "ARFGEF1": 7.425142708701657, "RASAL3": 1.616213609976482, "COL4A2": 3.9409418900373407, "COL4A3": 0.76385727554926, "PLXNB3": 6.5778027494116715, "COL7A1": 0.937287181528023, "NALCN": 2.129763702483439, "CNTN2": 0.873846701307293, "NOTCH3": 5.384822101827309, "COL6A3": 9.177495774280002, "HCN4": 5.345056267579423, "SNAI1": 0.552162658627917, "THBS2": 2.810549938305777, "APOB": 8.833084272354277, "PPARGC1A": 0.884499305732994, "EPN1": 1.3812081831593979, "LRP2": 16.430548551972606, "LRRFIP1": 1.419313752996161, "CUX1": 0.880919925676446, "AMPD3": 1.637215530562834, "SYNE1": 5.765314217844267, "ERCC6": 5.146556437220202, "NPR2": 0.813444408824154, "TICAM1": 0.571089460452318, "ARID1A": 73.25619980138386, "RIF1": 0.76025325080634, "CRTC1": 7.017821491858951, "SETD2": 4.5542634923149805, "MPO": 1.8205162144856142, "PLA2G2E": 3.197912311020422, "AXIN2": 1.7048088537881299, "PLB1": 6.8677153984315655, "TBK1": 0.844657089763522, "UBE4B": 0.832663482261279, "FURIN": 2.242888220397126, "PTPRK": 0.734555247445462, "USP9X": 6.920709249699339, "DDX54": 0.798797750698444, "PFKP": 0.721351831749426, "KLKB1": 3.630250401668365, "SAFB": 0.888397757259045, "EVC2": 2.775225316607324, "LRFN3": 0.8338583293349, "NOTUM": 0.878805121656301, "DERA": 1.3534326130826742, "FASN": 0.742412263139763, "CPS1": 1.562599335537916, "SERPINB1": 0.918749479690187, "CYP17A1": 1.801191503810438, "DPYD": 0.8921006669646, "RDH12": 1.8357114958618892, "CYP7B1": 5.714313657220244, "PAX5": 0.90131496173995, "ADCY7": 5.429124779052773, "DSCAM": 3.694769452391344, "FGFR2": 3.3666717086049998, "HTR2C": 4.655041744664989, "BRPF3": 0.846855895211645, "NRCAM": 0.945177436449654, "SEMA3A": 0.764941772406173, "GRP": 2.1930868516572373, "TGFB1": 5.542542974274632, "DTX1": 1.5932910548652108, "OBSL1": 5.763633759365358, "KCNJ16": 4.05341124424958, "PDK2": 0.775135452863899, "NEFH": 9.004340255991266, "GRIN3B": 3.543042695234064, "TFEC": 0.840222433596833, "TCF7L2": 7.321657377840664, "TBP": 5.339203890354298, "SCN3B": 0.884171689440004, "COL3A1": 2.357031181625417, "HOXD4": 0.411152106796596, "LRRK2": 0.621581163833865, "SELP": 1.621781053366112, "OR51S1": 0.873244767770455, "SCN2A": 12.44681128326557, "KCNQ5": 7.258872248345409, "TSC2": 1.470764202647443, "PLCG2": 0.939455119283507, "PAX6": 3.4506200422441, "OR2C1": 1.7586951936092179, "PRKACG": 2.3082741944857412, "ARHGAP35": 0.597608076409422, "TAS2R16": 0.825762655871216, "OR10A2": 1.689766546602928, "OR2A5": 10.39093909463533, "GP6": 10.303686981072055, "PDE6A": 0.931543105925988, "GMIP": 0.669762185836471, "COL4A4": 3.398295707887252, "NCAPD2": 0.694105794421699, "PKD1L1": 0.8845861017939, "TNFRSF10A": 0.598507624604088, "MUC16": 21.178099542338988, "PYGL": 2.219246809501041, "FBN3": 1.635353083169636, "NID1": 3.073583672991885, "HSP90B1": 2.548030142664791, "TYK2": 0.908379690060609, "MAMLD1": 1.594278829087648, "EPN3": 2.669597953253224, "B3GAT2": 0.824803182472524, "WWC2": 1.630285262317454, "ADAMTS9": 1.476516784000738, "MMP19": 0.748954341199389, "GMPR": 0.808682098829344, "GSTM4": 1.732853524335165, "GRIA2": 3.1417082188567935, "OR8J3": 15.555970804570745, "RASA2": 0.714631397759931, "UBA6": 0.577102620037726, "COL9A3": 4.221257562249653, "GOLGB1": 5.22620372441931, "CASQ2": 0.886051693149137, "COL6A5": 2.864139381506444, "GRIN3A": 0.92130299316297, "KCNN3": 2.269320653800547, "OR2L3": 16.106656349742426, "MAPK12": 0.929291446671488, "CHRM2": 0.854601863258665, "NOS3": 0.843711523421452, "COL5A1": 4.659943507872628, "ANKRD1": 1.478867024734801, "TGM2": 14.34586196072275, "COL12A1": 2.669072453299247, "MMP16": 0.949126625725177, "DNAH8": 1.448087513042029, "CD109": 0.873171605006068, "AMPD1": 1.592385297679432, "ANK2": 4.385214330739971, "GAD2": 4.233801992496779, "GNAS": 30.345934236870953, "ADAMTS20": 1.767589942173619, "DICER1": 2.599153682045381, "UNC13B": 0.919877236529587, "CYP2E1": 0.845401339703436, "ENPEP": 0.729407730142554, "HTT": 8.975867916251687, "MAPRE3": 0.716863062949229, "AGTR1": 4.451165623776643, "SYCP2": 0.824883117751886, "PTPRG": 0.906799976411729, "ITK": 0.794164778413428, "FNTA": 0.770872212655894, "FYN": 2.616201496296861, "PRKCI": 0.86483947424644, "GUCY1A2": 0.88934144812369, "PCCA": 0.683370678772846, "UGT2B4": 2.253058459161001, "SLC25A3": 0.825880407136201, "KIF5A": 0.884418326550481, "COL24A1": 2.367686321527657, "PLG": 0.891029035327149, "CDK5R1": 0.857868268557767, "ADCY8": 2.206100233203625, "OPRM1": 0.852450530182539, "JAK3": 2.690951616393198, "MYH6": 0.525234983061448, "GABRA5": 0.927722183146884, "SUPT16H": 2.6869905322325662, "ACAN": 10.468422319012188, "IRS2": 0.907828577942563, "TAS2R46": 2.200904419130807, "DAPK1": 1.6255396637723432, "MED15": 1.737476106726339, "KCNAB2": 0.812966666918011, "WNK1": 1.919439960949673, "AMPH": 2.669986612712636, "OR56B4": 0.834312807369114, "SYT5": 3.217898441729786, "DIRAS1": 0.842087453836901, "SCN8A": 3.330042425609966, "ESR2": 2.47325593917933, "PPP2R5A": 1.608097426971364, "PIK3CG": 3.9273293524920563, "B2M": 3.5134063369043025, "ADCY6": 2.200653182569484, "ADCY5": 0.860811894668869, "MAP3K11": 1.6741603324432761, "OR51A2": 3.2710384311704077, "GRIA1": 1.532970312213473, "OR2M4": 11.32699162481542, "CACNA1D": 1.9008854591824171, "CACNA1C": 0.899193426160686, "CACNA1S": 5.611479271494531, "VCAN": 3.290169598030066, "KCNJ4": 4.578078546638218, "NR2C2": 3.283623829278718, "DRD5": 6.065248588330162, "ITGAL": 2.211867491300267, "ITGA10": 4.219702293693009, "CTSC": 0.835901324227836, "RGS12": 7.927526478349711, "PREX2": 0.804245566549876, "KCNQ3": 7.089164999012733, "KCNJ11": 1.76627961557184, "C6": 0.76567484792323, "RYR1": 2.145002719554474, "NFASC": 9.723960596310622, "GALE": 0.842624773238702, "SCRIB": 2.294452439527223, "COL4A5": 0.721699492948152, "PKD1": 2.280596107448289, "STAB2": 3.069051867447283, "DNMBP": 0.911961391737677, "PPP2R2C": 0.90130511239847, "NCOA3": 0.775177691813232, "NFATC3": 0.900571556302592, "UBQLN2": 0.831680599633731, "CPSF6": 1.716272073051985, "RARB": 0.68479159555888, "APBA1": 1.512113314022336, "PPFIA3": 0.919140655246094, "PTGS1": 5.438228027403298, "APBA2": 8.6238787748896, "ENTPD2": 0.673122660892282, "C9orf3": 0.935169661531693, "AMPD2": 0.826998137562009, "WLS": 0.817972898888433, "HIF3A": 1.4669135166123088, "MED13": 4.887673906111167, "PER2": 0.88973385915111, "DLAT": 0.679282733265996, "NR5A1": 2.2413472075466, "DBT": 3.022726846337485, "ACAT1": 0.775326609455231, "ELANE": 5.575862005018459, "TBL1XR1": 2.009262483933952, "PDGFRB": 0.544212476106517, "IFNG": 0.838655079367759, "GPC5": 0.856650837012626, "GABBR1": 0.859405981848869, "RBMS1": 0.730572759008548, "REG3A": 1.695462251212808, "ARHGEF11": 0.831600463748758, "LEO1": 0.540659190506615, "MYO9B": 0.519298960903147, "PDLIM5": 0.956427631397803, "IFIH1": 0.0084365477280307, "HSD3B1": 2.614193155451508, "ALDH1A3": 10.010746993317245, "F2R": 3.160883927945815, "SMAD2": 3.4897664270550086, "SHC1": 0.749334618318511, "PTEN": 3.9130366912249452, "EPHA6": 5.988010145895428, "DLG1": 2.068517256310948, "COL18A1": 22.94644845028622, "CACNA1G": 2.369496536750709, "ITPR3": 0.850702930557574, "COG4": 0.944459293235974, "ABCA1": 7.783151319573792, "ITGA8": 3.8561497958342157, "PLCZ1": 0.845516012976005, "KIF26A": 2.38963635955076, "DOCK3": 2.5005551747393633, "OR10R2": 2.765775585470801, "OR4K2": 1.852061438655061, "ZBTB17": 2.194613946974304, "COL6A2": 6.631176001758176, "KCNS3": 2.392128399677296, "GRIK3": 0.892171718279508, "TUBAL3": 2.260576060398309, "AP1G2": 0.830380776582288, "WRN": 4.110252959029811, "NCOA6": 8.400308464466526, "ALOX12B": 0.851547021679917, "BPTF": 0.895745223604564, "EFCAB6": 0.872851006599702, "NOG": 0.745791587741163, "MYO3A": 2.207318350405051, "GPC3": 1.8337529991488788, "PRCP": 0.872667367768535, "USP34": 5.056032410381563, "PDHA2": 2.079799170896134, "LRP1": 14.847441984563334, "COL20A1": 4.193550034452808, "ADAMTS14": 3.029150214519426, "TLL2": 7.498657947438459, "ADAM9": 1.893366221116049, "STAT5A": 0.853471708696294, "P4HB": 0.944971865554963, "KIT": 5.162794441888627, "FGA": 0.724702462400935, "LAMB3": 0.947874993564317, "LAMC2": 3.727071830291437, "ANGPT1": 0.934870760426004, "COL4A1": 0.959652508794907, "IL2RG": 0.61315159099939, "VAV2": 0.834738093777137, "DVL3": 0.726016355818149, "VTN": 0.81539096269291, "MOV10": 1.179906312014201, "ALOX15B": 2.290346218797923, "GAK": 1.632047178403843, "BMP1": 3.801196494050232, "GRIP1": 1.572266096738494, "KIF2B": 5.36956302861768, "PTCH1": 0.568071265409419, "CHST6": 1.77189451586884, "UGT1A6": 2.194162444919368, "POFUT2": 4.047066321573858, "ADAMTS13": 2.731338013434422, "RAB8A": 0.861505395798776, "GNS": 0.698103204988569, "IGFALS": 3.753491800343379, "CDON": 0.798516809086774, "CACNA1F": 0.729288134281903, "GATA4": 0.836177645165786, "PKN1": 0.893817697621755, "INPPL1": 1.9878429062904939, "OPRD1": 2.223841133086012, "SEMA4D": 3.17594701412233, "CASP9": 6.2129544738794715, "MYO5C": 1.606887475309217, "LRP5": 0.905867989189492, "FZD2": 0.897540969207105, "COL25A1": 1.805435036059533, "PROS1": 4.589600775884415, "PDGFA": 0.661864331404621, "ADCY1": 0.782450973944222, "ADAMTSL1": 1.807059482607664, "UGT3A1": 1.575325680163848, "GABBR2": 6.953581407743597, "MUC17": 6.066688245500913, "CSNK2A1": 1.648059076553909, "ADAMTS3": 3.527196160419273, "MMP11": 1.642626738114229, "SCN10A": 6.564130338047297, "AGT": 4.778766021281335, "HDAC5": 9.635442205407116, "NRAS": 10.16932175293103, "MMP2": 3.754594690644274, "INSR": 2.575041475954906, "HSPG2": 15.004212326051778, "FN1": 0.517553445073222, "CFTR": 0.862772504395311, "PPARA": 1.7808401152155389, "ATP1B4": 3.135027143195638, "FOXO1": 0.712043301371564, "LCP2": 0.815945178296491, "PRKG2": 0.69518055073428, "TNC": 0.84629030268422, "FOXO4": 5.146517895495386, "NTSR2": 5.058629930732966, "KIF3C": 2.345568558658393, "BDNF": 0.916458206502507, "SMPD1": 0.503702474349617, "OR2T33": 13.949213732460114, "OR52K1": 3.690537630740219, "OR6C4": 0.928205040366806, "OR10K1": 3.303932936504213, "OR5M9": 9.744980774260537, "RXFP2": 15.591205162164972, "PDE4D": 0.866802572583232, "SHB": 0.856401018752563, "EPHA7": 0.795094384127865, "ASAP2": 0.760942031605355, "SPP1": 0.890486417585938, "TAS1R2": 26.757050108771402, "MUC20": 1.7585677169908411, "ZFYVE28": 1.966613981167354, "DOCK2": 0.861784710488199, "GRIK2": 2.304383732882498, "SPAG9": 0.729665497833266, "HIPK2": 2.285958397320397, "NLGN4X": 0.882893618865898, "GABRA1": 0.916247008561784, "MYO6": 3.8527679718574532, "ARHGEF10L": 0.906391253579597, "MAGI2": 0.789319835301662, "GALNT1": 0.951815944754646, "KAT2A": 5.0674192402820335, "SLC2A8": 0.527160710815539, "RXRA": 0.735493508447678, "POLR3A": 0.821015442815159, "MTMR1": 0.829291192169315, "LNPEP": 1.705542929261466, "CASK": 0.753056451330308, "SMARCA2": 3.503768665875545, "PLA2G6": 5.200504000986731, "PLA2G2C": 3.19711177924142, "PTGS2": 0.784198421517045, "PTPRF": 3.471337591858935, "MYT1": 1.467263292272249, "BACE1": 0.897111342704839, "RLBP1": 0.867480622164259, "ERBB2": 3.177360903505244, "TRAF2": 0.781049150317832, "MAML3": 10.43300961851502, "GRIN2C": 0.777879396172135, "ATP1B3": 0.847081327184397, "ROR1": 3.376421123345692, "SALL4": 3.623631348551068, "ENPP6": 1.58973087995726, "HNF4A": 1.146062414025267, "CYP2D6": 6.53221640449287, "DGAT2": 0.643682007636386, "CISH": 0.833184874687831, "TCEA3": 0.66168080205177, "MUC4": 1.76758423171295, "CACNA1H": 9.302529720742115, "PLA2G4D": 9.81373415975365, "NPW": 2.710263085403642, "SPHK1": 1.822857096041947, "INSL3": 4.392351976260228, "TRPC6": 2.200564809174772, "NEFM": 0.926257390207321, "TGIF1": 0.680472868574177, "CCR5": 1.536422993475744, "ITPR2": 2.115100117840507, "EDNRB": 4.624868710693702, "NOS2": 2.248171525071521, "AP2A2": 0.942162822678941, "MEF2A": 6.918878210918614, "GSK3B": 0.78965225946594, "CIITA": 0.899930362724474, "SIN3A": 2.003606949662683, "KCNJ2": 12.132217143565425, "OR2T6": 12.74834419815985, "MTNR1B": 0.893477723123613, "SCN1B": 1.86908404174075, "COPB1": 0.939745019583598, "FZD7": 0.941381479391175, "CACNA2D4": 0.925460611967686, "EPS15": 0.856033533905661, "RASGRP2": 0.912311646480632, "NUP107": 0.884332066881765, "GRIN2A": 3.93380889437567, "A1BG": 8.235342074982919, "DOCK8": 1.961797678867843, "GLI3": 0.727102509279255, "PCSK1": 0.920344757903621, "ITSN2": 0.934816983165587, "RGSL1": 0.824487572189515, "TRPV1": 0.819100996840974, "NLGN4Y": 0.881595267329246, "C8B": 0.861837577067176, "GABRA6": 0.920982151283166, "RGS10": 2.820103505642947, "CTGF": 2.6664896256160042, "CHD9": 0.772491395214391, "TBC1D4": 0.748217591710635, "TUBA8": 0.804063635497823, "TFAP2C": 4.23835874485056, "EPN2": 0.78932406499447, "SOD3": 1.663760515537781, "MED24": 0.760394959973961, "CYP3A7": 3.4185980046837168, "SDC4": 0.711561648230538, "SYT1": 0.60706764553703, "PPP2R3A": 0.900204384976328, "TLE1": 2.5753647196670446, "GUCY2D": 1.6426419317401288, "NSMAF": 1.264501260737564, "E2F7": 0.840092629646588, "GSTP1": 6.314266819763647, "ADO": 0.694426714724892, "CSF2RB": 1.349359819635606, "CSNK1A1L": 0.867970600452268, "GP1BA": 0.92437073994725, "IL18": 0.71370366964229, "ACTR1B": 0.862739871561486, "DOCK10": 0.818162642811088, "SRY": 2.26641933301106, "KRT1": 2.106406913405194, "TERT": 0.78229539162241, "GYS1": 2.569532323944396, "ITGA3": 0.489086632735667, "OR5W2": 15.12934711496209, "SOX2": 1.93715669613476, "PHC2": 1.68337047584564, "EPHB4": 0.298674871697066, "PRKD1": 0.868192040050695, "NECAP2": 1.710432626180455, "RASA1": 0.705401053904834, "EPS15L1": 1.4779461094976258, "CES1": 5.865475418568099, "TEX15": 4.402358439853965, "APAF1": 1.745437929654599, "PPP2R3B": 0.885229017299405, "CYP4A11": 3.662667849548745, "NUPL2": 0.405124500942849, "ITGB4": 3.2383882008909843, "ERBB3": 0.688736414466769, "ITGA7": 0.944221326719343, "ARID1B": 0.769331945620637, "SNX1": 0.811958369980446, "OAT": 0.481542383976271, "CDX2": 2.377681442629146, "ZFPM1": 0.80844510355151, "JMJD7-PLA2G4B": 0.818433930753615, "STAT3": 6.02353670147382, "NGF": 0.943049644662008, "COL4A6": 0.885008791867851, "GPC1": 0.406610917722856, "PLA2G3": 2.282959735920284, "MED14": 2.094055705331887, "ALDH9A1": 0.860704741650932, "PTPN3": 6.883904347256099, "POLR1A": 2.810141568664247, "BMPR1B": 0.724184706455909, "SULT2B1": 1.7133359688139138, "GATAD2A": 0.518758063918102, "HSD3B7": 4.079082687151377, "CYP11A1": 0.908905681777616, "OLA1": 3.318385078183625, "DNAJC6": 0.461035862903663, "APOA4": 1.217080516608453, "HLA-DOA": 2.272489172317937, "RGS14": 1.808720286170953, "C8G": 0.886484677982158, "C9": 0.637629380441509, "LRP6": 0.869141184713123, "PIK3AP1": 0.872075108271238, "SCN1A": 8.104517833536022, "PTGES2": 3.1376181075173073, "CCT6B": 11.642437398595174, "SDC3": 7.692474743635456, "HRH4": 2.632646286386567, "ABLIM3": 0.790052018454753, "DOK2": 0.941920200326176, "RIPK1": 0.785125559595636, "AMFR": 0.443160400754883, "GRIK5": 3.5217815979093268, "MYBPC2": 2.0725706813117153, "SCAI": 5.2999252271077415, "LGI1": 0.942602846784098, "GNB3": 0.888354565383944, "SPTBN4": 3.722438210766266, "PF4": 0.799512023024816, "SH3GL1": 0.854536995222774, "MAPK8": 0.935068968421881, "CCR10": 20.364541022378134, "HTR1E": 0.695286628326212, "TACR2": 4.801621766963216, "ITGA4": 6.749597887721727, "ITGA6": 1.9570260028813071, "ISLR": 1.660430921348432, "OR13A1": 0.924531192545301, "OR5AC2": 4.9637722472781665, "OR6B2": 0.932572663498906, "PICK1": 0.837032359251483, "TRPC5": 0.922416784081357, "WNT1": 0.902377420397014, "ETV5": 0.934416992148447, "KAT6A": 0.699398831672745, "PRKD3": 0.648743016574542, "SCN4A": 4.767706882663449, "COL9A1": 0.743088405954665, "FZD10": 0.898620080630967, "SEC16A": 0.748532743943213, "PPFIA1": 0.822699658837331, "SLC32A1": 5.784646060627175, "SCNN1A": 0.952144864899592, "ENTPD4": 0.886652116305227, "ACOX1": 7.211180711679411, "CPT1A": 0.865656784071374, "NCL": 3.347312223117203, "LRIG1": 2.061995444973288, "DDX17": 0.754238577786791, "GPR156": 1.760511509193567, "CSPG4": 0.865920967337683, "SHC4": 0.864843568016044, "OR5K1": 18.183426550295216, "SYT9": 0.108005980196511, "CYP2A13": 2.26603195854915, "KL": 6.593025257875195, "ALDH1A1": 1.773987597815164, "KRT5": 0.510914891086638, "GLUD2": 2.41924841240564, "CYP11B1": 3.606071975964297, "CYP4A22": 0.949463303134523, "IGF1": 0.788311339565406, "APP": 6.432880451627561, "INSRR": 7.436377527928084, "PIK3C2G": 0.824418767127934, "CHL1": 3.6366690693401065, "TRIM45": 3.684434119527218, "SLC8A1": 0.887677378809421, "OR4A15": 9.613709504045234, "OR2M2": 8.973206363232357, "OR2H2": 0.91897592126159, "OR52I2": 3.998603389098874, "OR14I1": 19.277028281685592, "TRAPPC5": 3.206740790191703, "CNTNAP1": 0.922467396632827, "AGFG1": 2.389632913249629, "SETDB1": 0.955246322600387, "USP12": 2.109272452151834, "IL22RA1": 0.894299280450055, "LRP12": 3.905452094575968, "CUBN": 1.402065153375674, "FGF8": 0.909972740775438, "RECK": 2.1563523570442147, "DSEL": 1.966196531834848, "ADAMTSL4": 8.669939901603039, "NMT1": 0.636199285622615, "GPC6": 2.908817334631561, "TBXAS1": 1.416553398009889, "NDUFS2": 0.376305908421904, "MC4R": 0.633408439795759, "OR11A1": 2.032869802486495, "OR8K5": 0.900201169199991, "OR5M8": 0.818729224101392, "PAK1": 1.643373095505944, "ENPP3": 3.0992089479810327, "GRB2": 1.594236607015152, "EGFR": 1.472139678412017, "PPP1CA": 0.753615439184495, "GPC2": 5.985532997826258, "DYNC1I1": 1.3100364282686758, "TCF4": 2.290572573306278, "B4GALT1": 0.924291829446699, "ATP1A2": 1.937435119776711, "POLR3B": 0.873653847429492, "MMP3": 1.853560414321551, "MAGED2": 0.762586783709191, "PTPN11": 2.304878210066006, "ITGB1": 0.890466670971208, "SPTBN1": 3.130958012027457, "ARPC1A": 0.682981871217073, "RASGRF1": 3.088308047271887, "LAMB4": 1.41262119257913, "NOTCH1": 4.48101056640498, "CDK4": 0.750620882694068, "PRKCQ": 0.302915248479125, "WNT5A": 2.262916723501144, "NTRK1": 0.615250330814682, "IL5RA": 0.909526551972023, "GATA2": 1.500867597929762, "KIF4A": 0.947221931556945, "ADAM12": 1.2937588039561239, "THBS1": 0.889411585938968, "IRAK2": 0.554668940384087, "SERPINA1": 0.911672295604732, "S1PR2": 0.732545724058011, "HEXB": 1.464435521147165, "ETV1": 0.817020784748343, "OR1J1": 1.730674418804648, "OR51Q1": 5.204224749400036, "OR1L4": 8.808507681147681, "OR5K3": 0.78770259980242, "OR13F1": 5.219313536174507, "OR11H4": 14.605514893228856, "OR1N2": 14.870508581580216, "OR2T8": 0.938452548531712, "CACNB2": 0.905392123099145, "ATP2B2": 2.03646431790506, "CATSPERD": 1.806253236573232, "KCNJ12": 12.467381120149014, "KCNQ4": 2.778953643711701, "PASK": 0.944338783715898, "FOXA1": 0.838498643346601, "KDM6A": 7.189583927630995, "CYP2B6": 1.768045179950267, "CYP7A1": 11.869284989666724, "GSTM3": 6.594726542681553, "ALDH1B1": 1.838080019501584, "IDO2": 3.011631937378428, "ALPL": 3.2965753947373253, "ENPP1": 7.189316000108602, "IBSP": 2.386068893337605, "PSMB1": 0.467542997413514, "TNIK": 3.170810104047662, "THADA": 0.793510683353806, "MMP14": 0.853325970065594, "SOAT2": 0.933349047718324, "ACYP2": 0.943079362533109, "GMPS": 0.880671626607538, "CALHM1": 1.895599299644281, "IL2RB": 0.453623697919698, "CHEK2": 0.441951685689535, "NOX1": 1.321254459532472, "ABLIM2": 0.878668534002505, "TAAR6": 5.270870848111645, "OR4A5": 2.428867865378677, "OR6C68": 0.853348375576408, "OR10C1": 5.396928618798274, "OR8H2": 26.842575486162712, "OR4N4": 1.8593642294855748, "OR10H5": 5.562776371316025, "OR2T35": 1.85362406574079, "TAS1R1": 14.177049465940874, "TAS1R3": 30.013863822983275, "ADAM28": 6.669703176664184, "GPLD1": 0.957126858529595, "YEATS2": 0.657448036201969, "IBTK": 0.843829035458705, "APEX1": 0.933440656012948, "INHBC": 0.844000984747567, "ABCC3": 0.880440345650708, "NPAS3": 2.267824045768706, "COL15A1": 3.344598578477003, "SLC16A8": 0.87581910761209, "ADAMTS2": 0.923548479425592, "ST3GAL3": 0.919425120864985, "SEMA5B": 0.9254799605978, "ADAMTS16": 6.3260518523619735, "ADAMTS5": 1.3905888351084479, "SETMAR": 0.955406358568747, "GPR50": 0.761680329462915, "WNT5B": 0.795182018243939, "DTNA": 1.811744271812308, "ALOX5": 4.560555657909064, "WDR5": 0.680155659182063, "XCR1": 0.695557600776831, "VCL": 0.901898433070648, "NAPA": 4.458259846479022, "TFDP1": 0.840272599177629, "MITF": 2.16712717292004, "OS9": 0.667185830450093, "SLC2A4": 0.871065826219787, "DGKQ": 0.831645381478599, "BNIP2": 0.582250357775483, "PPIB": 1.836404661072112, "PAX8": 0.834835295919472, "OR6C75": 1.7986381314566509, "NF2": 0.770364565738439, "PGM2L1": 3.577532569578242, "PAK4": 0.86960047534739, "PDYN": 0.902082665131722, "PRKAG1": 1.552943941216483, "TUBA1C": 0.793552910936129, "SH2B3": 0.76363597507174, "ASPN": 0.711503379147074, "RASGRF2": 1.6928692938282102, "OR10G2": 6.295084315036972, "HLA-G": 1.8531596316774739, "KCNC2": 0.958802828802517, "INHBB": 0.880238817373859, "NRIP1": 0.613916043700847, "ELK1": 1.580198577078256, "GH2": 0.908654074999091, "CYP2U1": 5.43947961147909, "WNT11": 0.910253300669432, "KCNG2": 3.26674340822732, "COL27A1": 3.768931856607246, "BAG4": 0.73185526393812, "EHMT1": 0.847109852161885, "OR4D1": 2.777019009631449, "SLC12A2": 0.748688338270258, "PIK3R2": 2.760211475385433, "MAP3K2": 1.310624083823095, "CX3CL1": 2.059684569739452, "RASAL2": 1.796765533373814, "SIPA1L1": 0.919654841600454, "TCF3": 0.781594643401051, "MED17": 0.716575975407245, "APBB1": 0.894181218033683, "DPP4": 0.764024222602222, "AKR1C3": 2.4942277817161207, "B4GALT2": 1.840213917117592, "UGT2B11": 1.7856449635561118, "CYP2A6": 6.711808241075583, "GGH": 0.919469026372525, "PHACTR2": 0.904049940794294, "COL22A1": 0.920539205282595, "PLOD2": 0.936792818034249, "OR52M1": 20.27120510040774, "TRAF3": 1.3319613661636671, "LONP1": 0.543504022333508, "PRKCG": 2.180479662105974, "SCO2": 0.676817656121257, "HSD17B1": 18.311100611260162, "ADCY3": 0.60694480648734, "RAB5A": 3.781521523900288, "EHHADH": 0.845650432398843, "DGKZ": 0.845979632931696, "DGKI": 4.627015783257922, "MYLK3": 1.558273502082831, "BEGAIN": 0.845787921508216, "C4A": 0.879146969669735, "MAP3K12": 0.668663184358815, "PDIA3": 1.52631200590895, "HPR": 1.742954144467372, "CYP1A2": 17.68367489950083, "GGT5": 2.243908328865106, "UGT1A5": 0.944285254095121, "CYP26A1": 0.922342449497293, "CNDP2": 0.895428256054728, "CEL": 0.783702373032831, "DGAT1": 0.851682082545794, "ALDH2": 0.781094089381102, "CYP46A1": 2.4432491901346776, "SLC3A2": 0.937954581589851, "REN": 0.94178751435799, "DCLRE1C": 1.673412392730498, "GEMIN5": 2.449885782589061, "TRIM62": 0.937194236584919, "PDCD1LG2": 0.679895084439221, "PIK3R5": 0.55664755785707, "LRPPRC": 0.814354016521542, "TLE4": 0.721280027239419, "MADD": 1.722747731292692, "TPO": 0.0991137709943335, "GSTA4": 4.9794658199527815, "PTGDS": 0.911624758598395, "GPX5": 0.892987603203642, "AHCYL1": 0.917767432920779, "COG5": 0.934900745825388, "FUT2": 0.771315727592198, "MUC5B": 8.693220902546091, "GALNTL6": 2.649102727897389, "ACTR8": 0.915788739521629, "GNG4": 5.3484321336929685, "VAMP3": 0.930024381639711, "ITGAD": 2.4581416584979987, "IKBKB": 0.91257881420192, "SERPINB3": 2.189861659197791, "BCL2L14": 0.875815169966797, "NR5A2": 3.685649219552059, "ATAD5": 3.54620538207138, "WDHD1": 7.871670757074092, "RPS6KB1": 0.872949373149333, "UGT2B15": 0.943886761549776, "ARNTL": 1.393700234363456, "OR52L1": 5.2507318323661085, "PLA2G4A": 0.695446880785926, "TRIM26": 0.615239106014158, "ETS1": 0.3828962937518742, "NCAM2": 0.820808566572181, "CGN": 0.653706386762686, "KCNH1": 1.875232609530411, "PAPSS1": 0.850482455497213, "ANPEP": 4.540408110856946, "GALNT3": 1.796928729806563, "MMRN1": 5.903054285542344, "PCDH7": 0.908415990503263, "DNAH3": 4.322409310386233, "RXRG": 6.198466665313679, "ADH5": 0.939905033126062, "NT5M": 0.879611529938387, "HIPK1": 0.87350487897314, "HIF1A": 6.5956059804972345, "ADAMTSL3": 2.70334234663069, "THBS4": 2.7020557010102157, "RAF1": 0.831021240493827, "HADHB": 0.925888412317101, "CYP4F3": 1.830234623034831, "OR1A2": 13.24516024046218, "ADRB2": 0.941749652120321, "CFHR3": 0.852122997587562, "SPRED1": 1.506718057090474, "TAS2R30": 1.4978696542625909, "NCAN": 0.853853340534671, "DGKH": 1.659331658308458, "PIK3CB": 1.138874565853557, "OR51B4": 0.907161062554377, "EXOC2": 0.773615973990214, "CP": 2.811590169892489, "LAP3": 2.167297203347109, "OR10AG1": 0.761271400587191, "COASY": 0.674279617540627, "KCND2": 2.353459515617803, "DOK6": 2.312414346716069, "CYP2C8": 7.126450171156498, "HEY1": 4.190202937024908, "MYB": 1.626328852862048, "SNIP1": 0.733257323094544, "ALDH3B2": 0.897778489110363, "HSD17B3": 1.6988730385274131, "AWAT2": 3.559438234127017, "FABP6": 1.779763938631368, "TLR4": 0.682372407740964, "MAP2K6": 0.455104606204463, "POLA2": 2.708620226427849, "FADS2": 0.879870144508175, "GGCT": 0.845966691854794, "FZD4": 0.8837345634924, "PAK3": 0.840249353126685, "SHC3": 0.851997712806905, "NMU": 2.601196438056682, "LPAR6": 0.939826971726444, "ZSCAN10": 0.887370503342182, "ACOT12": 1.581360264715378, "GPR132": 0.714288674187172, "SOS1": 1.722953463608084, "SMAD3": 3.60304653857449, "RNF165": 0.93645351691057, "RHEB": 0.79012792270677, "ARF5": 2.375327026326388, "TREM2": 0.838791902594136, "OR2G3": 0.928435606738522, "OR2J3": 0.918712815244082, "PDE4B": 0.814279931399799, "RGS4": 5.192811214881676, "RPS6KA4": 0.69264992874338, "CALCOCO1": 0.845188555081084, "GPX7": 0.908683762117049, "ADAMTS10": 2.727918350629814, "FGF12": 3.974920669152846, "MC3R": 0.724621320720722, "PRKX": 0.807853689047619, "SUCLA2": 0.90996980500607, "STK11": 2.462159062518906, "NR1H3": 1.459201327538702, "GGT7": 6.201267375190244, "KLRD1": 0.83697199083679, "PSMD2": 1.419622429345801, "FUT1": 0.893730675195688, "DNER": 1.848089280559843, "EDN1": 0.927328972863924, "ATP6V1B2": 0.848551538831031, "OR2AK2": 2.795764882471661, "PRKACB": 0.410676544715126, "CTPS2": 1.5093860017960559, "ABI2": 2.618805401672928, "EDNRA": 0.94389835521293, "ADAMTS17": 3.18411243229355, "MGP": 2.485993344168576, "GPC4": 0.361676487171761, "OR52K2": 0.854142842583616, "CCKAR": 12.99794267641553, "ITGA5": 1.8345624690447289, "OR1C1": 0.771638725525202, "MMP10": 2.235655459318436, "C1S": 2.2849671176279402, "ADAM2": 4.005382722042156, "ST8SIA2": 0.946394810819572, "GUCA1A": 0.904399787403382, "AKR1B10": 6.023607340354559, "CREB3L3": 0.920895781034395, "KCNMB2": 1.5682293844269601, "SMOX": 0.63216594277393, "B3GNTL1": 1.517590141003628, "KLF5": 2.694692246544002, "BCAN": 0.864737284690163, "PEG10": 1.427047444747486, "MLYCD": 0.735808770084622, "G6PD": 2.965115283599368, "PCOLCE2": 0.887928170552842, "TRAPPC6B": 0.93126183991662, "CYP26B1": 7.4229491707942, "OR2L5": 4.421026520393304, "APOOL": 0.88586722863165, "CYP3A5": 1.749380412803381, "ENO3": 0.910298832047069, "EPHX1": 6.607247841159378, "GOT2": 0.597422617621931, "PHF12": 0.752406026286477, "OR52B2": 2.6845889640548437, "EZR": 1.491225412898053, "EXOSC8": 0.542297523765647, "HSPA1L": 0.865193796067396, "SDSL": 1.4668052564639158, "CSF2": 0.657833583446219, "MASP2": 3.1533782927486422, "UTP3": 0.850512598635172, "CNGA3": 0.756986303844399, "OR51F2": 15.465372449906157, "TFDP2": 0.875967674903421, "CBS": 2.462156892107067, "AK3": 1.310054314890327, "PPP1R3F": 1.726728865579621, "SUCLG1": 0.942991104287935, "MMP15": 0.942053789556472, "SLC7A7": 0.92358456318906, "ADAMTS1": 1.76173155540583, "SORT1": 1.7438886780487328, "FGF17": 3.3928673798973166, "ADSL": 0.836963718585103, "MAX": 2.862647651854008, "F11": 0.861669786461015, "FMOD": 0.945008213604616, "CNTNAP2": 0.929005279657631, "IL20RA": 0.885216242594461, "B4GALT5": 2.646352437221955, "CYP26C1": 0.901146043790913, "ARSI": 0.866623331132653, "CACNB3": 0.916606823081286, "JAG2": 1.667299691214543, "SLC27A5": 1.725838035956757, "NSF": 0.847490083441804, "IFNA2": 0.869056131445945, "NFATC2": 1.6673230359241211, "ARSF": 1.738861150134702, "LIPE": 3.8519207880670674, "PSMD3": 0.915429167591316, "PTGES3": 0.863496097465381, "UBFD1": 0.241653754555855, "OR8B8": 3.553464542202033, "RASGRP1": 0.91626674632187, "OR6T1": 0.904977826607947, "PTPN5": 0.903351435743567, "OR5AN1": 1.7949473936121758, "OR4D6": 5.487170442089337, "GCLC": 4.154013174496051, "OR5P3": 1.569729915617216, "BGN": 1.794273519356464, "SLCO1B3": 0.836606909471845, "ADAMTS15": 1.772079561014366, "YWHAH": 0.833935142158367, "CTSZ": 0.777035391576606, "BICD2": 1.7213696926176292, "CYP2C18": 1.669646726832551, "FGF3": 0.728858897197747, "POLR2G": 0.825518855870728, "APCS": 3.0703981538405944, "RDH5": 2.733751959624907, "WNT3A": 1.65053522438681, "P4HA2": 0.944356557568311, "VBP1": 0.758170606796363, "BEX1": 0.75110458074229, "DBH": 0.836194843885804, "GSN": 0.859554760963583, "OR2W1": 2.50701750607544, "PPARG": 1.7416317739902798, "RPA3": 0.878127476181867, "CBL": 3.505766923281005, "FTL": 0.553809702942985, "CDC37L1": 2.646861006829382, "PSMA1": 0.908647835618289, "OR1M1": 17.947795786533455, "TFF3": 0.590615137440778, "BLNK": 0.943126074390948, "NR1H2": 0.883164229020497, "LHFPL2": 0.893047777130912, "MAT2A": 0.745633197838773, "CYP2S1": 0.856024192163825, "ECHDC1": 0.90655888178214, "PTGES": 0.934671916312307, "RGS8": 0.924773221463817, "KIF22": 0.914391566251743, "SLC17A7": 0.851586312162599}, "gene_adjustments": {"LAMA3": -1.0, "PBRM1": -0.5, "TP53": -32.5, "MMP9": -0.5, "TNN": -0.5, "ACACB": -0.5, "TGFBR2": 0.0, "APC": -20.5, "NMUR2": 0.0, "NRBP1": 0.0, "IRF5": -7.0, "PIK3CA": -11.5, "ATM": 0.0, "MTOR": -2.0, "TUBB1": 0.0, "GFPT2": 0.0, "FLT4": -1.5, "TTN": -1.5, "KRAS": -19.5, "NCAM1": -1.5, "SPTB": -0.5, "DOCK4": 0.0, "TBXA2R": -0.5, "SOX9": -4.0, "FBN2": -0.5, "TNXB": -1.5, "TNRC6A": -1.5, "COL5A3": -2.5, "DGKB": -1.5, "ITPR1": -1.5, "RXFP3": -0.5, "EXT1": 0.0, "SP100": -0.5, "F8": -0.5, "BAX": 0.0, "CTNNA1": 0.0, "TIAM1": 0.0, "OCA2": 0.0, "HGF": -0.5, "TLN1": 0.0, "PLCB3": 0.0, "MYC": -0.5, "EP300": -1.5, "SMARCE1": 0.0, "CHUK": 0.0, "OR5D18": -1.5, "OR5H15": -1.0, "OR10J5": 0.0, "SCN5A": -2.0, "CACNA2D3": -0.5, "PPP2R2B": 0.0, "RGS20": 0.0, "DLG2": -0.5, "NRXN2": -0.5, "CCDC129": 0.0, "MME": 0.0, "KCNQ2": -2.5, "PLCB1": 0.0, "EPHB1": 0.0, "GRIA4": -1.0, "CACNA1B": -1.5, "NGFR": 0.0, "A2M": -1.0, "COL11A1": -1.0, "TFAP2B": 0.0, "SERPINE1": 0.0, "VWF": -0.5, "AKT1": -1.0, "CTNNB1": -1.0, "STAT1": 0.0, "PRKCB": 0.0, "PIK3CD": 0.0, "MCHR2": 0.0, "MAPK10": -1.0, "MAP2K1": 0.0, "ACTN4": 0.0, "RRAS": 0.0, "CDH2": -0.5, "CLTC": 0.0, "SLC9A1": -0.5, "GRM7": 0.0, "GRM4": 0.0, "TEK": 0.0, "BRAF": -0.5, "RELN": -1.0, "AKAP9": -1.0, "ELMO1": -1.0, "ICAM1": 0.0, "OCRL": 0.0, "AR": -5.0, "SPTBN2": -1.0, "EPHA2": 0.0, "PLXNA4": -0.5, "NRG1": -0.5, "FLNB": 0.0, "DYNC2H1": 0.0, "NLK": -1.0, "TNRC6B": -1.0, "TSG101": 0.0, "CTNND1": -0.5, "NCOA2": -2.0, "GP9": 0.0, "RB1": 0.0, "SMAD4": -4.0, "RBP1": -1.0, "SCNN1G": 0.0, "CREBBP": -0.5, "NFATC1": -0.5, "PPP2CB": 0.0, "CAMK2G": -0.5, "PTK2": 0.0, "ESR1": 0.0, "NCOA1": 0.0, "IQGAP1": -0.5, "HLA-DRA": 0.0, "NCOR2": -0.5, "GFRA1": 0.0, "HLA-A": 0.0, "ACTA1": -0.5, "NOS1": -2.0, "TRIP6": -0.5, "CHRNA1": -0.5, "AGRN": 0.0, "MAD1L1": 0.0, "LAMA5": -2.5, "ITGA1": 0.0, "SPTBN5": -0.5, "AKAP13": 0.0, "NME1": 0.0, "ALB": 0.0, "ADCY10": 0.0, "RYR2": -1.5, "GATA3": -1.0, "GRM5": 0.0, "MYH11": 0.0, "FLNC": 0.0, "KDELR1": 0.0, "CACNA1A": -3.0, "CXCR3": 0.0, "CACNB1": 0.0, "ARHGEF1": -0.5, "EXOC1": 0.0, "ANK3": 0.0, "SLC6A3": -0.5, "FLNA": 0.0, "PLXNA2": 0.0, "COL2A1": -0.5, "OR1L3": -0.5, "OR2T27": -0.5, "OR8D1": 0.0, "ABCB1": -0.5, "CACNA1E": -1.5, "ATP2B3": -1.0, "ATP2B4": 0.0, "PYGB": -2.5, "KCNU1": 0.0, "KCNQ1": 0.0, "IFT140": 0.0, "NPHS1": -0.5, "KCNB1": -1.0, "SERPING1": 0.0, "CTNNA2": 0.0, "ITGB2": 0.0, "PIP5K1C": 0.0, "MKL1": 0.0, "ERBB4": 0.0, "PDE1B": -0.5, "TSHR": 0.0, "FZD6": -1.0, "NRXN3": 0.0, "RYR3": 0.0, "KIF4B": 0.0, "POU4F2": 0.0, "ARFGEF1": 0.0, "RASAL3": 0.0, "COL4A2": -0.5, "COL4A3": 0.0, "PLXNB3": -1.5, "COL7A1": 0.0, "NALCN": -0.5, "CNTN2": 0.0, "NOTCH3": -1.0, "COL6A3": -2.0, "HCN4": -1.5, "SNAI1": 0.0, "THBS2": 0.0, "APOB": -2.0, "PPARGC1A": 0.0, "EPN1": 0.0, "LRP2": -2.5, "LRRFIP1": 0.0, "CUX1": 0.0, "AMPD3": 0.0, "SYNE1": -1.5, "ERCC6": 0.0, "NPR2": 0.0, "TICAM1": 0.0, "ARID1A": 0.0, "RIF1": 0.0, "CRTC1": -2.0, "SETD2": -1.0, "MPO": 0.0, "PLA2G2E": -0.5, "AXIN2": 0.0, "PLB1": -2.0, "TBK1": 0.0, "UBE4B": 0.0, "FURIN": -0.5, "PTPRK": 0.0, "USP9X": -1.5, "DDX54": 0.0, "PFKP": 0.0, "KLKB1": -1.0, "SAFB": 0.0, "EVC2": -0.5, "LRFN3": 0.0, "NOTUM": 0.0, "DERA": 0.0, "FASN": 0.0, "CPS1": 0.0, "SERPINB1": 0.0, "CYP17A1": 0.0, "DPYD": 0.0, "RDH12": 0.0, "CYP7B1": -0.5, "PAX5": 0.0, "ADCY7": -0.5, "DSCAM": -0.5, "FGFR2": 0.0, "HTR2C": 0.0, "BRPF3": 0.0, "NRCAM": 0.0, "SEMA3A": 0.0, "GRP": -0.5, "TGFB1": -0.5, "DTX1": 0.0, "OBSL1": -1.0, "KCNJ16": -0.5, "PDK2": 0.0, "NEFH": -3.0, "GRIN3B": -1.0, "TFEC": 0.0, "TCF7L2": -2.0, "TBP": -2.0, "SCN3B": 0.0, "COL3A1": -0.5, "HOXD4": 0.0, "LRRK2": 0.0, "SELP": 0.0, "OR51S1": 0.0, "SCN2A": -3.5, "KCNQ5": -1.0, "TSC2": 0.0, "PLCG2": 0.0, "PAX6": -1.0, "OR2C1": 0.0, "PRKACG": -0.5, "ARHGAP35": 0.0, "TAS2R16": 0.0, "OR10A2": 0.0, "OR2A5": -0.5, "GP6": -2.0, "PDE6A": 0.0, "GMIP": 0.0, "COL4A4": -1.0, "NCAPD2": 0.0, "PKD1L1": 0.0, "TNFRSF10A": 0.0, "MUC16": -4.0, "PYGL": -0.5, "FBN3": 0.0, "NID1": -0.5, "HSP90B1": -0.5, "TYK2": 0.0, "MAMLD1": 0.0, "EPN3": 0.0, "B3GAT2": 0.0, "WWC2": 0.0, "ADAMTS9": 0.0, "MMP19": 0.0, "GMPR": 0.0, "GSTM4": 0.0, "GRIA2": -0.5, "OR8J3": 0.0, "RASA2": 0.0, "UBA6": 0.0, "COL9A3": -0.5, "GOLGB1": -1.5, "CASQ2": 0.0, "COL6A5": -0.5, "GRIN3A": 0.0, "KCNN3": -0.5, "OR2L3": 0.0, "MAPK12": 0.0, "CHRM2": 0.0, "NOS3": 0.0, "COL5A1": -1.0, "ANKRD1": 0.0, "TGM2": 0.0, "COL12A1": 0.0, "MMP16": 0.0, "DNAH8": 0.0, "CD109": 0.0, "AMPD1": 0.0, "ANK2": -1.0, "GAD2": -0.5, "GNAS": -5.0, "ADAMTS20": 0.0, "DICER1": 0.0, "UNC13B": 0.0, "CYP2E1": 0.0, "ENPEP": 0.0, "HTT": -2.5, "MAPRE3": 0.0, "AGTR1": -1.0, "SYCP2": 0.0, "PTPRG": 0.0, "ITK": 0.0, "FNTA": 0.0, "FYN": -0.5, "PRKCI": 0.0, "GUCY1A2": 0.0, "PCCA": 0.0, "UGT2B4": 0.0, "SLC25A3": 0.0, "KIF5A": 0.0, "COL24A1": -0.5, "PLG": 0.0, "CDK5R1": 0.0, "ADCY8": -0.5, "OPRM1": 0.0, "JAK3": -0.5, "MYH6": 0.0, "GABRA5": 0.0, "SUPT16H": 0.0, "ACAN": -2.0, "IRS2": 0.0, "TAS2R46": -0.5, "DAPK1": 0.0, "MED15": -0.5, "KCNAB2": 0.0, "WNK1": -0.5, "AMPH": 0.0, "OR56B4": 0.0, "SYT5": -0.5, "DIRAS1": 0.0, "SCN8A": -0.5, "ESR2": 0.0, "PPP2R5A": 0.0, "PIK3CG": -0.5, "B2M": -0.5, "ADCY6": -0.5, "ADCY5": 0.0, "MAP3K11": 0.0, "OR51A2": -0.5, "GRIA1": 0.0, "OR2M4": -0.5, "CACNA1D": 0.0, "CACNA1C": 0.0, "CACNA1S": -0.5, "VCAN": -0.5, "KCNJ4": -1.0, "NR2C2": 0.0, "DRD5": 0.0, "ITGAL": -0.5, "ITGA10": -0.5, "CTSC": 0.0, "RGS12": -1.5, "PREX2": 0.0, "KCNQ3": -1.5, "KCNJ11": 0.0, "C6": 0.0, "RYR1": -0.5, "NFASC": -2.5, "GALE": 0.0, "SCRIB": -0.5, "COL4A5": 0.0, "PKD1": -0.5, "STAB2": 0.0, "DNMBP": 0.0, "PPP2R2C": 0.0, "NCOA3": 0.0, "NFATC3": 0.0, "UBQLN2": 0.0, "CPSF6": 0.0, "RARB": 0.0, "APBA1": 0.0, "PPFIA3": 0.0, "PTGS1": -1.0, "APBA2": -2.5, "ENTPD2": 0.0, "C9orf3": 0.0, "AMPD2": 0.0, "WLS": 0.0, "HIF3A": 0.0, "MED13": -0.5, "PER2": 0.0, "DLAT": 0.0, "NR5A1": -0.5, "DBT": -0.5, "ACAT1": 0.0, "ELANE": 0.0, "TBL1XR1": -0.5, "PDGFRB": 0.0, "IFNG": 0.0, "GPC5": 0.0, "GABBR1": 0.0, "RBMS1": 0.0, "REG3A": 0.0, "ARHGEF11": 0.0, "LEO1": 0.0, "MYO9B": 0.0, "PDLIM5": 0.0, "IFIH1": 0.0, "HSD3B1": 0.0, "ALDH1A3": -1.5, "F2R": -0.5, "SMAD2": -0.5, "SHC1": 0.0, "PTEN": -0.5, "EPHA6": -0.5, "DLG1": -0.5, "COL18A1": -4.5, "CACNA1G": -0.5, "ITPR3": 0.0, "COG4": 0.0, "ABCA1": -1.5, "ITGA8": -0.5, "PLCZ1": 0.0, "KIF26A": -0.5, "DOCK3": 0.0, "OR10R2": 0.0, "OR4K2": 0.0, "ZBTB17": -0.5, "COL6A2": -1.0, "KCNS3": -0.5, "GRIK3": 0.0, "TUBAL3": 0.0, "AP1G2": 0.0, "WRN": 0.0, "NCOA6": -1.5, "ALOX12B": 0.0, "BPTF": 0.0, "EFCAB6": 0.0, "NOG": 0.0, "MYO3A": -0.5, "GPC3": 0.0, "PRCP": 0.0, "USP34": -1.0, "PDHA2": -0.5, "LRP1": -2.5, "COL20A1": -0.5, "ADAMTS14": -0.5, "TLL2": -1.0, "ADAM9": 0.0, "STAT5A": 0.0, "P4HB": 0.0, "KIT": -0.5, "FGA": 0.0, "LAMB3": 0.0, "LAMC2": 0.0, "ANGPT1": 0.0, "COL4A1": 0.0, "IL2RG": 0.0, "VAV2": 0.0, "DVL3": 0.0, "VTN": 0.0, "MOV10": 0.0, "ALOX15B": -0.5, "GAK": 0.0, "BMP1": -1.0, "GRIP1": 0.0, "KIF2B": -0.5, "PTCH1": 0.0, "CHST6": 0.0, "UGT1A6": -0.5, "POFUT2": -0.5, "ADAMTS13": 0.0, "RAB8A": 0.0, "GNS": 0.0, "IGFALS": -1.0, "CDON": 0.0, "CACNA1F": 0.0, "GATA4": 0.0, "PKN1": 0.0, "INPPL1": -0.5, "OPRD1": -0.5, "SEMA4D": 0.0, "CASP9": -1.5, "MYO5C": 0.0, "LRP5": 0.0, "FZD2": 0.0, "COL25A1": 0.0, "PROS1": -0.5, "PDGFA": 0.0, "ADCY1": 0.0, "ADAMTSL1": 0.0, "UGT3A1": 0.0, "GABBR2": -0.5, "MUC17": -1.0, "CSNK2A1": 0.0, "ADAMTS3": 0.0, "MMP11": 0.0, "SCN10A": -1.0, "AGT": -0.5, "HDAC5": -0.5, "NRAS": -2.5, "MMP2": -1.0, "INSR": 0.0, "HSPG2": -2.5, "FN1": 0.0, "CFTR": 0.0, "PPARA": 0.0, "ATP1B4": -0.5, "FOXO1": 0.0, "LCP2": 0.0, "PRKG2": 0.0, "TNC": 0.0, "FOXO4": -0.5, "NTSR2": -1.5, "KIF3C": -0.5, "BDNF": 0.0, "SMPD1": 0.0, "OR2T33": -0.5, "OR52K1": 0.0, "OR6C4": 0.0, "OR10K1": -0.5, "OR5M9": 0.0, "RXFP2": 0.0, "PDE4D": 0.0, "SHB": 0.0, "EPHA7": 0.0, "ASAP2": 0.0, "SPP1": 0.0, "TAS1R2": -2.0, "MUC20": 0.0, "ZFYVE28": -0.5, "DOCK2": 0.0, "GRIK2": -0.5, "SPAG9": 0.0, "HIPK2": -0.5, "NLGN4X": 0.0, "GABRA1": 0.0, "MYO6": -0.5, "ARHGEF10L": 0.0, "MAGI2": 0.0, "GALNT1": 0.0, "KAT2A": -0.5, "SLC2A8": 0.0, "RXRA": 0.0, "POLR3A": 0.0, "MTMR1": 0.0, "LNPEP": 0.0, "CASK": 0.0, "SMARCA2": -0.5, "PLA2G6": -1.0, "PLA2G2C": -0.5, "PTGS2": 0.0, "PTPRF": -1.0, "MYT1": 0.0, "BACE1": 0.0, "RLBP1": 0.0, "ERBB2": -0.5, "TRAF2": 0.0, "MAML3": -1.5, "GRIN2C": 0.0, "ATP1B3": 0.0, "ROR1": 0.0, "SALL4": -1.0, "ENPP6": 0.0, "HNF4A": 0.0, "CYP2D6": 0.0, "DGAT2": 0.0, "CISH": 0.0, "TCEA3": 0.0, "MUC4": 0.0, "CACNA1H": -2.5, "PLA2G4D": -2.0, "NPW": 0.0, "SPHK1": -0.5, "INSL3": 0.0, "TRPC6": -0.5, "NEFM": 0.0, "TGIF1": 0.0, "CCR5": 0.0, "ITPR2": -0.5, "EDNRB": -0.5, "NOS2": -0.5, "AP2A2": 0.0, "MEF2A": -1.0, "GSK3B": 0.0, "CIITA": 0.0, "SIN3A": -0.5, "KCNJ2": -1.0, "OR2T6": 0.0, "MTNR1B": 0.0, "SCN1B": 0.0, "COPB1": 0.0, "FZD7": 0.0, "CACNA2D4": 0.0, "EPS15": 0.0, "RASGRP2": 0.0, "NUP107": 0.0, "GRIN2A": -0.5, "A1BG": 0.0, "DOCK8": -0.5, "GLI3": 0.0, "PCSK1": 0.0, "ITSN2": 0.0, "RGSL1": 0.0, "TRPV1": 0.0, "NLGN4Y": 0.0, "C8B": 0.0, "GABRA6": 0.0, "RGS10": 0.0, "CTGF": 0.0, "CHD9": 0.0, "TBC1D4": 0.0, "TUBA8": 0.0, "TFAP2C": -1.0, "EPN2": 0.0, "SOD3": 0.0, "MED24": 0.0, "CYP3A7": 0.0, "SDC4": 0.0, "SYT1": 0.0, "PPP2R3A": 0.0, "TLE1": 0.0, "GUCY2D": 0.0, "NSMAF": -0.5, "E2F7": 0.0, "GSTP1": -1.0, "ADO": 0.0, "CSF2RB": 0.0, "CSNK1A1L": 0.0, "GP1BA": 0.0, "IL18": 0.0, "ACTR1B": 0.0, "DOCK10": 0.0, "SRY": -0.5, "KRT1": -0.5, "TERT": 0.0, "GYS1": 0.0, "ITGA3": 0.0, "OR5W2": 0.0, "SOX2": -0.5, "PHC2": 0.0, "EPHB4": 0.0, "PRKD1": 0.0, "NECAP2": 0.0, "RASA1": 0.0, "EPS15L1": 0.0, "CES1": -1.0, "TEX15": 0.0, "APAF1": -0.5, "PPP2R3B": 0.0, "CYP4A11": 0.0, "NUPL2": 0.0, "ITGB4": -0.5, "ERBB3": 0.0, "ITGA7": 0.0, "ARID1B": 0.0, "SNX1": 0.0, "OAT": 0.0, "CDX2": -0.5, "ZFPM1": 0.0, "JMJD7-PLA2G4B": 0.0, "STAT3": -0.5, "NGF": 0.0, "COL4A6": 0.0, "GPC1": 0.0, "PLA2G3": -0.5, "MED14": 0.0, "ALDH9A1": 0.0, "PTPN3": -1.5, "POLR1A": 0.0, "BMPR1B": 0.0, "SULT2B1": 0.0, "GATAD2A": 0.0, "HSD3B7": -0.5, "CYP11A1": 0.0, "OLA1": 0.0, "DNAJC6": 0.0, "APOA4": 0.0, "HLA-DOA": -0.5, "RGS14": -0.5, "C8G": 0.0, "C9": 0.0, "LRP6": 0.0, "PIK3AP1": 0.0, "SCN1A": -1.5, "PTGES2": 0.0, "CCT6B": 0.0, "SDC3": 0.0, "HRH4": 0.0, "ABLIM3": 0.0, "DOK2": 0.0, "RIPK1": 0.0, "AMFR": 0.0, "GRIK5": 0.0, "MYBPC2": -0.5, "SCAI": 0.0, "LGI1": 0.0, "GNB3": 0.0, "SPTBN4": -1.0, "PF4": 0.0, "SH3GL1": 0.0, "MAPK8": 0.0, "CCR10": 0.0, "HTR1E": 0.0, "TACR2": -0.5, "ITGA4": -1.0, "ITGA6": -0.5, "ISLR": 0.0, "OR13A1": 0.0, "OR5AC2": 0.0, "OR6B2": 0.0, "PICK1": 0.0, "TRPC5": 0.0, "WNT1": 0.0, "ETV5": 0.0, "KAT6A": 0.0, "PRKD3": 0.0, "SCN4A": -1.0, "COL9A1": 0.0, "FZD10": 0.0, "SEC16A": 0.0, "PPFIA1": 0.0, "SLC32A1": -1.0, "SCNN1A": 0.0, "ENTPD4": 0.0, "ACOX1": -0.5, "CPT1A": 0.0, "NCL": -1.0, "LRIG1": -0.5, "DDX17": 0.0, "GPR156": 0.0, "CSPG4": 0.0, "SHC4": 0.0, "OR5K1": -0.5, "SYT9": 0.0, "CYP2A13": -0.5, "KL": -1.5, "ALDH1A1": 0.0, "KRT5": 0.0, "GLUD2": 0.0, "CYP11B1": -0.5, "CYP4A22": 0.0, "IGF1": 0.0, "APP": 0.0, "INSRR": -0.5, "PIK3C2G": 0.0, "CHL1": -0.5, "TRIM45": 0.0, "SLC8A1": 0.0, "OR4A15": -0.5, "OR2M2": 0.0, "OR2H2": 0.0, "OR52I2": -0.5, "OR14I1": 0.0, "TRAPPC5": -0.5, "CNTNAP1": 0.0, "AGFG1": 0.0, "SETDB1": 0.0, "USP12": 0.0, "IL22RA1": 0.0, "LRP12": -0.5, "CUBN": 0.0, "FGF8": 0.0, "RECK": -0.5, "DSEL": -0.5, "ADAMTSL4": -0.5, "NMT1": 0.0, "GPC6": -0.5, "TBXAS1": 0.0, "NDUFS2": 0.0, "MC4R": 0.0, "OR11A1": -0.5, "OR8K5": 0.0, "OR5M8": 0.0, "PAK1": 0.0, "ENPP3": -0.5, "GRB2": 0.0, "EGFR": 0.0, "PPP1CA": 0.0, "GPC2": 0.0, "DYNC1I1": 0.0, "TCF4": 0.0, "B4GALT1": 0.0, "ATP1A2": -0.5, "POLR3B": 0.0, "MMP3": 0.0, "MAGED2": 0.0, "PTPN11": -0.5, "ITGB1": 0.0, "SPTBN1": -0.5, "ARPC1A": 0.0, "RASGRF1": -0.5, "LAMB4": 0.0, "NOTCH1": -0.5, "CDK4": 0.0, "PRKCQ": 0.0, "WNT5A": -0.5, "NTRK1": 0.0, "IL5RA": 0.0, "GATA2": 0.0, "KIF4A": 0.0, "ADAM12": 0.0, "THBS1": 0.0, "IRAK2": 0.0, "SERPINA1": 0.0, "S1PR2": 0.0, "HEXB": 0.0, "ETV1": 0.0, "OR1J1": 0.0, "OR51Q1": 0.0, "OR1L4": 0.0, "OR5K3": 0.0, "OR13F1": 0.0, "OR11H4": 0.0, "OR1N2": 0.0, "OR2T8": 0.0, "CACNB2": 0.0, "ATP2B2": -0.5, "CATSPERD": 0.0, "KCNJ12": -1.5, "KCNQ4": 0.0, "PASK": 0.0, "FOXA1": 0.0, "KDM6A": -0.5, "CYP2B6": 0.0, "CYP7A1": -2.0, "GSTM3": -1.0, "ALDH1B1": 0.0, "IDO2": -0.5, "ALPL": -0.5, "ENPP1": -1.0, "IBSP": -0.5, "PSMB1": 0.0, "TNIK": -0.5, "THADA": 0.0, "MMP14": 0.0, "SOAT2": 0.0, "ACYP2": 0.0, "GMPS": 0.0, "CALHM1": 0.0, "IL2RB": 0.0, "CHEK2": 0.0, "NOX1": 0.0, "ABLIM2": 0.0, "TAAR6": 0.0, "OR4A5": 0.0, "OR6C68": 0.0, "OR10C1": -0.5, "OR8H2": -0.5, "OR4N4": 0.0, "OR10H5": 0.0, "OR2T35": 0.0, "TAS1R1": -0.5, "TAS1R3": -1.5, "ADAM28": 0.0, "GPLD1": 0.0, "YEATS2": 0.0, "IBTK": 0.0, "APEX1": 0.0, "INHBC": 0.0, "ABCC3": 0.0, "NPAS3": 0.0, "COL15A1": -0.5, "SLC16A8": 0.0, "ADAMTS2": 0.0, "ST3GAL3": 0.0, "SEMA5B": 0.0, "ADAMTS16": -1.0, "ADAMTS5": 0.0, "SETMAR": 0.0, "GPR50": 0.0, "WNT5B": 0.0, "DTNA": 0.0, "ALOX5": -0.5, "WDR5": 0.0, "XCR1": 0.0, "VCL": 0.0, "NAPA": 0.0, "TFDP1": 0.0, "MITF": -0.5, "OS9": 0.0, "SLC2A4": 0.0, "DGKQ": 0.0, "BNIP2": 0.0, "PPIB": 0.0, "PAX8": 0.0, "OR6C75": 0.0, "NF2": 0.0, "PGM2L1": -0.5, "PAK4": 0.0, "PDYN": 0.0, "PRKAG1": -0.5, "TUBA1C": 0.0, "SH2B3": 0.0, "ASPN": 0.0, "RASGRF2": 0.0, "OR10G2": 0.0, "HLA-G": 0.0, "KCNC2": 0.0, "INHBB": 0.0, "NRIP1": 0.0, "ELK1": 0.0, "GH2": 0.0, "CYP2U1": -0.5, "WNT11": 0.0, "KCNG2": -0.5, "COL27A1": -1.0, "BAG4": 0.0, "EHMT1": 0.0, "OR4D1": 0.0, "SLC12A2": 0.0, "PIK3R2": 0.0, "MAP3K2": 0.0, "CX3CL1": -0.5, "RASAL2": 0.0, "SIPA1L1": 0.0, "TCF3": 0.0, "MED17": 0.0, "APBB1": 0.0, "DPP4": 0.0, "AKR1C3": 0.0, "B4GALT2": 0.0, "UGT2B11": 0.0, "CYP2A6": -0.5, "GGH": 0.0, "PHACTR2": 0.0, "COL22A1": 0.0, "PLOD2": 0.0, "OR52M1": 0.0, "TRAF3": 0.0, "LONP1": 0.0, "PRKCG": -0.5, "SCO2": 0.0, "HSD17B1": -3.0, "ADCY3": 0.0, "RAB5A": -0.5, "EHHADH": 0.0, "DGKZ": 0.0, "DGKI": -0.5, "MYLK3": 0.0, "BEGAIN": 0.0, "C4A": 0.0, "MAP3K12": 0.0, "PDIA3": 0.0, "HPR": 0.0, "CYP1A2": -1.5, "GGT5": -0.5, "UGT1A5": 0.0, "CYP26A1": 0.0, "CNDP2": 0.0, "CEL": 0.0, "DGAT1": 0.0, "ALDH2": 0.0, "CYP46A1": 0.0, "SLC3A2": 0.0, "REN": 0.0, "DCLRE1C": 0.0, "GEMIN5": 0.0, "TRIM62": 0.0, "PDCD1LG2": 0.0, "PIK3R5": 0.0, "LRPPRC": 0.0, "TLE4": 0.0, "MADD": 0.0, "TPO": 0.0, "GSTA4": 0.0, "PTGDS": 0.0, "GPX5": 0.0, "AHCYL1": 0.0, "COG5": 0.0, "FUT2": 0.0, "MUC5B": -1.0, "GALNTL6": 0.0, "ACTR8": 0.0, "GNG4": 0.0, "VAMP3": 0.0, "ITGAD": 0.0, "IKBKB": 0.0, "SERPINB3": -0.5, "BCL2L14": 0.0, "NR5A2": 0.0, "ATAD5": 0.0, "WDHD1": 0.0, "RPS6KB1": 0.0, "UGT2B15": 0.0, "ARNTL": 0.0, "OR52L1": 0.0, "PLA2G4A": 0.0, "TRIM26": 0.0, "ETS1": 0.0, "NCAM2": 0.0, "CGN": 0.0, "KCNH1": 0.0, "PAPSS1": 0.0, "ANPEP": -0.5, "GALNT3": 0.0, "MMRN1": 0.0, "PCDH7": 0.0, "DNAH3": 0.0, "RXRG": -0.5, "ADH5": 0.0, "NT5M": 0.0, "HIPK1": 0.0, "HIF1A": -2.0, "ADAMTSL3": 0.0, "THBS4": -0.5, "RAF1": 0.0, "HADHB": 0.0, "CYP4F3": 0.0, "OR1A2": 0.0, "ADRB2": 0.0, "CFHR3": 0.0, "SPRED1": 0.0, "TAS2R30": 0.0, "NCAN": 0.0, "DGKH": 0.0, "PIK3CB": 0.0, "OR51B4": 0.0, "EXOC2": 0.0, "CP": -0.5, "LAP3": 0.0, "OR10AG1": 0.0, "COASY": 0.0, "KCND2": -0.5, "DOK6": -0.5, "CYP2C8": 0.0, "HEY1": 0.0, "MYB": 0.0, "SNIP1": 0.0, "ALDH3B2": 0.0, "HSD17B3": 0.0, "AWAT2": -0.5, "FABP6": 0.0, "TLR4": 0.0, "MAP2K6": 0.0, "POLA2": 0.0, "FADS2": 0.0, "GGCT": 0.0, "FZD4": 0.0, "PAK3": 0.0, "SHC3": 0.0, "NMU": 0.0, "LPAR6": 0.0, "ZSCAN10": 0.0, "ACOT12": 0.0, "GPR132": 0.0, "SOS1": -0.5, "SMAD3": -0.5, "RNF165": 0.0, "RHEB": 0.0, "ARF5": -0.5, "TREM2": 0.0, "OR2G3": 0.0, "OR2J3": 0.0, "PDE4B": 0.0, "RGS4": 0.0, "RPS6KA4": 0.0, "CALCOCO1": 0.0, "GPX7": 0.0, "ADAMTS10": 0.0, "FGF12": -0.5, "MC3R": 0.0, "PRKX": 0.0, "SUCLA2": 0.0, "STK11": 0.0, "NR1H3": 0.0, "GGT7": 0.0, "KLRD1": 0.0, "PSMD2": 0.0, "FUT1": 0.0, "DNER": 0.0, "EDN1": 0.0, "ATP6V1B2": 0.0, "OR2AK2": 0.0, "PRKACB": 0.0, "CTPS2": 0.0, "ABI2": 0.0, "EDNRA": 0.0, "ADAMTS17": -0.5, "MGP": 0.0, "GPC4": 0.0, "OR52K2": 0.0, "CCKAR": 0.0, "ITGA5": 0.0, "OR1C1": 0.0, "MMP10": -0.5, "C1S": 0.0, "ADAM2": 0.0, "ST8SIA2": 0.0, "GUCA1A": 0.0, "AKR1B10": -0.5, "CREB3L3": 0.0, "KCNMB2": 0.0, "SMOX": 0.0, "B3GNTL1": 0.0, "KLF5": 0.0, "BCAN": 0.0, "PEG10": 0.0, "MLYCD": 0.0, "G6PD": -0.5, "PCOLCE2": 0.0, "TRAPPC6B": 0.0, "CYP26B1": -1.0, "OR2L5": 0.0, "APOOL": 0.0, "CYP3A5": 0.0, "ENO3": 0.0, "EPHX1": -0.5, "GOT2": 0.0, "PHF12": 0.0, "OR52B2": 0.0, "EZR": 0.0, "EXOSC8": 0.0, "HSPA1L": 0.0, "SDSL": 0.0, "CSF2": 0.0, "MASP2": 0.0, "UTP3": 0.0, "CNGA3": 0.0, "OR51F2": 0.0, "TFDP2": 0.0, "CBS": 0.0, "AK3": 0.0, "PPP1R3F": 0.0, "SUCLG1": 0.0, "MMP15": 0.0, "SLC7A7": 0.0, "ADAMTS1": 0.0, "SORT1": 0.0, "FGF17": 0.0, "ADSL": 0.0, "MAX": -0.5, "F11": 0.0, "FMOD": 0.0, "CNTNAP2": 0.0, "IL20RA": 0.0, "B4GALT5": 0.0, "CYP26C1": 0.0, "ARSI": 0.0, "CACNB3": 0.0, "JAG2": -0.5, "SLC27A5": 0.0, "NSF": 0.0, "IFNA2": 0.0, "NFATC2": 0.0, "ARSF": 0.0, "LIPE": -0.5, "PSMD3": 0.0, "PTGES3": 0.0, "UBFD1": 0.0, "OR8B8": 0.0, "RASGRP1": 0.0, "OR6T1": 0.0, "PTPN5": 0.0, "OR5AN1": 0.0, "OR4D6": 0.0, "GCLC": 0.0, "OR5P3": 0.0, "BGN": 0.0, "SLCO1B3": 0.0, "ADAMTS15": 0.0, "YWHAH": 0.0, "CTSZ": 0.0, "BICD2": 0.0, "CYP2C18": 0.0, "FGF3": 0.0, "POLR2G": 0.0, "APCS": 0.0, "RDH5": 0.0, "WNT3A": 0.0, "P4HA2": 0.0, "VBP1": 0.0, "BEX1": 0.0, "DBH": 0.0, "GSN": 0.0, "OR2W1": 0.0, "PPARG": 0.0, "RPA3": 0.0, "CBL": -0.5, "FTL": 0.0, "CDC37L1": 0.0, "PSMA1": 0.0, "OR1M1": 0.0, "TFF3": 0.0, "BLNK": 0.0, "NR1H2": 0.0, "LHFPL2": 0.0, "MAT2A": 0.0, "CYP2S1": 0.0, "ECHDC1": 0.0, "PTGES": 0.0, "RGS8": 0.0, "KIF22": 0.0, "SLC17A7": 0.0}, "total_sum_of_original_weights": 181261.62420003046}